-- MySQL dump 10.13  Distrib 9.0.1, for macos14.7 (arm64)
--
-- Host: localhost    Database: IMPCDb
-- ------------------------------------------------------
-- Server version	9.0.1

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `Analyses`
--

DROP TABLE IF EXISTS `Analyses`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `Analyses` (
  `analysis_id` varchar(15) NOT NULL,
  `gene_id` varchar(11) DEFAULT NULL,
  `mouse_life_stage` varchar(17) DEFAULT NULL,
  `mouse_strain` varchar(5) DEFAULT NULL,
  `parameter_id` varchar(18) DEFAULT NULL,
  `p_value` float DEFAULT NULL,
  PRIMARY KEY (`analysis_id`),
  KEY `gene_id` (`gene_id`),
  KEY `parameter_id` (`parameter_id`),
  CONSTRAINT `analyses_ibfk_1` FOREIGN KEY (`gene_id`) REFERENCES `Genes` (`gene_id`),
  CONSTRAINT `analyses_ibfk_2` FOREIGN KEY (`parameter_id`) REFERENCES `Parameters` (`parameter_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Stores analysis results linking Genes and Parameters (many-to-one), including p-values and strain info.';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `Analyses`
--

LOCK TABLES `Analyses` WRITE;
/*!40000 ALTER TABLE `Analyses` DISABLE KEYS */;
INSERT INTO `Analyses` VALUES ('0006ejmqkf6t05x','MGI:1921263','C57BL','Early','IMPC_CSD_024_001',0.754611),('00152gb042cv4om','MGI:2444631','C57BL','Early','IMPC_XRY_016_001',0.268638),('001do1s5l848u8a','MGI:1916413','C57BL','E9.5','IMPC_CBC_014_001',0.863747),('001rv0ok4b8uy6x','MGI:1920199','C57BL','E12.5','IMPC_CSD_013_001',0.977817),('0034yrl724hagpm','MGI:2140050','C57BL','E9.5','IMPC_GEO_019_001',0.599308),('003f878t6bp36em','MGI:1913420','C57BL','Early','IMPC_ACS_037_001',0.683773),('003r8i8i5c800rm','MGI:1924467','C57BL','Early','IMPC_IPG_010_001',0.000012715),('003y65o66ffzp7a','MGI:1924232','C57BL','Early','IMPC_HEM_019_001',0.47493),('004gd232v456sla','MGI:98386','C57BL','Early','IMPC_EYE_012_001',0.921714),('005k1zy63sv824a','MGI:1915862','C57BL','E18.5','IMPC_OFD_021_001',0.614892),('00601o4547t4h3x','MGI:1922776','C57BL','Middl','IMPC_CBC_016_001',0.605691),('006197j1j21991m','MGI:2684896','C57BL','Early','IMPC_EYE_027_001',0.297682),('006n7w96bpx62nx','MGI:1918398','129SV','Early','IMPC_CSD_025_001',0.275171),('00776w389yp711x','MGI:98960','C57BL','E15.5','IMPC_CSD_023_001',0.0954783),('0091w838456o5cx','MGI:2387617','C57BL','Early','IMPC_HEM_030_001',0.381643),('009w41n9c42iuda','MGI:1913721','C57BL','Early','IMPC_OFD_050_001',0.49449),('00gc404c8wspagm','MGI:1917770','C57BL','Early','IMPC_EYE_026_001',0.12411),('00swp4930bq3hta','MGI:1914199','C57BL','Early','IMPC_CSD_041_002',0.321265),('00ua48g0re4k03a','MGI:1927580','C59BL','Early','IMPC_CBC_003_001',0.970099),('00w34i52gq6t9sa','MGI:1915282','C57BL','Early','IMPC_HEM_006_001',0.939475),('00wn0ae6km4l59a','MGI:1924955','C57BL','Early','IMPC_EYE_017_001',0.5112),('00z341lw4tmt6na','MGI:97383','C57BL','Early','IMPC_GRS_010_001',0.294394),('00z890hx393ilox','MGI:1927753','C57BL','E15.5','IMPC_CSD_078_001',0.239086),('0101197v0wg94cm','MGI:1919880','C57BL','Early','IMPC_CSD_038_001',0.886675),('0104o7s3a87j8xm','MGI:1916428','C57BL','Early','IMPC_XRY_022_001',0.823006),('01154eyw6fr4ksa','MGI:1349164','C57BL','Early','IMPC_ABR_010_001',0.448839),('0119w207801674a','MGI:2442704','C57BL','Early','IMPC_HEM_019_001',0.239418),('0148j10rn67205m','MGI:2444631','C57BL','E12.5','IMPC_GEL_058_001',0.994442),('015r27o89nu19om','MGI:104899','C57BL','Early','IMPC_GEP_011_002',0.73645),('017con0zw292b4x','MGI:1914199','C57BL','Early','IMPC_HEM_001_001',0.36698),('01b921qek008jta','MGI:1917770','C57BL','Early','IMPC_GEM_069_001',0.236966),('01f54429u7lju0m','MGI:104294','C57BL','Early','IMPC_OFD_050_001',0.0829832),('01fj2o71qs42e5m','MGI:1350930','C57BL','Early','IMPC_CSD_030_001',0.614562),('01ge61dn8hi19ga','MGI:2444631','C57BL','Early','IMPC_OFD_018_001',0.100947),('01i07bze1ka0h7m','MGI:1914210','C57BL','Early','IMPC_GEO_043_002',0.841737),('01ie1b51678c33m','MGI:1096385','C57BL','Middl','IMPC_XRY_027_001',0.797713),('01m3xi97s2n51dm','MGI:1337072','C57BL','Late ','IMPC_EYE_017_001',0.175029),('01mu1hc5jp1385a','MGI:2140050','C57BL','E9.5','IMPC_IMM_040_002',0.701387),('01o8ma93k2jh04a','MGI:1919300','C57BL','Early','IMPC_ECH_012_001',0.364433),('01u86p9b1p7222m','MGI:104899','C57BL','E9.5','IMPC_EYE_063_001',0.387356),('01u8anlu2l5336x','MGI:2685869','C57BL','Early','IMPC_CBC_017_001',0.623032),('01u93w36bfs6i8x','MGI:2443564','C57BL','E9.5','IMPC_DXA_009_001',0.653087),('01uyr330u5w680m','MGI:104793','C57BL','Early','IMPC_GEP_034_001',0.123929),('01w2u3pbz77f0cx','MGI:1921520','C57BL','Early','IMPC_DXA_004_001',0.627383),('01w6y063oouz3cm','MGI:2443100','C57BL','Early','IMPC_GEM_025_002',0.0974809),('01y1t29rne9942m','MGI:2444508','C57BL','E15.5','IMPC_IMM_004_002',0.651046),('020b5moy7na7pya','MGI:2444508','C57BL','E12.5','IMPC_OFD_011_001',0.421259),('0210uj52sfnyq1m','MGI:1914210','C57BL','Early','IMPC_IMM_014_002',0.982141),('0218e8u318770dx','MGI:2443564','C57BL','E12.5','IMPC_CBC_002_001',0.0744348),('021r02vbxk91w0m','MGI:95975','C57BL','Early','IMPC_HEM_032_001',0.318936),('022gc237ebj202a','MGI:1890510','C57BL','Early','IMPC_DXA_009_001',0.00000000134313),('0232g8k88d03a3a','MGI:1915282','C57BL','Early','IMPC_ACS_006_001',0.539967),('023bk9d0i7s0i2x','MGI:2140050','C57BL','E9.5','IMPC_IMM_011_002',0.364402),('024a218si76x63x','MGI:107341','C57BL','Early','IMPC_EYE_063_001',0.057926),('0257jy8lbw1qugx','MGI:107171','C57BL','Early','IMPC_DXA_006_001',0.697847),('026260y2u9hb07x','MGI:1924486','C57BL','Early','IMPC_EYE_092_002',0.674248),('02698mow04s66px','MGI:1922387','C57BL','Early','IMPC_GEM_007_001',0.262801),('027390994v23u8m','MGI:1350930','C57BL','Early','IMPC_CSD_038_001',0.0609221),('027h5gy4d20558x','MGI:97565','C57BL','E12.5','IMPC_OFD_013_001',0.655038),('027r5454e3607tx','MGI:107171','C57BL','Early','IMPC_EYE_070_001',0.154989),('029dy8817hu966a','MGI:2140361','C57BL','E18.5','IMPC_GEM_025_002',0.315174),('02anbnosd8fb32m','MGI:3611233','C57BL','Early','IMPC_EYE_025_001',0.52673),('02b4f63i78a1e4a','MGI:107363','C57BL','Early','IMPC_IPG_010_001',0.889158),('02d92wf7l2gq8aa','MGI:2387617','C57BL','Early','IMPC_DXA_006_001',0.442059),('02j1r41e88pm4vx','MGI:1921735','C57BL','Early','IMPC_IMM_032_002',0.215329),('02osij4k0z0f32a','MGI:3588202','C57BL','Early','IMPC_EYE_027_001',0.590871),('02rzs5yrbg61t0a','MGI:1920199','C57BL','Early','IMPC_GEO_065_001',0.590594),('02x42vxp3s42h5m','MGI:106637','C57BL','Early','IMPC_CSD_015_001',0.812203),('02y4858mhj7tv0x','MGI:106925','C57BL','Middl','IMPC_EYE_056_001',0.471783),('031g5otg7s3o3ca','MGI:97383','C57BL','Early','IMPC_ECH_018_001',0.0824989),('034lv7865j4z97x','MGI:97324','C57BL','Early','IMPC_CSD_015_001',0.866029),('035v282575h65kx','MGI:104559','C57BL','Early','IMPC_ECG_010_001',0.946673),('037i9828h0of3na','MGI:1913491','C57BL','Early','IMPC_EYE_065_001',0.464355),('037qpl5cun9619a','MGI:103559','C57BL','Early','IMPC_CBC_004_001',0.224201),('038wb1ggu71dcix','MGI:1923953','C57BL','Early','IMPC_GEP_022_001',0.437636),('038y695v157946x','MGI:1921520','C57BL','Early','IMPC_CBC_013_001',0.322383),('039188n5m6n8nex','MGI:104516','C57BL','Early','IMPC_IMM_004_002',0.525513),('03a0e6b472bxv5m','MGI:1924467','C57BL','Early','IMPC_EYE_069_001',0.64724),('03d8m8977xa4wgx','MGI:1913721','C57BL','Early','IMPC_IMM_032_002',0.0916345),('03o34612ocewe5a','MGI:1919880','C57BL','Early','IMPC_EYE_025_001',0.737543),('03p58a68nvn188x','MGI:3576049','C57BL','Early','IMPC_EYE_070_001',0.688783),('03s5cuts2982d6a','MGI:1924232','C57BL','Early','IMPC_CSD_026_001',0.768311),('03w57iuaa187yaa','MGI:1350930','C57BL','E12.5','IMPC_DXA_009_001',0.373593),('03yk9pf19hv1w7a','MGI:1914454','C57BL','E12.5','IMPC_FEA_003_001',0.988137),('03zu94dlv7p138a','MGI:1915862','C57BL','E18.5','IMPC_CBC_023_001',0.547062),('04127f0ef0o025a','MGI:97565','C57BL','E9.5','IMPC_EYE_064_001',0.330234),('041n959wy0n065m','MGI:1926106','C57BL','Early','IMPC_HEM_038_001',0.852782),('042a5w3p49nouba','MGI:105383','C57BL','Early','IMPC_OFD_009_001',0.883371),('042lk77sc111t5a','MGI:2685195','C57BL','E9.5','IMPC_XRY_027_001',0.863495),('044za1ra467o5hm','MGI:2679260','C57BL','Early','IMPC_CSD_078_001',0.416295),('0452x7eg152rqim','MGI:2442177','C57BL','Early','IMPC_CSD_078_001',0.532636),('04dgvr83ox7zc5a','MGI:1346342','C57BL','Early','IMPC_GEO_043_002',0.0918994),('04f5vvhh4ig4u9m','MGI:106637','C57BL','Early','IMPC_CBC_009_001',0.702226),('04kj8m4x3b343kx','MGI:2676312','C57BL','Early','IMPC_OWT_002_001',0.590263),('04ku50665zepwcx','MGI:2384297','C57BL','E9.5','IMPC_ACS_006_001',0.305073),('04ri5w0ev3f00rx','MGI:1916987','C57BL','Early','IMPC_CSD_015_001',0.0629294),('04yp60752t1e07x','MGI:1201673','C57BL','E15.5','IMPC_GRS_009_001',0.10609),('050c25yjvdfe36a','MGI:1919369','C57BL','E9.5','IMPC_EYE_087_001',0.907695),('050t179i06k9ihx','MGI:106637','C57BL','E9.5','IMPC_ACS_035_001',0.147197),('05120v5c87h86ca','MGI:1918142','C57BL','Early','IMPC_CSD_028_001',0.318662),('05148743bn1j97x','MGI:1924232','C57BL','Early','IMPC_DXA_009_001',0.965512),('05382xo7rz29c4m','MGI:1917120','C57BL','Early','IMPC_IMM_040_002',0.795613),('053zgu37c1i991a','MGI:106925','C57BL','Early','IMPC_GRS_010_001',0.858232),('0543w6t53mw4j6m','MGI:106637','C54BL','E9.5','IMPC_CBC_016_001',0.267106),('0594f1f839q896x','MGI:3611450','C57BL','Early','IMPC_XRY_027_001',0.860063),('0596l05fbk52prx','MGI:1920199','C57BL','Early','IMPC_CBC_004_001',0.21261),('059f92d36g8kd7a','MGI:95777','129SV','Early','IMPC_CBC_003_001',0.303586),('05b6y0jr5z3mn5m','MGI:2444508','C57BL','E15.5','IMPC_XRY_023_001',0.334758),('05e51ha85tpjaox','MGI:1927241','C57BL','E12.5','IMPC_GRS_010_001',0.562837),('05j4m9u90038yxx','MGI:1922387','C57BL','E12.5','IMPC_CSD_013_001',0.957167),('05jf4518147g0ta','MGI:2387617','C57BL','Early','IMPC_XRY_023_001',1.17642),('05oaw9i8ezualka','MGI:1917770','C57BL','Early','IMPC_EYE_092_002',0.546627),('05tn172q45o55ux','MGI:1859866','C57BL','Early','IMPC_FEA_015_001',0.160015),('05upk1yr9wnej9m','MGI:101770','C57BL','Early','IMPC_ECH_013_001',0.532488),('05vtxg3c29a9rnm','MGI:2443805','C57BL','Early','IMPC_HEM_030_001',0.972213),('05w516on28k549m','MGI:2444274','C57BL','Early','IMPC_OFD_009_001',0.845219),('05x4s2z23639h1m','MGI:1927753','C57BL','E15.5','IMPC_HEM_004_001',0.623929),('0600hmp730pq49x','MGI:98386','C57BL','E9.5','IMPC_HEM_027_001',0.307018),('0608979s64gxtkx','MGI:1916987','C57BL','E12.5','IMPC_OFD_019_001',0.585085),('062a42w299j55jx','MGI:1914454','C57BL','E12.5','IMPC_IMM_011_002',0.511238),('062w1t19s06pp9m','MGI:107363','C57BL','E18.5','IMPC_GEM_068_001',0.509702),('0654dea30c8640m','MGI:88015','C57BL','E15.5','IMPC_EYE_017_001',0.126646),('067x1l1iyk6617x','MGI:1916330','C57BL','Early','IMPC_ECH_012_001',0.287702),('068k675497881ea','MGI:1919471','C57BL','Early','IMPC_GEO_064_001',0.709088),('06d94662b697njx','MGI:1922776','C57BL','Early','IMPC_HEM_027_001',0.110921),('06f26zf05j803ta','MGI:2138198','C57BL','Early','IMPC_CBC_024_001',0.63356),('06fninx58a1sh1x','MGI:2140050','C57BL','Early','IMPC_IPG_012_001',0.255091),('06h453ezyiy492a','MGI:98397','129SV','Early','IMPC_ECG_028_001',0.735295),('06w4k91o3mog7tm','MGI:2677271','C57BL','Early','IMPC_GEO_019_001',0.800492),('06z86l911i53ria','MGI:107674','C57BL','Early','IMPC_OFD_050_001',0.77792),('0723snm2ry79ztx','MGI:1914199','C57BL','E18.5','IMPC_HEM_003_001',0.351653),('072d6jz1dw34l6m','MGI:1096385','C57BL','Late ','IMPC_GEM_019_001',0.896033),('073778ia03bh34a','MGI:105383','C57BL','Early','IMPC_GEM_019_001',0.411765),('0747vht20q2p02a','MGI:107363','C57BL','E9.5','IMPC_CSD_007_001',0.808771),('07486sg57q2g88a','MGI:1914454','C57BL','Early','IMPC_GRS_009_001',0.439081),('074c04mnawg160a','MGI:1309469','C57BL','E15.5','IMPC_CBC_010_001',0.605751),('0752vvc4kcv351a','MGI:1922423','C57BL','Early','IMPC_EYE_023_001',0.725846),('076f05296k85ala','MGI:1921263','C57BL','Early','IMPC_XRY_057_001',0.322305),('076k1wlm51586ba','MGI:3576049','C57BL','Early','IMPC_EYE_063_001',0.494069),('078q5n56png8x0a','MGI:2444824','C57BL','Early','IMPC_CSD_014_001',0.135488),('079e3wj41fqfw5a','MGI:1309469','C57BL','E12.5','IMPC_GEL_011_001',0.97767),('07d6addk635079m','MGI:1922828','C57BL','Early','IMPC_XRY_006_001',0.505273),('07g7ee269889hqx','MGI:1919128','C57BL','Early','IMPC_CBC_003_001',0.722328),('07gqa9r89qz267a','MGI:1890510','C57BL','Early','IMPC_CSD_014_001',0.472668),('07nj8z7r81p6xex','MGI:104516','C57BL','Early','IMPC_EYE_065_001',0.960522),('07u3f43r4wxmjta','MGI:1095412','C57BL','Middl','IMPC_CBC_010_001',0.0612172),('07ub33903j8215a','MGI:104708','C57BL','E9.5','IMPC_CSD_023_001',0.787761),('07w4051nh0x3aea','MGI:97803','C57BL','E15.5','IMPC_GRS_011_001',0.994019),('07z2txj4tab59aa','MGI:2679420','C57BL','Early','IMPC_EYE_062_001',0.616322),('080vp2b940a4rtx','MGI:99218','C57BL','Early','IMPC_CBC_008_001',0.965804),('080z634t614r3sx','MGI:1096385','C57BL','Middl','IMPC_XRY_015_001',0.541202),('08235i547c481lm','MGI:1351315','C57BL','Early','IMPC_GEP_005_002',0.458024),('083efzr059b4k6a','MGI:1913761','C57BL','Early','IMPC_XRY_060_001',0.575077),('08441gk7s9bmwjm','MGI:1096385','C57BL','Early','IMPC_DXA_007_001',0.312138),('0868n25ok998e1a','MGI:88525','C57BL','Early','IMPC_CBC_001_001',0.205647),('086g16lplt382nm','MGI:1915862','C57BL','Early','IMPC_ECG_028_001',0.96662),('087hj61l5w7u2mm','MGI:2684789','C57BL','Early','IMPC_GEP_034_001',0.135323),('089834g693n7snm','MGI:1925835','C57BL','Early','IMPC_EYE_062_001',0.974902),('08e3d725v5u301x','MGI:1931071','C57BL','Early','IMPC_ECG_028_001',0.385426),('08hu634amg4p16m','MGI:1339755','C57BL','Early','IMPC_CSD_040_002',0.0782721),('08igxmzrs878e5x','MGI:2443925','C57BL','Early','IMPC_EYE_008_001',0.674995),('08kk1p1bmu2860m','MGI:109424','C57BL','Early','IMPC_CBC_012_001',0.419466),('08kxvel1t0849qx','MGI:1339968','C57BL','Early','IMPC_XRY_012_001',0.172649),('08u90dex56p4w9a','MGI:1918142','C57BL','Early','IMPC_CSD_025_001',0.524692),('08yb1o2cc62g2nx','MGI:1924265','C57BL','Early','IMPC_ECH_018_001',0.997411),('0901wl617qkx93m','MGI:1927753','C57BL','Early','IMPC_EYE_087_001',0.762178),('0915657j69xd0im','MGI:2444631','C57BL','E15.5','IMPC_GEP_022_001',0.992467),('0929814d2nte80m','MGI:1915643','C57BL','Early','IMPC_GEP_030_002',0.845233),('093yqd237y653ga','MGI:1278321','C57BL','Early','IMPC_CSD_036_001',0.593164),('0940k7x9cd0h2mx','MGI:2676312','C57BL','Early','IMPC_CSD_028_001',0.203056),('0958h4153iyh8dm','MGI:87879','C57BL','Early','IMPC_CBC_009_001',0.058766),('0970c14h32zc7zx','MGI:1918142','C57BL','Early','IMPC_GEL_058_001',0.255713),('098e18valwgcw8m','MGI:104559','C57BL','Early','IMPC_CSD_030_001',0.770163),('098l5d63wil8w3x','MGI:1914199','C57BL','E18.5','IMPC_CBC_002_001',0.987165),('09d4d0hw355q9xa','MGI:98960','C57BL','E12.5','IMPC_HEM_003_001',0.796572),('09e1be2j2o03elx','MGI:2444508','C57BL','E12.5','IMPC_HEM_019_001',0.145379),('09f1ren40713hbx','MGI:1913761','C57BL','Early','IMPC_HEM_004_001',0.580078),('09g2q4g07j0ql5a','MGI:109424','C57BL','Early','IMPC_GEO_065_001',0.752536),('09ia7nahdf211jm','MGI:97850','C57BL','Early','IMPC_GEL_011_001',0.376263),('09ki6i3a4z2l9cm','MGI:2444989','C58BL','Early','IMPC_CBC_020_001',0.555993),('09n00195640a7kx','MGI:1913761','C57BL','Early','IMPC_ECG_003_001',0.503881),('09n07yg45fh212x','MGI:1917770','C57BL','Early','IMPC_CSD_013_001',0.0910577),('09u578h7b5xrx7a','MGI:1921722','C57BL','Early','IMPC_GEL_060_001',0.224469),('09u8g8qj68058qa','MGI:109424','C57BL','Early','IMPC_GEM_019_001',0.664013),('0a6e4nl4nref8lm','MGI:108429','C57BL','E12.5','IMPC_EYE_017_001',0.445517),('0a8hr265t94uuqa','MGI:2676312','C57BL','Early','IMPC_XRY_022_001',0.304764),('0a9mwqcyk0suvfm','MGI:1918066','C57BL','Early','IMPC_CBC_009_001',0.83353),('0aew56p8o89jdbx','MGI:2139018','C57BL','Early','IMPC_EYE_012_001',0.12603),('0am5ydxb39r4jwa','MGI:1339968','C57BL','Early','IMPC_ABR_008_001',0.402188),('0as07i59mu32x8x','MGI:1916413','C57BL','E9.5','IMPC_EYE_063_001',0.433491),('0auecc5l5d0o96x','MGI:1927753','C57BL','E15.5','IMPC_XRY_016_001',0.0559769),('0b1762s9nwcsjhx','MGI:2443100','C57BL','Early','IMPC_CBC_013_001',0.605299),('0b996u260xerbea','MGI:2444631','C57BL','Early','IMPC_OWT_002_001',0.969167),('0b9gcwwqokwmdqx','MGI:2684789','C57BL','Early','IMPC_CAL_017_001',0.58118),('0c06c3l3582t7la','MGI:106925','C57BL','Early','IMPC_GEM_075_001',0.753629),('0c21ut6uqdf267x','MGI:2681832','C57BL','Early','IMPC_GEM_068_001',0.745042),('0c27n8k042bx9sm','MGI:1914454','C57BL','E9.5','IMPC_EYE_003_001',0.383755),('0c4333u26p084hm','MGI:1350930','C57BL','Early','IMPC_GEO_063_001',0.221348),('0c48wyf1h6i5ujx','MGI:97383','C57BL','Early','IMPC_ACS_006_001',0.772777),('0c6560nugg1498a','MGI:1913746','C57BL','Early','IMPC_OFD_022_001',0.921818),('0c66t7x52ihbxgx','MGI:3611450','C57BL','Early','IMPC_ECG_010_001',0.311152),('0c917u0xm94i5sx','MGI:1913692','C57BL','Early','IMPC_CBC_009_001',0.852854),('0cf4k5apu02ldim','MGI:1350930','C57BL','E12.5','IMPC_OFD_022_001',0.721847),('0chr0u6087rjg0a','MGI:1916987','C57BL','E15.5','IMPC_CSD_016_001',0.772496),('0ci95bvppw5gk6a','MGI:1337072','C57BL','Early','IMPC_GEO_017_002',0.0859841),('0cj05s4933b07wa','MGI:2384297','C57BL','E9.5','IMPC_CSD_007_001',0.743017),('0cn36325vpb3f5a','MGI:2444631','C57BL','Early','IMPC_EYE_068_001',0.466939),('0cnfk9121s3y1nx','MGI:1922776','C57BL','Early','IMPC_EYE_082_001',0.586655),('0d73715w89ywhba','MGI:1917120','C57BL','E18.5','IMPC_XRY_063_001',0.945762),('0dj36mf7lw3w39m','MGI:1914210','C57BL','Early','IMPC_IMM_032_002',0.411729),('0do4s7je4av98ga','MGI:109424','C57BL','Early','IMPC_EYE_068_001',0.632465),('0dz41j6w8x4sg4a','MGI:1923304','C57BL','Early','IMPC_XRY_016_001',0.510115),('0e2lh1thtdoc14a','MGI:97565','C57BL','Early','IMPC_GEM_069_001',0.362187),('0e41d108z6209zm','MGI:1339755','C57BL','Early','IMPC_CSD_037_001',0.386508),('0e4f56707q5ycoa','MGI:1914542','C57BL','Early','IMPC_CBC_010_001',0.559142),('0e7143fiwx5z5mx','MGI:2677271','C57BL','Early','IMPC_CBC_018_001',0.4778),('0e7wb9zw25mg65m','MGI:88015','C57BL','Early','IMPC_ECG_010_001',0.48917),('0e8a88a927rksra','MGI:101770','C57BL','Early','IMPC_CSD_005_001',0.560096),('0e8y4x023wvbbka','MGI:1350926','C57BL','Early','IMPC_OFD_018_001',0.529304),('0eb43gmm8x9965x','MGI:1917120','C57BL','E18.5','IMPC_GEP_026_001',0.260412),('0f4mm0z3z18213m','MGI:1923304','C57BL','Early','IMPC_GEO_019_001',0.966771),('0f5z298lp5af9mx','MGI:1919084','C57BL','Early','IMPC_CBC_058_001',0.681807),('0fk7wkrcmyb440m','MGI:106637','C57BL','E9.5','IMPC_EYE_092_002',0.327305),('0fq82960mwf924a','MGI:1922776','C57BL','Middl','IMPC_GEM_075_001',0.959361),('0fs178nm5vp3jom','MGI:95975','C57BL','Early','IMPC_HEM_029_001',0.835374),('0fsw4nvw89xiq9x','MGI:1919471','C57BL','Early','IMPC_CSD_033_001',0.952381),('0fvf125i531760m','MGI:98397','C57BL','Early','IMPC_GEL_058_001',0.611915),('0fx941j2g3r07fm','MGI:2444508','C57BL','E15.5','IMPC_CBC_014_001',0.948766),('0fz4944doy9o4tx','MGI:1332243','C57BL','Early','IMPC_HEM_003_001',0.167192),('0g9mwldf9g10b5m','MGI:1915862','C57BL','E12.5','IMPC_GEL_060_001',0.991886),('0h101605w9mw8rm','MGI:102844','C57BL','Early','IMPC_ACS_033_001',0.118496),('0h1j4vi8294np4a','MGI:1913692','C57BL','Early','IMPC_EYE_016_001',0.387198),('0h38f13v78nmg7x','MGI:98397','129SV','Early','IMPC_ECG_010_001',0.745006),('0h5034rmj1fi65m','MGI:106925','C59BL','Middl','IMPC_EYE_026_001',0.741974),('0hdd375278pmlhm','MGI:2385213','C57BL','Early','IMPC_ACS_033_001',0.255763),('0hf9149f6i1v19x','MGI:1095412','C57BL','Middl','IMPC_IMM_040_002',0.671072),('0hi37h84jp370ia','MGI:98960','C57BL','E12.5','IMPC_IMM_014_002',0.297862),('0i144t573h6gi8a','MGI:1914454','C57BL','E9.5','IMPC_CSD_016_001',0.366864),('0i4fgxiv8w05v5x','MGI:2441837','C57BL','E18.5','IMPC_DXA_009_001',0.755181),('0i6xck18w8vd70x','MGI:1350930','C57BL','E12.5','IMPC_OFD_007_001',0.639941),('0i79947z586y8fx','MGI:1343489','C57BL','Early','IMPC_XRY_063_001',0.332425),('0i82345e63468ia','MGI:1918142','C57BL','Early','IMPC_CBC_018_001',0.922648),('0igc20qf1h59d1a','MGI:104708','C57BL','E9.5','IMPC_XRY_012_001',0.0993488),('0iur14ljeg56wcm','MGI:95777','129SV','Early','IMPC_CBC_024_001',0.0977438),('0j1q46lr3rehi5m','MGI:1914199','C57BL','E18.5','IMPC_EYE_083_001',0.956888),('0j2865258885j6x','MGI:1914199','C57BL','E18.5','IMPC_CBC_020_001',0.495315),('0j82z772yw7pd8a','MGI:1915599','C57BL','Early','IMPC_CSD_016_001',0.587365),('0jz37t250h4fw3x','MGI:1916987','C57BL','E15.5','IMPC_EYE_017_001',0.951134),('0k0ysba2r6t15gm','MGI:109424','C57BL','Early','IMPC_GEM_069_001',0.316553),('0k323dfd4weh2ha','MGI:95975','C57BL','Early','IMPC_EYE_023_001',0.442959),('0k3bz94q4q5hsua','MGI:3041190','C57BL','Early','IMPC_CSD_025_001',0.774574),('0k4p107f128hi4m','MGI:1919369','C57BL','Early','IMPC_XRY_033_001',0.436034),('0kt5dr0h5s4584x','MGI:1919880','C57BL','Early','IMPC_GEM_069_001',0.527245),('0kv59x0e9rkzr0x','MGI:108429','C57BL','Early','IMPC_GEM_070_001',0.807182),('0l5g5d372sj6yia','MGI:2679260','C57BL','Early','IMPC_CSD_025_001',0.419759),('0l78sc9h82n2xkx','MGI:106637','C57BL','E9.5','IMPC_GRS_011_001',0.204908),('0lp94fr5q1r750x','MGI:1916413','C57BL','E9.5','IMPC_HEM_037_001',0.145369),('0lrgjor0qv3066m','MGI:106925','C57BL','Early','IMPC_OFD_013_001',0.0000355815),('0m19rs9yi5gl4dx','MGI:1919369','C57BL','E9.5','IMPC_CSD_040_002',0.677413),('0m8eioz0j1uklca','MGI:1914199','C57BL','E18.5','IMPC_EYE_088_001',0.111522),('0m8nzvd737qasjx','MGI:2443564','C57BL','E9.5','IMPC_CSD_015_001',0.985617),('0mo82376cexv7ja','MGI:88015','C57BL','E15.5','IMPC_GEL_060_001',0.564782),('0n435yvxczhq6ja','MGI:1927753','C57BL','Early','IMPC_XRY_016_001',0.936947),('0n5t8ln13ha9b5m','MGI:1350930','C57BL','Early','IMPC_CBC_023_001',0.826754),('0nc29z3sjw18nba','MGI:2154090','C57BL','Early','IMPC_GEO_043_002',0.447418),('0ncxa8vz52sj7sx','MGI:2442792','C57BL','Early','IMPC_XRY_012_001',0.745731),('0o01uc6i5eyj69a','MGI:107171','C57BL','Early','IMPC_GEM_070_001',0.53907),('0o05gr8m0z867ma','MGI:2684789','C57BL','Early','IMPC_HEM_029_001',0.869178),('0o1k058ajf9705m','MGI:1927753','C57BL','Early','IMPC_DXA_002_001',0.116641),('0o26sx4qi4a7hha','MGI:2444631','C57BL','E15.5','IMPC_CSD_007_001',0.688659),('0o55saokd570j7m','MGI:102519','C57BL','Early','IMPC_IMM_032_002',0.248173),('0o61936d42j9zha','MGI:1889549','C57BL','Early','IMPC_OFD_007_001',0.252426),('0obdt8792s878am','MGI:2679260','C57BL','Early','IMPC_CBC_016_001',0.290659),('0oe59d817jnk6qa','MGI:1309469','C57BL','E15.5','IMPC_HEM_032_001',0.43273),('0oinlw57w93dv9m','MGI:1915599','C57BL','Early','IMPC_DXA_004_001',0.494116),('0p4h6h917g5kfmx','MGI:3588216','C57BL','Early','IMPC_EYE_070_001',0.477222),('0p4v3li668e0d8m','MGI:1914210','C57BL','Early','IMPC_CSD_033_001',0.43566),('0p6f8tln7p3u0ja','MGI:1095412','C57BL','Early','IMPC_ECG_006_001',0.500296),('0p761ck91tn2u8x','MGI:101813','C57BL','E9.5','IMPC_CBC_012_001',0.592541),('0p8fl264vjazh2a','MGI:97850','C57BL','Early','IMPC_FEA_105_001',0.335345),('0q20l5c6r5i03zx','MGI:97324','C57BL','Early','IMPC_HEM_006_001',0.399471),('0q9f1ic8nsmap7a','MGI:2140592','C57BL','Early','IMPC_DXA_003_001',0.445229),('0q9r7406u79co9a','MGI:106637','C57BL','Early','IMPC_HWT_002_001',0.911078),('0r08qe41lkuiycm','MGI:1921263','C57BL','Early','IMPC_GRS_009_001',0.770704),('0r2345z14axp0bx','MGI:2685260','C57BL','Early','IMPC_GEM_069_001',0.714824),('0r840a69dvn2orm','MGI:1922423','C57BL','Early','IMPC_CAL_017_001',0.509881),('0rg0ezp8y6519da','MGI:1201673','C57BL','E9.5','IMPC_ABR_004_001',0.895742),('0ri80y5fn51oohx','MGI:1916987','C57BL','E12.5','IMPC_ACS_034_001',0.956417),('0rr8f7i2a151k1x','MGI:1917120','C57BL','E18.5','IMPC_EYE_064_001',0.224785),('0s1g54b9g6si71x','MGI:1916413','C57BL','E9.5','IMPC_DXA_005_001',0.286082),('0s291xpsp44vqax','MGI:1916413','C57BL','E9.5','IMPC_GEP_026_001',0.393023),('0s78e1bi2sc652a','MGI:1913420','C57BL','Early','IMPC_CSD_033_001',0.192039),('0sfd3f1h59vw20m','MGI:1309469','C57BL','E12.5','IMPC_HEM_019_001',0.525979),('0shlxc807x7o42m','MGI:109424','C57BL','Early','IMPC_CSD_005_001',0.835071),('0si094x2w2epjma','MGI:2444508','C57BL','Early','IMPC_HEM_038_001',0.536343),('0siey0r4tt7483a','MGI:2387617','C57BL','Early','IMPC_EYE_068_001',0.989249),('0sj7x6sg7oeb37x','MGI:102844','C57BL','Early','IMPC_HEM_003_001',0.412575),('0sxg50ri2kxn6nx','MGI:1923953','C57BL','Early','IMPC_EYE_012_001',0.702482),('0t6n21w5167030a','MGI:106637','C57BL','E9.5','IMPC_CBC_002_001',0.90032),('0tfeqq9svnp9ykm','MGI:1923304','C57BL','Early','IMPC_HEM_019_001',0.106378),('0tzv0466w322i3a','MGI:108429','C57BL','E12.5','IMPC_CBC_003_001',0.929409),('0u45364aws7q61x','MGI:104793','C57BL','Early','IMPC_GRS_010_001',0.564302),('0u7960ap0u6b7zm','MGI:97850','C57BL','Early','IMPC_IMM_014_002',0.411111),('0v3f7szmfv89s8a','MGI:1346342','C57BL','Early','IMPC_GPO_002_001',0.61925),('0v59ab88di74mmm','MGI:1927241','C57BL','Early','IMPC_GRS_010_001',0.547008),('0v61al1bro4vk4m','MGI:2385213','C57BL','Late ','IMPC_CSD_061_001',0.733082),('0vpku842j4p8g3a','MGI:1891259','C57BL','Early','IMPC_GEL_063_001',0.560591),('0w2e8a516df2qia','MGI:106637','C57BL','E9.5','IMPC_OFD_012_001',0.796156),('0w40p92i7p9s1oa','MGI:1337072','C57BL','Late ','IMPC_CSD_061_001',0.247212),('0wg6u50fc7667hm','MGI:1915247','C57BL','E9.5','IMPC_CBC_013_001',0.529313),('0wjtdf0fpwq22fx','MGI:98960','C57BL','E15.5','IMPC_IPG_012_001',0.112702),('0wqa146j1uh90pa','MGI:104793','C57BL','Early','IMPC_GEO_019_001',0.969656),('0wr9j3o9at64z3x','MGI:1915862','C59BL','E18.5','IMPC_GEM_019_001',0.148432),('0wyiut2r8320l8a','MGI:87867','C57BL','Early','IMPC_OFD_050_001',0.974288),('0x3ula9pxi8182x','MGI:1923304','C57BL','Early','IMPC_CSD_006_001',0.0637226),('0x517zw8z0i119x','MGI:2444681','C57BL','Early','IMPC_CBC_023_001',0.405936),('0xgzk172wgq474m','MGI:98386','C57BL','E9.5','IMPC_CBC_013_001',0.128496),('0y053g875uorelm','MGI:3576049','C57BL','Early','IMPC_GEO_017_002',0.178812),('0y0k02l465z11wa','MGI:1920199','C57BL','E18.5','IMPC_OFD_011_001',0.43206),('0y2p424i473l2im','MGI:1919369','C57BL','E9.5','IMPC_XRY_027_001',0.0698662),('0y3b4934s1203cx','MGI:2384297','C57BL','E12.5','IMPC_GEL_011_001',0.659377),('0y3rk747zeyu70m','MGI:2444631','C57BL','E15.5','IMPC_GEM_069_001',0.5068),('0y838p23wvv1d9x','MGI:101813','C57BL','Early','IMPC_IPG_010_001',0.980219),('0y8pa719ti566vx','MGI:1309469','C57BL','E15.5','IMPC_HEM_008_001',0.369146),('0ya332r6mf8covx','MGI:2685195','C57BL','Early','IMPC_CBC_025_001',0.690956),('0yf62x4c8m1l85m','MGI:2158201','C57BL','Early','IMPC_XRY_023_001',0.0854867),('0yhk48drv55529m','MGI:97324','C57BL','Early','IMPC_CBC_015_001',0.887553),('0yqy3a41u481w2x','MGI:3611233','C57BL','Early','IMPC_CBC_014_001',0.487016),('0yv56dzsjh49h7m','MGI:2385213','C57BL','Late ','IMPC_CSD_005_001',0.362184),('0z03r847t95t26m','MGI:97565','C57BL','Early','IMPC_EYE_092_001',0.617398),('0z20520u5qy2uza','MGI:1919300','C57BL','Early','IMPC_XRY_033_001',0.740046),('0z32aubhk94n82m','MGI:104559','C57BL','Early','IMPC_DXA_007_001',0.781135),('0zp620zy284l4wm','MGI:1927753','C57BL','Early','IMPC_HEM_004_001',0.205196),('103r2g445838j9a','MGI:1914199','C57BL','E12.5','IMPC_GEM_029_001',0.182337),('10633i32v82977m','MGI:1916428','129SV','Early','IMPC_EYE_024_001',0.334089),('106s3b1b7nn5x7m','MGI:107363','C57BL','Early','IMPC_OFD_019_001',0.216784),('106xa8zk4b9386m','MGI:1927753','C57BL','E15.5','IMPC_HEM_029_001',0.979222),('1079t3g1h23d64a','MGI:2385213','C57BL','Late ','IMPC_EYE_082_001',0.393894),('107pewvbbhbp6ca','MGI:1916330','C57BL','Early','IMPC_DXA_004_001',0.227931),('1083xuyz3zkkq9x','MGI:2448514','C57BL','Early','IMPC_CSD_015_001',0.994116),('10883m0cz5v8d9m','MGI:1919471','C57BL','Early','IMPC_CBC_005_001',0.465669),('10928m2om0hyvnm','MGI:1921735','C57BL','Early','IMPC_ABR_012_001',0.296197),('10994617g3521dm','MGI:101770','C57BL','Early','IMPC_GEM_019_001',0.871759),('109i3f4wf16umax','MGI:2441837','C57BL','E18.5','IMPC_CBC_025_001',0.930252),('10a39ydle79q80m','MGI:104899','C57BL','E9.5','IMPC_OFD_021_001',0.635398),('10at73j4nrq2i2x','MGI:98397','129SV','Early','IMPC_CBC_012_001',0.553378),('10d1h063917645a','MGI:1919084','C57BL','Early','IMPC_HEM_037_001',0.282358),('10j87vx79og3q4a','MGI:1917120','C57BL','E18.5','IMPC_XRY_022_001',0.608044),('10o4i0z09i1t15a','MGI:2444508','C57BL','E15.5','IMPC_OFD_014_001',0.580751),('10tje41ymi35k0x','MGI:1917770','C57BL','Early','IMPC_ABR_004_001',0.309698),('1100b9y006sxdyx','MGI:107674','C57BL','Early','IMPC_HEM_038_001',0.414515),('112ofuls94128cx','MGI:1923304','C57BL','Early','IMPC_DXA_008_001',0.431502),('11391j95581d7sx','MGI:1309469','C57BL','E15.5','IMPC_CSD_025_001',0.597644),('114100fj4zk68oa','MGI:1890510','C57BL','Early','IMPC_DXA_006_001',0.598595),('1142o7zq51er60a','MGI:98960','C57BL','Early','IMPC_CAL_017_001',0.380659),('114t38r3891q1vx','MGI:97565','C57BL','Early','IMPC_CSD_025_001',0.306437),('117h881m1r0dy3m','MGI:109424','C57BL','Early','IMPC_CSD_079_001',0.843013),('11882tn2f87xv3a','MGI:1913790','129SV','Early','IMPC_ECG_028_001',0.528945),('118x90x4059098m','MGI:2443564','C57BL','E18.5','IMPC_GEM_025_002',0.0913402),('119asywm1rxg76x','MGI:1922387','C57BL','E9.5','IMPC_OFD_021_001',0.54622),('11d68j2f9j0smqm','MGI:2444631','C57BL','E12.5','IMPC_GEO_043_002',0.6508),('11drj0z04pq993a','MGI:1927753','C57BL','Early','IMPC_EYE_088_001',0.619232),('11dry37gbil902a','MGI:2445096','C57BL','Early','IMPC_CSD_037_001',0.680799),('11f5en48jb5d69x','MGI:1918066','C57BL','Early','IMPC_ECH_018_001',0.113795),('11gqk5a57l8vm3x','MGI:1915282','C57BL','Early','IMPC_OFD_021_001',0.603069),('11h3rk12i0941ya','MGI:1350926','C57BL','Early','IMPC_CBC_017_001',0.154102),('11jk69y0po371tx','MGI:97565','C57BL','E9.5','IMPC_CSD_041_002',0.148203),('11wf3r5b694yb3a','MGI:107191','C57BL','Early','IMPC_EYE_061_001',0.0632771),('12004p0820u6vxa','MGI:3606212','C57BL','Early','IMPC_GEO_064_001',0.342534),('1207dqu5x09p40m','MGI:1913882','C57BL','Early','IMPC_GEM_075_001',0.140949),('1226l9v4vx966va','MGI:1915599','C57BL','Early','IMPC_CBC_001_001',0.960097),('122s702wbr0eh4a','MGI:1916987','C57BL','E12.5','IMPC_GRS_010_001',0.692527),('1244ds6x93c14gx','MGI:107191','C57BL','Early','IMPC_DXA_005_001',0.539549),('1246hm55xn47w0m','MGI:1916987','C57BL','E15.5','IMPC_GRS_009_001',0.313693),('125fpme813mwhqa','MGI:1924265','C57BL','Early','IMPC_CSD_030_001',0.738478),('12636ev59flstba','MGI:2444631','C57BL','E12.5','IMPC_CBC_002_001',0.548211),('126j0y02l24zq9a','MGI:104708','C57BL','E9.5','IMPC_ECG_003_001',0.457016),('127akqpj670o3px','MGI:1350930','C57BL','Early','IMPC_CBC_001_001',0.94785),('12802vs428176da','MGI:1919051','C57BL','Early','IMPC_OFD_016_001',0.680873),('12859d7p1y8v7tx','MGI:2135283','C57BL','Early','IMPC_GEP_017_001',0.130462),('12au980j5fa0v7m','MGI:1095412','C57BL','Early','IMPC_IMM_032_002',0.484643),('12b87j13k2947ra','MGI:1201673','C57BL','E9.5','IMPC_EYE_068_001',0.494748),('12bj79z2d3xb8bx','MGI:2385213','C57BL','Middl','IMPC_XRY_063_001',0.807811),('12fw4q3mf6bdwtx','MGI:1921735','C57BL','Early','IMPC_GEO_015_001',0.993186),('12hc2tb4195b9fx','MGI:2676312','C57BL','Early','IMPC_CBC_001_001',0.907737),('12j57w739216ldm','MGI:1098604','C57BL','Early','IMPC_EYE_003_001',0.295881),('12jmucso440rc0x','MGI:97565','C57BL','E9.5','IMPC_GEM_070_001',0.335087),('12m85segc1g43ra','MGI:1914542','C57BL','Early','IMPC_CSD_014_001',0.330447),('12nynhlw1cx0gua','MGI:107674','C57BL','Early','IMPC_CBC_004_001',0.891927),('12o2sei088i1jhm','MGI:107191','C57BL','Early','IMPC_GRS_010_001',0.934899),('12q7646z4m3554m','MGI:1350930','C57BL','E9.5','IMPC_OFD_012_001',0.379433),('12qx9d97mrm4p2m','MGI:98397','C57BL','Early','IMPC_EYE_065_001',0.510228),('12u254853p038pa','MGI:1350930','C57BL','E12.5','IMPC_IPG_010_001',0.936343),('133l9u2pd44vd6a','MGI:2140361','C57BL','Early','IMPC_ECG_004_001',0.299177),('136eh5b707p675a','MGI:99218','C57BL','Early','IMPC_FEA_003_001',0.922869),('138p39u8r94v6cx','MGI:2676312','C57BL','E18.5','IMPC_HEM_003_001',0.0627173),('138rj4iy24qe07m','MGI:2158201','C57BL','Early','IMPC_CBC_005_001',0.830109),('13b447wl386tg5m','MGI:106925','C57BL','Late ','IMPC_EYE_003_001',0.102017),('13b5cj605kjfh6m','MGI:101813','C57BL','Early','IMPC_CSD_040_002',0.902204),('13g5mub9r8yo4aa','MGI:2443805','C57BL','Early','IMPC_ACS_037_001',0.799525),('13m8c8iw0y861xa','MGI:106637','C57BL','E9.5','IMPC_HWT_002_001',0.714686),('13nf15zni131nlm','MGI:2441837','C57BL','Early','IMPC_OFD_012_001',0.926359),('13tl7k5g9oe32im','MGI:2444631','C57BL','Early','IMPC_XRY_027_001',0.479791),('13w499jn8y4144a','MGI:107363','C57BL','E18.5','IMPC_CBC_006_001',0.92805),('13w4y4r6043jnvm','MGI:1920199','C57BL','Early','IMPC_CSD_036_001',0.310745),('13wk27e16159uha','MGI:98386','C57BL','E9.5','IMPC_XRY_063_001',0.157809),('1400385gjo3896m','MGI:95777','129SV','Early','IMPC_GEM_025_002',0.901386),('141aa2e9527u80m','MGI:3590554','C57BL','Early','IMPC_CSD_014_001',0.108557),('143j003r168k8qa','MGI:1926106','C57BL','Early','IMPC_CBC_008_001',0.832395),('145505s3gqfo2mx','MGI:1921263','C57BL','Early','IMPC_CSD_024_001',0.829183),('146mdtzmvoh3qyx','MGI:97565','C57BL','Early','IMPC_CBC_005_001',0.37852),('14888e490yq1etx','MGI:2444631','C57BL','E15.5','IMPC_XRY_006_001',0.0697375),('14ax2m3132d872a','MGI:1860511','C57BL','Early','IMPC_EYE_069_001',0.936935),('14b2jc8mw22mr7x','MGI:2679420','C57BL','Early','IMPC_CSD_030_001',0.227025),('14bgze2s07u46ra','MGI:2444824','C57BL','Early','IMPC_GEP_005_002',0.197005),('14g9wf1o3jfg6ma','MGI:2153070','C57BL','Early','IMPC_EYE_064_001',0.180491),('14jhjtdo621a4zx','MGI:97324','C57BL','Early','IMPC_HEM_005_001',0.0000234544),('14n74i00a5k7d1m','MGI:97803','C57BL','E9.5','IMPC_GRS_010_001',0.661088),('14pgwb72jhwis7x','MGI:1096385','C57BL','Late ','IMPC_CSD_029_001',0.488628),('151a3u9zcn1801m','MGI:2384297','C57BL','Early','IMPC_CSD_014_001',0.959029),('151huy289qsnybm','MGI:107674','C57BL','Early','IMPC_ECG_014_001',0.440627),('1526lye54qsjg3m','MGI:2681832','C57BL','Early','IMPC_CSD_041_002',0.199478),('1541h110j7j26ta','MGI:1924467','C57BL','Early','IMPC_XRY_033_001',0.321767),('1545zhg080lndem','MGI:2444508','C57BL','Early','IMPC_HEM_030_001',0.839043),('155fwoz9k3d897m','MGI:1351315','C57BL','E9.5','IMPC_DXA_008_001',0.894999),('155g3a49d985jha','MGI:1913746','C57BL','Early','IMPC_CBC_020_001',0.20607),('159sz6wbw418eux','MGI:97565','C57BL','E12.5','IMPC_OFD_021_001',0.792666),('15b425xausi4r0x','MGI:1350930','C57BL','E12.5','IMPC_EYE_023_001',0.614545),('15f099d77o508vx','MGI:2444631','C57BL','Early','IMPC_GEO_064_001',0.267945),('15f7g8076vr423x','MGI:2676312','C57BL','Early','IMPC_XRY_023_001',0.853683),('15j5pvrjk3io1xa','MGI:2384297','C57BL','E12.5','IMPC_CBC_015_001',0.638482),('15m7l53x475g95m','MGI:1922423','C57BL','Early','IMPC_GEO_017_002',0.36996),('15oq106nm93670m','MGI:1201673','C57BL','Early','IMPC_FEA_003_001',0.443282),('15oz83376t5176a','MGI:3650206','C57BL','Early','IMPC_EYE_092_002',0.342793),('15pr6m8d9z2560a','MGI:1924232','C57BL','Early','IMPC_HEM_031_001',0.983589),('15r47p0lch4807m','MGI:1278321','C57BL','Early','IMPC_CSD_041_002',0.641294),('15y281o9310wuax','MGI:1353435','C57BL','Early','IMPC_HEM_037_001',0.718683),('1610205l8fdo3xx','MGI:101784','C57BL','Early','IMPC_GEL_027_001',0.378915),('162o228v574it7m','MGI:2441837','C57BL','Early','IMPC_XRY_006_001',0.542207),('16334f1sewg2tex','MGI:1915862','C57BL','E12.5','IMPC_CBC_018_001',0.0850923),('1637d20935cti1m','MGI:97565','C57BL','E12.5','IMPC_HWT_002_001',0.646464),('1646c32k187c9ta','MGI:1915862','C57BL','E18.5','IMPC_IMM_040_002',0.722109),('165ar37z2i22nxx','MGI:105383','C57BL','Early','IMPC_FEA_003_001',0.755603),('166960rwt5ozycm','MGI:2442704','C57BL','Early','IMPC_GEM_068_001',0.165172),('167o77o24fpghqx','MGI:101784','C57BL','Early','IMPC_EYE_003_001',0.559927),('16860f8331655nm','MGI:2138198','C57BL','Early','IMPC_FEA_003_001',0.0947251),('1689t273133n87x','MGI:1916987','C57BL','E15.5','IMPC_XRY_063_001',0.810644),('168sfmqlhvuaq2m','MGI:101813','C57BL','Early','IMPC_GEL_060_001',0.86716),('169dywe1s7lqu4a','MGI:1916732','C57BL','Early','IMPC_XRY_022_001',0.688194),('16d4s582rg25bja','MGI:103300','C57BL','Early','IMPC_EYE_068_001',0.916619),('16eh3o193xfcd6x','MGI:1921607','C57BL','Early','IMPC_XRY_012_001',0.0802387),('16fj3127x0r081x','MGI:104688','C57BL','Early','IMPC_HWT_002_001',0.5107),('16k2l2355mx6z3a','MGI:1921263','C57BL','Early','IMPC_CBC_002_001',0.389925),('16lg06pc439l8am','MGI:1921722','C57BL','Early','IMPC_DXA_003_001',0.126475),('16mshdhm7ijy88a','MGI:1920199','C59BL','E12.5','IMPC_GEL_011_001',0.0978239),('16nvrw599x7j9jm','MGI:1309469','C57BL','Early','IMPC_ACS_034_001',0.147603),('16p32949pw3z36a','MGI:2443100','C57BL','Early','IMPC_GEM_007_001',0.866844),('16t1e0m4g605c2x','MGI:1927753','C57BL','Early','IMPC_OFD_013_001',0.0692345),('16v1l949el8i87a','MGI:1915862','C57BL','E18.5','IMPC_CSD_061_001',0.716926),('16v5uzlaxw67a5a','MGI:2442704','C57BL','Early','IMPC_HEM_004_001',0.170577),('16w624l5ta6783x','MGI:1918066','C57BL','Early','IMPC_CBC_005_001',0.187907),('171471550kxi64a','MGI:2685195','C57BL','E9.5','IMPC_CBC_018_001',0.21043),('1717m5924be7ylx','MGI:2444631','C57BL','Early','IMPC_EYE_070_001',0.232956),('171x1914n1rt4qa','MGI:2444631','C57BL','E12.5','IMPC_XRY_021_001',0.921117),('1722io7cx5g380m','MGI:1924486','C57BL','Early','IMPC_IMM_032_002',0.627137),('1726120591zul3x','MGI:1346069','C57BL','Early','IMPC_CAL_017_001',0.28362),('172gh523zehzm7x','MGI:1920199','C57BL','E12.5','IMPC_ACS_033_001',0.825991),('174j8170d58ei7m','MGI:1914454','C57BL','Early','IMPC_GEP_022_001',0.873421),('175m31h7o2l51gx','MGI:1913692','C57BL','Early','IMPC_OFD_020_001',0.318631),('1766z8815lgdn7x','MGI:99218','C57BL','Early','IMPC_GEL_027_001',0.638122),('17696f42rje8lzx','MGI:2685869','C57BL','Early','IMPC_CSD_061_001',0.891728),('176n918uay91ilm','MGI:1201673','C57BL','E9.5','IMPC_CSD_036_001',0.587035),('1772rnnm0b5q10a','MGI:2444508','C57BL','E15.5','IMPC_EYE_087_001',0.36262),('177nkhgsfo6yj8a','MGI:2685195','C57BL','Early','IMPC_GEO_017_002',0.310659),('178gr4kl9447lba','MGI:1916413','C57BL','Early','IMPC_CBC_013_001',0.373955),('17d44m64v5mvs1x','MGI:102519','C57BL','E12.5','IMPC_ECG_010_001',0.611362),('17d750450r2391m','MGI:1353435','C57BL','Early','IMPC_GEL_027_001',0.712064),('17ds6k681476k3a','MGI:1922776','C57BL','Early','IMPC_GEM_019_001',0.26388),('17n0x87345a9f1a','MGI:1918066','C57BL','Early','IMPC_CSD_030_001',0.371682),('17s6bb7imp3ydjm','MGI:106925','C57BL','Middl','IMPC_GEL_058_001',0.645076),('17tf7v1225r4v4m','MGI:1860511','C57BL','Early','IMPC_CBC_015_001',0.970564),('17tg38254oa1ptx','MGI:2676312','C57BL','E18.5','IMPC_OFD_050_001',0.428082),('17u3b5myuby6u1x','MGI:1921520','C57BL','Early','IMPC_GEL_011_001',0.73663),('17uhwu9jn30zmwa','MGI:107674','C57BL','Early','IMPC_CBC_009_001',0.718672),('17y7wd7n4c3z84a','MGI:1341898','C57BL','Early','IMPC_GEP_022_001',0.277948),('17zd7l0rbqv679x','MGI:1309469','C57BL','Early','IMPC_EYE_088_001',0.574123),('1812692miq964nm','MGI:1921722','C57BL','Early','IMPC_HEM_001_001',0.492111),('182y941xrd4545a','MGI:1914210','C57BL','Early','IMPC_CBC_005_001',0.296144),('183oss62m0922fm','MGI:1337072','C57BL','Late ','IMPC_CBC_017_001',0.191164),('183x0k5908gv2om','MGI:109424','C57BL','Early','IMPC_IMM_028_002',0.689121),('1854348kel7lnox','MGI:2654325','C57BL','Early','IMPC_XRY_057_001',0.610698),('1854x3hab32vn2m','MGI:1922828','C57BL','Early','IMPC_HEM_032_001',0.662616),('1864ayc9yc4iy6a','MGI:2677271','C57BL','Early','IMPC_CBC_014_001',0.484196),('18652dflg44882m','MGI:1913692','C57BL','E9.5','IMPC_GRS_010_001',0.651462),('1865m904hg2b5aa','MGI:107363','C57BL','E9.5','IMPC_XRY_021_001',0.550615),('186kmotyk9978um','MGI:1916987','C57BL','E12.5','IMPC_XRY_012_001',0.944697),('187rhw3q03gu5km','MGI:1920199','C57BL','Early','IMPC_CSD_030_001',0.175029),('1886522d607ps0x','MGI:1917120','C57BL','Early','IMPC_CSD_032_001',0.358589),('188y5739787unha','MGI:2443564','C57BL','E12.5','IMPC_CSD_036_001',0.10985),('189g6uxo468hfpx','MGI:1927580','C57BL','Early','IMPC_HEM_004_001',0.721669),('189w32iabn825lm','MGI:97850','C57BL','Early','IMPC_ECH_013_001',0.907332),('18lh2q98w62k0nx','MGI:1919880','C57BL','Early','IMPC_HEM_031_001',0.216234),('18lu28g9hj25xom','MGI:2685195','C57BL','Early','IMPC_IMM_028_002',0.921762),('18rz33j495b4x3x','MGI:3588202','C57BL','Early','IMPC_HEM_030_001',0.891356),('18sg497u1m10lva','MGI:1859866','C57BL','E12.5','IMPC_EYE_027_001',0.860421),('191168ed9691ysa','MGI:1201673','C57BL','E9.5','IMPC_XRY_019_001',0.668987),('19487t7926tuy2a','MGI:1346086','C57BL','Early','IMPC_CSD_023_001',0.298065),('195t43k84v5147m','MGI:97565','C57BL','E12.5','IMPC_XRY_033_001',0.665552),('196fnsw8bj8499m','MGI:1921263','C59BL','Early','IMPC_HEM_005_001',0.512305),('196lyr4bmv36mpx','MGI:1890510','C57BL','Early','IMPC_GRS_010_001',0.0677078),('197a5989or46agm','MGI:1919369','C57BL','Early','IMPC_HEM_037_001',0.871392),('197ou4178zo7h2x','MGI:1922423','C57BL','Early','IMPC_HEM_002_001',0.0966458),('1980048gxy78vfx','MGI:107363','C57BL','E18.5','IMPC_CBC_001_001',0.125274),('198kzm1h199ho7a','MGI:2448514','C57BL','Early','IMPC_FEA_106_001',0.697189),('1999cuqztsu28gx','MGI:1924817','C57BL','Early','IMPC_CBC_014_001',0.00000340311),('19bp4g29e278y3m','MGI:2676312','C57BL','E18.5','IMPC_GEM_029_001',0.0792619),('19lg9roq249v08m','MGI:95777','129SV','Early','IMPC_EYE_083_001',0.632153),('19r9ot73j4io1hm','MGI:1353435','C57BL','Early','IMPC_EYE_068_001',0.82586),('19u83l4i7pifi3m','MGI:1922387','C57BL','E12.5','IMPC_OFD_010_001',0.733095),('19wt83tbpvs01im','MGI:3617846','C57BL','Early','IMPC_CSD_024_001',0.690369),('19x6478211ha2ra','MGI:2443564','C57BL','E12.5','IMPC_OFD_014_001',0.62813),('19zs75c0821c14m','MGI:1914542','C57BL','Early','IMPC_OFD_013_001',0.167437),('1a225z84ui29yem','MGI:1927753','C57BL','Early','IMPC_OFD_020_001',0.569588),('1a368297t53e2wx','MGI:1920484','C57BL','Early','IMPC_GEO_019_001',0.216395),('1au474egzs58b1x','MGI:104899','C57BL','E9.5','IMPC_ABR_012_001',0.670507),('1b5c2f6336j508m','MGI:1922776','C57BL','Early','IMPC_IMM_028_002',0.570207),('1b87cj26r6bmb4x','MGI:97565','C57BL','Early','IMPC_FEA_003_001',0.0761897),('1b9ur89vte170ha','MGI:107363','C57BL','Early','IMPC_ECH_012_001',0.507894),('1bj9c23aohthclx','MGI:3590554','C57BL','Early','IMPC_GEP_005_002',0.824384),('1bw89y5420423zx','MGI:1341898','C57BL','Early','IMPC_CSD_033_001',0.853048),('1c05850zr62d0mx','MGI:106925','C57BL','Early','IMPC_GEL_058_001',0.346378),('1c211m0157cal0x','MGI:1916987','C57BL','Early','IMPC_EYE_023_001',0.691248),('1c5e6ktsn6v71la','MGI:98386','C57BL','Early','IMPC_FEA_106_001',0.646405),('1cbh67h79y3lb3a','MGI:2385213','C57BL','Early','IMPC_ECG_010_001',0.893679),('1ci7w1t20jvcjoa','MGI:98386','C57BL','E9.5','IMPC_GRS_008_001',0.912049),('1ciwfrc00b521va','MGI:95777','129SV','Early','IMPC_HEM_027_001',0.128313),('1cu1e99jyxd575m','MGI:1916732','C57BL','Early','IMPC_OFD_013_001',0.589925),('1d0930ivkps3psm','MGI:1919051','C57BL','Early','IMPC_EYE_088_001',0.755217),('1d162948l8w182a','MGI:1913423','C57BL','Early','IMPC_GEM_075_001',0.101736),('1d23djy5336274x','MGI:1922946','C57BL','Early','IMPC_OFD_012_001',0.356036),('1d254e9s50syg8m','MGI:88015','C57BL','E15.5','IMPC_HEM_003_001',0.124379),('1d588ek99nr78xm','MGI:1859866','C57BL','Early','IMPC_XRY_060_001',0.238201),('1dd4p5lxknyr20x','MGI:106637','C57BL','E9.5','IMPC_XRY_033_001',0.984798),('1e28iz4qm38dx9m','MGI:1919471','C57BL','Early','IMPC_OFD_013_001',0.500078),('1e34947v9i9l91a','MGI:3045320','C57BL','Early','IMPC_IMM_032_002',0.560939),('1e6kuc0818yc53a','MGI:107341','C57BL','Early','IMPC_GRS_010_001',0.228454),('1e73rixy5yr86ga','MGI:1309469','C57BL','E12.5','IMPC_IMM_014_002',0.506476),('1eb5162nllg004x','MGI:1346086','C57BL','Early','IMPC_CSD_023_001',0.298065),('1el3p547802z73x','MGI:1096385','C57BL','Late ','IMPC_HEM_031_001',0.739515),('1ex6d683j456y9m','MGI:2444631','C57BL','E12.5','IMPC_GEO_017_002',0.456973),('1ey3t63h2j2gr2a','MGI:2153070','C57BL','Early','IMPC_DXA_010_001',0.92999),('1f40jeta4gge2hx','MGI:2139461','C57BL','Early','IMPC_OFD_022_001',0.544266),('1fc9kq5xhc93baa','MGI:1919300','C57BL','Early','IMPC_GRS_008_001',0.179114),('1g10fj71252721m','MGI:1095412','C57BL','Early','IMPC_GEP_030_002',0.601797),('1h27f183625935m','MGI:1919369','C57BL','E9.5','IMPC_CBC_023_001',0.351873),('1hcjsu701q6ue1m','MGI:98397','129SV','Early','IMPC_XRY_022_001',0.394025),('1hr90b094zd298m','MGI:101770','C57BL','Early','IMPC_GPO_002_001',0.748248),('1it3465e07h44vm','MGI:1923676','C57BL','Early','IMPC_HWT_002_001',0.782055),('1j4eaqd13z163km','MGI:1347355','C57BL','Early','IMPC_IMM_040_002',0.620294),('1jtr0a9t5qw30km','MGI:88015','C57BL','Early','IMPC_EYE_008_001',0.240016),('1k01jzlxy09ujtm','MGI:98960','C57BL','E12.5','IMPC_XRY_006_001',0.922838),('1k09rt15m0z739a','MGI:1309469','C57BL','E12.5','IMPC_GEM_025_002',0.106541),('1k2j2vn68nam8aa','MGI:1924265','C57BL','Early','IMPC_GEP_030_002',0.464127),('1k33353df29hola','MGI:1924232','C57BL','Early','IMPC_GRS_010_001',0.132297),('1kc411z6m7z0x1m','MGI:1915862','C57BL','Early','IMPC_XRY_022_001',0.176305),('1kq3fwg3a19l62a','MGI:1891259','C57BL','Early','IMPC_HEM_005_001',0.194245),('1kxsv139n3j4c8m','MGI:2443564','C57BL','E12.5','IMPC_XRY_060_001',0.93592),('1l77h406n6zzusa','MGI:1913882','C57BL','Early','IMPC_CSD_029_001',0.913753),('1lkmdpi0l14284m','MGI:1913420','C57BL','Early','IMPC_OFD_022_001',1.45246),('1m9zr36b5e13u1a','MGI:1309469','C57BL','E12.5','IMPC_OFD_007_001',0.53812),('1n77457rcl2g71a','MGI:1913491','C57BL','Early','IMPC_XRY_021_001',0.702358),('1n83880b5x2443m','MGI:2387617','C57BL','Early','IMPC_GEL_011_001',0.512016),('1o2895it902t3aa','MGI:1916987','C57BL','E12.5','IMPC_CSD_038_001',0.946135),('1o80s21xs2m0y9m','MGI:98960','C57BL','E15.5','IMPC_DXA_003_001',0.536075),('1opg071os4lyy8m','MGI:1920199','C57BL','E12.5','IMPC_HWT_002_001',0.831006),('1p83717hdbjr05a','MGI:3611233','C57BL','Early','IMPC_FEA_003_001',0.219749),('1prd3n65685386m','MGI:104899','C57BL','E9.5','IMPC_GEM_069_001',0.146022),('1pto9wfr7jxfo5m','MGI:1918066','C57BL','Early','IMPC_GEO_017_002',0.893464),('1py169t45z09f5a','MGI:99218','C57BL','Early','IMPC_OFD_009_001',0.605002),('1q072pq8yg73w4a','MGI:1915643','C57BL','Late ','IMPC_DXA_005_001',0.858506),('1q1xq680wmr793m','MGI:2685195','C57BL','Early','IMPC_CBC_020_001',0.341477),('1qh74k2nncqwrja','MGI:1891259','C57BL','Early','IMPC_GEO_017_002',0.854207),('1r5b5p1bg63ji5a','MGI:1917120','C57BL','E18.5','IMPC_DXA_006_001',0.751987),('1r95019n7mrca8a','MGI:2444824','C57BL','Early','IMPC_CSD_079_001',0.627786),('1rka56m3d4k0o3a','MGI:1927580','C57BL','Early','IMPC_XRY_022_001',0.53137),('1ru23tad1ur785m','MGI:2679420','C57BL','Early','IMPC_GEM_068_001',0.606177),('1s05ef3938lg6um','MGI:3588202','C57BL','Early','IMPC_GEO_064_001',0.226512),('1s08216916lpx1m','MGI:1915599','C57BL','Early','IMPC_EYE_082_001',0.670909),('1s2dz6sq99o5u8a','MGI:2139461','C57BL','Early','IMPC_HEM_032_001',0.800022),('1tj0lg2l8nn821a','MGI:1095412','C57BL','Late ','IMPC_ECH_012_001',0.805477),('1u60222742615ba','MGI:2158201','C57BL','Early','IMPC_GEO_015_001',0.05454),('1u8t8ig788swi7a','MGI:1918316','C57BL','Early','IMPC_CBC_025_001',0.995304),('1uj03q4h5258awa','MGI:1343489','C57BL','Early','IMPC_OFD_009_001',0.720921),('1w17r0zio5zf18a','MGI:1353665','C57BL','Early','IMPC_ECH_013_001',0.746451),('1wlr5c9zz69618a','MGI:1914199','C57BL','E18.5','IMPC_OFD_011_001',0.568962),('1wpho841u1vtt4a','MGI:1913790','C57BL','Early','IMPC_ACS_006_001',0.432023),('1xb5m9w3ghg9l1a','MGI:1095412','C57BL','Late ','IMPC_DXA_003_001',0.093287),('1y437v41p1qtt1a','MGI:1096385','C57BL','Late ','IMPC_ECH_013_001',0.948315),('1y69zs990mm6y7a','MGI:101813','C57BL','Early','IMPC_CBC_003_001',0.483771),('1y8fr84iq53461a','MGI:101813','C57BL','E9.5','IMPC_GRS_011_001',0.917708),('1yhdixwheqpq25a','MGI:1922946','C57BL','Early','IMPC_CBC_058_001',0.0580642),('1yuya17q1lt9b3a','MGI:1914199','C57BL','Early','IMPC_EYE_070_001',0.269433),('1z3ut62293cl7oa','MGI:102844','C57BL','Early','IMPC_EYE_016_001',0.49624),('1zi0525ncv6i44a','MGI:1922776','C57BL','Middl','IMPC_EYE_016_001',0.84155),('1zi85919l5ywboa','MGI:1919880','C57BL','Early','IMPC_CBC_004_001',0.590207),('205cim9g87c3d7a','MGI:1927753','C57BL','Early','IMPC_CSD_078_001',0.203296),('2105jn09ks5a49a','MGI:1919128','C57BL','Early','IMPC_HEM_008_001',0.0711827),('2117p274djm43aa','MGI:2684789','C57BL','Early','IMPC_OFD_010_001',0.209538),('21a604u0kwg695a','MGI:104559','C57BL','Early','IMPC_IMM_014_002',0.764322),('21egqng0mkc0zra','MGI:97898','C57BL','Early','IMPC_XRY_055_001',0.243233),('21wm44u0ecr4o8a','MGI:97565','C57BL','E12.5','IMPC_ECG_006_001',0.417803),('22i2mep34f4220a','MGI:2443564','C57BL','E18.5','IMPC_ECG_003_001',0.2917),('22mc8pl428v85pa','MGI:1920484','C57BL','Early','IMPC_GEP_030_002',0.0998095),('22rr5cyj1g94n8a','MGI:108429','C57BL','E12.5','IMPC_GEL_011_001',0.537822),('230w0345ccy1uqa','MGI:97803','C57BL','E15.5','IMPC_CSD_006_001',0.292421),('232mo0kpilsg68a','MGI:1913721','C57BL','Early','IMPC_EYE_023_001',0.524335),('2360b4n200bh7na','MGI:103559','C57BL','Early','IMPC_CSD_038_001',0.851924),('238mj5w98usp4ea','MGI:1927241','C57BL','E9.5','IMPC_DXA_002_001',0.27582),('2391154qw10793a','MGI:1918066','C57BL','Early','IMPC_OFD_016_001',0.398942),('23j0abc596p7jha','MGI:2654325','C57BL','Early','IMPC_CSD_061_001',0.718273),('245cq823zar881a','MGI:1920199','C57BL','E18.5','IMPC_ACS_006_001',0.747811),('2476tuh01256aja','MGI:1913790','129SV','Early','IMPC_GEM_075_001',0.42792),('249z6pu7sm6747a','MGI:1201673','C57BL','E9.5','IMPC_OFD_021_001',0.228568),('24kq6o71986qc5a','MGI:1309469','C57BL','Early','IMPC_GPO_002_001',0.0952833),('24l5211qnj03a0a','MGI:1913761','C57BL','Early','IMPC_IMM_014_002',0.141752),('24m5rwnbp11yj8a','MGI:106637','C57BL','E9.5','IMPC_ABR_008_001',0.879853),('24r71s7pvkuhpga','MGI:106925','C57BL','Early','IMPC_CSD_061_001',0.520539),('24s02g0dzw0e0ja','MGI:2444274','C57BL','Early','IMPC_CBC_017_001',0.4334),('24t8lml7n10hb0a','MGI:1927753','C57BL','E12.5','IMPC_XRY_016_001',0.927065),('24w64sy255g8q5a','MGI:107363','C57BL','Early','IMPC_HEM_038_001',0.946986),('25d9anb43y719ba','MGI:3045320','C57BL','Early','IMPC_EYE_027_001',0.703621),('25gz77yiz2qr39a','MGI:104559','C57BL','Early','IMPC_FEA_105_001',0.958172),('268jad1s079tg2a','MGI:1931071','C57BL','Early','IMPC_ECG_003_001',0.0855117),('26a7sm31m2g1xla','MGI:2442704','C57BL','Early','IMPC_ACS_006_001',0.857348),('26dh86y1raz6cja','MGI:2441837','C57BL','Early','IMPC_GEP_030_002',0.757818),('26x1519p50bw36a','MGI:1914199','C57BL','Early','IMPC_ABR_004_001',0.949024),('271f665ig9n9c4a','MGI:1921263','C57BL','Early','IMPC_HEM_030_001',0.334037),('272dr954tzggwaa','MGI:109424','C57BL','Early','IMPC_HWT_002_001',0.426738),('27351z5x80q890a','MGI:2676312','C57BL','Early','IMPC_CBC_023_001',0.279018),('274k297x48hbgna','MGI:1914454','C57BL','E12.5','IMPC_OFD_014_001',0.776186),('279o5956k04b8ia','MGI:1915599','129SV','Early','IMPC_XRY_060_001',0.389933),('27a272r6wuva9na','MGI:99218','C57BL','Early','IMPC_CBC_016_001',0.970377),('28016fyufi338pa','MGI:1916428','C57BL','Early','IMPC_OFD_012_001',0.500215),('28j29989036a92a','MGI:98386','C57BL','Early','IMPC_GEP_026_001',0.127912),('28qs8jzf43i8f1a','MGI:1915247','C57BL','E9.5','IMPC_EYE_069_001',0.394061),('28x97bm4y83rf7a','MGI:2384297','C57BL','E12.5','IMPC_ACS_036_001',0.426433),('2910y22w6i8208a','MGI:1913692','C57BL','E9.5','IMPC_CSD_006_001',0.561874),('292lz6132k5030a','MGI:1919369','C57BL','Early','IMPC_ABR_004_001',0.917786),('2969h9f6715l9ia','MGI:1919880','C57BL','Early','IMPC_GEP_017_001',0.208789),('29726wekzn5934a','MGI:108429','C57BL','Early','IMPC_GRS_011_001',0.405055),('29975b953850p0a','MGI:1923073','C57BL','Early','IMPC_ECG_006_001',0.753788),('29ha6e1983bl70a','MGI:98397','129SV','Early','IMPC_CSD_029_001',0.634373),('29j8xa51kj3104a','MGI:1913761','C57BL','Early','IMPC_EYE_026_001',0.22676),('29p182675nf5cka','MGI:3650206','C57BL','Early','IMPC_GEO_064_001',0.991897),('29v55me552lkm1a','MGI:104294','C57BL','Early','IMPC_HEM_008_001',0.523502),('29wsn5071eo1k7a','MGI:1095412','C57BL','Late ','IMPC_GEP_026_001',0.421064),('2a1n619r133qbta','MGI:2443925','C57BL','Early','IMPC_CSD_032_001',0.120507),('2a634x110346swa','MGI:95777','129SV','Early','IMPC_CSD_026_001',0.858102),('2a92mtq45zr2a8a','MGI:97565','C57BL','Early','IMPC_IMM_011_002',0.768916),('2au62fbr987uhya','MGI:1891259','C57BL','Early','IMPC_ABR_010_001',0.154826),('2b1w5w8l8s0q1ma','MGI:104516','C57BL','Early','IMPC_OFD_021_001',0.697451),('2d7yi0934fk035a','MGI:3588202','C57BL','Early','IMPC_ECG_010_001',0.477703),('2dmbamf8s49x9ja','MGI:1920199','C57BL','E18.5','IMPC_HEM_019_001',0.619086),('2ds7962ilq1s99a','MGI:1860511','C57BL','Early','IMPC_EYE_012_001',0.868106),('2dv9j1y4g1pzxfa','MGI:2679420','C57BL','Early','IMPC_CBC_015_001',0.628772),('2dy399c8gndte8a','MGI:2140361','C57BL','E12.5','IMPC_XRY_063_001',0.379748),('2e1263l1h86546a','MGI:1919880','C57BL','Early','IMPC_CSD_030_001',0.252641),('2ez42kdl367d92a','MGI:1337072','C57BL','Early','IMPC_CBC_002_001',0.284094),('2f2952q54pzoeoa','MGI:1916413','C57BL','Early','IMPC_XRY_060_001',0.0735571),('2fas53t0301b18a','MGI:1925835','C57BL','Early','IMPC_GEL_063_001',0.438599),('2fig3cl3l89ffsa','MGI:1922423','C57BL','Early','IMPC_ACS_033_001',0.890817),('2fs674589w6tnva','MGI:1859866','C57BL','E9.5','IMPC_CSD_033_001',0.551537),('2gdoir340v05b4a','MGI:1096385','C57BL','Early','IMPC_IMM_040_002',0.906494),('2h0s8shfwf85t9a','MGI:102519','C57BL','Early','IMPC_CBC_020_001',0.289746),('2h1k1amt54p727a','MGI:2443564','C57BL','E12.5','IMPC_XRY_021_001',0.494861),('2ha5193z9c1986a','MGI:1859866','C57BL','Early','IMPC_GEM_007_001',0.37415),('2hho56u2a9pnbla','MGI:98386','C57BL','E15.5','IMPC_CSD_025_001',0.703461),('2hloaoy41s0l48a','MGI:1095412','C57BL','Late ','IMPC_GEP_011_002',0.261661),('2i1robetqdp11ha','MGI:107341','C57BL','Early','IMPC_XRY_021_001',0.660359),('2i6grpzh147780a','MGI:2444508','C57BL','E15.5','IMPC_CBC_008_001',0.51731),('2i9858dv60hreca','MGI:1913790','C57BL','Early','IMPC_DXA_005_001',0.488487),('2ial2760ca0za2a','MGI:1920199','C57BL','Early','IMPC_EYE_092_001',0.639021);
/*!40000 ALTER TABLE `Analyses` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `Diseases`
--

DROP TABLE IF EXISTS `Diseases`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `Diseases` (
  `disease_id` varchar(50) NOT NULL,
  `disease_term` varchar(150) DEFAULT NULL,
  PRIMARY KEY (`disease_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Stores disease identifiers and terms. Linked to Genes in PhenodigmScores (many-to-many).';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `Diseases`
--

LOCK TABLES `Diseases` WRITE;
/*!40000 ALTER TABLE `Diseases` DISABLE KEYS */;
INSERT INTO `Diseases` VALUES ('DECIPHER:45','Xq28 (MECP2) duplication'),('DECIPHER:8','Smith-Magenis syndrome'),('OMIM:103900','Hyperaldosteronism, Familial, Type I'),('OMIM:104200','Alport Syndrome 3A, Autosomal Dominant'),('OMIM:106210','Aniridia 1'),('OMIM:106220','Aniridia And Absent Patella'),('OMIM:106230','Aniridia, Microcornea, And Spontaneously Reabsorbed Cataract'),('OMIM:107250','Anterior Segment Dysgenesis 1'),('OMIM:109100','Autoimmune Disease'),('OMIM:109150','Machado-Joseph Disease'),('OMIM:109720','Biliary Cirrhosis, Primary, 1'),('OMIM:110150','Blepharoptosis, Myopia, And Ectopia Lentis'),('OMIM:113650','Branchiootorenal Syndrome 1'),('OMIM:114290','Campomelic Dysplasia'),('OMIM:115650','Cataract 32, Multiple Types'),('OMIM:115660','Cataract 7'),('OMIM:115665','Cataract 8, Multiple Types'),('OMIM:115700','Cataract 4, Multiple Types'),('OMIM:115800','Cataract 29'),('OMIM:115900','Cataract 42'),('OMIM:116100','Cataract 20, Multiple Types'),('OMIM:116200','Cataract 1, Multiple Types'),('OMIM:116300','Cataract 30, Multiple Types'),('OMIM:116400','Cataract 41'),('OMIM:116600','Cataract 6, Multiple Types'),('OMIM:116700','Cataract 13 With Adult I Phenotype'),('OMIM:116800','Cataract 5, Multiple Types'),('OMIM:118450','Alagille Syndrome 1'),('OMIM:120040','Cochleosaccular Degeneration With Progressive Cataracts'),('OMIM:120433','Coloboma, Ocular, With Or Without Hearing Impairment, Cleft Lip/Palate, And/Or Impaired Intellectual Development'),('OMIM:120790','Complement Component 4, Partial Deficiency Of'),('OMIM:121390','Cornea Guttata With Anterior Polar Cataracts'),('OMIM:121800','Schnyder Corneal Dystrophy'),('OMIM:121900','Corneal Dystrophy, Groenouw Type I'),('OMIM:123450','Cri-Du-Chat Syndrome'),('OMIM:125851','Maturity-Onset Diabetes Of The Young, Type 2'),('OMIM:125852','Type 1 Diabetes Mellitus 2'),('OMIM:131430','Eosinophilopenia'),('OMIM:132900','Aortic Aneurysm, Familial Thoracic 4'),('OMIM:136520','Foveal Hypoplasia 1'),('OMIM:136580','Fragile Site, Distamycin A Type, Rare, Fra(16)(Q22.1)'),('OMIM:136800','Corneal Dystrophy, Fuchs Endothelial, 1'),('OMIM:137940','Hypotrichosis-Lymphedema-Telangiectasia-Renal Defect Syndrome'),('OMIM:140300','Hashimoto Thyroiditis'),('OMIM:143890','Hypercholesterolemia, Familial, 1'),('OMIM:144010','Hypercholesterolemia, Familial, 2'),('OMIM:144250','Hyperlipidemia, Familial Combined, 3'),('OMIM:144300','Hyperlipoproteinemia, Type Ii, And Deafness'),('OMIM:145750','Hypertriglyceridemia 1'),('OMIM:146200','Hypoparathyroidism, Familial Isolated, 1'),('OMIM:147610','Iris Pigment Layer, Cleavage Of'),('OMIM:147630','Insulinomatosis And Diabetes Mellitus'),('OMIM:147920','Kabuki Syndrome 1'),('OMIM:149500','Kyrle Disease'),('OMIM:151660','Lipodystrophy, Familial Partial, Type 2'),('OMIM:152700','Systemic Lupus Erythematosus'),('OMIM:154230','46, Xy Sex Reversal 4'),('OMIM:156850','Microphthalmia, Isolated, With Cataract 1'),('OMIM:157800','Cardiospondylocarpofacial Syndrome'),('OMIM:161200','Nail-Patella Syndrome'),('OMIM:162000','Tubulointerstitial Kidney Disease, Autosomal Dominant, 1'),('OMIM:164400','Spinocerebellar Ataxia 1'),('OMIM:165300','Optic Atrophy 3, Autosomal Dominant'),('OMIM:169610','Pemphigus Vulgaris, Familial'),('OMIM:172700','Pick Disease Of Brain'),('OMIM:174770','Actinic Prurigo'),('OMIM:176270','Prader-Willi Syndrome'),('OMIM:176410','Precocious Puberty, Male-Limited'),('OMIM:176670','Hutchinson-Gilford Progeria Syndrome'),('OMIM:177650','Exfoliation Syndrome'),('OMIM:177850','Pseudoxanthoma Elasticum, Forme Fruste'),('OMIM:178900','Pupillary Membrane, Persistence Of'),('OMIM:180104','Retinitis Pigmentosa 9'),('OMIM:182290','Smith-Magenis Syndrome'),('OMIM:183090','Spinocerebellar Ataxia 2'),('OMIM:183800','Split-Hand With Congenital Nystagmus, Fundal Changes, And Cataracts'),('OMIM:185070','Stormorken Syndrome'),('OMIM:190330','Trichomegaly'),('OMIM:193230','Vitreoretinal Degeneration, Snowflake Type'),('OMIM:194190','Wolf-Hirschhorn Syndrome'),('OMIM:200150','Choreoacanthocytosis'),('OMIM:201400','Acth Deficiency, Isolated'),('OMIM:201470','Acyl-Coa Dehydrogenase, Short-Chain, Deficiency Of'),('OMIM:201710','Lipoid Congenital Adrenal Hyperplasia'),('OMIM:201810','Adrenal Hyperplasia, Congenital, Due To 3-Beta-Hydroxysteroid Dehydrogenase 2 Deficiency'),('OMIM:201910','Adrenal Hyperplasia, Congenital, Due To 21-Hydroxylase Deficiency'),('OMIM:202010','Adrenal Hyperplasia, Congenital, Due To Steroid 11-Beta-Hydroxylase Deficiency'),('OMIM:202110','Adrenal Hyperplasia, Congenital, Due To 17-Alpha-Hydroxylase Deficiency'),('OMIM:202200','Glucocorticoid Deficiency 1'),('OMIM:203780','Alport Syndrome 2, Autosomal Recessive'),('OMIM:203800','Alstrom Syndrome'),('OMIM:205400','Tangier Disease'),('OMIM:207750','Apolipoprotein C-Ii Deficiency'),('OMIM:208060','Arteriosclerosis, Severe Juvenile'),('OMIM:208400','Aspartylglucosaminuria'),('OMIM:208920','Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia'),('OMIM:209010','Atherosclerosis, Premature, With Deafness, Nephropathy, Diabetes Mellitus, Photomyoclonus, And Degenerative Neurologic Disease'),('OMIM:209850','Autism'),('OMIM:209950','Immunodeficiency 27A'),('OMIM:210250','Sitosterolemia 1'),('OMIM:210500','Biliary Atresia, Extrahepatic'),('OMIM:211770','Cahmr Syndrome'),('OMIM:212065','Congenital Disorder Of Glycosylation, Type Ia'),('OMIM:212066','Congenital Disorder Of Glycosylation, Type Iia'),('OMIM:212400','Cataract And Congenital Ichthyosis'),('OMIM:212500','Cataract 46, Juvenile-Onset, With Or Without Arrhythmic Cardiomyopathy'),('OMIM:212550','Optic Disc Anomalies With Retinal And/Or Macular Dystrophy'),('OMIM:213200','Spinocerebellar Ataxia, Autosomal Recessive 2'),('OMIM:214800','Charge Syndrome'),('OMIM:216820','Coloboma, Ocular, Autosomal Recessive'),('OMIM:216950','Complement Component C1R/C1S Deficiency'),('OMIM:217000','Complement Component 2 Deficiency'),('OMIM:217600','Central Cloudy Dystrophy Of Francois'),('OMIM:217700','Corneal Endothelial Dystrophy'),('OMIM:219080','Acth-Independent Macronodular Adrenal Hyperplasia'),('OMIM:219090','Pituitary Adenoma 4, Acth-Secreting'),('OMIM:220200','Dandy-Walker Syndrome'),('OMIM:220220','Dandy-Walker Malformation With Postaxial Polydactyly'),('OMIM:221900','Persistent Hyperplastic Primary Vitreous, Autosomal Recessive'),('OMIM:222100','Type 1 Diabetes Mellitus'),('OMIM:223370','Dubowitz Syndrome'),('OMIM:224100','Anemia, Congenital Dyserythropoietic, Type Ii'),('OMIM:225100','Ectopia Lentis 2, Isolated, Autosomal Recessive'),('OMIM:225200','Ectopia Lentis Et Pupillae'),('OMIM:230200','Galactosemia Ii'),('OMIM:230650','Gm1-Gangliosidosis, Type Iii'),('OMIM:231550','Achalasia-Addisonianism-Alacrima Syndrome'),('OMIM:232700','Glycogen Storage Disease Vi'),('OMIM:233420','46, Xy Sex Reversal 7'),('OMIM:233450','Goodpasture Syndrome'),('OMIM:234700','Heart Block, Congenital'),('OMIM:235700','Anemia, Congenital, Nonspherocytic Hemolytic, 5'),('OMIM:236680','Hydrolethalus Syndrome 1'),('OMIM:237500','Dubin-Johnson Syndrome'),('OMIM:238600','Hyperlipoproteinemia, Type I'),('OMIM:239500','Hyperprolinemia, Type I'),('OMIM:239900','Hypertrophic Neuropathy And Cataract'),('OMIM:240500','Immunodeficiency, Common Variable, 2'),('OMIM:240950','Hypogonadism-Cataract Syndrome'),('OMIM:242900','Schimke Immunoosseous Dysplasia'),('OMIM:243910','Arima Syndrome'),('OMIM:244450','Kaufman Oculocerebrofacial Syndrome'),('OMIM:245348','Pyruvate Dehydrogenase E2 Deficiency'),('OMIM:245900','Lecithin:Cholesterol Acyltransferase Deficiency'),('OMIM:246700','Chylomicron Retention Disease'),('OMIM:247800','Lymphopenic Hypergammaglobulinemia, Antibody Deficiency, Autoimmune Hemolytic Anemia, And Glomerulonephritis'),('OMIM:248370','Mandibuloacral Dysplasia With Type A Lipodystrophy'),('OMIM:249000','Meckel Syndrome, Type 1'),('OMIM:249310','Neuhauser Syndrome'),('OMIM:250100','Metachromatic Leukodystrophy'),('OMIM:251750','Microspherophakia And/Or Megalocornea, With Ectopia Lentis And With Or Without Secondary Glaucoma'),('OMIM:254000','Muscular Dystrophy, Congenital, With Infantile Cataract And Hypogonadism'),('OMIM:255990','Nathalie Syndrome'),('OMIM:256020','Focal Segmental Glomerulosclerosis 10'),('OMIM:256300','Nephrotic Syndrome, Type 1'),('OMIM:256450','Hyperinsulinemic Hypoglycemia, Familial, 1'),('OMIM:256840','Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive'),('OMIM:257200','Niemann-Pick Disease, Type A'),('OMIM:257220','Niemann-Pick Disease, Type C1'),('OMIM:257550','Ocular Motor Apraxia'),('OMIM:259050','Primrose Syndrome'),('OMIM:262300','Achromatopsia 3'),('OMIM:264120','Prolactin Deficiency With Obesity And Enlarged Testes'),('OMIM:264800','Pseudoxanthoma Elasticum'),('OMIM:266200','Anemia, Congenital, Nonspherocytic Hemolytic, 2'),('OMIM:266510','Peroxisome Biogenesis Disorder 3B'),('OMIM:268100','Enhanced S-Cone Syndrome'),('OMIM:269400','Anterior Segment Dysgenesis 7'),('OMIM:269600','Sea-Blue Histiocyte Disease'),('OMIM:270150','Sjogren Syndrome'),('OMIM:270400','Smith-Lemli-Opitz Syndrome'),('OMIM:271250','Spinocerebellar Ataxia, Autosomal Recessive 3'),('OMIM:271320','Spinocerebellar Degeneration With Macular Corneal Dystrophy, Congenital Cataracts, And Myopia'),('OMIM:273150','Testes, Rudimentary'),('OMIM:273395','Tetraamelia Syndrome 1'),('OMIM:273680','Thanatophoric Dysplasia, Glasgow Variant'),('OMIM:274205','Thumb, Hypoplastic, With Choroid Coloboma, Poorly Developed Antihelix, And Deafness'),('OMIM:277460','Ataxia With Vitamin E Deficiency'),('OMIM:277700','Werner Syndrome'),('OMIM:278000','Cholesteryl Ester Storage Disease'),('OMIM:278850','46, Xx Sex Reversal 2'),('OMIM:300018','46, Xy Sex Reversal 2'),('OMIM:300055','Intellectual Developmental Disorder, X-Linked, Syndromic 13'),('OMIM:300062','Intellectual Developmental Disorder, X-Linked 14'),('OMIM:300143','Intellectual Developmental Disorder, X-Linked 21'),('OMIM:300200','Adrenal Hypoplasia, Congenital'),('OMIM:300238','Intellectual Developmental Disorder, X-Linked, Syndromic, Shashi Type'),('OMIM:300260','Intellectual Developmental Disorder, X-Linked, Syndromic, Lubs Type'),('OMIM:300271','Intellectual Developmental Disorder, X-Linked 72'),('OMIM:300352','Cerebral Creatine Deficiency Syndrome 1'),('OMIM:300425','Autism, Susceptibility To, X-Linked 1'),('OMIM:300428','Intellectual Developmental Disorder, X-Linked 2'),('OMIM:300486','Intellectual Developmental Disorder, X-Linked, Syndromic, Billuart Type'),('OMIM:300495','Autism, Susceptibility To, X-Linked 2'),('OMIM:300496','Autism, Susceptibility To, X-Linked 3'),('OMIM:300602','Clark-Baraitser syndrome'),('OMIM:300614','Deafness, X-Linked 5, With Peripheral Neuropathy'),('OMIM:300622','Tn Polyagglutination Syndrome'),('OMIM:300624','Fragile X Syndrome'),('OMIM:300672','Developmental And Epileptic Encephalopathy 2'),('OMIM:300706','Mental retardation, x-linked, syndromic, Turner type'),('OMIM:300719','Deafness, Cataract, Retinitis Pigmentosa, And Sperm Abnormalities'),('OMIM:300749','Intellectual Developmental Disorder With Microcephaly And Pontine And Cerebellar Hypoplasia'),('OMIM:300752','Protoporphyria, Erythropoietic, X-Linked'),('OMIM:300755','Agammaglobulinemia, X-Linked'),('OMIM:300779','Corneal Dystrophy, Endothelial, X-Linked'),('OMIM:300833','46, Xx Sex Reversal 3'),('OMIM:300845','Moyamoya Disease 4 With Short Stature, Hypergonadotropic Hypogonadism, And Facial Dysmorphism'),('OMIM:300855','Ogden Syndrome'),('OMIM:300886','Intellectual Developmental Disorder, X-Linked, Syndromic 32'),('OMIM:300912','Intellectual Developmental Disorder, X-Linked 98'),('OMIM:300972','Immunodeficiency 47'),('OMIM:300986','Intellectual Developmental Disorder, X-Linked, Syndromic, Bain Type'),('OMIM:301006','Galloway-Mowat Syndrome 2, X-Linked'),('OMIM:301029','Shukla-Vernon Syndrome'),('OMIM:301030','Van Esch-O\'Driscoll Syndrome'),('OMIM:301033','Hypothyroidism, Congenital, Nongoitrous, 8'),('OMIM:301040','Alpha-Thalassemia/Impaired Intellectual Development Syndrome, X-Linked'),('OMIM:301044','Developmental And Epileptic Encephalopathy 85 With Or Without Midline Brain Defects'),('OMIM:301066','Intellectual Developmental Disorder, X-Linked, Syndromic, With Pigmentary Mosaicism And Coarse Facies'),('OMIM:301078','Immunodeficiency 98 With Autoinflammation, X-Linked'),('OMIM:301094','Hijazi-Reis Syndrome'),('OMIM:301109','Autoinflammatory Disease, Multisystem, With Immune Dysregulation, X-Linked'),('OMIM:302200','Cataract 40'),('OMIM:304400','Deafness, X-Linked 2'),('OMIM:304730','Dermoids Of Cornea'),('OMIM:304790','Immunodysregulation, Polyendocrinopathy, And Enteropathy, X-Linked'),('OMIM:305800','Membranoproliferative Glomerulonephritis, X-Linked'),('OMIM:306000','Glycogen Storage Disease Ixa1'),('OMIM:307500','Hypogonadism, Male, With Impaired Intellectual Development And Skeletal Anomalies'),('OMIM:309000','Lowe Oculocerebrorenal Syndrome'),('OMIM:309300','Megalocornea'),('OMIM:309520','Intellectual Developmental Disorder, X-Linked, Syndromic, Lujan-Fryns Type'),('OMIM:309548','Intellectual Developmental Disorder, X-Linked 109'),('OMIM:309590','Intellectual Developmental Disorder, X-Linked, Syndromic, Turner Type'),('OMIM:310468','Nephrolithiasis, X-Linked Recessive, With Renal Failure'),('OMIM:310600','Norrie Disease'),('OMIM:312500','Reticuloendotheliosis, X-Linked'),('OMIM:312910','Spastic Paraparesis And Deafness'),('OMIM:314000','Thrombocytopenia With Elevated Serum Iga And Renal Disease'),('OMIM:400044','46, Xy Sex Reversal 1'),('OMIM:400045','46, Xx Sex Reversal 1'),('OMIM:600430','Chromosome 2Q37 Deletion Syndrome'),('OMIM:600496','Maturity-Onset Diabetes Of The Young, Type 3'),('OMIM:600791','Deafness, Autosomal Recessive 4, With Enlarged Vestibular Aqueduct'),('OMIM:600795','Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 7'),('OMIM:600803','Gallbladder Disease 1'),('OMIM:600881','Cataract 10, Multiple Types'),('OMIM:600886','Hyperferritinemia With Or Without Cataract'),('OMIM:600955','Proprotein Convertase 1/3 Deficiency'),('OMIM:601186','Microphthalmia, Syndromic 9'),('OMIM:601202','Cataract 24'),('OMIM:601371','Cataract, Age-Related Nuclear'),('OMIM:601547','Cataract 3, Multiple Types'),('OMIM:601552','Traboulsi Syndrome'),('OMIM:601666','Type 1 Diabetes Mellitus 15'),('OMIM:601794','Coloboma-Obesity-Hypogenitalism-Impaired Intellectual Development Syndrome'),('OMIM:601820','Hyperinsulinemic Hypoglycemia, Familial, 2'),('OMIM:601859','Autoimmune Lymphoproliferative Syndrome'),('OMIM:601885','Cataract 14, Multiple Types'),('OMIM:601941','Type 1 Diabetes Mellitus 6'),('OMIM:601942','Type 1 Diabetes Mellitus 10'),('OMIM:602247','Xanthomatosis, Susceptibility To'),('OMIM:602361','Gracile Bone Dysplasia'),('OMIM:602433','Amyotrophic Lateral Sclerosis 4, Juvenile'),('OMIM:602440','Amyotrophy, Monomelic'),('OMIM:602450','Severe Combined Immunodeficiency With Sensitivity To Ionizing Radiation'),('OMIM:602485','Hyperinsulinemic Hypoglycemia, Familial, 3'),('OMIM:602588','Branchiootic Syndrome 1'),('OMIM:603165','Dermatitis, Atopic'),('OMIM:603776','Hypercholesterolemia, Familial, 3'),('OMIM:603813','Hypercholesterolemia, Familial, 4'),('OMIM:603909','Autoimmune Lymphoproliferative Syndrome, Type Iia'),('OMIM:604091','Hypoalphalipoproteinemia, Primary, 1'),('OMIM:604219','Cataract 9, Multiple Types'),('OMIM:604229','Anterior Segment Dysgenesis 5'),('OMIM:604307','Cataract 2, Multiple Types'),('OMIM:604809','Panbronchiolitis, Diffuse'),('OMIM:604901','North American Indian Childhood Cirrhosis'),('OMIM:605387','Cataract 31, Multiple Types'),('OMIM:605479','Cholestasis, Benign Recurrent Intrahepatic, 2'),('OMIM:605814','Citrullinemia, Type Ii, Neonatal-Onset'),('OMIM:606053','Intellectual Developmental Disorder With Autism And Speech Delay'),('OMIM:606232','Phelan-Mcdermid Syndrome'),('OMIM:606392','Maturity-Onset Diabetes Of The Young, Type 4'),('OMIM:606394','Maturity-Onset Diabetes Of The Young, Type 6'),('OMIM:606721','Lipodystrophy, Familial Partial, Type 7'),('OMIM:606762','Hyperinsulinemic Hypoglycemia, Familial, 6'),('OMIM:607250','Spinocerebellar Ataxia, Autosomal Recessive, With Axonal Neuropathy 1'),('OMIM:607330','Lathosterolosis'),('OMIM:607373','Autism, Susceptibility To, 8'),('OMIM:607398','Glucocorticoid Deficiency 2'),('OMIM:607453','Deafness, Autosomal Dominant 44'),('OMIM:607459','Sensory Ataxic Neuropathy, Dysarthria, And Ophthalmoparesis'),('OMIM:607616','Niemann-Pick Disease, Type B'),('OMIM:607625','Niemann-Pick Disease, Type C2'),('OMIM:607765','Bile Acid Synthesis Defect, Congenital, 1'),('OMIM:608049','Autism, Susceptibility To, 3'),('OMIM:608184','Immunodeficiency With Hyper-Igm, Type 4'),('OMIM:608320','Coronary Artery Disease, Autosomal Dominant, 1'),('OMIM:608367','Myopia 17, Autosomal Dominant'),('OMIM:608600','Lipodystrophy, Familial Partial, Type 1'),('OMIM:608631','Asperger Syndrome, Susceptibility To, 2'),('OMIM:608636','Chromosome 15Q11-Q13 Duplication Syndrome'),('OMIM:608638','Asperger Syndrome, Susceptibility To, 1'),('OMIM:608709','Lipodystrophy, Partial, Acquired, Susceptibility To'),('OMIM:608776','Congenital Disorder Of Glycosylation, Type Il'),('OMIM:609136','Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, And Hirschsprung Disease'),('OMIM:609140','Corneal Dystrophy, Posterior Polymorphous, 2'),('OMIM:609197','Glucocorticoid Deficiency 3'),('OMIM:609376','Cataract 35'),('OMIM:609425','Chromosome 3Q29 Deletion Syndrome'),('OMIM:609529','Immunoglobulin A Deficiency 2'),('OMIM:609734','Obesity, Early-Onset, With Adrenal Insufficiency And Red Hair'),('OMIM:609741','Cataract 22, Multiple Types'),('OMIM:609939','Systemic Lupus Erythematosus, Susceptibility To, 6'),('OMIM:610019','Cataract 18'),('OMIM:610021','Hyperinsulinemic Hypoglycemia, Familial, 7'),('OMIM:610042','Pitt-Hopkins-Like Syndrome 1'),('OMIM:610092','Microphthalmia/Coloboma 3'),('OMIM:610156','Impaired Intellectual Development, Truncal Obesity, Retinal Dystrophy, And Micropenis Syndrome'),('OMIM:610202','Cataract 21, Multiple Types'),('OMIM:610253','Kleefstra Syndrome 1'),('OMIM:610256','Anterior Segment Dysgenesis 2'),('OMIM:610374','Diabetes Mellitus, Transient Neonatal, 2'),('OMIM:610425','Cataract 23, Multiple Types'),('OMIM:610475','Pigmented Nodular Adrenocortical Disease, Primary, 2'),('OMIM:610489','Pigmented Nodular Adrenocortical Disease, Primary, 1'),('OMIM:610508','Maturity-Onset Diabetes Of The Young, Type 7'),('OMIM:610539','Gaucher Disease, Atypical, Due To Saposin C Deficiency'),('OMIM:610600','Corticosterone Methyloxidase Type Ii Deficiency'),('OMIM:610623','Cataract 11, Multiple Types'),('OMIM:610644','Palmoplantar Hyperkeratosis With Squamous Cell Carcinoma Of Skin And 46, Xx Sex Reversal'),('OMIM:610688','Joubert Syndrome 6'),('OMIM:610842','Pseudoxanthoma Elasticum-Like Disorder With Multiple Coagulation Factor Deficiency'),('OMIM:610883','Potocki-Lupski Syndrome'),('OMIM:610947','Coronary Artery Disease, Autosomal Dominant 2'),('OMIM:610954','Pitt-Hopkins Syndrome'),('OMIM:610984','Complement Factor I Deficiency'),('OMIM:611391','Cataract 33, Multiple Types'),('OMIM:611465','Gallbladder Disease 4'),('OMIM:611489','Corticosteroid-Binding Globulin Deficiency'),('OMIM:611544','Cataract 17, Multiple Types'),('OMIM:611584','Waardenburg Syndrome, Type 2E'),('OMIM:611597','Cataract 12, Multiple Types'),('OMIM:611788','Aortic Aneurysm, Familial Thoracic 6'),('OMIM:611812','46, Xx Sex Reversal With Dysgenesis Of Kidneys, Adrenals, And Lungs'),('OMIM:611881','Glycogen Storage Disease Xii'),('OMIM:612018','Cataract 47'),('OMIM:612020','Spastic Paraplegia 39, Autosomal Recessive'),('OMIM:612069','Amyotrophic Lateral Sclerosis 10 With Or Without Frontotemporal Dementia'),('OMIM:612109','Oculoauricular Syndrome'),('OMIM:612227','Diabetes Mellitus, Ketosis-Prone'),('OMIM:612356','Heparin Cofactor Ii Deficiency'),('OMIM:612474','Chromosome 1Q21.1 Deletion Syndrome, 1.35-Mb'),('OMIM:612520','Type 1 Diabetes Mellitus 20'),('OMIM:612526','Lipodystrophy, Congenital Generalized, Type 3'),('OMIM:612651','Endocrine-Cerebroosteodysplasia'),('OMIM:612713','Kahrizi Syndrome'),('OMIM:612840','Leukocyte Adhesion Deficiency, Type Iii'),('OMIM:612965','46, Xy Sex Reversal 3'),('OMIM:613011','Lymphoproliferative Syndrome 1'),('OMIM:613076','Myopathy, Mitochondrial Progressive, With Congenital Cataract And Developmental Delay'),('OMIM:613080','46, Xy Sex Reversal 5'),('OMIM:613086','Glaucoma 3, Primary Congenital, D'),('OMIM:613174','Chromosome 5P13 Duplication Syndrome'),('OMIM:613179','Purine Nucleoside Phosphorylase Deficiency'),('OMIM:613195','Weill-Marchesani Syndrome 4'),('OMIM:613370','Maturity-Onset Diabetes Of The Young, Type 10'),('OMIM:613443','Neurodevelopmental Disorder With Hypotonia, Stereotypic Hand Movements, And Impaired Language'),('OMIM:613454','Rett Syndrome, Congenital Variant'),('OMIM:613470','Anemia, Congenital, Nonspherocytic Hemolytic, 4'),('OMIM:613496','Immunodeficiency, Common Variable, 6'),('OMIM:613571','Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency'),('OMIM:613652','C1Q Deficiency 1'),('OMIM:613670','Intellectual Developmental Disorder With Language Impairment And With Or Without Autistic Features'),('OMIM:613677','Hyperaldosteronism, Familial, Type Iii'),('OMIM:613743','Adrenal Insufficiency, Congenital, With 46, Xy Sex Reversal, Partial Or Complete'),('OMIM:613762','46, Xy Sex Reversal 6'),('OMIM:613763','Cataract 16, Multiple Types'),('OMIM:613779','Complement Component 3 Deficiency, Autosomal Recessive'),('OMIM:613783','Complement Component C1S Deficiency'),('OMIM:613791','Masp2 Deficiency'),('OMIM:613801','Retinitis Pigmentosa 40'),('OMIM:613826','Leber Congenital Amaurosis 6'),('OMIM:613829','Leber Congenital Amaurosis 7'),('OMIM:613886','Obesity, Hyperphagia, And Developmental Delay'),('OMIM:613887','Cataract 36'),('OMIM:613913','Lipodystrophy, Partial, Acquired, With Low Complement Component C3, With Or Without Glomerulonephritis'),('OMIM:614008','Nestor-Guillermo Progeria Syndrome'),('OMIM:614025','Hepatic Lipase Deficiency'),('OMIM:614063','N-Acetylaspartate Deficiency'),('OMIM:614104','Intellectual Developmental Disorder, Autosomal Dominant 7'),('OMIM:614156','Hyperbiliverdinemia'),('OMIM:614175','Meckel Syndrome, Type 10'),('OMIM:614186','Leber Congenital Amaurosis 16'),('OMIM:614190','Pigmented Nodular Adrenocortical Disease, Primary, 3'),('OMIM:614196','Nephrotic Syndrome, Type 6'),('OMIM:614199','Nephrotic Syndrome, Type 5, With Or Without Ocular Abnormalities'),('OMIM:614279','46, Xy Sex Reversal 8'),('OMIM:614284','Stickler Syndrome, Type V'),('OMIM:614292','Myopia, High, With Cataract And Vitreoretinal Degeneration'),('OMIM:614303','Edict Syndrome'),('OMIM:614338','Pancreatic Lipase Deficiency'),('OMIM:614376','Short-Rib Thoracic Dysplasia 5 With Or Without Polydactyly'),('OMIM:614377','Nephronophthisis 13'),('OMIM:614380','Complement Component 4A Deficiency'),('OMIM:614420','Systemic Lupus Erythematosus 16'),('OMIM:614422','Cataract 37'),('OMIM:614470','Ras-Associated Autoimmune Leukoproliferative Disorder'),('OMIM:614473','Arterial Calcification, Generalized, Of Infancy, 2'),('OMIM:614662','Cortisone Reductase Deficiency 2'),('OMIM:614674','Periodic Fever, Menstrual Cycle-Dependent'),('OMIM:614691','Cataract 38'),('OMIM:614736','Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency'),('OMIM:614756','Cerebellar Dysfunction With Variable Cognitive And Behavioral Abnormalities'),('OMIM:614809','C3 Glomerulopathy 3'),('OMIM:614831','Spinocerebellar Ataxia, Autosomal Recessive 13'),('OMIM:614878','Autoinflammation, Antibody Deficiency, And Immune Dysregulation'),('OMIM:614885','Peroxisome Biogenesis Disorder 11B'),('OMIM:615008','Nephrotic Syndrome, Type 7'),('OMIM:615184','Cardiomyopathy, Dilated, 1Ii'),('OMIM:615188','Cataract 39, Multiple Types'),('OMIM:615274','Cataract 15, Multiple Types'),('OMIM:615282','Cortical Dysplasia, Complex, With Other Brain Malformations 2'),('OMIM:615363','Estrogen Resistance'),('OMIM:615387','Immunodeficiency 7'),('OMIM:615401','Immunodeficiency 8 With Lymphoproliferation'),('OMIM:615412','Cortical Dysplasia, Complex, With Other Brain Malformations 4'),('OMIM:615485','Bainbridge-Ropers Syndrome'),('OMIM:615502','Intellectual Developmental Disorder, Autosomal Dominant 21'),('OMIM:615512','Triosephosphate Isomerase Deficiency'),('OMIM:615516','Intellectual Developmental Disorder, Autosomal Recessive 38'),('OMIM:615523','Corneal Dystrophy, Fuchs Endothelial, 8'),('OMIM:615541','Intellectual Developmental Disorder, Autosomal Recessive 39'),('OMIM:615558','Hypobetalipoproteinemia, Familial, 1'),('OMIM:615559','Autoimmune Lymphoproliferative Syndrome, Type Iii'),('OMIM:615574','Asparagine Synthetase Deficiency'),('OMIM:615619','Cholangiocarcinoma, Susceptibility To'),('OMIM:615637','Intellectual Developmental Disorder, Autosomal Recessive 41'),('OMIM:615656','Chromosome 15Q11.2 Deletion Syndrome'),('OMIM:615703','Morbid Obesity And Spermatogenic Failure'),('OMIM:615771','Cortical Dysplasia, Complex, With Other Brain Malformations 6'),('OMIM:615802','Neurodevelopmental Disorder With Dysmorphic Features, Spasticity, And Brain Abnormalities'),('OMIM:615812','Abdominal Obesity-Metabolic Syndrome 3'),('OMIM:615816','Immunodeficiency 23'),('OMIM:615830','Pigmented Nodular Adrenocortical Disease, Primary, 4'),('OMIM:615861','Nephrotic Syndrome, Type 10'),('OMIM:615863','Diarrhea 7, Protein-Losing Enteropathy Type'),('OMIM:615873','Helsmoortel-Van Der Aa Syndrome'),('OMIM:615935','Pancreatic Agenesis 2'),('OMIM:615947','Hyperlipoproteinemia, Type Id'),('OMIM:615952','Autoimmune Disease, Multisystem, Infantile-Onset, 1'),('OMIM:615954','Acth-Independent Macronodular Adrenal Hyperplasia 2'),('OMIM:615960','Poretti-Boltshauser Syndrome'),('OMIM:615995','Bardet-Biedl Syndrome 18'),('OMIM:616000','Analbuminemia'),('OMIM:616005','Immunodeficiency 36 With Lymphoproliferation'),('OMIM:616067','46, Xy Sex Reversal 9'),('OMIM:616217','Nephronophthisis 19'),('OMIM:616222','Temple Syndrome'),('OMIM:616267','Ataxia-Oculomotor Apraxia 4'),('OMIM:616268','Arboleda-Tham Syndrome'),('OMIM:616269','Intellectual Developmental Disorder, Autosomal Recessive 48'),('OMIM:616279','Cataract 43'),('OMIM:616341','Developmental And Epileptic Encephalopathy 30'),('OMIM:616351','Intellectual Developmental Disorder, Autosomal Dominant 34'),('OMIM:616364','White-Sutton Syndrome'),('OMIM:616393','Intellectual Developmental Disorder, Autosomal Dominant 38'),('OMIM:616414','Autoimmune Interstitial Lung, Joint, And Kidney Disease'),('OMIM:616425','46, Xy Sex Reversal 10'),('OMIM:616468','Exudative Vitreoretinopathy 6'),('OMIM:616509','Cataract 44'),('OMIM:616511','Maturity-Onset Diabetes Of The Young, Type 14'),('OMIM:616579','Neurodevelopmental Disorder With Hypotonia, Impaired Language, And Dysmorphic Features'),('OMIM:616682','Seizures, Scoliosis, And Macrocephaly/Microcephaly Syndrome'),('OMIM:616722','Retinal Dystrophy And Iris Coloboma With Or Without Cataract'),('OMIM:616730','Nephrotic Syndrome, Type 11'),('OMIM:616828','Congenital Disorder Of Glycosylation, Type Iio'),('OMIM:616829','Congenital Disorder Of Glycosylation, Type Iip'),('OMIM:616833','Paget Disease Of Bone 6'),('OMIM:616834','Microcephaly, Congenital Cataract, And Psoriasiform Dermatitis'),('OMIM:616851','Cataract 45'),('OMIM:616871','Myeloproliferative/Lymphoproliferative Neoplasms, Familial (Multiple Types), Susceptibility To'),('OMIM:616892','Nephrotic Syndrome, Type 12'),('OMIM:616939','Chorea, Childhood-Onset, With Psychomotor Retardation'),('OMIM:617006','Autoimmune Disease, Multisystem, Infantile-Onset, 2'),('OMIM:617044','Short Stature, Developmental Delay, And Congenital Heart Defects'),('OMIM:617053','Mirage Syndrome'),('OMIM:617061','Intellectual Developmental Disorder, Autosomal Dominant 44, With Microcephaly'),('OMIM:617101','Intellectual Developmental Disorder With Persistence Of Fetal Hemoglobin'),('OMIM:617133','Spinocerebellar Ataxia, Autosomal Recessive 24'),('OMIM:617141','Aniridia 2'),('OMIM:617142','Aniridia 3'),('OMIM:617168','Aortic Aneurysm, Familial Thoracic 10'),('OMIM:617171','Neurodevelopmental Disorder With Hypotonia And Impaired Expressive Language And With Or Without Seizures'),('OMIM:617251','Uncombable Hair Syndrome 2'),('OMIM:617270','Intellectual Developmental Disorder, Autosomal Recessive 58'),('OMIM:617315','Anterior Segment Dysgenesis 6'),('OMIM:617319','Anterior Segment Dysgenesis 8'),('OMIM:617330','Hypotonia, Ataxia, And Delayed Development Syndrome'),('OMIM:617393','Neurodevelopmental Disorder With Epilepsy, Cataracts, Feeding Difficulties, And Delayed Brain Myelination'),('OMIM:617394','Sclerosing Cholangitis, Neonatal'),('OMIM:617435','Lopes-Maciel-Rodan Syndrome'),('OMIM:617600','Intellectual Developmental Disorder, Autosomal Dominant 45'),('OMIM:617609','Nephrotic Syndrome, Type 15'),('OMIM:617682','Pilarowski-Bjornsson Syndrome'),('OMIM:617695','Pontocerebellar Hypoplasia, Type 11'),('OMIM:617718','Immunodeficiency 71 With Inflammatory Disease And Congenital Thrombocytopenia'),('OMIM:617751','Intellectual Developmental Disorder, Autosomal Dominant 48'),('OMIM:617783','Nephrotic Syndrome, Type 16'),('OMIM:617787','Intellectual Developmental Disorder, Autosomal Dominant 50, With Behavioral Abnormalities'),('OMIM:617796','Intellectual Developmental Disorder, Autosomal Dominant 52'),('OMIM:617802','Neurodevelopmental Disorder With Microcephaly, Seizures, And Cortical Atrophy'),('OMIM:617807','Neurodevelopmental Disorder With Ataxic Gait, Absent Speech, And Decreased Cortical White Matter'),('OMIM:617808','Coffin-Siris Syndrome 6'),('OMIM:617820','Neurodevelopmental Disorder With Or Without Hyperkinetic Movements And Seizures, Autosomal Recessive'),('OMIM:617825','Glucocorticoid Deficiency 5'),('OMIM:617830','Developmental And Epileptic Encephalopathy 58'),('OMIM:617862','Neurodevelopmental Disorder With Microcephaly, Epilepsy, And Brain Atrophy'),('OMIM:617903','Neurodevelopmental Disorder With Poor Language And Loss Of Hand Skills'),('OMIM:618004','Developmental And Epileptic Encephalopathy 64'),('OMIM:618013','Deafness, Autosomal Recessive 109'),('OMIM:618027','Coffin-Siris Syndrome 7'),('OMIM:618067','Developmental And Epileptic Encephalopathy 66'),('OMIM:618147','Intellectual Developmental Disorder With Hypertelorism And Distinctive Facies'),('OMIM:618156','Squalene Synthase Deficiency'),('OMIM:618205','Snijders Blok-Campeau Syndrome'),('OMIM:618218','Baker-Gordon Syndrome'),('OMIM:618220','Retinitis Pigmentosa 84'),('OMIM:618342','Intellectual Developmental Disorder With Abnormal Behavior, Microcephaly, And Short Stature'),('OMIM:618347','Galloway-Mowat Syndrome 6'),('OMIM:618348','Galloway-Mowat Syndrome 7'),('OMIM:618354','Houge-Janssens Syndrome 3'),('OMIM:618398','T-Cell Lymphoma, Subcutaneous Panniculitis-Like'),('OMIM:618415','Cataract 48'),('OMIM:618430','Developmental Delay With Variable Intellectual Impairment And Behavioral Abnormalities'),('OMIM:618463','Hypoalphalipoproteinemia, Primary, 2'),('OMIM:618495','Immunodeficiency 63 With Lymphoproliferation And Autoimmunity'),('OMIM:618497','Neurodevelopmental Disorder With Seizures And Nonepileptic Hyperkinetic Movements'),('OMIM:618504','Intellectual Developmental Disorder, Autosomal Recessive 71'),('OMIM:618534','Immunodeficiency 64 With Lymphoproliferation'),('OMIM:618620','Abdominal Obesity-Metabolic Syndrome 4'),('OMIM:618653','Intellectual Developmental Disorder With Impaired Language And Dysmorphic Facies'),('OMIM:618660','Anemia, Congenital, Nonspherocytic Hemolytic, 10'),('OMIM:618666','Sitosterolemia 2'),('OMIM:618709','Neurodevelopmental Disorder With Nonspecific Brain Abnormalities And With Or Without Seizures'),('OMIM:618718','Neurodevelopmental Disorder With Behavioral Abnormalities, Absent Speech, And Hypotonia'),('OMIM:618778','Deafness, Autosomal Dominant 75'),('OMIM:618810','Pontocerebellar Hypoplasia, Hypotonia, And Respiratory Insufficiency Syndrome, Neonatal Lethal'),('OMIM:618825','Intellectual Developmental Disorder, Autosomal Dominant 63, With Macrocephaly'),('OMIM:618835','Combined Oxidative Phosphorylation Deficiency 40'),('OMIM:618838','Combined Oxidative Phosphorylation Deficiency 41'),('OMIM:618839','Combined Oxidative Phosphorylation Deficiency 42'),('OMIM:618852','Autoinflammation With Episodic Fever And Lymphadenopathy'),('OMIM:618874','Chromosome 17Q11.2 Duplication Syndrome, 1.4-Mb'),('OMIM:618881','Galactosemia Iv'),('OMIM:618906','Intellectual Developmental Disorder With Autistic Features And Language Delay, With Or Without Seizures'),('OMIM:618912','Neuronopathy, Distal Hereditary Motor, Autosomal Recessive 8'),('OMIM:618914','Neurodevelopmental, Jaw, Eye, And Digital Syndrome'),('OMIM:618915','Deafness, Autosomal Dominant 77'),('OMIM:618917','Neurodevelopmental Disorder With Language Impairment And Behavioral Abnormalities'),('OMIM:618935','Granulomatous Disease, Chronic, Autosomal Recessive, 5'),('OMIM:618999','Autoinflammation, Immune Dysregulation, And Eosinophilia'),('OMIM:619005','Neurodevelopmental Disorder With Dysmorphic Facies, Impaired Speech, And Hypotonia'),('OMIM:619016','Ifap Syndrome 2'),('OMIM:619054','Mitochondrial Complex Iv Deficiency, Nuclear Type 11'),('OMIM:619082','Microcornea, Rod-Cone Dystrophy, Cataract, And Posterior Staphyloma 1'),('OMIM:619092','Neurodevelopmental Disorder With Microcephaly, Impaired Language, Epilepsy, And Gait Abnormalities'),('OMIM:619103','Neurodevelopmental Disorder With Dysmorphic Facies, Sleep Disturbance, And Brain Abnormalities'),('OMIM:619121','Neurodevelopmental Disorder With Cardiomyopathy, Spasticity, And Brain Abnormalities'),('OMIM:619126','Immunodeficiency 75 With Lymphoproliferation'),('OMIM:619150','Intellectual Developmental Disorder With Paroxysmal Dyskinesia Or Seizures'),('OMIM:619183','Proteasome-Associated Autoinflammatory Syndrome 4'),('OMIM:619201','Nephrotic Syndrome, Type 23'),('OMIM:619220','Immunodeficiency 78 With Autoimmunity And Developmental Delay'),('OMIM:619229','Den Hoed-De Boer-Voisin Syndrome'),('OMIM:619274','Deafness, Autosomal Dominant 80'),('OMIM:619290','Mahvash Disease'),('OMIM:619293','Blepharophimosis-Impaired Intellectual Development Syndrome'),('OMIM:619297','Kinsship Syndrome'),('OMIM:619306','Neurodevelopmental Disorder With Dysmorphic Facies And Cerebellar Hypoplasia'),('OMIM:619312','Radio-Tartaglia Syndrome'),('OMIM:619313','Immunodeficiency 80 With Or Without Congenital Cardiomyopathy'),('OMIM:619317','Developmental And Epileptic Encephalopathy 6B'),('OMIM:619324','Hypertriglyceridemia 2'),('OMIM:619325','Coffin-Siris Syndrome 12'),('OMIM:619338','Cataracts, Spastic Paraparesis, And Speech Delay'),('OMIM:619375','Autoinflammatory Syndrome, Familial, With Or Without Immunodeficiency'),('OMIM:619428','Focal Segmental Glomerulosclerosis And Neurodevelopmental Syndrome'),('OMIM:619435','Ritscher-Schinzel Syndrome 4'),('OMIM:619470','Neurodevelopmental Disorder With Motor And Speech Delay And Behavioral Abnormalities'),('OMIM:619471','Bardet-Biedl Syndrome 20'),('OMIM:619475','Developmental Delay, Impaired Speech, And Behavioral Abnormalities'),('OMIM:619512','Neurodevelopmental Disorder With Hypotonia And Brain Abnormalities'),('OMIM:619522','Neurodevelopmental-Craniofacial Syndrome With Variable Renal And Cardiac Abnormalities'),('OMIM:619525','Congenital Disorder Of Glycosylation, Type Iiw'),('OMIM:619534','Biliary, Renal, Neurologic, And Skeletal Syndrome'),('OMIM:619575','Developmental Delay With Or Without Intellectual Impairment Or Behavioral Abnormalities'),('OMIM:619580','Neurodevelopmental Disorder With Impaired Language And Ataxia And With Or Without Seizures'),('OMIM:619593','Cataract 49'),('OMIM:619621','Spastic Paraplegia 84, Autosomal Recessive'),('OMIM:619644','Immunodeficiency 91 And Hyperinflammation'),('OMIM:619648','Zaki Syndrome'),('OMIM:619649','Chromosome 16Q12 Duplication Syndrome'),('OMIM:619662','Cholestasis, Progressive Familial Intrahepatic, 8'),('OMIM:619690','Brunet-Wagner Neurodevelopmental Syndrome'),('OMIM:619695','Rauch-Steindl Syndrome'),('OMIM:619717','Intellectual Developmental Disorder, Autosomal Recessive 73'),('OMIM:619725','Neurodevelopmental Disorder With Or Without Variable Movement Or Behavioral Abnormalities'),('OMIM:619777','Developmental And Epileptic Encephalopathy 100'),('OMIM:619781','Myopia 28, Autosomal Recessive'),('OMIM:619802','Immunodeficiency 97 With Autoinflammation'),('OMIM:619813','Neutropenia, Severe Congenital, 9, Autosomal Dominant'),('OMIM:619846','Immunodeficiency 99 With Hypogammaglobulinemia And Autoimmune Cytopenias'),('OMIM:619849','Cholestasis, Progressive Familial Intrahepatic, 9'),('OMIM:619855','Thyroid Hormone Metabolism, Abnormal, 2'),('OMIM:619858','Autoinflammatory-Pancytopenia Syndrome'),('OMIM:619868','Cholestasis, Progressive Familial Intrahepatic, 10'),('OMIM:619869','Neurocardiofaciodigital Syndrome'),('OMIM:619877','Dentici-Novelli Neurodevelopmental Syndrome'),('OMIM:619950','Tessadori-Bicknell-Van Haaften Neurodevelopmental Syndrome 3'),('OMIM:620021','Intellectual Developmental Disorder With Autism And Dysmorphic Facies'),('OMIM:620033','Developmental And Epileptic Encephalopathy 107'),('OMIM:620058','Familial Apolipoprotein Gene Cluster Deletion Syndrome'),('OMIM:620065','Developmental Delay, Behavioral Abnormalities, And Neuropsychiatric Disorders'),('OMIM:620073','Neurodevelopmental Disorder With Dysmorphic Facies And Skeletal And Brain Abnormalities'),('OMIM:620141','Developmental Delay, Language Impairment, And Ocular Abnormalities'),('OMIM:620208','Spinocerebellar Ataxia, Autosomal Recessive 33'),('OMIM:620211','Hyperinsulinemic Hypoglycemia, Familial, 8'),('OMIM:620242','Neurodevelopmental Disorder With Poor Growth And Behavioral Abnormalities'),('OMIM:620253','Cataract 50 With Or Without Glaucoma'),('OMIM:620280','Deafness, Autosomal Dominant 86'),('OMIM:620281','Deafness, Autosomal Dominant 87'),('OMIM:620292','Neurodevelopmental Disorder With Language Delay And Behavioral Abnormalities, With Or Without Seizures'),('OMIM:620312','Leukoencephalopathy With Vanishing White Matter 2'),('OMIM:620330','Intellectual Developmental Disorder, Autosomal Dominant 71, With Behavioral Abnormalities'),('OMIM:620367','Pulmonary Fibrosis And/Or Bone Marrow Failure Syndrome, Telomere-Related, 8'),('OMIM:620425','Cataracts, Hearing Impairment, Nephrotic Syndrome, And Enterocolitis 2'),('OMIM:620428','Neurodevelopmental Disorder With Motor And Language Delay, Ocular Defects, And Brain Abnormalities'),('OMIM:620454','Congenital Disorder Of Glycosylation, Type Iiaa'),('OMIM:620469','Cranial Dysinnervation Disorder, Congenital, With Absent Corneal Reflex And Developmental Delay'),('OMIM:620494','Neurodevelopmental Disorder With Impaired Language, Behavioral Abnormalities, And Dysmorphic Facies'),('OMIM:620502','Neurodevelopmental Disorder With Language Delay And Variable Cognitive Abnormalities'),('OMIM:620565','Immunodeficiency 113 With Autoimmunity And Autoinflammation'),('OMIM:620642','Ciliary Dyskinesia, Primary, 53'),('OMIM:620719','Neurodevelopmental Disorder With Motor Abnormalities, Seizures, And Facial Dysmorphism'),('OMIM:620747','Neurodevelopmental Disorder With Early-Onset Parkinsonism And Behavioral Abnormalities'),('OMIM:620786','Basal Ganglia Calcification, Idiopathic, 9, Autosomal Recessive'),('OMIM:620795','Autoinflammation With Episodic Fever And Immune Dysregulation'),('ORPHA:10','48, Xxyy Syndrome'),('ORPHA:100026','Gamma-Heavy Chain Disease'),('ORPHA:100086','Gallbladder Neuroendocrine Tumor'),('ORPHA:1001','2Q37 Microdeletion Syndrome'),('ORPHA:100924','Porphyria Due To Ala Dehydratase Deficiency'),('ORPHA:100973','Fraxe Intellectual Disability'),('ORPHA:100986','Autosomal Recessive Spastic Paraplegia Type 5A'),('ORPHA:101085','Charcot-Marie-Tooth Disease Type 1F'),('ORPHA:1067','Aniridia-Ptosis-Intellectual Disability-Familial Obesity Syndrome'),('ORPHA:1068','Aniridia-Intellectual Disability Syndrome'),('ORPHA:1069','Aniridia-Absent Patella Syndrome'),('ORPHA:107','Bor Syndrome'),('ORPHA:117','Behçet Disease'),('ORPHA:1170','Autosomal Recessive Cerebelloparenchymal Disorder Type 3'),('ORPHA:1192','Atherosclerosis-Deafness-Diabetes-Epilepsy-Nephropathy Syndrome'),('ORPHA:1193','Atkin-Flaitz Syndrome'),('ORPHA:1303','Bronchiolitis Obliterans'),('ORPHA:1304','Brucellosis'),('ORPHA:131','Budd-Chiari Syndrome'),('ORPHA:1359','Carney Complex'),('ORPHA:1366','Autosomal Recessive Palmoplantar Keratoderma And Congenital Alopecia'),('ORPHA:1369','Congenital Cataract-Hypertrophic Cardiomyopathy-Mitochondrial Myopathy Syndrome'),('ORPHA:1373','Cataract-Aberrant Oral Frenula-Growth Delay Syndrome'),('ORPHA:1377','Cataract-Microcornea Syndrome'),('ORPHA:138','Charge Syndrome'),('ORPHA:1380','Cataract-Nephropathy-Encephalopathy Syndrome'),('ORPHA:1381','Cataract-Intellectual Disability-Anal Atresia-Urinary Defects Syndrome'),('ORPHA:139399','Adrenomyeloneuropathy'),('ORPHA:139431','Epilepsy With Eyelid Myoclonia'),('ORPHA:139466','Serkal Syndrome'),('ORPHA:139474','17Q11.2 Microduplication Syndrome'),('ORPHA:139480','Autosomal Recessive Spastic Paraplegia Type 39'),('ORPHA:1397','Hydrocephaly-Cerebellar Agenesis Syndrome'),('ORPHA:14','Abetalipoproteinemia'),('ORPHA:140905','Hyperlipidemia Due To Hepatic Triacylglycerol Lipase Deficiency'),('ORPHA:1435','Xq21 Microdeletion Syndrome'),('ORPHA:1457','Aorta Coarctation'),('ORPHA:1473','Uveal Coloboma-Cleft Lip And Palate-Intellectual Disability'),('ORPHA:1501','Adrenocortical Carcinoma'),('ORPHA:157941','Huntington Disease-Like 1'),('ORPHA:157946','Huntington Disease-Like 3'),('ORPHA:158061','Macrophage Activation Syndrome'),('ORPHA:1606','1P36 Deletion Syndrome'),('ORPHA:163','Hereditary Hyperferritinemia-Cataract Syndrome'),('ORPHA:1656','Dermatitis Herpetiformis'),('ORPHA:167','Chédiak-Higashi Syndrome'),('ORPHA:168558','46, Xy Difference Of Sex Development-Adrenal Insufficiency Due To Cyp11A1 Deficiency'),('ORPHA:168782','Childhood Disintegrative Disorder'),('ORPHA:169090','Combined Immunodeficiency Due To Crac Channel Dysfunction'),('ORPHA:170','Woolly Hair'),('ORPHA:171680','Lissencephaly Due To Tuba1A Mutation'),('ORPHA:171844','Blindness-Scoliosis-Arachnodactyly Syndrome'),('ORPHA:1727','22Q11.2 Duplication Syndrome'),('ORPHA:1766','Dysequilibrium Syndrome'),('ORPHA:177907','Prader-Willi Syndrome Due To Translocation'),('ORPHA:18','Distal Renal Tubular Acidosis'),('ORPHA:180229','Polyembryoma'),('ORPHA:1830','Schimke Immuno-Osseous Dysplasia'),('ORPHA:183675','Recurrent Infections Associated With Rare Immunoglobulin Isotypes Deficiency'),('ORPHA:186','Primary Biliary Cholangitis'),('ORPHA:1885','Isolated Ectopia Lentis'),('ORPHA:189427','Cushing Syndrome Due To Bilateral Macronodular Adrenocortical Disease'),('ORPHA:190','Coats Disease'),('ORPHA:191','Cockayne Syndrome'),('ORPHA:1979','Lipodystrophy Due To Peptidic Growth Factors Deficiency'),('ORPHA:199296','Congenital Isolated Acth Deficiency'),('ORPHA:199299','Late-Onset Isolated Acth Deficiency'),('ORPHA:199354','Cerebral Autosomal Recessive Arteriopathy-Subcortical Infarcts-Leukoencephalopathy'),('ORPHA:2035','Lymphatic Filariasis'),('ORPHA:2047','Flynn-Aird Syndrome'),('ORPHA:206572','Overlap Myositis'),('ORPHA:2067','Gapo Syndrome'),('ORPHA:2069','Gastrocutaneous Syndrome'),('ORPHA:2073','Narcolepsy Type 1'),('ORPHA:2075','Genitopalatocardiac Syndrome'),('ORPHA:2084','Glaucoma-Ectopia Lentis-Microspherophakia-Stiff Joints-Short Stature Syndrome'),('ORPHA:208441','Bilateral Parasagittal Parieto-Occipital Polymicrogyria'),('ORPHA:208447','Bilateral Generalized Polymicrogyria'),('ORPHA:209902','Hypercholesterolemia Due To Cholesterol 7Alpha-Hydroxylase Deficiency'),('ORPHA:213','Cystinosis'),('ORPHA:2137','Autoimmune Hepatitis'),('ORPHA:2152','Mowat-Wilson Syndrome'),('ORPHA:217','Isolated Dandy-Walker Malformation'),('ORPHA:2172','Microcephaly-Glomerulonephritis-Marfanoid Habitus Syndrome'),('ORPHA:217253','Nmda Receptor Encephalitis'),('ORPHA:220295','Xeroderma Pigmentosum-Cockayne Syndrome Complex'),('ORPHA:2253','Foveal Hypoplasia-Presenile Cataract Syndrome'),('ORPHA:2278','Ichthyosis-Intellectual Disability-Dwarfism-Renal Impairment Syndrome'),('ORPHA:227982','Autoimmune Polyendocrinopathy Type 3'),('ORPHA:227990','Autoimmune Polyendocrinopathy Type 4'),('ORPHA:228384','5Q14.3 Microdeletion Syndrome'),('ORPHA:228402','2Q23.1 Microdeletion Syndrome'),('ORPHA:228426','Syndromic Multisystem Autoimmune Disease Due To Itch Deficiency'),('ORPHA:229','Familial Aortic Dissection'),('ORPHA:229717','Isolated Agammaglobulinemia'),('ORPHA:230839','Classical-Like Ehlers-Danlos Syndrome Type 1'),('ORPHA:2310','Absence Deformity Of Leg-Cataract Syndrome'),('ORPHA:231154','Combined Immunodeficiency Due To Partial Rag1 Deficiency'),('ORPHA:231160','Familial Cerebral Saccular Aneurysm'),('ORPHA:231169','Usher Syndrome Type 1'),('ORPHA:231183','Usher Syndrome Type 3'),('ORPHA:231580','Primary Unilateral Adrenal Hyperplasia'),('ORPHA:2331','Kawasaki Disease'),('ORPHA:2334','Autosomal Dominant Keratitis'),('ORPHA:2348','Familial Partial Lipodystrophy, Dunnigan Type'),('ORPHA:238750','4Q21 Microdeletion Syndrome'),('ORPHA:240103','Progressive Supranuclear Palsy-Corticobasal Syndrome'),('ORPHA:2457','Mandibuloacral Dysplasia'),('ORPHA:247245','Superficial Siderosis'),('ORPHA:247585','Citrullinemia Type Ii'),('ORPHA:247598','Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency'),('ORPHA:2477','Megalencephaly'),('ORPHA:247815','Autosomal Recessive Ataxia Due To Pex10 Deficiency'),('ORPHA:2479','Megalocornea-Intellectual Disability Syndrome'),('ORPHA:250923','Isolated Aniridia'),('ORPHA:251004','Paternal Uniparental Disomy Of Chromosome 1'),('ORPHA:251061','7Q31 Microdeletion Syndrome'),('ORPHA:251274','Familial Hyperaldosteronism Type Iii'),('ORPHA:251282','Autosomal Dominant Spastic Ataxia Type 1'),('ORPHA:251347','Ataxia-Telangiectasia-Like Disorder'),('ORPHA:254531','Temple Syndrome Due To Paternal 14Q32.2 Hypomethylation'),('ORPHA:254704','Genetic Hyperferritinemia Without Iron Overload'),('ORPHA:2571','X-Linked Immunoneurologic Disorder'),('ORPHA:261144','Foxg1 Syndrome Due To 14Q12 Microdeletion'),('ORPHA:261183','15Q11.2 Microdeletion Syndrome'),('ORPHA:261197','Proximal 16P11.2 Microdeletion Syndrome'),('ORPHA:261318','Trisomy 20P'),('ORPHA:261494','Kleefstra Syndrome'),('ORPHA:261537','Mowat-Wilson Syndrome Due To Monosomy 2Q22'),('ORPHA:261552','Mowat-Wilson Syndrome Due To A Zeb2 Point Mutation'),('ORPHA:263479','Fuchs Heterochromic Iridocyclitis'),('ORPHA:263501','Cog4-Cdg'),('ORPHA:264580','Glycogen Storage Disease Due To Liver Phosphorylase Kinase Deficiency'),('ORPHA:264675','Hereditary Pulmonary Alveolar Proteinosis'),('ORPHA:2663','Nathalie Syndrome'),('ORPHA:26792','Short Chain Acyl-Coa Dehydrogenase Deficiency'),('ORPHA:2724','Odontomatosis-Aortae Esophagus Stenosis Syndrome'),('ORPHA:273','Steinert Myotonic Dystrophy'),('ORPHA:275761','Lysosomal Acid Lipase Deficiency'),('ORPHA:275864','Behavioral Variant Of Frontotemporal Dementia'),('ORPHA:276','T-B+ Severe Combined Immunodeficiency Due To Gamma Chain Deficiency'),('ORPHA:276238','Machado-Joseph Disease Type 1'),('ORPHA:276241','Machado-Joseph Disease Type 2'),('ORPHA:276244','Machado-Joseph Disease Type 3'),('ORPHA:276432','Ogden Syndrome'),('ORPHA:277','Severe Combined Immunodeficiency Due To Adenosine Deaminase Deficiency'),('ORPHA:280','Wolf-Hirschhorn Syndrome'),('ORPHA:280365','Autosomal Semi-Dominant Severe Lipodystrophic Laminopathy'),('ORPHA:280679','Moyamoya Angiopathy-Short Stature-Facial Dysmorphism-Hypergonadotropic Hypogonadism Syndrome'),('ORPHA:280763','Severe Intellectual Disability And Progressive Spastic Paraplegia'),('ORPHA:2822','Autosomal Recessive Spastic Paraplegia Type 11'),('ORPHA:2826','Spastic Paraplegia-Precocious Puberty Syndrome'),('ORPHA:284180','Xp22.13P22.2 Duplication Syndrome'),('ORPHA:2869','Peutz-Jeghers Syndrome'),('ORPHA:289390','Primary Sjögren Syndrome'),('ORPHA:289548','Inherited Isolated Adrenal Insufficiency Due To Partial Cyp11A1 Deficiency'),('ORPHA:291','Congenital Varicella Syndrome'),('ORPHA:293621','X-Linked Endothelial Corneal Dystrophy'),('ORPHA:293939','Distal Xq28 Microduplication Syndrome'),('ORPHA:293978','Deficiency In Anterior Pituitary Function-Variable Immunodeficiency Syndrome'),('ORPHA:2968','Leukocyte Adhesion Deficiency'),('ORPHA:3000','Familial Peripheral Male-Limited Precocious Puberty'),('ORPHA:300570','Cortical Dysgenesis With Pontocerebellar Hypoplasia Due To Tubb3 Mutation'),('ORPHA:3077','X-Linked Intellectual Disability-Psychosis-Macroorchidism Syndrome'),('ORPHA:3078','Severe X-Linked Intellectual Disability, Gustavson Type'),('ORPHA:309246','Gm2 Gangliosidosis, Ab Variant'),('ORPHA:309256','Metachromatic Leukodystrophy, Late Infantile Form'),('ORPHA:309263','Metachromatic Leukodystrophy, Juvenile Form'),('ORPHA:309271','Metachromatic Leukodystrophy, Adult Form'),('ORPHA:31150','Tangier Disease'),('ORPHA:313892','Developmental And Speech Delay Due To Sox5 Deficiency'),('ORPHA:319182','Wiedemann-Steiner Syndrome'),('ORPHA:319671','Alazami Syndrome'),('ORPHA:320','Apparent Mineralocorticoid Excess'),('ORPHA:3233','Cochleosaccular Degeneration-Cataract Syndrome'),('ORPHA:324410','X-Linked Intellectual Disability-Cardiomegaly-Congestive Heart Failure Syndrome'),('ORPHA:325124','Testicular Agenesis'),('ORPHA:325345','46, Xy Ovotesticular Difference Of Sex Development'),('ORPHA:3261','Autoimmune Lymphoproliferative Syndrome'),('ORPHA:329308','Fatty Acid Hydroxylase-Associated Neurodegeneration'),('ORPHA:329918','C3 Glomerulopathy'),('ORPHA:3306','Inverted Duplicated Chromosome 15 Syndrome'),('ORPHA:33111','Granulomatous Slack Skin'),('ORPHA:331206','Severe Combined Immunodeficiency Due To Complete Rag1/2 Deficiency'),('ORPHA:333','Farber Disease'),('ORPHA:33577','Nodular Non-Suppurative Panniculitis'),('ORPHA:3376','Triploidy'),('ORPHA:3385','African Trypanosomiasis'),('ORPHA:340','Hemorrhagic Fever-Renal Syndrome'),('ORPHA:34145','Immunoglobulin A Nephropathy'),('ORPHA:3449','Weill-Marchesani Syndrome'),('ORPHA:3453','Autoimmune Polyendocrinopathy Type 1'),('ORPHA:349','Fucosidosis'),('ORPHA:35125','Epidermal Nevus Syndrome'),('ORPHA:352490','Autism Spectrum Disorder Due To Auts2 Deficiency'),('ORPHA:353277','Rubinstein-Taybi Syndrome Due To Crebbp Mutations'),('ORPHA:353281','Rubinstein-Taybi Syndrome Due To 16P13.3 Microdeletion'),('ORPHA:353284','Rubinstein-Taybi Syndrome Due To Ep300 Haploinsufficiency'),('ORPHA:35664','Aldh18A1-Related De Barsy Syndrome'),('ORPHA:35689','Primary Lateral Sclerosis'),('ORPHA:357058','Autosomal Recessive Cutis Laxa Type 2A'),('ORPHA:35737','Morning Glory Disc Anomaly'),('ORPHA:361','Familial Glucocorticoid Deficiency'),('ORPHA:36234','Bacterial Toxic-Shock Syndrome'),('ORPHA:363558','New-Onset Refractory Status Epilepticus'),('ORPHA:363618','Lmna-Related Cardiocutaneous Progeria Syndrome'),('ORPHA:363722','Alexander Disease Type Ii'),('ORPHA:36913','Autoimmune Hypoparathyroidism'),('ORPHA:369837','Intellectual Disability-Seizures-Hypophosphatasia-Ophthalmic-Skeletal Anomalies Syndrome'),('ORPHA:369929','Primary Hyperaldosteronism-Seizures-Neurological Abnormalities Syndrome'),('ORPHA:370022','Ataxia-Intellectual Disability-Oculomotor Apraxia-Cerebellar Cysts Syndrome'),('ORPHA:37042','Immune Dysregulation-Polyendocrinopathy-Enteropathy-X-Linked Syndrome'),('ORPHA:370959','Congenital Muscular Dystrophy With Cerebellar Involvement'),('ORPHA:37202','Interstitial Cystitis'),('ORPHA:375','Anti-Glomerular Basement Membrane Disease'),('ORPHA:382','Guanidinoacetate Methyltransferase Deficiency'),('ORPHA:39041','Omenn Syndrome'),('ORPHA:391307','Severe Intellectual Disability-Short Stature-Behavioral Abnormalities-Facial Dysmorphism Syndrome'),('ORPHA:391665','Homozygous Familial Hypercholesterolemia'),('ORPHA:393','46, Xx Testicular Difference Of Sex Development'),('ORPHA:395','Homocystinuria Due To Methylene Tetrahydrofolate Reductase Deficiency'),('ORPHA:397596','Activated Pi3K-Delta Syndrome'),('ORPHA:397612','Macrocephaly-Developmental Delay Syndrome'),('ORPHA:397933','Severe Intellectual Disability-Progressive Postnatal Microcephaly-Midline Stereotypic Hand Movements Syndrome'),('ORPHA:399805','Male Infertility With Azoospermia Or Oligozoospermia Due To Single Gene Mutation'),('ORPHA:399808','Male Infertility With Teratozoospermia Due To Single Gene Mutation'),('ORPHA:400','Cystic Echinococcosis'),('ORPHA:401830','Autosomal Recessive Spastic Paraplegia Type 69'),('ORPHA:401923','9Q31.1Q31.3 Microdeletion Syndrome'),('ORPHA:403','Familial Hyperaldosteronism Type I'),('ORPHA:404','Familial Hyperaldosteronism Type Ii'),('ORPHA:411511','Angelman Syndrome Due To A Point Mutation'),('ORPHA:411593','Insulin Autoimmune Syndrome'),('ORPHA:411986','Early-Onset Epileptic Encephalopathy-Cortical Blindness-Intellectual Disability-Facial Dysmorphism Syndrome'),('ORPHA:412','Dysbetalipoproteinemia'),('ORPHA:425','Apolipoprotein A-I Deficiency'),('ORPHA:434179','Orofaciodigital Syndrome Type 14'),('ORPHA:435638','3P25.3 Microdeletion Syndrome'),('ORPHA:436151','Intellectual Disability-Expressive Aphasia-Facial Dysmorphism Syndrome'),('ORPHA:438274','Gcgr-Related Hyperglucagonemia'),('ORPHA:439232','Aapoaiv Amyloidosis'),('ORPHA:439254','Itm2B Amyloidosis'),('ORPHA:443811','Pgm3-Cdg'),('ORPHA:444463','Autoimmune Hemolytic Anemia-Autoimmune Thrombocytopenia-Primary Immunodeficiency Syndrome Due To Tpp2 Deficiency'),('ORPHA:445062','Juvenile-Onset Diabetes Mellitus-Central And Peripheral Neurodegeneration Syndrome'),('ORPHA:447757','Autosomal Dominant Spastic Paraplegia Type 9B'),('ORPHA:447997','Spastic Tetraplegia-Thin Corpus Callosum-Progressive Postnatal Microcephaly Syndrome'),('ORPHA:449291','Symptomatic Form Of Fragile X Syndrome In Female Carriers'),('ORPHA:449395','Igg4-Related Kidney Disease'),('ORPHA:449432','Igg4-Related Submandibular Gland Disease'),('ORPHA:457240','X-Linked Intellectual Disability-Short Stature-Overweight Syndrome'),('ORPHA:457279','Intellectual Disability-Macrocephaly-Hypotonia-Behavioral Abnormalities Syndrome'),('ORPHA:457351','Microcephaly-Intellectual Disability-Sensorineural Hearing Loss-Epilepsy-Abnormal Muscle Tone Syndrome'),('ORPHA:464306','Dyrk1A-Related Intellectual Disability Syndrome'),('ORPHA:464311','Intellectual Disability Syndrome Due To A Dyrk1A Point Mutation'),('ORPHA:46488','Linear Iga Dermatosis'),('ORPHA:466768','Autosomal Dominant Charcot-Marie-Tooth Disease Type 2Z'),('ORPHA:468631','Microcephalic Cortical Malformations-Short Stature Due To Rttn Deficiency'),('ORPHA:468678','White-Sutton Syndrome'),('ORPHA:470','Lysinuric Protein Intolerance'),('ORPHA:47612','Felty Syndrome'),('ORPHA:476126','Micrognathia-Recurrent Infections-Behavioral Abnormalities-Mild Intellectual Disability Syndrome'),('ORPHA:480880','X-Linked Female Restricted Facial Dysmorphism-Short Stature-Choanal Atresia-Intellectual Disability'),('ORPHA:482','Kimura Disease'),('ORPHA:48377','Subcorneal Pustular Dermatosis'),('ORPHA:48435','Postinfectious Vasculitis'),('ORPHA:488618','Transketolase Deficiency'),('ORPHA:488650','Distal Myopathy, Tateyama Type'),('ORPHA:49','Penile Agenesis'),('ORPHA:49041','Igg4-Related Retroperitoneal Fibrosis'),('ORPHA:494424','Extracranial Carotid Artery Aneurysm'),('ORPHA:496641','Early-Onset Progressive Diffuse Brain Atrophy-Microcephaly-Muscle Weakness-Optic Atrophy Syndrome'),('ORPHA:500159','Microcephaly-Corpus Callosum And Cerebellar Vermis Hypoplasia-Facial Dysmorphism-Intellectual Disability Syndrom'),('ORPHA:50815','Branchiogenic Deafness Syndrome'),('ORPHA:508498','Intellectual Disability-Cardiac Anomalies-Short Stature-Joint Laxity Syndrome'),('ORPHA:508533','Skeletal Dysplasia-T-Cell Immunodeficiency-Developmental Delay Syndrome'),('ORPHA:513456','Intellectual Disability-Seizures-Abnormal Gait-Facial Dysmorphism Syndrome'),('ORPHA:51608','Generalized Arterial Calcification Of Infancy'),('ORPHA:522077','Infantile Hypotonia-Oculomotor Anomalies-Hyperkinetic Movements-Developmental Delay Syndrome'),('ORPHA:523','Hereditary Leiomyomatosis And Renal Cell Cancer'),('ORPHA:52368','Mohr-Tranebjaerg Syndrome'),('ORPHA:528','Congenital Generalized Lipodystrophy'),('ORPHA:52901','Isolated Follicle Stimulating Hormone Deficiency'),('ORPHA:529965','Intellectual Disability-Autism-Speech Apraxia-Craniofacial Dysmorphism Syndrome'),('ORPHA:530983','Lamb-Shaffer Syndrome'),('ORPHA:533','Listeriosis'),('ORPHA:534','Oculocerebrorenal Syndrome Of Lowe'),('ORPHA:536','Systemic Lupus Erythematosus'),('ORPHA:54370','Primary Membranoproliferative Glomerulonephritis'),('ORPHA:544254','Syngap1-Related Developmental And Epileptic Encephalopathy'),('ORPHA:552','Mody'),('ORPHA:556030','Early-Onset Familial Hypoaldosteronism'),('ORPHA:556037','Late-Onset Familial Hypoaldosteronism'),('ORPHA:56','Alkaptonuria'),('ORPHA:561854','Foxg1 Syndrome'),('ORPHA:562','Mccune-Albright Syndrome'),('ORPHA:562639','Primary Biliary Cholangitis/Primary Sclerosing Cholangitis And Autoimmune Hepatitis Overlap Syndrome'),('ORPHA:56425','Cold Agglutinin Disease'),('ORPHA:565612','Primary Triglyceride Deposit Cardiomyovasculopathy'),('ORPHA:567544','Idiopathic Non-Lupus Full-House Nephropathy'),('ORPHA:567546','Idiopathic Steroid-Sensitive Nephrotic Syndrome With Secondary Steroid Resistance'),('ORPHA:567548','Idiopathic Steroid-Resistant Nephrotic Syndrome'),('ORPHA:570422','Galactose Mutarotase Deficiency'),('ORPHA:572013','Posterior-Predominant Lissencephaly-Broad Flat Pons And Medulla-Midline Crossing Defects Syndrome'),('ORPHA:572798','Wars2-Related Combined Oxidative Phosphorylation Defect'),('ORPHA:580','Mucopolysaccharidosis Type 2'),('ORPHA:60026','Pulmonary Nodular Lymphoid Hyperplasia'),('ORPHA:606','Proximal Myotonic Myopathy'),('ORPHA:633','Laron Syndrome'),('ORPHA:64','Alström Syndrome'),('ORPHA:64280','Childhood Absence Epilepsy'),('ORPHA:646','Niemann-Pick Disease Type C'),('ORPHA:64753','Spinocerebellar Ataxia With Axonal Neuropathy Type 2'),('ORPHA:647799','Myt1L-Related Developmental Delay-Intellectual Disability-Obesity Syndrome'),('ORPHA:648','Noonan Syndrome'),('ORPHA:649','Norrie Disease'),('ORPHA:650','Lcat Deficiency'),('ORPHA:656','Genetic Steroid-Resistant Nephrotic Syndrome'),('ORPHA:66624','Pandas'),('ORPHA:67043','Amoebic Keratitis'),('ORPHA:69063','Congenital Membranous Nephropathy Due To Fetomaternal Anti-Neutral Endopeptidase Alloimmunization'),('ORPHA:69663','Low Phospholipid-Associated Cholelithiasis'),('ORPHA:69665','Intrahepatic Cholestasis Of Pregnancy'),('ORPHA:699','Pearson Syndrome'),('ORPHA:703','Bullous Pemphigoid'),('ORPHA:705','Pendred Syndrome'),('ORPHA:70595','Sensory Ataxic Neuropathy-Dysarthria-Ophthalmoparesis Syndrome'),('ORPHA:708','Peters Anomaly'),('ORPHA:71','Chylomicron Retention Disease'),('ORPHA:71272','Sandifer Syndrome'),('ORPHA:71518','Benign Paroxysmal Torticollis Of Infancy'),('ORPHA:727','Microscopic Polyangiitis'),('ORPHA:73245','Spinal Muscular Atrophy-Dandy-Walker Malformation-Cataracts Syndrome'),('ORPHA:740','Hutchinson-Gilford Progeria Syndrome'),('ORPHA:744','Proteus Syndrome'),('ORPHA:747','Autoimmune Pulmonary Alveolar Proteinosis'),('ORPHA:75234','Cholesteryl Ester Storage Disease'),('ORPHA:758','Pseudoxanthoma Elasticum'),('ORPHA:75858','Morm Syndrome'),('ORPHA:77293','Chronic Visceral Acid Sphingomyelinase Deficiency'),('ORPHA:77296','Morgagni-Stewart-Morel Syndrome'),('ORPHA:776','Lujan-Fryns Syndrome'),('ORPHA:778','Rett Syndrome'),('ORPHA:781','Q Fever'),('ORPHA:785','Estrogen Resistance Syndrome'),('ORPHA:786','Generalized Glucocorticoid Resistance Syndrome'),('ORPHA:79083','Pparg-Related Familial Partial Lipodystrophy'),('ORPHA:79084','Familial Partial Lipodystrophy, Köbberling Type'),('ORPHA:79087','Acquired Partial Lipodystrophy'),('ORPHA:79136','Episodic Ataxia Type 4'),('ORPHA:79155','Hydroxykynureninuria'),('ORPHA:79237','Galactokinase Deficiency'),('ORPHA:79240','Glycogen Storage Disease Due To Liver And Muscle Phosphorylase Kinase Deficiency'),('ORPHA:79259','Glycogen Storage Disease Due To Glucose-6-Phosphatase Deficiency Type Ib'),('ORPHA:79281','Alpha-N-Acetylgalactosaminidase Deficiency Type 3'),('ORPHA:79282','Methylmalonic Acidemia With Homocystinuria, Type Cblc'),('ORPHA:79292','Fish-Eye Disease'),('ORPHA:79302','Congenital Bile Acid Synthesis Defect Type 3'),('ORPHA:79324','Alg12-Cdg'),('ORPHA:79408','Autosomal Recessive Generalized Dystrophic Epidermolysis Bullosa, Severe Form'),('ORPHA:79414','Woolly Hair Nevus'),('ORPHA:79474','Atypical Werner Syndrome'),('ORPHA:79480','Pemphigus Erythematosus'),('ORPHA:79500','Doors Syndrome'),('ORPHA:79506','Cholesterol-Ester Transfer Protein Deficiency'),('ORPHA:8','47, Xyy Syndrome'),('ORPHA:809','Mixed Connective Tissue Disease'),('ORPHA:81','Antisynthetase Syndrome'),('ORPHA:818','Smith-Lemli-Opitz Syndrome'),('ORPHA:819','Smith-Magenis Syndrome'),('ORPHA:85112','Palmoplantar Keratoderma-Xx Sex Reversal-Predisposition To Squamous Cell Carcinoma Syndrome'),('ORPHA:85138','Addison Disease'),('ORPHA:85277','X-Linked Intellectual Disability, Cantagrel Type'),('ORPHA:85278','Christianson Syndrome'),('ORPHA:85286','X-Linked Intellectual Disability, Shashi Type'),('ORPHA:85320','X-Linked Intellectual Disability-Macrocephaly-Macroorchidism Syndrome'),('ORPHA:85327','X-Linked Intellectual Disability-Acromegaly-Hyperactivity Syndrome'),('ORPHA:85414','Systemic-Onset Juvenile Idiopathic Arthritis'),('ORPHA:86816','Congenital Analbuminemia'),('ORPHA:86822','Lissencephaly Type 3-Metacarpal Bone Dysplasia Syndrome'),('ORPHA:87','Apert Syndrome'),('ORPHA:887','Vacterl/Vater Association'),('ORPHA:89844','Lissencephaly Syndrome, Norman-Roberts Type'),('ORPHA:90002','Undifferentiated Connective Tissue Syndrome'),('ORPHA:90033','Autoimmune Hemolytic Anemia, Warm Type'),('ORPHA:90036','Mixed-Type Autoimmune Hemolytic Anemia'),('ORPHA:90041','Gaisböck Syndrome'),('ORPHA:90060','Diffuse Alveolar Hemorrhage'),('ORPHA:90065','Acquired Aneurysmal Subarachnoid Hemorrhage'),('ORPHA:90068','Cocaine Intoxication'),('ORPHA:90186','Meige Disease'),('ORPHA:902','Werner Syndrome'),('ORPHA:90283','Lupus Erythematosus Tumidus'),('ORPHA:90291','Systemic Sclerosis'),('ORPHA:90324','Cockayne Syndrome Type 3'),('ORPHA:90363','Secondary Intestinal Lymphangiectasia'),('ORPHA:90646','Deafness-Hypogonadism Syndrome'),('ORPHA:90654','Stickler Syndrome Type 2'),('ORPHA:90674','Isolated Thyroid-Stimulating Hormone Deficiency'),('ORPHA:90790','Congenital Lipoid Adrenal Hyperplasia Due To Star Deficency'),('ORPHA:90791','Congenital Adrenal Hyperplasia Due To 3-Beta-Hydroxysteroid Dehydrogenase Deficiency'),('ORPHA:90793','Congenital Adrenal Hyperplasia Due To 17-Alpha-Hydroxylase Deficiency'),('ORPHA:90794','Classic Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency'),('ORPHA:90795','Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency'),('ORPHA:90796','46, Xy Difference Of Sex Development Due To Isolated 17, 20-Lyase Deficiency'),('ORPHA:908','Fragile X Syndrome'),('ORPHA:909','Cerebrotendinous Xanthomatosis'),('ORPHA:91','Aromatase Deficiency'),('ORPHA:911','Combined Immunodeficiency Due To Zap70 Deficiency'),('ORPHA:91135','Body Skin Hyperlaxity Due To Vitamin K-Dependent Coagulation Factor Deficiency'),('ORPHA:91139','Simple Cryoglobulinemia'),('ORPHA:91348','Functioning Gonadotropic Adenoma'),('ORPHA:91349','Non-Functioning Pituitary Adenoma'),('ORPHA:91355','Sheehan Syndrome'),('ORPHA:91387','Familial Thoracic Aortic Aneurysm And Aortic Dissection'),('ORPHA:91495','Persistent Hyperplastic Primary Vitreous'),('ORPHA:926','Acatalasemia'),('ORPHA:927','Hyperammonemia Due To N-Acetylglutamate Synthase Deficiency'),('ORPHA:93','Aspartylglucosaminuria'),('ORPHA:93126','Pauci-Immune Glomerulonephritis'),('ORPHA:93598','Primary Hyperoxaluria Type 1'),('ORPHA:94083','Partington Syndrome'),('ORPHA:94124','Spinocerebellar Ataxia With Axonal Neuropathy Type 1'),('ORPHA:95','Friedreich Ataxia'),('ORPHA:95409','Acute Adrenal Insufficiency'),('ORPHA:95427','Secondary Short Bowel Syndrome'),('ORPHA:95512','Adenohypophysitis'),('ORPHA:95513','Panhypophysitis'),('ORPHA:95699','Congenital Adrenal Hyperplasia Due To Cytochrome P450 Oxidoreductase Deficiency'),('ORPHA:96121','7Q11.23 Microduplication Syndrome'),('ORPHA:96148','Distal Deletion 10Q'),('ORPHA:96180','Maternal Uniparental Disomy Of Chromosome 4'),('ORPHA:96181','Maternal Uniparental Disomy Of Chromosome 6'),('ORPHA:96184','Temple Syndrome Due To Maternal Uniparental Disomy Of Chromosome 14'),('ORPHA:96253','Cushing Disease'),('ORPHA:97283','Somatostatinoma'),('ORPHA:983','Testicular Regression Syndrome'),('ORPHA:98784','Autosomal Dominant Nocturnal Frontal Lobe Epilepsy'),('ORPHA:98807','Primary Dystonia, Dyt13 Type'),('ORPHA:98827','Unclassified Myelodysplastic Syndrome'),('ORPHA:98908','Neutral Lipid Storage Disease With Myopathy'),('ORPHA:99027','Adult-Onset Autosomal Dominant Leukodystrophy'),('ORPHA:99827','Crimean-Congo Hemorrhagic Fever'),('ORPHA:99867','Thymoma'),('ORPHA:99889','Cushing Syndrome Due To Ectopic Acth Secretion'),('ORPHA:99931','Idiopathic Pulmonary Hemosiderosis'),('ORPHA:99965','O\'Sullivan-Mcleod Syndrome');
/*!40000 ALTER TABLE `Diseases` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `Genes`
--

DROP TABLE IF EXISTS `Genes`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `Genes` (
  `gene_id` varchar(11) NOT NULL,
  `gene_symbol` varchar(13) DEFAULT NULL,
  PRIMARY KEY (`gene_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Stores gene identifiers and symbols. Referenced by Analyses and PhenodigmScores (one-to-many).';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `Genes`
--

LOCK TABLES `Genes` WRITE;
/*!40000 ALTER TABLE `Genes` DISABLE KEYS */;
INSERT INTO `Genes` VALUES ('MGI:101770','Bfsp1'),('MGI:101784','Nes'),('MGI:101813','Coq3'),('MGI:102519','Cst3'),('MGI:102844','Mybpc3'),('MGI:103300','Rbl1'),('MGI:103559','Sox18'),('MGI:104294','Tyro3'),('MGI:104511','NA'),('MGI:104516','Slc23a3'),('MGI:104559','Rcn1'),('MGI:104688','Col4a3'),('MGI:104708','Cct3'),('MGI:104793','Runx1t1'),('MGI:104899','Mob4'),('MGI:105383','Il18r1'),('MGI:106637','Slc30a2'),('MGI:106925','Cldn11'),('MGI:107171','Ppp3r2'),('MGI:107191','Bmpr1b'),('MGI:107341','Ctss'),('MGI:107363','Stxbp1'),('MGI:107674','Cd1d1'),('MGI:108429','Lpar1'),('MGI:109279','NA'),('MGI:109424','Abca4'),('MGI:1095412','Unc5c'),('MGI:1096385','Bcan'),('MGI:1098604','Rragd'),('MGI:1201673','Shox2'),('MGI:1278321','Epc2'),('MGI:1309469','Casq2'),('MGI:1332243','Ugcg'),('MGI:1337072','Ier5'),('MGI:1339755','Csf3r'),('MGI:1339968','Cth'),('MGI:1341898','Nmur1'),('MGI:1341907','Fjx1'),('MGI:1343489','Mpdz'),('MGI:1345961','NA'),('MGI:1346069','Cdh20'),('MGI:1346086','Aplnr'),('MGI:1346342','Clca1'),('MGI:1347355','Slc7a11'),('MGI:1349164','Sdc4'),('MGI:1350926','Etv3'),('MGI:1350930','Srp9'),('MGI:1351315','Eloa'),('MGI:1351634','NA'),('MGI:1353435','Fbxw2'),('MGI:1353665','Usp21'),('MGI:1859866','Cdc20'),('MGI:1860511','Heyl'),('MGI:1889549','Txnip'),('MGI:1890510','Atp6v0b'),('MGI:1891259','Lrat'),('MGI:1913420','Chchd5'),('MGI:1913423','CCDC107'),('MGI:1913491','Tmem9'),('MGI:1913692','Spc25'),('MGI:1913721','Anp32e'),('MGI:1913746','Ppdpf'),('MGI:1913761','Chtop'),('MGI:1913790','Fam107b'),('MGI:1913882','Dph6'),('MGI:1914199','Trim59'),('MGI:1914210','Mindy3'),('MGI:1914454','Eif2s2'),('MGI:1914542','Pigc'),('MGI:1915247','Ddx59'),('MGI:1915282','Emc4'),('MGI:1915599','Ndufs3'),('MGI:1915643','Mogat1'),('MGI:1915862','Ube2c'),('MGI:1916022','Smpdl3b'),('MGI:1916330','Gmppa'),('MGI:1916413','Mrpl44'),('MGI:1916428','Snx5'),('MGI:1916732','Nup35'),('MGI:1916987','Ttl'),('MGI:1917120','Polr3gl'),('MGI:1917770','Glipr2'),('MGI:1918066','Rpusd2'),('MGI:1918142','Ttll7'),('MGI:1918316','Hsfy2'),('MGI:1918398','Mier1'),('MGI:1919051','Plekhf2'),('MGI:1919084','Zbtb43'),('MGI:1919128','Fam83d'),('MGI:1919163','Tmem79'),('MGI:1919300','Poglut2'),('MGI:1919369','Tpx2'),('MGI:1919471','Cimip1'),('MGI:1919880','Hspa12b'),('MGI:1920199','Ccnt2'),('MGI:1920484','Snorc'),('MGI:1921263','Rftn2'),('MGI:1921520','Usp20'),('MGI:1921607','Efhd1'),('MGI:1921722','Stpg3'),('MGI:1921735','Lrrc71'),('MGI:1922387','Rprd2'),('MGI:1922423','Tex38'),('MGI:1922776','Eppin'),('MGI:1922828','Fggy'),('MGI:1922946','Prpf6'),('MGI:1923073','Fam227b'),('MGI:1923304','Prrc2b'),('MGI:1923676','Fam209'),('MGI:1923953','Cpb1'),('MGI:1924232','Vxn'),('MGI:1924256','Ddrgk1'),('MGI:1924265','Mpped2'),('MGI:1924467','Rspo4'),('MGI:1924486','Sccpdh'),('MGI:1924817','Tram2'),('MGI:1924933','Ehmt1'),('MGI:1924955','Cstdc2'),('MGI:1925835','Jade1'),('MGI:1926106','Fam163b'),('MGI:1927241','Wdr12'),('MGI:1927580','Bloc1s6'),('MGI:1927753','Inpp5e'),('MGI:1928271','NA'),('MGI:1931054','Slc43a3'),('MGI:1931071','Sec61a2'),('MGI:2135283','Igsf9'),('MGI:2138198','D630023F18Rik'),('MGI:2139018','Olah'),('MGI:2139461','Tmem62'),('MGI:2140050','Ints3'),('MGI:2140259','Zmynd12'),('MGI:2140361','Slc35d1'),('MGI:2140592','Slc44a1'),('MGI:2140712','Phf24'),('MGI:2151053','Serpinb7'),('MGI:2153070','Synpo2'),('MGI:2154090','Igsf8'),('MGI:2158201','Acot8'),('MGI:2384297','Map7d1'),('MGI:2385213','Pdik1l'),('MGI:2387617','Obp2a'),('MGI:2441837','Adgrb3'),('MGI:2442177','Pced1a'),('MGI:2442704','Frrs1l'),('MGI:2442792','Cdh7'),('MGI:2443100','Bend7'),('MGI:2443564','Ambra1'),('MGI:2443805','Bnc2'),('MGI:2443925','Thsd7b'),('MGI:2444274','Cfap65'),('MGI:2444391','Slc25a44'),('MGI:2444508','Fitm2'),('MGI:2444631','Bltp1'),('MGI:2444681','Hhat'),('MGI:2444824','Sirpb1a'),('MGI:2444989','Spg11'),('MGI:2445096','Dhtkd1'),('MGI:2448514','R3hdm1'),('MGI:2654325','Gba2'),('MGI:2676312','Abca12'),('MGI:2677271','Slc24a5'),('MGI:2679260','Crb2'),('MGI:2679420','Pak6'),('MGI:2681832','Cspp1'),('MGI:2684789','Lrsam1'),('MGI:2684896','Maneal'),('MGI:2685195','Zbtb34'),('MGI:2685260','Otol1'),('MGI:2685869','Dpy19l4'),('MGI:3041190','Skint7'),('MGI:3045320','Mgat4f'),('MGI:3576049','Ugt1a2'),('MGI:3588202','Garin4'),('MGI:3588216','Ube2u'),('MGI:3590554','FIRRM'),('MGI:3606212','Rbbp8nl'),('MGI:3611233','Tox2'),('MGI:3611450','Mettl21c'),('MGI:3617846','Ankrd34a'),('MGI:3646006','Gm5148'),('MGI:3649135','Gm7694'),('MGI:3650206','Gm12695'),('MGI:3665157','NA'),('MGI:87867','Acadm'),('MGI:87868','NA'),('MGI:87879','Aco1'),('MGI:88015','Ampd1'),('MGI:88525','Cryge'),('MGI:95281','Ect2'),('MGI:95777','Gnas'),('MGI:95975','Ifi44l'),('MGI:96090','NA'),('MGI:96429','Ifi204'),('MGI:97324','Nhlh2'),('MGI:97383','Ntrk1'),('MGI:97565','Pgm1'),('MGI:97803','Ptma'),('MGI:97850','Raly'),('MGI:97898','Ren1'),('MGI:98266','NA'),('MGI:98386','Sptan1'),('MGI:98397','Src'),('MGI:98960','Wnt6'),('MGI:98967',NULL),('MGI:99218','Cdh4');
/*!40000 ALTER TABLE `Genes` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `ParameterGroupings`
--

DROP TABLE IF EXISTS `ParameterGroupings`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `ParameterGroupings` (
  `grouping_id` int NOT NULL AUTO_INCREMENT,
  `grouping_name` varchar(50) DEFAULT NULL,
  PRIMARY KEY (`grouping_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Defines groups of parameters. Linked to Parameters via a many-to-many join.';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `ParameterGroupings`
--

LOCK TABLES `ParameterGroupings` WRITE;
/*!40000 ALTER TABLE `ParameterGroupings` DISABLE KEYS */;
/*!40000 ALTER TABLE `ParameterGroupings` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `Parameters`
--

DROP TABLE IF EXISTS `Parameters`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `Parameters` (
  `parameter_id` varchar(18) NOT NULL,
  `parameter_name` varchar(74) DEFAULT NULL,
  `parameter_description` varchar(1000) DEFAULT NULL,
  PRIMARY KEY (`parameter_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Stores parameter metadata. Linked to Procedures and ParameterGroupings (many-to-many) and referenced by Analyses (one-to-many).';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `Parameters`
--

LOCK TABLES `Parameters` WRITE;
/*!40000 ALTER TABLE `Parameters` DISABLE KEYS */;
INSERT INTO `Parameters` VALUES ('IMPC_ABR_001_001','Body weight','body_weight'),('IMPC_ABR_002_001','Click-evoked ABR threshold','click_evoked_abr_threshold'),('IMPC_ABR_003_001','Click-evoked ABR waveforms (numerical format)','click_evoked_abr_waveforms_numerical_format_'),('IMPC_ABR_004_001','6kHz-evoked ABR Threshold','6khz_evoked_abr_threshold'),('IMPC_ABR_005_001','6kHz-evoked ABR waveforms (numerical format)','6khz_evoked_abr_waveforms_numerical_format_'),('IMPC_ABR_006_001','12kHz-evoked ABR Threshold','12khz_evoked_abr_threshold'),('IMPC_ABR_007_001','12kHz-evoked ABR waveforms (numerical format)','12khz_evoked_abr_waveforms_numerical_format_'),('IMPC_ABR_008_001','18kHz-evoked ABR Threshold','18khz_evoked_abr_threshold'),('IMPC_ABR_009_001','18kHz-evoked ABR waveforms (numerical format)','18khz_evoked_abr_waveforms_numerical_format_'),('IMPC_ABR_010_001','24kHz-evoked ABR Threshold','24khz_evoked_abr_threshold'),('IMPC_ABR_011_001','24kHz-evoked ABR waveforms (numerical format)','24khz_evoked_abr_waveforms_numerical_format_'),('IMPC_ABR_012_001','30kHz-evoked ABR Threshold','30khz_evoked_abr_threshold'),('IMPC_ABR_013_001','30kHz-evoked ABR waveforms (numerical format)','30khz_evoked_abr_waveforms_numerical_format_'),('IMPC_ABR_014_001','Click-evoked + 6 to 30kHz tone waveforms (pdf format)','click_evoked_6_to_30khz_tone_waveforms_pdf_format_'),('IMPC_ABR_015_001','Audiograms','audiograms'),('IMPC_ABR_016_001','Preyer Reflex','preyer_reflex'),('IMPC_ABR_017_001','Click +20dB waveforms (numerical format)','click_20db_waveforms_numerical_format_'),('IMPC_ABR_018_001','Click +50dB waveforms (numerical format)','click_50db_waveforms_numerical_format_'),('IMPC_ABR_019_001','Click +20dB+50dB waveforms (pdf format)','click_20db_50db_waveforms_pdf_format_'),('IMPC_ABR_020_001','P1-N1 amplitude (at each stimulus level)','p1_n1_amplitude_at_each_stimulus_level_'),('IMPC_ABR_021_001','P3-N3 amplitude (at each stimulus level)','p3_n3_amplitude_at_each_stimulus_level_'),('IMPC_ABR_022_001','P1 Latency (at each stimulus level)','p1_latency_at_each_stimulus_level_'),('IMPC_ABR_023_001','N1 Latency (at each stimulus level)','n1_latency_at_each_stimulus_level_'),('IMPC_ABR_024_001','P3 Latency (at each stimulus level)','p3_latency_at_each_stimulus_level_'),('IMPC_ABR_025_001','N3 Latency (at each stimulus level)','n3_latency_at_each_stimulus_level_'),('IMPC_ABR_026_001','P1-P3 Interval (at each stimulus level)','p1_p3_interval_at_each_stimulus_level_'),('IMPC_ABR_027_001','N1-N3 Interval (at each stimulus level)','n1_n3_interval_at_each_stimulus_level_'),('IMPC_ABR_028_001','Range of test stimuli used','range_of_test_stimuli_used'),('IMPC_ABR_029_001','Range of stimulus levels used - Click','range_of_stimulus_levels_used_click'),('IMPC_ABR_030_001','Range of stimulus levels used - 6kHz','range_of_stimulus_levels_used_6khz'),('IMPC_ABR_031_001','Range of stimulus levels used - 12kHz','range_of_stimulus_levels_used_12khz'),('IMPC_ABR_032_001','Range of stimulus levels used - 18kHz','range_of_stimulus_levels_used_18khz'),('IMPC_ABR_033_001','Range of stimulus levels used - 24kHz','range_of_stimulus_levels_used_24khz'),('IMPC_ABR_034_001','Range of stimulus levels used - 30kHz','range_of_stimulus_levels_used_30khz'),('IMPC_ABR_035_001','Extension of stimulus levels','extension_of_stimulus_levels'),('IMPC_ABR_036_001','Stimulus level step size','stimulus_level_step_size'),('IMPC_ABR_037_001','Tone Pip Duration','tone_pip_duration'),('IMPC_ABR_038_001','Tone Pip rise/fall','tone_pip_rise_fall'),('IMPC_ABR_039_001','Repetition Rate','repetition_rate'),('IMPC_ABR_040_001','Number averages','number_averages'),('IMPC_ABR_041_001','Recording Environment','recording_environment'),('IMPC_ABR_042_001','Anesthetic agent 1','anesthetic_agent_1'),('IMPC_ABR_043_001','Anesthetic agent 2','anesthetic_agent_2'),('IMPC_ABR_044_001','Anesthetic agent 1 dosage','anesthetic_agent_1_dosage'),('IMPC_ABR_045_001','Anesthetic agent 2 dosage','anesthetic_agent_2_dosage'),('IMPC_ABR_046_001','Anesthetic administration route','anesthetic_administration_route'),('IMPC_ABR_047_001','Date of Test','date_of_test'),('IMPC_ABR_048_001','Time of injection','time_of_injection'),('IMPC_ABR_049_001','Equipment ID','equipment_id'),('IMPC_ABR_050_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_ABR_051_001','Equipment model','equipment_model'),('IMPC_ABR_052_001','Software','software'),('IMPC_ABR_053_001','Experimenter ID','experimenter_id'),('IMPC_ABR_054_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_ACS_001_001','Response amplitude - BN','response_amplitude_bn'),('IMPC_ACS_002_001','Response amplitude - PP1','response_amplitude_pp1'),('IMPC_ACS_003_001','Response amplitude - PP2','response_amplitude_pp2'),('IMPC_ACS_004_001','Response amplitude - PP3','response_amplitude_pp3'),('IMPC_ACS_005_001','Response amplitude - PP4','response_amplitude_pp4'),('IMPC_ACS_006_001','Response amplitude - S','response_amplitude_s'),('IMPC_ACS_007_001','Response amplitude - PP1_S','response_amplitude_pp1_s'),('IMPC_ACS_008_001','Response amplitude - PP2_S','response_amplitude_pp2_s'),('IMPC_ACS_009_001','Response amplitude - PP3_S','response_amplitude_pp3_s'),('IMPC_ACS_010_001','Response amplitude - PP4_S','response_amplitude_pp4_s'),('IMPC_ACS_011_001','Light level in chamber','light_level_in_chamber'),('IMPC_ACS_012_001','Date and time','date_and_time'),('IMPC_ACS_013_001','Inter PP-S stimulus interval','NA'),('IMPC_ACS_014_001','Experimenter ID','experimenter'),('IMPC_ACS_015_001','Startle stimulus','startle_pulse'),('IMPC_ACS_016_001','Background noise','background_noise'),('IMPC_ACS_017_001','Pre-pulse stimulus 1','pre_pulse_stimulus_1'),('IMPC_ACS_018_001','Pre-pulse stimulus 2','pre_pulse_stimulus_2'),('IMPC_ACS_019_001','Pre-pulse stimulus 3','pre_pulse_stimulus_3'),('IMPC_ACS_020_001','Pre-pulse stimulus 4','pre_pulse_stimulus_4'),('IMPC_ACS_021_001','Inter-trial interval','inter_trial_interval'),('IMPC_ACS_022_001','Number of trials','number_of_trials'),('IMPC_ACS_023_001','In-chamber adapt time','in_chamber_adapt_time'),('IMPC_ACS_024_001','Stimulus order','stimulus_order'),('IMPC_ACS_025_001','Mouse chamber ID','mouse_chamber_id'),('IMPC_ACS_026_001','Equipment ID','equipment_name'),('IMPC_ACS_027_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_ACS_028_001','Equipment model','equipment_model'),('IMPC_ACS_029_001','Software version','software_version'),('IMPC_ACS_030_001','Mouse chamber dimension','mouse_chamber_dimension'),('IMPC_ACS_031_001','Sound generator manufacturer','sound_generator'),('IMPC_ACS_032_001','Sound-proof box dimension','sound_proof_box_dimension'),('IMPC_ACS_033_001','% Pre-pulse inhibition - PPI1','_pre_pulse_inhibition_pp1'),('IMPC_ACS_034_001','% Pre-pulse inhibition - PPI2','_pre_pulse_inhibition_pp2'),('IMPC_ACS_035_001','% Pre-pulse inhibition - PPI3','_pre_pulse_inhibition_pp3'),('IMPC_ACS_036_001','% Pre-pulse inhibition - PPI4','_pre_pulse_inhibition_pp4'),('IMPC_ACS_037_001','% Pre-pulse inhibition - Global','_pre_pulse_inhibition_global'),('IMPC_ACS_038_001','Date equipment last calibrated','NA'),('IMPC_ACS_039_001','Sound generator model','NA'),('IMPC_ACS_040_001','Acoustic startle response measure','NA'),('IMPC_ALZ_001_001','Adrenal gland','adrenal'),('IMPC_ALZ_002_001','Lower Urinary Tract','lower_urinary_tract'),('IMPC_ALZ_003_001','Brain','brain'),('IMPC_ALZ_004_001','Eye','eye'),('IMPC_ALZ_005_001','Heart','heart'),('IMPC_ALZ_006_001','Kidney','kidney'),('IMPC_ALZ_007_001','Liver','liver'),('IMPC_ALZ_008_001','Lymph Node','lymph_node'),('IMPC_ALZ_009_001','Mammary gland','mammary_gland'),('IMPC_ALZ_010_001','Ovary','ovary'),('IMPC_ALZ_011_001','Oviduct','oviduct'),('IMPC_ALZ_012_001','Skin','skin_with_mg'),('IMPC_ALZ_013_001','Stomach','stomach'),('IMPC_ALZ_014_001','Testis','testis_epididymus'),('IMPC_ALZ_015_001','Thymus','thymus'),('IMPC_ALZ_016_001','Trachea','trachea'),('IMPC_ALZ_017_001','Uterus','uterus'),('IMPC_ALZ_018_001','Large Intestine','large_intestine'),('IMPC_ALZ_019_001','Esophagus','esophagus'),('IMPC_ALZ_020_001','Spinal cord','spinal_cord'),('IMPC_ALZ_021_001','Thyroid gland','thyroid'),('IMPC_ALZ_022_001','Pituitary gland','pituitary'),('IMPC_ALZ_023_001','Skeletal Muscle','skeletal_muscle'),('IMPC_ALZ_024_001','Small Intestine','small_intestine'),('IMPC_ALZ_025_001','White Adipose Tissue','white_adipose_tissue'),('IMPC_ALZ_026_001','Lung','lungs'),('IMPC_ALZ_027_001','Aorta','aorta'),('IMPC_ALZ_028_001','Pancreas','pancreas'),('IMPC_ALZ_029_001','Prostate gland','prostate'),('IMPC_ALZ_030_001','Spleen','spleen'),('IMPC_ALZ_031_001','Brainstem','brainstem'),('IMPC_ALZ_032_001','Cartilage tissue','cartilage'),('IMPC_ALZ_033_001','Cerebral Cortex','cerebral_cortex'),('IMPC_ALZ_034_001','Cerebellum','cerebellum'),('IMPC_ALZ_035_001','Hippocampus','hippocampus'),('IMPC_ALZ_036_001','Hypothalamus','hypothalamus'),('IMPC_ALZ_037_001','Olfactory Lobe','olfactory_lobe'),('IMPC_ALZ_038_001','Peripheral Nervous System','peripheral_nervous_system'),('IMPC_ALZ_039_001','Peyers Patch','peyers_patch'),('IMPC_ALZ_040_001','Striatum','straiatum'),('IMPC_ALZ_041_001','Vascular System','vascular_system'),('IMPC_ALZ_042_001','Urinary bladder','urinary bladder'),('IMPC_ALZ_043_001','Bone','bone'),('IMPC_ALZ_044_001','Cecum','cecum'),('IMPC_ALZ_045_001','Colon','colon'),('IMPC_ALZ_046_001','Duodenum','duodenum'),('IMPC_ALZ_047_001','Ileum','ileum'),('IMPC_ALZ_048_001','Jejunum','jejunum'),('IMPC_ALZ_049_001','Gonadal fat pad','adipose_gonad'),('IMPC_ALZ_050_001','Bone  Marrow','bone_marrow'),('IMPC_ALZ_051_001','Vas Deferens','vas_deferens'),('IMPC_ALZ_052_001','Brown adipose tissue','adipose_brown'),('IMPC_ALZ_053_001','Mesenteric adipose tissue','adipose_mesenteric'),('IMPC_ALZ_054_001','Blood','blood_smear'),('IMPC_ALZ_055_001','Diaphragm','diaphragm'),('IMPC_ALZ_056_001','Gall Bladder','gall_bladder'),('IMPC_ALZ_057_001','Harderian Gland','hardarian_gland'),('IMPC_ALZ_058_001','Hindlimb','hind_limb'),('IMPC_ALZ_059_001','Quadriceps','muscle_quad'),('IMPC_ALZ_060_001','Parathyroid gland','parathyroid'),('IMPC_ALZ_061_001','Parotid gland','parotid_gland'),('IMPC_ALZ_062_001','Penis','penis'),('IMPC_ALZ_063_001','Stomach pyloric region','pylorus'),('IMPC_ALZ_064_001','Chest bone','ribcage'),('IMPC_ALZ_065_001','Sciatic nerve','sciatic_nerve_quad'),('IMPC_ALZ_066_001','Cranium','skull'),('IMPC_ALZ_067_001','Sublingual Gland','sublingual_gland'),('IMPC_ALZ_068_001','Submandibular Gland','submandibular_gland'),('IMPC_ALZ_069_001','Tongue','tongue'),('IMPC_ALZ_070_001','Trigeminal V nerve','trigeminal_nerve'),('IMPC_ALZ_071_001','Vagina','vagina'),('IMPC_ALZ_072_001','Vesicular Gland','vesicular_gland'),('IMPC_ALZ_073_001','Mesenteric Lymph Node','mesenteric_lymph_node'),('IMPC_ALZ_074_001','Oral epithelium','oral_epithelia'),('IMPC_ALZ_075_001','LacZ Images Section','lacz_images_section'),('IMPC_ALZ_076_001','LacZ Images Wholemount','lacz_images_wholemount'),('IMPC_ALZ_077_001','Free Ontology','free_ontology'),('IMPC_ALZ_078_001','Free Ontology Annotation reason','free_ontology_annotation_reason'),('IMPC_ALZ_079_001','Free text comment','free_text_comment'),('IMPC_ALZ_080_001','Microscope equipment id','microscope_equipment_id'),('IMPC_ALZ_081_001','Microscope equipment manufacturer','microscope_equipment_manufacturer'),('IMPC_ALZ_082_001','Microscope equipment model','microscope_equipment_model'),('IMPC_ALZ_083_001','Date Microscope last calibrated','date_microscope_last_calibrated'),('IMPC_ALZ_084_001','Detector equipment manufacturer','detector_equipment_manufacturer'),('IMPC_ALZ_085_001','Detector equipment model','detector_equipment_model'),('IMPC_ALZ_086_001','Objective equipment company','objective_equipment_company'),('IMPC_ALZ_087_001','Objective equipment model','objective_equipment_model'),('IMPC_ALZ_088_001','Objective magnification','objective_magnification'),('IMPC_ALZ_089_001','Illumination source manufacturer','illumination_source_manufacturer'),('IMPC_ALZ_090_001','Illumination source model','illumination_source_model'),('IMPC_ALZ_091_001','Sample preparation stain name','sample_preparation_stain_name'),('IMPC_ALZ_092_001','Sample preparation reference impc','sample_preparation_reference_impc'),('IMPC_ALZ_093_001','Bit Depth','bit_depth'),('IMPC_ALZ_094_001','Colorspace','colorspace'),('IMPC_ALZ_095_001','Experimental category','experimental_category'),('IMPC_ALZ_096_001','Orientation','orientation'),('IMPC_ALZ_097_001','Pixels per millimeter before processing','pixels_per_millimeter_before_processing'),('IMPC_ALZ_098_001','Pixels per millimeter after processing','pixels_per_millimeter_after_processing'),('IMPC_ALZ_099_001','Showcase image','showcase_image'),('IMPC_ALZ_100_001','Date of Sacrifice','date_of_sacrifice'),('IMPC_ALZ_101_001','Date of Perfusion','date_of_perfusion'),('IMPC_ALZ_102_001','Epididymis','NA'),('IMPC_ALZ_103_001','Main olfactory bulb','NA'),('IMPC_ALZ_104_001','Midbrain','NA'),('IMPC_ALZ_105_001','Thalamus','NA'),('IMPC_BLK_001_001','Date of sacrifice','NA'),('IMPC_BLK_002_001','Date of necropsy','NA'),('IMPC_BLK_003_001','Experimenter ID','experimenter'),('IMPC_BLK_006_001','Fixative','fixative'),('IMPC_BLK_007_001','Tissue storage ID(s)','cassette_id'),('IMPC_BLK_008_001','Embedding medium','embedding_medium'),('IMPC_BLK_009_001','Embedding orientation','embedding_orientation'),('IMPC_BLK_010_001','Brain','brain'),('IMPC_BLK_011_001','Eye 1 with optic nerve (optic nerve parallel to cassette surface)','eye_1_with_optic_nerve_optic_nerve_parallel_to_cassette_surface_'),('IMPC_BLK_012_001','Eye 2 with optic nerve (within skull)','eye_2_with_optic_nerve_within_skull_'),('IMPC_BLK_013_001','Spinal cord','spinal_cord'),('IMPC_BLK_014_001','Thymus','thymus'),('IMPC_BLK_015_001','Thyroid','thyroid'),('IMPC_BLK_016_001','Heart','heart'),('IMPC_BLK_017_001','Trachea','trachea'),('IMPC_BLK_018_001','Esophagus','esophagus'),('IMPC_BLK_019_001','Lung','lung'),('IMPC_BLK_020_001','Liver','liver'),('IMPC_BLK_021_001','Gall bladder','gall_bladder'),('IMPC_BLK_022_001','Stomach','stomach'),('IMPC_BLK_023_001','Small intestine','small_intestine'),('IMPC_BLK_024_001','Large intestine','large_intestine'),('IMPC_BLK_025_001','Pancreas','pancreas'),('IMPC_BLK_026_001','Spleen','spleen'),('IMPC_BLK_027_001','Left Kidney','left_kidney'),('IMPC_BLK_028_001','Right Kidney','right_kidney'),('IMPC_BLK_029_001','Left Adrenal gland','left_adrenal_gland'),('IMPC_BLK_030_001','Right Adrenal gland','right_adrenal_gland'),('IMPC_BLK_031_001','Mammary gland','mammary_gland'),('IMPC_BLK_032_001','Lymph node','lymph_node'),('IMPC_BLK_033_001','Skin','skin'),('IMPC_BLK_034_001','Skeletal muscle','skeletal_muscle'),('IMPC_BLK_035_001','Urinary bladder','urinary_bladder'),('IMPC_BLK_036_001','Testes','testes'),('IMPC_BLK_037_001','Epididymis','epididymis'),('IMPC_BLK_038_001','Prostate','prostate'),('IMPC_BLK_039_001','Seminal vesicles','seminal_vesicles'),('IMPC_BLK_040_001','Ovary','ovary'),('IMPC_BLK_041_001','Uterus','uterus'),('IMPC_BLK_042_001','Additional tissues','additional_tissues'),('IMPC_BLK_043_001','Salivary gland','NA'),('IMPC_BLK_044_001','Sternum','NA'),('IMPC_BLK_045_001','Femur','NA'),('IMPC_BLK_046_001','Bone marrow','NA'),('IMPC_BLK_047_001','Brown fat','NA'),('IMPC_BLK_048_001','Tibia','NA'),('IMPC_BLK_049_001','Knee joint','NA'),('IMPC_BLK_050_001','Trigeminal V nerve','NA'),('IMPC_BLK_051_001','Nasal cavity','NA'),('IMPC_BLK_052_001','Ear','NA'),('IMPC_BLK_053_001','Tooth','NA'),('IMPC_BLK_054_001','Tongue','NA'),('IMPC_BLK_055_001','Sciatic nerve','NA'),('IMPC_BLK_056_001','Bone','NA'),('IMPC_BWT_001_001','Body weight','body_weight'),('IMPC_BWT_002_001','General comments about the mouse','general_comments_about_the_mouse'),('IMPC_BWT_003_001','Equipment ID','equipment_name'),('IMPC_BWT_004_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_BWT_005_001','Experimenter ID','experimenter_id'),('IMPC_BWT_006_001','Date equipment last calibrated','NA'),('IMPC_BWT_007_001','Equipment model','NA'),('IMPC_BWT_008_001','Body weight curve','Derivation to collect all body weights measured (when available) and plot them correctly as time series.'),('IMPC_CAL_001_001','Body weight before experiment','body_weight_before_experiment'),('IMPC_CAL_002_001','Body weight after experiment','body_weight_after_experiment'),('IMPC_CAL_003_001','Oxygen consumption','oxygen_consumption'),('IMPC_CAL_004_001','Carbon dioxide production','carbon_dioxide_production'),('IMPC_CAL_005_001','Heat production (metabolic rate)','heat_production_metabolic_rate_'),('IMPC_CAL_006_001','Ambulatory activity  (no. of beam cuts)','ambulatory_activity_no_of_beam_cuts_'),('IMPC_CAL_007_001','Total activity  (no. of fine movement + no. of beam cuts)','total_activity_no_of_fine_movement_no_of_beam_cuts_'),('IMPC_CAL_008_001','Total food intake','total_food_intake'),('IMPC_CAL_009_001','Cumulative food intake','cumulative_food_intake'),('IMPC_CAL_010_001','Time of dark cycle start','The starting time of the dark cycle. E.g. 7 p.m.'),('IMPC_CAL_010_002','Time of dark cycle start','The starting time of the dark cycle. E.g. 7 p.m.'),('IMPC_CAL_010_003','Time of dark cycle start','The starting datetime of the dark cycle. E.g. 2013-02-28T06:25:00-08:00+01 or 2013-02-28T06:25:00Z'),('IMPC_CAL_011_001','Room temperature','room_temperature'),('IMPC_CAL_012_001','Acclimation to respirometry cages','acclimation_to_respirometry_cages'),('IMPC_CAL_013_001','Duration of test','duration_of_test'),('IMPC_CAL_014_001','Equipment ID','equipment_name'),('IMPC_CAL_015_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_CAL_016_001','Equipment model','equipment'),('IMPC_CAL_017_001','Respiratory Exchange Ratio','respiratory_exchange_ratio'),('IMPC_CAL_018_001','Experimenter ID','NA'),('IMPC_CAL_019_001','Date equipment last calibrated','NA'),('IMPC_CAL_020_001','Time of dark cycle end','The ending time of the dark cycle. E.g. 7 a.m.'),('IMPC_CAL_020_002','Time of dark cycle end','The ending time of the dark cycle. E.g. 7 a.m.'),('IMPC_CAL_020_003','Time of dark cycle end','The ending time of the dark cycle. E.g. 2013-02-28T06:25:00-08:00+01 or 2013-02-28T06:25:00Z'),('IMPC_CAL_021_001','Total water intake','NA'),('IMPC_CAL_022_001','Cumulative water intake','NA'),('IMPC_CAL_023_001','Room temperature max','NA'),('IMPC_CAL_024_001','Room temperature min','NA'),('IMPC_CAL_025_001','Chamber temperature min','NA'),('IMPC_CAL_026_001','Chamber temperature max','NA'),('IMPC_CAL_027_001','Outer dimension of cage','(L, cm) x  (W, cm) x  (H, cm)'),('IMPC_CAL_028_001','Inner dimension of cage','(L, cm) x  (W, cm) x  (H, cm)'),('IMPC_CAL_029_001','Height from platform to lid assembly','NA'),('IMPC_CAL_030_001','Available space for mouse','(L, cm) x  (W, cm) x  (H, cm)'),('IMPC_CAL_031_001','Infrared beam setting on X axis','Orizontal activity: locomotion.N beams with L cm spacing, H cm above platform'),('IMPC_CAL_032_001','Infrared beam setting on Y axis','Orizontal activity: locomotion.N beams with L cm spacing, H cm above platform'),('IMPC_CAL_033_001','Infrared beam setting on Z axis','Vertical activity: rearing/jumping.N beams with L cm spacing, H cm above platform.'),('IMPC_CAL_034_001','Beam strip placement on exterior of chamber','NA'),('IMPC_CAL_035_001','Lightbeam wavelength','NA'),('IMPC_CAL_036_001','Scanning rate','NA'),('IMPC_CAL_037_001','Refractory period','NA'),('IMPC_CAL_038_001','Presence of bedding into the cage','NA'),('IMPC_CAL_039_001','Igloo in cage','NA'),('IMPC_CAL_040_001','Calibration method','NA'),('IMPC_CAL_041_001','Acclimation period','NA'),('IMPC_CAL_042_001','Respiratory Exchange Ratio series','NA'),('IMPC_CBC_001_001','Sodium','sodium'),('IMPC_CBC_002_001','Potassium','potassium'),('IMPC_CBC_003_001','Chloride','chloride'),('IMPC_CBC_004_001','Urea (Blood Urea Nitrogen - BUN)','urea'),('IMPC_CBC_005_001','Creatinine','creatinine_enzymatic_method_preferred_'),('IMPC_CBC_006_001','Total protein','total_protein'),('IMPC_CBC_007_001','Albumin','albumin'),('IMPC_CBC_008_001','Total bilirubin','total_bilirubin'),('IMPC_CBC_009_001','Calcium','calcium'),('IMPC_CBC_010_001','Phosphorus','phosphate'),('IMPC_CBC_011_001','Iron','iron'),('IMPC_CBC_012_001','Aspartate aminotransferase','aspartate_aminotransferase'),('IMPC_CBC_013_001','Alanine aminotransferase','alanine_aminotransferase'),('IMPC_CBC_014_001','Alkaline phosphatase','alkaline_phosphatase'),('IMPC_CBC_015_001','Total cholesterol','total_cholesterol'),('IMPC_CBC_016_001','HDL-cholesterol','hdl_cholesterol'),('IMPC_CBC_017_001','Triglycerides','triglycerides'),('IMPC_CBC_018_001','Glucose','glucose'),('IMPC_CBC_019_001','LIH (Hemolysis Severity - available on AU analysers)','lih_hemolysis_severity_available_on_au_analysers_'),('IMPC_CBC_020_001','Fructosamine','fructosamine'),('IMPC_CBC_021_001','Lipase','lipase'),('IMPC_CBC_022_001','Lactate dehydrogenase','lactate_dehydrogenase'),('IMPC_CBC_023_001','Alpha-amylase','alpha_amylase'),('IMPC_CBC_024_001','UIBC (unsaturated iron binding capacity)','uibc_unsaturated_iron_binding_capacity_'),('IMPC_CBC_025_001','LDL-cholesterol','ldl_cholesterol'),('IMPC_CBC_026_001','Free fatty acids','free_fatty_acids'),('IMPC_CBC_027_001','Glycerol','glycerol'),('IMPC_CBC_028_001','Creatine kinase','creatine_kinase'),('IMPC_CBC_029_001','Uric acid','uric_acid'),('IMPC_CBC_030_001','Ferritin','ferritin'),('IMPC_CBC_031_001','Transferrin','transferrin'),('IMPC_CBC_032_001','C-reactive protein','c_reactive_protein'),('IMPC_CBC_033_001','Equipment ID','equipment_name'),('IMPC_CBC_034_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_CBC_035_001','Equipment model','equipment_model'),('IMPC_CBC_036_001','Anesthesia used for blood collection','anesthesia_used_for_blood_collection'),('IMPC_CBC_037_001','Method of blood collection','method_of_blood_collection'),('IMPC_CBC_038_001','Anticoagulant','anticoagulant'),('IMPC_CBC_039_001','Blood collection tubes','NA'),('IMPC_CBC_040_001','Date and time of sacrifice','NA'),('IMPC_CBC_041_001','Storage temperature from blood collection till measurement','NA'),('IMPC_CBC_042_001','Samples kept on ice between collection and analysis','samples_kept_on_ice_between_collection_and_analysis'),('IMPC_CBC_043_001','Sample status','sample_status'),('IMPC_CBC_044_001','Sample dilution','plasma_dilution'),('IMPC_CBC_045_001','ID of blood collection SOP','id_of_blood_collection_sop'),('IMPC_CBC_046_001','Date and time of blood collection','date_and_time_of_blood_collection'),('IMPC_CBC_047_001','Date of measurement','date_of_measurement'),('IMPC_CBC_048_001','Hemolysis status','hemolysis_status'),('IMPC_CBC_049_001','Blood collection experimenter ID','NA'),('IMPC_CBC_050_001','Date equipment last calibrated','NA'),('IMPC_CBC_051_001','Blood analysis experimenter ID','NA'),('IMPC_CBC_052_001','Glycosilated hemoglobin A1c (HbA1c)','NA'),('IMPC_CBC_053_001','Thyroxine','NA'),('IMPC_CBC_054_001','Magnesium','NA'),('IMPC_CBC_055_001','Difficult bleed','NA'),('IMPC_CBC_056_001','Sample type','NA'),('IMPC_CBC_057_001','Fasting','NA'),('IMPC_CBC_058_001','Cholesterol ratio','TC/HDLC ratio'),('IMPC_CBC_059_001','Reagent manufacturer','NA'),('IMPC_CBC_060_001','Reagent manufacturer','NA'),('IMPC_CHL_001_001','Body weight','NA'),('IMPC_CHL_002_001','Frequency of breathing (f)','NA'),('IMPC_CHL_003_001','Tidal volume (TVb)','NA'),('IMPC_CHL_004_001','Minute volume (MVb)','NA'),('IMPC_CHL_005_001','Peak expiratory flow (PEFb)','NA'),('IMPC_CHL_006_001','Peak inspiratory flow (PIFb)','NA'),('IMPC_CHL_007_001','Pause (PAU)','NA'),('IMPC_CHL_008_001','Inspiratory time (Ti)','NA'),('IMPC_CHL_009_001','Expiratory time (Te)','NA'),('IMPC_CHL_010_001','Relaxation time (Tr)','NA'),('IMPC_CHL_011_001','Time of pause (Tp)','NA'),('IMPC_CHL_012_001','Enhanced pause (Penh)','NA'),('IMPC_CHL_013_001','Rejection index (Rinx)','NA'),('IMPC_CHL_014_001','Rpef','NA'),('IMPC_CHL_015_001','TB','NA'),('IMPC_CHL_016_001','Compensation (Comp)','NA'),('IMPC_CHL_017_001','Flow at point 50% TV expired (EF50)','NA'),('IMPC_CHL_018_001','Equipment ID','NA'),('IMPC_CHL_019_001','Experimenter ID','NA'),('IMPC_CHL_020_001','Equipment manufacturer','NA'),('IMPC_CHL_021_001','Equipment model','NA'),('IMPC_CHL_022_001','Date equipment last calibrated','NA'),('IMPC_CHL_023_001','Methacholine challenge: duration of PBS measurement period','Length in minutes of the period for measuring reaction to PBS.'),('IMPC_CHL_024_001','Methacholine challenge: duration of 12.5 mg/ml MCh measurement period','Length in minutes of the period for measuring reaction to 12.5mg/ml MCh.'),('IMPC_CHL_025_001','Methacholine challenge: duration of 25 mg/ml MCh measurement period','Length in minutes of the period for measuring reaction to 25mg/ml MCh.'),('IMPC_CHL_026_001','Chamber temperature (Tc)','NA'),('IMPC_CHL_027_001','Relative Humidity (RH)','NA'),('IMPC_CHL_028_001','Hypoxia challenge: duration of Unchallenged measurement period','NA'),('IMPC_CHL_029_001','Hypoxia challenge data present in submission','NA'),('IMPC_CHL_030_001','Methacholine challenge: duration of 50 mg/ml MCh measurement period','Length in minutes of the period for measuring reaction to 50mg/ml MCh.'),('IMPC_CHL_031_001','Methacholine challenge: start of PBS measurement timestamp','NA'),('IMPC_CHL_032_001','Methacholine challenge: end of PBS measurement timestamp','NA'),('IMPC_CHL_033_001','Methacholine challenge: start of 12.5 mg/ml MCh measurement timestamp','NA'),('IMPC_CHL_034_001','Methacholine challenge: end of 12.5 mg/ml MCh measurement timestamp','NA'),('IMPC_CHL_035_001','Methacholine challenge: start of 25 mg/ml MCh measurement timestamp','NA'),('IMPC_CHL_036_001','Methacholine challenge: end of 25 mg/ml MCh measurement timestamp','NA'),('IMPC_CHL_037_001','Methacholine challenge: start of 50 mg/ml MCh measurement timestamp','NA'),('IMPC_CHL_038_001','Methacholine challenge: end of 50 mg/ml MCh measurement timestamp','NA'),('IMPC_CHL_039_001','Hypoxia challenge: start of Unchallenged measurement timestamp','NA'),('IMPC_CHL_040_001','Hypoxia challenge: end of Unchallenged measurement timestamp','NA'),('IMPC_CHL_041_001','Hypoxia challenge: duration of 10% O2 measurement period','NA'),('IMPC_CHL_042_001','Hypoxia challenge: start of 10% O2 measurement timestamp','NA'),('IMPC_CHL_043_001','Hypoxia challenge: end of 10% O2 measurement timestamp','NA'),('IMPC_CHL_044_001','Hypoxia challenge: duration of 21% O2 measurement period','NA'),('IMPC_CHL_045_001','Hypoxia challenge: start of 21% O2 measurement timestamp','NA'),('IMPC_CHL_046_001','Hypoxia challenge: end of 21% O2 measurement timestamp','NA'),('IMPC_CHL_047_001','Hypoxia challenge: duration of Baseline measurement period','NA'),('IMPC_CHL_048_001','Hypoxia challenge: start of Baseline measurement timestamp','NA'),('IMPC_CHL_049_001','Hypoxia challenge: end of Baseline measurement timestamp','NA'),('IMPC_CSD_001_001','Tail - presence','tail_presence'),('IMPC_CSD_002_001','Tail - length','tail_length'),('IMPC_CSD_003_001','Tail - thickness','tail_thickness'),('IMPC_CSD_004_001','Tail - morphology','tail_morphology'),('IMPC_CSD_005_001','Coat - color - back','coat_color_back'),('IMPC_CSD_006_001','Coat - color - head','coat_color_head'),('IMPC_CSD_007_001','Coat - color - abdomen','coat_color_abdomen'),('IMPC_CSD_008_001','Coat - color pattern - back','coat_color_pattern_back'),('IMPC_CSD_009_001','Coat - color pattern - head','coat_color_pattern_head'),('IMPC_CSD_010_001','Coat - color pattern - abdomen','coat_color_pattern_abdomen'),('IMPC_CSD_011_001','Coat - hair distribution - back','coat_hair_distribution_back'),('IMPC_CSD_012_001','Coat - hair distribution - head','coat_hair_distribution_head'),('IMPC_CSD_013_001','Coat - hair distribution - abdomen','coat_hair_distribution_abdomen'),('IMPC_CSD_014_001','Coat - hair texture / appearance - back','coat_hair_texture_appearance_back'),('IMPC_CSD_015_001','Coat - hair texture / appearance - head','coat_hair_texture_appearance_head'),('IMPC_CSD_016_001','Coat - hair texture / appearance - abdomen','coat_hair_texture_appearance_abdomen'),('IMPC_CSD_017_001','Forelimbs - position','forelimbs_position'),('IMPC_CSD_018_001','Forelimbs - shape','forelimbs_shape'),('IMPC_CSD_019_001','Forelimbs - size','forelimbs_size'),('IMPC_CSD_020_001','Hindlimbs - position','hindlimbs_position'),('IMPC_CSD_021_001','Hindlimbs - shape','hindlimbs_shape'),('IMPC_CSD_022_001','Hindlimbs - size','hindlimbs_size'),('IMPC_CSD_023_001','Vibrissae - presence','vibrissae_presence'),('IMPC_CSD_024_001','Vibrissae - appearance','vibrissae_appearance'),('IMPC_CSD_025_001','Head size','head_size'),('IMPC_CSD_026_001','Head morphology','head_morphology'),('IMPC_CSD_027_001','Ears','ears'),('IMPC_CSD_028_001','Snout size','snout_size'),('IMPC_CSD_029_001','Activity (body position)','activity_body_position_'),('IMPC_CSD_030_001','Tremor','tremor'),('IMPC_CSD_031_001','Transfer arousal','transfer_arousal'),('IMPC_CSD_032_001','Locomotor activity','locomotor_activity'),('IMPC_CSD_033_001','Gait','gait'),('IMPC_CSD_034_001','Tail elevation','tail_elevation'),('IMPC_CSD_035_001','Touch escape','touch_escape'),('IMPC_CSD_036_001','Startle response','startle_response'),('IMPC_CSD_037_001','Unexpected behaviors','unexpected_behaviors'),('IMPC_CSD_038_001','Trunk curl','trunk_curl'),('IMPC_CSD_039_001','Limb grasp','limb_grasp'),('IMPC_CSD_040_001','Forepaw - size','forepaw_size'),('IMPC_CSD_040_002','Forepaw - size','forepaw_size'),('IMPC_CSD_041_001','Hindpaw - size','hindpaw_size'),('IMPC_CSD_041_002','Hindpaw - size','hindpaw_size'),('IMPC_CSD_042_001','Forepaw - shape','forepaw_shape'),('IMPC_CSD_042_002','Forepaw - shape','forepaw_shape'),('IMPC_CSD_043_001','Hindpaw - shape','hindpaw_shape'),('IMPC_CSD_043_002','Hindpaw - shape','hindpaw_shape'),('IMPC_CSD_044_001','Forelimb digit - number','forelimb_digit_number'),('IMPC_CSD_044_002','Forelimb digit - number','forelimb_digit_number'),('IMPC_CSD_045_001','Hindlimb digit - number','hindlimb_digit_number'),('IMPC_CSD_045_002','Hindlimb digit - number','hindlimb_digit_number'),('IMPC_CSD_046_001','Forelimb digit - size','forelimb_digit_size'),('IMPC_CSD_047_001','Hindlimb digit - size','hindlimb_digit_size'),('IMPC_CSD_048_001','Forelimb digit - shape','forelimb_digit_shape'),('IMPC_CSD_048_002','Forelimb digit - shape','forelimb_digit_shape'),('IMPC_CSD_049_001','Hindlimb digit - shape','hindlimb_digit_shape'),('IMPC_CSD_049_002','Hindlimb digit - shape','hindlimb_digit_shape'),('IMPC_CSD_050_001','Forelimb nail - number','forelimb_nail_number'),('IMPC_CSD_050_002','Forelimb nail - number','forelimb_nail_number'),('IMPC_CSD_051_001','Hindlimb nail - number','hindlimb_nail_number'),('IMPC_CSD_051_002','Hindlimb nail - number','hindlimb_nail_number'),('IMPC_CSD_052_001','Forelimb nail - length','forelimb_nail_length'),('IMPC_CSD_052_002','Forelimb nail - length','forelimb_nail_length'),('IMPC_CSD_053_001','Hindlimb nail - length','hindlimb_nail_length'),('IMPC_CSD_053_002','Hindlimb nail - length','hindlimb_nail_length'),('IMPC_CSD_054_001','Forelimb nail - shape','forelimb_nail_shape'),('IMPC_CSD_054_002','Forelimb nail - shape','forelimb_nail_shape'),('IMPC_CSD_055_001','Hindlimb nail - shape','hindlimb_nail_shape'),('IMPC_CSD_055_002','Hindlimb nail - shape','hindlimb_nail_shape'),('IMPC_CSD_056_001','Skin color - whole body','skin_color_whole_body'),('IMPC_CSD_057_001','Skin color - snout','skin_color_snout'),('IMPC_CSD_058_001','Skin color - ear','skin_color_ear'),('IMPC_CSD_059_001','Skin color - front paws','skin_color_front_paws'),('IMPC_CSD_060_001','Skin color - back paws','skin_color_back_paws'),('IMPC_CSD_061_001','Skin color - tail','skin_color_tail'),('IMPC_CSD_062_001','Skin texture - whole body','skin_texture_whole_body'),('IMPC_CSD_063_001','Skin texture - snout','skin_texture_snout'),('IMPC_CSD_064_001','Skin texture - ear','skin_texture_ear'),('IMPC_CSD_065_001','Skin texture - front paws','skin_texture_front_paws'),('IMPC_CSD_066_001','Skin texture - back paws','skin_texture_back_paws'),('IMPC_CSD_067_001','Skin texture - tail','skin_texture_tail'),('IMPC_CSD_068_001','Teeth presence','teeth_presence'),('IMPC_CSD_069_001','Upper teeth appearance','upper_teeth_appearance'),('IMPC_CSD_070_001','Lower teeth appearance','lower_teeth_appearance'),('IMPC_CSD_071_001','Genitalia - presence','genitalia_presence'),('IMPC_CSD_072_001','Genitalia - size','genitalia_size'),('IMPC_CSD_073_001','Genitalia - morphology','genitalia_morphology'),('IMPC_CSD_074_001','Mouth morphology','mouth_morphology'),('IMPC_CSD_075_001','Upper lip morphology','upper_lip_morphology'),('IMPC_CSD_076_001','Lower lip morphology','lower_lip_morphology'),('IMPC_CSD_077_001','Contact righting','contact_righting'),('IMPC_CSD_078_001','Vocalization','vocalization'),('IMPC_CSD_079_001','Aggression','aggression'),('IMPC_CSD_080_001','Head bobbing','head_bobbing'),('IMPC_CSD_081_001','Experimenter ID','NA'),('IMPC_CSD_082_001','Location of test','location_of_test'),('IMPC_CSD_083_001','Number of animals in cage','number_of_animals'),('IMPC_CSD_084_001','Number of days since cage changed','NA'),('IMPC_CSD_085_001','Images','NA'),('IMPC_CSD_086_001','Size of squares in arena','NA'),('IMPC_CSD_087_001','Comments (in English)','General comments, in English'),('IMPC_DXA_001_001','Body weight','body_weight'),('IMPC_DXA_002_001','Fat mass','fat_mass'),('IMPC_DXA_003_001','Lean mass','lean_mass'),('IMPC_DXA_004_001','Bone Mineral Density (excluding skull)','bone_mineral_density_excluding_skull_'),('IMPC_DXA_005_001','Bone Mineral Content (excluding skull)','bone_mineral_content_excluding_skull_'),('IMPC_DXA_006_001','Body length','body_length'),('IMPC_DXA_007_001','BMC/Body weight','bmc_body_weight'),('IMPC_DXA_008_001','Lean/Body weight','lean_body_weight'),('IMPC_DXA_009_001','Fat/Body weight','fat_body_weight'),('IMPC_DXA_010_001','Bone Area','bone_area_bmc_bmd_'),('IMPC_DXA_011_001','Equipment ID','equipment_name'),('IMPC_DXA_012_001','Equipment manufacturer','equipment_manufactuer'),('IMPC_DXA_013_001','Equipment model','equipment_model'),('IMPC_DXA_014_001','Mouse Status','mouse_status'),('IMPC_DXA_015_001','Anesthesia','anesthesia'),('IMPC_DXA_016_001','Experimenter ID','NA'),('IMPC_DXA_017_001','Date equipment last calibrated','NA'),('IMPC_DXA_018_001','HAW','NA'),('IMPC_ECG_001_001','Number of signals','NA'),('IMPC_ECG_002_001','HR','NA'),('IMPC_ECG_003_001','CV','NA'),('IMPC_ECG_004_001','RR','NA'),('IMPC_ECG_005_001','PQ','NA'),('IMPC_ECG_006_001','PR','NA'),('IMPC_ECG_007_001','QRS','NA'),('IMPC_ECG_008_001','ST','NA'),('IMPC_ECG_009_001','QTc','NA'),('IMPC_ECG_009_002','QTc','NA'),('IMPC_ECG_010_001','HRV','NA'),('IMPC_ECG_011_001','QTc Dispersion','NA'),('IMPC_ECG_012_001','Mean SR amplitude','NA'),('IMPC_ECG_013_001','Mean R amplitude','NA'),('IMPC_ECG_014_001','rMSSD','NA'),('IMPC_ECG_015_001','pNN5(6>ms)','NA'),('IMPC_ECG_016_001','Equipment ID','NA'),('IMPC_ECG_017_001','Equipment Manufacturer','NA'),('IMPC_ECG_018_001','Equipment Model','NA'),('IMPC_ECG_019_001','Anesthetic','NA'),('IMPC_ECG_020_001','Experimenter ID','NA'),('IMPC_ECG_021_001','Noise level','NA'),('IMPC_ECG_022_001','Light level','NA'),('IMPC_ECG_023_001','Date equipment last calibrated','NA'),('IMPC_ECG_024_001','Analysis Software','NA'),('IMPC_ECG_025_001','Waveform Image','NA'),('IMPC_ECG_026_001','Waveform Image Comment','Free text comment on the waveform image. Use parameterAssociation of the image parameter to link to this text.'),('IMPC_ECG_027_001','Lead Configuration','NA'),('IMPC_ECG_028_001','QT','NA'),('IMPC_ECG_029_001','QT Dispersion','NA'),('IMPC_ECG_030_001','Data acquisition sampling rate','NA'),('IMPC_ECG_031_001','Abnormal ECG detected','NA'),('IMPC_ECH_001_001','End-Systolic Diameter','NA'),('IMPC_ECH_002_001','End-Diastolic Diameter','NA'),('IMPC_ECH_003_001','Stroke Volume','NA'),('IMPC_ECH_004_001','Ejection Fraction','NA'),('IMPC_ECH_005_001','Fractional Shortening','NA'),('IMPC_ECH_006_001','Cardiac Output','NA'),('IMPC_ECH_007_001','LVAWd','NA'),('IMPC_ECH_008_001','LVIDd','NA'),('IMPC_ECH_009_001','LVPWd','NA'),('IMPC_ECH_010_001','LVAWs','NA'),('IMPC_ECH_011_001','LVIDs','NA'),('IMPC_ECH_012_001','LVPWs','NA'),('IMPC_ECH_013_001','HR','NA'),('IMPC_ECH_014_001','Body Temp','NA'),('IMPC_ECH_015_001','VTI of aortic flow (Pulse wave doppler mode)','NA'),('IMPC_ECH_016_001','Aortic diameter (Dao)','NA'),('IMPC_ECH_017_001','Tpeak Tend Interval','NA'),('IMPC_ECH_018_001','Respiration Rate','NA'),('IMPC_ECH_019_001','Equipment ID','NA'),('IMPC_ECH_020_001','Equipment Manufacturer','NA'),('IMPC_ECH_021_001','Equipment Model','NA'),('IMPC_ECH_022_001','Anesthetic','NA'),('IMPC_ECH_023_001','Experimenter ID','NA'),('IMPC_ECH_024_001','Date equipment last calibrated','NA'),('IMPC_ECH_025_001','M-Mode Images','NA'),('IMPC_ELZ_001_001','Embryo','NA'),('IMPC_ELZ_002_001','Head','NA'),('IMPC_ELZ_003_001','Forelimb','NA'),('IMPC_ELZ_004_001','Forearm','NA'),('IMPC_ELZ_005_001','Radius-ulna pre cartilage condensation','NA'),('IMPC_ELZ_006_001','Upper arm','NA'),('IMPC_ELZ_007_001','Humerus pre-cartilage condensation','NA'),('IMPC_ELZ_008_001','Handplate','NA'),('IMPC_ELZ_009_001','Hindlimb','NA'),('IMPC_ELZ_010_001','Footplate','NA'),('IMPC_ELZ_011_001','Lower leg','NA'),('IMPC_ELZ_012_001','Upper leg','NA'),('IMPC_ELZ_013_001','Femur pre-cartilage condensation','NA'),('IMPC_ELZ_014_001','Head mesenchyme','NA'),('IMPC_ELZ_015_001','Trunk mesenchyme','NA'),('IMPC_ELZ_016_001','Notochord','NA'),('IMPC_ELZ_017_001','Skin','NA'),('IMPC_ELZ_018_001','Vibrissa','NA'),('IMPC_ELZ_019_001','Oral cavity','NA'),('IMPC_ELZ_020_001','Mandibular process','NA'),('IMPC_ELZ_021_001','Meckel\'s cartilage','NA'),('IMPC_ELZ_022_001','Maxillary process','NA'),('IMPC_ELZ_023_001','Gut','NA'),('IMPC_ELZ_024_001','Pharynx','NA'),('IMPC_ELZ_025_001','Tongue','NA'),('IMPC_ELZ_026_001','Stomach','NA'),('IMPC_ELZ_027_001','Pancreas','NA'),('IMPC_ELZ_028_001','Liver','NA'),('IMPC_ELZ_029_001','Urinary system','NA'),('IMPC_ELZ_030_001','Metanephros','NA'),('IMPC_ELZ_031_001','Mesonephros of male','NA'),('IMPC_ELZ_032_001','Mesonephros of female','NA'),('IMPC_ELZ_033_001','Lung','NA'),('IMPC_ELZ_034_001','Trachea','NA'),('IMPC_ELZ_035_001','Umbilical artery embryonic part','NA'),('IMPC_ELZ_036_001','Heart','NA'),('IMPC_ELZ_037_001','Atrium','NA'),('IMPC_ELZ_038_001','Outflow tract','NA'),('IMPC_ELZ_039_001','Pericardium','NA'),('IMPC_ELZ_040_001','Heart ventricle','NA'),('IMPC_ELZ_041_001','Umbilical vein embryonic part','NA'),('IMPC_ELZ_042_001','Brain','NA'),('IMPC_ELZ_043_001','Forebrain','NA'),('IMPC_ELZ_044_001','Midbrain','NA'),('IMPC_ELZ_045_001','Central nervous system ganglion','NA'),('IMPC_ELZ_046_001','Spinal cord','NA'),('IMPC_ELZ_047_001','Dorsal root ganglion','NA'),('IMPC_ELZ_048_001','Ear','NA'),('IMPC_ELZ_049_001','External ear','NA'),('IMPC_ELZ_050_001','Inner Ear','NA'),('IMPC_ELZ_051_001','Eye','NA'),('IMPC_ELZ_052_001','Nose','NA'),('IMPC_ELZ_053_001','Nasal septum','NA'),('IMPC_ELZ_054_001','Fronto-nasal process','NA'),('IMPC_ELZ_055_001','Skeleton','NA'),('IMPC_ELZ_056_001','Axial skeleton','NA'),('IMPC_ELZ_057_001','Rib pre-cartilage condensation','NA'),('IMPC_ELZ_058_001','Thoracic vertebral cartilage condensation','NA'),('IMPC_ELZ_059_001','Cranium','NA'),('IMPC_ELZ_060_001','Tail','NA'),('IMPC_ELZ_061_001','Tail somite group','NA'),('IMPC_ELZ_062_001','Intestine','NA'),('IMPC_ELZ_063_001','LacZ images section','NA'),('IMPC_ELZ_064_001','LacZ images wholemount','NA'),('IMPC_ELZ_065_001','Free ontology','NA'),('IMPC_ELZ_066_001','Free ontology annotation reason','NA'),('IMPC_ELZ_067_001','Free text comment','NA'),('IMPC_ELZ_068_001','Microscope equipment id','NA'),('IMPC_ELZ_069_001','Microscope equipment manufacturer','NA'),('IMPC_ELZ_070_001','Microscope equipment model','NA'),('IMPC_ELZ_071_001','Date Microscope last calibrated','NA'),('IMPC_ELZ_072_001','Detector equipment manufacturer','NA'),('IMPC_ELZ_073_001','Detector equipment model','NA'),('IMPC_ELZ_074_001','Objective equipment company','NA'),('IMPC_ELZ_075_001','Objective equipment model','NA'),('IMPC_ELZ_076_001','Objective magnification','NA'),('IMPC_ELZ_077_001','Illumination source manufacturer','NA'),('IMPC_ELZ_079_001','Sample preparation stain name','NA'),('IMPC_ELZ_080_001','Sample preparation reference impc','NA'),('IMPC_ELZ_081_001','Bit depth','NA'),('IMPC_ELZ_082_001','Colorspace','NA'),('IMPC_ELZ_083_001','Experimental category','NA'),('IMPC_ELZ_084_001','Orientation','NA'),('IMPC_ELZ_085_001','Pixels per millimeter before processing','NA'),('IMPC_ELZ_086_001','Pixels per millimeter after processing','NA'),('IMPC_ELZ_087_001','Showcase image','NA'),('IMPC_ELZ_088_001','Date of sacrifice','NA'),('IMPC_ELZ_089_001','Date of staining','NA'),('IMPC_ELZ_090_001','Date of annotation','NA'),('IMPC_ELZ_091_001','Date of image capture','NA'),('IMPC_ELZ_092_001','Hindbrain','NA'),('IMPC_ELZ_093_001','Placenta','NA'),('IMPC_EMA_001_001','Embryo reconstruction','NA'),('IMPC_EMA_002_001','Experimenter ID','NA'),('IMPC_EMA_003_001','Equipment ID','NA'),('IMPC_EMA_004_001','Equipment Manufacturer','NA'),('IMPC_EMA_005_001','Equipment Model','NA'),('IMPC_EMA_006_001','Equipment Version','NA'),('IMPC_EMA_007_001','Image Pixel Size','NA'),('IMPC_EMA_008_001','E18.5 MicroCT Preparation protocol','NA'),('IMPC_EMA_009_001','Date equipment last calibrated','NA'),('IMPC_EMA_010_001','Date of Sacrifice','NA'),('IMPC_EMA_011_001','Date Preparation Finished','NA'),('IMPC_EMA_012_001','Date of Scan','NA'),('IMPC_EMA_013_001','Source Voltage','NA'),('IMPC_EMA_014_001','Source Current','NA'),('IMPC_EMA_015_001','Object to Source','NA'),('IMPC_EMA_016_001','Camera to Source','NA'),('IMPC_EMA_017_001','Screenshots','NA'),('IMPC_EMA_018_001','Limb digits','NA'),('IMPC_EMA_019_001','Tail','NA'),('IMPC_EMA_020_001','Limbs','NA'),('IMPC_EMA_021_001','Pinna','NA'),('IMPC_EMA_022_001','Vibrissa','NA'),('IMPC_EMA_023_001','Edema','NA'),('IMPC_EMA_024_001','Embryo size','NA'),('IMPC_EMA_025_001','Spinal Cord','NA'),('IMPC_EMA_026_001','Spine curvature','NA'),('IMPC_EMA_027_001','Craniofacial morphology','NA'),('IMPC_EMA_028_001','Hindbrain subarachnoid space','NA'),('IMPC_EMA_029_001','Midbrain roof plate','NA'),('IMPC_EMA_030_001','Midbrain','NA'),('IMPC_EMA_031_001','Cerebellum','NA'),('IMPC_EMA_032_001','Cerebral cortex','NA'),('IMPC_EMA_033_001','Thalamus','NA'),('IMPC_EMA_034_001','Corpus striatum','NA'),('IMPC_EMA_035_001','Hippocampus','NA'),('IMPC_EMA_036_001','Hypothalamus','NA'),('IMPC_EMA_037_001','Pineal gland','NA'),('IMPC_EMA_038_001','Pons','NA'),('IMPC_EMA_039_001','Medulla oblongata','NA'),('IMPC_EMA_040_001','Lateral ventricles','NA'),('IMPC_EMA_041_001','Lateral ventricle choroid plexus','NA'),('IMPC_EMA_042_001','4th ventricle choroid plexus','NA'),('IMPC_EMA_043_001','4th Ventricle','NA'),('IMPC_EMA_044_001','Cerebral aqueduct','NA'),('IMPC_EMA_045_001','Median sulcus','NA'),('IMPC_EMA_046_001','3rd ventricle','NA'),('IMPC_EMA_047_001','Olfactory lobe','NA'),('IMPC_EMA_048_001','Trigeminal ganglion','NA'),('IMPC_EMA_049_001','Pituitary gland','NA'),('IMPC_EMA_050_001','Spinal cord cervical region','NA'),('IMPC_EMA_051_001','Dorsal root ganglion','NA'),('IMPC_EMA_052_001','Cochlea','NA'),('IMPC_EMA_053_001','Nasal septum','NA'),('IMPC_EMA_054_001','Nasal cavity','NA'),('IMPC_EMA_055_001','Nasopharynx','NA'),('IMPC_EMA_056_001','Vomeronasal organ','NA'),('IMPC_EMA_057_001','Oropharynx','NA'),('IMPC_EMA_058_001','Oral cavity','NA'),('IMPC_EMA_059_001','Optic nerve','NA'),('IMPC_EMA_060_001','Intraretinal space','NA'),('IMPC_EMA_061_001','Hyaloid cavity','NA'),('IMPC_EMA_062_001','Cornea','NA'),('IMPC_EMA_063_001','Lens','NA'),('IMPC_EMA_064_001','Eyelids','NA'),('IMPC_EMA_065_001','Temporal bone','NA'),('IMPC_EMA_066_001','Pharyngo-tympanic tube','NA'),('IMPC_EMA_067_001','Palate','NA'),('IMPC_EMA_068_001','Epiglottis','NA'),('IMPC_EMA_069_001','Tongue','NA'),('IMPC_EMA_070_001','Mandible','NA'),('IMPC_EMA_071_001','Lower jaw molar','NA'),('IMPC_EMA_072_001','Upper jaw molar','NA'),('IMPC_EMA_073_001','Sphenoid bone','NA'),('IMPC_EMA_074_001','Thyroid gland','NA'),('IMPC_EMA_075_001','Submandibular gland','NA'),('IMPC_EMA_076_001','Brown fat','NA'),('IMPC_EMA_077_001','Vertebrae','NA'),('IMPC_EMA_078_001','Esophagus','NA'),('IMPC_EMA_079_001','Clavicle','NA'),('IMPC_EMA_080_001','Scapula','NA'),('IMPC_EMA_081_001','Ulna','NA'),('IMPC_EMA_082_001','Humerus','NA'),('IMPC_EMA_083_001','Arytenoid cartilage','NA'),('IMPC_EMA_084_001','Cricoid cartilage','NA'),('IMPC_EMA_085_001','Trachea','NA'),('IMPC_EMA_086_001','Carotid artery','NA'),('IMPC_EMA_087_001','Thymus','NA'),('IMPC_EMA_088_001','Sternum','NA'),('IMPC_EMA_089_001','Rib','NA'),('IMPC_EMA_090_001','T1 rib','NA'),('IMPC_EMA_091_001','Vena cava','NA'),('IMPC_EMA_092_001','Inferior vena cava','NA'),('IMPC_EMA_093_001','Superior vena cava','NA'),('IMPC_EMA_094_001','Jugular vein','NA'),('IMPC_EMA_095_001','Ductus arteriosus','NA'),('IMPC_EMA_096_001','Pulmonary valve','NA'),('IMPC_EMA_097_001','Pulmonary trunk','NA'),('IMPC_EMA_098_001','Dorsal aorta','NA'),('IMPC_EMA_099_001','Ductus venosus','NA'),('IMPC_EMA_100_001','Aorta','NA'),('IMPC_EMA_101_001','Aortic valve','NA'),('IMPC_EMA_102_001','Heart atrium','NA'),('IMPC_EMA_103_001','Heart ventricle','NA'),('IMPC_EMA_104_001','Tricuspid valve','NA'),('IMPC_EMA_105_001','Mitral valve','NA'),('IMPC_EMA_106_001','Interventricular septum','NA'),('IMPC_EMA_107_001','Pericardial cavity','NA'),('IMPC_EMA_108_001','Pericardium','NA'),('IMPC_EMA_109_001','Main bronchus','NA'),('IMPC_EMA_110_001','Bronchus','NA'),('IMPC_EMA_111_001','Right lung cranial lobe','NA'),('IMPC_EMA_112_001','Right lung middle lobe','NA'),('IMPC_EMA_113_001','Right lung caudal lobe','NA'),('IMPC_EMA_114_001','Right lung accessory lobe','NA'),('IMPC_EMA_115_001','Left lung','NA'),('IMPC_EMA_116_001','Diaphragm','NA'),('IMPC_EMA_117_001','Peritoneal cavity','NA'),('IMPC_EMA_118_001','Liver','NA'),('IMPC_EMA_119_001','Liver left lobe','NA'),('IMPC_EMA_120_001','Liver right lobe','NA'),('IMPC_EMA_121_001','Liver caudate lobe','NA'),('IMPC_EMA_122_001','Gallbladder','NA'),('IMPC_EMA_123_001','Liver lobar interzone','NA'),('IMPC_EMA_124_001','Pancreas','NA'),('IMPC_EMA_125_001','Stomach','NA'),('IMPC_EMA_126_001','Pyloric antrum','NA'),('IMPC_EMA_127_001','Stomach fundus','NA'),('IMPC_EMA_128_001','Stomach lumen','NA'),('IMPC_EMA_129_001','Small intestine','NA'),('IMPC_EMA_130_001','Hindgut','NA'),('IMPC_EMA_131_001','Midgut','NA'),('IMPC_EMA_132_001','Hip joint','NA'),('IMPC_EMA_133_001','Femur','NA'),('IMPC_EMA_134_001','Fibula','NA'),('IMPC_EMA_135_001','Tibia','NA'),('IMPC_EMA_136_001','Adrenal gland','NA'),('IMPC_EMA_137_001','Kidney','NA'),('IMPC_EMA_138_001','Renal calyx','NA'),('IMPC_EMA_139_001','Bladder','NA'),('IMPC_EMA_140_001','Rectum','NA'),('IMPC_EMA_141_001','Spleen','NA'),('IMPC_EMA_142_001','Ovary','NA'),('IMPC_EMA_143_001','Testes','NA'),('IMPC_EMA_144_001','Penis','NA'),('IMPC_EMA_145_001','Circumventricular organ','NA'),('IMPC_EMA_146_001','Hyoid','NA'),('IMPC_EMA_147_001','Severely dysmorphic','NA'),('IMPC_EMA_148_001','Delayed embryonic development','NA'),('IMPC_EMA_149_001','Annotator ID','NA'),('IMPC_EMA_150_001','Date of Annotation','NA'),('IMPC_EML_001_001','Embryo reconstruction','NA'),('IMPC_EML_002_001','Experimenter ID','NA'),('IMPC_EML_003_001','Equipment ID','NA'),('IMPC_EML_004_001','Equipment Manufacturer','NA'),('IMPC_EML_005_001','Equipment Model','NA'),('IMPC_EML_006_001','Equipment Version','NA'),('IMPC_EML_007_001','Image Pixel Size','NA'),('IMPC_EML_008_001','E9.5 MicroCT Preparation protocol','NA'),('IMPC_EML_009_001','Object to Source','NA'),('IMPC_EML_010_001','Camera to Source','NA'),('IMPC_EML_011_001','Date equipment last calibrated','NA'),('IMPC_EML_012_001','Date of Sacrifice','NA'),('IMPC_EML_013_001','Date Preparation Finished','NA'),('IMPC_EML_014_001','Date of Scan','NA'),('IMPC_EML_015_001','Source Voltage','NA'),('IMPC_EML_016_001','Source Current','NA'),('IMPC_EML_017_001','Screenshots','NA'),('IMPC_EML_018_001','Hindbrain','NA'),('IMPC_EML_019_001','4th ventricle','NA'),('IMPC_EML_020_001','Mesencephalic vesicle','NA'),('IMPC_EML_021_001','Forebrain','NA'),('IMPC_EML_022_001','Telecenphalic (lateral) ventricle','NA'),('IMPC_EML_023_001','Rhombomeres','NA'),('IMPC_EML_024_001','Notochord','NA'),('IMPC_EML_025_001','Infundibular recess of 3rd ventricle','NA'),('IMPC_EML_026_001','Rathke\'s pouch','NA'),('IMPC_EML_027_001','Optic vesicle','NA'),('IMPC_EML_028_001','Otocyst','NA'),('IMPC_EML_029_001','1st branchial arch','NA'),('IMPC_EML_030_001','1st arch artery','NA'),('IMPC_EML_031_001','2nd branchial arch','NA'),('IMPC_EML_032_001','2nd arch artery','NA'),('IMPC_EML_033_001','Oropharynx','NA'),('IMPC_EML_034_001','3rd branchial arch','NA'),('IMPC_EML_035_001','3rd arch artery','NA'),('IMPC_EML_036_001','Aortic sac','NA'),('IMPC_EML_037_001','Common atrial chamber','NA'),('IMPC_EML_038_001','Atrioventricular canal','NA'),('IMPC_EML_039_001','Heart ventricle','NA'),('IMPC_EML_040_001','Primitive heart tube cardiac muscle','NA'),('IMPC_EML_041_001','Dorsal aorta','NA'),('IMPC_EML_042_001','Hepatic primordium','NA'),('IMPC_EML_043_001','Hindgut','NA'),('IMPC_EML_044_001','Forelimb bud','NA'),('IMPC_EML_045_001','Neural tube','NA'),('IMPC_EML_046_001','Caudal neuropore','NA'),('IMPC_EML_047_001','Somite','NA'),('IMPC_EML_048_001','Somite count','NA'),('IMPC_EML_049_001','Delayed embryonic development','NA'),('IMPC_EML_050_001','Vitelline artery','NA'),('IMPC_EML_051_001','Umbilical vein','NA'),('IMPC_EML_052_001','Foregut','NA'),('IMPC_EML_053_001','Midgut','NA'),('IMPC_EML_054_001','Pericardial cavity','NA'),('IMPC_EML_055_001','Peritoneal cavity','NA'),('IMPC_EML_056_001','Sinus venosus','NA'),('IMPC_EML_057_001','Annotator ID','NA'),('IMPC_EML_058_001','Date of Annotation','NA'),('IMPC_EMO_001_001','Embryo reconstruction','NA'),('IMPC_EMO_002_001','Experimenter ID','NA'),('IMPC_EMO_003_001','Equipment ID','NA'),('IMPC_EMO_004_001','Equipment Manufacturer','NA'),('IMPC_EMO_005_001','Equipment Model','NA'),('IMPC_EMO_006_001','Equipment Version','NA'),('IMPC_EMO_007_001','Image Pixel Size','NA'),('IMPC_EMO_008_001','E14.5-E15.5 MicroCT Preparation protocol','NA'),('IMPC_EMO_009_001','Object to Source','NA'),('IMPC_EMO_010_001','Camera to Source','NA'),('IMPC_EMO_011_001','Date equipment last calibrated','NA'),('IMPC_EMO_012_001','Date of Sacrifice','NA'),('IMPC_EMO_013_001','Date Preparation Finished','NA'),('IMPC_EMO_014_001','Date of Scan','NA'),('IMPC_EMO_015_001','Source Voltage','NA'),('IMPC_EMO_016_001','Source Current','NA'),('IMPC_EMO_017_001','Screenshots','NA'),('IMPC_EMO_017_002','Screenshots','NA'),('IMPC_EMO_018_001','3rd ventricle','3rd_ventricle'),('IMPC_EMO_019_001','Median sulcus','median_sulcus'),('IMPC_EMO_020_001','4th ventricle','4th_ventricle'),('IMPC_EMO_021_001','Adrenal gland','adrenal_gland'),('IMPC_EMO_022_001','Aorta','aorta'),('IMPC_EMO_023_001','Arch of aorta','arch_of_aorta'),('IMPC_EMO_024_001','Heart atrium','heart_atrium'),('IMPC_EMO_025_001','basioccipital bone','basioccipital_bone'),('IMPC_EMO_026_001','Bladder','bladder'),('IMPC_EMO_027_001','Bronchus','bronchus'),('IMPC_EMO_028_001','Brown fat','brown_fat'),('IMPC_EMO_029_001','Dorsal root ganglia','dorsal_root_ganglia'),('IMPC_EMO_030_001','Carotid artery','carotid_artery'),('IMPC_EMO_031_001','Cerbral aqueduct','cerbral_aqueduct'),('IMPC_EMO_032_001','Cerebellum','cerebellum'),('IMPC_EMO_033_001','4th ventricle choroid plexus','4th_ventricle_choroid_plexus'),('IMPC_EMO_034_001','lateral ventricle choroid plexus','lateral_ventricle_choroid_plexus'),('IMPC_EMO_035_001','Clavicle','clavicle'),('IMPC_EMO_036_001','Cochlea','cochlea'),('IMPC_EMO_037_001','Cerebral cortex','cerebral_cortex'),('IMPC_EMO_038_001','Ductus arteriosus','ductus_arteriosus'),('IMPC_EMO_039_001','Diaphragm','diaphragm'),('IMPC_EMO_040_001','Diencephalon','diencephalon'),('IMPC_EMO_041_001','Limb digit','limb_digit'),('IMPC_EMO_042_001','Dorsal aorta','dorsal_aorta'),('IMPC_EMO_043_001','Duodenum','duodenum'),('IMPC_EMO_044_001','Ejaculatory duct','ejaculatory_duct'),('IMPC_EMO_045_001','Spinal cord cervical region','spinal_cord_cervical_region'),('IMPC_EMO_046_001','Epiglottis','epiglottis'),('IMPC_EMO_047_001','Esophagus','esophagus'),('IMPC_EMO_048_001','Pharyngo-tympanic tube','pharyngo_tympanic_tube'),('IMPC_EMO_049_001','Exoccipital bone','exoccipital_bone'),('IMPC_EMO_050_001','Eyelid','eyelid'),('IMPC_EMO_051_001','Femur','femur'),('IMPC_EMO_052_001','Fibula','fibula'),('IMPC_EMO_053_001','T1 rib','t1_rib'),('IMPC_EMO_054_001','Soft palate','soft_palate'),('IMPC_EMO_055_001','Palate','palate'),('IMPC_EMO_056_001','Gallbladder','gallbladder'),('IMPC_EMO_057_001','Gluteus maximus','gluteus_maximus'),('IMPC_EMO_058_001','Hepatic duct','hepatic_duct'),('IMPC_EMO_059_001','Midgut','midgut'),('IMPC_EMO_060_001','herniated abdominal wall','herniated_abdominal_wall'),('IMPC_EMO_061_001','Hindbrain','hindbrain'),('IMPC_EMO_062_001','Hindgut','hindgut'),('IMPC_EMO_063_001','Hip','hip'),('IMPC_EMO_064_001','Hippocampus','hippocampus'),('IMPC_EMO_065_001','Humerus','humerus'),('IMPC_EMO_066_001','Hyaloid cavity','hyaloid_cavity'),('IMPC_EMO_067_001','Hyoid bone','hyoid_bone'),('IMPC_EMO_068_001','Hypothalamus','hypothalamus'),('IMPC_EMO_069_001','Inferior vena cava','inferior_vena_cava'),('IMPC_EMO_070_001','Pituitary gland','pituitary_gland'),('IMPC_EMO_071_001','Pigmented retinal epiithelium','pigmented_retinal_epiithelium'),('IMPC_EMO_072_001','Innominate artery','innominate_artery'),('IMPC_EMO_073_001','Interventricular septum','interventricular_septum'),('IMPC_EMO_074_001','Intraretinal space','intraretinal_space'),('IMPC_EMO_075_001','Vomeronasal organ','vomeronasal_organ'),('IMPC_EMO_076_001','Jejunum','jejunum'),('IMPC_EMO_077_001','Jugular lymph sac','jugular_lymph_sac'),('IMPC_EMO_078_001','Kidney','kidney'),('IMPC_EMO_079_001','Kidney pelvis','kidney_pelvix'),('IMPC_EMO_080_001','Renal cortex','renal_cortex'),('IMPC_EMO_081_001','Renal medulla','renal_medulla'),('IMPC_EMO_082_001','Larynx','larynx'),('IMPC_EMO_083_001','Lateral ventricle','lateral_ventricle'),('IMPC_EMO_084_001','Lens','lens'),('IMPC_EMO_085_001','Limb muscle','limb_muscle'),('IMPC_EMO_086_001','Liver','liver'),('IMPC_EMO_087_001','Liver lobe','liver_lobe'),('IMPC_EMO_088_001','Liver caudate lobe','liver_caudate_lobe'),('IMPC_EMO_089_001','Ductus venosus','ductus_venosus'),('IMPC_EMO_090_001','Liver left lobe','liver_left_lobe'),('IMPC_EMO_091_001','Liver right lobe','liver_right_lobe'),('IMPC_EMO_092_001','Lower jaw molar','lower_jaw_molar'),('IMPC_EMO_093_001','Right lung cranial lobe','right_lung_cranial_lobe'),('IMPC_EMO_094_001','Right lung accessory lobe','right_lung_accessory_lobe'),('IMPC_EMO_095_001','Right lung caudal lobe','right_lung_caudal_lobe'),('IMPC_EMO_096_001','Left lung','left_lung'),('IMPC_EMO_097_001','Right lung middle lobe','right_lung_middle_lobe'),('IMPC_EMO_098_001','Mandible','mandible'),('IMPC_EMO_099_001','Masseter','masseter'),('IMPC_EMO_100_001','Meckel\'s cartilage','meckel_s_cartilage'),('IMPC_EMO_101_001','Medulla oblongata','medulla_oblongata'),('IMPC_EMO_102_001','Midbrain','midbrain'),('IMPC_EMO_103_001','Midbrain roof plate','midbrain_roof_plate'),('IMPC_EMO_104_001','Mitral valve','mitral_valve'),('IMPC_EMO_105_001','Nasal capsule','nasal_capsule'),('IMPC_EMO_106_001','Nasal cavity','nasal_cavity'),('IMPC_EMO_107_001','Nasal septum','nasal_septum'),('IMPC_EMO_108_001','Nasopharynx','nasopharynx'),('IMPC_EMO_109_001','Neural retina','neural_retina'),('IMPC_EMO_110_001','Olfactory epithelium','olfactory_epithelium'),('IMPC_EMO_111_001','Olfactory lobe','olfactory_lobe'),('IMPC_EMO_112_001','Optic nerve','optic_nerve'),('IMPC_EMO_113_001','Oropharynx','oropharynx'),('IMPC_EMO_114_001','Oral cavity','oral_cavity'),('IMPC_EMO_115_001','Ovary','ovary'),('IMPC_EMO_116_001','Palatal shelf','palatal_shelf'),('IMPC_EMO_117_001','Pancreas','pancreas'),('IMPC_EMO_118_001','Parathyroid gland','parathyroid_gland'),('IMPC_EMO_119_001','Penis','penis'),('IMPC_EMO_120_001','Pericardial cavity','pericardial_cavity'),('IMPC_EMO_121_001','Pericardium','pericardium'),('IMPC_EMO_122_001','Peritoneal cavity','peritoneal_cavity'),('IMPC_EMO_123_001','Pineal primordium','pineal_primordium'),('IMPC_EMO_124_001','Pinna','pinna'),('IMPC_EMO_125_001','Pons','pons'),('IMPC_EMO_126_001','Portal vein','portal_vein'),('IMPC_EMO_127_001','Primary palate','primary_palate'),('IMPC_EMO_128_001','Pulmonary artery','pulmonary_artery'),('IMPC_EMO_129_001','Quadriceps muscle','quadriceps_muscle'),('IMPC_EMO_130_001','Radius','radius'),('IMPC_EMO_131_001','Rathke\'s pouch','rathke_s_pouch'),('IMPC_EMO_132_001','Rectum','rectum'),('IMPC_EMO_133_001','Rib','rib'),('IMPC_EMO_134_001','S1 vertebral cartilage condensation','s1_vertebral_cartilage_condensation'),('IMPC_EMO_135_001','Scapula','scapula'),('IMPC_EMO_136_001','Semicircular canal','semicircular_canal'),('IMPC_EMO_137_001','Small intestine','small_intestine'),('IMPC_EMO_138_001','Sphenoid bone','sphenoid_bone'),('IMPC_EMO_139_001','Spinal cord','spinal_cord'),('IMPC_EMO_140_001','Spinal cord central canal','spinal_cord_central_canal'),('IMPC_EMO_141_001','Spleen primordium','spleen_primordium'),('IMPC_EMO_142_001','Sternum','sternum'),('IMPC_EMO_143_001','Stomach','stomach'),('IMPC_EMO_144_001','Stomach lumen','stomach_lumen'),('IMPC_EMO_145_001','Stomach wall','stomach_wall'),('IMPC_EMO_146_001','Stomach fundus','stomach_fundus'),('IMPC_EMO_147_001','Stomach pyloric region','stomach_pyloric_region'),('IMPC_EMO_148_001','Subclavian artery','subclavian_artery'),('IMPC_EMO_149_001','Submandibular gland','submandibular_gland'),('IMPC_EMO_150_001','Tail','tail'),('IMPC_EMO_151_001','Nucleus pulposus','nucleus_pulposus'),('IMPC_EMO_152_001','Temporal bone','temporal_bone'),('IMPC_EMO_153_001','Testis','testis'),('IMPC_EMO_154_001','Thalamus','thalamus'),('IMPC_EMO_155_001','Descending aorta','descending_thoracic_aorta'),('IMPC_EMO_156_001','Thymus','thymus'),('IMPC_EMO_157_001','Thyroid gland','thyroid_gland'),('IMPC_EMO_158_001','Tibia','tibia'),('IMPC_EMO_159_001','Tongue','tongue'),('IMPC_EMO_160_001','Trachea','trachea'),('IMPC_EMO_161_001','Tricuspid valve','tricuspid_valve'),('IMPC_EMO_162_001','Trigeminal V ganglion','trigeminal_v_ganglion'),('IMPC_EMO_163_001','Ulna','ulna'),('IMPC_EMO_164_001','Upper jaw incisor','upper_jaw_incisor'),('IMPC_EMO_165_001','Upper jaw molar','upper_jaw_molar'),('IMPC_EMO_166_001','Urethra','urethra'),('IMPC_EMO_167_001','Vagal trunk','vagal_trunk'),('IMPC_EMO_168_001','Vena cava','vena_cava'),('IMPC_EMO_169_001','Heart ventricle','heart_ventricle'),('IMPC_EMO_170_001','Vertebra','vertebra'),('IMPC_EMO_171_001','Vibrissa','vibrissa'),('IMPC_EMO_172_001','Oedema','oedema'),('IMPC_EMO_173_001','physiological umbilical hernia morphology','physiological_umbilical_hernia_morphology'),('IMPC_EMO_174_001','Cervical flexure morphology','cervical_flexure_morphology'),('IMPC_EMO_175_001','Size','size'),('IMPC_EMO_176_001','Spine curvature','spine_curvature'),('IMPC_EMO_177_001','Craniofacial morphology','craniofacial_morphology'),('IMPC_EMO_178_001','Annotator ID','annotator_id'),('IMPC_EMO_179_001','Date of Annotation','date_of_annotation'),('IMPC_EOL_001_001','Embryo reconstruction','NA'),('IMPC_EOL_002_001','Experimenter ID','NA'),('IMPC_EOL_003_001','Equipment ID','NA'),('IMPC_EOL_004_001','Equipment Manufacturer','NA'),('IMPC_EOL_005_001','Equipment Model','NA'),('IMPC_EOL_006_001','Image Pixel Size','NA'),('IMPC_EOL_007_001','E9.5 OPT preperation protocol','NA'),('IMPC_EOL_008_001','Date equipment last calibrated','NA'),('IMPC_EOL_009_001','Date of Sacrifice','NA'),('IMPC_EOL_010_001','Date Preparation Finished','NA'),('IMPC_EOL_011_001','Date of Scan','NA'),('IMPC_EOL_012_001','Screenshots','NA'),('IMPC_EOL_013_001','Hindbrain','NA'),('IMPC_EOL_014_001','4th ventricle','NA'),('IMPC_EOL_015_001','Mesencephalic vesicle','NA'),('IMPC_EOL_016_001','Forebrain','NA'),('IMPC_EOL_017_001','Telecenphalic (lateral) ventricle','NA'),('IMPC_EOL_018_001','Rhombomeres','NA'),('IMPC_EOL_019_001','Notochord','NA'),('IMPC_EOL_020_001','Infundibular recess of 3rd ventricle','NA'),('IMPC_EOL_021_001','Rathke\'s pouch','NA'),('IMPC_EOL_022_001','Optic vesicle','NA'),('IMPC_EOL_023_001','Otocyst','NA'),('IMPC_EOL_024_001','1st branchial arch','NA'),('IMPC_EOL_025_001','1st arch artery','NA'),('IMPC_EOL_026_001','2nd branchial arch','NA'),('IMPC_EOL_027_001','2nd arch artery','NA'),('IMPC_EOL_028_001','Oropharynx','NA'),('IMPC_EOL_029_001','3rd branchial arch','NA'),('IMPC_EOL_030_001','3rd arch artery','NA'),('IMPC_EOL_031_001','Aortic sac','NA'),('IMPC_EOL_032_001','Common atrial chamber','NA'),('IMPC_EOL_033_001','Atrioventricular canal','NA'),('IMPC_EOL_034_001','Heart ventricle','NA'),('IMPC_EOL_035_001','Primitive heart tube cardiac muscle','NA'),('IMPC_EOL_036_001','Dorsal aorta','NA'),('IMPC_EOL_037_001','Hepatic primordium','NA'),('IMPC_EOL_038_001','Hindgut','NA'),('IMPC_EOL_039_001','Forelimb bud','NA'),('IMPC_EOL_040_001','Neural tube','NA'),('IMPC_EOL_041_001','Caudal neuropore','NA'),('IMPC_EOL_042_001','Somite','NA'),('IMPC_EOL_043_001','Somite count','NA'),('IMPC_EOL_044_001','Delayed embryonic development','NA'),('IMPC_EOL_045_001','Vitelline artery','NA'),('IMPC_EOL_046_001','Umbilical vein','NA'),('IMPC_EOL_047_001','Foregut','NA'),('IMPC_EOL_048_001','Midgut','NA'),('IMPC_EOL_049_001','Pericardial cavity','NA'),('IMPC_EOL_050_001','Peritoneal cavity','NA'),('IMPC_EOL_051_001','Sinus venosus','NA'),('IMPC_EOL_052_001','Annotator ID','NA'),('IMPC_EOL_053_001','Date of Annotation','NA'),('IMPC_EVL_001_001','Outcome','NA'),('IMPC_EVL_002_001','Total embryos','NA'),('IMPC_EVL_003_001','% embryos WT','NA'),('IMPC_EVL_004_001','Time of dark cycle start','NA'),('IMPC_EVL_005_001','Decision','NA'),('IMPC_EVL_006_001','Comment on Decision (in English)','NA'),('IMPC_EVL_007_001','Total embryos WT','NA'),('IMPC_EVL_008_001','Total embryos heterozygous','NA'),('IMPC_EVL_009_001','Total embryos homozygous','NA'),('IMPC_EVL_010_001','Total dead embryos','NA'),('IMPC_EVL_011_001','Total dead WT','NA'),('IMPC_EVL_012_001','Total dead heterozygous','NA'),('IMPC_EVL_013_001','Total dead homozygous','NA'),('IMPC_EVL_014_001','Total gross defect at dissection (alive or dead) embryos','NA'),('IMPC_EVL_015_001','Total gross defect at dissection (alive or dead) WT','NA'),('IMPC_EVL_016_001','Total gross defect at dissection (alive or dead) heterozygous','NA'),('IMPC_EVL_017_001','Total gross defect at dissection (alive or dead) homozygous','NA'),('IMPC_EVL_018_001','Number of reabsorptions','NA'),('IMPC_EVL_019_001','% embryos heterozygous','NA'),('IMPC_EVL_020_001','% embryos homozygous','NA'),('IMPC_EVL_021_001','Average Litter Size','NA'),('IMPC_EVL_022_001','Time of dark cycle end','NA'),('IMPC_EVL_023_001','Embryo medium','NA'),('IMPC_EVL_024_001','Total live embryos','NA'),('IMPC_EVL_025_001','Total live heterozygous','NA'),('IMPC_EVL_026_001','Total live WT','NA'),('IMPC_EVL_027_001','Total live homozygous','NA'),('IMPC_EVM_001_001','Outcome','NA'),('IMPC_EVM_002_001','Decision','NA'),('IMPC_EVM_003_001','Comment on Decision (in English)','NA'),('IMPC_EVM_004_001','Total embryos WT','NA'),('IMPC_EVM_005_001','Total embryos heterozygous','NA'),('IMPC_EVM_006_001','Total embryos homozygous','NA'),('IMPC_EVM_007_001','Total dead embryos','NA'),('IMPC_EVM_008_001','Total dead WT','NA'),('IMPC_EVM_009_001','Total dead heterozygous','NA'),('IMPC_EVM_010_001','Total dead homozygous','NA'),('IMPC_EVM_011_001','Total gross defect at dissection (alive or dead) embryos','NA'),('IMPC_EVM_012_001','Total gross defect at dissection (alive or dead) WT','NA'),('IMPC_EVM_013_001','Total gross defect at dissection (alive or dead) heterozygous','NA'),('IMPC_EVM_014_001','Total gross defect at dissection (alive or dead) homozygous','NA'),('IMPC_EVM_015_001','Number of reabsorptions','NA'),('IMPC_EVM_016_001','% embryos WT','NA'),('IMPC_EVM_017_001','% embryos heterozygous','NA'),('IMPC_EVM_018_001','% embryos homozygous','NA'),('IMPC_EVM_019_001','Average Litter Size','NA'),('IMPC_EVM_020_001','Time of dark cycle start','NA'),('IMPC_EVM_021_001','Time of dark cycle end','NA'),('IMPC_EVM_022_001','Embryo medium','NA'),('IMPC_EVM_023_001','Total embryos','NA'),('IMPC_EVM_024_001','Total live embryos','NA'),('IMPC_EVM_025_001','Total live heterozygous','NA'),('IMPC_EVM_026_001','Total live WT','NA'),('IMPC_EVM_027_001','Total live homozygous','NA'),('IMPC_EVO_001_001','Outcome','NA'),('IMPC_EVO_002_001','Decision','NA'),('IMPC_EVO_003_001','Comment on Decision (in English)','NA'),('IMPC_EVO_004_001','Total embryos','NA'),('IMPC_EVO_005_001','Total embryos WT','NA'),('IMPC_EVO_006_001','Total embryos heterozygous','NA'),('IMPC_EVO_007_001','Total embryos homozygous','NA'),('IMPC_EVO_008_001','Total dead embryos','NA'),('IMPC_EVO_009_001','Total dead WT','NA'),('IMPC_EVO_010_001','Total dead heterozygous','NA'),('IMPC_EVO_011_001','Total dead homozygous','NA'),('IMPC_EVO_012_001','Total gross defect at dissection (alive or dead) embryos','NA'),('IMPC_EVO_013_001','Total gross defect at dissection (alive or dead) WT','NA'),('IMPC_EVO_014_001','Total gross defect at dissection (alive or dead) heterozygous','NA'),('IMPC_EVO_015_001','Total gross defect at dissection (alive or dead) homozygous','NA'),('IMPC_EVO_016_001','Number of reabsorptions','NA'),('IMPC_EVO_017_001','Average Litter Size','NA'),('IMPC_EVO_018_001','% embryos WT','NA'),('IMPC_EVO_019_001','% embryos heterozygous','NA'),('IMPC_EVO_020_001','% embryos homozygous','NA'),('IMPC_EVO_021_001','Time of dark cycle start','NA'),('IMPC_EVO_022_001','Time of dark cycle end','NA'),('IMPC_EVO_023_001','Embryo medium','NA'),('IMPC_EVO_024_001','Total live embryos','NA'),('IMPC_EVO_025_001','Total live heterozygous','NA'),('IMPC_EVO_026_001','Total live WT','NA'),('IMPC_EVO_027_001','Total live homozygous','NA'),('IMPC_EVP_001_001','Outcome','NA'),('IMPC_EVP_002_001','Decision','NA'),('IMPC_EVP_003_001','Comment on Decision (in English)','NA'),('IMPC_EVP_004_001','Total embryos','NA'),('IMPC_EVP_005_001','Total embryos heterozygous','NA'),('IMPC_EVP_006_001','Total embryos homozygous','NA'),('IMPC_EVP_007_001','Total dead embryos','NA'),('IMPC_EVP_008_001','Total dead WT','NA'),('IMPC_EVP_009_001','Total dead heterozygous','NA'),('IMPC_EVP_010_001','Total dead homozygous','NA'),('IMPC_EVP_011_001','Total gross defect at dissection (alive or dead) embryos','NA'),('IMPC_EVP_012_001','Total gross defect at dissection (alive or dead) WT','NA'),('IMPC_EVP_013_001','Total gross defect at dissection (alive or dead) heterozygous','NA'),('IMPC_EVP_014_001','Total gross defect at dissection (alive or dead) homozygous','NA'),('IMPC_EVP_015_001','Number of reabsorptions','NA'),('IMPC_EVP_016_001','Average Litter Size','NA'),('IMPC_EVP_017_001','% embryos WT','NA'),('IMPC_EVP_018_001','% embryos heterozygous','NA'),('IMPC_EVP_019_001','% embryos homozygous','NA'),('IMPC_EVP_020_001','Time of dark cycle start','NA'),('IMPC_EVP_021_001','Time of dark cycle end','NA'),('IMPC_EVP_022_001','Embryo medium','NA'),('IMPC_EVP_023_001','Total embryos WT','NA'),('IMPC_EVP_024_001','Total live embryos','NA'),('IMPC_EVP_025_001','Total live heterozygous','NA'),('IMPC_EVP_026_001','Total live WT','NA'),('IMPC_EVP_027_001','Total live homozygous','NA'),('IMPC_EXD_001_001','Submitter ID','submitter_id'),('IMPC_EXD_002_001','Name of phenotyping project','name_of_phenotyping_project'),('IMPC_EXD_003_001','Name of pipeline','name_of_pipeline'),('IMPC_EXD_003_002','Pipeline ID(s)','pipeline_ids_applicable_to_housing_conditions'),('IMPC_EXD_004_001','Start date','start_date'),('IMPC_EXD_004_002','Date effective from','date_effective_from'),('IMPC_EXD_005_001','End date','end_date'),('IMPC_EXD_005_002','Date effective until','date_effective_until'),('IMPC_EXD_006_001','Control design','control_design'),('IMPC_EXD_007_001','Control phenotyping design','frequency_of_controls'),('IMPC_EXD_008_001','Minimum number of male controls','number_male_controls'),('IMPC_EXD_009_001','Minimum number of female controls','number_female_controls'),('IMPC_EXD_010_001','Genetic background','genetic_background'),('IMPC_EXD_011_001','Controls and knockout same source','controls_and_knockout_same_source'),('IMPC_EXD_012_001','Control animal production location','control_animal_source'),('IMPC_EXD_012_002','Control animal production location','control_animal_source'),('IMPC_EXD_013_001','Core colony source','core_colony_source'),('IMPC_EXD_014_001','Control stock management','core_stock_strategy'),('IMPC_EXD_015_001','Knockout phenotyping design','knockout_phenotyping_design'),('IMPC_EXD_016_001','Blinding  - Body Weight','blinding_body_weight'),('IMPC_EXD_017_001','Blinding  - CSD','blinding_csd'),('IMPC_EXD_018_001','Blinding  - Grip strength','blinding_grip_strength'),('IMPC_EXD_019_001','Blinding  - Acoustic startle','blinding_acoustic_startle'),('IMPC_EXD_020_001','Blinding  - Calorimetry','blinding_calorimetry'),('IMPC_EXD_021_001','Blinding  - IPGTT','blinding_ipgtt'),('IMPC_EXD_022_001','Blinding  - ABR collection','blinding_abr_collection'),('IMPC_EXD_023_001','Blinding  - ABR annotation','blinding_abr_annotation'),('IMPC_EXD_024_001','Blinding  - DEXA','blinding_dexa'),('IMPC_EXD_025_001','Blinding  - X-ray imaging','blinding_x_ray_imaging'),('IMPC_EXD_026_001','Blinding  - X-ray annotation','blinding_x_ray_annotation'),('IMPC_EXD_027_001','Blinding  - Slit lamp collection','blinding_slit_lamp_collection'),('IMPC_EXD_028_001','Blinding  - Slit lamp annotation','blinding_slit_lamp_annotation'),('IMPC_EXD_029_001','Blinding  - Ophthalmoscope collection','blinding_ophthalmoscope_collection'),('IMPC_EXD_030_001','Blinding  - Ophthalmoscope annotation','blinding_ophthalmoscope_annotation'),('IMPC_EXD_031_001','Blinding  - Hematology','blinding_hematology'),('IMPC_EXD_032_001','Blinding  - Clinical chemistry','blinding_clinical_chemistry'),('IMPC_EXD_033_001','Blinding  - Insulin','blinding_insulin'),('IMPC_EXD_034_001','Blinding  - Immunophenotyping collection','blinding_immunophenotyping_collection'),('IMPC_EXD_035_001','Blinding  - Immunophenotyping annotation','blinding_immunophenotyping_annotation'),('IMPC_EXD_036_001','Blinding  - Heart weight','blinding_heart_weight'),('IMPC_EXD_037_001','Blinding  - Open field','blinding_open_field'),('IMPC_EXD_038_001','Blinding  - Gross pathology collection','blinding_gross_pathology_collection'),('IMPC_EXD_039_001','Blinding  - Gross pathology annotation','blinding_gross_pathology_annotation'),('IMPC_EXD_040_001','Blinding - ECG','blinding_ecg'),('IMPC_EXD_041_001','Blinding  - Echo','blinding_echo'),('IMPC_EXD_042_001','Blinding  - Plethysmography','blinding_plethysmography'),('IMPC_EXD_043_001','Blinding  - Adult Lac Z collection','blinding_adult_lac_z_collection'),('IMPC_EXD_044_001','Blinding  - Adult Lac Z annotation','blinding_adult_lac_z_annotation'),('IMPC_EXD_045_001','Blinding  - Embryo Lac Z collection','blinding_embryo_lac_z_collection'),('IMPC_EXD_046_001','Blinding  - Embryo Lac Z annotation','blinding_embryo_lac_z_annotation'),('IMPC_EXD_047_001','Instrumentation effects - Body weight','instrumentation_effects_body_weight'),('IMPC_EXD_048_001','Instrumentation effects - Heart weight','instrumentation_effects_heart_weight'),('IMPC_EXD_049_001','Instrumentation effects - Grip strength','instrumentation_effects_grip_strength'),('IMPC_EXD_050_001','Instrumentation effects - Acoustic startle','instrumentation_effects_acoustic_startle'),('IMPC_EXD_051_001','Instrumentation effects - Calorimetry','instrumentation_effects_calorimetry'),('IMPC_EXD_052_001','Instrumentation effects - IPGTT','instrumentation_effects_ipgtt'),('IMPC_EXD_053_001','Instrumentation effects - ABR','instrumentation_effects_abr'),('IMPC_EXD_054_001','Instrumentation effects - DEXA','instrumentation_effects_dexa'),('IMPC_EXD_055_001','Instrumentation effects - Slit lamp','instrumentation_effects_slit_lamp'),('IMPC_EXD_056_001','Instrumentation effects - Ophthalmoscope','instrumentation_effects_ophthalmoscope'),('IMPC_EXD_057_001','Instrumentation effects - Hematology','instrumentation_effects_hematology'),('IMPC_EXD_058_001','Instrumentation effects - Clinical chemistry','instrumentation_effects_clinical_chemistry'),('IMPC_EXD_059_001','Instrumentation effects - Immunophenotyping','instrumentation_effects_immunophenotyping'),('IMPC_EXD_060_001','Instrumentation effects - Open field','instrumentation_effects_open_field'),('IMPC_EXD_061_001','Instrumentation effects - ECG','instrumentation_effects_ecg'),('IMPC_EXD_062_001','Instrumentation effects - Echo','instrumentation_effects_echo'),('IMPC_EXD_063_001','Instrumentation effects - Plethysmography','instrumentation_effects_plethysmography'),('IMPC_EXD_064_001','Instrumentation effects - Gross pathology','instrumentation_effects_gross_pathology'),('IMPC_EXD_065_001','Instrumentation effects - Insulin','instrumentation_effects_insulin'),('IMPC_EXD_066_001','Instrumentation effects - Embryo Lac Z','instrumentation_effects_embryo_lac_z'),('IMPC_EXD_067_001','Instrumentation effects - Adult Lac Z','instrumentation_effects_adult_lac_z'),('IMPC_EXD_068_001','Instrumentation effects - X-ray','instrumentation_effects_x_ray'),('IMPC_EXD_069_001','Operator effects - Body weight','operator_effects_body_weight'),('IMPC_EXD_070_001','Operator effects - Open field','operator_effects_open_field'),('IMPC_EXD_071_001','Operator effects - CSD','operator_effects_csd'),('IMPC_EXD_072_001','Operator effects - Grip strength','operator_effects_grip_strength'),('IMPC_EXD_073_001','Operator effects - Acoustic startle','operator_effects_acoustic_startle'),('IMPC_EXD_074_001','Operator effects - Calorimetry','operator_effects_calorimetry'),('IMPC_EXD_075_001','Operator effects - IPGTT','operator_effects_ipgtt'),('IMPC_EXD_076_001','Operator effects - ABR collection','operator_effects_abr_collection'),('IMPC_EXD_077_001','Operator effects - ABR annotation','operator_effects_abr_annotation'),('IMPC_EXD_078_001','Operator effects - DEXA','operator_effects_dexa'),('IMPC_EXD_079_001','Operator effects - X-ray imaging','operator_effects_x_ray_imaging'),('IMPC_EXD_080_001','Operator effects - X-ray annotation','operator_effects_x_ray_annotation'),('IMPC_EXD_081_001','Operator effects - Slit lamp','operator_effects_slit_lamp'),('IMPC_EXD_082_001','Operator effects - Ophthalmoscope','operator_effects_ophthalmoscope'),('IMPC_EXD_083_001','Operator effects - Hematology','operator_effects_hematology'),('IMPC_EXD_084_001','Operator effects - Clinical chemistry','operator_effects_clinical_chemistry'),('IMPC_EXD_085_001','Operator effects - Immunophenotyping collection','operator_effects_immunophenotyping_collection'),('IMPC_EXD_086_001','Operator effects - Immunophenotyping analysis','operator_effects_immunophenotyping_analysis'),('IMPC_EXD_087_001','Operator effects - Heart weight','operator_effects_heart_weight'),('IMPC_EXD_088_001','Operator effects - Gross pathology collection','operator_effects_gross_pathology_collection'),('IMPC_EXD_089_001','Operator effects - Gross pathology annotation','operator_effects_gross_pathology_annotation'),('IMPC_EXD_090_001','Operator effects - ECG','operator_effects_ecg'),('IMPC_EXD_091_001','Operator effects - Echo','operator_effects_echo'),('IMPC_EXD_092_001','Operator effects - Plethysmography','operator_effects_plethysmography'),('IMPC_EXD_093_001','Operator effects - Insulin','operator_effects_insulin'),('IMPC_EXD_094_001','Operator effects - Embryo Lac Z collection','operator_effects_embryo_lac_z_collection'),('IMPC_EXD_095_001','Operator effects - Embryo Lac Z annotation','operator_effects_embryo_lac_z_annotation'),('IMPC_EXD_096_001','Operator effects - Adult Lac Z collection','operator_effects_adult_lac_z_collection'),('IMPC_EXD_097_001','Operator effects - Adult Lac Z annotation','operator_effects_adult_lac_z_annotation'),('IMPC_EXD_098_001','Time effects','time_effects'),('IMPC_EXD_098_002','Time effect strategy','time_effects'),('IMPC_EXD_099_001','Order effects - Body weight','order_effects_body_weight'),('IMPC_EXD_100_001','Order effects - CSD','order_effects_csd'),('IMPC_EXD_101_001','Order effects - Grip strength','order_effects_grip_strength'),('IMPC_EXD_102_001','Order effects - Acoustic startle','order_effects_acoustic_startle'),('IMPC_EXD_103_001','Order effects - Calorimetry','order_effects_calorimetry'),('IMPC_EXD_104_001','Order effects - IPGTT','order_effects_ipgtt'),('IMPC_EXD_105_001','Order effects - ABR collection','order_effects_abr_collection'),('IMPC_EXD_106_001','Order effects - ABR annotation','order_effects_abr_annotation'),('IMPC_EXD_107_001','Order effects - DEXA','order_effects_dexa'),('IMPC_EXD_108_001','Order effects - X-ray imaging','order_effects_x_ray_imaging'),('IMPC_EXD_109_001','Order effects - X-ray annotation','order_effects_x_ray_annotation'),('IMPC_EXD_110_001','Order effects - Slit lamp','order_effects_slit_lamp'),('IMPC_EXD_111_001','Order effects - Ophthalmoscope','order_effects_ophthalmoscope'),('IMPC_EXD_112_001','Order effects - Hematology','order_effects_hematology'),('IMPC_EXD_113_001','Order effects - Clinical chemistry','order_effects_clinical_chemistry'),('IMPC_EXD_114_001','Order effects - Immunophenotyping','order_effects_immunophenotyping'),('IMPC_EXD_115_001','Order effects - Heart weight','order_effects_heart_weight'),('IMPC_EXD_116_001','Order effects - Open field','order_effects_open_field'),('IMPC_EXD_117_001','Order effects - Gross pathology collection','order_effects_gross_pathology_collection'),('IMPC_EXD_118_001','Order effects - Gross pathology annotation','order_effects_gross_pathology_annotation'),('IMPC_EXD_119_001','Order effects - ECG','order_effects_ecg'),('IMPC_EXD_120_001','Order effects - Echo','order_effects_echo'),('IMPC_EXD_121_001','Order effects - Plethysmography','order_effects_plethysmography'),('IMPC_EXD_122_001','Order effects - Insulin','order_effects_insulin'),('IMPC_EXD_123_001','Order effects - Embryo Lac Z','order_effects_embryo_lac_z'),('IMPC_EXD_124_001','Order effects - Adult Lac Z','order_effects_adult_lac_z'),('IMPC_EXD_125_001','Subject selection - ABR','subject_selection_abr'),('IMPC_EXD_126_001','Subject selection - Gross pathology','subject_selection_gross_pathology'),('IMPC_EXD_127_001','Blinding strategy','blinding_strategy'),('IMPC_EXD_128_001','Instrumentation bias management','instrumentation_bias_management'),('IMPC_EXD_129_001','Operator effect control strategy','operator_effect_control_strategy'),('IMPC_EXD_130_001','Order effect control strategy','order_effect_control_strategy'),('IMPC_EXD_131_001','Subject selection strategy','subject_selection_strategy'),('IMPC_EXD_132_001','Phenotyping lifestage','phenotyping_lifestage'),('IMPC_EXD_133_001','Submission Identifier','NA'),('IMPC_EXD_134_001','Knockout animal production location','knockout_animal_production_location'),('IMPC_EXD_135_001','Maximum number of female controls','NA'),('IMPC_EXD_136_001','Maximum number of male controls','NA'),('IMPC_EYE_001_001','Eye','eye'),('IMPC_EYE_002_001','Bulging eye','bulging_eye'),('IMPC_EYE_003_001','Eye Hemorrhage or Blood Presence','eye_hemorrhage_or_blood_presence'),('IMPC_EYE_004_001','Eyelid morphology','eyelid_morphology'),('IMPC_EYE_005_001','Eyelid closure','eyelid_closure'),('IMPC_EYE_006_001','Narrow eye opening','narrow_eye_opening'),('IMPC_EYE_007_001','Cornea','cornea'),('IMPC_EYE_008_001','Corneal opacity','corneal_opacity'),('IMPC_EYE_009_001','Corneal vascularization','corneal_vascularization'),('IMPC_EYE_010_001','Iris/Pupil','iris_pupil'),('IMPC_EYE_011_001','Pupil Position','pupil_position'),('IMPC_EYE_012_001','Pupil Shape','pupil_shape'),('IMPC_EYE_013_001','Pupil Dilation','pupil_dilation'),('IMPC_EYE_014_001','Pupil Light Response','pupil_light_response'),('IMPC_EYE_015_001','Iris Pigmentation','iris_pigmentation'),('IMPC_EYE_016_001','Lens','lens'),('IMPC_EYE_017_001','Lens Opacity','lens_opacity'),('IMPC_EYE_018_001','Fusion between cornea and lens','fusion_between_cornea_and_lens'),('IMPC_EYE_019_001','Synechia','synechia'),('IMPC_EYE_020_001','Retina','retina'),('IMPC_EYE_021_001','Retinal Pigmentation','retinal_pigmentation'),('IMPC_EYE_022_001','Retinal Structure','retinal_structure'),('IMPC_EYE_023_001','Optic Disc','optic_disc'),('IMPC_EYE_024_001','Retinal Blood Vessels','retinal_blood_vessels'),('IMPC_EYE_025_001','Retinal Blood Vessels Structure','retinal_blood_vessels_structure'),('IMPC_EYE_026_001','Retinal Blood Vessels Pattern','retinal_blood_vessels_pattern'),('IMPC_EYE_027_001','Persistence of hyaloid vascular system','persistence_of_hyaloid_vascular_system'),('IMPC_EYE_028_001','Slit Lamp observation','slit_lamp_observation'),('IMPC_EYE_029_001','Ophthalmoscope Observation','ophthalmoscope_observation'),('IMPC_EYE_030_001','Slit Lamp Equipment ID','slit_lamp_equipment_id'),('IMPC_EYE_031_001','Slit Lamp Equipment Manufacturer','slit_lamp_equipment_manufacturer'),('IMPC_EYE_032_001','Slit Lamp Equipment Model','slit_lamp_equipment_model'),('IMPC_EYE_033_001','Ophthalmoscope Equipment ID','ophthalmoscope_equipment_id'),('IMPC_EYE_034_001','Ophthalmoscope Equipment Manufacturer','ophthalmoscope_equipment_manufacturer'),('IMPC_EYE_035_001','Ophthalmoscope Equipment Model','ophthalmoscope_equipment_model'),('IMPC_EYE_036_001','Experimenter ID','experimenter_id'),('IMPC_EYE_037_001','Optical Coherence Tomography Equipment ID','optical_coherence_tomography_equipment_id'),('IMPC_EYE_038_001','Optical Coherence Tomography Equipment Manufacturer','optical_coherence_tomography_equipment_manufacturer'),('IMPC_EYE_039_001','Optical Coherence Tomography Equipment Model','optical_coherence_tomography_equipment_model'),('IMPC_EYE_040_001','Scheimpflug Equipment ID','scheimpflug_equipment_id'),('IMPC_EYE_041_001','Scheimpflug Equipment Manufacturer','scheimpflug_equipment_manufacturer'),('IMPC_EYE_042_001','Scheimpflug Equipment Model','scheimpflug_equipment_model'),('IMPC_EYE_043_001','Dilation Method','dilation_method'),('IMPC_EYE_044_001','Topical Anesthetic','topical_anesthetic'),('IMPC_EYE_045_001','General Anesthetic','general_anesthetic'),('IMPC_EYE_046_001','Date Slit Lamp equipment last calibrated','NA'),('IMPC_EYE_047_001','Date Ophthalmoscope equipment last calibrated','NA'),('IMPC_EYE_048_001','Date Scheimpflug equipment last calibrated','NA'),('IMPC_EYE_049_001','Date OCT equipment last calibrated','NA'),('IMPC_EYE_050_001','Images Ophthalmoscopy','NA'),('IMPC_EYE_051_001','Images Slit Lamp','NA'),('IMPC_EYE_052_001','Sheimpflug Lens description','NA'),('IMPC_EYE_053_001','Scheimpflug description','NA'),('IMPC_EYE_054_001','Min left eye lens density','NA'),('IMPC_EYE_055_001','Max left eye lens density','NA'),('IMPC_EYE_056_001','Mean left eye lens density','NA'),('IMPC_EYE_057_001','Min right eye lens density','NA'),('IMPC_EYE_058_001','Max right eye lens density','NA'),('IMPC_EYE_059_001','Mean right eye lens density','NA'),('IMPC_EYE_060_001','Right corneal thickness','NA'),('IMPC_EYE_061_001','Right anterior chamber depth','NA'),('IMPC_EYE_062_001','Right total retinal thickness','NA'),('IMPC_EYE_063_001','Right inner nuclear layer','NA'),('IMPC_EYE_064_001','Right outer nuclear layer','NA'),('IMPC_EYE_065_001','Right posterior chamber depth','NA'),('IMPC_EYE_066_001','Left corneal thickness','NA'),('IMPC_EYE_067_001','Left anterior chamber depth','NA'),('IMPC_EYE_068_001','Left total retinal thickness','NA'),('IMPC_EYE_069_001','Left inner nuclear layer','NA'),('IMPC_EYE_070_001','Left outer nuclear layer','NA'),('IMPC_EYE_071_001','Left posterior chamber depth','NA'),('IMPC_EYE_072_001','B-scan of right retina','NA'),('IMPC_EYE_073_001','B-scan of left retina','NA'),('IMPC_EYE_074_001','VIP of right fundus','NA'),('IMPC_EYE_075_001','VIP of left fundus','NA'),('IMPC_EYE_076_001','B-scan of right cornea and lens','NA'),('IMPC_EYE_077_001','B-scan of left cornea and lens','NA'),('IMPC_EYE_078_001','VIP of right eye','NA'),('IMPC_EYE_079_001','VIP of left eye','NA'),('IMPC_EYE_080_001','Corneal Sclerization','NA'),('IMPC_EYE_081_001','Corneal deposits','NA'),('IMPC_EYE_082_001','Iris transilumination','NA'),('IMPC_EYE_083_001','Vitreous','NA'),('IMPC_EYE_084_001','Corneal mineralization','NA'),('IMPC_EYE_085_001','Corneal ulcer','NA'),('IMPC_EYE_086_001','Lacrimation','NA'),('IMPC_EYE_087_001','Right vitreous humor thickness','NA'),('IMPC_EYE_088_001','Left vitreous humour thickness','NA'),('IMPC_EYE_089_001','Ophthalmoscope Lens Model','NA'),('IMPC_EYE_090_001','Right eye diameter','NA'),('IMPC_EYE_091_001','Left eye diameter','NA'),('IMPC_EYE_092_001','Retina (combined)','NA'),('IMPC_EYE_092_002','Retina (combined)','NA'),('IMPC_FEA_001_001','Conditioning Baseline Freeze Count','conditioning_baseline_freeze_count'),('IMPC_FEA_002_001','Conditioning Baseline Freezing Time','conditioning_baseline_freezing_time'),('IMPC_FEA_003_001','Conditioning Baseline % Freezing Time','conditioning_baseline_freezing_time'),('IMPC_FEA_004_001','Conditioning Baseline Average Motion Index','conditioning_baseline_average_motion_index'),('IMPC_FEA_005_001','Conditioning Baseline Minimum Motion Index','conditioning_baseline_minimum_motion_index'),('IMPC_FEA_006_001','Conditioning Baseline Maximum Motion Index','conditioning_baseline_maximum_motion_index'),('IMPC_FEA_007_001','Context Freeze Count','context_freeze_count'),('IMPC_FEA_008_001','Context Freezing Time','context_freezing_time'),('IMPC_FEA_009_001','Context % Freezing Time','context_freezing_time'),('IMPC_FEA_010_001','Context Average Motion Index','context_average_motion_index'),('IMPC_FEA_011_001','Context Minimum Motion Index','context_minimum_motion_index'),('IMPC_FEA_012_001','Context Maximum Motion Index','context_maximum_motion_index'),('IMPC_FEA_013_001','Cue Baseline Freeze Count','cue_baseline_freeze_count'),('IMPC_FEA_014_001','Cue Baseline Freezing Time','cue_baseline_freezing_time'),('IMPC_FEA_015_001','Cue Baseline % Freezing Time','cue_baseline_freezing_time'),('IMPC_FEA_016_001','Cue Baseline Average Motion Index','cue_baseline_average_motion_index'),('IMPC_FEA_017_001','Cue Baseline Minimum Motion Index','cue_baseline_minimum_motion_index'),('IMPC_FEA_018_001','Cue Baseline Maximum Motion Index','cue_baseline_maximum_motion_index'),('IMPC_FEA_019_001','Cue Tone Freeze Count','cue_tone_freeze_count'),('IMPC_FEA_020_001','Cue Tone Freezing Time','cue_tone_freezing_time'),('IMPC_FEA_021_001','Cue Tone % Freezing Time','cue_tone_freezing_time'),('IMPC_FEA_022_001','Cue Tone Average Motion Index','cue_tone_average_motion_index'),('IMPC_FEA_023_001','Cue Tone Minimum Motion Index','cue_tone_minimum_motion_index'),('IMPC_FEA_024_001','Cue Tone Maximum Motion Index','cue_tone_maximum_motion_index'),('IMPC_FEA_025_001','Conditioning: Date and time','conditioning_date_and_time'),('IMPC_FEA_026_001','Conditioning: Room acclimation time','conditioning_room_acclimation_time'),('IMPC_FEA_027_001','Conditioning: White house light level in arena','conditioning_white_house_light_level_in_arena'),('IMPC_FEA_028_001','Conditioning: Olfactory cue','conditioning_olfactory_cue'),('IMPC_FEA_029_001','Conditioning: Mouse arena shape','conditioning_mouse_arena_shape'),('IMPC_FEA_030_001','Conditioning: Mouse arena dimension','conditioning_mouse_arena_dimension'),('IMPC_FEA_031_001','Conditioning: Mouse arena colour','conditioning_mouse_arena_colour'),('IMPC_FEA_032_001','Conditioning: Mouse arena floor','conditioning_mouse_arena_floor'),('IMPC_FEA_033_001','Conditioning: Length of time baseline','conditioning_length_of_time_baseline'),('IMPC_FEA_034_001','Conditioning: Tone stimulus intensity ( dB; conditioned stimulus)','conditioning_tone_stimulus_intensity_db_conditioned_stimulus'),('IMPC_FEA_035_001','Conditioning: Tone stimulus frequency (Hz; conditioned stimulus)','conditioning_tone_stimulus_frequency_hz_conditioned_stimulus'),('IMPC_FEA_036_001','Conditioning: Length of time tone stimulus','conditioning_length_of_time_tone_stimulus'),('IMPC_FEA_037_001','Conditioning: Shock stimulus intensity (unconditioned stimulus)','conditioning_shock_stimulus_intensity_unconditioned_stimulus'),('IMPC_FEA_038_001','Conditioning: Length of time shock stimulus','conditioning_length_of_time_shock_stimulus'),('IMPC_FEA_039_001','Conditioning: Length of time no stimulus','conditioning_length_of_time_no_stimulus'),('IMPC_FEA_040_001','Conditioning: Total time','conditioning_total_time'),('IMPC_FEA_041_001','Context: Date and time','context_date_and_time'),('IMPC_FEA_042_001','Context: Room acclimation time','context_room_acclimation_time'),('IMPC_FEA_043_001','Context: White house light level in arena','context_white_house_light_level_in_arena'),('IMPC_FEA_044_001','Context: Olfactory cue','context_olfactory_cue'),('IMPC_FEA_045_001','Context: Mouse arena shape','context_mouse_arena_shape'),('IMPC_FEA_046_001','Context: Mouse arena dimension','context_mouse_arena_dimension'),('IMPC_FEA_047_001','Context: Mouse arena colour','context_mouse_arena_colour'),('IMPC_FEA_048_001','Context: Mouse arena floor','context_mouse_arena_floor'),('IMPC_FEA_049_001','Context: Total time','context_total_time'),('IMPC_FEA_050_001','Cue: Date and time','cue_date_and_time'),('IMPC_FEA_051_001','Cue: White house light level in arena','cue_white_house_light_level_in_arena'),('IMPC_FEA_052_001','Cue: Olfactory cue','cue_olfactory_cue'),('IMPC_FEA_053_001','Cue: Mouse arena shape','cue_mouse_arena_shape'),('IMPC_FEA_054_001','Cue: Mouse arena dimension','cue_mouse_arena_dimension'),('IMPC_FEA_055_001','Cue: Mouse arena colour','cue_mouse_arena_colour'),('IMPC_FEA_056_001','Cue: Mouse arena floor','cue_mouse_arena_floor'),('IMPC_FEA_057_001','Cue: Length of time baseline','cue_length_of_time_baseline'),('IMPC_FEA_058_001','Cue: Tone stimulus intensity  (conditioned stimulus)','cue_tone_stimulus_intensity_conditioned_stimulus'),('IMPC_FEA_059_001','Cue: Tone stimulus frequency (Hz; conditioned stimulus)','cue_tone_stimulus_frequency_hz_conditioned_stimulus'),('IMPC_FEA_060_001','Cue: tone response measurement time','NA'),('IMPC_FEA_061_001','Cue: Length of time no stimulus','cue_length_of_time_no_stimulus'),('IMPC_FEA_062_001','Cue: Total time','cue_total_time'),('IMPC_FEA_063_001','Mouse arenaID','mouse_arenaid'),('IMPC_FEA_064_001','Equipment ID','equipment_id'),('IMPC_FEA_065_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_FEA_066_001','Equipment Model','equipment_model'),('IMPC_FEA_067_001','Tracking Method','tracking_method'),('IMPC_FEA_068_001','Software','software'),('IMPC_FEA_069_001','Sound generator manufacturer','sound_generator_manufacturer'),('IMPC_FEA_070_001','Sound generator model','sound_generator_model'),('IMPC_FEA_071_001','Sound-proof box dimension','sound_proof_box_dimension'),('IMPC_FEA_072_001','Experimenter ID','experimenter_id'),('IMPC_FEA_073_001','Experimenter ID  day 2','experimenter_id_day_2'),('IMPC_FEA_074_001','Experimenter ID day 2 cue','experimenter_id_day_2_cue'),('IMPC_FEA_075_001','Date equipment last calibrated (shock)','date_equipment_last_calibrated_shock'),('IMPC_FEA_076_001','Date equipment last calibrated (tone)','date_equipment_last_calibrated_tone'),('IMPC_FEA_077_001','Freeze definition','freeze_definition'),('IMPC_FEA_078_001','Conditioning: Near infra red light  arena','conditioning_near_infra_red_light_arena'),('IMPC_FEA_079_001','Context: Near infra red light  arena','context_near_infra_red_light_arena'),('IMPC_FEA_080_001','Cue: Near infra red light  arena','cue_near_infra_red_light_arena'),('IMPC_FEA_081_001','Conditioning: Start time of baseline','conditioning_start_time_of_baseline'),('IMPC_FEA_082_001','Conditioning: Start time of each tone stimulus','conditioning_start_time_of_each_tone_stimulus'),('IMPC_FEA_083_001','Conditioning: Start time of each shock stimulus','conditioning_start_time_of_each_shock_stimulus'),('IMPC_FEA_084_001','Conditioning: Start time of no stimulus','conditioning_start_time_of_no_stimulus'),('IMPC_FEA_085_001','Cue: Start time of baseline','cue_start_time_of_baseline'),('IMPC_FEA_086_001','Cue: Start time of each tone stimulus','cue_start_time_of_each_tone_stimulus'),('IMPC_FEA_087_001','Cue: Start time of no stimulus','cue_start_time_of_no_stimulus'),('IMPC_FEA_088_001','Cue: arena rotation','cue_arena_rotation'),('IMPC_FEA_089_001','Conditioning Tone Freeze Count','conditioning_tone_freeze_count'),('IMPC_FEA_090_001','Conditioning Tone Freezing Time','conditioning_tone_freezing_time'),('IMPC_FEA_091_001','Conditioning Tone % Freezing Time','conditioning_tone_freezing_time'),('IMPC_FEA_092_001','Conditioning Tone Average Motion Index','conditioning_tone_average_motion_index'),('IMPC_FEA_093_001','Conditioning Tone Minimum Motion Index','conditioning_tone_minimum_motion_index'),('IMPC_FEA_094_001','Conditioning Tone Maximum Motion Index','conditioning_tone_maximum_motion_index'),('IMPC_FEA_095_001','Conditioning Shock Average Motion Index','conditioning_shock_average_motion_index'),('IMPC_FEA_096_001','Conditioning Shock Minimum Motion Index','conditioning_shock_minimum_motion_index'),('IMPC_FEA_097_001','Conditioning Shock Maximum Motion Index','conditioning_shock_maximum_motion_index'),('IMPC_FEA_098_001','Conditioning Post-shock Freeze Count','conditioning_post_shock_freeze_count'),('IMPC_FEA_099_001','Conditioning Post-shock Freezing Time','conditioning_post_shock_freezing_time'),('IMPC_FEA_100_001','Conditioning Post-shock % Freezing Time','conditioning_post_shock_freezing_time'),('IMPC_FEA_101_001','Conditioning Post-shock Average Motion Index','conditioning_post_shock_average_motion_index'),('IMPC_FEA_102_001','Conditioning Post-shock Minimum Motion Index','conditioning_post_shock_minimum_motion_index'),('IMPC_FEA_103_001','Conditioning Post-shock Maximum Motion Index','conditioning_post_shock_maximum_motion_index'),('IMPC_FEA_104_001','Freeze definition (minimum motion index)','freeze_definition_minimum_motion_index'),('IMPC_FEA_105_001','Difference in Context and Conditioning Baseline % Freezing','NA'),('IMPC_FEA_106_001','Difference in Cue Tone and Cue Baseline % Freezing','NA'),('IMPC_FEA_107_001','Difference in Conditioning Post-shock and Conditioning Baseline % Freezing','NA'),('IMPC_FEA_108_001','Cue: Length of time tone stimulus','NA'),('IMPC_FER_001_001','Gross Findings Male','gross_findings'),('IMPC_FER_002_001','Pups born (primary)','pups_born_primary_'),('IMPC_FER_003_001','Total matings (primary)','total_matings_primary_'),('IMPC_FER_004_001','Total litters (primary)','total_litters_primary_'),('IMPC_FER_005_001','Total pups with dissection (primary)','total_pups_primary_'),('IMPC_FER_006_001','Pups born (Male screen)','pups_born_male_screen_'),('IMPC_FER_007_001','Total matings (Male screen)','total_matings_male_screen_'),('IMPC_FER_008_001','Total litters (Male screen)','total_litters_male_screen_'),('IMPC_FER_009_001','Total pups/embryos (Male Screen)','total_pups_embryos_male_screen_'),('IMPC_FER_010_001','Pups born (Female Screen)','pups_born_female_screen_'),('IMPC_FER_011_001','Total matings (Female Screen)','total_matings_female_screen_'),('IMPC_FER_012_001','Total litters (Female Screen)','total_litters_female_screen_'),('IMPC_FER_013_001','Total pups/embryos (Female Screen)','total_pups_embryos_female_screen_'),('IMPC_FER_014_001','Age of set up','age_of_set_up'),('IMPC_FER_015_001','Time spent in breeding','time_breeding'),('IMPC_FER_016_001','Test strain genotype','test_strain_genotype'),('IMPC_FER_017_001','Test strain background secondary  (MGI ID)','test_strain_background'),('IMPC_FER_018_001','Date of matings','date_of_matings'),('IMPC_FER_019_001','Gross Findings Female','NA'),('IMPC_FER_020_001','Age of set up (Male screen)','NA'),('IMPC_FER_021_001','Age of set up (Female screen)','NA'),('IMPC_FER_022_001','Time spent in  breeding (Male screen)','NA'),('IMPC_FER_023_001','Time spent in breeding (Female screen)','NA'),('IMPC_FER_024_001','Heterozygous - Gross Findings Male','NA'),('IMPC_FER_025_001','Heterozygous - Gross Findings Female','NA'),('IMPC_FOR_001_001','Total duration of lick/bite behaviour','NA'),('IMPC_FOR_002_001','Total number of lick/bite events','NA'),('IMPC_FOR_003_001','Total duration of drag/limp behaviour','NA'),('IMPC_FOR_004_001','Total number of drag/limp events','NA'),('IMPC_FOR_005_001','Total duration of flinch behaviour','NA'),('IMPC_FOR_006_001','Total number of flinch events','NA'),('IMPC_FOR_007_001','Anaesthetic','NA'),('IMPC_FOR_008_001','Formalin Concentration','NA'),('IMPC_FOR_009_001','Amount of formalin injected','NA'),('IMPC_FOR_010_001','Syringe Gauge','NA'),('IMPC_FOR_011_001','Site of formalin injection','NA'),('IMPC_FOR_012_001','Arena Manufacturer','NA'),('IMPC_FOR_013_001','Size of testing arena','NA'),('IMPC_FOR_014_001','Recording Software','NA'),('IMPC_FOR_015_001','Data scoring method','NA'),('IMPC_FOR_016_001','Annotation Software','NA'),('IMPC_FOR_017_001','Duration of observation period','NA'),('IMPC_FOR_018_001','Camera Position','NA'),('IMPC_FOR_019_001','Disinfectant','NA'),('IMPC_FOR_020_001','Duration of lick/bite behaviour','NA'),('IMPC_FOR_021_001','Duration of drag/limp behaviour','NA'),('IMPC_FOR_022_001','Duration of flinch behaviour','NA'),('IMPC_FOR_023_001','Duration of licking/biting behavior (10-60 minutes)','NA'),('IMPC_FOR_024_001','Time per bin/increment','NA'),('IMPC_FOR_025_001','Time bins excluded','NA'),('IMPC_FOR_026_001','Experimenter ID','NA'),('IMPC_GEL_001_001','Alive','alive'),('IMPC_GEL_002_001','Scored','scored'),('IMPC_GEL_003_001','Cardiovascular System','cardiovascular_system'),('IMPC_GEL_004_001','Cardiovascular Development','cardiovascular_development'),('IMPC_GEL_005_001','Vascular Development','vascular_development'),('IMPC_GEL_006_001','Pericardium Morphology','pericardium_morphology'),('IMPC_GEL_007_001','Failure heart looping','failure_heart_looping'),('IMPC_GEL_007_002','Failure heart looping','failure_heart_looping'),('IMPC_GEL_008_001','Absent heartbeat','absent_heartbeat'),('IMPC_GEL_008_002','Absent heartbeat','absent_heartbeat'),('IMPC_GEL_009_001','Embryogenesis Phenotype','embryogenesis_phenotype'),('IMPC_GEL_010_001','Abnormal Gastrulation','abnormal_gastrulation'),('IMPC_GEL_011_001','Embryo turning','embryo_turning'),('IMPC_GEL_012_001','Incomplete embryo turning','incomplete_embryo_turning'),('IMPC_GEL_012_002','Incomplete embryo turning','incomplete_embryo_turning'),('IMPC_GEL_013_001','Extraembryonic tissue morphology','extraembryonic_tissue_morphology'),('IMPC_GEL_014_001','Allantois Morphology','allantois_morphology'),('IMPC_GEL_015_001','Vitelline vasculature morphology','vitelline_vasculature_morphology'),('IMPC_GEL_016_001','Vitelline vein morphology','vitelline_vein_morphology'),('IMPC_GEL_017_001','Pale yolk sac','pale_yolk_sac'),('IMPC_GEL_017_002','Pale yolk sac','pale_yolk_sac'),('IMPC_GEL_018_001','Visceral yolk sac morphology','visceral_yolk_sac_morphology'),('IMPC_GEL_019_001','Chorioallantoic fusion','chorioallantoic_fusion'),('IMPC_GEL_020_001','Developmental Patterning','developmental_patterning'),('IMPC_GEL_021_001','Left-right axis patterning','left_right_axis_patterning'),('IMPC_GEL_022_001','Direction of heart looping','direction_of_heart_looping'),('IMPC_GEL_023_001','Somite development','somite_development'),('IMPC_GEL_024_001','Branchial arch morphology','branchial_arch_morphology'),('IMPC_GEL_025_001','Neural fold mophology','neural_fold_mophology'),('IMPC_GEL_026_001','Neural tube morphology/development','neural_tube_morphology_development'),('IMPC_GEL_027_001','Neural tube closure','neural_tube_closure'),('IMPC_GEL_028_001','Forebrain','forebrain'),('IMPC_GEL_029_001','Midbrain','midbrain'),('IMPC_GEL_030_001','Hindbrain','hindbrain'),('IMPC_GEL_031_001','Spinal cord','spinal_cord'),('IMPC_GEL_032_001','Embryo Size','embryo_size'),('IMPC_GEL_033_001','Tail bud morphology','tail_bud_morphology'),('IMPC_GEL_034_001','Integument','integument'),('IMPC_GEL_035_001','Skin Appearance','skin_appearance'),('IMPC_GEL_036_001','Pallor','pallor'),('IMPC_GEL_036_002','Pallor','pallor'),('IMPC_GEL_037_001','Blebs','blebs'),('IMPC_GEL_037_002','Blebs','blebs'),('IMPC_GEL_038_001','Limb Bud Morphology','limb_bud_morphology'),('IMPC_GEL_039_001','Vision/Eye','vision_eye'),('IMPC_GEL_040_001','Eye development','eye_development'),('IMPC_GEL_041_001','Hearing/Vestibular/Ear','hearing_vestibular_ear'),('IMPC_GEL_042_001','Otic vesicle morphology','otic_vesicle_morphology'),('IMPC_GEL_043_001','Comment on image','comment_on_image'),('IMPC_GEL_044_001','Images','images'),('IMPC_GEL_045_001','Experimenter ID','experimenter_id'),('IMPC_GEL_046_001','Equipment ID','equipment_id'),('IMPC_GEL_047_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GEL_048_001','Equipment Model','equipment_model'),('IMPC_GEL_049_001','Fixative','fixative'),('IMPC_GEL_050_001','Time of Dissection','time_of_dissection'),('IMPC_GEL_051_001','Somite Stage','somite_stage'),('IMPC_GEL_052_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GEL_053_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GEL_054_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GEL_055_001','Severely Dysmorphic','NA'),('IMPC_GEL_056_001','Edema','NA'),('IMPC_GEL_057_001','Heart looping','NA'),('IMPC_GEL_058_001','Heart morphology','NA'),('IMPC_GEL_059_001','Hemorrhage','NA'),('IMPC_GEL_060_001','Neural tube morphology','NA'),('IMPC_GEL_061_001','Optic vesicle morphology','NA'),('IMPC_GEL_062_001','CRL','NA'),('IMPC_GEL_063_001','Delayed embryonic development','NA'),('IMPC_GEL_064_001','Somite Morphology','NA'),('IMPC_GEL_065_001','Left-right axis patterning','NA'),('IMPC_GEL_066_001','Vascular morphology','NA'),('IMPC_GEM_001_001','Alive','alive'),('IMPC_GEM_002_001','Scored','scored'),('IMPC_GEM_003_001','Cardiovascular System','cardiovascular_system'),('IMPC_GEM_004_001','Cardiovascular Development','cardiovascular_development'),('IMPC_GEM_005_001','Vascular Development','vascular_development'),('IMPC_GEM_006_001','Outflow tract development','outflow_tract_development'),('IMPC_GEM_007_001','Pericardium Morphology','pericardium_morphology'),('IMPC_GEM_008_001','Absent heartbeat','absent_heartbeat'),('IMPC_GEM_008_002','Absent Heartbeat','NA'),('IMPC_GEM_009_001','Craniofacial','craniofacial'),('IMPC_GEM_010_001','Craniofacial Development','craniofacial_development'),('IMPC_GEM_011_001','Embryogenesis Phenotype','embryogenesis_phenotype'),('IMPC_GEM_012_001','Extraembryonic tissue morphology','extraembryonic_tissue_morphology'),('IMPC_GEM_013_001','Allantois Morphology','allantois_morphology'),('IMPC_GEM_014_001','Vitelline vasculature morphology','vitelline_vasculature_morphology'),('IMPC_GEM_015_001','Vitelline vein morphology','vitelline_vein_morphology'),('IMPC_GEM_016_001','Pale yolk sac','pale_yolk_sac'),('IMPC_GEM_016_002','Pale yolk sac','pale_yolk_sac'),('IMPC_GEM_017_001','Visceral yolk sac morphology','visceral_yolk_sac_morphology'),('IMPC_GEM_018_001','Chorioallantoic fusion','chorioallantoic_fusion'),('IMPC_GEM_019_001','Embryo Size','embryo_size'),('IMPC_GEM_020_001','Hearing/Vestibular/Ear Phenotype','hearing_vestibular_ear_phenotype'),('IMPC_GEM_021_001','Ear Morphology','abnormal_ear_morphology'),('IMPC_GEM_022_001','Ear Development','ear_development'),('IMPC_GEM_023_001','Integument','integument'),('IMPC_GEM_024_001','Skin Appearance','skin_appearance'),('IMPC_GEM_025_001','Pallor','pallor'),('IMPC_GEM_025_002','Pallor','pallor'),('IMPC_GEM_026_001','Blebs','blebs'),('IMPC_GEM_026_002','Blebs','blebs'),('IMPC_GEM_027_001','Limb Bud Morphology','limb_bud_morphology'),('IMPC_GEM_028_001','Limb Plate Morphology','limb_plate_morphology'),('IMPC_GEM_029_001','Tail Morphology','tail_morphology'),('IMPC_GEM_030_001','Liver/Biliary','liver_biliary'),('IMPC_GEM_031_001','Liver Morphology','liver_morphology'),('IMPC_GEM_032_001','Liver Size','liver_size'),('IMPC_GEM_033_001','Pale Liver','pale_liver'),('IMPC_GEM_033_002','Pale Liver','pale_liver'),('IMPC_GEM_034_001','Gastroschisis (herniated abdominal wall)','gastroschisis_herniated_abdominal_wall'),('IMPC_GEM_034_002','Gastroschisis (herniated abdominal wall)','NA'),('IMPC_GEM_035_001','Nervous System','nervous_system'),('IMPC_GEM_036_001','Neural Tube Closure','neural_tube_closure'),('IMPC_GEM_037_001','Forebrain development','forebrain_development'),('IMPC_GEM_038_001','Midbrain development','midbrain_development'),('IMPC_GEM_039_001','Hindbrain development','hindbrain_development'),('IMPC_GEM_040_001','Vision/Eye','vision_eye'),('IMPC_GEM_041_001','Eye Morphology','eye_morphology'),('IMPC_GEM_042_001','Eye Size','eye_size'),('IMPC_GEM_043_001','Microphthalmia','microphthalmia'),('IMPC_GEM_043_002','Microphthalmia','microphthalmia'),('IMPC_GEM_044_001','Anophthalmia','anophthalmia'),('IMPC_GEM_044_002','Anophthalmia','anophthalmia'),('IMPC_GEM_045_001','Failure heart looping','failure_heart_looping'),('IMPC_GEM_046_001','Gastrulation','abnormal_gastrulation'),('IMPC_GEM_047_001','Head shape','head_shape'),('IMPC_GEM_048_001','Comment on image','comment_on_image'),('IMPC_GEM_049_001','Images','images'),('IMPC_GEM_050_001','Experimenter ID','experimenter_id'),('IMPC_GEM_051_001','Equipment ID','equipment_id'),('IMPC_GEM_052_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GEM_053_001','Equipment Model','equipment_model'),('IMPC_GEM_054_001','Fixative','fixative'),('IMPC_GEM_055_001','Time of Dissection','time_of_dissection'),('IMPC_GEM_056_001','Somite Stage','somite_stage'),('IMPC_GEM_057_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GEM_058_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GEM_059_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GEM_060_001','Severely Dysmorphic','NA'),('IMPC_GEM_061_001','Abdominal wall','NA'),('IMPC_GEM_062_001','Craniofacial morphology','NA'),('IMPC_GEM_063_001','Facial cleft','NA'),('IMPC_GEM_064_001','Facial hypoplasia','NA'),('IMPC_GEM_065_001','Heart looping','NA'),('IMPC_GEM_066_001','Heart morphology','NA'),('IMPC_GEM_067_001','Left-right axis patterning','NA'),('IMPC_GEM_068_001','Forebrain morphology','NA'),('IMPC_GEM_069_001','Hindbrain morphology','NA'),('IMPC_GEM_070_001','Midbrain morphology','NA'),('IMPC_GEM_071_001','Microcephaly','NA'),('IMPC_GEM_072_001','Rostal-caudal patterning','NA'),('IMPC_GEM_073_001','Vascular morphology','NA'),('IMPC_GEM_074_001','CRL','NA'),('IMPC_GEM_075_001','Delayed embryonic development','NA'),('IMPC_GEM_076_001','Edema','NA'),('IMPC_GEM_077_001','Hemorrhage','NA'),('IMPC_GEM_078_001','Polydactyly','NA'),('IMPC_GEM_079_001','Exencephaly','exencephaly'),('IMPC_GEO_001_001','Alive','alive'),('IMPC_GEO_002_001','Scored','scored'),('IMPC_GEO_003_001','Cardiovascular System','cardiovascular_system'),('IMPC_GEO_004_001','Cardiovascular Development','cardiovascular_development'),('IMPC_GEO_005_001','Heart Development','heart_development'),('IMPC_GEO_006_001','Outflow tract development','outflow_tract_development'),('IMPC_GEO_007_001','Absent heartbeat','absent_heartbeat'),('IMPC_GEO_007_002','Absent heartbeat','absent_heartbeat'),('IMPC_GEO_008_001','Heart Morphology','heart_morphology'),('IMPC_GEO_009_001','Hemorrhage','hemorrhage'),('IMPC_GEO_009_002','Hemorrhage','hemorrhage'),('IMPC_GEO_010_001','Skin Hemorrhage','skin_hemorrhage'),('IMPC_GEO_010_002','Skin Hemorrhage','skin_hemorrhage'),('IMPC_GEO_011_001','Blood Vessel Morphology','blood_vessel_morphology'),('IMPC_GEO_012_001','Developmental Vascular Remodelling','developmental_vascular_remodelling'),('IMPC_GEO_013_001','Craniofacial','craniofacial'),('IMPC_GEO_014_001','Craniofacial Development','craniofacial_development'),('IMPC_GEO_015_001','Head shape','head_shape'),('IMPC_GEO_016_001','Head size','head_size'),('IMPC_GEO_017_001','Facial Cleft','facial_cleft'),('IMPC_GEO_017_002','Facial Cleft','facial_cleft'),('IMPC_GEO_018_001','Cleft Palate','cleft_palate'),('IMPC_GEO_018_002','Cleft Palate','cleft_palate'),('IMPC_GEO_019_001','Embryo Size','embryo_size'),('IMPC_GEO_020_001','Body wall morphology','body_wall_morphology'),('IMPC_GEO_021_001','Hearing/Vestibular/Ear','hearing_vestibular_ear'),('IMPC_GEO_022_001','Ear Morphology','abnormal_ear_morphology'),('IMPC_GEO_023_001','Ear Development','ear_development'),('IMPC_GEO_024_001','Homeostasis/metabolism','homeostasis_metabolism'),('IMPC_GEO_025_001','Hydrops fetalis (fetal adema)','hydrops_fetalis_fetal_adema'),('IMPC_GEO_025_002','Hydrops fetalis (fetal adema)','hydrops_fetalis_fetal_adema'),('IMPC_GEO_026_001','Gastroschisis (herniated abdominal wall)','gastroschisis_herniated_abdominal_wall'),('IMPC_GEO_026_002','Gastroschisis (herniated abdominal wall)','gastroschisis_herniated_abdominal_wall'),('IMPC_GEO_027_001','Integument','integument'),('IMPC_GEO_028_001','Vibrissa Morphology','vibrissa_morphology'),('IMPC_GEO_029_001','Skin Appearance','skin_appearance'),('IMPC_GEO_030_001','Skin Coloration','skin_coloration'),('IMPC_GEO_031_001','Limb Bud Morphology','limb_bud_morphology'),('IMPC_GEO_032_001','Limb Plate Morphology','limb_plate_morphology'),('IMPC_GEO_033_001','Tail Morphology','tail_morphology'),('IMPC_GEO_034_001','Polydactyly','polydactyly'),('IMPC_GEO_034_002','Polydactyly','polydactyly'),('IMPC_GEO_035_001','Liver/Biliary','liver_biliary'),('IMPC_GEO_036_001','Liver Morphology','liver_morphology'),('IMPC_GEO_037_001','Liver Size','liver_size'),('IMPC_GEO_038_001','Pale Liver','pale_liver'),('IMPC_GEO_038_002','Pale Liver','pale_liver'),('IMPC_GEO_039_001','Nervous System','nervous_system'),('IMPC_GEO_040_001','Brain Development','brain_development'),('IMPC_GEO_041_001','Exencephaly','exencephaly'),('IMPC_GEO_041_002','Exencephaly','exencephaly'),('IMPC_GEO_042_001','Holoprosencephaly','holoprosencephaly'),('IMPC_GEO_042_002','Holoprosencephaly','holoprosencephaly'),('IMPC_GEO_043_001','spina bifida','spina_bifida'),('IMPC_GEO_043_002','spina bifida','spina_bifida'),('IMPC_GEO_044_001','Vision/Eye','vision_eye'),('IMPC_GEO_045_001','Eye Morphology','eye_morphology'),('IMPC_GEO_046_001','Eye Size','eye_size'),('IMPC_GEO_047_001','Microphthalmia','microphthalmia'),('IMPC_GEO_047_002','Microphthalmia','microphthalmia'),('IMPC_GEO_048_001','Anophthalmia','anophthalmia'),('IMPC_GEO_048_002','Anophthalmia','anophthalmia'),('IMPC_GEO_049_001','Comment on image','comment_on_image'),('IMPC_GEO_050_001','Images','images'),('IMPC_GEO_051_001','Experimenter ID','experimenter_id'),('IMPC_GEO_052_001','Equipment ID','equipment_id'),('IMPC_GEO_053_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GEO_054_001','Equipment Model','equipment_model'),('IMPC_GEO_055_001','Fixative','fixative'),('IMPC_GEO_056_001','Time of Dissection','time_of_dissection'),('IMPC_GEO_057_001','Somite Stage','somite_stage'),('IMPC_GEO_058_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GEO_059_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GEO_060_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GEO_061_001','Severely Dysmorphic','NA'),('IMPC_GEO_062_001','Abdominal wall','NA'),('IMPC_GEO_063_001','Craniofacial morphology','NA'),('IMPC_GEO_064_001','Edema','NA'),('IMPC_GEO_065_001','Limb morphology','NA'),('IMPC_GEO_066_001','Microcephaly','NA'),('IMPC_GEO_067_001','Syndactyly','NA'),('IMPC_GEO_068_001','CRL','NA'),('IMPC_GEO_069_001','Delayed embryonic development','NA'),('IMPC_GEO_070_001','Blebs','NA'),('IMPC_GEO_071_001','Facial hypoplasia','NA'),('IMPC_GEO_072_001','Pallor','NA'),('IMPC_GEP_001_001','Alive','alive'),('IMPC_GEP_002_001','Scored','scored'),('IMPC_GEP_003_001','Behavior/neurological','behavior_neurological'),('IMPC_GEP_004_001','No spontaneous movement','no_spontaneous_movement'),('IMPC_GEP_004_002','Spontaneous movement','no_spontaneous_movement'),('IMPC_GEP_005_001','Unresponsive to tactile stimuli','unresponsive_to_tactile_stimuli'),('IMPC_GEP_005_002','Responsive to tactile stimuli','unresponsive_to_tactile_stimuli'),('IMPC_GEP_006_001','Cardiovascular System','cardiovascular_system'),('IMPC_GEP_007_001','Cardiovascular Development','cardiovascular_development'),('IMPC_GEP_008_001','Heart Development','heart_development'),('IMPC_GEP_009_001','Outflow tract development','outflow_tract_development'),('IMPC_GEP_010_001','Heart Morphology','heart_morphology'),('IMPC_GEP_011_001','Hemorrhage','hemorrhage'),('IMPC_GEP_011_002','Hemorrhage','hemorrhage'),('IMPC_GEP_012_001','Skin Hemorrhage','skin_hemorrhage'),('IMPC_GEP_012_002','Skin Hemorrhage','skin_hemorrhage'),('IMPC_GEP_013_001','Blood Vessel Morphology','blood_vessel_morphology'),('IMPC_GEP_014_001','Craniofacial','craniofacial'),('IMPC_GEP_015_001','Head shape','head_shape'),('IMPC_GEP_016_001','Head size','head_size'),('IMPC_GEP_017_001','Facial Morphology','facial_morphology'),('IMPC_GEP_018_001','Facial Cleft','facial_cleft'),('IMPC_GEP_018_002','Facial Cleft','facial_cleft'),('IMPC_GEP_019_001','Cleft Palate','cleft_palate'),('IMPC_GEP_019_002','Cleft Palate','cleft_palate'),('IMPC_GEP_020_001','Digestive/alimentary','digestive_alimentary'),('IMPC_GEP_021_001','Digestive System Morphology','digestive_system_morphology'),('IMPC_GEP_022_001','Embryo Size','embryo_size'),('IMPC_GEP_023_001','Embryo weight','embryo_weight'),('IMPC_GEP_024_001','Body wall morphology','body_wall_morphology'),('IMPC_GEP_025_001','Hearing/Vestibular/Ear','hearing_vestibular_ear'),('IMPC_GEP_026_001','Outer ear morpholgy','outer_ear_morpholgy'),('IMPC_GEP_027_001','Ear Development','ear_development'),('IMPC_GEP_028_001','Homeostasis/metabolism','homeostasis_metabolism'),('IMPC_GEP_029_001','Cyanosis','cyanosis'),('IMPC_GEP_029_002','Cyanosis','cyanosis'),('IMPC_GEP_030_001','Edema','edema'),('IMPC_GEP_030_002','Edema','edema'),('IMPC_GEP_031_001','Hydrops fetalis (fetal adema)','hydrops_fetalis_fetal_adema'),('IMPC_GEP_031_002','Hydrops fetalis (fetal adema)','hydrops_fetalis_fetal_adema'),('IMPC_GEP_032_001','Integument','integument'),('IMPC_GEP_033_001','Vibrissa Morphology','vibrissa_morphology'),('IMPC_GEP_034_001','Skin Appearance','skin_appearance'),('IMPC_GEP_035_001','Pallor','pallor'),('IMPC_GEP_035_002','Pallor','pallor'),('IMPC_GEP_036_001','Skin Coloration','skin_coloration'),('IMPC_GEP_037_001','Limb Morphology','limb_morphology'),('IMPC_GEP_038_001','Tail Morphology','tail_morphology'),('IMPC_GEP_039_001','Polydactyly','polydactyly'),('IMPC_GEP_039_002','Polydactyly','polydactyly'),('IMPC_GEP_040_001','Liver/Biliary','liver_biliary'),('IMPC_GEP_041_001','Liver Morphology','liver_morphology'),('IMPC_GEP_042_001','Liver Size','liver_size'),('IMPC_GEP_043_001','Muscle','muscle'),('IMPC_GEP_044_001','Diaphragm Morphology','diaphragm_morphology'),('IMPC_GEP_045_001','Nervous System','nervous_system'),('IMPC_GEP_046_001','Brain Development','brain_development'),('IMPC_GEP_047_001','Exencephaly','exencephaly'),('IMPC_GEP_047_002','Exencephaly','exencephaly'),('IMPC_GEP_048_001','Holoprosencephaly','holoprosencephaly'),('IMPC_GEP_048_002','Holoprosencephaly','holoprosencephaly'),('IMPC_GEP_049_001','spina bifida','spina_bifida'),('IMPC_GEP_049_002','spina bifida','spina_bifida'),('IMPC_GEP_050_001','Renal/Urinary','renal_urinary'),('IMPC_GEP_051_001','Kidney','kidney'),('IMPC_GEP_052_001','Respiratory System','respiratory_system'),('IMPC_GEP_053_001','Lung Morphology','lung_morphology'),('IMPC_GEP_054_001','Lung Development','lung_development'),('IMPC_GEP_055_001','Respiratory Failure','respiratory_failure'),('IMPC_GEP_055_002','Respiratory Failure','respiratory_failure'),('IMPC_GEP_056_001','Vision/Eye','vision_eye'),('IMPC_GEP_057_001','Eye Morphology','eye_morphology'),('IMPC_GEP_058_001','Eye Size','eye_size'),('IMPC_GEP_059_001','Microphthalmia','microphthalmia'),('IMPC_GEP_059_002','Microphthalmia','microphthalmia'),('IMPC_GEP_060_001','Anophthalmia','anophthalmia'),('IMPC_GEP_060_002','Anophthalmia','anophthalmia'),('IMPC_GEP_061_001','Failure of Eyelid Fusion','failure_of_eyelid_fusion'),('IMPC_GEP_061_002','Failure of Eyelid Fusion','failure_of_eyelid_fusion'),('IMPC_GEP_062_001','Number of cervical vertebrae','number_of_cervical_vertebrae'),('IMPC_GEP_063_001','Comment on image','comment_on_image'),('IMPC_GEP_064_001','Images','images'),('IMPC_GEP_065_001','Experimenter ID','experimenter_id'),('IMPC_GEP_066_001','Equipment ID','equipment_id'),('IMPC_GEP_067_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GEP_068_001','Equipment Model','equipment_model'),('IMPC_GEP_069_001','Fixative','fixative'),('IMPC_GEP_070_001','Time of Dissection','time_of_dissection'),('IMPC_GEP_071_001','Somite Stage','somite_stage'),('IMPC_GEP_072_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GEP_073_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GEP_074_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GEP_075_001','Severely Dysmorphic','NA'),('IMPC_GEP_076_001','Cleft palate','NA'),('IMPC_GEP_078_001','Curl or short tail','NA'),('IMPC_GEP_079_001','Facial hypoplasia','NA'),('IMPC_GEP_080_001','Microcephaly','NA'),('IMPC_GEP_081_001','Pale liver','NA'),('IMPC_GEP_082_001','Syndactyly','NA'),('IMPC_GEP_083_001','Tongue out','NA'),('IMPC_GEP_084_001','Limb morphology','NA'),('IMPC_GEP_085_001','CRL','NA'),('IMPC_GEP_086_001','Delayed embryonic development','NA'),('IMPC_GEP_087_001','Blebs','NA'),('IMPC_GPL_001_001','Placenta Development','placenta_development'),('IMPC_GPL_002_001','Placenta Morphology','placenta_morphology'),('IMPC_GPL_003_001','Placenta Vasculature','placenta_vasculature'),('IMPC_GPL_004_001','Placenta Size','placenta_size'),('IMPC_GPL_005_001','Umbilical cord morphology','umbilical_cord_morphology'),('IMPC_GPL_006_001','Comment on image','comment_on_image'),('IMPC_GPL_007_001','Images','images'),('IMPC_GPL_008_001','Experimenter ID','experimenter_id'),('IMPC_GPL_009_001','Equipment ID','equipment_id'),('IMPC_GPL_010_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GPL_011_001','Equipment Model','equipment_model'),('IMPC_GPL_012_001','Fixative','fixative'),('IMPC_GPL_013_001','Time of Dissection','time_of_dissection'),('IMPC_GPL_014_001','Somite Stage','somite_stage'),('IMPC_GPL_015_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GPL_016_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GPL_017_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GPM_001_001','Placenta Development','placenta_development'),('IMPC_GPM_002_001','Placenta Morphology','placenta_morphology'),('IMPC_GPM_003_001','Placenta Vasculature','placenta_vasculature'),('IMPC_GPM_004_001','Placenta Size','placenta_size'),('IMPC_GPM_005_001','Umbilical cord morphology','umbilical_cord_morphology'),('IMPC_GPM_006_001','Comment on image','comment_on_image'),('IMPC_GPM_007_001','Images','images'),('IMPC_GPM_008_001','Experimenter ID','experimenter_id'),('IMPC_GPM_009_001','Equipment ID','equipment_id'),('IMPC_GPM_010_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GPM_011_001','Equipment Model','equipment_model'),('IMPC_GPM_012_001','Fixative','fixative'),('IMPC_GPM_013_001','Time of Dissection','time_of_dissection'),('IMPC_GPM_014_001','Somite Stage','somite_stage'),('IMPC_GPM_015_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GPM_016_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GPM_017_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GPM_018_001','Placenta color','NA'),('IMPC_GPO_001_001','Placenta Development','placenta_development'),('IMPC_GPO_002_001','Placenta Morphology','placenta_morphology'),('IMPC_GPO_003_001','Placenta Vasculature','placenta_vasculature'),('IMPC_GPO_004_001','Placenta Size','placenta_size'),('IMPC_GPO_005_001','Umbilical cord morphology','umbilical_cord_morphology'),('IMPC_GPO_006_001','Comment on image','comment_on_image'),('IMPC_GPO_007_001','Images','images'),('IMPC_GPO_008_001','Experimenter ID','experimenter_id'),('IMPC_GPO_009_001','Equipment ID','equipment_id'),('IMPC_GPO_010_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GPO_011_001','Equipment Model','equipment_model'),('IMPC_GPO_012_001','Fixative','fixative'),('IMPC_GPO_013_001','Time of Dissection','time_of_dissection'),('IMPC_GPO_014_001','Somite Stage','somite_stage'),('IMPC_GPO_015_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GPO_016_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GPO_017_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GPO_018_001','Pale placenta','NA'),('IMPC_GPP_001_001','Placenta Development','placenta_development'),('IMPC_GPP_002_001','Placenta Morphology','placenta_morphology'),('IMPC_GPP_003_001','Placenta Vasculature','placenta_vasculature'),('IMPC_GPP_004_001','Placenta Size','placenta_size'),('IMPC_GPP_005_001','Umbilical cord morphology','umbilical_cord_morphology'),('IMPC_GPP_006_001','Comment on image','comment_on_image'),('IMPC_GPP_007_001','Images','images'),('IMPC_GPP_008_001','Experimenter ID','experimenter_id'),('IMPC_GPP_009_001','Equipment ID','equipment_id'),('IMPC_GPP_010_001','Equipment Manufacturer','equipment_manufacturer'),('IMPC_GPP_011_001','Equipment Model','equipment_model'),('IMPC_GPP_012_001','Fixative','fixative'),('IMPC_GPP_013_001','Time of Dissection','time_of_dissection'),('IMPC_GPP_014_001','Somite Stage','somite_stage'),('IMPC_GPP_015_001','Time of dark cycle start','time_of_dark_cycle_start'),('IMPC_GPP_016_001','Time of dark cycle end','time_of_dark_cycle_end'),('IMPC_GPP_017_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_GPP_018_001','Placenta color','NA'),('IMPC_GRS_001_001','Forelimb grip strength measurement','forelimb_grip_strength_measurement'),('IMPC_GRS_002_001','Forelimb and hindlimb grip strength measurement','forelimb_and_hindlimb_grip_strength_measurement'),('IMPC_GRS_003_001','Body weight','body_weight'),('IMPC_GRS_004_001','General comments about the mouse','general_comments_about_the_mouse'),('IMPC_GRS_005_001','Equipment ID','equipment_name'),('IMPC_GRS_006_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_GRS_007_001','Grid model','grid_model'),('IMPC_GRS_008_001','Forelimb grip strength measurement mean','forelimb_grip_strength_measurement_mean'),('IMPC_GRS_009_001','Forelimb and hindlimb grip strength measurement mean','forelimb_and_hindlimb_grip_strength_measurement_mean'),('IMPC_GRS_010_001','Forelimb grip strength normalised against body weight','forelimb_grip_strength_normalised_against_body_weight'),('IMPC_GRS_011_001','Forelimb and hindlimb grip strength normalised against body weight','forelimb_and_hindlimb_grip_strength_normalised_against_body_weight'),('IMPC_GRS_012_001','Experimenter ID','NA'),('IMPC_GRS_013_001','Equipment model','NA'),('IMPC_GRS_014_001','Date equipment last calibrated','NA'),('IMPC_HEM_001_001','White blood cell count','white_blood_cell_count'),('IMPC_HEM_002_001','Red blood cell count','red_blood_cell_count'),('IMPC_HEM_003_001','Hemoglobin','hemoglobin'),('IMPC_HEM_004_001','Hematocrit','hematocrit'),('IMPC_HEM_005_001','Mean cell volume','mean_cell_volume'),('IMPC_HEM_006_001','Mean corpuscular hemoglobin','mean_corpuscular_hemoglobin'),('IMPC_HEM_007_001','Mean cell hemoglobin concentration','mean_cell_hemoglobin_concentration'),('IMPC_HEM_008_001','Platelet count','platelet_count'),('IMPC_HEM_009_001','Equipment ID','equipment_name'),('IMPC_HEM_010_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_HEM_011_001','Equipment model','equipment_model'),('IMPC_HEM_012_001','Anesthesia used for blood collection','anesthesia_used_for_blood_collection'),('IMPC_HEM_013_001','Method of blood collection','method_of_blood_collection'),('IMPC_HEM_014_001','Anticoagulant','anticoagulant'),('IMPC_HEM_015_001','Blood collection tubes','NA'),('IMPC_HEM_016_001','Date and time of sacrifice','NA'),('IMPC_HEM_017_001','Blood analysis experimenter ID','NA'),('IMPC_HEM_018_001','Samples kept on ice between collection and analysis','samples_kept_on_ice_between_collection_and_analysis_'),('IMPC_HEM_019_001','Mean platelet volume','NA'),('IMPC_HEM_020_001','ID for blood collection SOP','id_for_blood_collection_sop'),('IMPC_HEM_021_001','Date and time of blood collection','date_and_time_of_blood_collection'),('IMPC_HEM_022_001','Date of measurement','date_of_measurement'),('IMPC_HEM_023_001','Chip card number','chip_card_number'),('IMPC_HEM_024_001','Blood collection experimenter ID','NA'),('IMPC_HEM_025_001','Date equipment last calibrated','NA'),('IMPC_HEM_026_001','Storage temperature from blood collection until measurement','NA'),('IMPC_HEM_027_001','Red blood cell distribution width','NA'),('IMPC_HEM_028_001','Fight wounds','NA'),('IMPC_HEM_029_001','Neutrophil differential count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_030_001','Neutrophil cell count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_031_001','Lymphocyte differential count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_032_001','Lymphocyte cell count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_033_001','Monocyte differential count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_034_001','Monocyte cell count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_035_001','Eosinophil differential count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_036_001','Eosinophil cell count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_037_001','Basophil cell count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_038_001','Basophil differential count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_039_001','Large Unstained Cell (LUC) count','A white blood cell (WBC) count measures the number of white blood cells in your blood. A WBC differential determines the percentage of each type of white blood cell present in your blood. A differential can also detect immature white blood cells or any abnormalities, both of which are signs of a potential problem.'),('IMPC_HEM_040_001','Large Unstained Cell (LUC) differential count','NA'),('IMPC_HEM_041_001','Sample clotted','NA'),('IMPC_HEM_042_001','Service-related calibration start date','Harwell-required metadata parameter (req analysis) due to ADVIA analyser causing shift in data.'),('IMPC_HEM_043_001','LIH (Hemolysis Severity - available on AU analysers)','Copied from the same parameter in Clinical Blood Chemistry, as the same blood samples are used for both procedures, and the level of hemolysis has an effect on the results of hematology as well as CBC'),('IMPC_HIS_001_001','Brain - MPATH diagnostic term','NA'),('IMPC_HIS_001_002','Brain - MPATH pathological entity term','NA'),('IMPC_HIS_002_001','Brain - Free text diagnostic term','NA'),('IMPC_HIS_003_001','Brain - MPATH process term','NA'),('IMPC_HIS_003_002','Brain - MPATH pathological process term','NA'),('IMPC_HIS_004_001','Brain - Severity score','NA'),('IMPC_HIS_005_001','Brain - Descriptor PATO','NA'),('IMPC_HIS_006_001','Brain - Description','NA'),('IMPC_HIS_007_001','Eye with optic nerve - MPATH diagnostic term','NA'),('IMPC_HIS_007_002','Eye - MPATH pathological entity term','NA'),('IMPC_HIS_008_001','Eye with optic nerve - Free text diagnostic term','NA'),('IMPC_HIS_009_001','Eye with optic nerve - MPATH process term','NA'),('IMPC_HIS_009_002','Eye - MPATH pathological process term','NA'),('IMPC_HIS_010_001','Eye with optic nerve - Severity score','NA'),('IMPC_HIS_011_001','Eye with optic nerve - Descriptor PATO','NA'),('IMPC_HIS_012_001','Eye with optic nerve - Description','NA'),('IMPC_HIS_013_001','Spinal cord - MPATH diagnostic term','NA'),('IMPC_HIS_013_002','Spinal cord - MPATH pathological entity term','NA'),('IMPC_HIS_014_001','Spinal cord - Free text diagnostic term','NA'),('IMPC_HIS_015_001','Spinal cord - MPATH process term','NA'),('IMPC_HIS_015_002','Spinal cord - MPATH pathological process term','NA'),('IMPC_HIS_016_001','Spinal cord - Severity score','NA'),('IMPC_HIS_017_001','Spinal cord - Descriptor PATO','NA'),('IMPC_HIS_018_001','Spinal cord - Description','NA'),('IMPC_HIS_019_001','Thymus - MPATH diagnostic term','NA'),('IMPC_HIS_019_002','Thymus - MPATH pathological entity term','NA'),('IMPC_HIS_020_001','Thymus - Free text diagnostic term','NA'),('IMPC_HIS_021_001','Thymus - MPATH process term','NA'),('IMPC_HIS_021_002','Thymus - MPATH pathological process term','NA'),('IMPC_HIS_022_001','Thymus - Severity score','NA'),('IMPC_HIS_023_001','Thymus - Descriptor PATO','NA'),('IMPC_HIS_024_001','Thymus - Description','NA'),('IMPC_HIS_025_001','Thyroid - MPATH diagnostic term','NA'),('IMPC_HIS_025_002','Thyroid - MPATH pathological entity term','NA'),('IMPC_HIS_026_001','Thyroid - Free text diagnostic term','NA'),('IMPC_HIS_027_001','Thyroid - MPATH process term','NA'),('IMPC_HIS_027_002','Thyroid - MPATH pathological process term','NA'),('IMPC_HIS_028_001','Thyroid - Severity score','NA'),('IMPC_HIS_029_001','Thyroid - Descriptor PATO','NA'),('IMPC_HIS_030_001','Thyroid - Description','NA'),('IMPC_HIS_031_001','Heart - MPATH diagnostic term','NA'),('IMPC_HIS_031_002','Heart - MPATH pathological entity term','NA'),('IMPC_HIS_032_001','Heart - Free text diagnostic term','NA'),('IMPC_HIS_033_001','Heart - MPATH process term','NA'),('IMPC_HIS_033_002','Heart - MPATH pathological process term','NA'),('IMPC_HIS_034_001','Heart - Severity score','NA'),('IMPC_HIS_035_001','Heart - Descriptor PATO','NA'),('IMPC_HIS_036_001','Heart - Description','NA'),('IMPC_HIS_037_001','Trachea - MPATH diagnostic term','NA'),('IMPC_HIS_037_002','Trachea - MPATH pathological entity term','NA'),('IMPC_HIS_038_001','Trachea - Free text diagnostic term','NA'),('IMPC_HIS_039_001','Trachea - MPATH process term','NA'),('IMPC_HIS_039_002','Trachea - MPATH pathological process term','NA'),('IMPC_HIS_040_001','Trachea - Severity score','NA'),('IMPC_HIS_041_001','Trachea - Descriptor PATO','NA'),('IMPC_HIS_042_001','Trachea - Description','NA'),('IMPC_HIS_043_001','Esophagus - MPATH diagnostic term','NA'),('IMPC_HIS_043_002','Esophagus - MPATH pathological entity term','NA'),('IMPC_HIS_044_001','Esophagus - Free text diagnostic term','NA'),('IMPC_HIS_045_001','Esophagus - MPATH process term','NA'),('IMPC_HIS_045_002','Esophagus - MPATH pathological process term','NA'),('IMPC_HIS_046_001','Esophagus - Severity score','NA'),('IMPC_HIS_047_001','Esophagus - Descriptor PATO','NA'),('IMPC_HIS_048_001','Esophagus - Description','NA'),('IMPC_HIS_049_001','Lung - MPATH diagnostic term','NA'),('IMPC_HIS_049_002','Lung - MPATH pathological entity term','NA'),('IMPC_HIS_050_001','Lung - Free text diagnostic term','NA'),('IMPC_HIS_051_001','Lung - MPATH process term','NA'),('IMPC_HIS_051_002','Lung - MPATH pathological process term','NA'),('IMPC_HIS_052_001','Lung - Severity score','NA'),('IMPC_HIS_053_001','Lung - Descriptor PATO','NA'),('IMPC_HIS_054_001','Lung - Description','NA'),('IMPC_HIS_055_001','Liver - MPATH diagnostic term','NA'),('IMPC_HIS_055_002','Liver - MPATH pathological entity term','NA'),('IMPC_HIS_056_001','Liver - Free text diagnostic term','NA'),('IMPC_HIS_057_001','Liver - MPATH process term','NA'),('IMPC_HIS_057_002','Liver - MPATH pathological process term','NA'),('IMPC_HIS_058_001','Liver - Severity score','NA'),('IMPC_HIS_059_001','Liver - Descriptor PATO','NA'),('IMPC_HIS_060_001','Liver - Description','NA'),('IMPC_HIS_061_001','Gall bladder - MPATH diagnostic term','NA'),('IMPC_HIS_061_002','Gall bladder - MPATH pathological entity term','NA'),('IMPC_HIS_062_001','Gall bladder - Free text diagnostic term','NA'),('IMPC_HIS_063_001','Gall bladder - MPATH process term','NA'),('IMPC_HIS_063_002','Gall bladder - MPATH pathological process term','NA'),('IMPC_HIS_064_001','Gall bladder - Severity score','NA'),('IMPC_HIS_065_001','Gall bladder - Descriptor PATO','NA'),('IMPC_HIS_066_001','Gall bladder - Description','NA'),('IMPC_HIS_067_001','Stomach - MPATH diagnostic term','NA'),('IMPC_HIS_067_002','Stomach - MPATH pathological entity term','NA'),('IMPC_HIS_068_001','Stomach - Free text diagnostic term','NA'),('IMPC_HIS_069_001','Stomach - MPATH process term','NA'),('IMPC_HIS_069_002','Stomach - MPATH pathological process term','NA'),('IMPC_HIS_070_001','Stomach - Severity score','NA'),('IMPC_HIS_071_001','Stomach - Descriptor PATO','NA'),('IMPC_HIS_072_001','Stomach - Description','NA'),('IMPC_HIS_073_001','Small intestine - MPATH diagnostic term','NA'),('IMPC_HIS_073_002','Small intestine - MPATH pathological entity term','NA'),('IMPC_HIS_074_001','Small intestine - Free text diagnostic term','NA'),('IMPC_HIS_075_001','Small intestine - MPATH process term','NA'),('IMPC_HIS_075_002','Small intestine - MPATH pathological process term','NA'),('IMPC_HIS_076_001','Small intestine - Severity score','NA'),('IMPC_HIS_077_001','Small intestine - Descriptor PATO','NA'),('IMPC_HIS_078_001','Small intestine - Description','NA'),('IMPC_HIS_079_001','Large intestine - MPATH diagnostic term','NA'),('IMPC_HIS_079_002','Large intestine - MPATH pathological entity term','NA'),('IMPC_HIS_080_001','Large intestine - Free text diagnostic term','NA'),('IMPC_HIS_081_001','Large intestine - MPATH process term','NA'),('IMPC_HIS_081_002','Large intestine - MPATH pathological process term','NA'),('IMPC_HIS_082_001','Large intestine - Severity score','NA'),('IMPC_HIS_083_001','Large intestine - Descriptor PATO','NA'),('IMPC_HIS_084_001','Large intestine - Description','NA'),('IMPC_HIS_085_001','Pancreas - MPATH diagnostic term','NA'),('IMPC_HIS_085_002','Pancreas - MPATH pathological entity term','NA'),('IMPC_HIS_086_001','Pancreas - Free text diagnostic term','NA'),('IMPC_HIS_087_001','Pancreas - MPATH process term','NA'),('IMPC_HIS_087_002','Pancreas - MPATH pathological process term','NA'),('IMPC_HIS_088_001','Pancreas - Severity score','NA'),('IMPC_HIS_089_001','Pancreas - Descriptor PATO','NA'),('IMPC_HIS_090_001','Pancreas - Description','NA'),('IMPC_HIS_091_001','Spleen - MPATH diagnostic term','NA'),('IMPC_HIS_091_002','Spleen - MPATH pathological entity term','NA'),('IMPC_HIS_092_001','Spleen - Free text diagnostic term','NA'),('IMPC_HIS_093_001','Spleen - MPATH process term','NA'),('IMPC_HIS_093_002','Spleen - MPATH pathological process term','NA'),('IMPC_HIS_094_001','Spleen - Severity score','NA'),('IMPC_HIS_095_001','Spleen - Descriptor PATO','NA'),('IMPC_HIS_096_001','Spleen - Description','NA'),('IMPC_HIS_097_001','Kidney - MPATH diagnostic term','NA'),('IMPC_HIS_097_002','Kidney - MPATH pathological entity term','NA'),('IMPC_HIS_098_001','Kidney - Free text diagnostic term','NA'),('IMPC_HIS_099_001','Kidney - MPATH process term','NA'),('IMPC_HIS_099_002','Kidney - MPATH pathological process term','NA'),('IMPC_HIS_100_001','Kidney - Severity score','NA'),('IMPC_HIS_101_001','Kidney - Descriptor PATO','NA'),('IMPC_HIS_102_001','Kidney - Description','NA'),('IMPC_HIS_103_001','Adrenal gland - MPATH diagnostic term','NA'),('IMPC_HIS_103_002','Adrenal gland - MPATH pathological entity term','NA'),('IMPC_HIS_104_001','Adrenal gland - Free text diagnostic term','NA'),('IMPC_HIS_105_001','Adrenal gland - MPATH process term','NA'),('IMPC_HIS_105_002','Adrenal gland - MPATH pathological process term','NA'),('IMPC_HIS_106_001','Adrenal gland - Severity score','NA'),('IMPC_HIS_107_001','Adrenal gland - Descriptor PATO','NA'),('IMPC_HIS_108_001','Adrenal gland - Description','NA'),('IMPC_HIS_109_001','Mammary gland - MPATH diagnostic term','NA'),('IMPC_HIS_109_002','Mammary gland - MPATH pathological entity term','NA'),('IMPC_HIS_110_001','Mammary gland - Free text diagnostic term','NA'),('IMPC_HIS_111_001','Mammary gland - MPATH process term','NA'),('IMPC_HIS_111_002','Mammary gland - MPATH pathological process term','NA'),('IMPC_HIS_112_001','Mammary gland - Severity score','NA'),('IMPC_HIS_113_001','Mammary gland - Descriptor PATO','NA'),('IMPC_HIS_114_001','Mammary gland - Description','NA'),('IMPC_HIS_115_001','Lymph node - MPATH diagnostic term','NA'),('IMPC_HIS_115_002','Lymph node - MPATH pathological entity term','NA'),('IMPC_HIS_116_001','Lymph node - Free text diagnostic term','NA'),('IMPC_HIS_117_001','Lymph node - MPATH process term','NA'),('IMPC_HIS_117_002','Lymph node - MPATH pathological process term','NA'),('IMPC_HIS_118_001','Lymph node - Severity score','NA'),('IMPC_HIS_119_001','Lymph node - Descriptor PATO','NA'),('IMPC_HIS_120_001','Lymph node - Description','NA'),('IMPC_HIS_121_001','Skin - MPATH diagnostic term','NA'),('IMPC_HIS_121_002','Skin - MPATH pathological entity term','NA'),('IMPC_HIS_122_001','Skin - Free text diagnostic term','NA'),('IMPC_HIS_123_001','Skin - MPATH process term','NA'),('IMPC_HIS_123_002','Skin - MPATH pathological process term','NA'),('IMPC_HIS_124_001','Skin - Severity score','NA'),('IMPC_HIS_125_001','Skin - Descriptor PATO','NA'),('IMPC_HIS_126_001','Skin - Description','NA'),('IMPC_HIS_127_001','Skeletal muscle - MPATH diagnostic term','NA'),('IMPC_HIS_127_002','Skeletal muscle - MPATH pathological entity term','NA'),('IMPC_HIS_128_001','Skeletal muscle - Free text diagnostic term','NA'),('IMPC_HIS_129_001','Skeletal muscle - MPATH process term','NA'),('IMPC_HIS_129_002','Skeletal muscle - MPATH pathological process term','NA'),('IMPC_HIS_130_001','Skeletal muscle - Severity score','NA'),('IMPC_HIS_131_001','Skeletal muscle - Descriptor PATO','NA'),('IMPC_HIS_132_001','Skeletal muscle - Description','NA'),('IMPC_HIS_133_001','Urinary bladder - MPATH diagnostic term','NA'),('IMPC_HIS_133_002','Urinary bladder - MPATH pathological entity term','NA'),('IMPC_HIS_134_001','Urinary bladder - Free text diagnostic term','NA'),('IMPC_HIS_135_001','Urinary bladder - MPATH process term','NA'),('IMPC_HIS_135_002','Urinary bladder - MPATH pathological process term','NA'),('IMPC_HIS_136_001','Urinary bladder - Severity score','NA'),('IMPC_HIS_137_001','Urinary bladder - Descriptor PATO','NA'),('IMPC_HIS_138_001','Urinary bladder - Description','NA'),('IMPC_HIS_139_001','Testes - MPATH diagnostic term','NA'),('IMPC_HIS_139_002','Testis - MPATH pathological entity term','NA'),('IMPC_HIS_140_001','Testes - Free text diagnostic term','NA'),('IMPC_HIS_141_001','Testes - MPATH process term','NA'),('IMPC_HIS_141_002','Testis - MPATH pathological process term','NA'),('IMPC_HIS_142_001','Testes - Severity score','NA'),('IMPC_HIS_143_001','Testes - Descriptor PATO','NA'),('IMPC_HIS_144_001','Testes - Description','NA'),('IMPC_HIS_145_001','Epididymis - MPATH diagnostic term','NA'),('IMPC_HIS_145_002','Epididymis - MPATH pathological entity term','NA'),('IMPC_HIS_146_001','Epididymis - Free text diagnostic term','NA'),('IMPC_HIS_147_001','Epididymis - MPATH process term','NA'),('IMPC_HIS_147_002','Epididymis - MPATH pathological process term','NA'),('IMPC_HIS_148_001','Epididymis - Severity score','NA'),('IMPC_HIS_149_001','Epididymis - Descriptor PATO','NA'),('IMPC_HIS_150_001','Epididymis - Description','NA'),('IMPC_HIS_151_001','Prostate - MPATH diagnostic term','NA'),('IMPC_HIS_151_002','Prostate gland - MPATH pathological entity term','NA'),('IMPC_HIS_152_001','Prostate - Free text diagnostic term','NA'),('IMPC_HIS_153_001','Prostate - MPATH process term','NA'),('IMPC_HIS_153_002','Prostate gland - MPATH pathological process term','NA'),('IMPC_HIS_154_001','Prostate - Severity score','NA'),('IMPC_HIS_155_001','Prostate - Descriptor PATO','NA'),('IMPC_HIS_156_001','Prostate - Description','NA'),('IMPC_HIS_157_001','Seminal vesicle - MPATH diagnostic term','NA'),('IMPC_HIS_157_002','Seminal vesicle - MPATH pathological entity term','NA'),('IMPC_HIS_158_001','Seminal vesicle - Free text diagnostic term','NA'),('IMPC_HIS_159_001','Seminal vesicle - MPATH process term','NA'),('IMPC_HIS_159_002','Seminal vesicle - MPATH pathological process term','NA'),('IMPC_HIS_160_001','Seminal vesicle - Severity score','NA'),('IMPC_HIS_161_001','Seminal vesicle - Descriptor PATO','NA'),('IMPC_HIS_162_001','Seminal vesicle - Description','NA'),('IMPC_HIS_163_001','Ovary - MPATH diagnostic term','NA'),('IMPC_HIS_163_002','Ovary - MPATH pathological entity term','NA'),('IMPC_HIS_164_001','Ovary - Free text diagnostic term','NA'),('IMPC_HIS_165_001','Ovary - MPATH process term','NA'),('IMPC_HIS_165_002','Ovary - MPATH pathological process term','NA'),('IMPC_HIS_166_001','Ovary - Severity score','NA'),('IMPC_HIS_167_001','Ovary - Descriptor PATO','NA'),('IMPC_HIS_168_001','Ovary - Description','NA'),('IMPC_HIS_169_001','Uterus - MPATH diagnostic term','NA'),('IMPC_HIS_169_002','Uterus - MPATH pathological entity term','NA'),('IMPC_HIS_170_001','Uterus - Free text diagnostic term','NA'),('IMPC_HIS_171_001','Uterus - MPATH process term','NA'),('IMPC_HIS_171_002','Uterus - MPATH pathological process term','NA'),('IMPC_HIS_172_001','Uterus - Severity score','NA'),('IMPC_HIS_173_001','Uterus - Descriptor PATO','NA'),('IMPC_HIS_174_001','Uterus - Description','NA'),('IMPC_HIS_175_001','Stain','NA'),('IMPC_HIS_176_001','Section thickness','NA'),('IMPC_HIS_177_001','Images','NA'),('IMPC_HIS_178_001','Severity maximum score','NA'),('IMPC_HIS_179_001','Brain - Significance score','NA'),('IMPC_HIS_179_002','Brain - Significance score','NA'),('IMPC_HIS_180_001','Eye with optic nerve - Significance score','NA'),('IMPC_HIS_180_002','Eye with optic nerve - Significance score','NA'),('IMPC_HIS_181_001','Spinal cord - Significance score','NA'),('IMPC_HIS_181_002','Spinal cord - Significance score','NA'),('IMPC_HIS_182_001','Thymus - Significance score','NA'),('IMPC_HIS_182_002','Thymus - Significance score','NA'),('IMPC_HIS_183_001','Thyroid - Significance score','NA'),('IMPC_HIS_183_002','Thyroid - Significance score','NA'),('IMPC_HIS_184_001','Heart - Significance score','NA'),('IMPC_HIS_184_002','Heart - Significance score','NA'),('IMPC_HIS_185_001','Trachea - Significance score','NA'),('IMPC_HIS_185_002','Trachea - Significance score','NA'),('IMPC_HIS_186_001','Esophagus - Significance score','NA'),('IMPC_HIS_186_002','Esophagus - Significance score','NA'),('IMPC_HIS_187_001','Lung - Significance score','NA'),('IMPC_HIS_187_002','Lung - Significance score','NA'),('IMPC_HIS_188_001','Liver - Significance score','NA'),('IMPC_HIS_188_002','Liver - Significance score','NA'),('IMPC_HIS_189_001','Gall bladder - Significance score','NA'),('IMPC_HIS_189_002','Gall bladder - Significance score','NA'),('IMPC_HIS_190_001','Stomach - Significance score','NA'),('IMPC_HIS_190_002','Stomach - Significance score','NA'),('IMPC_HIS_191_001','Small intestine - Significance score','NA'),('IMPC_HIS_191_002','Small intestine - Significance score','NA'),('IMPC_HIS_192_001','Large intestine - Significance score','NA'),('IMPC_HIS_192_002','Large intestine - Significance score','NA'),('IMPC_HIS_193_001','Pancreas - Significance score','NA'),('IMPC_HIS_193_002','Pancreas - Significance score','NA'),('IMPC_HIS_194_001','Spleen - Significance score','NA'),('IMPC_HIS_194_002','Spleen - Significance score','NA'),('IMPC_HIS_195_001','Kidney - Significance score','NA'),('IMPC_HIS_195_002','Kidney - Significance score','NA'),('IMPC_HIS_196_001','Adrenal gland - Significance score','NA'),('IMPC_HIS_196_002','Adrenal gland - Significance score','NA'),('IMPC_HIS_197_001','Mammary gland - Significance score','NA'),('IMPC_HIS_197_002','Mammary gland - Significance score','NA'),('IMPC_HIS_198_001','Lymph node - Significance score','NA'),('IMPC_HIS_198_002','Lymph node - Significance score','NA'),('IMPC_HIS_199_001','Skin - Significance score','NA'),('IMPC_HIS_199_002','Skin - Significance score','NA'),('IMPC_HIS_200_001','Skeletal muscle - Significance score','NA'),('IMPC_HIS_200_002','Skeletal muscle - Significance score','NA'),('IMPC_HIS_201_001','Urinary bladder - Significance score','NA'),('IMPC_HIS_201_002','Urinary bladder - Significance score','NA'),('IMPC_HIS_202_001','Testes - Significance score','NA'),('IMPC_HIS_202_002','Testes - Significance score','NA'),('IMPC_HIS_203_001','Epididymis - Significance score','NA'),('IMPC_HIS_203_002','Epididymis - Significance score','NA'),('IMPC_HIS_204_001','Prostate - Significance score','NA'),('IMPC_HIS_204_002','Prostate - Significance score','NA'),('IMPC_HIS_205_001','Seminal vesicle - Significance score','NA'),('IMPC_HIS_205_002','Seminal vesicle - Significance score','NA'),('IMPC_HIS_206_001','Ovary - Significance score','NA'),('IMPC_HIS_206_002','Ovary - Significance score','NA'),('IMPC_HIS_207_001','Uterus - Significance score','NA'),('IMPC_HIS_207_002','Uterus - Significance score','NA'),('IMPC_HIS_208_001','Experimenter ID','NA'),('IMPC_HIS_209_001','Salivary gland - MPATH diagnostic term','NA'),('IMPC_HIS_209_002','Salivary gland - MPATH pathological entity term','NA'),('IMPC_HIS_210_001','Salivary gland - Free text diagnostic term','NA'),('IMPC_HIS_211_001','Salivary gland - MPATH process term','NA'),('IMPC_HIS_211_002','Salivary gland - MPATH pathological process term','NA'),('IMPC_HIS_212_001','Salivary gland - Severity score','NA'),('IMPC_HIS_213_001','Salivary gland - Descriptor PATO','NA'),('IMPC_HIS_214_001','Salivary gland - Description','NA'),('IMPC_HIS_215_001','Salivary gland - Significance score','NA'),('IMPC_HIS_216_001','Sternum - MPATH diagnostic term','NA'),('IMPC_HIS_216_002','Sternum - MPATH pathological entity term','NA'),('IMPC_HIS_217_001','Sternum - Free text diagnostic term','NA'),('IMPC_HIS_218_001','Sternum - MPATH process term','NA'),('IMPC_HIS_218_002','Sternum - MPATH pathological process term','NA'),('IMPC_HIS_219_001','Sternum - Severity score','NA'),('IMPC_HIS_220_001','Sternum - Descriptor PATO','NA'),('IMPC_HIS_221_001','Sternum - Description','NA'),('IMPC_HIS_222_001','Sternum - Significance score','NA'),('IMPC_HIS_223_001','Femur - MPATH diagnostic term','NA'),('IMPC_HIS_223_002','Femur - MPATH pathological entity term','NA'),('IMPC_HIS_224_001','Femur - Free text diagnostic term','NA'),('IMPC_HIS_225_001','Femur - MPATH process term','NA'),('IMPC_HIS_225_002','Femur - MPATH pathological process term','NA'),('IMPC_HIS_226_001','Femur - Severity score','NA'),('IMPC_HIS_227_001','Femur - Descriptor PATO','NA'),('IMPC_HIS_228_001','Femur - Description','NA'),('IMPC_HIS_229_001','Femur - Significance score','NA'),('IMPC_HIS_230_001','Bone marrow - MPATH diagnostic term','NA'),('IMPC_HIS_230_002','Bone marrow - MPATH pathological entity term','NA'),('IMPC_HIS_231_001','Bone marrow - Free text diagnostic term','NA'),('IMPC_HIS_232_001','Bone marrow - MPATH process term','NA'),('IMPC_HIS_232_002','Bone marrow - MPATH pathological process term','NA'),('IMPC_HIS_233_001','Bone marrow - Severity score','NA'),('IMPC_HIS_234_001','Bone marrow - Descriptor PATO','NA'),('IMPC_HIS_235_001','Bone marrow - Description','NA'),('IMPC_HIS_236_001','Bone marrow - Significance score','NA'),('IMPC_HIS_237_001','Brown adipose tissue - MPATH diagnostic term','NA'),('IMPC_HIS_237_002','Brown adipose tissue - MPATH pathological entity term','NA'),('IMPC_HIS_238_001','Brown adipose tissue - Free text diagnostic term','NA'),('IMPC_HIS_239_001','Brown adipose tissue - MPATH process term','NA'),('IMPC_HIS_239_002','Brown adipose tissue - MPATH pathological process term','NA'),('IMPC_HIS_240_001','Brown adipose tissue - Severity score','NA'),('IMPC_HIS_241_001','Brown adipose tissue - Descriptor PATO','NA'),('IMPC_HIS_242_001','Brown adipose tissue - Description','NA'),('IMPC_HIS_243_001','Brown adipose tissue - Significance score','NA'),('IMPC_HIS_244_001','Tibia - MPATH diagnostic term','NA'),('IMPC_HIS_244_002','Tibia - MPATH pathological entity term','NA'),('IMPC_HIS_245_001','Tibia - Free text diagnostic term','NA'),('IMPC_HIS_246_001','Tibia - MPATH process term','NA'),('IMPC_HIS_246_002','Tibia - MPATH pathological process term','NA'),('IMPC_HIS_247_001','Tibia - Severity score','NA'),('IMPC_HIS_247_002','Tibia - Severity score','NA'),('IMPC_HIS_248_001','Tibia - Descriptor PATO','NA'),('IMPC_HIS_249_001','Tibia - Description','NA'),('IMPC_HIS_250_001','Tibia - Significance score','NA'),('IMPC_HIS_251_001','Knee joint - MPATH diagnostic term','NA'),('IMPC_HIS_251_002','Knee joint - MPATH pathological entity term','NA'),('IMPC_HIS_252_001','Knee joint - Free text diagnostic term','NA'),('IMPC_HIS_253_001','Knee joint - MPATH process term','NA'),('IMPC_HIS_253_002','Knee joint - MPATH pathological process term','NA'),('IMPC_HIS_254_001','Knee joint - Severity score','NA'),('IMPC_HIS_255_001','Knee joint - Descriptor PATO','NA'),('IMPC_HIS_256_001','Knee joint - Description','NA'),('IMPC_HIS_257_001','Knee joint - Significance score','NA'),('IMPC_HIS_258_001','Trigeminal V nerve - MPATH diagnostic term','NA'),('IMPC_HIS_258_002','Trigeminal V ganglion - MPATH pathological entity term','NA'),('IMPC_HIS_259_001','Trigeminal V nerve - Free text diagnostic term','NA'),('IMPC_HIS_260_001','Trigeminal V nerve - MPATH process term','NA'),('IMPC_HIS_260_002','Trigeminal V ganglion - MPATH pathological process term','NA'),('IMPC_HIS_261_001','Trigeminal V nerve - Severity score','NA'),('IMPC_HIS_262_001','Trigeminal V nerve - Descriptor PATO','NA'),('IMPC_HIS_263_001','Trigeminal V nerve - Description','NA'),('IMPC_HIS_264_001','Trigeminal V nerve - Significance score','NA'),('IMPC_HIS_265_001','Nasal cavity - MPATH diagnostic term','NA'),('IMPC_HIS_265_002','Nasal cavity - MPATH pathological entity term','NA'),('IMPC_HIS_266_001','Nasal cavity - Free text diagnostic term','NA'),('IMPC_HIS_267_001','Nasal cavity - MPATH process term','NA'),('IMPC_HIS_267_002','Nasal cavity - MPATH pathological process term','NA'),('IMPC_HIS_268_001','Nasal cavity - Severity score','NA'),('IMPC_HIS_269_001','Nasal cavity - Descriptor PATO','NA'),('IMPC_HIS_270_001','Nasal cavity - Description','NA'),('IMPC_HIS_271_001','Nasal cavity - Significance score','NA'),('IMPC_HIS_272_001','Ear - MPATH diagnostic term','NA'),('IMPC_HIS_272_002','Ear - MPATH pathological entity term','NA'),('IMPC_HIS_273_001','Ear - Free text diagnostic term','NA'),('IMPC_HIS_274_001','Ear - MPATH process term','NA'),('IMPC_HIS_274_002','Ear - MPATH pathological process term','NA'),('IMPC_HIS_275_001','Ear - Severity score','NA'),('IMPC_HIS_276_001','Ear - Descriptor PATO','NA'),('IMPC_HIS_277_001','Ear - Description','NA'),('IMPC_HIS_278_001','Ear - Significance score','NA'),('IMPC_HIS_279_001','Tooth - MPATH diagnostic term','NA'),('IMPC_HIS_279_002','Tooth - MPATH pathological entity term','NA'),('IMPC_HIS_280_001','Tooth - Free text diagnostic term','NA'),('IMPC_HIS_281_001','Tooth - MPATH process term','NA'),('IMPC_HIS_281_002','Tooth - MPATH pathological process term','NA'),('IMPC_HIS_282_001','Tooth - Severity score','NA'),('IMPC_HIS_283_001','Tooth - Descriptor PATO','NA'),('IMPC_HIS_284_001','Tooth - Description','NA'),('IMPC_HIS_285_001','Tooth - Significance score','NA'),('IMPC_HIS_286_001','Tongue - MPATH diagnostic term','NA'),('IMPC_HIS_286_002','Tongue - MPATH pathological entity term','NA'),('IMPC_HIS_287_001','Tongue - Free text diagnostic term','NA'),('IMPC_HIS_288_001','Tongue - MPATH process term','NA'),('IMPC_HIS_288_002','Tongue - MPATH pathological process term','NA'),('IMPC_HIS_289_001','Tongue - Severity score','NA'),('IMPC_HIS_290_001','Tongue - Descriptor PATO','NA'),('IMPC_HIS_291_001','Tongue - Description','NA'),('IMPC_HIS_292_001','Tongue - Significance score','NA'),('IMPC_HIS_293_001','Sciatic nerve - MPATH diagnostic term','NA'),('IMPC_HIS_293_002','Sciatic nerve - MPATH pathological entity term','NA'),('IMPC_HIS_294_001','Sciatic nerve - Free text diagnostic term','NA'),('IMPC_HIS_295_001','Sciatic nerve - MPATH process term','NA'),('IMPC_HIS_295_002','Sciatic nerve - MPATH pathological process term','NA'),('IMPC_HIS_296_001','Sciatic nerve - Severity score','NA'),('IMPC_HIS_297_001','Sciatic nerve - Descriptor PATO','NA'),('IMPC_HIS_298_001','Sciatic nerve - Description','NA'),('IMPC_HIS_299_001','Sciatic nerve - Significance score','NA'),('IMPC_HIS_300_001','Brain','NA'),('IMPC_HIS_301_001','Eye with optic nerve','NA'),('IMPC_HIS_302_001','Spinal cord','NA'),('IMPC_HIS_303_001','Thymus','NA'),('IMPC_HIS_304_001','Thyroid','NA'),('IMPC_HIS_305_001','Heart','NA'),('IMPC_HIS_306_001','Trachea','NA'),('IMPC_HIS_307_001','Esophagus','NA'),('IMPC_HIS_308_001','Lung','NA'),('IMPC_HIS_309_001','Liver','NA'),('IMPC_HIS_310_001','Gall bladder','NA'),('IMPC_HIS_311_001','Stomach','NA'),('IMPC_HIS_312_001','Small intestine','NA'),('IMPC_HIS_313_001','Large intestine','NA'),('IMPC_HIS_314_001','Pancreas','NA'),('IMPC_HIS_315_001','Spleen','NA'),('IMPC_HIS_316_001','Kidney','NA'),('IMPC_HIS_317_001','Adrenal gland','NA'),('IMPC_HIS_318_001','Mammary gland','NA'),('IMPC_HIS_319_001','Lymph node','NA'),('IMPC_HIS_320_001','Skin','NA'),('IMPC_HIS_321_001','Skeletal muscle','NA'),('IMPC_HIS_322_001','Urinary bladder','NA'),('IMPC_HIS_323_001','Testes','NA'),('IMPC_HIS_324_001','Epididymis','NA'),('IMPC_HIS_325_001','Prostate','NA'),('IMPC_HIS_326_001','Seminal vesicle','NA'),('IMPC_HIS_327_001','Ovary','NA'),('IMPC_HIS_328_001','Uterus','NA'),('IMPC_HIS_329_001','Salivary gland','NA'),('IMPC_HIS_330_001','Sternum','NA'),('IMPC_HIS_331_001','Femur','NA'),('IMPC_HIS_332_001','Bone marrow','NA'),('IMPC_HIS_333_001','Brown adipose tissue','NA'),('IMPC_HIS_334_001','Tibia','NA'),('IMPC_HIS_335_001','Knee joint','NA'),('IMPC_HIS_336_001','Trigeminal V nerve','NA'),('IMPC_HIS_337_001','Nasal cavity','NA'),('IMPC_HIS_338_001','Ear','NA'),('IMPC_HIS_339_001','Tooth','NA'),('IMPC_HIS_340_001','Tongue','NA'),('IMPC_HIS_341_001','Sciatic nerve','NA'),('IMPC_HIS_342_001','Bone - MPATH diagnostic term','NA'),('IMPC_HIS_342_002','Bone - MPATH pathological entity term','NA'),('IMPC_HIS_343_001','Bone - Free text diagnostic term','NA'),('IMPC_HIS_344_001','Bone - MPATH process term','NA'),('IMPC_HIS_344_002','Bone - MPATH pathological process term','NA'),('IMPC_HIS_345_001','Bone - Severity score','NA'),('IMPC_HIS_345_002','Bone - Severity score','NA'),('IMPC_HIS_346_001','Bone - Descriptor PATO','NA'),('IMPC_HIS_347_001','Bone - Description','NA'),('IMPC_HIS_348_001','Bone - Significance score','NA'),('IMPC_HIS_348_002','Bone - Significance score','NA'),('IMPC_HIS_349_001','Bone','NA'),('IMPC_HIS_350_001','Adrenal gland - MA term','NA'),('IMPC_HIS_351_001','Bone - MA term','NA'),('IMPC_HIS_352_001','Bone marrow - MA term','NA'),('IMPC_HIS_353_001','Brain - MA term','NA'),('IMPC_HIS_354_001','Brown adipose tissue - MA term','NA'),('IMPC_HIS_355_001','Ear - MA term','NA'),('IMPC_HIS_356_001','Epididymis - MA term','NA'),('IMPC_HIS_357_001','Esophagus - MA term','NA'),('IMPC_HIS_358_001','Eye - MA term','NA'),('IMPC_HIS_359_001','Femur - MA term','NA'),('IMPC_HIS_360_001','Gall bladder - MA term','NA'),('IMPC_HIS_361_001','Heart - MA term','NA'),('IMPC_HIS_362_001','Kidney - MA term','NA'),('IMPC_HIS_363_001','Knee joint - MA term','NA'),('IMPC_HIS_364_001','Large intestine - MA term','NA'),('IMPC_HIS_365_001','Liver - MA term','NA'),('IMPC_HIS_366_001','Lung - MA term','NA'),('IMPC_HIS_367_001','Lymph node - MA term','NA'),('IMPC_HIS_368_001','Mammary gland - MA term','NA'),('IMPC_HIS_369_001','Nasal cavity - MA term','NA'),('IMPC_HIS_370_001','Ovary - MA term','NA'),('IMPC_HIS_371_001','Pancreas - MA term','NA'),('IMPC_HIS_372_001','Pituitary gland - Description','NA'),('IMPC_HIS_373_001','Pituitary gland - Descriptor PATO','NA'),('IMPC_HIS_374_001','Pituitary gland - Free text diagnostic term','NA'),('IMPC_HIS_375_001','Pituitary gland - MA term','NA'),('IMPC_HIS_376_001','Pituitary gland - MPATH pathological entity term','NA'),('IMPC_HIS_377_001','Pituitary gland - MPATH pathological process term','NA'),('IMPC_HIS_378_001','Pituitary gland - Severity score','NA'),('IMPC_HIS_379_001','Pituitary gland - Significance score','NA'),('IMPC_HIS_380_001','Prostate gland - MA term','NA'),('IMPC_HIS_381_001','Salivary gland - MA term','NA'),('IMPC_HIS_382_001','Sciatic nerve - MA term','NA'),('IMPC_HIS_383_001','Seminal vesicle - MA term','NA'),('IMPC_HIS_384_001','Skeletal muscle - MA term','NA'),('IMPC_HIS_385_001','Skin - MA term','NA'),('IMPC_HIS_386_001','Small intestine - MA term','NA'),('IMPC_HIS_387_001','Spinal cord - MA term','NA'),('IMPC_HIS_388_001','Spleen - MA term','NA'),('IMPC_HIS_389_001','Sternum - MA term','NA'),('IMPC_HIS_390_001','Stomach - MA term','NA'),('IMPC_HIS_391_001','Testis - MA term','NA'),('IMPC_HIS_392_001','Thymus - MA term','NA'),('IMPC_HIS_393_001','Thyroid - MA term','NA'),('IMPC_HIS_394_001','Tibia - MA term','NA'),('IMPC_HIS_395_001','Tongue - MA term','NA'),('IMPC_HIS_396_001','Tooth - MA term','NA'),('IMPC_HIS_397_001','Trachea - MA term','NA'),('IMPC_HIS_398_001','Trigeminal V ganglion - MA term','NA'),('IMPC_HIS_399_001','Urinary bladder - MA term','NA'),('IMPC_HIS_400_001','Uterus - MA term','NA'),('IMPC_HIS_401_001','White adipose tissue - Description','NA'),('IMPC_HIS_402_001','White adipose tissue - Descriptor PATO','NA'),('IMPC_HIS_403_001','White adipose tissue - Free text diagnostic term','NA'),('IMPC_HIS_404_001','White adipose tissue - MA term','NA'),('IMPC_HIS_405_001','White adipose tissue - MPATH pathological entity term','NA'),('IMPC_HIS_406_001','White adipose tissue - MPATH pathological process term','NA'),('IMPC_HIS_407_001','White adipose tissue - Severity score','NA'),('IMPC_HIS_408_001','White adipose tissue - Significance score','NA'),('IMPC_HIS_409_001','Subcutaneous adipose tissue - Description','NA'),('IMPC_HIS_410_001','Subcutaneous adipose tissue - Descriptor PATO','NA'),('IMPC_HIS_411_001','Subcutaneous adipose tissue - Free text diagnostic term','NA'),('IMPC_HIS_412_001','Subcutaneous adipose tissue - MA term','NA'),('IMPC_HIS_413_001','Subcutaneous adipose tissue - MPATH pathological entity term','NA'),('IMPC_HIS_414_001','Subcutaneous adipose tissue - MPATH pathological process term','NA'),('IMPC_HIS_415_001','Subcutaneous adipose tissue - Severity score','NA'),('IMPC_HIS_416_001','Subcutaneous adipose tissue - Significance score','NA'),('IMPC_HIS_417_001','Optic II nerve - Description','optic_II_nerve_description'),('IMPC_HIS_418_001','Optic II nerve - Descriptor PATO','NA'),('IMPC_HIS_419_001','Optic II nerve - Free text diagnostic term','NA'),('IMPC_HIS_420_001','Optic II nerve - MA term','NA'),('IMPC_HIS_421_001','Optic II nerve - MPATH pathological entity term','NA'),('IMPC_HIS_422_001','Optic II nerve - MPATH pathological process term','NA'),('IMPC_HIS_423_001','Optic II nerve - Severity score','NA'),('IMPC_HIS_424_001','Optic II nerve - Significance score','NA'),('IMPC_HIS_425_001','Date of sacrifice','date_of_sacrifice'),('IMPC_HOU_001_001','Submitter ID','submitter_id'),('IMPC_HOU_002_001','Phenotyping project(s)','phenotyping_project_s'),('IMPC_HOU_003_001','Pipeline ID(s)','pipeline_id_s'),('IMPC_HOU_003_002','Pipeline ID(s)','pipeline_ids_applicable_to_housing_conditions'),('IMPC_HOU_004_001','Start Date','start_date'),('IMPC_HOU_004_002','Date effective from','date_effective_from'),('IMPC_HOU_005_001','End Date','end_date'),('IMPC_HOU_005_002','Date effective until','date_effective_until'),('IMPC_HOU_006_001','Stage of the pipeline(s) - Start Week','stage_of_the_pipeline_s_start_week'),('IMPC_HOU_007_001','Stage of the pipeline(s) - End Week','stage_of_the_pipeline_s_end_week'),('IMPC_HOU_008_001','Procedure IDs associated with this block','procedure_ids_associated_with_this_stage_of_the_pipeline_s'),('IMPC_HOU_009_001','Housing - temperature regulated','housing_temperature_regulated'),('IMPC_HOU_010_001','Housing - temperature range - Minimum','housing_temperature_range_minimum'),('IMPC_HOU_011_001','Housing - temperature range - Maximum','housing_temperature_range_maximum'),('IMPC_HOU_012_001','Housing - relative humidity regulated','housing_relative_humidity_regulated'),('IMPC_HOU_013_001','Housing - relative humidity range - Minimum','housing_relative_humidity_range_minimum'),('IMPC_HOU_014_001','Housing - relative humidity range - Maximum','housing_relative_humidity_range_maximum'),('IMPC_HOU_015_001','Housing - ventilation managed','housing_ventilation_managed'),('IMPC_HOU_016_001','Housing - air changes per hour in the room - Minimum','housing_air_changes_per_hour_in_the_room_minimum'),('IMPC_HOU_017_001','Housing - air changes per hour in the room - Maximum','housing_air_changes_per_hour_in_the_room_maximum'),('IMPC_HOU_018_001','Housing - air changes per hour in the room - Units','housing_air_changes_per_hour_in_the_room_units'),('IMPC_HOU_019_001','Housing - IVC ventilation','housing_ivc_ventilation'),('IMPC_HOU_020_001','Housing - air changes per hour in the IVC unit - Minimum','housing_air_changes_per_hour_in_the_ivc_unit_minimum'),('IMPC_HOU_021_001','Housing - air changes per hour in the IVC unit - Maximum','housing_air_changes_per_hour_in_the_ivc_unit_maximum'),('IMPC_HOU_022_001','Housing - air changes per hour in the IVC unit - Units','housing_air_changes_per_hour_in_the_ivc_unit_units'),('IMPC_HOU_023_001','Housing - light source','housing_light_source'),('IMPC_HOU_024_001','Housing - can you quantify the light intensity range experienced','housing_can_you_quantify_the_light_intensity_range_experienced'),('IMPC_HOU_025_001','Housing - light intensity range - Minimum','housing_light_intensity_range_minimum'),('IMPC_HOU_026_001','Housing - light intensity range - Maximum','housing_light_intensity_range_maximum'),('IMPC_HOU_027_001','Housing - time lights switched on','housing_time_lights_switched_on'),('IMPC_HOU_028_001','Housing - time lights switched off','housing_time_lights_switched_off'),('IMPC_HOU_029_001','Housing - cage manufacturer and racking system','housing_cage_manufacturer_and_racking_system'),('IMPC_HOU_030_001','Housing - cage dimensions - Height','housing_cage_dimensions_height'),('IMPC_HOU_031_001','Housing - cage dimensions - Length','housing_cage_dimensions_length'),('IMPC_HOU_032_001','Housing - cage dimensions - Width','housing_cage_dimensions_width'),('IMPC_HOU_033_001','Housing - animals per cage - Minimum','housing_animals_per_cage_minimum'),('IMPC_HOU_034_001','Housing - animals per cage - Maximum','housing_animals_per_cage_maximum'),('IMPC_HOU_035_001','Housing - bedding type','housing_bedding_type'),('IMPC_HOU_035_002','Housing - bedding type','housing_bedding_type'),('IMPC_HOU_036_001','Housing - bedding pre-treatment','housing_bedding_pre_treatment'),('IMPC_HOU_037_001','Housing - cage enrichment','housing_cage_enrichment'),('IMPC_HOU_037_002','Housing - cage enrichment','housing_cage_enrichment'),('IMPC_HOU_038_001','Housing - frequency of cage cleaning','housing_frequency_of_cage_cleaning'),('IMPC_HOU_039_001','Housing - frequency of handling','housing_frequency_of_handling'),('IMPC_HOU_039_002','Housing - frequency of handling (excluding phenotyping)','housing_frequency_of_handling'),('IMPC_HOU_040_001','Nutrition - supplier and product ID of diet','nutrition_supplier_and_product_id_of_diet'),('IMPC_HOU_041_001','Nutrition - diet type','nutrition_diet_type'),('IMPC_HOU_042_001','Nutrition - do you know the composition of the diet (average based on mass','nutrition_do_you_know_the_composition_of_the_diet_average_based_on_mass'),('IMPC_HOU_043_001','Nutrition - average composition (based on mass) - Carbohydrate','nutrition_average_composition_based_on_mass_carbohydrate'),('IMPC_HOU_043_002','Nutrition - average composition (based on mass) - Carbohydrate','nutrition_average_composition_based_on_mass_carbohydrate'),('IMPC_HOU_044_001','Nutrition - average composition (based on mass) - Fat','nutrition_average_composition_based_on_mass_fat'),('IMPC_HOU_044_002','Nutrition - average composition (based on mass) - Fat','nutrition_average_composition_based_on_mass_fat'),('IMPC_HOU_045_001','Nutrition - average composition (based on mass) - Protein','nutrition_average_composition_based_on_mass_protein'),('IMPC_HOU_045_002','Nutrition - average composition (based on mass) - Protein','nutrition_average_composition_based_on_mass_protein'),('IMPC_HOU_046_001','Nutrition - do you know the composition of the diet (average based on calo','nutrition_do_you_know_the_composition_of_the_diet_average_based_on_calorific_content'),('IMPC_HOU_047_001','Nutrition - average composition (based on calorific content) - Carbohydrat','nutrition_average_composition_based_on_calorific_content_carbohydrate'),('IMPC_HOU_048_001','Nutrition - average composition (based on calorific content) - Fat','nutrition_average_composition_based_on_calorific_content_fat'),('IMPC_HOU_049_001','Nutrition - average composition (based on calorific content) - Protein','nutrition_average_composition_based_on_calorific_content_protein'),('IMPC_HOU_050_001','Nutrition - feeding regime (excluding fasting periods)','nutrition_feeding_regime_excluding_fasting_periods'),('IMPC_HOU_051_001','Nutrition - source of lipids','nutrition_source_of_lipids'),('IMPC_HOU_051_002','Nutrition - source of lipids','nutrition_source_of_lipids'),('IMPC_HOU_052_001','Water - quality monitored','water_quality_monitored'),('IMPC_HOU_053_001','Water - pre-treatment','water_pre_treatment'),('IMPC_HOU_053_002','Water - pre-treatment','water_pre_treatment'),('IMPC_HOU_054_001','Water - schedule (quantity)','water_schedule_quantity'),('IMPC_HOU_055_001','Water - supply method','water_supply_method'),('IMPC_HOU_056_001','Microbiological status - status of your centre','microbiological_status_status_of_your_centre'),('IMPC_HOU_057_001','Microbiological status - method used to protect the status','microbiological_status_method_used_to_protect_the_status'),('IMPC_HOU_058_001','Microbiological status - closed barrier detail','microbiological_status_closed_barrier_detail'),('IMPC_HOU_059_001','Microbiological status - quarantine method','microbiological_status_quarantine_method'),('IMPC_HOU_060_001','Microbiological status - live animals allowed to join the unit','microbiological_status_live_animals_allowed_to_join_the_unit'),('IMPC_HOU_061_001','Microbiological status - acclimation period for live animals - Minimum','microbiological_status_acclimation_period_for_live_animals_minimum'),('IMPC_HOU_062_001','Microbiological status - acclimation period for live animals - Maximum','microbiological_status_acclimation_period_for_live_animals_maximum'),('IMPC_HOU_063_001','Microbiological status - pathogens tested for','microbiological_status_pathogens_tested_for'),('IMPC_HOU_064_001','Microbiological status - is your unit positive for any of the pathogens te','microbiological_status_is_your_unit_positive_for_any_of_the_pathogens_tested'),('IMPC_HOU_065_001','Microbiological status - pathogens your unit is positive for','microbiological_status_pathogens_your_unit_is_positive_for'),('IMPC_HOU_066_001','Nutrition - do you know the source of lipids','NA'),('IMPC_HOU_067_001','Block descriptor','NA'),('IMPC_HOU_068_001','Housing - temperature range','housing_temperature_range'),('IMPC_HOU_069_001','Housing - relative humidity range','housing_relative_humidity_range'),('IMPC_HOU_070_001','Housing - air changes per hour in the room (range)','housing_air_changes_per_hour_in_the_room_range'),('IMPC_HOU_071_001','Housing - air changes per hour in the IVC unit (range)','housing_ivc_ventilation_managed'),('IMPC_HOU_072_001','Housing - light intensity (range)','housing_light_intensity_range'),('IMPC_HOU_073_001','Housing - cage manufacturer','housing_cage_manufacturer'),('IMPC_HOU_074_001','Housing - cage model','housing_cage_model'),('IMPC_HOU_075_001','Housing - Racking system manufacturer','housing_rack_system_manufacturer'),('IMPC_HOU_076_001','Housing - cage dimensions (L x W x H','in mm) , housing_cage_dimensions_lxwxh'),('IMPC_HOU_077_001','Housing - animals per cage - Female maximum','housing_female_animals_per_cage_max'),('IMPC_HOU_078_001','Housing - animals per cage - Female minimum','housing_female_animals_per_cage_min'),('IMPC_HOU_079_001','Housing - animals per cage - Male maximum','housing_male_animals_per_cage_max'),('IMPC_HOU_080_001','Housing - animals per cage - Male minimum','housing_male_animals_per_cage_min'),('IMPC_HOU_081_001','Housing - frequency of animal welfare assessments','housing_frequency_of_animal_welfare_assessments'),('IMPC_HOU_082_001','Nutrition - supplier of diet','nutrition_diet_supplier'),('IMPC_HOU_083_001','Nutrition - product ID of diet','nutrition_product_id'),('IMPC_HOU_084_001','Microbiological status - pathogens testing frequency','microbiological_testing_frequency'),('IMPC_HOU_085_001','Phenotyping lifestage','phenotyping_lifestage'),('IMPC_HOU_086_001','Submission Identifier','NA'),('IMPC_HWT_001_001','Date of sacrifice','NA'),('IMPC_HWT_002_001','Tibia length','tibia_length'),('IMPC_HWT_003_001','Experimenter ID','experimenter'),('IMPC_HWT_005_001','Method of sacrifice','sacrifice'),('IMPC_HWT_006_001','Equipment ID','equipment_name'),('IMPC_HWT_007_001','Body weight','body_weight'),('IMPC_HWT_008_001','Heart weight','heart_weight'),('IMPC_HWT_009_001','Date equipment last calibrated','NA'),('IMPC_HWT_010_001','Equipment manufacturer','NA'),('IMPC_HWT_011_001','Equipment model','NA'),('IMPC_HWT_012_001','Heart weight normalised against body weight','NA'),('IMPC_HWT_013_001','Heart weight normalised against tibia length','NA'),('IMPC_IMM_001_001','Spleen weight','NA'),('IMPC_IMM_001_002','Spleen weight','NA'),('IMPC_IMM_002_001','Percentage of live gated events in Panel A','NA'),('IMPC_IMM_002_002','Live leukocytes (Panel A) -  % of total events','NA'),('IMPC_IMM_003_001','T cells (panel A)','NA'),('IMPC_IMM_003_002','T cells (Panel A) - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_004_001','NKT cells (panel A)','NA'),('IMPC_IMM_004_002','NKT cells (panel A) - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_005_001','NK cells (panel A)','NA'),('IMPC_IMM_005_002','NK cells (Panel A) - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_006_001','Others','NA'),('IMPC_IMM_007_001','CD4 T cells','NA'),('IMPC_IMM_007_002','CD4 T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_008_001','CD8 T cells','NA'),('IMPC_IMM_008_002','CD8+ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_009_001','DN T cells','NA'),('IMPC_IMM_010_001','DP T cells','NA'),('IMPC_IMM_011_001','CD4 NKT cells','NA'),('IMPC_IMM_011_002','CD4+ NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_012_001','CD8 NKT cells','NA'),('IMPC_IMM_013_001','DN NKT cells','NA'),('IMPC_IMM_013_002','CD4- NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_014_001','CD4 CD25+ T cells','NA'),('IMPC_IMM_014_002','Treg cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_015_001','CD4 CD25- T cells','NA'),('IMPC_IMM_015_002','CD4+ T helper cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_016_001','CD8 CD25+ T cells','NA'),('IMPC_IMM_017_001','CD8 CD25- T cells','NA'),('IMPC_IMM_018_001','DN CD25+ T cells','NA'),('IMPC_IMM_019_001','DN CD25- T cells','NA'),('IMPC_IMM_020_001','CD4 CD25+ NKT cells','NA'),('IMPC_IMM_021_001','CD4 CD25- NKT cells','NA'),('IMPC_IMM_022_001','CD8 CD25+ NKT cells','NA'),('IMPC_IMM_023_001','CD8 CD25- NKT cells','NA'),('IMPC_IMM_024_001','DN CD25+ NKT cells','NA'),('IMPC_IMM_025_001','DN CD25- NKT cells','NA'),('IMPC_IMM_026_001','Total number of acquired events in Panel A','NA'),('IMPC_IMM_026_002','Total events (Panel A)','NA'),('IMPC_IMM_027_001','Total number of acquired events in Panel B','NA'),('IMPC_IMM_027_002','Total events (Panel B)','NA'),('IMPC_IMM_028_001','CD4 CD44+CD62L- T cells','NA'),('IMPC_IMM_028_002','Effector CD4+ T helper cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_029_001','CD4 CD44+CD62L+ T cells','NA'),('IMPC_IMM_029_002','Resting CD4+ T helper cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_030_001','CD4 CD44-CD62L+ T cells','NA'),('IMPC_IMM_031_001','CD4 CD44-CD62L- T cells','NA'),('IMPC_IMM_032_001','CD8 CD44+CD62L- T cells','NA'),('IMPC_IMM_032_002','Effector CD8+ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_033_001','CD8 CD44+CD62L+ T cells','NA'),('IMPC_IMM_033_002','NaÃÂ¯ve CD8+ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_034_001','CD8 CD44-CD62L+ T cells','NA'),('IMPC_IMM_034_002','Resting CD8+ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_035_001','CD8 CD44-CD62L- T cells','NA'),('IMPC_IMM_036_001','DN CD44+CD62L- T cells','NA'),('IMPC_IMM_037_001','DN CD44+CD62L+ T cells','NA'),('IMPC_IMM_038_001','DN CD44-CD62L+ T cells','NA'),('IMPC_IMM_039_001','DN CD44-CD62L- T cells','NA'),('IMPC_IMM_040_001','CD4 CD44+CD62L- NKT cells','NA'),('IMPC_IMM_040_002','Effector CD4+ NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_041_001','CD4 CD44+CD62L+ NKT cells','NA'),('IMPC_IMM_041_002','Resting CD4+ NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_042_001','CD4 CD44-CD62L+ NKT cells','NA'),('IMPC_IMM_043_001','CD8 CD44+CD62L- NKT cells','NA'),('IMPC_IMM_044_001','CD8 CD44+CD62L+ NKT cells','NA'),('IMPC_IMM_045_001','CD8 CD44-CD62L+ NKT cells','NA'),('IMPC_IMM_046_001','DN CD44+CD62L- NKT cells','NA'),('IMPC_IMM_046_002','Effector CD4- NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_047_001','DN CD44+CD62L+ NKT cells','NA'),('IMPC_IMM_047_002','Resting CD4- NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_048_001','DN CD44-CD62L+ NKT cells','NA'),('IMPC_IMM_049_001','Percentage of live gated events in Panel B','NA'),('IMPC_IMM_049_002','Live leukocytes (Panel B) -  % of total events (Panel B)','NA'),('IMPC_IMM_050_001','Neutrophils','NA'),('IMPC_IMM_050_002','Granulocytes - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_051_001','Monocytes','NA'),('IMPC_IMM_051_002','Monocytes - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_052_001','Eosinophils','NA'),('IMPC_IMM_052_002','Eosinophils - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_053_001','NK Cells (panel B)','NA'),('IMPC_IMM_053_002','NK cells (Panel B) - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_054_001','NK Subsets (Q1)','NA'),('IMPC_IMM_054_002','Ly6C+ CD11b- NK cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_055_001','NK Subsets (Q2)','NA'),('IMPC_IMM_055_002','Ly6C+ CD11b+ NK cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_056_001','NK Subsets (Q3)','NA'),('IMPC_IMM_056_002','CD11b- NK cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_057_001','NK Subsets (Q4)','NA'),('IMPC_IMM_057_002','CD11b+ NK cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_058_001','NKT Cells (panel B)','NA'),('IMPC_IMM_058_002','NKT cells (panel B) - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_059_001','NKT Subsets (Q1)','NA'),('IMPC_IMM_059_002','Ly6C+ NKT cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_060_001','NKT Subsets (Q3)','NA'),('IMPC_IMM_061_001','T Cells (panel B)','NA'),('IMPC_IMM_061_002','T cells (panel B) - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_062_001','T Subset','NA'),('IMPC_IMM_063_001','B Cells','NA'),('IMPC_IMM_063_002','B cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_064_001','B1B Cells','NA'),('IMPC_IMM_065_001','B2B Cells','NA'),('IMPC_IMM_066_001','Follicular B Cells','NA'),('IMPC_IMM_067_001','Follicular B Cells (CD21/35+)','NA'),('IMPC_IMM_067_002','Follicular B cells  - % of B cells (Panel B)','NA'),('IMPC_IMM_068_001','Transitional B Cells','NA'),('IMPC_IMM_069_001','Transitional B Cells (CD21/35 low)','NA'),('IMPC_IMM_070_001','MZB','NA'),('IMPC_IMM_071_001','MZB (CD21/35 high)','NA'),('IMPC_IMM_071_002','Marginal zone B cells  - % of B cells (Panel B)','NA'),('IMPC_IMM_072_001','cDCs','NA'),('IMPC_IMM_072_002','Conventional DC - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_073_001','cDCs CD11b Type','NA'),('IMPC_IMM_074_001','pDCs','NA'),('IMPC_IMM_074_002','Plasmacytoid DC- % of live leukocytes (Panel B)','NA'),('IMPC_IMM_075_001','RP Macrophage (F4/80+)','NA'),('IMPC_IMM_075_002','Macrophages- % of live leukocytes (Panel B)','NA'),('IMPC_IMM_076_001','RP Macrophage (CD19-  CD11c-)','NA'),('IMPC_IMM_077_001','Equipment name','NA'),('IMPC_IMM_077_002','Equipment name','NA'),('IMPC_IMM_078_001','Equipment manufacturer','NA'),('IMPC_IMM_078_002','Equipment manufacturer','NA'),('IMPC_IMM_079_001','Equipment model','NA'),('IMPC_IMM_079_002','Equipment model','NA'),('IMPC_IMM_080_001','CS&T Bead lot','NA'),('IMPC_IMM_080_002','CS&T Bead lot','NA'),('IMPC_IMM_081_001','Anesthesia','NA'),('IMPC_IMM_081_002','Anesthesia','NA'),('IMPC_IMM_082_001','Cell digestion','NA'),('IMPC_IMM_082_002','Cell digestion','NA'),('IMPC_IMM_083_001','Cell digestion agent','NA'),('IMPC_IMM_083_002','Cell digestion agent','NA'),('IMPC_IMM_084_001','Cell digestion agent manufacturer','NA'),('IMPC_IMM_084_002','Cell digestion agent manufacturer','NA'),('IMPC_IMM_085_001','Cell digestion agent catalog number','NA'),('IMPC_IMM_085_002','Cell digestion agent catalog number','NA'),('IMPC_IMM_086_001','Cell counting','NA'),('IMPC_IMM_086_002','Cell counting performed','NA'),('IMPC_IMM_087_001','Cell counting equipment manufacturer','NA'),('IMPC_IMM_087_002','Cell counting equipment manufacturer','NA'),('IMPC_IMM_088_001','Cell counting equipment model','NA'),('IMPC_IMM_088_002','Cell counting equipment model','NA'),('IMPC_IMM_089_001','Cell counting equipment name','NA'),('IMPC_IMM_089_002','Cell counting equipment name','NA'),('IMPC_IMM_090_001','Cell lysis buffer manufacturer','NA'),('IMPC_IMM_090_002','Cell lysis buffer manufacturer','NA'),('IMPC_IMM_091_001','Cell lysis buffer catalog number','NA'),('IMPC_IMM_091_002','Cell lysis buffer catalog number','NA'),('IMPC_IMM_092_001','Date and time of sacrifice','NA'),('IMPC_IMM_092_002','Date and time of sacrifice','NA'),('IMPC_IMM_093_001','Date and time of sample preparation','NA'),('IMPC_IMM_093_002','Date and time of sample preparation','NA'),('IMPC_IMM_094_001','Sample storage temperature until analysis (in Celsius)','NA'),('IMPC_IMM_094_002','Sample storage temperature until analysis (in Celsius)','NA'),('IMPC_IMM_095_001','FCS repository reference (URL/ID)','NA'),('IMPC_IMM_095_002','FCS repository reference (URL/ID)','NA'),('IMPC_IMM_096_001','Balanced salt solution type','NA'),('IMPC_IMM_096_002','Balanced salt solution type','NA'),('IMPC_IMM_097_001','Balanced salt solution manufacturer','NA'),('IMPC_IMM_097_002','Balanced salt solution manufacturer','NA'),('IMPC_IMM_098_001','Balanced salt solution catalog number','NA'),('IMPC_IMM_098_002','Balanced salt solution catalog number','NA'),('IMPC_IMM_099_001','RPMI manufacturer','NA'),('IMPC_IMM_099_002','RPMI manufacturer','NA'),('IMPC_IMM_100_001','RPMI catalog number','NA'),('IMPC_IMM_100_002','RPMI catalog number','NA'),('IMPC_IMM_101_001','DNAse I manufacturer','NA'),('IMPC_IMM_101_002','DNAse I manufacturer','NA'),('IMPC_IMM_102_001','DNAse I catalog number','NA'),('IMPC_IMM_102_002','DNAse I catalog number','NA'),('IMPC_IMM_103_001','Dead cell exclusion dye','NA'),('IMPC_IMM_103_002','Dead cell exclusion dye','NA'),('IMPC_IMM_104_001','Dead cell exclusion dye manufacturer','NA'),('IMPC_IMM_104_002','Dead cell exclusion dye manufacturer','NA'),('IMPC_IMM_105_001','Dead cell exclusion dye catalog number','NA'),('IMPC_IMM_105_002','Dead cell exclusion dye catalog number','NA'),('IMPC_IMM_106_001','Cell digestion temperature (in Celsius)','NA'),('IMPC_IMM_106_002','Cell digestion temperature (in Celsius)','NA'),('IMPC_IMM_107_001','Panel A FCS file(s)','NA'),('IMPC_IMM_107_002','Panel A FCS file(s)','NA'),('IMPC_IMM_108_001','Panel B FCS file(s)','NA'),('IMPC_IMM_108_002','Panel B FCS file(s)','NA'),('IMPC_IMM_109_001','Automated analysis','NA'),('IMPC_IMM_109_002','Automated analysis','NA'),('IMPC_IMM_110_001','Collection buffer manufacturer','NA'),('IMPC_IMM_110_002','Collection buffer manufacturer','NA'),('IMPC_IMM_111_001','Collection buffer catalog number number','NA'),('IMPC_IMM_111_002','Collection buffer catalog number number','NA'),('IMPC_IMM_112_001','FACS buffer manufacturer','NA'),('IMPC_IMM_112_002','FACS buffer manufacturer','NA'),('IMPC_IMM_113_001','FACS buffer catalog number','NA'),('IMPC_IMM_113_002','FACS buffer catalog number','NA'),('IMPC_IMM_114_001','Enzyme buffer manufacturer','NA'),('IMPC_IMM_114_002','Enzyme buffer manufacturer','NA'),('IMPC_IMM_115_001','Enzyme buffer catalog number','NA'),('IMPC_IMM_115_002','Enzyme buffer catalog number','NA'),('IMPC_IMM_116_001','Total spleen leukocyte count','NA'),('IMPC_IMM_117_001','Clog- events (Panel A)','NA'),('IMPC_IMM_118_001','FSC/SSC Singlets (Panel A)','NA'),('IMPC_IMM_119_001','Effector NK cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_120_001','Effector Treg cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_121_001','Effector γδ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_122_001','Klrg1+ CD4- NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_123_001','Klrg1+ CD4+ NKT cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_124_001','Klrg1+ CD4+ T helper cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_125_001','Klrg1+ CD8 T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_126_001','Klrg1+ NK cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_127_001','Klrg1+ Treg cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_128_001','Klrg1+ γδ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_129_001','Resting NK cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_130_001','Resting Treg cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_131_001','Resting γδ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_132_001','αβ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_133_001','γδ T cells - % of live leukocytes (Panel A)','NA'),('IMPC_IMM_134_001','CD4- NKT cells - % of NKT cells (Panel A)','NA'),('IMPC_IMM_135_001','CD4+ NKT cells - % of NKT cells (Panel A)','NA'),('IMPC_IMM_136_001','CD4+ T cells - % of T cells','NA'),('IMPC_IMM_137_001','CD4+ T helper cells - % of CD4 T cells','NA'),('IMPC_IMM_138_001','CD8+ T cells - % of T cells','NA'),('IMPC_IMM_139_001','Effector CD4- NKT cells  - % of CD4- NKT cells','NA'),('IMPC_IMM_140_001','Effector CD4+ NKT cells  - % of CD4+ NKT cells','NA'),('IMPC_IMM_141_001','Effector CD4+ T helper cells - % of CD4+ T helper cells','NA'),('IMPC_IMM_142_001','Effector CD8+ T cells - % of CD8+ T cells','NA'),('IMPC_IMM_143_001','Effector NK cells - % of NK cells (Panel A)','NA'),('IMPC_IMM_144_001','Effector Treg cells - % of Treg cells','NA'),('IMPC_IMM_145_001','Effector γδ T cells - % of γδ T cells','NA'),('IMPC_IMM_146_001','Klrg1+ CD4- NKT cells  - % of CD4- NKT cells','NA'),('IMPC_IMM_147_001','Klrg1+ CD4+ NKT cells  - % of CD4+ NKT cells','NA'),('IMPC_IMM_148_001','Klrg1+ CD4+ T helper cells  - % of CD4+ T helper cells','NA'),('IMPC_IMM_149_001','Klrg1+ CD8 T cells - % of CD8+ T cells','NA'),('IMPC_IMM_150_001','Klrg1+ NK cells - % of NK cells (Panel A)','NA'),('IMPC_IMM_151_001','Klrg1+ Treg cells - % of Treg cells','NA'),('IMPC_IMM_152_001','Klrg1+ γδ T cells - % of γδ T cells','NA'),('IMPC_IMM_153_001','Naïve CD8+ T cells - % of CD8+ T cells','NA'),('IMPC_IMM_154_001','Resting CD4- NKT cells  - % of CD4- NKT cells','NA'),('IMPC_IMM_155_001','Resting CD4+ NKT cells  - % of CD4+ NKT cells','NA'),('IMPC_IMM_156_001','Resting CD4+ T helper cells  - % of CD4+ T helper cells','NA'),('IMPC_IMM_157_001','Resting CD8+ T cells - % of CD8+ T cells','NA'),('IMPC_IMM_158_001','Resting NK cells - % of NK cells (Panel A)','NA'),('IMPC_IMM_159_001','Resting Treg cells - % of Treg cells','NA'),('IMPC_IMM_160_001','Resting γδ T cells - % of γδ T cells','NA'),('IMPC_IMM_161_001','Treg cells - % of CD4 T cells','NA'),('IMPC_IMM_162_001','Clog- events (Panel B)','NA'),('IMPC_IMM_163_001','FSC/SSC Singlets (Panel B)','NA'),('IMPC_IMM_164_001','B1a cells  - % of B cells (Panel B)','NA'),('IMPC_IMM_165_001','B1b cells  - % of B cells (Panel B)','NA'),('IMPC_IMM_166_001','CD11b-high cDC - % of conventional DC (Panel B)','NA'),('IMPC_IMM_167_001','CD11b-low cDC - % of conventional DC (Panel B)','NA'),('IMPC_IMM_168_001','CD161+ B cells - % of live leukocytes (Panel B)','NA'),('IMPC_IMM_169_001','Transitional 1 B cells  - % of B cells (Panel B)','NA'),('IMPC_IMM_170_001','Transitional 2 B cells  - % of B cells (Panel B)','NA'),('IMPC_IMM_171_001','CD11b- NK cells - % of NK cells (Panel B)','NA'),('IMPC_IMM_172_001','CD11b+ NK cells - % of NK cells (Panel B)','NA'),('IMPC_IMM_173_001','CD161+ B cells - % of B cells','NA'),('IMPC_IMM_174_001','Follicular B cells  - % of B cells','NA'),('IMPC_IMM_175_001','Ly6C+ CD11b- NK cells - % of NK cells (Panel B)','NA'),('IMPC_IMM_176_001','Ly6C+ CD11b+ NK cells - % of NK cells (Panel B)','NA'),('IMPC_IMM_177_001','Ly6C+ NKT cells - % of NKT cells (Panel B)','NA'),('IMPC_IMM_178_001','Marginal zone B cells  - % of B cells','NA'),('IMPC_IMM_179_001','Transitional 1 Bcells  - % of B cells','NA'),('IMPC_IMM_180_001','Transitional 2 B cells  - % of B cells','NA'),('IMPC_IMM_181_001','T cells (Panel A) - cell count','NA'),('IMPC_IMM_182_001','αβ T cells - cell count','NA'),('IMPC_IMM_183_001','CD8+ T cells - cell count','NA'),('IMPC_IMM_184_001','Effector CD8+ T cells - cell count','NA'),('IMPC_IMM_185_001','Resting CD8+ T cells - cell count','NA'),('IMPC_IMM_186_001','Naïve CD8+ T cells - cell count','NA'),('IMPC_IMM_187_001','Klrg1+ CD8 T cells - cell count','NA'),('IMPC_IMM_188_001','CD4 T cells - cell count','NA'),('IMPC_IMM_189_001','CD4+ T helper cells - cell count','NA'),('IMPC_IMM_190_001','Effector CD4+ T helper cells - cell count','NA'),('IMPC_IMM_191_001','Resting CD4+ T helper cells - cell count','NA'),('IMPC_IMM_192_001','Klrg1+ CD4+ T helper cells - cell count','NA'),('IMPC_IMM_193_001','Treg cells - cell count','NA'),('IMPC_IMM_194_001','Effector Treg cells - cell count','NA'),('IMPC_IMM_195_001','Resting Treg cells - cell count','NA'),('IMPC_IMM_196_001','Klrg1+ Treg cells - cell count','NA'),('IMPC_IMM_197_001','γδ T cells - cell count','NA'),('IMPC_IMM_198_001','Effector γδ T cells - cell count','NA'),('IMPC_IMM_199_001','Resting γδ T cells - cell count','NA'),('IMPC_IMM_200_001','Klrg1+ γδ T cells - cell count','NA'),('IMPC_IMM_201_001','NKT cells (panel A) - cell count','NA'),('IMPC_IMM_202_001','CD4+ NKT cells - cell count','NA'),('IMPC_IMM_203_001','Effector CD4+ NKT cells - cell count','NA'),('IMPC_IMM_204_001','Resting CD4+ NKT cells - cell count','NA'),('IMPC_IMM_205_001','Klrg1+ CD4+ NKT cells - cell count','NA'),('IMPC_IMM_206_001','CD4- NKT cells - cell count','NA'),('IMPC_IMM_207_001','Effector CD4- NKT cells - cell count','NA'),('IMPC_IMM_208_001','Resting CD4- NKT cells - cell count','NA'),('IMPC_IMM_209_001','Klrg1+ CD4- NKT cells - cell count','NA'),('IMPC_IMM_210_001','NK cells (Panel A) - cell count','NA'),('IMPC_IMM_211_001','Effector NK cells - cell count','NA'),('IMPC_IMM_212_001','Resting NK cells - cell count','NA'),('IMPC_IMM_213_001','Klrg1+ NK cells - cell count','NA'),('IMPC_IMM_214_001','T cells (panel B) - cell count','NA'),('IMPC_IMM_215_001','NKT cells (panel B) - cell count','NA'),('IMPC_IMM_216_001','Ly6C+ NKT cells - cell count','NA'),('IMPC_IMM_217_001','NK cells (Panel B) - cell count','NA'),('IMPC_IMM_218_001','CD11b- NK cells - cell count','NA'),('IMPC_IMM_219_001','Ly6C+ CD11b- NK cells - cell count','NA'),('IMPC_IMM_220_001','CD11b+ NK cells - cell count','NA'),('IMPC_IMM_221_001','Ly6C+ CD11b+ NK cells - cell count','NA'),('IMPC_IMM_222_001','B cells - cell count','NA'),('IMPC_IMM_223_001','B1a cells - cell count','NA'),('IMPC_IMM_224_001','B1b cells - cell count','NA'),('IMPC_IMM_225_001','Follicular B cells - cell count','NA'),('IMPC_IMM_226_001','Marginal zone B cells - cell count','NA'),('IMPC_IMM_227_001','Transitional 1 B cells - cell count','NA'),('IMPC_IMM_228_001','Transitional 2 B cells - cell count','NA'),('IMPC_IMM_229_001','CD161+ B cells - cell count','NA'),('IMPC_IMM_230_001','Conventional DC - cell count','NA'),('IMPC_IMM_231_001','CD11b-low cDC - cell count','NA'),('IMPC_IMM_232_001','CD11b-high cDC - cell count','NA'),('IMPC_IMM_233_001','Plasmacytoid DC - cell count','NA'),('IMPC_IMM_234_001','Macrophages - cell count','NA'),('IMPC_IMM_235_001','Monocytes - cell count','NA'),('IMPC_IMM_236_001','Granulocytes - cell count','NA'),('IMPC_IMM_237_001','Eosinophils - cell count','NA'),('IMPC_IMM_238_001','Panel A anti-CD5 clone','NA'),('IMPC_IMM_239_001','Panel A anti-CD5 fluorochrome','NA'),('IMPC_IMM_240_001','Panel A anti-CD5 RRID','NA'),('IMPC_IMM_241_001','Panel A anti-CD4 clone','NA'),('IMPC_IMM_242_001','Panel A anti-CD4 fluorochrome','NA'),('IMPC_IMM_243_001','Panel A anti-CD4 RRID','NA'),('IMPC_IMM_244_001','Panel A anti-CD44 clone','NA'),('IMPC_IMM_245_001','Panel A anti-CD44 fluorochrome','NA'),('IMPC_IMM_246_001','Panel A anti-CD44 RRID','NA'),('IMPC_IMM_247_001','Panel A anti-CD8a clone','NA'),('IMPC_IMM_248_001','Panel A anti-CD8a fluorochrome','NA'),('IMPC_IMM_249_001','Panel A anti-CD8a RRID','NA'),('IMPC_IMM_250_001','Panel A anti-CD25 clone','NA'),('IMPC_IMM_251_001','Panel A anti-CD25 fluorochrome','NA'),('IMPC_IMM_252_001','Panel A anti-CD25 RRID','NA'),('IMPC_IMM_253_001','Panel A anti-CD161 clone','NA'),('IMPC_IMM_254_001','Panel A anti-CD161 fluorochrome','NA'),('IMPC_IMM_255_001','Panel A anti-CD161 RRID','NA'),('IMPC_IMM_256_001','Panel A anti-CD62L clone','NA'),('IMPC_IMM_257_001','Panel A anti-CD62L fluorochrome','NA'),('IMPC_IMM_258_001','Panel A anti-CD62L RRID','NA'),('IMPC_IMM_259_001','Panel A Live/Dead stain','NA'),('IMPC_IMM_260_001','Panel A additional maker 1 name','NA'),('IMPC_IMM_261_001','Panel A additional marker 1 clone','NA'),('IMPC_IMM_262_001','Panel A additional marker 1 fluorochrome','NA'),('IMPC_IMM_263_001','Panel A additional marker 1 RRID','NA'),('IMPC_IMM_264_001','Panel A additional maker 2 name','NA'),('IMPC_IMM_265_001','Panel A additional marker 2 clone','NA'),('IMPC_IMM_266_001','Panel A additional marker 2 fluorochrome','NA'),('IMPC_IMM_267_001','Panel A additional marker 2 RRID','NA'),('IMPC_IMM_268_001','Panel A additional maker 3 name','NA'),('IMPC_IMM_269_001','Panel A additional marker 3 clone','NA'),('IMPC_IMM_270_001','Panel A additional marker 3 fluorochrome','NA'),('IMPC_IMM_271_001','Panel A additional marker 3 RRID','NA'),('IMPC_IMM_272_001','Panel A additional maker 4 name','NA'),('IMPC_IMM_273_001','Panel A additional marker 4 clone','NA'),('IMPC_IMM_274_001','Panel A additional marker 4 fluorochrome','NA'),('IMPC_IMM_275_001','Panel A additional marker 4 RRID','NA'),('IMPC_IMM_276_001','Panel A additional maker 5 name','NA'),('IMPC_IMM_277_001','Panel A additional marker 5 clone','NA'),('IMPC_IMM_278_001','Panel A additional marker 5 fluorochrome','NA'),('IMPC_IMM_279_001','Panel A additional marker 5 RRID','NA'),('IMPC_IMM_280_001','Panel B anti-CD5 clone','NA'),('IMPC_IMM_281_001','Panel B anti-CD5 fluorochrome','NA'),('IMPC_IMM_282_001','Panel B anti-CD5 RRID','NA'),('IMPC_IMM_283_001','Panel B anti-Ly6G clone','NA'),('IMPC_IMM_284_001','Panel B anti-Ly6G fluorochrome','NA'),('IMPC_IMM_285_001','Panel B anti-Ly6G RRID','NA'),('IMPC_IMM_286_001','Panel B anti-CD19 clone','NA'),('IMPC_IMM_287_001','Panel B anti-CD19 fluorochrome','NA'),('IMPC_IMM_288_001','Panel B anti-CD19 RRID','NA'),('IMPC_IMM_289_001','Panel B anti-Ly6C clone','NA'),('IMPC_IMM_290_001','Panel B anti-Ly6c fluorochrome','NA'),('IMPC_IMM_291_001','Panel B anti-Ly6c RRID','NA'),('IMPC_IMM_292_001','Panel B anti-CD21/35 clone','NA'),('IMPC_IMM_293_001','Panel B anti-CD21/35 fluorochrome','NA'),('IMPC_IMM_294_001','Panel B anti-CD21/35 RRID','NA'),('IMPC_IMM_295_001','Panel B anti-CD11b clone','NA'),('IMPC_IMM_296_001','Panel B anti-CD11b fluorochrome','NA'),('IMPC_IMM_297_001','Panel B anti-CD11b RRID','NA'),('IMPC_IMM_298_001','Panel B anti-CD11c clone','NA'),('IMPC_IMM_299_001','Panel B anti-CD11c fluorochrome','NA'),('IMPC_IMM_300_001','Panel B anti-CD11c RRID','NA'),('IMPC_IMM_301_001','Panel B anti-CD161 clone','NA'),('IMPC_IMM_302_001','Panel B anti-CD161 fluorochrome','NA'),('IMPC_IMM_303_001','Panel B anti-CD161 RRID','NA'),('IMPC_IMM_304_001','Panel B anti-MHCII clone','NA'),('IMPC_IMM_305_001','Panel B anti-MHCII fluorochrome','NA'),('IMPC_IMM_306_001','Panel B anti-MHCII RRID','NA'),('IMPC_IMM_307_001','Panel B Live/Dead stain','NA'),('IMPC_IMM_308_001','Panel B additional maker 1 name','NA'),('IMPC_IMM_309_001','Panel B additional marker 1 clone','NA'),('IMPC_IMM_310_001','Panel B additional marker 1 fluorochrome','NA'),('IMPC_IMM_311_001','Panel B additional marker 1 RRID','NA'),('IMPC_IMM_312_001','Panel B additional maker 2 name','NA'),('IMPC_IMM_313_001','Panel B additional marker 2 clone','NA'),('IMPC_IMM_314_001','Panel B additional marker 2 fluorochrome','NA'),('IMPC_IMM_315_001','Panel B additional marker 2 RRID','NA'),('IMPC_IMM_316_001','Panel B additional maker 3 name','NA'),('IMPC_IMM_317_001','Panel B additional marker 3 clone','NA'),('IMPC_IMM_318_001','Panel B additional marker 3 fluorochrome','NA'),('IMPC_IMM_319_001','Panel B additional marker 3 RRID','NA'),('IMPC_IMM_320_001','Panel B additional maker 4 name','NA'),('IMPC_IMM_321_001','Panel B additional marker 4 clone','NA'),('IMPC_IMM_322_001','Panel B additional marker 4 fluorochrome','NA'),('IMPC_IMM_323_001','Panel B additional marker 4 RRID','NA'),('IMPC_IMM_324_001','Panel B additional maker 5 name','NA'),('IMPC_IMM_325_001','Panel B additional marker 5 clone','NA'),('IMPC_IMM_326_001','Panel B additional marker 5 fluorochrome','NA'),('IMPC_IMM_327_001','Panel B additional marker 5 RRID','NA'),('IMPC_IMM_328_001','Analysis results file','A csv file with the analysis results for the mutant line'),('IMPC_INS_001_001','Insulin','insulin'),('IMPC_INS_002_001','Type of kit','type_of_kit'),('IMPC_INS_003_001','Kit manufacturer','kit_manufacturer'),('IMPC_INS_004_001','Kit lot number','kit_lot_number'),('IMPC_INS_005_001','Equipment ID','equipment_id'),('IMPC_INS_006_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_INS_007_001','Equipment model','equipment_model'),('IMPC_INS_008_001','Blood collection tubes','blood_collection_tubes'),('IMPC_INS_009_001','Anesthesia used for blood collection','anesthesia_used_for_blood_collection'),('IMPC_INS_010_001','Method of blood collection','method_of_blood_collection'),('IMPC_INS_011_001','Anticoagulant','anticoagulant'),('IMPC_INS_012_001','Date and time of blood collection','date_and_time_of_blood_collection'),('IMPC_INS_013_001','Date of measurement','date_of_measurement'),('IMPC_INS_014_001','Sample status','sample_status'),('IMPC_INS_015_001','Samples kept on ice between collection and analysis','samples_kept_on_ice_between_collection_and_analysis'),('IMPC_INS_016_001','Sample dilution','sample_dilution'),('IMPC_INS_017_001','Replicates','replicates'),('IMPC_INS_018_001','ID of blood collection SOP','id_of_blood_collection_sop'),('IMPC_INS_019_001','Hemolysis status','hemolysis_status'),('IMPC_INS_020_001','Blood collection experimenter ID','blood_collection_experimenter_id'),('IMPC_INS_021_001','Blood analysis experimenter ID','blood_analysis_experimenter_id'),('IMPC_INS_022_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_INS_023_001','Sample type','NA'),('IMPC_IPG_001_001','Body Weight','body_weight'),('IMPC_IPG_002_001','Blood glucose concentration','blood_glucose_concentration'),('IMPC_IPG_003_001','Equipment ID','equipment_name'),('IMPC_IPG_004_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_IPG_005_001','Equipment model','equipment_model'),('IMPC_IPG_006_001','Mouse restrained','mouse_restrained'),('IMPC_IPG_007_001','Type of strip','type_of_strip'),('IMPC_IPG_008_001','Experimenter ID','NA'),('IMPC_IPG_009_001','Date equipment last calibrated','NA'),('IMPC_IPG_010_001','Fasted blood glucose concentration','NA'),('IMPC_IPG_011_001','Initial response to glucose challenge','NA'),('IMPC_IPG_012_001','Area under glucose response curve','NA'),('IMPC_IPG_013_001','Upper limit of the meter','NA'),('IMPC_LDT_001_001','Side changes','side_changes'),('IMPC_LDT_002_001','Light side time spent','light_side_time_spent'),('IMPC_LDT_003_001','Time mobile light side','time_mobile_light_side'),('IMPC_LDT_004_001','Dark side time spent','dark_side_time_spent'),('IMPC_LDT_005_001','Time mobile dark side','time_mobile_dark_side'),('IMPC_LDT_006_001','Latency to first transition into dark','latency_to_first_transition_into_dark'),('IMPC_LDT_007_001','Percent time in dark','percent_time_in_dark'),('IMPC_LDT_008_001','Percent time in light','percent_time_in_light'),('IMPC_LDT_009_001','Transition','transition'),('IMPC_LDT_010_001','Light side distance travelled','light_side_distance_travelled'),('IMPC_LDT_011_001','Dark side distance travelled','dark_side_distance_travelled'),('IMPC_LDT_012_001','Vertical activity (rearing)','vertical_activity_rearing'),('IMPC_LDT_013_001','Horizontal activity','horizontal_activity'),('IMPC_LDT_014_001','Repetitive beam break (\'stereotypy counts\')','repetitive_beam_break_stereotypy_counts'),('IMPC_LDT_015_001','Total distance travelled','total_distance_travelled'),('IMPC_LDT_016_001','Light level light chamber','light_level_light_chamber'),('IMPC_LDT_017_001','Light level dark chamber','light_level_dark_chamber'),('IMPC_LDT_018_001','Experimenter ID','experimenter_id'),('IMPC_LDT_019_001','Start time','start_time'),('IMPC_LDT_020_001','Arena ID','arena_id'),('IMPC_LDT_021_001','Arena version','arena_version'),('IMPC_LDT_022_001','Equipment ID','equipment_id'),('IMPC_LDT_023_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_LDT_024_001','Equipment model','equipment_model'),('IMPC_LDT_025_001','Disinfectant','disinfectant'),('IMPC_LDT_026_001','Starting position','starting_position'),('IMPC_LDT_027_001','Light-Dark box\'s walls opaque','light_dark_box_s_walls_opaque'),('IMPC_LDT_028_001','Light-Dark box set-up','light_dark_box_set_up'),('IMPC_LDT_029_001','Light side arena dimensions (L x W x H','in mm), light_side_arena_dimensions_l_x_w_x_h_in_mm'),('IMPC_LDT_030_001','Dark side arena dimensions (L x W x H','in mm), dark_side_arena_dimensions_l_x_w_x_h_in_mm'),('IMPC_LDT_031_001','Entry way dimensions (L x W x H','in mm), entry_way_dimensions_l_x_w_x_h_in_mm'),('IMPC_LDT_032_001','Time spent in the light side in the first 5 minutes','NA'),('IMPC_LDT_033_001','Test duration','NA'),('IMPC_LDT_034_001','Software version','NA'),('IMPC_MAA_001_001','Population average','NA'),('IMPC_MAA_002_001','T-statistics determinents','NA'),('IMPC_MAA_003_001','T-statistics intensities','NA'),('IMPC_MAA_004_001','FDR thresholds for determinents','NA'),('IMPC_MAA_005_001','FDR thresholds for intensities','NA'),('IMPC_MAA_006_001','Used WT specimen names','NA'),('IMPC_MAA_007_001','Used MUT specimen names','NA'),('IMPC_MAA_008_001','Version of pydpiper','NA'),('IMPC_MAA_009_001','Data analysis finished','NA'),('IMPC_OFD_001_001','Whole arena resting time series','NA'),('IMPC_OFD_002_001','Whole arena average speed series','NA'),('IMPC_OFD_003_001','Periphery distance travelled series','NA'),('IMPC_OFD_004_001','Periphery resting time series','NA'),('IMPC_OFD_005_001','Distance travelled','distance_travelled'),('IMPC_OFD_006_001','Number of Rears','number_of_rears'),('IMPC_OFD_007_001','Whole arena resting time','whole_arena_resting_time'),('IMPC_OFD_008_001','Whole arena permanence','whole_arena_permanence'),('IMPC_OFD_009_001','Whole arena average speed','whole_arena_average_speed'),('IMPC_OFD_010_001','Periphery distance travelled','periphery_distance_travelled'),('IMPC_OFD_011_001','Periphery resting time','periphery_resting_time'),('IMPC_OFD_012_001','Periphery permanence time','periphery_permanence_time'),('IMPC_OFD_013_001','Periphery average speed','periphery_average_speed'),('IMPC_OFD_014_001','Center distance travelled','center_distance_travelled'),('IMPC_OFD_015_001','Center resting time','center_resting_time'),('IMPC_OFD_016_001','Center permanence time','center_permanence_time'),('IMPC_OFD_017_001','Center average speed','center_average_speed'),('IMPC_OFD_018_001','Latency to center entry','latency_to_center_entry'),('IMPC_OFD_019_001','Number of center entries','number_of_center_entries'),('IMPC_OFD_020_001','Distance travelled - total','distance_travelled_total'),('IMPC_OFD_021_001','Number of rears - total','number_of_rears_total'),('IMPC_OFD_022_001','Percentage center time','percentage_center_time'),('IMPC_OFD_023_001','Equipment ID','equipment_name'),('IMPC_OFD_024_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_OFD_025_001','Equipment model','equipment_model'),('IMPC_OFD_026_001','Central zone surface area','central_zone_surface_area'),('IMPC_OFD_027_001','Light intensity in the centre of the arena','light_intensity_in_the_centre_of_the_arena'),('IMPC_OFD_028_001','Number of animals per cage','number_of_animals_per_cage'),('IMPC_OFD_029_001','Color of arena','color_of_arena'),('IMPC_OFD_030_001','Height of the wall','height_of_the_wall'),('IMPC_OFD_031_001','Distance from light source: if direct illumination','distance_from_light_source_if_direct_illuminaton'),('IMPC_OFD_032_001','Periphery zone','periphery_zone'),('IMPC_OFD_033_001','Type of analysis','type_of_analysis'),('IMPC_OFD_034_001','Arena Size','arena_size'),('IMPC_OFD_035_001','Experimenter ID','experimenter'),('IMPC_OFD_036_001','Disinfectant','disinfectant'),('IMPC_OFD_037_001','Start Time','start_time'),('IMPC_OFD_038_001','Arena ID','arena_id'),('IMPC_OFD_039_001','Software Version','software_version'),('IMPC_OFD_040_001','Arena Material','arena_material'),('IMPC_OFD_041_001','Date equipment last calibrated','NA'),('IMPC_OFD_042_001','Periphery permanence time series','NA'),('IMPC_OFD_043_001','Periphery average speed series','NA'),('IMPC_OFD_044_001','Center distance travelled series','NA'),('IMPC_OFD_045_001','Center resting time series','NA'),('IMPC_OFD_046_001','Center permanence time series','NA'),('IMPC_OFD_047_001','Center average speed series','NA'),('IMPC_OFD_048_001','Number of center entries series','NA'),('IMPC_OFD_049_001','Light beam barrier height (Z axis)','height of the Z axis light beam used to determine when mouse is rearing'),('IMPC_OFD_050_001','Percentage center movement time','percentage_center_movement_time'),('IMPC_OFD_051_001','Resting definition threshold','Parameter measuring how the equipment defines a \'resting\' animal'),('IMPC_OFD_052_001','Rearing definition threshold','Parameter measuring how the equipment defines a \'rearing\' animal'),('IMPC_OWT_001_001','Body weight','body_weight'),('IMPC_OWT_002_001','Spleen weight','spleen_weight'),('IMPC_OWT_003_001','Left kidney weight','left_kidney_weight'),('IMPC_OWT_004_001','Right kidney weight','right_kidney_weight'),('IMPC_OWT_005_001','Epididymis weight','epididymis_weight'),('IMPC_OWT_007_001','Seminal vesicle weight','seminal_vesicle_weight'),('IMPC_OWT_008_001','Spleen weight to body weight ratio','spleen_weight_to_body_weight_ratio'),('IMPC_OWT_009_001','Left kidney weight to body weight ratio','left_kidney_weight_to_body_weight_ratio'),('IMPC_OWT_010_001','Right kidney weight to body weight ratio','right_kidney_weight_to_body_weight_ratio'),('IMPC_OWT_012_001','Epididymis weight to body weight ratio','epididymis_weight_to_body_weight_ratio'),('IMPC_OWT_013_001','Seminal vesicle weight to body weight ratio','seminal_vesicle_weight_to_body_weight_ratio'),('IMPC_OWT_014_001','Experimenter ID','experimenter_id'),('IMPC_OWT_015_001','Date of sacrifice','date_of_sacrifice'),('IMPC_OWT_016_001','Method of sacrifice','method_of_sacrifice'),('IMPC_OWT_017_001','Equipment ID','equipment_id'),('IMPC_OWT_018_001','Date equipment last calibrated','date_equipment_last_calibrated'),('IMPC_OWT_019_001','Equipment manufacturer','equipment_manufacturer'),('IMPC_OWT_020_001','Equipment model','equipment_model'),('IMPC_OWT_021_001','Left testis weight','left_testis_weight'),('IMPC_OWT_022_001','Right testis weight','right_testis_weight'),('IMPC_OWT_023_001','Whole liver weight','whole_liver_weight'),('IMPC_OWT_024_001','Right lung all lobes weight','right_lung_all_lobes_weight'),('IMPC_OWT_025_001','Left lung weight','left_lung_weight'),('IMPC_OWT_026_001','Left testis weight to body weight ratio','left_testis_weight_to_body_weight_ratio'),('IMPC_OWT_027_001','Right testis weight to body weight ratio','right_testis_weight_to_body_weight_ratio'),('IMPC_OWT_028_001','Whole liver weight to body weight ratio','whole_liver_weight_to_body_weight_ratio'),('IMPC_OWT_029_001','Right lung all lobes weight to body weight ratio','right_lung_all_lobes_weight_to_body_weight_ratio'),('IMPC_OWT_030_001','Left lung weight to body weight ratio','left_lung_weight_to_body_weight_ratio'),('IMPC_OWT_031_001','Whole lung weight','whole_lung_weight'),('IMPC_PAT_001_001','Brain','brain'),('IMPC_PAT_001_002','Brain','brain'),('IMPC_PAT_002_001','Eye with optic nerve','eye_with_optic_nerve'),('IMPC_PAT_002_002','Eye with optic nerve','eye_with_optic_nerve'),('IMPC_PAT_003_001','Spinal cord','spinal_cord'),('IMPC_PAT_003_002','Spinal cord','spinal_cord'),('IMPC_PAT_004_001','Thymus','thymus'),('IMPC_PAT_004_002','Thymus','thymus'),('IMPC_PAT_005_001','Thyroid','thyroid'),('IMPC_PAT_005_002','Thyroid','thyroid'),('IMPC_PAT_006_001','Heart','heart'),('IMPC_PAT_006_002','Heart','heart'),('IMPC_PAT_007_001','Trachea','trachea'),('IMPC_PAT_007_002','Trachea','trachea'),('IMPC_PAT_008_001','Esophagus','esophagus'),('IMPC_PAT_008_002','Esophagus','esophagus'),('IMPC_PAT_009_001','Lung','lung'),('IMPC_PAT_009_002','Lung','lung'),('IMPC_PAT_010_001','Liver','liver'),('IMPC_PAT_010_002','Liver','liver'),('IMPC_PAT_011_001','Gall bladder','gall_bladder'),('IMPC_PAT_011_002','Gall bladder','gall_bladder'),('IMPC_PAT_012_001','Stomach','stomach'),('IMPC_PAT_012_002','Stomach','stomach'),('IMPC_PAT_013_001','Small intestine','small_intestine'),('IMPC_PAT_013_002','Small intestine','small_intestine'),('IMPC_PAT_014_001','Large intestine','large_intestine'),('IMPC_PAT_014_002','Large intestine','large_intestine'),('IMPC_PAT_015_001','Pancreas','pancreas'),('IMPC_PAT_015_002','Pancreas','pancreas'),('IMPC_PAT_016_001','Spleen','spleen'),('IMPC_PAT_016_002','Spleen','spleen'),('IMPC_PAT_017_001','Kidney','kidney'),('IMPC_PAT_017_002','Kidney','kidney'),('IMPC_PAT_018_001','Adrenal gland','adrenal_gland'),('IMPC_PAT_018_002','Adrenal gland','adrenal_gland'),('IMPC_PAT_019_001','Mammary gland','mammary_gland'),('IMPC_PAT_019_002','Mammary gland','mammary_gland'),('IMPC_PAT_020_001','Lymph node','lymph_node'),('IMPC_PAT_020_002','Lymph node','lymph_node'),('IMPC_PAT_021_001','Skin','skin'),('IMPC_PAT_021_002','Skin','skin'),('IMPC_PAT_022_001','Skeletal muscle','skeletal_muscle'),('IMPC_PAT_022_002','Skeletal muscle','skeletal_muscle'),('IMPC_PAT_023_001','Urinary bladder','urinary_bladder'),('IMPC_PAT_023_002','Urinary bladder','urinary_bladder'),('IMPC_PAT_024_001','Testes','testes'),('IMPC_PAT_024_002','Testes','testes'),('IMPC_PAT_025_001','Epididymis','epididymis'),('IMPC_PAT_025_002','Epididymis','epididymis'),('IMPC_PAT_026_001','Prostate','prostate'),('IMPC_PAT_026_002','Prostate','prostate'),('IMPC_PAT_027_001','Seminal vesicle','seminal_vesicles'),('IMPC_PAT_027_002','Seminal vesicle','seminal_vesicles'),('IMPC_PAT_028_001','Ovary','ovary'),('IMPC_PAT_028_002','Ovary','ovary'),('IMPC_PAT_029_001','Uterus','uterus'),('IMPC_PAT_029_002','Uterus','uterus'),('IMPC_PAT_030_001','Date of sacrifice','NA'),('IMPC_PAT_030_002','Date of sacrifice','NA'),('IMPC_PAT_031_001','ID for sample banking protocol','ID for center-specific cassette processing protocol'),('IMPC_PAT_031_002','ID for sample banking protocol','ID for center-specific cassette processing protocol'),('IMPC_PAT_032_001','Comments (in English)','General comments, in English'),('IMPC_PAT_032_002','Comments (in English)','General comments, in English'),('IMPC_PAT_033_001','Balance manufacturer','NA'),('IMPC_PAT_034_001','Balance model','NA'),('IMPC_PAT_035_001','Camera resolution','NA'),('IMPC_PAT_036_001','Eye fixative','NA'),('IMPC_PAT_049_001','Body Weight','body_weight'),('IMPC_PAT_049_002','Body Weight','body_weight'),('IMPC_PAT_052_001','Experimenter ID','experimenter'),('IMPC_PAT_052_002','Experimenter ID','experimenter'),('IMPC_PAT_054_001','Method of sacrifice','sacrifice'),('IMPC_PAT_054_002','Method of sacrifice','sacrifice'),('IMPC_PAT_055_001','Method of Blood Collection','blood_collection'),('IMPC_PAT_055_002','Method of Blood Collection','blood_collection'),('IMPC_PAT_056_001','Equipment ID','equipment_name'),('IMPC_PAT_056_002','Equipment ID','equipment_name'),('IMPC_PAT_057_001','Images','images'),('IMPC_PAT_057_002','Images','images'),('IMPC_PAT_058_001','Fixative','fixative'),('IMPC_PAT_058_002','Fixative','fixative'),('IMPC_PAT_059_001','Date equipment last calibrated','NA'),('IMPC_PAT_059_002','Date equipment last calibrated','NA'),('IMPC_PAT_060_001','Equipment manufacturer','NA'),('IMPC_PAT_060_002','Equipment manufacturer','NA'),('IMPC_PAT_061_001','Equipment model','NA'),('IMPC_PAT_061_002','Equipment model','NA'),('IMPC_PAT_062_001','Salivary gland','NA'),('IMPC_PAT_063_001','Sternum','NA'),('IMPC_PAT_064_001','Femur','NA'),('IMPC_PAT_065_001','Bone marrow','NA'),('IMPC_PAT_066_001','Brown fat','NA'),('IMPC_PAT_067_001','Tibia','NA'),('IMPC_PAT_068_001','Knee joint','NA'),('IMPC_PAT_069_001','Trigeminal V nerve','NA'),('IMPC_PAT_070_001','Nasal cavity','NA'),('IMPC_PAT_071_001','Ear','NA'),('IMPC_PAT_072_001','Tooth','NA'),('IMPC_PAT_073_001','Tongue','NA'),('IMPC_PAT_074_001','Sciatic nerve','NA'),('IMPC_PAT_075_001','Bone','NA'),('IMPC_PAT_076_001','Tissue available for distribution','Are there tissue blocks available for distribution?'),('IMPC_VIA_001_001','Viability Outcome','NA'),('IMPC_VIA_002_001','Additional Outcome','NA'),('IMPC_VIA_003_001','Total pups','NA'),('IMPC_VIA_004_001','Total pups WT','NA'),('IMPC_VIA_005_001','Total pups heterozygous','NA'),('IMPC_VIA_006_001','Total pups homozygous','NA'),('IMPC_VIA_007_001','Total male WT','NA'),('IMPC_VIA_008_001','Total male heterozygous','NA'),('IMPC_VIA_009_001','Total male homozygous','NA'),('IMPC_VIA_010_001','Total male pups','NA'),('IMPC_VIA_011_001','Total female WT','NA'),('IMPC_VIA_012_001','Total female heterozygous','NA'),('IMPC_VIA_013_001','Total female homozygous','NA'),('IMPC_VIA_014_001','Total female pups','NA'),('IMPC_VIA_015_001','% pups WT','NA'),('IMPC_VIA_016_001','Free Comment','NA'),('IMPC_VIA_017_001','Average litter size','NA'),('IMPC_VIA_018_001','% pups heterozygous','NA'),('IMPC_VIA_019_001','% pups homozygous','NA'),('IMPC_VIA_020_001','% male WT','NA'),('IMPC_VIA_021_001','% male heterozygous','NA'),('IMPC_VIA_022_001','% male homozygous','NA'),('IMPC_VIA_023_001','% female WT','NA'),('IMPC_VIA_024_001','% female heterozygous','NA'),('IMPC_VIA_025_001','% female homozygous','NA'),('IMPC_VIA_026_001','Female age earliest start','NA'),('IMPC_VIA_027_001','Female age oldest end','NA'),('IMPC_VIA_028_001','Time of dark cycle start','NA'),('IMPC_VIA_029_001','Time of dark cycle end','NA'),('IMPC_VIA_030_001','Age of pups at genotype','NA'),('IMPC_VIA_031_001','Breeding Strategy','NA'),('IMPC_VIA_032_001','P-value for outcome call','NA'),('IMPC_VIA_033_001','Additional Subviable Outcome','NA'),('IMPC_VIA_034_001','Gene category','Type of gene inheritance pattern'),('IMPC_VIA_035_001','Male parents genotype','Genotype of male parent(s)'),('IMPC_VIA_036_001','Female parents genotype','Genotype of female parent(s)'),('IMPC_VIA_037_001','Litter male parent specimen id','ID of male parent of litter'),('IMPC_VIA_038_001','Litter female parent 1 specimen id','ID of female parent'),('IMPC_VIA_039_001','Litter female parent 2 specimen id','ID of optional second female parent for trio matings'),('IMPC_VIA_040_001','Litter date of birth','Date of birth of litter'),('IMPC_VIA_041_001','Number of WT males','Number of wild-type males in litter, or total wild-type males if litter data is not available'),('IMPC_VIA_042_001','Number of WT females','Number of wild-type females in litter, or total wild-type females if litter data is not available'),('IMPC_VIA_043_001','Number of heterozygous males','Number of heterozygous males in litter, or total heterozygous males if litter data is not available'),('IMPC_VIA_044_001','Number of heterozygous females','Number of heterozygous females in litter, or total heterozygous females if litter data is not available'),('IMPC_VIA_045_001','Number of homozygous males','Number of homozygous males in litter, or total homozygous males if litter data is not available'),('IMPC_VIA_046_001','Number of homozygous females','Number of homozygous females in litter, or total homozygousfe males if litter data is not available'),('IMPC_VIA_047_001','Number of hemizygous males','Number of hemizygous males in litter, or total hemizygous males if litter data is not available'),('IMPC_VIA_048_001','Number of anzygous females','Number of anzygous (i.e. no copies of gene as it is Y-chromosome) females in litter, or total anzygous females if litter data is not available'),('IMPC_VIA_049_001','Total WT males','Total wild-type males'),('IMPC_VIA_050_001','Total WT females','Total wild-type females'),('IMPC_VIA_051_001','Total heterozygous males','Total heterozygous males'),('IMPC_VIA_052_001','Total heterozygous females','Total heterozygous females'),('IMPC_VIA_053_001','Total homozygous males','Total homozygous males'),('IMPC_VIA_054_001','Total homozygous females','Total homozygous males'),('IMPC_VIA_055_001','Total of hemizygous males','Total hemizygous males'),('IMPC_VIA_056_001','Total anzygous females','Total anzygous (i.e. no copies of gene as it is Y-chromosome) females'),('IMPC_VIA_057_001','Total pups','Total pups'),('IMPC_VIA_058_001','Total WTs','Total wild-type pups'),('IMPC_VIA_059_001','Total heterozygotes','Total heterozygous pups'),('IMPC_VIA_060_001','Total homozygotes','Total homozygous pups'),('IMPC_VIA_061_001','Total males','Total male pups'),('IMPC_VIA_062_001','Total females','Total female pups'),('IMPC_VIA_063_001','Homozygous males viability','Outcome of viability assessment for homozygous males'),('IMPC_VIA_064_001','Homozygous females viability','Outcome of viability assessment for homozygous females'),('IMPC_VIA_065_001','Hemizygous males viability','Outcome of viability assessment for hemizygous males'),('IMPC_VIA_066_001','Heterozygous animals viability','Outcome of viability assessment for heterozygous animals'),('IMPC_VIA_067_001','Homozygous animals viability','Outcome of viability assessment for homozygous animals'),('IMPC_VIA_068_001','Embryo Vignette','Poster style vignette to highlight the embryo development for a line'),('IMPC_WEL_001_001','Welfare terms','Welfare term(s) that categorise the issue(s)'),('IMPC_WEL_002_001','Free-text comments','Free-text comments describing the welfare issue(s)'),('IMPC_WEL_003_001','Images','Images to visually document welfare issue(s)'),('IMPC_WEL_004_001','Date of observation','Date the welfare issue(s) were observed'),('IMPC_WEL_005_001','Animal Status','NA'),('IMPC_XRY_001_001','Skull shape','skull_shape'),('IMPC_XRY_002_001','Zygomatic bone','zygomatic_bone'),('IMPC_XRY_003_001','Maxilla/Pre-maxilla','maxilla'),('IMPC_XRY_004_001','Mandibles','mandibles'),('IMPC_XRY_005_001','Teeth','teeth'),('IMPC_XRY_006_001','Scapulae','scapulae'),('IMPC_XRY_007_001','Clavicle','clavicle'),('IMPC_XRY_008_001','Number of ribs right','number_of_ribs_right'),('IMPC_XRY_009_001','Number of ribs left','number_of_ribs_left'),('IMPC_XRY_010_001','Shape of ribs','shape_of_ribs'),('IMPC_XRY_011_001','Fusion of ribs','fusion_of_ribs'),('IMPC_XRY_012_001','Pelvis','pelvis'),('IMPC_XRY_013_001','Number of cervical vertebrae','number_of_cervical_vertebrae'),('IMPC_XRY_014_001','Number of thoracic vertebrae','number_of_thoracic_vertebrae'),('IMPC_XRY_015_001','Number of lumbar vertebrae','number_of_lumbar_vertebrae'),('IMPC_XRY_016_001','Number of pelvic vertebrae','number_of_pelvic_vertebrae'),('IMPC_XRY_017_001','Number of caudal vertebrae','number_of_caudal_vertebrae'),('IMPC_XRY_018_001','Shape of vertebrae','shape_of_vertebrae'),('IMPC_XRY_019_001','Fusion of vertebrae','fusion_of_vertebrae'),('IMPC_XRY_020_001','Processes on vertebrae','processes_on_vertebrae'),('IMPC_XRY_021_001','Humerus','humerus'),('IMPC_XRY_022_001','Radius','radius'),('IMPC_XRY_023_001','Ulna','ulna'),('IMPC_XRY_024_001','Femur','femur'),('IMPC_XRY_025_001','Tibia','tibia'),('IMPC_XRY_026_001','Fibula','fibula'),('IMPC_XRY_027_001','Joints','joints'),('IMPC_XRY_028_001','Number of digits','number_of_digits'),('IMPC_XRY_029_001','Syndactylism','syndactylism'),('IMPC_XRY_030_001','Brachydactyly','completeness_of_digits'),('IMPC_XRY_031_001','Digit integrity','digit_integrity'),('IMPC_XRY_032_001','Comment on XRay image','comment_on_xray_image'),('IMPC_XRY_033_001','Tibia length','tibia_length'),('IMPC_XRY_034_001','XRay Images Whole Body Dorso Ventral','xray_images'),('IMPC_XRY_035_001','Alive','alive'),('IMPC_XRY_036_001','Xray equipment ID','xray_equipment_name'),('IMPC_XRY_037_001','Xray equipment manufacturer','xray_equipment_manufacturer'),('IMPC_XRY_038_001','Xray equipment model','xray_equipment_model'),('IMPC_XRY_039_001','Settings time of exposure','settings_time_of_exposure'),('IMPC_XRY_040_001','Settings level','settings_level'),('IMPC_XRY_041_001','Experimenter ID (scan)','experimenter_scan_'),('IMPC_XRY_042_001','Experimenter ID (analysis)','experimenter_analysis_'),('IMPC_XRY_043_001','Voltage settings','voltage_settings'),('IMPC_XRY_044_001','Scanner equipment ID','scanner_equipment_name'),('IMPC_XRY_045_001','Scanner equipment manufacturer','scanner_equipment_manufacturer'),('IMPC_XRY_046_001','Scanner equipment model','scanner_equipment_model'),('IMPC_XRY_047_001','Date Xray equipment last calibrated','NA'),('IMPC_XRY_048_001','XRay Images Whole Body Lateral Orientation','NA'),('IMPC_XRY_049_001','XRay Images Forepaw','NA'),('IMPC_XRY_050_001','XRay Images Skull Lateral Orientation','NA'),('IMPC_XRY_051_001','XRay Images Skull Dorso Ventral Orientation','NA'),('IMPC_XRY_052_001','XRay Images Hind Leg and Hip','NA'),('IMPC_XRY_053_001','Date Scanner equipment last calibrated','NA'),('IMPC_XRY_054_001','Free Ontology','NA'),('IMPC_XRY_055_001','Shape of spine','NA'),('IMPC_XRY_056_001','Scoliosis','NA'),('IMPC_XRY_057_001','Kyphosis','NA'),('IMPC_XRY_058_001','Lordosis','NA'),('IMPC_XRY_059_001','Shape of ribcage','NA'),('IMPC_XRY_060_001','Transitional vertebrae','NA'),('IMPC_XRY_061_001','Fusion of processes','NA'),('IMPC_XRY_062_001','Polysyndactylism','NA'),('IMPC_XRY_063_001','Cervical processes','NA'),('IMPC_XRY_064_001','Thoracic processes','NA'),('IMPC_XRY_065_001','Lumbar processes','NA'),('IMPC_XRY_066_001','Sacral processes','NA'),('IMPC_XRY_067_001','Caudal processes','NA'),('IMPC_XRY_068_001','Missing cranial rib','NA'),('IMPC_XRY_069_001','Rib morphology','rib_morphology'),('IMPC_XRY_070_001','Cervical vertebrae morphology','cervical_vertebrae_morphology'),('IMPC_XRY_071_001','Thoracic vertebrae morphology','thoracic_vertebrae_morphology'),('IMPC_XRY_072_001','Lumbar vertebrae morphology','lumbar_vertebrae_morphology'),('IMPC_XRY_073_001','Pelvic vertebrae morphology','pelvic_vertebrae_morphology'),('IMPC_XRY_074_001','Caudal vertebrae morphology','caudal_vertebrae_morphology'),('IMPC_YMZ_001_001','Latency to leave start arm','latency_to_leave_start_arm'),('IMPC_YMZ_002_001','Total arm entries','total_arm_entries'),('IMPC_YMZ_003_001','Number of triplets','number_of_triplets'),('IMPC_YMZ_004_001','Number of spontaneous alternations','spontaneous_alternations'),('IMPC_YMZ_005_001','Alternation ratio per number of triplets','alternation_ratio'),('IMPC_YMZ_006_001','Number of alternate arm entries','alternate_arm_entries'),('IMPC_YMZ_007_001','Alternate arm entry ratio per number of triplets','alternate_arm_entry_ratio'),('IMPC_YMZ_008_001','Number of same arm entries by number of doublets','same_arm_entries'),('IMPC_YMZ_009_001','Same arm entry ratio per total arm entries','same_arm_entry_ratio'),('IMPC_YMZ_010_001','Feacal boli (count)','feacal_boli_count'),('IMPC_YMZ_011_001','Acclimatisation time (minimum)','acclimatisation_time_minimum'),('IMPC_YMZ_012_001','Arm dimensions','arm_dimensions'),('IMPC_YMZ_013_001','Light level','light_level'),('IMPC_YMZ_015_001','Placement in start arm','placement_in_start_arm'),('IMPC_YMZ_016_001','Cleaning agent/disinfectant','cleaning_agent_disinfectant'),('IMPC_YMZ_017_001','Tracking method','tracking_method'),('IMPC_YMZ_018_001','Scoring method','scoring_method'),('IMPC_YMZ_019_001','Duration at centre prior to arm re-entry','duration_at_centre_prior_to_arm_re_entry'),('IMPC_YMZ_020_001','Experimenter ID','experimenter_id'),('IMPC_YMZ_021_001','Maze ID','maze_id'),('IMPC_YMZ_022_001','Maze manufacturer','maze_manufacturer'),('IMPC_YMZ_023_001','Maze model','maze_model'),('IMPC_YMZ_024_001','Tracking equipment ID','tracking_equipment_id'),('IMPC_YMZ_025_001','Tracking equipment manufacturer','tracking_equipment_manufacturer'),('IMPC_YMZ_026_001','Tracking equipment model','tracking_equipment_model'),('IMPC_YMZ_027_001','Date tracking equipment last calibrated','date_tracking_equipment_last_calibrated'),('IMPC_YMZ_028_001','Software','software'),('IMPC_YMZ_029_001','Alternating start arm','NA');
/*!40000 ALTER TABLE `Parameters` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `parameterXgroup`
--

DROP TABLE IF EXISTS `parameterXgroup`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `parameterXgroup` (
  `grouping_id` int NOT NULL,
  `parameter_id` varchar(18) NOT NULL,
  PRIMARY KEY (`grouping_id`,`parameter_id`),
  KEY `parameter_id` (`parameter_id`),
  CONSTRAINT `parameterxgroup_ibfk_1` FOREIGN KEY (`grouping_id`) REFERENCES `ParameterGroupings` (`grouping_id`),
  CONSTRAINT `parameterxgroup_ibfk_2` FOREIGN KEY (`parameter_id`) REFERENCES `Parameters` (`parameter_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Join table linking Parameters to ParameterGroupings (many-to-many).';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `parameterXgroup`
--

LOCK TABLES `parameterXgroup` WRITE;
/*!40000 ALTER TABLE `parameterXgroup` DISABLE KEYS */;
/*!40000 ALTER TABLE `parameterXgroup` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `parameterXprocedure`
--

DROP TABLE IF EXISTS `parameterXprocedure`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `parameterXprocedure` (
  `parameter_id` varchar(18) NOT NULL,
  `procedure_id` int NOT NULL,
  PRIMARY KEY (`parameter_id`,`procedure_id`),
  KEY `procedure_id` (`procedure_id`),
  CONSTRAINT `parameterxprocedure_ibfk_1` FOREIGN KEY (`parameter_id`) REFERENCES `Parameters` (`parameter_id`),
  CONSTRAINT `parameterxprocedure_ibfk_2` FOREIGN KEY (`procedure_id`) REFERENCES `Procedures` (`procedure_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Join table linking Parameters to Procedures (many-to-many).';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `parameterXprocedure`
--

LOCK TABLES `parameterXprocedure` WRITE;
/*!40000 ALTER TABLE `parameterXprocedure` DISABLE KEYS */;
INSERT INTO `parameterXprocedure` VALUES ('IMPC_MAA_001_001',7636),('IMPC_MAA_002_001',7637),('IMPC_MAA_003_001',7638),('IMPC_MAA_004_001',7639),('IMPC_MAA_005_001',7640),('IMPC_MAA_006_001',7641),('IMPC_MAA_007_001',7642),('IMPC_MAA_008_001',7643),('IMPC_MAA_009_001',7644),('IMPC_OFD_005_001',16384),('IMPC_OFD_006_001',16385),('IMPC_OFD_007_001',16386),('IMPC_OFD_008_001',16387),('IMPC_OFD_009_001',16388),('IMPC_OFD_010_001',16389),('IMPC_OFD_011_001',16390),('IMPC_OFD_012_001',16391),('IMPC_OFD_013_001',16392),('IMPC_OFD_014_001',16393),('IMPC_OFD_015_001',16394),('IMPC_OFD_016_001',16395),('IMPC_OFD_017_001',16396),('IMPC_OFD_018_001',16397),('IMPC_OFD_019_001',16398),('IMPC_OFD_020_001',16399),('IMPC_OFD_021_001',16400),('IMPC_OFD_022_001',16401),('IMPC_OFD_023_001',16402),('IMPC_OFD_024_001',16403),('IMPC_OFD_025_001',16404),('IMPC_OFD_026_001',16405),('IMPC_OFD_027_001',16406),('IMPC_OFD_028_001',16407),('IMPC_OFD_029_001',16408),('IMPC_OFD_030_001',16409),('IMPC_OFD_031_001',16410),('IMPC_OFD_032_001',16411),('IMPC_OFD_033_001',16412),('IMPC_OFD_034_001',16413),('IMPC_OFD_035_001',16414),('IMPC_OFD_036_001',16415),('IMPC_OFD_037_001',16416),('IMPC_OFD_038_001',16417),('IMPC_OFD_039_001',16418),('IMPC_OFD_040_001',16419),('IMPC_OFD_041_001',16420),('IMPC_OFD_001_001',16421),('IMPC_OFD_002_001',16422),('IMPC_OFD_003_001',16423),('IMPC_OFD_004_001',16424),('IMPC_OFD_042_001',16425),('IMPC_OFD_043_001',16426),('IMPC_OFD_044_001',16427),('IMPC_OFD_045_001',16428),('IMPC_OFD_046_001',16429),('IMPC_OFD_047_001',16430),('IMPC_OFD_048_001',16431),('IMPC_OFD_049_001',16432),('IMPC_CSD_001_001',16825),('IMPC_CSD_002_001',16826),('IMPC_CSD_003_001',16827),('IMPC_CSD_004_001',16828),('IMPC_CSD_005_001',16829),('IMPC_CSD_006_001',16830),('IMPC_CSD_007_001',16831),('IMPC_CSD_008_001',16832),('IMPC_CSD_009_001',16833),('IMPC_CSD_010_001',16834),('IMPC_CSD_011_001',16835),('IMPC_CSD_012_001',16836),('IMPC_CSD_013_001',16837),('IMPC_CSD_014_001',16838),('IMPC_CSD_015_001',16839),('IMPC_CSD_016_001',16840),('IMPC_CSD_017_001',16841),('IMPC_CSD_018_001',16842),('IMPC_CSD_019_001',16843),('IMPC_CSD_020_001',16844),('IMPC_CSD_021_001',16845),('IMPC_CSD_022_001',16846),('IMPC_CSD_023_001',16847),('IMPC_CSD_024_001',16848),('IMPC_CSD_025_001',16849),('IMPC_CSD_026_001',16850),('IMPC_CSD_027_001',16851),('IMPC_CSD_028_001',16852),('IMPC_CSD_029_001',16853),('IMPC_CSD_030_001',16854),('IMPC_CSD_031_001',16855),('IMPC_CSD_032_001',16856),('IMPC_CSD_033_001',16857),('IMPC_CSD_034_001',16858),('IMPC_CSD_035_001',16859),('IMPC_CSD_036_001',16860),('IMPC_CSD_037_001',16861),('IMPC_CSD_038_001',16862),('IMPC_CSD_039_001',16863),('IMPC_CSD_040_001',16864),('IMPC_CSD_041_001',16865),('IMPC_CSD_042_001',16866),('IMPC_CSD_043_001',16867),('IMPC_CSD_044_001',16868),('IMPC_CSD_045_001',16869),('IMPC_CSD_046_001',16870),('IMPC_CSD_047_001',16871),('IMPC_CSD_048_001',16872),('IMPC_CSD_049_001',16873),('IMPC_CSD_050_001',16874),('IMPC_CSD_051_001',16875),('IMPC_CSD_052_001',16876),('IMPC_CSD_053_001',16877),('IMPC_CSD_054_001',16878),('IMPC_CSD_055_001',16879),('IMPC_CSD_056_001',16880),('IMPC_CSD_057_001',16881),('IMPC_CSD_058_001',16882),('IMPC_CSD_059_001',16883),('IMPC_CSD_060_001',16884),('IMPC_CSD_061_001',16885),('IMPC_CSD_062_001',16886),('IMPC_CSD_063_001',16887),('IMPC_CSD_064_001',16888),('IMPC_CSD_065_001',16889),('IMPC_CSD_066_001',16890),('IMPC_CSD_067_001',16891),('IMPC_CSD_068_001',16892),('IMPC_CSD_069_001',16893),('IMPC_CSD_070_001',16894),('IMPC_CSD_071_001',16895),('IMPC_CSD_072_001',16896),('IMPC_CSD_073_001',16897),('IMPC_CSD_074_001',16898),('IMPC_CSD_075_001',16899),('IMPC_CSD_076_001',16900),('IMPC_CSD_077_001',16901),('IMPC_CSD_078_001',16902),('IMPC_CSD_079_001',16903),('IMPC_CSD_080_001',16904),('IMPC_CSD_081_001',16905),('IMPC_CSD_082_001',16906),('IMPC_CSD_083_001',16907),('IMPC_CSD_084_001',16908),('IMPC_CSD_085_001',16909),('IMPC_CSD_086_001',16910),('IMPC_CSD_087_001',16911),('IMPC_GRS_001_001',17587),('IMPC_GRS_002_001',17588),('IMPC_GRS_003_001',17589),('IMPC_GRS_004_001',17590),('IMPC_GRS_005_001',17591),('IMPC_GRS_006_001',17592),('IMPC_GRS_007_001',17593),('IMPC_GRS_008_001',17594),('IMPC_GRS_009_001',17595),('IMPC_GRS_010_001',17596),('IMPC_GRS_011_001',17597),('IMPC_GRS_012_001',17598),('IMPC_GRS_013_001',17599),('IMPC_GRS_014_001',17600),('IMPC_ACS_001_001',17722),('IMPC_ACS_002_001',17723),('IMPC_ACS_003_001',17724),('IMPC_ACS_004_001',17725),('IMPC_ACS_005_001',17726),('IMPC_ACS_006_001',17727),('IMPC_ACS_007_001',17728),('IMPC_ACS_008_001',17729),('IMPC_ACS_009_001',17730),('IMPC_ACS_010_001',17731),('IMPC_ACS_011_001',17732),('IMPC_ACS_012_001',17733),('IMPC_ACS_014_001',17734),('IMPC_ACS_015_001',17735),('IMPC_ACS_016_001',17736),('IMPC_ACS_017_001',17737),('IMPC_ACS_018_001',17738),('IMPC_ACS_019_001',17739),('IMPC_ACS_020_001',17740),('IMPC_ACS_021_001',17741),('IMPC_ACS_022_001',17742),('IMPC_ACS_023_001',17743),('IMPC_ACS_024_001',17744),('IMPC_ACS_025_001',17745),('IMPC_ACS_026_001',17746),('IMPC_ACS_027_001',17747),('IMPC_ACS_028_001',17748),('IMPC_ACS_029_001',17749),('IMPC_ACS_030_001',17750),('IMPC_ACS_031_001',17751),('IMPC_ACS_032_001',17752),('IMPC_ACS_033_001',17753),('IMPC_ACS_034_001',17754),('IMPC_ACS_035_001',17755),('IMPC_ACS_036_001',17756),('IMPC_ACS_037_001',17757),('IMPC_ACS_038_001',17758),('IMPC_ACS_013_001',17759),('IMPC_ACS_039_001',17760),('IMPC_CAL_001_001',18100),('IMPC_CAL_002_001',18101),('IMPC_CAL_003_001',18102),('IMPC_CAL_004_001',18103),('IMPC_CAL_005_001',18104),('IMPC_CAL_006_001',18105),('IMPC_CAL_007_001',18106),('IMPC_CAL_008_001',18107),('IMPC_CAL_009_001',18108),('IMPC_CAL_010_001',18109),('IMPC_CAL_011_001',18110),('IMPC_CAL_012_001',18111),('IMPC_CAL_013_001',18112),('IMPC_CAL_014_001',18113),('IMPC_CAL_015_001',18114),('IMPC_CAL_016_001',18115),('IMPC_CAL_017_001',18116),('IMPC_CAL_018_001',18117),('IMPC_CAL_019_001',18118),('IMPC_CAL_020_001',18119),('IMPC_CAL_021_001',18120),('IMPC_CAL_022_001',18121),('IMPC_IPG_001_001',18301),('IMPC_IPG_002_001',18302),('IMPC_IPG_003_001',18303),('IMPC_IPG_004_001',18304),('IMPC_IPG_005_001',18305),('IMPC_IPG_006_001',18306),('IMPC_IPG_007_001',18307),('IMPC_IPG_008_001',18308),('IMPC_IPG_009_001',18309),('IMPC_IPG_010_001',18310),('IMPC_IPG_011_001',18311),('IMPC_IPG_012_001',18312),('IMPC_IPG_013_001',18313),('IMPC_CHL_001_001',18421),('IMPC_CHL_002_001',18422),('IMPC_CHL_003_001',18423),('IMPC_CHL_004_001',18424),('IMPC_CHL_005_001',18425),('IMPC_CHL_006_001',18426),('IMPC_CHL_007_001',18427),('IMPC_CHL_008_001',18428),('IMPC_CHL_009_001',18429),('IMPC_CHL_010_001',18430),('IMPC_CHL_011_001',18431),('IMPC_CHL_012_001',18432),('IMPC_CHL_013_001',18433),('IMPC_CHL_014_001',18434),('IMPC_CHL_015_001',18435),('IMPC_CHL_016_001',18436),('IMPC_CHL_017_001',18437),('IMPC_CHL_018_001',18438),('IMPC_CHL_019_001',18439),('IMPC_CHL_020_001',18440),('IMPC_CHL_021_001',18441),('IMPC_CHL_022_001',18442),('IMPC_CHL_026_001',18443),('IMPC_CHL_027_001',18444),('IMPC_CHL_029_001',18445),('IMPC_CHL_023_001',18446),('IMPC_CHL_024_001',18447),('IMPC_CHL_025_001',18448),('IMPC_CHL_030_001',18449),('IMPC_CHL_031_001',18450),('IMPC_CHL_032_001',18451),('IMPC_CHL_033_001',18452),('IMPC_CHL_034_001',18453),('IMPC_CHL_035_001',18454),('IMPC_CHL_036_001',18455),('IMPC_CHL_037_001',18456),('IMPC_CHL_038_001',18457),('IMPC_CHL_028_001',18458),('IMPC_CHL_039_001',18459),('IMPC_CHL_040_001',18460),('IMPC_CHL_041_001',18461),('IMPC_CHL_042_001',18462),('IMPC_CHL_043_001',18463),('IMPC_CHL_044_001',18464),('IMPC_CHL_045_001',18465),('IMPC_CHL_046_001',18466),('IMPC_CHL_047_001',18467),('IMPC_CHL_048_001',18468),('IMPC_CHL_049_001',18469),('IMPC_ABR_001_001',18547),('IMPC_ABR_002_001',18548),('IMPC_ABR_003_001',18549),('IMPC_ABR_004_001',18550),('IMPC_ABR_005_001',18551),('IMPC_ABR_006_001',18552),('IMPC_ABR_007_001',18553),('IMPC_ABR_008_001',18554),('IMPC_ABR_009_001',18555),('IMPC_ABR_010_001',18556),('IMPC_ABR_011_001',18557),('IMPC_ABR_012_001',18558),('IMPC_ABR_013_001',18559),('IMPC_ABR_014_001',18560),('IMPC_ABR_015_001',18561),('IMPC_ABR_016_001',18562),('IMPC_ABR_017_001',18563),('IMPC_ABR_018_001',18564),('IMPC_ABR_019_001',18565),('IMPC_ABR_020_001',18566),('IMPC_ABR_021_001',18567),('IMPC_ABR_022_001',18568),('IMPC_ABR_023_001',18569),('IMPC_ABR_024_001',18570),('IMPC_ABR_025_001',18571),('IMPC_ABR_026_001',18572),('IMPC_ABR_027_001',18573),('IMPC_ABR_028_001',18574),('IMPC_ABR_029_001',18575),('IMPC_ABR_030_001',18576),('IMPC_ABR_031_001',18577),('IMPC_ABR_032_001',18578),('IMPC_ABR_033_001',18579),('IMPC_ABR_034_001',18580),('IMPC_ABR_035_001',18581),('IMPC_ABR_036_001',18582),('IMPC_ABR_037_001',18583),('IMPC_ABR_038_001',18584),('IMPC_ABR_039_001',18585),('IMPC_ABR_040_001',18586),('IMPC_ABR_041_001',18587),('IMPC_ABR_042_001',18588),('IMPC_ABR_043_001',18589),('IMPC_ABR_044_001',18590),('IMPC_ABR_045_001',18591),('IMPC_ABR_046_001',18592),('IMPC_ABR_047_001',18593),('IMPC_ABR_048_001',18594),('IMPC_ABR_049_001',18595),('IMPC_ABR_050_001',18596),('IMPC_ABR_051_001',18597),('IMPC_ABR_052_001',18598),('IMPC_ABR_053_001',18599),('IMPC_ABR_054_001',18600),('IMPC_DXA_001_001',18988),('IMPC_DXA_002_001',18989),('IMPC_DXA_003_001',18990),('IMPC_DXA_004_001',18991),('IMPC_DXA_005_001',18992),('IMPC_DXA_006_001',18993),('IMPC_DXA_007_001',18994),('IMPC_DXA_008_001',18995),('IMPC_DXA_009_001',18996),('IMPC_DXA_010_001',18997),('IMPC_DXA_011_001',18998),('IMPC_DXA_012_001',18999),('IMPC_DXA_013_001',19000),('IMPC_DXA_014_001',19001),('IMPC_DXA_015_001',19002),('IMPC_DXA_016_001',19003),('IMPC_DXA_017_001',19004),('IMPC_DXA_018_001',19005),('IMPC_XRY_001_001',19236),('IMPC_XRY_002_001',19237),('IMPC_XRY_003_001',19238),('IMPC_XRY_004_001',19239),('IMPC_XRY_005_001',19240),('IMPC_XRY_006_001',19241),('IMPC_XRY_007_001',19242),('IMPC_XRY_008_001',19243),('IMPC_XRY_009_001',19244),('IMPC_XRY_010_001',19245),('IMPC_XRY_011_001',19246),('IMPC_XRY_012_001',19247),('IMPC_XRY_013_001',19248),('IMPC_XRY_014_001',19249),('IMPC_XRY_015_001',19250),('IMPC_XRY_016_001',19251),('IMPC_XRY_017_001',19252),('IMPC_XRY_018_001',19253),('IMPC_XRY_019_001',19254),('IMPC_XRY_020_001',19255),('IMPC_XRY_021_001',19256),('IMPC_XRY_022_001',19257),('IMPC_XRY_023_001',19258),('IMPC_XRY_024_001',19259),('IMPC_XRY_025_001',19260),('IMPC_XRY_026_001',19261),('IMPC_XRY_027_001',19262),('IMPC_XRY_028_001',19263),('IMPC_XRY_029_001',19264),('IMPC_XRY_030_001',19265),('IMPC_XRY_031_001',19266),('IMPC_XRY_032_001',19267),('IMPC_XRY_033_001',19268),('IMPC_XRY_034_001',19269),('IMPC_XRY_035_001',19270),('IMPC_XRY_036_001',19271),('IMPC_XRY_037_001',19272),('IMPC_XRY_038_001',19273),('IMPC_XRY_039_001',19274),('IMPC_XRY_040_001',19275),('IMPC_XRY_041_001',19276),('IMPC_XRY_042_001',19277),('IMPC_XRY_043_001',19278),('IMPC_XRY_044_001',19279),('IMPC_XRY_045_001',19280),('IMPC_XRY_046_001',19281),('IMPC_XRY_047_001',19282),('IMPC_XRY_048_001',19283),('IMPC_XRY_049_001',19284),('IMPC_XRY_050_001',19285),('IMPC_XRY_051_001',19286),('IMPC_XRY_052_001',19287),('IMPC_XRY_053_001',19288),('IMPC_XRY_054_001',19289),('IMPC_XRY_055_001',19290),('IMPC_XRY_056_001',19291),('IMPC_XRY_057_001',19292),('IMPC_XRY_058_001',19293),('IMPC_XRY_059_001',19294),('IMPC_XRY_060_001',19295),('IMPC_XRY_061_001',19296),('IMPC_XRY_062_001',19297),('IMPC_XRY_063_001',19298),('IMPC_XRY_064_001',19299),('IMPC_XRY_065_001',19300),('IMPC_XRY_066_001',19301),('IMPC_XRY_067_001',19302),('IMPC_XRY_068_001',19303),('IMPC_EYE_001_001',20252),('IMPC_EYE_002_001',20253),('IMPC_EYE_003_001',20254),('IMPC_EYE_004_001',20255),('IMPC_EYE_005_001',20256),('IMPC_EYE_006_001',20257),('IMPC_EYE_007_001',20258),('IMPC_EYE_008_001',20259),('IMPC_EYE_009_001',20260),('IMPC_EYE_010_001',20261),('IMPC_EYE_011_001',20262),('IMPC_EYE_012_001',20263),('IMPC_EYE_013_001',20264),('IMPC_EYE_014_001',20265),('IMPC_EYE_015_001',20266),('IMPC_EYE_016_001',20267),('IMPC_EYE_017_001',20268),('IMPC_EYE_018_001',20269),('IMPC_EYE_019_001',20270),('IMPC_EYE_020_001',20271),('IMPC_EYE_021_001',20272),('IMPC_EYE_022_001',20273),('IMPC_EYE_023_001',20274),('IMPC_EYE_024_001',20275),('IMPC_EYE_025_001',20276),('IMPC_EYE_026_001',20277),('IMPC_EYE_027_001',20278),('IMPC_EYE_028_001',20279),('IMPC_EYE_029_001',20280),('IMPC_EYE_030_001',20281),('IMPC_EYE_031_001',20282),('IMPC_EYE_032_001',20283),('IMPC_EYE_033_001',20284),('IMPC_EYE_034_001',20285),('IMPC_EYE_035_001',20286),('IMPC_EYE_036_001',20287),('IMPC_EYE_037_001',20288),('IMPC_EYE_038_001',20289),('IMPC_EYE_039_001',20290),('IMPC_EYE_040_001',20291),('IMPC_EYE_041_001',20292),('IMPC_EYE_042_001',20293),('IMPC_EYE_043_001',20294),('IMPC_EYE_044_001',20295),('IMPC_EYE_045_001',20296),('IMPC_EYE_046_001',20297),('IMPC_EYE_047_001',20298),('IMPC_EYE_048_001',20299),('IMPC_EYE_049_001',20300),('IMPC_EYE_050_001',20301),('IMPC_EYE_051_001',20302),('IMPC_EYE_052_001',20303),('IMPC_EYE_053_001',20304),('IMPC_EYE_054_001',20305),('IMPC_EYE_055_001',20306),('IMPC_EYE_056_001',20307),('IMPC_EYE_057_001',20308),('IMPC_EYE_058_001',20309),('IMPC_EYE_059_001',20310),('IMPC_EYE_060_001',20311),('IMPC_EYE_061_001',20312),('IMPC_EYE_062_001',20313),('IMPC_EYE_063_001',20314),('IMPC_EYE_064_001',20315),('IMPC_EYE_065_001',20316),('IMPC_EYE_066_001',20317),('IMPC_EYE_067_001',20318),('IMPC_EYE_068_001',20319),('IMPC_EYE_069_001',20320),('IMPC_EYE_070_001',20321),('IMPC_EYE_071_001',20322),('IMPC_EYE_072_001',20323),('IMPC_EYE_073_001',20324),('IMPC_EYE_074_001',20325),('IMPC_EYE_075_001',20326),('IMPC_EYE_076_001',20327),('IMPC_EYE_077_001',20328),('IMPC_EYE_078_001',20329),('IMPC_EYE_079_001',20330),('IMPC_EYE_080_001',20331),('IMPC_EYE_081_001',20332),('IMPC_EYE_082_001',20333),('IMPC_EYE_083_001',20334),('IMPC_EYE_084_001',20335),('IMPC_EYE_085_001',20336),('IMPC_EYE_086_001',20337),('IMPC_EYE_087_001',20338),('IMPC_EYE_088_001',20339),('IMPC_EYE_089_001',20340),('IMPC_EYE_090_001',20341),('IMPC_EYE_091_001',20342),('IMPC_EYE_092_001',20343),('IMPC_HEM_001_001',21172),('IMPC_HEM_002_001',21173),('IMPC_HEM_003_001',21174),('IMPC_HEM_004_001',21175),('IMPC_HEM_005_001',21176),('IMPC_HEM_006_001',21177),('IMPC_HEM_007_001',21178),('IMPC_HEM_008_001',21179),('IMPC_HEM_009_001',21180),('IMPC_HEM_010_001',21181),('IMPC_HEM_011_001',21182),('IMPC_HEM_012_001',21183),('IMPC_HEM_013_001',21184),('IMPC_HEM_014_001',21185),('IMPC_HEM_018_001',21186),('IMPC_HEM_020_001',21187),('IMPC_HEM_021_001',21188),('IMPC_HEM_022_001',21189),('IMPC_HEM_023_001',21190),('IMPC_HEM_024_001',21191),('IMPC_HEM_025_001',21192),('IMPC_HEM_026_001',21193),('IMPC_HEM_015_001',21194),('IMPC_HEM_016_001',21195),('IMPC_HEM_017_001',21196),('IMPC_HEM_019_001',21197),('IMPC_HEM_027_001',21198),('IMPC_CBC_001_001',21452),('IMPC_CBC_002_001',21453),('IMPC_CBC_003_001',21454),('IMPC_CBC_004_001',21455),('IMPC_CBC_005_001',21456),('IMPC_CBC_006_001',21457),('IMPC_CBC_007_001',21458),('IMPC_CBC_008_001',21459),('IMPC_CBC_009_001',21460),('IMPC_CBC_010_001',21461),('IMPC_CBC_011_001',21462),('IMPC_CBC_012_001',21463),('IMPC_CBC_013_001',21464),('IMPC_CBC_014_001',21465),('IMPC_CBC_015_001',21466),('IMPC_CBC_016_001',21467),('IMPC_CBC_017_001',21468),('IMPC_CBC_018_001',21469),('IMPC_CBC_019_001',21470),('IMPC_CBC_020_001',21471),('IMPC_CBC_021_001',21472),('IMPC_CBC_022_001',21473),('IMPC_CBC_023_001',21474),('IMPC_CBC_024_001',21475),('IMPC_CBC_025_001',21476),('IMPC_CBC_026_001',21477),('IMPC_CBC_027_001',21478),('IMPC_CBC_028_001',21479),('IMPC_CBC_029_001',21480),('IMPC_CBC_030_001',21481),('IMPC_CBC_031_001',21482),('IMPC_CBC_032_001',21483),('IMPC_CBC_033_001',21484),('IMPC_CBC_034_001',21485),('IMPC_CBC_035_001',21486),('IMPC_CBC_036_001',21487),('IMPC_CBC_037_001',21488),('IMPC_CBC_038_001',21489),('IMPC_CBC_042_001',21490),('IMPC_CBC_043_001',21491),('IMPC_CBC_044_001',21492),('IMPC_CBC_045_001',21493),('IMPC_CBC_046_001',21494),('IMPC_CBC_047_001',21495),('IMPC_CBC_048_001',21496),('IMPC_CBC_049_001',21497),('IMPC_CBC_050_001',21498),('IMPC_CBC_039_001',21499),('IMPC_CBC_040_001',21500),('IMPC_CBC_041_001',21501),('IMPC_CBC_051_001',21502),('IMPC_CBC_052_001',21503),('IMPC_CBC_053_001',21504),('IMPC_CBC_054_001',21505),('IMPC_CBC_060_001',21506),('IMPC_INS_001_001',21861),('IMPC_INS_002_001',21862),('IMPC_INS_003_001',21863),('IMPC_INS_004_001',21864),('IMPC_INS_005_001',21865),('IMPC_INS_006_001',21866),('IMPC_INS_007_001',21867),('IMPC_INS_008_001',21868),('IMPC_INS_009_001',21869),('IMPC_INS_010_001',21870),('IMPC_INS_011_001',21871),('IMPC_INS_012_001',21872),('IMPC_INS_013_001',21873),('IMPC_INS_014_001',21874),('IMPC_INS_015_001',21875),('IMPC_INS_016_001',21876),('IMPC_INS_017_001',21877),('IMPC_INS_018_001',21878),('IMPC_INS_019_001',21879),('IMPC_INS_020_001',21880),('IMPC_INS_021_001',21881),('IMPC_INS_022_001',21882),('IMPC_PAT_001_001',22110),('IMPC_PAT_002_001',22111),('IMPC_PAT_003_001',22112),('IMPC_PAT_004_001',22113),('IMPC_PAT_005_001',22114),('IMPC_PAT_006_001',22115),('IMPC_PAT_007_001',22116),('IMPC_PAT_008_001',22117),('IMPC_PAT_009_001',22118),('IMPC_PAT_010_001',22119),('IMPC_PAT_011_001',22120),('IMPC_PAT_012_001',22121),('IMPC_PAT_013_001',22122),('IMPC_PAT_014_001',22123),('IMPC_PAT_015_001',22124),('IMPC_PAT_016_001',22125),('IMPC_PAT_017_001',22126),('IMPC_PAT_018_001',22127),('IMPC_PAT_019_001',22128),('IMPC_PAT_020_001',22129),('IMPC_PAT_021_001',22130),('IMPC_PAT_022_001',22131),('IMPC_PAT_023_001',22132),('IMPC_PAT_024_001',22133),('IMPC_PAT_025_001',22134),('IMPC_PAT_026_001',22135),('IMPC_PAT_027_001',22136),('IMPC_PAT_028_001',22137),('IMPC_PAT_029_001',22138),('IMPC_PAT_049_001',22139),('IMPC_PAT_052_001',22140),('IMPC_PAT_054_001',22141),('IMPC_PAT_055_001',22142),('IMPC_PAT_056_001',22143),('IMPC_PAT_057_001',22144),('IMPC_PAT_058_001',22145),('IMPC_PAT_059_001',22146),('IMPC_PAT_060_001',22147),('IMPC_PAT_061_001',22148),('IMPC_PAT_030_001',22149),('IMPC_PAT_031_001',22150),('IMPC_PAT_032_001',22151),('IMPC_HWT_003_001',22503),('IMPC_HWT_005_001',22504),('IMPC_HWT_006_001',22505),('IMPC_HWT_007_001',22506),('IMPC_HWT_008_001',22507),('IMPC_HWT_009_001',22508),('IMPC_HWT_010_001',22509),('IMPC_HWT_011_001',22510),('IMPC_HWT_001_001',22511),('IMPC_HWT_002_001',22512),('IMPC_HWT_012_001',22513),('IMPC_HWT_013_001',22514),('IMPC_BLK_003_001',22656),('IMPC_BLK_006_001',22657),('IMPC_BLK_007_001',22658),('IMPC_BLK_008_001',22659),('IMPC_BLK_009_001',22660),('IMPC_BLK_010_001',22661),('IMPC_BLK_011_001',22662),('IMPC_BLK_012_001',22663),('IMPC_BLK_013_001',22664),('IMPC_BLK_014_001',22665),('IMPC_BLK_015_001',22666),('IMPC_BLK_016_001',22667),('IMPC_BLK_017_001',22668),('IMPC_BLK_018_001',22669),('IMPC_BLK_019_001',22670),('IMPC_BLK_020_001',22671),('IMPC_BLK_021_001',22672),('IMPC_BLK_022_001',22673),('IMPC_BLK_023_001',22674),('IMPC_BLK_024_001',22675),('IMPC_BLK_025_001',22676),('IMPC_BLK_026_001',22677),('IMPC_BLK_027_001',22678),('IMPC_BLK_028_001',22679),('IMPC_BLK_029_001',22680),('IMPC_BLK_030_001',22681),('IMPC_BLK_031_001',22682),('IMPC_BLK_032_001',22683),('IMPC_BLK_033_001',22684),('IMPC_BLK_034_001',22685),('IMPC_BLK_035_001',22686),('IMPC_BLK_036_001',22687),('IMPC_BLK_037_001',22688),('IMPC_BLK_038_001',22689),('IMPC_BLK_039_001',22690),('IMPC_BLK_040_001',22691),('IMPC_BLK_041_001',22692),('IMPC_BLK_042_001',22693),('IMPC_BLK_001_001',22694),('IMPC_BLK_002_001',22695),('IMPC_BLK_043_001',22696),('IMPC_BLK_044_001',22697),('IMPC_BLK_045_001',22698),('IMPC_BLK_046_001',22699),('IMPC_BLK_047_001',22700),('IMPC_BLK_048_001',22701),('IMPC_BLK_049_001',22702),('IMPC_BLK_050_001',22703),('IMPC_BLK_051_001',22704),('IMPC_BLK_052_001',22705),('IMPC_BLK_053_001',22706),('IMPC_BLK_054_001',22707),('IMPC_BLK_055_001',22708),('IMPC_BLK_056_001',22709),('IMPC_HIS_001_001',23608),('IMPC_HIS_002_001',23609),('IMPC_HIS_003_001',23610),('IMPC_HIS_004_001',23611),('IMPC_HIS_005_001',23612),('IMPC_HIS_006_001',23613),('IMPC_HIS_007_001',23614),('IMPC_HIS_008_001',23615),('IMPC_HIS_009_001',23616),('IMPC_HIS_010_001',23617),('IMPC_HIS_011_001',23618),('IMPC_HIS_012_001',23619),('IMPC_HIS_013_001',23620),('IMPC_HIS_014_001',23621),('IMPC_HIS_015_001',23622),('IMPC_HIS_016_001',23623),('IMPC_HIS_017_001',23624),('IMPC_HIS_018_001',23625),('IMPC_HIS_019_001',23626),('IMPC_HIS_020_001',23627),('IMPC_HIS_021_001',23628),('IMPC_HIS_022_001',23629),('IMPC_HIS_023_001',23630),('IMPC_HIS_024_001',23631),('IMPC_HIS_025_001',23632),('IMPC_HIS_026_001',23633),('IMPC_HIS_027_001',23634),('IMPC_HIS_028_001',23635),('IMPC_HIS_029_001',23636),('IMPC_HIS_030_001',23637),('IMPC_HIS_031_001',23638),('IMPC_HIS_032_001',23639),('IMPC_HIS_033_001',23640),('IMPC_HIS_034_001',23641),('IMPC_HIS_035_001',23642),('IMPC_HIS_036_001',23643),('IMPC_HIS_037_001',23644),('IMPC_HIS_038_001',23645),('IMPC_HIS_039_001',23646),('IMPC_HIS_040_001',23647),('IMPC_HIS_041_001',23648),('IMPC_HIS_042_001',23649),('IMPC_HIS_043_001',23650),('IMPC_HIS_044_001',23651),('IMPC_HIS_045_001',23652),('IMPC_HIS_046_001',23653),('IMPC_HIS_047_001',23654),('IMPC_HIS_048_001',23655),('IMPC_HIS_049_001',23656),('IMPC_HIS_050_001',23657),('IMPC_HIS_051_001',23658),('IMPC_HIS_052_001',23659),('IMPC_HIS_053_001',23660),('IMPC_HIS_054_001',23661),('IMPC_HIS_055_001',23662),('IMPC_HIS_056_001',23663),('IMPC_HIS_057_001',23664),('IMPC_HIS_058_001',23665),('IMPC_HIS_059_001',23666),('IMPC_HIS_060_001',23667),('IMPC_HIS_061_001',23668),('IMPC_HIS_062_001',23669),('IMPC_HIS_063_001',23670),('IMPC_HIS_064_001',23671),('IMPC_HIS_065_001',23672),('IMPC_HIS_066_001',23673),('IMPC_HIS_067_001',23674),('IMPC_HIS_068_001',23675),('IMPC_HIS_069_001',23676),('IMPC_HIS_070_001',23677),('IMPC_HIS_071_001',23678),('IMPC_HIS_072_001',23679),('IMPC_HIS_073_001',23680),('IMPC_HIS_074_001',23681),('IMPC_HIS_075_001',23682),('IMPC_HIS_076_001',23683),('IMPC_HIS_077_001',23684),('IMPC_HIS_078_001',23685),('IMPC_HIS_079_001',23686),('IMPC_HIS_080_001',23687),('IMPC_HIS_081_001',23688),('IMPC_HIS_082_001',23689),('IMPC_HIS_083_001',23690),('IMPC_HIS_084_001',23691),('IMPC_HIS_085_001',23692),('IMPC_HIS_086_001',23693),('IMPC_HIS_087_001',23694),('IMPC_HIS_088_001',23695),('IMPC_HIS_089_001',23696),('IMPC_HIS_090_001',23697),('IMPC_HIS_091_001',23698),('IMPC_HIS_092_001',23699),('IMPC_HIS_093_001',23700),('IMPC_HIS_094_001',23701),('IMPC_HIS_095_001',23702),('IMPC_HIS_096_001',23703),('IMPC_HIS_097_001',23704),('IMPC_HIS_098_001',23705),('IMPC_HIS_099_001',23706),('IMPC_HIS_100_001',23707),('IMPC_HIS_101_001',23708),('IMPC_HIS_102_001',23709),('IMPC_HIS_103_001',23710),('IMPC_HIS_104_001',23711),('IMPC_HIS_105_001',23712),('IMPC_HIS_106_001',23713),('IMPC_HIS_107_001',23714),('IMPC_HIS_108_001',23715),('IMPC_HIS_109_001',23716),('IMPC_HIS_110_001',23717),('IMPC_HIS_111_001',23718),('IMPC_HIS_112_001',23719),('IMPC_HIS_113_001',23720),('IMPC_HIS_114_001',23721),('IMPC_HIS_115_001',23722),('IMPC_HIS_116_001',23723),('IMPC_HIS_117_001',23724),('IMPC_HIS_118_001',23725),('IMPC_HIS_119_001',23726),('IMPC_HIS_120_001',23727),('IMPC_HIS_121_001',23728),('IMPC_HIS_122_001',23729),('IMPC_HIS_123_001',23730),('IMPC_HIS_124_001',23731),('IMPC_HIS_125_001',23732),('IMPC_HIS_126_001',23733),('IMPC_HIS_127_001',23734),('IMPC_HIS_128_001',23735),('IMPC_HIS_129_001',23736),('IMPC_HIS_130_001',23737),('IMPC_HIS_131_001',23738),('IMPC_HIS_132_001',23739),('IMPC_HIS_133_001',23740),('IMPC_HIS_134_001',23741),('IMPC_HIS_135_001',23742),('IMPC_HIS_136_001',23743),('IMPC_HIS_137_001',23744),('IMPC_HIS_138_001',23745),('IMPC_HIS_139_001',23746),('IMPC_HIS_140_001',23747),('IMPC_HIS_141_001',23748),('IMPC_HIS_142_001',23749),('IMPC_HIS_143_001',23750),('IMPC_HIS_144_001',23751),('IMPC_HIS_145_001',23752),('IMPC_HIS_146_001',23753),('IMPC_HIS_147_001',23754),('IMPC_HIS_148_001',23755),('IMPC_HIS_149_001',23756),('IMPC_HIS_150_001',23757),('IMPC_HIS_151_001',23758),('IMPC_HIS_152_001',23759),('IMPC_HIS_153_001',23760),('IMPC_HIS_154_001',23761),('IMPC_HIS_155_001',23762),('IMPC_HIS_156_001',23763),('IMPC_HIS_157_001',23764),('IMPC_HIS_158_001',23765),('IMPC_HIS_159_001',23766),('IMPC_HIS_160_001',23767),('IMPC_HIS_161_001',23768),('IMPC_HIS_162_001',23769),('IMPC_HIS_163_001',23770),('IMPC_HIS_164_001',23771),('IMPC_HIS_165_001',23772),('IMPC_HIS_166_001',23773),('IMPC_HIS_167_001',23774),('IMPC_HIS_168_001',23775),('IMPC_HIS_169_001',23776),('IMPC_HIS_170_001',23777),('IMPC_HIS_171_001',23778),('IMPC_HIS_172_001',23779),('IMPC_HIS_173_001',23780),('IMPC_HIS_174_001',23781),('IMPC_HIS_175_001',23782),('IMPC_HIS_176_001',23783),('IMPC_HIS_177_001',23784),('IMPC_HIS_178_001',23785),('IMPC_HIS_179_001',23786),('IMPC_HIS_180_001',23787),('IMPC_HIS_181_001',23788),('IMPC_HIS_182_001',23789),('IMPC_HIS_183_001',23790),('IMPC_HIS_184_001',23791),('IMPC_HIS_185_001',23792),('IMPC_HIS_186_001',23793),('IMPC_HIS_187_001',23794),('IMPC_HIS_188_001',23795),('IMPC_HIS_189_001',23796),('IMPC_HIS_190_001',23797),('IMPC_HIS_191_001',23798),('IMPC_HIS_192_001',23799),('IMPC_HIS_193_001',23800),('IMPC_HIS_194_001',23801),('IMPC_HIS_195_001',23802),('IMPC_HIS_196_001',23803),('IMPC_HIS_197_001',23804),('IMPC_HIS_198_001',23805),('IMPC_HIS_199_001',23806),('IMPC_HIS_200_001',23807),('IMPC_HIS_201_001',23808),('IMPC_HIS_202_001',23809),('IMPC_HIS_203_001',23810),('IMPC_HIS_204_001',23811),('IMPC_HIS_205_001',23812),('IMPC_HIS_206_001',23813),('IMPC_HIS_207_001',23814),('IMPC_HIS_208_001',23815),('IMPC_HIS_209_001',23816),('IMPC_HIS_210_001',23817),('IMPC_HIS_211_001',23818),('IMPC_HIS_212_001',23819),('IMPC_HIS_213_001',23820),('IMPC_HIS_214_001',23821),('IMPC_HIS_215_001',23822),('IMPC_HIS_216_001',23823),('IMPC_HIS_217_001',23824),('IMPC_HIS_218_001',23825),('IMPC_HIS_219_001',23826),('IMPC_HIS_220_001',23827),('IMPC_HIS_221_001',23828),('IMPC_HIS_222_001',23829),('IMPC_HIS_223_001',23830),('IMPC_HIS_224_001',23831),('IMPC_HIS_225_001',23832),('IMPC_HIS_226_001',23833),('IMPC_HIS_227_001',23834),('IMPC_HIS_228_001',23835),('IMPC_HIS_229_001',23836),('IMPC_HIS_230_001',23837),('IMPC_HIS_231_001',23838),('IMPC_HIS_232_001',23839),('IMPC_HIS_233_001',23840),('IMPC_HIS_234_001',23841),('IMPC_HIS_235_001',23842),('IMPC_HIS_236_001',23843),('IMPC_HIS_237_001',23844),('IMPC_HIS_238_001',23845),('IMPC_HIS_239_001',23846),('IMPC_HIS_240_001',23847),('IMPC_HIS_241_001',23848),('IMPC_HIS_242_001',23849),('IMPC_HIS_243_001',23850),('IMPC_HIS_244_001',23851),('IMPC_HIS_245_001',23852),('IMPC_HIS_246_001',23853),('IMPC_HIS_247_001',23854),('IMPC_HIS_248_001',23855),('IMPC_HIS_249_001',23856),('IMPC_HIS_250_001',23857),('IMPC_HIS_251_001',23858),('IMPC_HIS_252_001',23859),('IMPC_HIS_253_001',23860),('IMPC_HIS_254_001',23861),('IMPC_HIS_255_001',23862),('IMPC_HIS_256_001',23863),('IMPC_HIS_257_001',23864),('IMPC_HIS_258_001',23865),('IMPC_HIS_259_001',23866),('IMPC_HIS_260_001',23867),('IMPC_HIS_261_001',23868),('IMPC_HIS_262_001',23869),('IMPC_HIS_263_001',23870),('IMPC_HIS_264_001',23871),('IMPC_HIS_265_001',23872),('IMPC_HIS_266_001',23873),('IMPC_HIS_267_001',23874),('IMPC_HIS_268_001',23875),('IMPC_HIS_269_001',23876),('IMPC_HIS_270_001',23877),('IMPC_HIS_271_001',23878),('IMPC_HIS_272_001',23879),('IMPC_HIS_273_001',23880),('IMPC_HIS_274_001',23881),('IMPC_HIS_275_001',23882),('IMPC_HIS_276_001',23883),('IMPC_HIS_277_001',23884),('IMPC_HIS_278_001',23885),('IMPC_HIS_279_001',23886),('IMPC_HIS_280_001',23887),('IMPC_HIS_281_001',23888),('IMPC_HIS_282_001',23889),('IMPC_HIS_283_001',23890),('IMPC_HIS_284_001',23891),('IMPC_HIS_285_001',23892),('IMPC_HIS_286_001',23893),('IMPC_HIS_287_001',23894),('IMPC_HIS_288_001',23895),('IMPC_HIS_289_001',23896),('IMPC_HIS_290_001',23897),('IMPC_HIS_291_001',23898),('IMPC_HIS_292_001',23899),('IMPC_HIS_293_001',23900),('IMPC_HIS_294_001',23901),('IMPC_HIS_295_001',23902),('IMPC_HIS_296_001',23903),('IMPC_HIS_297_001',23904),('IMPC_HIS_298_001',23905),('IMPC_HIS_299_001',23906),('IMPC_HIS_300_001',23907),('IMPC_HIS_301_001',23908),('IMPC_HIS_302_001',23909),('IMPC_HIS_303_001',23910),('IMPC_HIS_304_001',23911),('IMPC_HIS_305_001',23912),('IMPC_HIS_306_001',23913),('IMPC_HIS_307_001',23914),('IMPC_HIS_308_001',23915),('IMPC_HIS_309_001',23916),('IMPC_HIS_310_001',23917),('IMPC_HIS_311_001',23918),('IMPC_HIS_312_001',23919),('IMPC_HIS_313_001',23920),('IMPC_HIS_314_001',23921),('IMPC_HIS_315_001',23922),('IMPC_HIS_316_001',23923),('IMPC_HIS_317_001',23924),('IMPC_HIS_318_001',23925),('IMPC_HIS_319_001',23926),('IMPC_HIS_320_001',23927),('IMPC_HIS_321_001',23928),('IMPC_HIS_322_001',23929),('IMPC_HIS_323_001',23930),('IMPC_HIS_324_001',23931),('IMPC_HIS_325_001',23932),('IMPC_HIS_326_001',23933),('IMPC_HIS_327_001',23934),('IMPC_HIS_328_001',23935),('IMPC_HIS_329_001',23936),('IMPC_HIS_330_001',23937),('IMPC_HIS_331_001',23938),('IMPC_HIS_332_001',23939),('IMPC_HIS_333_001',23940),('IMPC_HIS_334_001',23941),('IMPC_HIS_335_001',23942),('IMPC_HIS_336_001',23943),('IMPC_HIS_337_001',23944),('IMPC_HIS_338_001',23945),('IMPC_HIS_339_001',23946),('IMPC_HIS_340_001',23947),('IMPC_HIS_341_001',23948),('IMPC_HIS_342_001',23949),('IMPC_HIS_343_001',23950),('IMPC_HIS_344_001',23951),('IMPC_HIS_345_001',23952),('IMPC_HIS_346_001',23953),('IMPC_HIS_347_001',23954),('IMPC_HIS_348_001',23955),('IMPC_HIS_349_001',23956),('IMPC_BWT_001_001',27185),('IMPC_BWT_002_001',27186),('IMPC_BWT_003_001',27187),('IMPC_BWT_004_001',27188),('IMPC_BWT_005_001',27189),('IMPC_BWT_006_001',27190),('IMPC_BWT_007_001',27191),('IMPC_BWT_008_001',27192),('IMPC_FER_001_001',27320),('IMPC_FER_002_001',27321),('IMPC_FER_003_001',27322),('IMPC_FER_004_001',27323),('IMPC_FER_005_001',27324),('IMPC_FER_006_001',27325),('IMPC_FER_007_001',27326),('IMPC_FER_008_001',27327),('IMPC_FER_009_001',27328),('IMPC_FER_010_001',27329),('IMPC_FER_011_001',27330),('IMPC_FER_012_001',27331),('IMPC_FER_013_001',27332),('IMPC_FER_014_001',27333),('IMPC_FER_015_001',27334),('IMPC_FER_016_001',27335),('IMPC_FER_017_001',27336),('IMPC_FER_018_001',27337),('IMPC_FER_019_001',27338),('IMPC_FER_020_001',27339),('IMPC_FER_021_001',27340),('IMPC_FER_022_001',27341),('IMPC_FER_023_001',27342),('IMPC_ALZ_001_001',27568),('IMPC_ALZ_002_001',27569),('IMPC_ALZ_003_001',27570),('IMPC_ALZ_004_001',27571),('IMPC_ALZ_005_001',27572),('IMPC_ALZ_006_001',27573),('IMPC_ALZ_007_001',27574),('IMPC_ALZ_008_001',27575),('IMPC_ALZ_009_001',27576),('IMPC_ALZ_010_001',27577),('IMPC_ALZ_011_001',27578),('IMPC_ALZ_012_001',27579),('IMPC_ALZ_013_001',27580),('IMPC_ALZ_014_001',27581),('IMPC_ALZ_015_001',27582),('IMPC_ALZ_016_001',27583),('IMPC_ALZ_017_001',27584),('IMPC_ALZ_018_001',27585),('IMPC_ALZ_019_001',27586),('IMPC_ALZ_020_001',27587),('IMPC_ALZ_021_001',27588),('IMPC_ALZ_022_001',27589),('IMPC_ALZ_023_001',27590),('IMPC_ALZ_024_001',27591),('IMPC_ALZ_025_001',27592),('IMPC_ALZ_026_001',27593),('IMPC_ALZ_027_001',27594),('IMPC_ALZ_028_001',27595),('IMPC_ALZ_029_001',27596),('IMPC_ALZ_030_001',27597),('IMPC_ALZ_031_001',27598),('IMPC_ALZ_032_001',27599),('IMPC_ALZ_033_001',27600),('IMPC_ALZ_034_001',27601),('IMPC_ALZ_035_001',27602),('IMPC_ALZ_036_001',27603),('IMPC_ALZ_037_001',27604),('IMPC_ALZ_038_001',27605),('IMPC_ALZ_039_001',27606),('IMPC_ALZ_040_001',27607),('IMPC_ALZ_041_001',27608),('IMPC_ALZ_042_001',27609),('IMPC_ALZ_043_001',27610),('IMPC_ALZ_044_001',27611),('IMPC_ALZ_045_001',27612),('IMPC_ALZ_046_001',27613),('IMPC_ALZ_047_001',27614),('IMPC_ALZ_048_001',27615),('IMPC_ALZ_049_001',27616),('IMPC_ALZ_050_001',27617),('IMPC_ALZ_051_001',27618),('IMPC_ALZ_052_001',27619),('IMPC_ALZ_053_001',27620),('IMPC_ALZ_054_001',27621),('IMPC_ALZ_055_001',27622),('IMPC_ALZ_056_001',27623),('IMPC_ALZ_057_001',27624),('IMPC_ALZ_058_001',27625),('IMPC_ALZ_059_001',27626),('IMPC_ALZ_060_001',27627),('IMPC_ALZ_061_001',27628),('IMPC_ALZ_062_001',27629),('IMPC_ALZ_063_001',27630),('IMPC_ALZ_064_001',27631),('IMPC_ALZ_065_001',27632),('IMPC_ALZ_066_001',27633),('IMPC_ALZ_067_001',27634),('IMPC_ALZ_068_001',27635),('IMPC_ALZ_069_001',27636),('IMPC_ALZ_070_001',27637),('IMPC_ALZ_071_001',27638),('IMPC_ALZ_072_001',27639),('IMPC_ALZ_073_001',27640),('IMPC_ALZ_074_001',27641),('IMPC_ALZ_075_001',27642),('IMPC_ALZ_076_001',27643),('IMPC_ALZ_077_001',27644),('IMPC_ALZ_078_001',27645),('IMPC_ALZ_079_001',27646),('IMPC_ALZ_080_001',27647),('IMPC_ALZ_081_001',27648),('IMPC_ALZ_082_001',27649),('IMPC_ALZ_083_001',27650),('IMPC_ALZ_084_001',27651),('IMPC_ALZ_085_001',27652),('IMPC_ALZ_086_001',27653),('IMPC_ALZ_087_001',27654),('IMPC_ALZ_088_001',27655),('IMPC_ALZ_089_001',27656),('IMPC_ALZ_090_001',27657),('IMPC_ALZ_091_001',27658),('IMPC_ALZ_092_001',27659),('IMPC_ALZ_093_001',27660),('IMPC_ALZ_094_001',27661),('IMPC_ALZ_095_001',27662),('IMPC_ALZ_096_001',27663),('IMPC_ALZ_097_001',27664),('IMPC_ALZ_098_001',27665),('IMPC_ALZ_099_001',27666),('IMPC_ALZ_100_001',27667),('IMPC_ALZ_101_001',27668),('IMPC_ALZ_102_001',27669),('IMPC_ALZ_103_001',27670),('IMPC_ALZ_104_001',27671),('IMPC_ALZ_105_001',27672),('IMPC_ECG_001_001',28488),('IMPC_ECG_002_001',28489),('IMPC_ECG_003_001',28490),('IMPC_ECG_004_001',28491),('IMPC_ECG_005_001',28492),('IMPC_ECG_006_001',28493),('IMPC_ECG_007_001',28494),('IMPC_ECG_008_001',28495),('IMPC_ECG_009_001',28496),('IMPC_ECG_010_001',28497),('IMPC_ECG_011_001',28498),('IMPC_ECG_012_001',28499),('IMPC_ECG_013_001',28500),('IMPC_ECG_014_001',28501),('IMPC_ECG_015_001',28502),('IMPC_ECG_016_001',28503),('IMPC_ECG_017_001',28504),('IMPC_ECG_018_001',28505),('IMPC_ECG_019_001',28506),('IMPC_ECG_020_001',28507),('IMPC_ECG_021_001',28508),('IMPC_ECG_022_001',28509),('IMPC_ECG_023_001',28510),('IMPC_ECG_024_001',28511),('IMPC_ECG_025_001',28512),('IMPC_ECG_026_001',28513),('IMPC_ECH_001_001',28674),('IMPC_ECH_002_001',28675),('IMPC_ECH_003_001',28676),('IMPC_ECH_004_001',28677),('IMPC_ECH_005_001',28678),('IMPC_ECH_006_001',28679),('IMPC_ECH_007_001',28680),('IMPC_ECH_008_001',28681),('IMPC_ECH_009_001',28682),('IMPC_ECH_010_001',28683),('IMPC_ECH_011_001',28684),('IMPC_ECH_012_001',28685),('IMPC_ECH_013_001',28686),('IMPC_ECH_014_001',28687),('IMPC_ECH_015_001',28688),('IMPC_ECH_016_001',28689),('IMPC_ECH_017_001',28690),('IMPC_ECH_018_001',28691),('IMPC_ECH_019_001',28692),('IMPC_ECH_020_001',28693),('IMPC_ECH_021_001',28694),('IMPC_ECH_022_001',28695),('IMPC_ECH_023_001',28696),('IMPC_ECH_024_001',28697),('IMPC_ECH_025_001',28698),('IMPC_ACS_001_001',28829),('IMPC_ACS_002_001',28830),('IMPC_ACS_003_001',28831),('IMPC_ACS_004_001',28832),('IMPC_ACS_005_001',28833),('IMPC_ACS_006_001',28834),('IMPC_ACS_007_001',28835),('IMPC_ACS_008_001',28836),('IMPC_ACS_009_001',28837),('IMPC_ACS_010_001',28838),('IMPC_ACS_011_001',28839),('IMPC_ACS_014_001',28840),('IMPC_ACS_015_001',28841),('IMPC_ACS_016_001',28842),('IMPC_ACS_017_001',28843),('IMPC_ACS_018_001',28844),('IMPC_ACS_019_001',28845),('IMPC_ACS_020_001',28846),('IMPC_ACS_021_001',28847),('IMPC_ACS_022_001',28848),('IMPC_ACS_023_001',28849),('IMPC_ACS_024_001',28850),('IMPC_ACS_025_001',28851),('IMPC_ACS_026_001',28852),('IMPC_ACS_027_001',28853),('IMPC_ACS_028_001',28854),('IMPC_ACS_029_001',28855),('IMPC_ACS_030_001',28856),('IMPC_ACS_031_001',28857),('IMPC_ACS_032_001',28858),('IMPC_ACS_033_001',28859),('IMPC_ACS_034_001',28860),('IMPC_ACS_035_001',28861),('IMPC_ACS_036_001',28862),('IMPC_ACS_037_001',28863),('IMPC_ACS_038_001',28864),('IMPC_ACS_013_001',28865),('IMPC_ACS_039_001',28866),('IMPC_ABR_001_001',29207),('IMPC_ABR_002_001',29208),('IMPC_ABR_003_001',29209),('IMPC_ABR_004_001',29210),('IMPC_ABR_005_001',29211),('IMPC_ABR_006_001',29212),('IMPC_ABR_007_001',29213),('IMPC_ABR_008_001',29214),('IMPC_ABR_009_001',29215),('IMPC_ABR_010_001',29216),('IMPC_ABR_011_001',29217),('IMPC_ABR_012_001',29218),('IMPC_ABR_013_001',29219),('IMPC_ABR_014_001',29220),('IMPC_ABR_015_001',29221),('IMPC_ABR_016_001',29222),('IMPC_ABR_017_001',29223),('IMPC_ABR_018_001',29224),('IMPC_ABR_019_001',29225),('IMPC_ABR_020_001',29226),('IMPC_ABR_021_001',29227),('IMPC_ABR_022_001',29228),('IMPC_ABR_023_001',29229),('IMPC_ABR_024_001',29230),('IMPC_ABR_025_001',29231),('IMPC_ABR_026_001',29232),('IMPC_ABR_027_001',29233),('IMPC_ABR_028_001',29234),('IMPC_ABR_029_001',29235),('IMPC_ABR_030_001',29236),('IMPC_ABR_031_001',29237),('IMPC_ABR_032_001',29238),('IMPC_ABR_033_001',29239),('IMPC_ABR_034_001',29240),('IMPC_ABR_035_001',29241),('IMPC_ABR_036_001',29242),('IMPC_ABR_037_001',29243),('IMPC_ABR_038_001',29244),('IMPC_ABR_039_001',29245),('IMPC_ABR_040_001',29246),('IMPC_ABR_041_001',29247),('IMPC_ABR_042_001',29248),('IMPC_ABR_043_001',29249),('IMPC_ABR_044_001',29250),('IMPC_ABR_045_001',29251),('IMPC_ABR_046_001',29252),('IMPC_ABR_048_001',29253),('IMPC_ABR_049_001',29254),('IMPC_ABR_050_001',29255),('IMPC_ABR_051_001',29256),('IMPC_ABR_052_001',29257),('IMPC_ABR_053_001',29258),('IMPC_ABR_054_001',29259),('IMPC_HEM_001_001',29774),('IMPC_HEM_002_001',29775),('IMPC_HEM_003_001',29776),('IMPC_HEM_004_001',29777),('IMPC_HEM_005_001',29778),('IMPC_HEM_006_001',29779),('IMPC_HEM_007_001',29780),('IMPC_HEM_008_001',29781),('IMPC_HEM_009_001',29782),('IMPC_HEM_010_001',29783),('IMPC_HEM_011_001',29784),('IMPC_HEM_012_001',29785),('IMPC_HEM_013_001',29786),('IMPC_HEM_014_001',29787),('IMPC_HEM_018_001',29788),('IMPC_HEM_020_001',29789),('IMPC_HEM_021_001',29790),('IMPC_HEM_023_001',29791),('IMPC_HEM_024_001',29792),('IMPC_HEM_025_001',29793),('IMPC_HEM_026_001',29794),('IMPC_HEM_015_001',29795),('IMPC_HEM_016_001',29796),('IMPC_HEM_017_001',29797),('IMPC_HEM_019_001',29798),('IMPC_HEM_027_001',29799),('IMPC_HEM_028_001',29800),('IMPC_HEM_029_001',29801),('IMPC_HEM_030_001',29802),('IMPC_HEM_031_001',29803),('IMPC_HEM_032_001',29804),('IMPC_HEM_033_001',29805),('IMPC_HEM_034_001',29806),('IMPC_HEM_035_001',29807),('IMPC_HEM_036_001',29808),('IMPC_HEM_037_001',29809),('IMPC_HEM_038_001',29810),('IMPC_HEM_039_001',29811),('IMPC_HEM_040_001',29812),('IMPC_HEM_041_001',29813),('IMPC_HEM_042_001',29814),('IMPC_HEM_043_001',29815),('IMPC_CBC_001_001',30278),('IMPC_CBC_002_001',30279),('IMPC_CBC_003_001',30280),('IMPC_CBC_004_001',30281),('IMPC_CBC_005_001',30282),('IMPC_CBC_006_001',30283),('IMPC_CBC_007_001',30284),('IMPC_CBC_008_001',30285),('IMPC_CBC_009_001',30286),('IMPC_CBC_010_001',30287),('IMPC_CBC_011_001',30288),('IMPC_CBC_012_001',30289),('IMPC_CBC_013_001',30290),('IMPC_CBC_014_001',30291),('IMPC_CBC_015_001',30292),('IMPC_CBC_016_001',30293),('IMPC_CBC_017_001',30294),('IMPC_CBC_018_001',30295),('IMPC_CBC_019_001',30296),('IMPC_CBC_020_001',30297),('IMPC_CBC_021_001',30298),('IMPC_CBC_022_001',30299),('IMPC_CBC_023_001',30300),('IMPC_CBC_024_001',30301),('IMPC_CBC_025_001',30302),('IMPC_CBC_026_001',30303),('IMPC_CBC_027_001',30304),('IMPC_CBC_028_001',30305),('IMPC_CBC_029_001',30306),('IMPC_CBC_030_001',30307),('IMPC_CBC_031_001',30308),('IMPC_CBC_032_001',30309),('IMPC_CBC_033_001',30310),('IMPC_CBC_034_001',30311),('IMPC_CBC_035_001',30312),('IMPC_CBC_036_001',30313),('IMPC_CBC_037_001',30314),('IMPC_CBC_038_001',30315),('IMPC_CBC_042_001',30316),('IMPC_CBC_043_001',30317),('IMPC_CBC_044_001',30318),('IMPC_CBC_045_001',30319),('IMPC_CBC_046_001',30320),('IMPC_CBC_048_001',30321),('IMPC_CBC_049_001',30322),('IMPC_CBC_050_001',30323),('IMPC_CBC_039_001',30324),('IMPC_CBC_040_001',30325),('IMPC_CBC_041_001',30326),('IMPC_CBC_051_001',30327),('IMPC_CBC_052_001',30328),('IMPC_CBC_053_001',30329),('IMPC_CBC_054_001',30330),('IMPC_CBC_055_001',30331),('IMPC_INS_001_001',30750),('IMPC_INS_002_001',30751),('IMPC_INS_003_001',30752),('IMPC_INS_004_001',30753),('IMPC_INS_005_001',30754),('IMPC_INS_006_001',30755),('IMPC_INS_007_001',30756),('IMPC_INS_008_001',30757),('IMPC_INS_009_001',30758),('IMPC_INS_010_001',30759),('IMPC_INS_011_001',30760),('IMPC_INS_012_001',30761),('IMPC_INS_014_001',30762),('IMPC_INS_015_001',30763),('IMPC_INS_016_001',30764),('IMPC_INS_017_001',30765),('IMPC_INS_018_001',30766),('IMPC_INS_019_001',30767),('IMPC_INS_020_001',30768),('IMPC_INS_021_001',30769),('IMPC_INS_022_001',30770),('IMPC_CAL_001_001',30936),('IMPC_CAL_002_001',30937),('IMPC_CAL_003_001',30938),('IMPC_CAL_004_001',30939),('IMPC_CAL_005_001',30940),('IMPC_CAL_006_001',30941),('IMPC_CAL_007_001',30942),('IMPC_CAL_008_001',30943),('IMPC_CAL_009_001',30944),('IMPC_CAL_012_001',30945),('IMPC_CAL_013_001',30946),('IMPC_CAL_014_001',30947),('IMPC_CAL_015_001',30948),('IMPC_CAL_016_001',30949),('IMPC_CAL_017_001',30950),('IMPC_CAL_018_001',30951),('IMPC_CAL_019_001',30952),('IMPC_CAL_021_001',30953),('IMPC_CAL_022_001',30954),('IMPC_CAL_023_001',30955),('IMPC_CAL_024_001',30956),('IMPC_CAL_025_001',30957),('IMPC_CAL_026_001',30958),('IMPC_CAL_010_002',30959),('IMPC_CAL_020_002',30960),('IMPC_CAL_027_001',30961),('IMPC_CAL_028_001',30962),('IMPC_CAL_029_001',30963),('IMPC_CAL_030_001',30964),('IMPC_CAL_031_001',30965),('IMPC_CAL_032_001',30966),('IMPC_CAL_033_001',30967),('IMPC_CAL_034_001',30968),('IMPC_CAL_035_001',30969),('IMPC_CAL_036_001',30970),('IMPC_CAL_037_001',30971),('IMPC_CAL_038_001',30972),('IMPC_CAL_039_001',30973),('IMPC_CAL_040_001',30974),('IMPC_CAL_041_001',30975),('IMPC_VIA_001_001',31377),('IMPC_VIA_002_001',31378),('IMPC_VIA_003_001',31379),('IMPC_VIA_004_001',31380),('IMPC_VIA_005_001',31381),('IMPC_VIA_006_001',31382),('IMPC_VIA_007_001',31383),('IMPC_VIA_008_001',31384),('IMPC_VIA_009_001',31385),('IMPC_VIA_010_001',31386),('IMPC_VIA_011_001',31387),('IMPC_VIA_012_001',31388),('IMPC_VIA_013_001',31389),('IMPC_VIA_014_001',31390),('IMPC_VIA_015_001',31391),('IMPC_VIA_016_001',31392),('IMPC_VIA_017_001',31393),('IMPC_VIA_018_001',31394),('IMPC_VIA_019_001',31395),('IMPC_VIA_020_001',31396),('IMPC_VIA_021_001',31397),('IMPC_VIA_022_001',31398),('IMPC_VIA_023_001',31399),('IMPC_VIA_024_001',31400),('IMPC_VIA_025_001',31401),('IMPC_VIA_026_001',31402),('IMPC_VIA_027_001',31403),('IMPC_VIA_028_001',31404),('IMPC_VIA_029_001',31405),('IMPC_VIA_030_001',31406),('IMPC_VIA_031_001',31407),('IMPC_VIA_032_001',31408),('IMPC_VIA_033_001',31409),('IMPC_CSD_001_001',31881),('IMPC_CSD_002_001',31882),('IMPC_CSD_003_001',31883),('IMPC_CSD_004_001',31884),('IMPC_CSD_005_001',31885),('IMPC_CSD_006_001',31886),('IMPC_CSD_007_001',31887),('IMPC_CSD_008_001',31888),('IMPC_CSD_009_001',31889),('IMPC_CSD_010_001',31890),('IMPC_CSD_011_001',31891),('IMPC_CSD_012_001',31892),('IMPC_CSD_013_001',31893),('IMPC_CSD_014_001',31894),('IMPC_CSD_015_001',31895),('IMPC_CSD_016_001',31896),('IMPC_CSD_017_001',31897),('IMPC_CSD_018_001',31898),('IMPC_CSD_019_001',31899),('IMPC_CSD_020_001',31900),('IMPC_CSD_021_001',31901),('IMPC_CSD_022_001',31902),('IMPC_CSD_023_001',31903),('IMPC_CSD_024_001',31904),('IMPC_CSD_025_001',31905),('IMPC_CSD_026_001',31906),('IMPC_CSD_027_001',31907),('IMPC_CSD_028_001',31908),('IMPC_CSD_029_001',31909),('IMPC_CSD_030_001',31910),('IMPC_CSD_031_001',31911),('IMPC_CSD_032_001',31912),('IMPC_CSD_033_001',31913),('IMPC_CSD_034_001',31914),('IMPC_CSD_035_001',31915),('IMPC_CSD_036_001',31916),('IMPC_CSD_037_001',31917),('IMPC_CSD_038_001',31918),('IMPC_CSD_039_001',31919),('IMPC_CSD_046_001',31920),('IMPC_CSD_047_001',31921),('IMPC_CSD_056_001',31922),('IMPC_CSD_057_001',31923),('IMPC_CSD_058_001',31924),('IMPC_CSD_059_001',31925),('IMPC_CSD_060_001',31926),('IMPC_CSD_061_001',31927),('IMPC_CSD_062_001',31928),('IMPC_CSD_063_001',31929),('IMPC_CSD_064_001',31930),('IMPC_CSD_065_001',31931),('IMPC_CSD_066_001',31932),('IMPC_CSD_067_001',31933),('IMPC_CSD_068_001',31934),('IMPC_CSD_069_001',31935),('IMPC_CSD_070_001',31936),('IMPC_CSD_071_001',31937),('IMPC_CSD_072_001',31938),('IMPC_CSD_073_001',31939),('IMPC_CSD_074_001',31940),('IMPC_CSD_075_001',31941),('IMPC_CSD_076_001',31942),('IMPC_CSD_077_001',31943),('IMPC_CSD_078_001',31944),('IMPC_CSD_079_001',31945),('IMPC_CSD_080_001',31946),('IMPC_CSD_081_001',31947),('IMPC_CSD_082_001',31948),('IMPC_CSD_083_001',31949),('IMPC_CSD_084_001',31950),('IMPC_CSD_085_001',31951),('IMPC_CSD_086_001',31952),('IMPC_CSD_087_001',31953),('IMPC_CSD_040_002',31954),('IMPC_CSD_041_002',31955),('IMPC_CSD_042_002',31956),('IMPC_CSD_043_002',31957),('IMPC_CSD_044_002',31958),('IMPC_CSD_045_002',31959),('IMPC_CSD_048_002',31960),('IMPC_CSD_049_002',31961),('IMPC_CSD_050_002',31962),('IMPC_CSD_051_002',31963),('IMPC_CSD_053_002',31964),('IMPC_CSD_052_002',31965),('IMPC_CSD_054_002',31966),('IMPC_CSD_055_002',31967),('IMPC_ELZ_001_001',32643),('IMPC_ELZ_002_001',32644),('IMPC_ELZ_003_001',32645),('IMPC_ELZ_004_001',32646),('IMPC_ELZ_005_001',32647),('IMPC_ELZ_006_001',32648),('IMPC_ELZ_007_001',32649),('IMPC_ELZ_008_001',32650),('IMPC_ELZ_009_001',32651),('IMPC_ELZ_010_001',32652),('IMPC_ELZ_011_001',32653),('IMPC_ELZ_012_001',32654),('IMPC_ELZ_013_001',32655),('IMPC_ELZ_014_001',32656),('IMPC_ELZ_015_001',32657),('IMPC_ELZ_016_001',32658),('IMPC_ELZ_017_001',32659),('IMPC_ELZ_018_001',32660),('IMPC_ELZ_019_001',32661),('IMPC_ELZ_020_001',32662),('IMPC_ELZ_021_001',32663),('IMPC_ELZ_022_001',32664),('IMPC_ELZ_023_001',32665),('IMPC_ELZ_024_001',32666),('IMPC_ELZ_025_001',32667),('IMPC_ELZ_026_001',32668),('IMPC_ELZ_027_001',32669),('IMPC_ELZ_028_001',32670),('IMPC_ELZ_029_001',32671),('IMPC_ELZ_030_001',32672),('IMPC_ELZ_031_001',32673),('IMPC_ELZ_032_001',32674),('IMPC_ELZ_033_001',32675),('IMPC_ELZ_034_001',32676),('IMPC_ELZ_035_001',32677),('IMPC_ELZ_036_001',32678),('IMPC_ELZ_037_001',32679),('IMPC_ELZ_038_001',32680),('IMPC_ELZ_039_001',32681),('IMPC_ELZ_040_001',32682),('IMPC_ELZ_041_001',32683),('IMPC_ELZ_042_001',32684),('IMPC_ELZ_043_001',32685),('IMPC_ELZ_044_001',32686),('IMPC_ELZ_045_001',32687),('IMPC_ELZ_046_001',32688),('IMPC_ELZ_047_001',32689),('IMPC_ELZ_048_001',32690),('IMPC_ELZ_049_001',32691),('IMPC_ELZ_050_001',32692),('IMPC_ELZ_051_001',32693),('IMPC_ELZ_052_001',32694),('IMPC_ELZ_053_001',32695),('IMPC_ELZ_054_001',32696),('IMPC_ELZ_055_001',32697),('IMPC_ELZ_056_001',32698),('IMPC_ELZ_057_001',32699),('IMPC_ELZ_058_001',32700),('IMPC_ELZ_059_001',32701),('IMPC_ELZ_060_001',32702),('IMPC_ELZ_061_001',32703),('IMPC_ELZ_062_001',32704),('IMPC_ELZ_063_001',32705),('IMPC_ELZ_064_001',32706),('IMPC_ELZ_065_001',32707),('IMPC_ELZ_066_001',32708),('IMPC_ELZ_067_001',32709),('IMPC_ELZ_068_001',32710),('IMPC_ELZ_069_001',32711),('IMPC_ELZ_070_001',32712),('IMPC_ELZ_071_001',32713),('IMPC_ELZ_072_001',32714),('IMPC_ELZ_073_001',32715),('IMPC_ELZ_074_001',32716),('IMPC_ELZ_075_001',32717),('IMPC_ELZ_076_001',32718),('IMPC_ELZ_077_001',32719),('IMPC_ELZ_079_001',32720),('IMPC_ELZ_080_001',32721),('IMPC_ELZ_081_001',32722),('IMPC_ELZ_082_001',32723),('IMPC_ELZ_083_001',32724),('IMPC_ELZ_084_001',32725),('IMPC_ELZ_085_001',32726),('IMPC_ELZ_086_001',32727),('IMPC_ELZ_087_001',32728),('IMPC_ELZ_088_001',32729),('IMPC_ELZ_089_001',32730),('IMPC_ELZ_090_001',32731),('IMPC_ELZ_091_001',32732),('IMPC_ELZ_092_001',32733),('IMPC_ELZ_093_001',32734),('IMPC_HOU_001_001',33532),('IMPC_HOU_002_001',33533),('IMPC_HOU_003_001',33534),('IMPC_HOU_004_001',33535),('IMPC_HOU_005_001',33536),('IMPC_HOU_006_001',33537),('IMPC_HOU_007_001',33538),('IMPC_HOU_008_001',33539),('IMPC_HOU_009_001',33540),('IMPC_HOU_010_001',33541),('IMPC_HOU_011_001',33542),('IMPC_HOU_012_001',33543),('IMPC_HOU_013_001',33544),('IMPC_HOU_014_001',33545),('IMPC_HOU_015_001',33546),('IMPC_HOU_016_001',33547),('IMPC_HOU_017_001',33548),('IMPC_HOU_018_001',33549),('IMPC_HOU_019_001',33550),('IMPC_HOU_020_001',33551),('IMPC_HOU_021_001',33552),('IMPC_HOU_022_001',33553),('IMPC_HOU_023_001',33554),('IMPC_HOU_024_001',33555),('IMPC_HOU_025_001',33556),('IMPC_HOU_026_001',33557),('IMPC_HOU_027_001',33558),('IMPC_HOU_028_001',33559),('IMPC_HOU_029_001',33560),('IMPC_HOU_030_001',33561),('IMPC_HOU_031_001',33562),('IMPC_HOU_032_001',33563),('IMPC_HOU_033_001',33564),('IMPC_HOU_034_001',33565),('IMPC_HOU_035_001',33566),('IMPC_HOU_036_001',33567),('IMPC_HOU_037_001',33568),('IMPC_HOU_038_001',33569),('IMPC_HOU_039_001',33570),('IMPC_HOU_040_001',33571),('IMPC_HOU_041_001',33572),('IMPC_HOU_042_001',33573),('IMPC_HOU_043_001',33574),('IMPC_HOU_044_001',33575),('IMPC_HOU_045_001',33576),('IMPC_HOU_046_001',33577),('IMPC_HOU_047_001',33578),('IMPC_HOU_048_001',33579),('IMPC_HOU_049_001',33580),('IMPC_HOU_050_001',33581),('IMPC_HOU_051_001',33582),('IMPC_HOU_052_001',33583),('IMPC_HOU_053_001',33584),('IMPC_HOU_054_001',33585),('IMPC_HOU_055_001',33586),('IMPC_HOU_056_001',33587),('IMPC_HOU_057_001',33588),('IMPC_HOU_058_001',33589),('IMPC_HOU_059_001',33590),('IMPC_HOU_060_001',33591),('IMPC_HOU_061_001',33592),('IMPC_HOU_062_001',33593),('IMPC_HOU_063_001',33594),('IMPC_HOU_064_001',33595),('IMPC_HOU_065_001',33596),('IMPC_HOU_066_001',33597),('IMPC_HOU_067_001',33598),('IMPC_IMM_001_001',34548),('IMPC_IMM_002_001',34549),('IMPC_IMM_003_001',34550),('IMPC_IMM_004_001',34551),('IMPC_IMM_005_001',34552),('IMPC_IMM_006_001',34553),('IMPC_IMM_007_001',34554),('IMPC_IMM_008_001',34555),('IMPC_IMM_009_001',34556),('IMPC_IMM_010_001',34557),('IMPC_IMM_011_001',34558),('IMPC_IMM_012_001',34559),('IMPC_IMM_013_001',34560),('IMPC_IMM_014_001',34561),('IMPC_IMM_015_001',34562),('IMPC_IMM_016_001',34563),('IMPC_IMM_017_001',34564),('IMPC_IMM_018_001',34565),('IMPC_IMM_019_001',34566),('IMPC_IMM_020_001',34567),('IMPC_IMM_021_001',34568),('IMPC_IMM_022_001',34569),('IMPC_IMM_023_001',34570),('IMPC_IMM_024_001',34571),('IMPC_IMM_025_001',34572),('IMPC_IMM_028_001',34573),('IMPC_IMM_029_001',34574),('IMPC_IMM_030_001',34575),('IMPC_IMM_031_001',34576),('IMPC_IMM_032_001',34577),('IMPC_IMM_033_001',34578),('IMPC_IMM_034_001',34579),('IMPC_IMM_035_001',34580),('IMPC_IMM_036_001',34581),('IMPC_IMM_037_001',34582),('IMPC_IMM_038_001',34583),('IMPC_IMM_039_001',34584),('IMPC_IMM_040_001',34585),('IMPC_IMM_041_001',34586),('IMPC_IMM_042_001',34587),('IMPC_IMM_043_001',34588),('IMPC_IMM_044_001',34589),('IMPC_IMM_045_001',34590),('IMPC_IMM_046_001',34591),('IMPC_IMM_047_001',34592),('IMPC_IMM_048_001',34593),('IMPC_IMM_049_001',34594),('IMPC_IMM_050_001',34595),('IMPC_IMM_051_001',34596),('IMPC_IMM_052_001',34597),('IMPC_IMM_053_001',34598),('IMPC_IMM_054_001',34599),('IMPC_IMM_055_001',34600),('IMPC_IMM_056_001',34601),('IMPC_IMM_057_001',34602),('IMPC_IMM_058_001',34603),('IMPC_IMM_059_001',34604),('IMPC_IMM_060_001',34605),('IMPC_IMM_061_001',34606),('IMPC_IMM_062_001',34607),('IMPC_IMM_063_001',34608),('IMPC_IMM_064_001',34609),('IMPC_IMM_065_001',34610),('IMPC_IMM_066_001',34611),('IMPC_IMM_067_001',34612),('IMPC_IMM_068_001',34613),('IMPC_IMM_069_001',34614),('IMPC_IMM_070_001',34615),('IMPC_IMM_071_001',34616),('IMPC_IMM_072_001',34617),('IMPC_IMM_073_001',34618),('IMPC_IMM_074_001',34619),('IMPC_IMM_075_001',34620),('IMPC_IMM_076_001',34621),('IMPC_IMM_077_001',34622),('IMPC_IMM_078_001',34623),('IMPC_IMM_079_001',34624),('IMPC_IMM_080_001',34625),('IMPC_IMM_081_001',34626),('IMPC_IMM_082_001',34627),('IMPC_IMM_083_001',34628),('IMPC_IMM_084_001',34629),('IMPC_IMM_085_001',34630),('IMPC_IMM_086_001',34631),('IMPC_IMM_087_001',34632),('IMPC_IMM_088_001',34633),('IMPC_IMM_089_001',34634),('IMPC_IMM_090_001',34635),('IMPC_IMM_091_001',34636),('IMPC_IMM_092_001',34637),('IMPC_IMM_093_001',34638),('IMPC_IMM_094_001',34639),('IMPC_IMM_095_001',34640),('IMPC_IMM_026_001',34641),('IMPC_IMM_027_001',34642),('IMPC_IMM_096_001',34643),('IMPC_IMM_097_001',34644),('IMPC_IMM_098_001',34645),('IMPC_IMM_099_001',34646),('IMPC_IMM_100_001',34647),('IMPC_IMM_101_001',34648),('IMPC_IMM_102_001',34649),('IMPC_IMM_103_001',34650),('IMPC_IMM_104_001',34651),('IMPC_IMM_105_001',34652),('IMPC_IMM_106_001',34653),('IMPC_IMM_107_001',34654),('IMPC_IMM_108_001',34655),('IMPC_IMM_109_001',34656),('IMPC_IMM_110_001',34657),('IMPC_IMM_111_001',34658),('IMPC_IMM_112_001',34659),('IMPC_IMM_113_001',34660),('IMPC_IMM_114_001',34661),('IMPC_IMM_115_001',34662),('IMPC_ACS_001_001',35564),('IMPC_ACS_002_001',35565),('IMPC_ACS_003_001',35566),('IMPC_ACS_004_001',35567),('IMPC_ACS_005_001',35568),('IMPC_ACS_006_001',35569),('IMPC_ACS_007_001',35570),('IMPC_ACS_008_001',35571),('IMPC_ACS_009_001',35572),('IMPC_ACS_010_001',35573),('IMPC_ACS_011_001',35574),('IMPC_ACS_014_001',35575),('IMPC_ACS_015_001',35576),('IMPC_ACS_016_001',35577),('IMPC_ACS_017_001',35578),('IMPC_ACS_018_001',35579),('IMPC_ACS_019_001',35580),('IMPC_ACS_020_001',35581),('IMPC_ACS_021_001',35582),('IMPC_ACS_022_001',35583),('IMPC_ACS_023_001',35584),('IMPC_ACS_024_001',35585),('IMPC_ACS_025_001',35586),('IMPC_ACS_026_001',35587),('IMPC_ACS_027_001',35588),('IMPC_ACS_028_001',35589),('IMPC_ACS_029_001',35590),('IMPC_ACS_030_001',35591),('IMPC_ACS_031_001',35592),('IMPC_ACS_032_001',35593),('IMPC_ACS_033_001',35594),('IMPC_ACS_034_001',35595),('IMPC_ACS_035_001',35596),('IMPC_ACS_036_001',35597),('IMPC_ACS_037_001',35598),('IMPC_ACS_038_001',35599),('IMPC_ACS_013_001',35600),('IMPC_ACS_039_001',35601),('IMPC_ACS_040_001',35602),('IMPC_EVL_001_001',36068),('IMPC_EVL_002_001',36069),('IMPC_EVL_003_001',36070),('IMPC_EVL_004_001',36071),('IMPC_EVL_005_001',36072),('IMPC_EVL_006_001',36073),('IMPC_EVL_007_001',36074),('IMPC_EVL_008_001',36075),('IMPC_EVL_009_001',36076),('IMPC_EVL_010_001',36077),('IMPC_EVL_011_001',36078),('IMPC_EVL_012_001',36079),('IMPC_EVL_013_001',36080),('IMPC_EVL_014_001',36081),('IMPC_EVL_015_001',36082),('IMPC_EVL_016_001',36083),('IMPC_EVL_017_001',36084),('IMPC_EVL_018_001',36085),('IMPC_EVL_019_001',36086),('IMPC_EVL_020_001',36087),('IMPC_EVL_021_001',36088),('IMPC_EVL_022_001',36089),('IMPC_EVL_023_001',36090),('IMPC_EVL_024_001',36091),('IMPC_EVL_025_001',36092),('IMPC_EVL_026_001',36093),('IMPC_EVL_027_001',36094),('IMPC_EVM_001_001',36285),('IMPC_EVM_002_001',36286),('IMPC_EVM_003_001',36287),('IMPC_EVM_004_001',36288),('IMPC_EVM_005_001',36289),('IMPC_EVM_006_001',36290),('IMPC_EVM_007_001',36291),('IMPC_EVM_008_001',36292),('IMPC_EVM_009_001',36293),('IMPC_EVM_010_001',36294),('IMPC_EVM_011_001',36295),('IMPC_EVM_012_001',36296),('IMPC_EVM_013_001',36297),('IMPC_EVM_014_001',36298),('IMPC_EVM_015_001',36299),('IMPC_EVM_016_001',36300),('IMPC_EVM_017_001',36301),('IMPC_EVM_018_001',36302),('IMPC_EVM_019_001',36303),('IMPC_EVM_020_001',36304),('IMPC_EVM_021_001',36305),('IMPC_EVM_022_001',36306),('IMPC_EVM_023_001',36307),('IMPC_EVM_024_001',36308),('IMPC_EVM_025_001',36309),('IMPC_EVM_026_001',36310),('IMPC_EVM_027_001',36311),('IMPC_EVO_001_001',36471),('IMPC_EVO_002_001',36472),('IMPC_EVO_003_001',36473),('IMPC_EVO_004_001',36474),('IMPC_EVO_005_001',36475),('IMPC_EVO_006_001',36476),('IMPC_EVO_007_001',36477),('IMPC_EVO_008_001',36478),('IMPC_EVO_009_001',36479),('IMPC_EVO_010_001',36480),('IMPC_EVO_011_001',36481),('IMPC_EVO_012_001',36482),('IMPC_EVO_013_001',36483),('IMPC_EVO_014_001',36484),('IMPC_EVO_015_001',36485),('IMPC_EVO_016_001',36486),('IMPC_EVO_017_001',36487),('IMPC_EVO_018_001',36488),('IMPC_EVO_019_001',36489),('IMPC_EVO_020_001',36490),('IMPC_EVO_021_001',36491),('IMPC_EVO_022_001',36492),('IMPC_EVO_023_001',36493),('IMPC_EVO_024_001',36494),('IMPC_EVO_025_001',36495),('IMPC_EVO_026_001',36496),('IMPC_EVO_027_001',36497),('IMPC_EVP_001_001',36688),('IMPC_EVP_002_001',36689),('IMPC_EVP_003_001',36690),('IMPC_EVP_004_001',36691),('IMPC_EVP_005_001',36692),('IMPC_EVP_006_001',36693),('IMPC_EVP_007_001',36694),('IMPC_EVP_008_001',36695),('IMPC_EVP_009_001',36696),('IMPC_EVP_010_001',36697),('IMPC_EVP_011_001',36698),('IMPC_EVP_012_001',36699),('IMPC_EVP_013_001',36700),('IMPC_EVP_014_001',36701),('IMPC_EVP_015_001',36702),('IMPC_EVP_016_001',36703),('IMPC_EVP_017_001',36704),('IMPC_EVP_018_001',36705),('IMPC_EVP_019_001',36706),('IMPC_EVP_020_001',36707),('IMPC_EVP_021_001',36708),('IMPC_EVP_022_001',36709),('IMPC_EVP_023_001',36710),('IMPC_EVP_024_001',36711),('IMPC_EVP_025_001',36712),('IMPC_EVP_026_001',36713),('IMPC_EVP_027_001',36714),('IMPC_PAT_001_002',36937),('IMPC_PAT_002_002',36938),('IMPC_PAT_003_002',36939),('IMPC_PAT_004_002',36940),('IMPC_PAT_005_002',36941),('IMPC_PAT_006_002',36942),('IMPC_PAT_007_002',36943),('IMPC_PAT_008_002',36944),('IMPC_PAT_009_002',36945),('IMPC_PAT_010_002',36946),('IMPC_PAT_011_002',36947),('IMPC_PAT_012_002',36948),('IMPC_PAT_013_002',36949),('IMPC_PAT_014_002',36950),('IMPC_PAT_015_002',36951),('IMPC_PAT_016_002',36952),('IMPC_PAT_017_002',36953),('IMPC_PAT_018_002',36954),('IMPC_PAT_019_002',36955),('IMPC_PAT_020_002',36956),('IMPC_PAT_021_002',36957),('IMPC_PAT_022_002',36958),('IMPC_PAT_023_002',36959),('IMPC_PAT_024_002',36960),('IMPC_PAT_025_002',36961),('IMPC_PAT_026_002',36962),('IMPC_PAT_027_002',36963),('IMPC_PAT_028_002',36964),('IMPC_PAT_029_002',36965),('IMPC_PAT_049_002',36966),('IMPC_PAT_057_002',36967),('IMPC_PAT_032_002',36968),('IMPC_PAT_052_002',36969),('IMPC_PAT_054_002',36970),('IMPC_PAT_055_002',36971),('IMPC_PAT_056_002',36972),('IMPC_PAT_058_002',36973),('IMPC_PAT_059_002',36974),('IMPC_PAT_060_002',36975),('IMPC_PAT_061_002',36976),('IMPC_PAT_030_002',36977),('IMPC_PAT_031_002',36978),('IMPC_PAT_033_001',36979),('IMPC_PAT_034_001',36980),('IMPC_PAT_035_001',36981),('IMPC_PAT_036_001',36982),('IMPC_PAT_062_001',36983),('IMPC_PAT_063_001',36984),('IMPC_PAT_064_001',36985),('IMPC_PAT_065_001',36986),('IMPC_PAT_066_001',36987),('IMPC_PAT_067_001',36988),('IMPC_PAT_068_001',36989),('IMPC_PAT_069_001',36990),('IMPC_PAT_070_001',36991),('IMPC_PAT_071_001',36992),('IMPC_PAT_072_001',36993),('IMPC_PAT_073_001',36994),('IMPC_PAT_074_001',36995),('IMPC_PAT_075_001',36996),('IMPC_PAT_076_001',36997),('IMPC_CBC_001_001',37378),('IMPC_CBC_002_001',37379),('IMPC_CBC_003_001',37380),('IMPC_CBC_004_001',37381),('IMPC_CBC_005_001',37382),('IMPC_CBC_006_001',37383),('IMPC_CBC_007_001',37384),('IMPC_CBC_008_001',37385),('IMPC_CBC_009_001',37386),('IMPC_CBC_010_001',37387),('IMPC_CBC_011_001',37388),('IMPC_CBC_012_001',37389),('IMPC_CBC_013_001',37390),('IMPC_CBC_014_001',37391),('IMPC_CBC_015_001',37392),('IMPC_CBC_016_001',37393),('IMPC_CBC_017_001',37394),('IMPC_CBC_018_001',37395),('IMPC_CBC_019_001',37396),('IMPC_CBC_020_001',37397),('IMPC_CBC_021_001',37398),('IMPC_CBC_022_001',37399),('IMPC_CBC_023_001',37400),('IMPC_CBC_024_001',37401),('IMPC_CBC_025_001',37402),('IMPC_CBC_026_001',37403),('IMPC_CBC_027_001',37404),('IMPC_CBC_028_001',37405),('IMPC_CBC_029_001',37406),('IMPC_CBC_030_001',37407),('IMPC_CBC_031_001',37408),('IMPC_CBC_032_001',37409),('IMPC_CBC_033_001',37410),('IMPC_CBC_034_001',37411),('IMPC_CBC_035_001',37412),('IMPC_CBC_036_001',37413),('IMPC_CBC_037_001',37414),('IMPC_CBC_038_001',37415),('IMPC_CBC_042_001',37416),('IMPC_CBC_043_001',37417),('IMPC_CBC_044_001',37418),('IMPC_CBC_045_001',37419),('IMPC_CBC_046_001',37420),('IMPC_CBC_048_001',37421),('IMPC_CBC_049_001',37422),('IMPC_CBC_050_001',37423),('IMPC_CBC_039_001',37424),('IMPC_CBC_040_001',37425),('IMPC_CBC_041_001',37426),('IMPC_CBC_051_001',37427),('IMPC_CBC_052_001',37428),('IMPC_CBC_053_001',37429),('IMPC_CBC_054_001',37430),('IMPC_CBC_055_001',37431),('IMPC_CBC_056_001',37432),('IMPC_CBC_057_001',37433),('IMPC_CBC_058_001',37434),('IMPC_CBC_059_001',37435),('IMPC_INS_001_001',37882),('IMPC_INS_002_001',37883),('IMPC_INS_003_001',37884),('IMPC_INS_004_001',37885),('IMPC_INS_005_001',37886),('IMPC_INS_006_001',37887),('IMPC_INS_007_001',37888),('IMPC_INS_008_001',37889),('IMPC_INS_009_001',37890),('IMPC_INS_010_001',37891),('IMPC_INS_011_001',37892),('IMPC_INS_012_001',37893),('IMPC_INS_014_001',37894),('IMPC_INS_015_001',37895),('IMPC_INS_016_001',37896),('IMPC_INS_017_001',37897),('IMPC_INS_018_001',37898),('IMPC_INS_019_001',37899),('IMPC_INS_020_001',37900),('IMPC_INS_021_001',37901),('IMPC_INS_022_001',37902),('IMPC_INS_023_001',37903),('IMPC_CSD_001_001',38099),('IMPC_CSD_002_001',38100),('IMPC_CSD_003_001',38101),('IMPC_CSD_004_001',38102),('IMPC_CSD_005_001',38103),('IMPC_CSD_006_001',38104),('IMPC_CSD_007_001',38105),('IMPC_CSD_008_001',38106),('IMPC_CSD_009_001',38107),('IMPC_CSD_010_001',38108),('IMPC_CSD_011_001',38109),('IMPC_CSD_012_001',38110),('IMPC_CSD_013_001',38111),('IMPC_CSD_014_001',38112),('IMPC_CSD_015_001',38113),('IMPC_CSD_016_001',38114),('IMPC_CSD_017_001',38115),('IMPC_CSD_018_001',38116),('IMPC_CSD_019_001',38117),('IMPC_CSD_020_001',38118),('IMPC_CSD_021_001',38119),('IMPC_CSD_022_001',38120),('IMPC_CSD_023_001',38121),('IMPC_CSD_024_001',38122),('IMPC_CSD_025_001',38123),('IMPC_CSD_026_001',38124),('IMPC_CSD_027_001',38125),('IMPC_CSD_028_001',38126),('IMPC_CSD_029_001',38127),('IMPC_CSD_030_001',38128),('IMPC_CSD_031_001',38129),('IMPC_CSD_032_001',38130),('IMPC_CSD_033_001',38131),('IMPC_CSD_034_001',38132),('IMPC_CSD_036_001',38133),('IMPC_CSD_037_001',38134),('IMPC_CSD_038_001',38135),('IMPC_CSD_039_001',38136),('IMPC_CSD_046_001',38137),('IMPC_CSD_047_001',38138),('IMPC_CSD_056_001',38139),('IMPC_CSD_057_001',38140),('IMPC_CSD_058_001',38141),('IMPC_CSD_059_001',38142),('IMPC_CSD_060_001',38143),('IMPC_CSD_061_001',38144),('IMPC_CSD_062_001',38145),('IMPC_CSD_063_001',38146),('IMPC_CSD_064_001',38147),('IMPC_CSD_065_001',38148),('IMPC_CSD_066_001',38149),('IMPC_CSD_067_001',38150),('IMPC_CSD_068_001',38151),('IMPC_CSD_069_001',38152),('IMPC_CSD_070_001',38153),('IMPC_CSD_071_001',38154),('IMPC_CSD_072_001',38155),('IMPC_CSD_073_001',38156),('IMPC_CSD_074_001',38157),('IMPC_CSD_075_001',38158),('IMPC_CSD_076_001',38159),('IMPC_CSD_077_001',38160),('IMPC_CSD_078_001',38161),('IMPC_CSD_079_001',38162),('IMPC_CSD_080_001',38163),('IMPC_CSD_081_001',38164),('IMPC_CSD_082_001',38165),('IMPC_CSD_083_001',38166),('IMPC_CSD_084_001',38167),('IMPC_CSD_085_001',38168),('IMPC_CSD_086_001',38169),('IMPC_CSD_087_001',38170),('IMPC_CSD_040_002',38171),('IMPC_CSD_041_002',38172),('IMPC_CSD_042_002',38173),('IMPC_CSD_043_002',38174),('IMPC_CSD_044_002',38175),('IMPC_CSD_045_002',38176),('IMPC_CSD_048_002',38177),('IMPC_CSD_049_002',38178),('IMPC_CSD_050_002',38179),('IMPC_CSD_051_002',38180),('IMPC_CSD_053_002',38181),('IMPC_CSD_052_002',38182),('IMPC_CSD_054_002',38183),('IMPC_CSD_055_002',38184),('IMPC_EXD_001_001',38988),('IMPC_EXD_002_001',38989),('IMPC_EXD_003_001',38990),('IMPC_EXD_004_001',38991),('IMPC_EXD_005_001',38992),('IMPC_EXD_006_001',38993),('IMPC_EXD_007_001',38994),('IMPC_EXD_008_001',38995),('IMPC_EXD_009_001',38996),('IMPC_EXD_010_001',38997),('IMPC_EXD_011_001',38998),('IMPC_EXD_012_001',38999),('IMPC_EXD_013_001',39000),('IMPC_EXD_014_001',39001),('IMPC_EXD_015_001',39002),('IMPC_EXD_016_001',39003),('IMPC_EXD_017_001',39004),('IMPC_EXD_018_001',39005),('IMPC_EXD_019_001',39006),('IMPC_EXD_020_001',39007),('IMPC_EXD_021_001',39008),('IMPC_EXD_022_001',39009),('IMPC_EXD_023_001',39010),('IMPC_EXD_024_001',39011),('IMPC_EXD_025_001',39012),('IMPC_EXD_026_001',39013),('IMPC_EXD_027_001',39014),('IMPC_EXD_028_001',39015),('IMPC_EXD_029_001',39016),('IMPC_EXD_030_001',39017),('IMPC_EXD_031_001',39018),('IMPC_EXD_032_001',39019),('IMPC_EXD_033_001',39020),('IMPC_EXD_034_001',39021),('IMPC_EXD_035_001',39022),('IMPC_EXD_036_001',39023),('IMPC_EXD_037_001',39024),('IMPC_EXD_038_001',39025),('IMPC_EXD_039_001',39026),('IMPC_EXD_040_001',39027),('IMPC_EXD_041_001',39028),('IMPC_EXD_042_001',39029),('IMPC_EXD_043_001',39030),('IMPC_EXD_044_001',39031),('IMPC_EXD_045_001',39032),('IMPC_EXD_046_001',39033),('IMPC_EXD_047_001',39034),('IMPC_EXD_048_001',39035),('IMPC_EXD_049_001',39036),('IMPC_EXD_050_001',39037),('IMPC_EXD_051_001',39038),('IMPC_EXD_052_001',39039),('IMPC_EXD_053_001',39040),('IMPC_EXD_054_001',39041),('IMPC_EXD_055_001',39042),('IMPC_EXD_056_001',39043),('IMPC_EXD_057_001',39044),('IMPC_EXD_058_001',39045),('IMPC_EXD_059_001',39046),('IMPC_EXD_060_001',39047),('IMPC_EXD_061_001',39048),('IMPC_EXD_062_001',39049),('IMPC_EXD_063_001',39050),('IMPC_EXD_064_001',39051),('IMPC_EXD_065_001',39052),('IMPC_EXD_066_001',39053),('IMPC_EXD_067_001',39054),('IMPC_EXD_068_001',39055),('IMPC_EXD_069_001',39056),('IMPC_EXD_070_001',39057),('IMPC_EXD_071_001',39058),('IMPC_EXD_072_001',39059),('IMPC_EXD_073_001',39060),('IMPC_EXD_074_001',39061),('IMPC_EXD_075_001',39062),('IMPC_EXD_076_001',39063),('IMPC_EXD_077_001',39064),('IMPC_EXD_078_001',39065),('IMPC_EXD_079_001',39066),('IMPC_EXD_080_001',39067),('IMPC_EXD_081_001',39068),('IMPC_EXD_082_001',39069),('IMPC_EXD_083_001',39070),('IMPC_EXD_084_001',39071),('IMPC_EXD_085_001',39072),('IMPC_EXD_086_001',39073),('IMPC_EXD_087_001',39074),('IMPC_EXD_088_001',39075),('IMPC_EXD_089_001',39076),('IMPC_EXD_090_001',39077),('IMPC_EXD_091_001',39078),('IMPC_EXD_092_001',39079),('IMPC_EXD_093_001',39080),('IMPC_EXD_094_001',39081),('IMPC_EXD_095_001',39082),('IMPC_EXD_096_001',39083),('IMPC_EXD_097_001',39084),('IMPC_EXD_098_001',39085),('IMPC_EXD_099_001',39086),('IMPC_EXD_100_001',39087),('IMPC_EXD_101_001',39088),('IMPC_EXD_102_001',39089),('IMPC_EXD_103_001',39090),('IMPC_EXD_104_001',39091),('IMPC_EXD_105_001',39092),('IMPC_EXD_106_001',39093),('IMPC_EXD_107_001',39094),('IMPC_EXD_108_001',39095),('IMPC_EXD_109_001',39096),('IMPC_EXD_110_001',39097),('IMPC_EXD_111_001',39098),('IMPC_EXD_112_001',39099),('IMPC_EXD_113_001',39100),('IMPC_EXD_114_001',39101),('IMPC_EXD_115_001',39102),('IMPC_EXD_116_001',39103),('IMPC_EXD_117_001',39104),('IMPC_EXD_118_001',39105),('IMPC_EXD_119_001',39106),('IMPC_EXD_120_001',39107),('IMPC_EXD_121_001',39108),('IMPC_EXD_122_001',39109),('IMPC_EXD_123_001',39110),('IMPC_EXD_124_001',39111),('IMPC_EXD_125_001',39112),('IMPC_EXD_126_001',39113),('IMPC_GPL_001_001',40004),('IMPC_GPL_002_001',40005),('IMPC_GPL_003_001',40006),('IMPC_GPL_004_001',40007),('IMPC_GPL_005_001',40008),('IMPC_GPL_006_001',40009),('IMPC_GPL_007_001',40010),('IMPC_GPL_008_001',40011),('IMPC_GPL_009_001',40012),('IMPC_GPL_010_001',40013),('IMPC_GPL_011_001',40014),('IMPC_GPL_012_001',40015),('IMPC_GPL_013_001',40016),('IMPC_GPL_014_001',40017),('IMPC_GPL_015_001',40018),('IMPC_GPL_016_001',40019),('IMPC_GPL_017_001',40020),('IMPC_GPM_001_001',40190),('IMPC_GPM_002_001',40191),('IMPC_GPM_003_001',40192),('IMPC_GPM_004_001',40193),('IMPC_GPM_005_001',40194),('IMPC_GPM_006_001',40195),('IMPC_GPM_007_001',40196),('IMPC_GPM_008_001',40197),('IMPC_GPM_009_001',40198),('IMPC_GPM_010_001',40199),('IMPC_GPM_011_001',40200),('IMPC_GPM_012_001',40201),('IMPC_GPM_013_001',40202),('IMPC_GPM_014_001',40203),('IMPC_GPM_015_001',40204),('IMPC_GPM_016_001',40205),('IMPC_GPM_017_001',40206),('IMPC_GPM_018_001',40207),('IMPC_GPO_001_001',40345),('IMPC_GPO_002_001',40346),('IMPC_GPO_003_001',40347),('IMPC_GPO_004_001',40348),('IMPC_GPO_005_001',40349),('IMPC_GPO_006_001',40350),('IMPC_GPO_007_001',40351),('IMPC_GPO_008_001',40352),('IMPC_GPO_009_001',40353),('IMPC_GPO_010_001',40354),('IMPC_GPO_011_001',40355),('IMPC_GPO_012_001',40356),('IMPC_GPO_013_001',40357),('IMPC_GPO_014_001',40358),('IMPC_GPO_015_001',40359),('IMPC_GPO_016_001',40360),('IMPC_GPO_017_001',40361),('IMPC_GPO_018_001',40362),('IMPC_GPP_001_001',40531),('IMPC_GPP_002_001',40532),('IMPC_GPP_003_001',40533),('IMPC_GPP_004_001',40534),('IMPC_GPP_005_001',40535),('IMPC_GPP_006_001',40536),('IMPC_GPP_007_001',40537),('IMPC_GPP_008_001',40538),('IMPC_GPP_009_001',40539),('IMPC_GPP_010_001',40540),('IMPC_GPP_011_001',40541),('IMPC_GPP_012_001',40542),('IMPC_GPP_013_001',40543),('IMPC_GPP_014_001',40544),('IMPC_GPP_015_001',40545),('IMPC_GPP_016_001',40546),('IMPC_GPP_017_001',40547),('IMPC_GPP_018_001',40548),('IMPC_EOL_001_001',40655),('IMPC_EOL_002_001',40656),('IMPC_EOL_003_001',40657),('IMPC_EOL_004_001',40658),('IMPC_EOL_005_001',40659),('IMPC_EOL_006_001',40660),('IMPC_EOL_007_001',40661),('IMPC_EOL_008_001',40662),('IMPC_EOL_009_001',40663),('IMPC_EOL_010_001',40664),('IMPC_EOL_011_001',40665),('IMPC_EOL_012_001',40666),('IMPC_EMO_001_001',40745),('IMPC_EMO_002_001',40746),('IMPC_EMO_003_001',40747),('IMPC_EMO_004_001',40748),('IMPC_EMO_005_001',40749),('IMPC_EMO_006_001',40750),('IMPC_EMO_007_001',40751),('IMPC_EMO_008_001',40752),('IMPC_EMO_009_001',40753),('IMPC_EMO_010_001',40754),('IMPC_EMO_011_001',40755),('IMPC_EMO_012_001',40756),('IMPC_EMO_013_001',40757),('IMPC_EMO_014_001',40758),('IMPC_EMO_015_001',40759),('IMPC_EMO_016_001',40760),('IMPC_EMO_017_001',40761),('IMPC_EMA_001_001',40931),('IMPC_EMA_002_001',40932),('IMPC_EMA_003_001',40933),('IMPC_EMA_004_001',40934),('IMPC_EMA_005_001',40935),('IMPC_EMA_006_001',40936),('IMPC_EMA_007_001',40937),('IMPC_EMA_008_001',40938),('IMPC_EMA_009_001',40939),('IMPC_EMA_010_001',40940),('IMPC_EMA_011_001',40941),('IMPC_EMA_012_001',40942),('IMPC_EMA_013_001',40943),('IMPC_EMA_014_001',40944),('IMPC_EMA_015_001',40945),('IMPC_EMA_016_001',40946),('IMPC_EMA_017_001',40947),('IMPC_CAL_001_001',41404),('IMPC_CAL_002_001',41405),('IMPC_CAL_003_001',41406),('IMPC_CAL_004_001',41407),('IMPC_CAL_005_001',41408),('IMPC_CAL_006_001',41409),('IMPC_CAL_007_001',41410),('IMPC_CAL_008_001',41411),('IMPC_CAL_009_001',41412),('IMPC_CAL_012_001',41413),('IMPC_CAL_013_001',41414),('IMPC_CAL_014_001',41415),('IMPC_CAL_015_001',41416),('IMPC_CAL_016_001',41417),('IMPC_CAL_017_001',41418),('IMPC_CAL_018_001',41419),('IMPC_CAL_019_001',41420),('IMPC_CAL_021_001',41421),('IMPC_CAL_022_001',41422),('IMPC_CAL_023_001',41423),('IMPC_CAL_024_001',41424),('IMPC_CAL_025_001',41425),('IMPC_CAL_026_001',41426),('IMPC_CAL_027_001',41427),('IMPC_CAL_028_001',41428),('IMPC_CAL_029_001',41429),('IMPC_CAL_030_001',41430),('IMPC_CAL_031_001',41431),('IMPC_CAL_032_001',41432),('IMPC_CAL_033_001',41433),('IMPC_CAL_034_001',41434),('IMPC_CAL_035_001',41435),('IMPC_CAL_036_001',41436),('IMPC_CAL_037_001',41437),('IMPC_CAL_038_001',41438),('IMPC_CAL_039_001',41439),('IMPC_CAL_040_001',41440),('IMPC_CAL_041_001',41441),('IMPC_CAL_010_003',41442),('IMPC_CAL_020_003',41443),('IMPC_CAL_042_001',41444),('IMPC_GEL_001_001',41908),('IMPC_GEL_002_001',41909),('IMPC_GEL_003_001',41910),('IMPC_GEL_004_001',41911),('IMPC_GEL_005_001',41912),('IMPC_GEL_006_001',41913),('IMPC_GEL_007_001',41914),('IMPC_GEL_008_001',41915),('IMPC_GEL_009_001',41916),('IMPC_GEL_010_001',41917),('IMPC_GEL_011_001',41918),('IMPC_GEL_012_001',41919),('IMPC_GEL_013_001',41920),('IMPC_GEL_014_001',41921),('IMPC_GEL_015_001',41922),('IMPC_GEL_016_001',41923),('IMPC_GEL_017_001',41924),('IMPC_GEL_018_001',41925),('IMPC_GEL_019_001',41926),('IMPC_GEL_020_001',41927),('IMPC_GEL_021_001',41928),('IMPC_GEL_022_001',41929),('IMPC_GEL_023_001',41930),('IMPC_GEL_024_001',41931),('IMPC_GEL_025_001',41932),('IMPC_GEL_026_001',41933),('IMPC_GEL_027_001',41934),('IMPC_GEL_028_001',41935),('IMPC_GEL_029_001',41936),('IMPC_GEL_030_001',41937),('IMPC_GEL_031_001',41938),('IMPC_GEL_032_001',41939),('IMPC_GEL_033_001',41940),('IMPC_GEL_034_001',41941),('IMPC_GEL_035_001',41942),('IMPC_GEL_036_001',41943),('IMPC_GEL_037_001',41944),('IMPC_GEL_038_001',41945),('IMPC_GEL_039_001',41946),('IMPC_GEL_040_001',41947),('IMPC_GEL_041_001',41948),('IMPC_GEL_042_001',41949),('IMPC_GEL_043_001',41950),('IMPC_GEL_044_001',41951),('IMPC_GEL_045_001',41952),('IMPC_GEL_046_001',41953),('IMPC_GEL_047_001',41954),('IMPC_GEL_048_001',41955),('IMPC_GEL_049_001',41956),('IMPC_GEL_050_001',41957),('IMPC_GEL_051_001',41958),('IMPC_GEL_052_001',41959),('IMPC_GEL_053_001',41960),('IMPC_GEL_054_001',41961),('IMPC_GEL_001_001',42223),('IMPC_GEL_002_001',42224),('IMPC_GEL_003_001',42225),('IMPC_GEL_004_001',42226),('IMPC_GEL_005_001',42227),('IMPC_GEL_006_001',42228),('IMPC_GEL_009_001',42229),('IMPC_GEL_010_001',42230),('IMPC_GEL_011_001',42231),('IMPC_GEL_013_001',42232),('IMPC_GEL_014_001',42233),('IMPC_GEL_015_001',42234),('IMPC_GEL_016_001',42235),('IMPC_GEL_018_001',42236),('IMPC_GEL_019_001',42237),('IMPC_GEL_020_001',42238),('IMPC_GEL_021_001',42239),('IMPC_GEL_022_001',42240),('IMPC_GEL_023_001',42241),('IMPC_GEL_024_001',42242),('IMPC_GEL_025_001',42243),('IMPC_GEL_026_001',42244),('IMPC_GEL_027_001',42245),('IMPC_GEL_028_001',42246),('IMPC_GEL_029_001',42247),('IMPC_GEL_030_001',42248),('IMPC_GEL_031_001',42249),('IMPC_GEL_032_001',42250),('IMPC_GEL_033_001',42251),('IMPC_GEL_034_001',42252),('IMPC_GEL_035_001',42253),('IMPC_GEL_038_001',42254),('IMPC_GEL_039_001',42255),('IMPC_GEL_040_001',42256),('IMPC_GEL_041_001',42257),('IMPC_GEL_042_001',42258),('IMPC_GEL_043_001',42259),('IMPC_GEL_044_001',42260),('IMPC_GEL_045_001',42261),('IMPC_GEL_046_001',42262),('IMPC_GEL_047_001',42263),('IMPC_GEL_048_001',42264),('IMPC_GEL_049_001',42265),('IMPC_GEL_050_001',42266),('IMPC_GEL_051_001',42267),('IMPC_GEL_052_001',42268),('IMPC_GEL_053_001',42269),('IMPC_GEL_054_001',42270),('IMPC_GEL_007_002',42271),('IMPC_GEL_008_002',42272),('IMPC_GEL_012_002',42273),('IMPC_GEL_017_002',42274),('IMPC_GEL_036_002',42275),('IMPC_GEL_037_002',42276),('IMPC_GEL_055_001',42277),('IMPC_GEL_006_001',42538),('IMPC_GEL_011_001',42539),('IMPC_GEL_014_001',42540),('IMPC_GEL_015_001',42541),('IMPC_GEL_018_001',42542),('IMPC_GEL_019_001',42543),('IMPC_GEL_024_001',42544),('IMPC_GEL_027_001',42545),('IMPC_GEL_028_001',42546),('IMPC_GEL_029_001',42547),('IMPC_GEL_030_001',42548),('IMPC_GEL_032_001',42549),('IMPC_GEL_033_001',42550),('IMPC_GEL_038_001',42551),('IMPC_GEL_042_001',42552),('IMPC_GEL_043_001',42553),('IMPC_GEL_044_001',42554),('IMPC_GEL_045_001',42555),('IMPC_GEL_046_001',42556),('IMPC_GEL_047_001',42557),('IMPC_GEL_048_001',42558),('IMPC_GEL_049_001',42559),('IMPC_GEL_050_001',42560),('IMPC_GEL_051_001',42561),('IMPC_GEL_052_001',42562),('IMPC_GEL_053_001',42563),('IMPC_GEL_054_001',42564),('IMPC_GEL_017_002',42565),('IMPC_GEL_036_002',42566),('IMPC_GEL_037_002',42567),('IMPC_GEL_055_001',42568),('IMPC_GEL_056_001',42569),('IMPC_GEL_057_001',42570),('IMPC_GEL_058_001',42571),('IMPC_GEL_059_001',42572),('IMPC_GEL_060_001',42573),('IMPC_GEL_061_001',42574),('IMPC_GEL_062_001',42575),('IMPC_GEL_063_001',42576),('IMPC_GEL_064_001',42577),('IMPC_GEL_065_001',42578),('IMPC_GEL_066_001',42579),('IMPC_GEM_001_001',42916),('IMPC_GEM_002_001',42917),('IMPC_GEM_003_001',42918),('IMPC_GEM_004_001',42919),('IMPC_GEM_005_001',42920),('IMPC_GEM_006_001',42921),('IMPC_GEM_007_001',42922),('IMPC_GEM_008_001',42923),('IMPC_GEM_009_001',42924),('IMPC_GEM_010_001',42925),('IMPC_GEM_011_001',42926),('IMPC_GEM_012_001',42927),('IMPC_GEM_013_001',42928),('IMPC_GEM_014_001',42929),('IMPC_GEM_015_001',42930),('IMPC_GEM_016_001',42931),('IMPC_GEM_017_001',42932),('IMPC_GEM_018_001',42933),('IMPC_GEM_019_001',42934),('IMPC_GEM_020_001',42935),('IMPC_GEM_021_001',42936),('IMPC_GEM_022_001',42937),('IMPC_GEM_023_001',42938),('IMPC_GEM_024_001',42939),('IMPC_GEM_025_001',42940),('IMPC_GEM_026_001',42941),('IMPC_GEM_027_001',42942),('IMPC_GEM_028_001',42943),('IMPC_GEM_029_001',42944),('IMPC_GEM_030_001',42945),('IMPC_GEM_031_001',42946),('IMPC_GEM_032_001',42947),('IMPC_GEM_033_001',42948),('IMPC_GEM_034_001',42949),('IMPC_GEM_035_001',42950),('IMPC_GEM_036_001',42951),('IMPC_GEM_037_001',42952),('IMPC_GEM_038_001',42953),('IMPC_GEM_039_001',42954),('IMPC_GEM_040_001',42955),('IMPC_GEM_041_001',42956),('IMPC_GEM_042_001',42957),('IMPC_GEM_043_001',42958),('IMPC_GEM_044_001',42959),('IMPC_GEM_045_001',42960),('IMPC_GEM_046_001',42961),('IMPC_GEM_047_001',42962),('IMPC_GEM_048_001',42963),('IMPC_GEM_049_001',42964),('IMPC_GEM_050_001',42965),('IMPC_GEM_051_001',42966),('IMPC_GEM_052_001',42967),('IMPC_GEM_053_001',42968),('IMPC_GEM_054_001',42969),('IMPC_GEM_055_001',42970),('IMPC_GEM_056_001',42971),('IMPC_GEM_057_001',42972),('IMPC_GEM_058_001',42973),('IMPC_GEM_059_001',42974),('IMPC_GEO_001_001',43231),('IMPC_GEO_002_001',43232),('IMPC_GEO_003_001',43233),('IMPC_GEO_004_001',43234),('IMPC_GEO_005_001',43235),('IMPC_GEO_006_001',43236),('IMPC_GEO_007_001',43237),('IMPC_GEO_008_001',43238),('IMPC_GEO_009_001',43239),('IMPC_GEO_010_001',43240),('IMPC_GEO_011_001',43241),('IMPC_GEO_012_001',43242),('IMPC_GEO_013_001',43243),('IMPC_GEO_014_001',43244),('IMPC_GEO_015_001',43245),('IMPC_GEO_016_001',43246),('IMPC_GEO_017_001',43247),('IMPC_GEO_018_001',43248),('IMPC_GEO_019_001',43249),('IMPC_GEO_020_001',43250),('IMPC_GEO_021_001',43251),('IMPC_GEO_022_001',43252),('IMPC_GEO_023_001',43253),('IMPC_GEO_024_001',43254),('IMPC_GEO_025_001',43255),('IMPC_GEO_026_001',43256),('IMPC_GEO_027_001',43257),('IMPC_GEO_028_001',43258),('IMPC_GEO_029_001',43259),('IMPC_GEO_030_001',43260),('IMPC_GEO_031_001',43261),('IMPC_GEO_032_001',43262),('IMPC_GEO_033_001',43263),('IMPC_GEO_034_001',43264),('IMPC_GEO_035_001',43265),('IMPC_GEO_036_001',43266),('IMPC_GEO_037_001',43267),('IMPC_GEO_038_001',43268),('IMPC_GEO_039_001',43269),('IMPC_GEO_040_001',43270),('IMPC_GEO_041_001',43271),('IMPC_GEO_042_001',43272),('IMPC_GEO_043_001',43273),('IMPC_GEO_044_001',43274),('IMPC_GEO_045_001',43275),('IMPC_GEO_046_001',43276),('IMPC_GEO_047_001',43277),('IMPC_GEO_048_001',43278),('IMPC_GEO_049_001',43279),('IMPC_GEO_050_001',43280),('IMPC_GEO_051_001',43281),('IMPC_GEO_052_001',43282),('IMPC_GEO_053_001',43283),('IMPC_GEO_054_001',43284),('IMPC_GEO_055_001',43285),('IMPC_GEO_056_001',43286),('IMPC_GEO_057_001',43287),('IMPC_GEO_058_001',43288),('IMPC_GEO_059_001',43289),('IMPC_GEO_060_001',43290),('IMPC_GEP_001_001',43546),('IMPC_GEP_002_001',43547),('IMPC_GEP_003_001',43548),('IMPC_GEP_004_001',43549),('IMPC_GEP_005_001',43550),('IMPC_GEP_006_001',43551),('IMPC_GEP_007_001',43552),('IMPC_GEP_008_001',43553),('IMPC_GEP_009_001',43554),('IMPC_GEP_010_001',43555),('IMPC_GEP_011_001',43556),('IMPC_GEP_012_001',43557),('IMPC_GEP_013_001',43558),('IMPC_GEP_014_001',43559),('IMPC_GEP_015_001',43560),('IMPC_GEP_016_001',43561),('IMPC_GEP_017_001',43562),('IMPC_GEP_018_001',43563),('IMPC_GEP_019_001',43564),('IMPC_GEP_020_001',43565),('IMPC_GEP_021_001',43566),('IMPC_GEP_022_001',43567),('IMPC_GEP_023_001',43568),('IMPC_GEP_024_001',43569),('IMPC_GEP_025_001',43570),('IMPC_GEP_026_001',43571),('IMPC_GEP_027_001',43572),('IMPC_GEP_028_001',43573),('IMPC_GEP_029_001',43574),('IMPC_GEP_030_001',43575),('IMPC_GEP_031_001',43576),('IMPC_GEP_032_001',43577),('IMPC_GEP_033_001',43578),('IMPC_GEP_034_001',43579),('IMPC_GEP_035_001',43580),('IMPC_GEP_036_001',43581),('IMPC_GEP_037_001',43582),('IMPC_GEP_038_001',43583),('IMPC_GEP_039_001',43584),('IMPC_GEP_040_001',43585),('IMPC_GEP_041_001',43586),('IMPC_GEP_042_001',43587),('IMPC_GEP_043_001',43588),('IMPC_GEP_044_001',43589),('IMPC_GEP_045_001',43590),('IMPC_GEP_046_001',43591),('IMPC_GEP_047_001',43592),('IMPC_GEP_048_001',43593),('IMPC_GEP_049_001',43594),('IMPC_GEP_050_001',43595),('IMPC_GEP_051_001',43596),('IMPC_GEP_052_001',43597),('IMPC_GEP_053_001',43598),('IMPC_GEP_054_001',43599),('IMPC_GEP_055_001',43600),('IMPC_GEP_056_001',43601),('IMPC_GEP_057_001',43602),('IMPC_GEP_058_001',43603),('IMPC_GEP_059_001',43604),('IMPC_GEP_060_001',43605),('IMPC_GEP_061_001',43606),('IMPC_GEP_062_001',43607),('IMPC_GEP_063_001',43608),('IMPC_GEP_064_001',43609),('IMPC_GEP_065_001',43610),('IMPC_GEP_066_001',43611),('IMPC_GEP_067_001',43612),('IMPC_GEP_068_001',43613),('IMPC_GEP_069_001',43614),('IMPC_GEP_070_001',43615),('IMPC_GEP_071_001',43616),('IMPC_GEP_072_001',43617),('IMPC_GEP_073_001',43618),('IMPC_GEP_074_001',43619),('IMPC_GEM_001_001',44181),('IMPC_GEM_002_001',44182),('IMPC_GEM_003_001',44183),('IMPC_GEM_004_001',44184),('IMPC_GEM_005_001',44185),('IMPC_GEM_006_001',44186),('IMPC_GEM_007_001',44187),('IMPC_GEM_009_001',44188),('IMPC_GEM_010_001',44189),('IMPC_GEM_011_001',44190),('IMPC_GEM_012_001',44191),('IMPC_GEM_013_001',44192),('IMPC_GEM_014_001',44193),('IMPC_GEM_015_001',44194),('IMPC_GEM_017_001',44195),('IMPC_GEM_018_001',44196),('IMPC_GEM_019_001',44197),('IMPC_GEM_020_001',44198),('IMPC_GEM_021_001',44199),('IMPC_GEM_022_001',44200),('IMPC_GEM_023_001',44201),('IMPC_GEM_024_001',44202),('IMPC_GEM_027_001',44203),('IMPC_GEM_028_001',44204),('IMPC_GEM_029_001',44205),('IMPC_GEM_030_001',44206),('IMPC_GEM_031_001',44207),('IMPC_GEM_032_001',44208),('IMPC_GEM_035_001',44209),('IMPC_GEM_036_001',44210),('IMPC_GEM_037_001',44211),('IMPC_GEM_038_001',44212),('IMPC_GEM_039_001',44213),('IMPC_GEM_040_001',44214),('IMPC_GEM_041_001',44215),('IMPC_GEM_042_001',44216),('IMPC_GEM_045_001',44217),('IMPC_GEM_046_001',44218),('IMPC_GEM_047_001',44219),('IMPC_GEM_048_001',44220),('IMPC_GEM_049_001',44221),('IMPC_GEM_050_001',44222),('IMPC_GEM_051_001',44223),('IMPC_GEM_052_001',44224),('IMPC_GEM_053_001',44225),('IMPC_GEM_054_001',44226),('IMPC_GEM_055_001',44227),('IMPC_GEM_056_001',44228),('IMPC_GEM_057_001',44229),('IMPC_GEM_058_001',44230),('IMPC_GEM_059_001',44231),('IMPC_GEM_016_002',44232),('IMPC_GEM_025_002',44233),('IMPC_GEM_026_002',44234),('IMPC_GEM_033_002',44235),('IMPC_GEM_043_002',44236),('IMPC_GEM_044_002',44237),('IMPC_GEM_060_001',44238),('IMPC_GEM_008_002',44239),('IMPC_GEM_034_002',44240),('IMPC_GEO_001_001',44496),('IMPC_GEO_002_001',44497),('IMPC_GEO_003_001',44498),('IMPC_GEO_004_001',44499),('IMPC_GEO_005_001',44500),('IMPC_GEO_006_001',44501),('IMPC_GEO_008_001',44502),('IMPC_GEO_011_001',44503),('IMPC_GEO_012_001',44504),('IMPC_GEO_013_001',44505),('IMPC_GEO_014_001',44506),('IMPC_GEO_015_001',44507),('IMPC_GEO_016_001',44508),('IMPC_GEO_019_001',44509),('IMPC_GEO_020_001',44510),('IMPC_GEO_021_001',44511),('IMPC_GEO_022_001',44512),('IMPC_GEO_023_001',44513),('IMPC_GEO_024_001',44514),('IMPC_GEO_027_001',44515),('IMPC_GEO_028_001',44516),('IMPC_GEO_029_001',44517),('IMPC_GEO_030_001',44518),('IMPC_GEO_031_001',44519),('IMPC_GEO_032_001',44520),('IMPC_GEO_033_001',44521),('IMPC_GEO_035_001',44522),('IMPC_GEO_036_001',44523),('IMPC_GEO_037_001',44524),('IMPC_GEO_039_001',44525),('IMPC_GEO_040_001',44526),('IMPC_GEO_044_001',44527),('IMPC_GEO_045_001',44528),('IMPC_GEO_046_001',44529),('IMPC_GEO_049_001',44530),('IMPC_GEO_050_001',44531),('IMPC_GEO_051_001',44532),('IMPC_GEO_052_001',44533),('IMPC_GEO_053_001',44534),('IMPC_GEO_054_001',44535),('IMPC_GEO_055_001',44536),('IMPC_GEO_056_001',44537),('IMPC_GEO_057_001',44538),('IMPC_GEO_058_001',44539),('IMPC_GEO_059_001',44540),('IMPC_GEO_060_001',44541),('IMPC_GEO_007_002',44542),('IMPC_GEO_009_002',44543),('IMPC_GEO_010_002',44544),('IMPC_GEO_017_002',44545),('IMPC_GEO_018_002',44546),('IMPC_GEO_025_002',44547),('IMPC_GEO_026_002',44548),('IMPC_GEO_034_002',44549),('IMPC_GEO_038_002',44550),('IMPC_GEO_041_002',44551),('IMPC_GEO_042_002',44552),('IMPC_GEO_043_002',44553),('IMPC_GEO_047_002',44554),('IMPC_GEO_048_002',44555),('IMPC_GEO_061_001',44556),('IMPC_GEP_001_001',44811),('IMPC_GEP_002_001',44812),('IMPC_GEP_003_001',44813),('IMPC_GEP_006_001',44814),('IMPC_GEP_007_001',44815),('IMPC_GEP_008_001',44816),('IMPC_GEP_009_001',44817),('IMPC_GEP_010_001',44818),('IMPC_GEP_013_001',44819),('IMPC_GEP_014_001',44820),('IMPC_GEP_015_001',44821),('IMPC_GEP_016_001',44822),('IMPC_GEP_017_001',44823),('IMPC_GEP_020_001',44824),('IMPC_GEP_021_001',44825),('IMPC_GEP_022_001',44826),('IMPC_GEP_023_001',44827),('IMPC_GEP_024_001',44828),('IMPC_GEP_025_001',44829),('IMPC_GEP_026_001',44830),('IMPC_GEP_027_001',44831),('IMPC_GEP_028_001',44832),('IMPC_GEP_032_001',44833),('IMPC_GEP_033_001',44834),('IMPC_GEP_034_001',44835),('IMPC_GEP_036_001',44836),('IMPC_GEP_037_001',44837),('IMPC_GEP_038_001',44838),('IMPC_GEP_040_001',44839),('IMPC_GEP_041_001',44840),('IMPC_GEP_042_001',44841),('IMPC_GEP_043_001',44842),('IMPC_GEP_044_001',44843),('IMPC_GEP_045_001',44844),('IMPC_GEP_046_001',44845),('IMPC_GEP_050_001',44846),('IMPC_GEP_051_001',44847),('IMPC_GEP_052_001',44848),('IMPC_GEP_053_001',44849),('IMPC_GEP_054_001',44850),('IMPC_GEP_056_001',44851),('IMPC_GEP_057_001',44852),('IMPC_GEP_058_001',44853),('IMPC_GEP_062_001',44854),('IMPC_GEP_063_001',44855),('IMPC_GEP_064_001',44856),('IMPC_GEP_065_001',44857),('IMPC_GEP_066_001',44858),('IMPC_GEP_067_001',44859),('IMPC_GEP_068_001',44860),('IMPC_GEP_069_001',44861),('IMPC_GEP_070_001',44862),('IMPC_GEP_071_001',44863),('IMPC_GEP_072_001',44864),('IMPC_GEP_073_001',44865),('IMPC_GEP_074_001',44866),('IMPC_GEP_004_002',44867),('IMPC_GEP_005_002',44868),('IMPC_GEP_011_002',44869),('IMPC_GEP_012_002',44870),('IMPC_GEP_018_002',44871),('IMPC_GEP_019_002',44872),('IMPC_GEP_029_002',44873),('IMPC_GEP_030_002',44874),('IMPC_GEP_031_002',44875),('IMPC_GEP_035_002',44876),('IMPC_GEP_039_002',44877),('IMPC_GEP_047_002',44878),('IMPC_GEP_048_002',44879),('IMPC_GEP_049_002',44880),('IMPC_GEP_055_002',44881),('IMPC_GEP_059_002',44882),('IMPC_GEP_060_002',44883),('IMPC_GEP_061_002',44884),('IMPC_GEP_075_001',44885),('IMPC_GEM_007_001',45446),('IMPC_GEM_017_001',45447),('IMPC_GEM_019_001',45448),('IMPC_GEM_021_001',45449),('IMPC_GEM_024_001',45450),('IMPC_GEM_027_001',45451),('IMPC_GEM_028_001',45452),('IMPC_GEM_029_001',45453),('IMPC_GEM_032_001',45454),('IMPC_GEM_036_001',45455),('IMPC_GEM_041_001',45456),('IMPC_GEM_047_001',45457),('IMPC_GEM_048_001',45458),('IMPC_GEM_049_001',45459),('IMPC_GEM_050_001',45460),('IMPC_GEM_051_001',45461),('IMPC_GEM_052_001',45462),('IMPC_GEM_053_001',45463),('IMPC_GEM_054_001',45464),('IMPC_GEM_055_001',45465),('IMPC_GEM_056_001',45466),('IMPC_GEM_057_001',45467),('IMPC_GEM_058_001',45468),('IMPC_GEM_059_001',45469),('IMPC_GEM_016_002',45470),('IMPC_GEM_025_002',45471),('IMPC_GEM_026_002',45472),('IMPC_GEM_033_002',45473),('IMPC_GEM_043_002',45474),('IMPC_GEM_044_002',45475),('IMPC_GEM_060_001',45476),('IMPC_GEM_061_001',45477),('IMPC_GEM_062_001',45478),('IMPC_GEM_063_001',45479),('IMPC_GEM_064_001',45480),('IMPC_GEM_065_001',45481),('IMPC_GEM_066_001',45482),('IMPC_GEM_067_001',45483),('IMPC_GEM_068_001',45484),('IMPC_GEM_069_001',45485),('IMPC_GEM_070_001',45486),('IMPC_GEM_071_001',45487),('IMPC_GEM_072_001',45488),('IMPC_GEM_073_001',45489),('IMPC_GEM_074_001',45490),('IMPC_GEM_075_001',45491),('IMPC_GEM_076_001',45492),('IMPC_GEM_077_001',45493),('IMPC_GEM_078_001',45494),('IMPC_GEO_008_001',45824),('IMPC_GEO_011_001',45825),('IMPC_GEO_015_001',45826),('IMPC_GEO_016_001',45827),('IMPC_GEO_019_001',45828),('IMPC_GEO_022_001',45829),('IMPC_GEO_028_001',45830),('IMPC_GEO_029_001',45831),('IMPC_GEO_030_001',45832),('IMPC_GEO_033_001',45833),('IMPC_GEO_037_001',45834),('IMPC_GEO_049_001',45835),('IMPC_GEO_050_001',45836),('IMPC_GEO_051_001',45837),('IMPC_GEO_052_001',45838),('IMPC_GEO_053_001',45839),('IMPC_GEO_054_001',45840),('IMPC_GEO_055_001',45841),('IMPC_GEO_056_001',45842),('IMPC_GEO_057_001',45843),('IMPC_GEO_058_001',45844),('IMPC_GEO_059_001',45845),('IMPC_GEO_060_001',45846),('IMPC_GEO_009_002',45847),('IMPC_GEO_017_002',45848),('IMPC_GEO_018_002',45849),('IMPC_GEO_034_002',45850),('IMPC_GEO_038_002',45851),('IMPC_GEO_041_002',45852),('IMPC_GEO_042_002',45853),('IMPC_GEO_043_002',45854),('IMPC_GEO_047_002',45855),('IMPC_GEO_048_002',45856),('IMPC_GEO_061_001',45857),('IMPC_GEO_062_001',45858),('IMPC_GEO_063_001',45859),('IMPC_GEO_064_001',45860),('IMPC_GEO_065_001',45861),('IMPC_GEO_066_001',45862),('IMPC_GEO_067_001',45863),('IMPC_GEO_068_001',45864),('IMPC_GEO_069_001',45865),('IMPC_GEO_070_001',45866),('IMPC_GEO_071_001',45867),('IMPC_GEO_072_001',45868),('IMPC_GEP_010_001',46202),('IMPC_GEP_013_001',46203),('IMPC_GEP_015_001',46204),('IMPC_GEP_016_001',46205),('IMPC_GEP_017_001',46206),('IMPC_GEP_022_001',46207),('IMPC_GEP_023_001',46208),('IMPC_GEP_024_001',46209),('IMPC_GEP_026_001',46210),('IMPC_GEP_033_001',46211),('IMPC_GEP_034_001',46212),('IMPC_GEP_035_001',46213),('IMPC_GEP_036_001',46214),('IMPC_GEP_038_001',46215),('IMPC_GEP_042_001',46216),('IMPC_GEP_052_001',46217),('IMPC_GEP_063_001',46218),('IMPC_GEP_064_001',46219),('IMPC_GEP_065_001',46220),('IMPC_GEP_066_001',46221),('IMPC_GEP_067_001',46222),('IMPC_GEP_068_001',46223),('IMPC_GEP_069_001',46224),('IMPC_GEP_070_001',46225),('IMPC_GEP_071_001',46226),('IMPC_GEP_072_001',46227),('IMPC_GEP_073_001',46228),('IMPC_GEP_074_001',46229),('IMPC_GEP_004_002',46230),('IMPC_GEP_005_002',46231),('IMPC_GEP_011_002',46232),('IMPC_GEP_018_002',46233),('IMPC_GEP_029_002',46234),('IMPC_GEP_030_002',46235),('IMPC_GEP_039_002',46236),('IMPC_GEP_047_002',46237),('IMPC_GEP_048_002',46238),('IMPC_GEP_049_002',46239),('IMPC_GEP_059_002',46240),('IMPC_GEP_060_002',46241),('IMPC_GEP_061_002',46242),('IMPC_GEP_075_001',46243),('IMPC_GEP_076_001',46244),('IMPC_GEP_078_001',46245),('IMPC_GEP_079_001',46246),('IMPC_GEP_080_001',46247),('IMPC_GEP_081_001',46248),('IMPC_GEP_082_001',46249),('IMPC_GEP_083_001',46250),('IMPC_GEP_084_001',46251),('IMPC_GEP_085_001',46252),('IMPC_GEP_086_001',46253),('IMPC_GEP_087_001',46254),('IMPC_EYE_001_001',46580),('IMPC_EYE_002_001',46581),('IMPC_EYE_003_001',46582),('IMPC_EYE_004_001',46583),('IMPC_EYE_005_001',46584),('IMPC_EYE_006_001',46585),('IMPC_EYE_007_001',46586),('IMPC_EYE_008_001',46587),('IMPC_EYE_009_001',46588),('IMPC_EYE_010_001',46589),('IMPC_EYE_011_001',46590),('IMPC_EYE_012_001',46591),('IMPC_EYE_013_001',46592),('IMPC_EYE_014_001',46593),('IMPC_EYE_015_001',46594),('IMPC_EYE_016_001',46595),('IMPC_EYE_017_001',46596),('IMPC_EYE_018_001',46597),('IMPC_EYE_019_001',46598),('IMPC_EYE_023_001',46599),('IMPC_EYE_024_001',46600),('IMPC_EYE_025_001',46601),('IMPC_EYE_026_001',46602),('IMPC_EYE_027_001',46603),('IMPC_EYE_028_001',46604),('IMPC_EYE_029_001',46605),('IMPC_EYE_030_001',46606),('IMPC_EYE_031_001',46607),('IMPC_EYE_032_001',46608),('IMPC_EYE_033_001',46609),('IMPC_EYE_034_001',46610),('IMPC_EYE_035_001',46611),('IMPC_EYE_036_001',46612),('IMPC_EYE_037_001',46613),('IMPC_EYE_038_001',46614),('IMPC_EYE_039_001',46615),('IMPC_EYE_040_001',46616),('IMPC_EYE_041_001',46617),('IMPC_EYE_042_001',46618),('IMPC_EYE_043_001',46619),('IMPC_EYE_044_001',46620),('IMPC_EYE_045_001',46621),('IMPC_EYE_046_001',46622),('IMPC_EYE_047_001',46623),('IMPC_EYE_048_001',46624),('IMPC_EYE_049_001',46625),('IMPC_EYE_050_001',46626),('IMPC_EYE_051_001',46627),('IMPC_EYE_052_001',46628),('IMPC_EYE_053_001',46629),('IMPC_EYE_054_001',46630),('IMPC_EYE_055_001',46631),('IMPC_EYE_056_001',46632),('IMPC_EYE_057_001',46633),('IMPC_EYE_058_001',46634),('IMPC_EYE_059_001',46635),('IMPC_EYE_060_001',46636),('IMPC_EYE_061_001',46637),('IMPC_EYE_062_001',46638),('IMPC_EYE_063_001',46639),('IMPC_EYE_064_001',46640),('IMPC_EYE_065_001',46641),('IMPC_EYE_066_001',46642),('IMPC_EYE_067_001',46643),('IMPC_EYE_068_001',46644),('IMPC_EYE_069_001',46645),('IMPC_EYE_070_001',46646),('IMPC_EYE_071_001',46647),('IMPC_EYE_072_001',46648),('IMPC_EYE_073_001',46649),('IMPC_EYE_074_001',46650),('IMPC_EYE_075_001',46651),('IMPC_EYE_076_001',46652),('IMPC_EYE_077_001',46653),('IMPC_EYE_078_001',46654),('IMPC_EYE_079_001',46655),('IMPC_EYE_080_001',46656),('IMPC_EYE_081_001',46657),('IMPC_EYE_082_001',46658),('IMPC_EYE_083_001',46659),('IMPC_EYE_084_001',46660),('IMPC_EYE_085_001',46661),('IMPC_EYE_086_001',46662),('IMPC_EYE_087_001',46663),('IMPC_EYE_088_001',46664),('IMPC_EYE_089_001',46665),('IMPC_EYE_090_001',46666),('IMPC_EYE_091_001',46667),('IMPC_EYE_092_001',46668),('IMPC_ECG_001_001',47596),('IMPC_ECG_002_001',47597),('IMPC_ECG_003_001',47598),('IMPC_ECG_004_001',47599),('IMPC_ECG_005_001',47600),('IMPC_ECG_006_001',47601),('IMPC_ECG_007_001',47602),('IMPC_ECG_008_001',47603),('IMPC_ECG_010_001',47604),('IMPC_ECG_011_001',47605),('IMPC_ECG_012_001',47606),('IMPC_ECG_013_001',47607),('IMPC_ECG_014_001',47608),('IMPC_ECG_015_001',47609),('IMPC_ECG_016_001',47610),('IMPC_ECG_017_001',47611),('IMPC_ECG_018_001',47612),('IMPC_ECG_019_001',47613),('IMPC_ECG_020_001',47614),('IMPC_ECG_021_001',47615),('IMPC_ECG_022_001',47616),('IMPC_ECG_023_001',47617),('IMPC_ECG_009_002',47618),('IMPC_ECG_024_001',47619),('IMPC_ECG_025_001',47620),('IMPC_ECG_026_001',47621),('IMPC_OWT_001_001',47813),('IMPC_OWT_002_001',47814),('IMPC_OWT_003_001',47815),('IMPC_OWT_004_001',47816),('IMPC_OWT_005_001',47817),('IMPC_OWT_007_001',47819),('IMPC_OWT_008_001',47820),('IMPC_OWT_009_001',47821),('IMPC_OWT_010_001',47822),('IMPC_OWT_012_001',47824),('IMPC_OWT_013_001',47825),('IMPC_OWT_014_001',47826),('IMPC_OWT_015_001',47827),('IMPC_OWT_016_001',47828),('IMPC_OWT_017_001',47829),('IMPC_OWT_018_001',47830),('IMPC_OWT_019_001',47831),('IMPC_OWT_020_001',47832),('IMPC_HIS_001_001',47968),('IMPC_HIS_002_001',47969),('IMPC_HIS_003_001',47970),('IMPC_HIS_004_001',47971),('IMPC_HIS_005_001',47972),('IMPC_HIS_006_001',47973),('IMPC_HIS_007_001',47974),('IMPC_HIS_008_001',47975),('IMPC_HIS_009_001',47976),('IMPC_HIS_010_001',47977),('IMPC_HIS_011_001',47978),('IMPC_HIS_012_001',47979),('IMPC_HIS_013_001',47980),('IMPC_HIS_014_001',47981),('IMPC_HIS_015_001',47982),('IMPC_HIS_016_001',47983),('IMPC_HIS_017_001',47984),('IMPC_HIS_018_001',47985),('IMPC_HIS_019_001',47986),('IMPC_HIS_020_001',47987),('IMPC_HIS_021_001',47988),('IMPC_HIS_022_001',47989),('IMPC_HIS_023_001',47990),('IMPC_HIS_024_001',47991),('IMPC_HIS_025_001',47992),('IMPC_HIS_026_001',47993),('IMPC_HIS_027_001',47994),('IMPC_HIS_028_001',47995),('IMPC_HIS_029_001',47996),('IMPC_HIS_030_001',47997),('IMPC_HIS_031_001',47998),('IMPC_HIS_032_001',47999),('IMPC_HIS_033_001',48000),('IMPC_HIS_034_001',48001),('IMPC_HIS_035_001',48002),('IMPC_HIS_036_001',48003),('IMPC_HIS_037_001',48004),('IMPC_HIS_038_001',48005),('IMPC_HIS_039_001',48006),('IMPC_HIS_040_001',48007),('IMPC_HIS_041_001',48008),('IMPC_HIS_042_001',48009),('IMPC_HIS_043_001',48010),('IMPC_HIS_044_001',48011),('IMPC_HIS_045_001',48012),('IMPC_HIS_046_001',48013),('IMPC_HIS_047_001',48014),('IMPC_HIS_048_001',48015),('IMPC_HIS_049_001',48016),('IMPC_HIS_050_001',48017),('IMPC_HIS_051_001',48018),('IMPC_HIS_052_001',48019),('IMPC_HIS_053_001',48020),('IMPC_HIS_054_001',48021),('IMPC_HIS_055_001',48022),('IMPC_HIS_056_001',48023),('IMPC_HIS_057_001',48024),('IMPC_HIS_058_001',48025),('IMPC_HIS_059_001',48026),('IMPC_HIS_060_001',48027),('IMPC_HIS_061_001',48028),('IMPC_HIS_062_001',48029),('IMPC_HIS_063_001',48030),('IMPC_HIS_064_001',48031),('IMPC_HIS_065_001',48032),('IMPC_HIS_066_001',48033),('IMPC_HIS_067_001',48034),('IMPC_HIS_068_001',48035),('IMPC_HIS_069_001',48036),('IMPC_HIS_070_001',48037),('IMPC_HIS_071_001',48038),('IMPC_HIS_072_001',48039),('IMPC_HIS_073_001',48040),('IMPC_HIS_074_001',48041),('IMPC_HIS_075_001',48042),('IMPC_HIS_076_001',48043),('IMPC_HIS_077_001',48044),('IMPC_HIS_078_001',48045),('IMPC_HIS_079_001',48046),('IMPC_HIS_080_001',48047),('IMPC_HIS_081_001',48048),('IMPC_HIS_082_001',48049),('IMPC_HIS_083_001',48050),('IMPC_HIS_084_001',48051),('IMPC_HIS_085_001',48052),('IMPC_HIS_086_001',48053),('IMPC_HIS_087_001',48054),('IMPC_HIS_088_001',48055),('IMPC_HIS_089_001',48056),('IMPC_HIS_090_001',48057),('IMPC_HIS_091_001',48058),('IMPC_HIS_092_001',48059),('IMPC_HIS_093_001',48060),('IMPC_HIS_094_001',48061),('IMPC_HIS_095_001',48062),('IMPC_HIS_096_001',48063),('IMPC_HIS_097_001',48064),('IMPC_HIS_098_001',48065),('IMPC_HIS_099_001',48066),('IMPC_HIS_100_001',48067),('IMPC_HIS_101_001',48068),('IMPC_HIS_102_001',48069),('IMPC_HIS_103_001',48070),('IMPC_HIS_104_001',48071),('IMPC_HIS_105_001',48072),('IMPC_HIS_106_001',48073),('IMPC_HIS_107_001',48074),('IMPC_HIS_108_001',48075),('IMPC_HIS_109_001',48076),('IMPC_HIS_110_001',48077),('IMPC_HIS_111_001',48078),('IMPC_HIS_112_001',48079),('IMPC_HIS_113_001',48080),('IMPC_HIS_114_001',48081),('IMPC_HIS_115_001',48082),('IMPC_HIS_116_001',48083),('IMPC_HIS_117_001',48084),('IMPC_HIS_118_001',48085),('IMPC_HIS_119_001',48086),('IMPC_HIS_120_001',48087),('IMPC_HIS_121_001',48088),('IMPC_HIS_122_001',48089),('IMPC_HIS_123_001',48090),('IMPC_HIS_124_001',48091),('IMPC_HIS_125_001',48092),('IMPC_HIS_126_001',48093),('IMPC_HIS_127_001',48094),('IMPC_HIS_128_001',48095),('IMPC_HIS_129_001',48096),('IMPC_HIS_130_001',48097),('IMPC_HIS_131_001',48098),('IMPC_HIS_132_001',48099),('IMPC_HIS_133_001',48100),('IMPC_HIS_134_001',48101),('IMPC_HIS_135_001',48102),('IMPC_HIS_136_001',48103),('IMPC_HIS_137_001',48104),('IMPC_HIS_138_001',48105),('IMPC_HIS_139_001',48106),('IMPC_HIS_140_001',48107),('IMPC_HIS_141_001',48108),('IMPC_HIS_142_001',48109),('IMPC_HIS_143_001',48110),('IMPC_HIS_144_001',48111),('IMPC_HIS_145_001',48112),('IMPC_HIS_146_001',48113),('IMPC_HIS_147_001',48114),('IMPC_HIS_148_001',48115),('IMPC_HIS_149_001',48116),('IMPC_HIS_150_001',48117),('IMPC_HIS_151_001',48118),('IMPC_HIS_152_001',48119),('IMPC_HIS_153_001',48120),('IMPC_HIS_154_001',48121),('IMPC_HIS_155_001',48122),('IMPC_HIS_156_001',48123),('IMPC_HIS_157_001',48124),('IMPC_HIS_158_001',48125),('IMPC_HIS_159_001',48126),('IMPC_HIS_160_001',48127),('IMPC_HIS_161_001',48128),('IMPC_HIS_162_001',48129),('IMPC_HIS_163_001',48130),('IMPC_HIS_164_001',48131),('IMPC_HIS_165_001',48132),('IMPC_HIS_166_001',48133),('IMPC_HIS_167_001',48134),('IMPC_HIS_168_001',48135),('IMPC_HIS_169_001',48136),('IMPC_HIS_170_001',48137),('IMPC_HIS_171_001',48138),('IMPC_HIS_172_001',48139),('IMPC_HIS_173_001',48140),('IMPC_HIS_174_001',48141),('IMPC_HIS_175_001',48142),('IMPC_HIS_176_001',48143),('IMPC_HIS_177_001',48144),('IMPC_HIS_178_001',48145),('IMPC_HIS_208_001',48146),('IMPC_HIS_209_001',48147),('IMPC_HIS_210_001',48148),('IMPC_HIS_211_001',48149),('IMPC_HIS_212_001',48150),('IMPC_HIS_213_001',48151),('IMPC_HIS_214_001',48152),('IMPC_HIS_215_001',48153),('IMPC_HIS_216_001',48154),('IMPC_HIS_217_001',48155),('IMPC_HIS_218_001',48156),('IMPC_HIS_219_001',48157),('IMPC_HIS_220_001',48158),('IMPC_HIS_221_001',48159),('IMPC_HIS_222_001',48160),('IMPC_HIS_223_001',48161),('IMPC_HIS_224_001',48162),('IMPC_HIS_225_001',48163),('IMPC_HIS_226_001',48164),('IMPC_HIS_227_001',48165),('IMPC_HIS_228_001',48166),('IMPC_HIS_229_001',48167),('IMPC_HIS_230_001',48168),('IMPC_HIS_231_001',48169),('IMPC_HIS_232_001',48170),('IMPC_HIS_233_001',48171),('IMPC_HIS_234_001',48172),('IMPC_HIS_235_001',48173),('IMPC_HIS_236_001',48174),('IMPC_HIS_237_001',48175),('IMPC_HIS_238_001',48176),('IMPC_HIS_239_001',48177),('IMPC_HIS_240_001',48178),('IMPC_HIS_241_001',48179),('IMPC_HIS_242_001',48180),('IMPC_HIS_243_001',48181),('IMPC_HIS_244_001',48182),('IMPC_HIS_245_001',48183),('IMPC_HIS_246_001',48184),('IMPC_HIS_247_001',48185),('IMPC_HIS_248_001',48186),('IMPC_HIS_249_001',48187),('IMPC_HIS_250_001',48188),('IMPC_HIS_251_001',48189),('IMPC_HIS_252_001',48190),('IMPC_HIS_253_001',48191),('IMPC_HIS_254_001',48192),('IMPC_HIS_255_001',48193),('IMPC_HIS_256_001',48194),('IMPC_HIS_257_001',48195),('IMPC_HIS_258_001',48196),('IMPC_HIS_259_001',48197),('IMPC_HIS_260_001',48198),('IMPC_HIS_261_001',48199),('IMPC_HIS_262_001',48200),('IMPC_HIS_263_001',48201),('IMPC_HIS_264_001',48202),('IMPC_HIS_265_001',48203),('IMPC_HIS_266_001',48204),('IMPC_HIS_267_001',48205),('IMPC_HIS_268_001',48206),('IMPC_HIS_269_001',48207),('IMPC_HIS_270_001',48208),('IMPC_HIS_271_001',48209),('IMPC_HIS_272_001',48210),('IMPC_HIS_273_001',48211),('IMPC_HIS_274_001',48212),('IMPC_HIS_275_001',48213),('IMPC_HIS_276_001',48214),('IMPC_HIS_277_001',48215),('IMPC_HIS_278_001',48216),('IMPC_HIS_279_001',48217),('IMPC_HIS_280_001',48218),('IMPC_HIS_281_001',48219),('IMPC_HIS_282_001',48220),('IMPC_HIS_283_001',48221),('IMPC_HIS_284_001',48222),('IMPC_HIS_285_001',48223),('IMPC_HIS_286_001',48224),('IMPC_HIS_287_001',48225),('IMPC_HIS_288_001',48226),('IMPC_HIS_289_001',48227),('IMPC_HIS_290_001',48228),('IMPC_HIS_291_001',48229),('IMPC_HIS_292_001',48230),('IMPC_HIS_293_001',48231),('IMPC_HIS_294_001',48232),('IMPC_HIS_295_001',48233),('IMPC_HIS_296_001',48234),('IMPC_HIS_297_001',48235),('IMPC_HIS_298_001',48236),('IMPC_HIS_299_001',48237),('IMPC_HIS_300_001',48238),('IMPC_HIS_301_001',48239),('IMPC_HIS_302_001',48240),('IMPC_HIS_303_001',48241),('IMPC_HIS_304_001',48242),('IMPC_HIS_305_001',48243),('IMPC_HIS_306_001',48244),('IMPC_HIS_307_001',48245),('IMPC_HIS_308_001',48246),('IMPC_HIS_309_001',48247),('IMPC_HIS_310_001',48248),('IMPC_HIS_311_001',48249),('IMPC_HIS_312_001',48250),('IMPC_HIS_313_001',48251),('IMPC_HIS_314_001',48252),('IMPC_HIS_315_001',48253),('IMPC_HIS_316_001',48254),('IMPC_HIS_317_001',48255),('IMPC_HIS_318_001',48256),('IMPC_HIS_319_001',48257),('IMPC_HIS_320_001',48258),('IMPC_HIS_321_001',48259),('IMPC_HIS_322_001',48260),('IMPC_HIS_323_001',48261),('IMPC_HIS_324_001',48262),('IMPC_HIS_325_001',48263),('IMPC_HIS_326_001',48264),('IMPC_HIS_327_001',48265),('IMPC_HIS_328_001',48266),('IMPC_HIS_329_001',48267),('IMPC_HIS_330_001',48268),('IMPC_HIS_331_001',48269),('IMPC_HIS_332_001',48270),('IMPC_HIS_333_001',48271),('IMPC_HIS_334_001',48272),('IMPC_HIS_335_001',48273),('IMPC_HIS_336_001',48274),('IMPC_HIS_337_001',48275),('IMPC_HIS_338_001',48276),('IMPC_HIS_339_001',48277),('IMPC_HIS_340_001',48278),('IMPC_HIS_341_001',48279),('IMPC_HIS_342_001',48280),('IMPC_HIS_343_001',48281),('IMPC_HIS_344_001',48282),('IMPC_HIS_345_001',48283),('IMPC_HIS_346_001',48284),('IMPC_HIS_347_001',48285),('IMPC_HIS_348_001',48286),('IMPC_HIS_349_001',48287),('IMPC_HIS_179_002',48288),('IMPC_HIS_180_002',48289),('IMPC_HIS_181_002',48290),('IMPC_HIS_182_002',48291),('IMPC_HIS_183_002',48292),('IMPC_HIS_184_002',48293),('IMPC_HIS_185_002',48294),('IMPC_HIS_186_002',48295),('IMPC_HIS_187_002',48296),('IMPC_HIS_188_002',48297),('IMPC_HIS_189_002',48298),('IMPC_HIS_190_002',48299),('IMPC_HIS_191_002',48300),('IMPC_HIS_192_002',48301),('IMPC_HIS_193_002',48302),('IMPC_HIS_194_002',48303),('IMPC_HIS_195_002',48304),('IMPC_HIS_196_002',48305),('IMPC_HIS_197_002',48306),('IMPC_HIS_198_002',48307),('IMPC_HIS_199_002',48308),('IMPC_HIS_200_002',48309),('IMPC_HIS_201_002',48310),('IMPC_HIS_202_002',48311),('IMPC_HIS_203_002',48312),('IMPC_HIS_204_002',48313),('IMPC_HIS_205_002',48314),('IMPC_HIS_206_002',48315),('IMPC_HIS_207_002',48316),('IMPC_FEA_001_001',51545),('IMPC_FEA_002_001',51546),('IMPC_FEA_003_001',51547),('IMPC_FEA_004_001',51548),('IMPC_FEA_005_001',51549),('IMPC_FEA_006_001',51550),('IMPC_FEA_007_001',51551),('IMPC_FEA_008_001',51552),('IMPC_FEA_009_001',51553),('IMPC_FEA_010_001',51554),('IMPC_FEA_011_001',51555),('IMPC_FEA_012_001',51556),('IMPC_FEA_013_001',51557),('IMPC_FEA_014_001',51558),('IMPC_FEA_015_001',51559),('IMPC_FEA_016_001',51560),('IMPC_FEA_017_001',51561),('IMPC_FEA_018_001',51562),('IMPC_FEA_019_001',51563),('IMPC_FEA_020_001',51564),('IMPC_FEA_021_001',51565),('IMPC_FEA_022_001',51566),('IMPC_FEA_023_001',51567),('IMPC_FEA_024_001',51568),('IMPC_FEA_025_001',51569),('IMPC_FEA_026_001',51570),('IMPC_FEA_027_001',51571),('IMPC_FEA_028_001',51572),('IMPC_FEA_029_001',51573),('IMPC_FEA_030_001',51574),('IMPC_FEA_031_001',51575),('IMPC_FEA_032_001',51576),('IMPC_FEA_033_001',51577),('IMPC_FEA_034_001',51578),('IMPC_FEA_035_001',51579),('IMPC_FEA_036_001',51580),('IMPC_FEA_037_001',51581),('IMPC_FEA_038_001',51582),('IMPC_FEA_039_001',51583),('IMPC_FEA_040_001',51584),('IMPC_FEA_041_001',51585),('IMPC_FEA_042_001',51586),('IMPC_FEA_043_001',51587),('IMPC_FEA_044_001',51588),('IMPC_FEA_045_001',51589),('IMPC_FEA_046_001',51590),('IMPC_FEA_047_001',51591),('IMPC_FEA_048_001',51592),('IMPC_FEA_049_001',51593),('IMPC_FEA_050_001',51594),('IMPC_FEA_051_001',51595),('IMPC_FEA_052_001',51596),('IMPC_FEA_053_001',51597),('IMPC_FEA_054_001',51598),('IMPC_FEA_055_001',51599),('IMPC_FEA_056_001',51600),('IMPC_FEA_057_001',51601),('IMPC_FEA_058_001',51602),('IMPC_FEA_059_001',51603),('IMPC_FEA_060_001',51604),('IMPC_FEA_061_001',51605),('IMPC_FEA_062_001',51606),('IMPC_FEA_063_001',51607),('IMPC_FEA_064_001',51608),('IMPC_FEA_065_001',51609),('IMPC_FEA_066_001',51610),('IMPC_FEA_067_001',51611),('IMPC_FEA_068_001',51612),('IMPC_FEA_069_001',51613),('IMPC_FEA_070_001',51614),('IMPC_FEA_071_001',51615),('IMPC_FEA_072_001',51616),('IMPC_FEA_073_001',51617),('IMPC_FEA_074_001',51618),('IMPC_FEA_075_001',51619),('IMPC_FEA_076_001',51620),('IMPC_FEA_077_001',51621),('IMPC_FEA_078_001',51622),('IMPC_FEA_079_001',51623),('IMPC_FEA_080_001',51624),('IMPC_FEA_081_001',51625),('IMPC_FEA_082_001',51626),('IMPC_FEA_083_001',51627),('IMPC_FEA_084_001',51628),('IMPC_FEA_085_001',51629),('IMPC_FEA_086_001',51630),('IMPC_FEA_087_001',51631),('IMPC_FEA_088_001',51632),('IMPC_FEA_089_001',51633),('IMPC_FEA_090_001',51634),('IMPC_FEA_091_001',51635),('IMPC_FEA_092_001',51636),('IMPC_FEA_093_001',51637),('IMPC_FEA_094_001',51638),('IMPC_FEA_095_001',51639),('IMPC_FEA_096_001',51640),('IMPC_FEA_097_001',51641),('IMPC_FEA_098_001',51642),('IMPC_FEA_099_001',51643),('IMPC_FEA_100_001',51644),('IMPC_FEA_101_001',51645),('IMPC_FEA_102_001',51646),('IMPC_FEA_103_001',51647),('IMPC_FEA_104_001',51648),('IMPC_YMZ_001_001',52053),('IMPC_YMZ_002_001',52054),('IMPC_YMZ_003_001',52055),('IMPC_YMZ_004_001',52056),('IMPC_YMZ_005_001',52057),('IMPC_YMZ_006_001',52058),('IMPC_YMZ_007_001',52059),('IMPC_YMZ_008_001',52060),('IMPC_YMZ_009_001',52061),('IMPC_YMZ_010_001',52062),('IMPC_YMZ_011_001',52063),('IMPC_YMZ_012_001',52064),('IMPC_YMZ_013_001',52065),('IMPC_YMZ_015_001',52067),('IMPC_YMZ_016_001',52068),('IMPC_YMZ_017_001',52069),('IMPC_YMZ_018_001',52070),('IMPC_YMZ_019_001',52071),('IMPC_YMZ_020_001',52072),('IMPC_YMZ_021_001',52073),('IMPC_YMZ_022_001',52074),('IMPC_YMZ_023_001',52075),('IMPC_YMZ_024_001',52076),('IMPC_YMZ_025_001',52077),('IMPC_YMZ_026_001',52078),('IMPC_YMZ_027_001',52079),('IMPC_YMZ_028_001',52080),('IMPC_YMZ_029_001',52081),('IMPC_LDT_001_001',52084),('IMPC_LDT_002_001',52085),('IMPC_LDT_003_001',52086),('IMPC_LDT_004_001',52087),('IMPC_LDT_005_001',52088),('IMPC_LDT_006_001',52089),('IMPC_LDT_007_001',52090),('IMPC_LDT_008_001',52091),('IMPC_LDT_009_001',52092),('IMPC_LDT_010_001',52093),('IMPC_LDT_011_001',52094),('IMPC_LDT_012_001',52095),('IMPC_LDT_013_001',52096),('IMPC_LDT_014_001',52097),('IMPC_LDT_015_001',52098),('IMPC_LDT_016_001',52099),('IMPC_LDT_017_001',52100),('IMPC_LDT_018_001',52101),('IMPC_LDT_019_001',52102),('IMPC_LDT_020_001',52103),('IMPC_LDT_021_001',52104),('IMPC_LDT_022_001',52105),('IMPC_LDT_023_001',52106),('IMPC_LDT_024_001',52107),('IMPC_LDT_025_001',52108),('IMPC_LDT_026_001',52109),('IMPC_LDT_027_001',52110),('IMPC_LDT_028_001',52111),('IMPC_LDT_029_001',52112),('IMPC_LDT_030_001',52113),('IMPC_LDT_031_001',52114),('IMPC_EMO_001_001',52270),('IMPC_EMO_002_001',52271),('IMPC_EMO_003_001',52272),('IMPC_EMO_004_001',52273),('IMPC_EMO_005_001',52274),('IMPC_EMO_006_001',52275),('IMPC_EMO_007_001',52276),('IMPC_EMO_008_001',52277),('IMPC_EMO_009_001',52278),('IMPC_EMO_010_001',52279),('IMPC_EMO_011_001',52280),('IMPC_EMO_012_001',52281),('IMPC_EMO_013_001',52282),('IMPC_EMO_014_001',52283),('IMPC_EMO_015_001',52284),('IMPC_EMO_016_001',52285),('IMPC_EMO_017_002',52286),('IMPC_EMO_018_001',52287),('IMPC_EMO_019_001',52288),('IMPC_EMO_020_001',52289),('IMPC_EMO_021_001',52290),('IMPC_EMO_022_001',52291),('IMPC_EMO_023_001',52292),('IMPC_EMO_024_001',52293),('IMPC_EMO_025_001',52294),('IMPC_EMO_026_001',52295),('IMPC_EMO_027_001',52296),('IMPC_EMO_028_001',52297),('IMPC_EMO_029_001',52298),('IMPC_EMO_030_001',52299),('IMPC_EMO_031_001',52300),('IMPC_EMO_032_001',52301),('IMPC_EMO_033_001',52302),('IMPC_EMO_034_001',52303),('IMPC_EMO_035_001',52304),('IMPC_EMO_036_001',52305),('IMPC_EMO_037_001',52306),('IMPC_EMO_038_001',52307),('IMPC_EMO_039_001',52308),('IMPC_EMO_040_001',52309),('IMPC_EMO_041_001',52310),('IMPC_EMO_042_001',52311),('IMPC_EMO_043_001',52312),('IMPC_EMO_044_001',52313),('IMPC_EMO_045_001',52314),('IMPC_EMO_046_001',52315),('IMPC_EMO_047_001',52316),('IMPC_EMO_048_001',52317),('IMPC_EMO_049_001',52318),('IMPC_EMO_050_001',52319),('IMPC_EMO_051_001',52320),('IMPC_EMO_052_001',52321),('IMPC_EMO_053_001',52322),('IMPC_EMO_054_001',52323),('IMPC_EMO_055_001',52324),('IMPC_EMO_056_001',52325),('IMPC_EMO_057_001',52326),('IMPC_EMO_058_001',52327),('IMPC_EMO_059_001',52328),('IMPC_EMO_060_001',52329),('IMPC_EMO_061_001',52330),('IMPC_EMO_062_001',52331),('IMPC_EMO_063_001',52332),('IMPC_EMO_064_001',52333),('IMPC_EMO_065_001',52334),('IMPC_EMO_066_001',52335),('IMPC_EMO_067_001',52336),('IMPC_EMO_068_001',52337),('IMPC_EMO_069_001',52338),('IMPC_EMO_070_001',52339),('IMPC_EMO_071_001',52340),('IMPC_EMO_072_001',52341),('IMPC_EMO_073_001',52342),('IMPC_EMO_074_001',52343),('IMPC_EMO_075_001',52344),('IMPC_EMO_076_001',52345),('IMPC_EMO_077_001',52346),('IMPC_EMO_078_001',52347),('IMPC_EMO_079_001',52348),('IMPC_EMO_080_001',52349),('IMPC_EMO_081_001',52350),('IMPC_EMO_082_001',52351),('IMPC_EMO_083_001',52352),('IMPC_EMO_084_001',52353),('IMPC_EMO_085_001',52354),('IMPC_EMO_086_001',52355),('IMPC_EMO_087_001',52356),('IMPC_EMO_088_001',52357),('IMPC_EMO_089_001',52358),('IMPC_EMO_090_001',52359),('IMPC_EMO_091_001',52360),('IMPC_EMO_092_001',52361),('IMPC_EMO_093_001',52362),('IMPC_EMO_094_001',52363),('IMPC_EMO_095_001',52364),('IMPC_EMO_096_001',52365),('IMPC_EMO_097_001',52366),('IMPC_EMO_098_001',52367),('IMPC_EMO_099_001',52368),('IMPC_EMO_100_001',52369),('IMPC_EMO_101_001',52370),('IMPC_EMO_102_001',52371),('IMPC_EMO_103_001',52372),('IMPC_EMO_104_001',52373),('IMPC_EMO_105_001',52374),('IMPC_EMO_106_001',52375),('IMPC_EMO_107_001',52376),('IMPC_EMO_108_001',52377),('IMPC_EMO_109_001',52378),('IMPC_EMO_110_001',52379),('IMPC_EMO_111_001',52380),('IMPC_EMO_112_001',52381),('IMPC_EMO_113_001',52382),('IMPC_EMO_114_001',52383),('IMPC_EMO_115_001',52384),('IMPC_EMO_116_001',52385),('IMPC_EMO_117_001',52386),('IMPC_EMO_118_001',52387),('IMPC_EMO_119_001',52388),('IMPC_EMO_120_001',52389),('IMPC_EMO_121_001',52390),('IMPC_EMO_122_001',52391),('IMPC_EMO_123_001',52392),('IMPC_EMO_124_001',52393),('IMPC_EMO_125_001',52394),('IMPC_EMO_126_001',52395),('IMPC_EMO_127_001',52396),('IMPC_EMO_128_001',52397),('IMPC_EMO_129_001',52398),('IMPC_EMO_130_001',52399),('IMPC_EMO_131_001',52400),('IMPC_EMO_132_001',52401),('IMPC_EMO_133_001',52402),('IMPC_EMO_134_001',52403),('IMPC_EMO_135_001',52404),('IMPC_EMO_136_001',52405),('IMPC_EMO_137_001',52406),('IMPC_EMO_138_001',52407),('IMPC_EMO_139_001',52408),('IMPC_EMO_140_001',52409),('IMPC_EMO_141_001',52410),('IMPC_EMO_142_001',52411),('IMPC_EMO_143_001',52412),('IMPC_EMO_144_001',52413),('IMPC_EMO_145_001',52414),('IMPC_EMO_146_001',52415),('IMPC_EMO_147_001',52416),('IMPC_EMO_148_001',52417),('IMPC_EMO_149_001',52418),('IMPC_EMO_150_001',52419),('IMPC_EMO_151_001',52420),('IMPC_EMO_152_001',52421),('IMPC_EMO_153_001',52422),('IMPC_EMO_154_001',52423),('IMPC_EMO_155_001',52424),('IMPC_EMO_156_001',52425),('IMPC_EMO_157_001',52426),('IMPC_EMO_158_001',52427),('IMPC_EMO_159_001',52428),('IMPC_EMO_160_001',52429),('IMPC_EMO_161_001',52430),('IMPC_EMO_162_001',52431),('IMPC_EMO_163_001',52432),('IMPC_EMO_164_001',52433),('IMPC_EMO_165_001',52434),('IMPC_EMO_166_001',52435),('IMPC_EMO_167_001',52436),('IMPC_EMO_168_001',52437),('IMPC_EMO_169_001',52438),('IMPC_EMO_170_001',52439),('IMPC_EMO_171_001',52440),('IMPC_EMO_172_001',52441),('IMPC_EMO_173_001',52442),('IMPC_EMO_174_001',52443),('IMPC_EMO_175_001',52444),('IMPC_EMO_176_001',52445),('IMPC_EMO_177_001',52446),('IMPC_EMO_178_001',52447),('IMPC_EMO_179_001',52448),('IMPC_XRY_069_001',57175),('IMPC_XRY_070_001',57176),('IMPC_XRY_071_001',57177),('IMPC_XRY_072_001',57178),('IMPC_XRY_073_001',57179),('IMPC_XRY_074_001',57180),('IMPC_VIA_034_001',66104),('IMPC_VIA_035_001',66105),('IMPC_VIA_036_001',66106),('IMPC_VIA_037_001',66107),('IMPC_VIA_038_001',66108),('IMPC_VIA_039_001',66109),('IMPC_VIA_040_001',66110),('IMPC_VIA_041_001',66111),('IMPC_VIA_042_001',66112),('IMPC_VIA_043_001',66113),('IMPC_VIA_044_001',66114),('IMPC_VIA_045_001',66115),('IMPC_VIA_046_001',66116),('IMPC_VIA_047_001',66117),('IMPC_VIA_048_001',66118),('IMPC_VIA_049_001',66119),('IMPC_VIA_050_001',66120),('IMPC_VIA_051_001',66121),('IMPC_VIA_052_001',66122),('IMPC_VIA_053_001',66123),('IMPC_VIA_054_001',66124),('IMPC_VIA_055_001',66125),('IMPC_VIA_056_001',66126),('IMPC_VIA_057_001',66127),('IMPC_VIA_058_001',66128),('IMPC_VIA_059_001',66129),('IMPC_VIA_060_001',66130),('IMPC_VIA_061_001',66131),('IMPC_VIA_062_001',66132),('IMPC_VIA_026_001',66133),('IMPC_VIA_027_001',66134),('IMPC_VIA_030_001',66135),('IMPC_FEA_105_001',67026),('IMPC_FEA_106_001',67033),('IMPC_FEA_107_001',67034),('IMPC_EML_010_001',67252),('IMPC_EML_006_001',67253),('IMPC_EML_007_001',67254),('IMPC_EML_014_001',67255),('IMPC_EML_004_001',67256),('IMPC_EML_003_001',67257),('IMPC_EML_008_001',67258),('IMPC_EML_017_001',67259),('IMPC_EML_009_001',67260),('IMPC_EML_016_001',67261),('IMPC_EML_012_001',67262),('IMPC_EML_013_001',67263),('IMPC_EML_001_001',67264),('IMPC_EML_002_001',67265),('IMPC_EML_015_001',67266),('IMPC_EML_011_001',67267),('IMPC_EML_005_001',67268),('IMPC_WEL_001_001',67597),('IMPC_WEL_002_001',67598),('IMPC_WEL_003_001',67599),('IMPC_WEL_004_001',67600),('IMPC_LDT_032_001',67722),('IMPC_LDT_033_001',67723),('IMPC_LDT_034_001',67724),('IMPC_IMM_001_002',67929),('IMPC_IMM_002_002',67930),('IMPC_IMM_003_002',67931),('IMPC_IMM_004_002',67932),('IMPC_IMM_005_002',67933),('IMPC_IMM_007_002',67934),('IMPC_IMM_008_002',67935),('IMPC_IMM_011_002',67936),('IMPC_IMM_013_002',67937),('IMPC_IMM_014_002',67938),('IMPC_IMM_015_002',67939),('IMPC_IMM_026_002',67940),('IMPC_IMM_027_002',67941),('IMPC_IMM_028_002',67942),('IMPC_IMM_029_002',67943),('IMPC_IMM_032_002',67944),('IMPC_IMM_033_002',67945),('IMPC_IMM_034_002',67946),('IMPC_IMM_040_002',67947),('IMPC_IMM_041_002',67948),('IMPC_IMM_046_002',67949),('IMPC_IMM_047_002',67950),('IMPC_IMM_049_002',67951),('IMPC_IMM_050_002',67952),('IMPC_IMM_051_002',67953),('IMPC_IMM_052_002',67954),('IMPC_IMM_053_002',67955),('IMPC_IMM_054_002',67956),('IMPC_IMM_055_002',67957),('IMPC_IMM_056_002',67958),('IMPC_IMM_057_002',67959),('IMPC_IMM_058_002',67960),('IMPC_IMM_059_002',67961),('IMPC_IMM_061_002',67962),('IMPC_IMM_063_002',67963),('IMPC_IMM_067_002',67964),('IMPC_IMM_071_002',67965),('IMPC_IMM_072_002',67966),('IMPC_IMM_074_002',67967),('IMPC_IMM_075_002',67968),('IMPC_IMM_077_002',67969),('IMPC_IMM_078_002',67970),('IMPC_IMM_079_002',67971),('IMPC_IMM_080_002',67972),('IMPC_IMM_081_002',67973),('IMPC_IMM_082_002',67974),('IMPC_IMM_083_002',67975),('IMPC_IMM_084_002',67976),('IMPC_IMM_085_002',67977),('IMPC_IMM_086_002',67978),('IMPC_IMM_087_002',67979),('IMPC_IMM_088_002',67980),('IMPC_IMM_089_002',67981),('IMPC_IMM_090_002',67982),('IMPC_IMM_091_002',67983),('IMPC_IMM_092_002',67984),('IMPC_IMM_093_002',67985),('IMPC_IMM_094_002',67986),('IMPC_IMM_095_002',67987),('IMPC_IMM_096_002',67988),('IMPC_IMM_097_002',67989),('IMPC_IMM_098_002',67990),('IMPC_IMM_099_002',67991),('IMPC_IMM_100_002',67992),('IMPC_IMM_101_002',67993),('IMPC_IMM_102_002',67994),('IMPC_IMM_103_002',67995),('IMPC_IMM_104_002',67996),('IMPC_IMM_105_002',67997),('IMPC_IMM_106_002',67998),('IMPC_IMM_107_002',67999),('IMPC_IMM_108_002',68000),('IMPC_IMM_109_002',68001),('IMPC_IMM_110_002',68002),('IMPC_IMM_111_002',68003),('IMPC_IMM_112_002',68004),('IMPC_IMM_113_002',68005),('IMPC_IMM_114_002',68006),('IMPC_IMM_115_002',68007),('IMPC_IMM_116_001',68008),('IMPC_IMM_117_001',68009),('IMPC_IMM_118_001',68010),('IMPC_IMM_119_001',68011),('IMPC_IMM_120_001',68012),('IMPC_IMM_121_001',68013),('IMPC_IMM_122_001',68014),('IMPC_IMM_123_001',68015),('IMPC_IMM_124_001',68016),('IMPC_IMM_125_001',68017),('IMPC_IMM_126_001',68018),('IMPC_IMM_127_001',68019),('IMPC_IMM_128_001',68020),('IMPC_IMM_129_001',68021),('IMPC_IMM_130_001',68022),('IMPC_IMM_131_001',68023),('IMPC_IMM_132_001',68024),('IMPC_IMM_133_001',68025),('IMPC_IMM_134_001',68026),('IMPC_IMM_135_001',68027),('IMPC_IMM_136_001',68028),('IMPC_IMM_137_001',68029),('IMPC_IMM_138_001',68030),('IMPC_IMM_139_001',68031),('IMPC_IMM_140_001',68032),('IMPC_IMM_141_001',68033),('IMPC_IMM_142_001',68034),('IMPC_IMM_143_001',68035),('IMPC_IMM_144_001',68036),('IMPC_IMM_145_001',68037),('IMPC_IMM_146_001',68038),('IMPC_IMM_147_001',68039),('IMPC_IMM_148_001',68040),('IMPC_IMM_149_001',68041),('IMPC_IMM_150_001',68042),('IMPC_IMM_151_001',68043),('IMPC_IMM_152_001',68044),('IMPC_IMM_153_001',68045),('IMPC_IMM_154_001',68046),('IMPC_IMM_155_001',68047),('IMPC_IMM_156_001',68048),('IMPC_IMM_157_001',68049),('IMPC_IMM_158_001',68050),('IMPC_IMM_159_001',68051),('IMPC_IMM_160_001',68052),('IMPC_IMM_161_001',68053),('IMPC_IMM_162_001',68054),('IMPC_IMM_163_001',68055),('IMPC_IMM_164_001',68056),('IMPC_IMM_165_001',68057),('IMPC_IMM_166_001',68058),('IMPC_IMM_167_001',68059),('IMPC_IMM_168_001',68060),('IMPC_IMM_169_001',68061),('IMPC_IMM_170_001',68062),('IMPC_IMM_171_001',68063),('IMPC_IMM_172_001',68064),('IMPC_IMM_173_001',68065),('IMPC_IMM_174_001',68066),('IMPC_IMM_175_001',68067),('IMPC_IMM_176_001',68068),('IMPC_IMM_177_001',68069),('IMPC_IMM_178_001',68070),('IMPC_IMM_179_001',68071),('IMPC_IMM_180_001',68072),('IMPC_IMM_181_001',68073),('IMPC_IMM_182_001',68074),('IMPC_IMM_183_001',68075),('IMPC_IMM_184_001',68076),('IMPC_IMM_185_001',68077),('IMPC_IMM_186_001',68078),('IMPC_IMM_187_001',68079),('IMPC_IMM_188_001',68080),('IMPC_IMM_189_001',68081),('IMPC_IMM_190_001',68082),('IMPC_IMM_191_001',68083),('IMPC_IMM_192_001',68084),('IMPC_IMM_193_001',68085),('IMPC_IMM_194_001',68086),('IMPC_IMM_195_001',68087),('IMPC_IMM_196_001',68088),('IMPC_IMM_197_001',68089),('IMPC_IMM_198_001',68090),('IMPC_IMM_199_001',68091),('IMPC_IMM_200_001',68092),('IMPC_IMM_201_001',68093),('IMPC_IMM_202_001',68094),('IMPC_IMM_203_001',68095),('IMPC_IMM_204_001',68096),('IMPC_IMM_205_001',68097),('IMPC_IMM_206_001',68098),('IMPC_IMM_207_001',68099),('IMPC_IMM_208_001',68100),('IMPC_IMM_209_001',68101),('IMPC_IMM_210_001',68102),('IMPC_IMM_211_001',68103),('IMPC_IMM_212_001',68104),('IMPC_IMM_213_001',68105),('IMPC_IMM_214_001',68106),('IMPC_IMM_215_001',68107),('IMPC_IMM_216_001',68108),('IMPC_IMM_217_001',68109),('IMPC_IMM_218_001',68110),('IMPC_IMM_219_001',68111),('IMPC_IMM_220_001',68112),('IMPC_IMM_221_001',68113),('IMPC_IMM_222_001',68114),('IMPC_IMM_223_001',68115),('IMPC_IMM_224_001',68116),('IMPC_IMM_225_001',68117),('IMPC_IMM_226_001',68118),('IMPC_IMM_227_001',68119),('IMPC_IMM_228_001',68120),('IMPC_IMM_229_001',68121),('IMPC_IMM_230_001',68122),('IMPC_IMM_231_001',68123),('IMPC_IMM_232_001',68124),('IMPC_IMM_233_001',68125),('IMPC_IMM_234_001',68126),('IMPC_IMM_235_001',68127),('IMPC_IMM_236_001',68128),('IMPC_IMM_237_001',68129),('IMPC_IMM_238_001',68130),('IMPC_IMM_239_001',68131),('IMPC_IMM_240_001',68132),('IMPC_IMM_241_001',68133),('IMPC_IMM_242_001',68134),('IMPC_IMM_243_001',68135),('IMPC_IMM_244_001',68136),('IMPC_IMM_245_001',68137),('IMPC_IMM_246_001',68138),('IMPC_IMM_247_001',68139),('IMPC_IMM_248_001',68140),('IMPC_IMM_249_001',68141),('IMPC_IMM_250_001',68142),('IMPC_IMM_251_001',68143),('IMPC_IMM_252_001',68144),('IMPC_IMM_253_001',68145),('IMPC_IMM_254_001',68146),('IMPC_IMM_255_001',68147),('IMPC_IMM_256_001',68148),('IMPC_IMM_257_001',68149),('IMPC_IMM_258_001',68150),('IMPC_IMM_259_001',68151),('IMPC_IMM_260_001',68152),('IMPC_IMM_261_001',68153),('IMPC_IMM_262_001',68154),('IMPC_IMM_263_001',68155),('IMPC_IMM_264_001',68156),('IMPC_IMM_265_001',68157),('IMPC_IMM_266_001',68158),('IMPC_IMM_267_001',68159),('IMPC_IMM_268_001',68160),('IMPC_IMM_269_001',68161),('IMPC_IMM_270_001',68162),('IMPC_IMM_271_001',68163),('IMPC_IMM_272_001',68164),('IMPC_IMM_273_001',68165),('IMPC_IMM_274_001',68166),('IMPC_IMM_275_001',68167),('IMPC_IMM_276_001',68168),('IMPC_IMM_277_001',68169),('IMPC_IMM_278_001',68170),('IMPC_IMM_279_001',68171),('IMPC_IMM_280_001',68172),('IMPC_IMM_281_001',68173),('IMPC_IMM_282_001',68174),('IMPC_IMM_283_001',68175),('IMPC_IMM_284_001',68176),('IMPC_IMM_285_001',68177),('IMPC_IMM_286_001',68178),('IMPC_IMM_287_001',68179),('IMPC_IMM_288_001',68180),('IMPC_IMM_289_001',68181),('IMPC_IMM_290_001',68182),('IMPC_IMM_291_001',68183),('IMPC_IMM_292_001',68184),('IMPC_IMM_293_001',68185),('IMPC_IMM_294_001',68186),('IMPC_IMM_295_001',68187),('IMPC_IMM_296_001',68188),('IMPC_IMM_297_001',68189),('IMPC_IMM_298_001',68190),('IMPC_IMM_299_001',68191),('IMPC_IMM_300_001',68192),('IMPC_IMM_301_001',68193),('IMPC_IMM_302_001',68194),('IMPC_IMM_303_001',68195),('IMPC_IMM_304_001',68196),('IMPC_IMM_305_001',68197),('IMPC_IMM_306_001',68198),('IMPC_IMM_307_001',68199),('IMPC_IMM_308_001',68200),('IMPC_IMM_309_001',68201),('IMPC_IMM_310_001',68202),('IMPC_IMM_311_001',68203),('IMPC_IMM_312_001',68204),('IMPC_IMM_313_001',68205),('IMPC_IMM_314_001',68206),('IMPC_IMM_315_001',68207),('IMPC_IMM_316_001',68208),('IMPC_IMM_317_001',68209),('IMPC_IMM_318_001',68210),('IMPC_IMM_319_001',68211),('IMPC_IMM_320_001',68212),('IMPC_IMM_321_001',68213),('IMPC_IMM_322_001',68214),('IMPC_IMM_323_001',68215),('IMPC_IMM_324_001',68216),('IMPC_IMM_325_001',68217),('IMPC_IMM_326_001',68218),('IMPC_IMM_327_001',68219),('IMPC_VIA_063_001',71972),('IMPC_VIA_064_001',71973),('IMPC_VIA_065_001',71974),('IMPC_VIA_066_001',71975),('IMPC_VIA_067_001',71976),('IMPC_EOL_001_001',72162),('IMPC_EOL_002_001',72163),('IMPC_EOL_003_001',72164),('IMPC_EOL_004_001',72165),('IMPC_EOL_005_001',72166),('IMPC_EOL_006_001',72167),('IMPC_EOL_007_001',72168),('IMPC_EOL_008_001',72169),('IMPC_EOL_009_001',72170),('IMPC_EOL_010_001',72171),('IMPC_EOL_011_001',72172),('IMPC_EOL_012_001',72173),('IMPC_EOL_013_001',72174),('IMPC_EOL_014_001',72175),('IMPC_EOL_015_001',72176),('IMPC_EOL_016_001',72177),('IMPC_EOL_017_001',72178),('IMPC_EOL_018_001',72179),('IMPC_EOL_019_001',72180),('IMPC_EOL_020_001',72181),('IMPC_EOL_021_001',72182),('IMPC_EOL_022_001',72183),('IMPC_EOL_023_001',72184),('IMPC_EOL_024_001',72185),('IMPC_EOL_025_001',72186),('IMPC_EOL_026_001',72187),('IMPC_EOL_027_001',72188),('IMPC_EOL_028_001',72189),('IMPC_EOL_029_001',72190),('IMPC_EOL_030_001',72191),('IMPC_EOL_031_001',72192),('IMPC_EOL_032_001',72193),('IMPC_EOL_033_001',72194),('IMPC_EOL_034_001',72195),('IMPC_EOL_035_001',72196),('IMPC_EOL_036_001',72197),('IMPC_EOL_037_001',72198),('IMPC_EOL_038_001',72199),('IMPC_EOL_039_001',72200),('IMPC_EOL_040_001',72201),('IMPC_EOL_041_001',72202),('IMPC_EOL_042_001',72203),('IMPC_EOL_043_001',72204),('IMPC_EOL_044_001',72205),('IMPC_EOL_045_001',72206),('IMPC_EOL_046_001',72207),('IMPC_EOL_047_001',72208),('IMPC_EOL_048_001',72209),('IMPC_EOL_049_001',72210),('IMPC_EOL_050_001',72211),('IMPC_EOL_051_001',72212),('IMPC_EOL_052_001',72213),('IMPC_EML_010_001',72219),('IMPC_EML_006_001',72220),('IMPC_EML_007_001',72221),('IMPC_EML_014_001',72222),('IMPC_EML_004_001',72223),('IMPC_EML_003_001',72224),('IMPC_EML_008_001',72225),('IMPC_EML_017_001',72226),('IMPC_EML_009_001',72227),('IMPC_EML_016_001',72228),('IMPC_EML_012_001',72229),('IMPC_EML_013_001',72230),('IMPC_EML_001_001',72231),('IMPC_EML_002_001',72232),('IMPC_EML_015_001',72233),('IMPC_EML_011_001',72234),('IMPC_EML_005_001',72235),('IMPC_EML_018_001',72236),('IMPC_EML_019_001',72237),('IMPC_EML_020_001',72238),('IMPC_EML_021_001',72239),('IMPC_EML_022_001',72240),('IMPC_EML_023_001',72241),('IMPC_EML_024_001',72242),('IMPC_EML_025_001',72243),('IMPC_EML_026_001',72244),('IMPC_EML_027_001',72245),('IMPC_EML_028_001',72246),('IMPC_EML_029_001',72247),('IMPC_EML_030_001',72248),('IMPC_EML_031_001',72249),('IMPC_EML_032_001',72250),('IMPC_EML_033_001',72251),('IMPC_EML_034_001',72252),('IMPC_EML_035_001',72253),('IMPC_EML_036_001',72254),('IMPC_EML_037_001',72255),('IMPC_EML_038_001',72256),('IMPC_EML_039_001',72257),('IMPC_EML_040_001',72258),('IMPC_EML_041_001',72259),('IMPC_EML_042_001',72260),('IMPC_EML_043_001',72261),('IMPC_EML_044_001',72262),('IMPC_EML_045_001',72263),('IMPC_EML_046_001',72264),('IMPC_EML_047_001',72265),('IMPC_EML_048_001',72266),('IMPC_EML_049_001',72267),('IMPC_EML_050_001',72268),('IMPC_EML_051_001',72269),('IMPC_EML_052_001',72270),('IMPC_EML_053_001',72271),('IMPC_EML_054_001',72272),('IMPC_EML_055_001',72273),('IMPC_EML_056_001',72274),('IMPC_EML_057_001',72275),('IMPC_EML_058_001',72276),('IMPC_EOL_053_001',72720),('IMPC_EMA_001_001',73074),('IMPC_EMA_002_001',73075),('IMPC_EMA_003_001',73076),('IMPC_EMA_004_001',73077),('IMPC_EMA_005_001',73078),('IMPC_EMA_006_001',73079),('IMPC_EMA_007_001',73080),('IMPC_EMA_008_001',73081),('IMPC_EMA_009_001',73082),('IMPC_EMA_010_001',73083),('IMPC_EMA_011_001',73084),('IMPC_EMA_012_001',73085),('IMPC_EMA_013_001',73086),('IMPC_EMA_014_001',73087),('IMPC_EMA_015_001',73088),('IMPC_EMA_016_001',73089),('IMPC_EMA_017_001',73090),('IMPC_EMA_018_001',73091),('IMPC_EMA_019_001',73092),('IMPC_EMA_020_001',73093),('IMPC_EMA_021_001',73094),('IMPC_EMA_022_001',73095),('IMPC_EMA_023_001',73096),('IMPC_EMA_024_001',73097),('IMPC_EMA_025_001',73098),('IMPC_EMA_026_001',73099),('IMPC_EMA_027_001',73100),('IMPC_EMA_028_001',73101),('IMPC_EMA_029_001',73102),('IMPC_EMA_030_001',73103),('IMPC_EMA_031_001',73104),('IMPC_EMA_032_001',73105),('IMPC_EMA_033_001',73106),('IMPC_EMA_034_001',73107),('IMPC_EMA_035_001',73108),('IMPC_EMA_036_001',73109),('IMPC_EMA_037_001',73110),('IMPC_EMA_038_001',73111),('IMPC_EMA_039_001',73112),('IMPC_EMA_040_001',73113),('IMPC_EMA_041_001',73114),('IMPC_EMA_042_001',73115),('IMPC_EMA_043_001',73116),('IMPC_EMA_044_001',73117),('IMPC_EMA_045_001',73118),('IMPC_EMA_046_001',73119),('IMPC_EMA_047_001',73120),('IMPC_EMA_048_001',73121),('IMPC_EMA_049_001',73122),('IMPC_EMA_050_001',73123),('IMPC_EMA_051_001',73124),('IMPC_EMA_052_001',73125),('IMPC_EMA_053_001',73126),('IMPC_EMA_054_001',73127),('IMPC_EMA_055_001',73128),('IMPC_EMA_056_001',73129),('IMPC_EMA_057_001',73130),('IMPC_EMA_058_001',73131),('IMPC_EMA_059_001',73132),('IMPC_EMA_060_001',73133),('IMPC_EMA_061_001',73134),('IMPC_EMA_062_001',73135),('IMPC_EMA_063_001',73136),('IMPC_EMA_064_001',73137),('IMPC_EMA_065_001',73138),('IMPC_EMA_066_001',73139),('IMPC_EMA_067_001',73140),('IMPC_EMA_068_001',73141),('IMPC_EMA_069_001',73142),('IMPC_EMA_070_001',73143),('IMPC_EMA_071_001',73144),('IMPC_EMA_072_001',73145),('IMPC_EMA_073_001',73146),('IMPC_EMA_074_001',73147),('IMPC_EMA_075_001',73148),('IMPC_EMA_076_001',73149),('IMPC_EMA_077_001',73150),('IMPC_EMA_078_001',73151),('IMPC_EMA_079_001',73152),('IMPC_EMA_080_001',73153),('IMPC_EMA_081_001',73154),('IMPC_EMA_082_001',73155),('IMPC_EMA_083_001',73156),('IMPC_EMA_084_001',73157),('IMPC_EMA_085_001',73158),('IMPC_EMA_086_001',73159),('IMPC_EMA_087_001',73160),('IMPC_EMA_088_001',73161),('IMPC_EMA_089_001',73162),('IMPC_EMA_090_001',73163),('IMPC_EMA_091_001',73164),('IMPC_EMA_092_001',73165),('IMPC_EMA_093_001',73166),('IMPC_EMA_094_001',73167),('IMPC_EMA_095_001',73168),('IMPC_EMA_096_001',73169),('IMPC_EMA_097_001',73170),('IMPC_EMA_098_001',73171),('IMPC_EMA_099_001',73172),('IMPC_EMA_100_001',73173),('IMPC_EMA_101_001',73174),('IMPC_EMA_102_001',73175),('IMPC_EMA_103_001',73176),('IMPC_EMA_104_001',73177),('IMPC_EMA_105_001',73178),('IMPC_EMA_106_001',73179),('IMPC_EMA_107_001',73180),('IMPC_EMA_108_001',73181),('IMPC_EMA_109_001',73182),('IMPC_EMA_110_001',73183),('IMPC_EMA_111_001',73184),('IMPC_EMA_112_001',73185),('IMPC_EMA_113_001',73186),('IMPC_EMA_114_001',73187),('IMPC_EMA_115_001',73188),('IMPC_EMA_116_001',73189),('IMPC_EMA_117_001',73190),('IMPC_EMA_118_001',73191),('IMPC_EMA_119_001',73192),('IMPC_EMA_120_001',73193),('IMPC_EMA_121_001',73194),('IMPC_EMA_122_001',73195),('IMPC_EMA_123_001',73196),('IMPC_EMA_124_001',73197),('IMPC_EMA_125_001',73198),('IMPC_EMA_126_001',73199),('IMPC_EMA_127_001',73200),('IMPC_EMA_128_001',73201),('IMPC_EMA_129_001',73202),('IMPC_EMA_130_001',73203),('IMPC_EMA_131_001',73204),('IMPC_EMA_132_001',73205),('IMPC_EMA_133_001',73206),('IMPC_EMA_134_001',73207),('IMPC_EMA_135_001',73208),('IMPC_EMA_136_001',73209),('IMPC_EMA_137_001',73210),('IMPC_EMA_138_001',73211),('IMPC_EMA_139_001',73212),('IMPC_EMA_140_001',73213),('IMPC_EMA_141_001',73214),('IMPC_EMA_142_001',73215),('IMPC_EMA_143_001',73216),('IMPC_EMA_144_001',73217),('IMPC_EMA_145_001',73218),('IMPC_EMA_146_001',73219),('IMPC_EMA_147_001',73220),('IMPC_EMA_148_001',73221),('IMPC_EMA_149_001',73222),('IMPC_EMA_150_001',73223),('IMPC_OWT_021_001',73974),('IMPC_OWT_022_001',73975),('IMPC_OWT_023_001',73976),('IMPC_OWT_024_001',73977),('IMPC_OWT_025_001',73978),('IMPC_OWT_026_001',73979),('IMPC_OWT_027_001',73980),('IMPC_OWT_028_001',73981),('IMPC_OWT_029_001',73982),('IMPC_OWT_030_001',73983),('IMPC_OFD_050_001',74092),('IMPC_OWT_031_001',74113),('IMPC_WEL_005_001',74120),('IMPC_ECG_027_001',74751),('IMPC_HIS_107_001',75512),('IMPC_HIS_350_001',75513),('IMPC_HIS_103_002',75514),('IMPC_HIS_105_002',75515),('IMPC_HIS_346_001',75516),('IMPC_HIS_351_001',75517),('IMPC_HIS_342_002',75518),('IMPC_HIS_344_002',75519),('IMPC_HIS_234_001',75520),('IMPC_HIS_352_001',75521),('IMPC_HIS_230_002',75522),('IMPC_HIS_232_002',75523),('IMPC_HIS_005_001',75524),('IMPC_HIS_353_001',75525),('IMPC_HIS_001_002',75526),('IMPC_HIS_003_002',75527),('IMPC_HIS_241_001',75528),('IMPC_HIS_354_001',75529),('IMPC_HIS_237_002',75530),('IMPC_HIS_239_002',75531),('IMPC_HIS_276_001',75532),('IMPC_HIS_355_001',75533),('IMPC_HIS_272_002',75534),('IMPC_HIS_274_002',75535),('IMPC_HIS_149_001',75536),('IMPC_HIS_356_001',75537),('IMPC_HIS_145_002',75538),('IMPC_HIS_147_002',75539),('IMPC_HIS_047_001',75540),('IMPC_HIS_357_001',75541),('IMPC_HIS_043_002',75542),('IMPC_HIS_045_002',75543),('IMPC_HIS_011_001',75544),('IMPC_HIS_358_001',75545),('IMPC_HIS_007_002',75546),('IMPC_HIS_009_002',75547),('IMPC_HIS_227_001',75548),('IMPC_HIS_359_001',75549),('IMPC_HIS_223_002',75550),('IMPC_HIS_225_002',75551),('IMPC_HIS_065_001',75552),('IMPC_HIS_360_001',75553),('IMPC_HIS_061_002',75554),('IMPC_HIS_063_002',75555),('IMPC_HIS_035_001',75556),('IMPC_HIS_361_001',75557),('IMPC_HIS_031_002',75558),('IMPC_HIS_033_002',75559),('IMPC_HIS_101_001',75560),('IMPC_HIS_362_001',75561),('IMPC_HIS_097_002',75562),('IMPC_HIS_099_002',75563),('IMPC_HIS_255_001',75564),('IMPC_HIS_363_001',75565),('IMPC_HIS_251_002',75566),('IMPC_HIS_253_002',75567),('IMPC_HIS_083_001',75568),('IMPC_HIS_364_001',75569),('IMPC_HIS_079_002',75570),('IMPC_HIS_081_002',75571),('IMPC_HIS_059_001',75572),('IMPC_HIS_365_001',75573),('IMPC_HIS_055_002',75574),('IMPC_HIS_057_002',75575),('IMPC_HIS_053_001',75576),('IMPC_HIS_366_001',75577),('IMPC_HIS_049_002',75578),('IMPC_HIS_051_002',75579),('IMPC_HIS_119_001',75580),('IMPC_HIS_367_001',75581),('IMPC_HIS_115_002',75582),('IMPC_HIS_117_002',75583),('IMPC_HIS_113_001',75584),('IMPC_HIS_368_001',75585),('IMPC_HIS_109_002',75586),('IMPC_HIS_111_002',75587),('IMPC_HIS_269_001',75588),('IMPC_HIS_369_001',75589),('IMPC_HIS_265_002',75590),('IMPC_HIS_267_002',75591),('IMPC_HIS_167_001',75592),('IMPC_HIS_370_001',75593),('IMPC_HIS_163_002',75594),('IMPC_HIS_165_002',75595),('IMPC_HIS_089_001',75596),('IMPC_HIS_371_001',75597),('IMPC_HIS_085_002',75598),('IMPC_HIS_087_002',75599),('IMPC_HIS_373_001',75600),('IMPC_HIS_375_001',75601),('IMPC_HIS_376_001',75602),('IMPC_HIS_377_001',75603),('IMPC_HIS_155_001',75604),('IMPC_HIS_380_001',75605),('IMPC_HIS_151_002',75606),('IMPC_HIS_153_002',75607),('IMPC_HIS_213_001',75608),('IMPC_HIS_381_001',75609),('IMPC_HIS_209_002',75610),('IMPC_HIS_211_002',75611),('IMPC_HIS_297_001',75612),('IMPC_HIS_382_001',75613),('IMPC_HIS_293_002',75614),('IMPC_HIS_295_002',75615),('IMPC_HIS_161_001',75616),('IMPC_HIS_383_001',75617),('IMPC_HIS_157_002',75618),('IMPC_HIS_159_002',75619),('IMPC_HIS_131_001',75620),('IMPC_HIS_384_001',75621),('IMPC_HIS_127_002',75622),('IMPC_HIS_129_002',75623),('IMPC_HIS_125_001',75624),('IMPC_HIS_385_001',75625),('IMPC_HIS_121_002',75626),('IMPC_HIS_123_002',75627),('IMPC_HIS_077_001',75628),('IMPC_HIS_386_001',75629),('IMPC_HIS_073_002',75630),('IMPC_HIS_075_002',75631),('IMPC_HIS_017_001',75632),('IMPC_HIS_387_001',75633),('IMPC_HIS_013_002',75634),('IMPC_HIS_015_002',75635),('IMPC_HIS_095_001',75636),('IMPC_HIS_388_001',75637),('IMPC_HIS_091_002',75638),('IMPC_HIS_093_002',75639),('IMPC_HIS_220_001',75640),('IMPC_HIS_389_001',75641),('IMPC_HIS_216_002',75642),('IMPC_HIS_218_002',75643),('IMPC_HIS_071_001',75644),('IMPC_HIS_390_001',75645),('IMPC_HIS_067_002',75646),('IMPC_HIS_069_002',75647),('IMPC_HIS_143_001',75648),('IMPC_HIS_391_001',75649),('IMPC_HIS_139_002',75650),('IMPC_HIS_141_002',75651),('IMPC_HIS_023_001',75652),('IMPC_HIS_392_001',75653),('IMPC_HIS_019_002',75654),('IMPC_HIS_021_002',75655),('IMPC_HIS_029_001',75656),('IMPC_HIS_393_001',75657),('IMPC_HIS_025_002',75658),('IMPC_HIS_027_002',75659),('IMPC_HIS_248_001',75660),('IMPC_HIS_394_001',75661),('IMPC_HIS_244_002',75662),('IMPC_HIS_246_002',75663),('IMPC_HIS_290_001',75664),('IMPC_HIS_395_001',75665),('IMPC_HIS_286_002',75666),('IMPC_HIS_288_002',75667),('IMPC_HIS_283_001',75668),('IMPC_HIS_396_001',75669),('IMPC_HIS_279_002',75670),('IMPC_HIS_281_002',75671),('IMPC_HIS_041_001',75672),('IMPC_HIS_397_001',75673),('IMPC_HIS_037_002',75674),('IMPC_HIS_039_002',75675),('IMPC_HIS_262_001',75676),('IMPC_HIS_398_001',75677),('IMPC_HIS_258_002',75678),('IMPC_HIS_260_002',75679),('IMPC_HIS_137_001',75680),('IMPC_HIS_399_001',75681),('IMPC_HIS_133_002',75682),('IMPC_HIS_135_002',75683),('IMPC_HIS_173_001',75684),('IMPC_HIS_400_001',75685),('IMPC_HIS_169_002',75686),('IMPC_HIS_171_002',75687),('IMPC_HIS_402_001',75688),('IMPC_HIS_404_001',75689),('IMPC_HIS_405_001',75690),('IMPC_HIS_406_001',75691),('IMPC_HIS_208_001',75692),('IMPC_HIS_176_001',75693),('IMPC_HIS_178_001',75694),('IMPC_HIS_175_001',75695),('IMPC_HIS_177_001',75696),('IMPC_HIS_108_001',75697),('IMPC_HIS_104_001',75698),('IMPC_HIS_106_001',75699),('IMPC_HIS_196_002',75700),('IMPC_HIS_347_001',75701),('IMPC_HIS_343_001',75702),('IMPC_HIS_345_002',75703),('IMPC_HIS_348_002',75704),('IMPC_HIS_235_001',75705),('IMPC_HIS_231_001',75706),('IMPC_HIS_233_001',75707),('IMPC_HIS_236_001',75708),('IMPC_HIS_006_001',75709),('IMPC_HIS_002_001',75710),('IMPC_HIS_004_001',75711),('IMPC_HIS_179_002',75712),('IMPC_HIS_242_001',75713),('IMPC_HIS_238_001',75714),('IMPC_HIS_240_001',75715),('IMPC_HIS_243_001',75716),('IMPC_HIS_277_001',75717),('IMPC_HIS_273_001',75718),('IMPC_HIS_275_001',75719),('IMPC_HIS_278_001',75720),('IMPC_HIS_150_001',75721),('IMPC_HIS_146_001',75722),('IMPC_HIS_148_001',75723),('IMPC_HIS_203_002',75724),('IMPC_HIS_048_001',75725),('IMPC_HIS_044_001',75726),('IMPC_HIS_046_001',75727),('IMPC_HIS_186_002',75728),('IMPC_HIS_012_001',75729),('IMPC_HIS_008_001',75730),('IMPC_HIS_010_001',75731),('IMPC_HIS_180_002',75732),('IMPC_HIS_228_001',75733),('IMPC_HIS_224_001',75734),('IMPC_HIS_226_001',75735),('IMPC_HIS_229_001',75736),('IMPC_HIS_066_001',75737),('IMPC_HIS_062_001',75738),('IMPC_HIS_064_001',75739),('IMPC_HIS_189_002',75740),('IMPC_HIS_036_001',75741),('IMPC_HIS_032_001',75742),('IMPC_HIS_034_001',75743),('IMPC_HIS_184_002',75744),('IMPC_HIS_102_001',75745),('IMPC_HIS_098_001',75746),('IMPC_HIS_100_001',75747),('IMPC_HIS_195_002',75748),('IMPC_HIS_256_001',75749),('IMPC_HIS_252_001',75750),('IMPC_HIS_254_001',75751),('IMPC_HIS_257_001',75752),('IMPC_HIS_084_001',75753),('IMPC_HIS_080_001',75754),('IMPC_HIS_082_001',75755),('IMPC_HIS_192_002',75756),('IMPC_HIS_060_001',75757),('IMPC_HIS_056_001',75758),('IMPC_HIS_058_001',75759),('IMPC_HIS_188_002',75760),('IMPC_HIS_054_001',75761),('IMPC_HIS_050_001',75762),('IMPC_HIS_052_001',75763),('IMPC_HIS_187_002',75764),('IMPC_HIS_120_001',75765),('IMPC_HIS_116_001',75766),('IMPC_HIS_118_001',75767),('IMPC_HIS_198_002',75768),('IMPC_HIS_114_001',75769),('IMPC_HIS_110_001',75770),('IMPC_HIS_112_001',75771),('IMPC_HIS_197_002',75772),('IMPC_HIS_270_001',75773),('IMPC_HIS_266_001',75774),('IMPC_HIS_268_001',75775),('IMPC_HIS_271_001',75776),('IMPC_HIS_168_001',75777),('IMPC_HIS_164_001',75778),('IMPC_HIS_166_001',75779),('IMPC_HIS_206_002',75780),('IMPC_HIS_090_001',75781),('IMPC_HIS_086_001',75782),('IMPC_HIS_088_001',75783),('IMPC_HIS_193_002',75784),('IMPC_HIS_372_001',75785),('IMPC_HIS_374_001',75786),('IMPC_HIS_378_001',75787),('IMPC_HIS_379_001',75788),('IMPC_HIS_156_001',75789),('IMPC_HIS_152_001',75790),('IMPC_HIS_154_001',75791),('IMPC_HIS_204_002',75792),('IMPC_HIS_214_001',75793),('IMPC_HIS_210_001',75794),('IMPC_HIS_212_001',75795),('IMPC_HIS_215_001',75796),('IMPC_HIS_298_001',75797),('IMPC_HIS_294_001',75798),('IMPC_HIS_296_001',75799),('IMPC_HIS_299_001',75800),('IMPC_HIS_162_001',75801),('IMPC_HIS_158_001',75802),('IMPC_HIS_160_001',75803),('IMPC_HIS_205_002',75804),('IMPC_HIS_132_001',75805),('IMPC_HIS_128_001',75806),('IMPC_HIS_130_001',75807),('IMPC_HIS_200_002',75808),('IMPC_HIS_126_001',75809),('IMPC_HIS_122_001',75810),('IMPC_HIS_124_001',75811),('IMPC_HIS_199_002',75812),('IMPC_HIS_078_001',75813),('IMPC_HIS_074_001',75814),('IMPC_HIS_076_001',75815),('IMPC_HIS_191_002',75816),('IMPC_HIS_018_001',75817),('IMPC_HIS_014_001',75818),('IMPC_HIS_016_001',75819),('IMPC_HIS_181_002',75820),('IMPC_HIS_096_001',75821),('IMPC_HIS_092_001',75822),('IMPC_HIS_094_001',75823),('IMPC_HIS_194_002',75824),('IMPC_HIS_221_001',75825),('IMPC_HIS_217_001',75826),('IMPC_HIS_219_001',75827),('IMPC_HIS_222_001',75828),('IMPC_HIS_072_001',75829),('IMPC_HIS_068_001',75830),('IMPC_HIS_070_001',75831),('IMPC_HIS_190_002',75832),('IMPC_HIS_144_001',75833),('IMPC_HIS_140_001',75834),('IMPC_HIS_142_001',75835),('IMPC_HIS_202_002',75836),('IMPC_HIS_024_001',75837),('IMPC_HIS_020_001',75838),('IMPC_HIS_022_001',75839),('IMPC_HIS_182_002',75840),('IMPC_HIS_030_001',75841),('IMPC_HIS_026_001',75842),('IMPC_HIS_028_001',75843),('IMPC_HIS_183_002',75844),('IMPC_HIS_249_001',75845),('IMPC_HIS_245_001',75846),('IMPC_HIS_247_002',75847),('IMPC_HIS_250_001',75848),('IMPC_HIS_291_001',75849),('IMPC_HIS_287_001',75850),('IMPC_HIS_289_001',75851),('IMPC_HIS_292_001',75852),('IMPC_HIS_284_001',75853),('IMPC_HIS_280_001',75854),('IMPC_HIS_282_001',75855),('IMPC_HIS_285_001',75856),('IMPC_HIS_042_001',75857),('IMPC_HIS_038_001',75858),('IMPC_HIS_040_001',75859),('IMPC_HIS_185_002',75860),('IMPC_HIS_263_001',75861),('IMPC_HIS_259_001',75862),('IMPC_HIS_261_001',75863),('IMPC_HIS_264_001',75864),('IMPC_HIS_138_001',75865),('IMPC_HIS_134_001',75866),('IMPC_HIS_136_001',75867),('IMPC_HIS_201_002',75868),('IMPC_HIS_174_001',75869),('IMPC_HIS_170_001',75870),('IMPC_HIS_172_001',75871),('IMPC_HIS_207_002',75872),('IMPC_HIS_401_001',75873),('IMPC_HIS_403_001',75874),('IMPC_HIS_407_001',75875),('IMPC_HIS_408_001',75876),('IMPC_HIS_409_001',75877),('IMPC_HIS_410_001',75878),('IMPC_HIS_411_001',75879),('IMPC_HIS_412_001',75880),('IMPC_HIS_413_001',75881),('IMPC_HIS_414_001',75882),('IMPC_HIS_415_001',75883),('IMPC_HIS_416_001',75884),('IMPC_HIS_417_001',75885),('IMPC_HIS_418_001',75886),('IMPC_HIS_419_001',75887),('IMPC_HIS_420_001',75888),('IMPC_HIS_421_001',75889),('IMPC_HIS_422_001',75890),('IMPC_HIS_423_001',75891),('IMPC_HIS_424_001',75892),('IMPC_FEA_108_001',85373),('IMPC_HIS_425_001',85609),('IMPC_EYE_001_001',85868),('IMPC_EYE_002_001',85869),('IMPC_EYE_003_001',85870),('IMPC_EYE_004_001',85871),('IMPC_EYE_005_001',85872),('IMPC_EYE_006_001',85873),('IMPC_EYE_007_001',85874),('IMPC_EYE_008_001',85875),('IMPC_EYE_009_001',85876),('IMPC_EYE_010_001',85877),('IMPC_EYE_011_001',85878),('IMPC_EYE_012_001',85879),('IMPC_EYE_013_001',85880),('IMPC_EYE_014_001',85881),('IMPC_EYE_015_001',85882),('IMPC_EYE_016_001',85883),('IMPC_EYE_017_001',85884),('IMPC_EYE_018_001',85885),('IMPC_EYE_019_001',85886),('IMPC_EYE_023_001',85887),('IMPC_EYE_024_001',85888),('IMPC_EYE_025_001',85889),('IMPC_EYE_026_001',85890),('IMPC_EYE_027_001',85891),('IMPC_EYE_028_001',85892),('IMPC_EYE_029_001',85893),('IMPC_EYE_030_001',85894),('IMPC_EYE_031_001',85895),('IMPC_EYE_032_001',85896),('IMPC_EYE_033_001',85897),('IMPC_EYE_034_001',85898),('IMPC_EYE_035_001',85899),('IMPC_EYE_036_001',85900),('IMPC_EYE_037_001',85901),('IMPC_EYE_038_001',85902),('IMPC_EYE_039_001',85903),('IMPC_EYE_040_001',85904),('IMPC_EYE_041_001',85905),('IMPC_EYE_042_001',85906),('IMPC_EYE_043_001',85907),('IMPC_EYE_044_001',85908),('IMPC_EYE_045_001',85909),('IMPC_EYE_046_001',85910),('IMPC_EYE_047_001',85911),('IMPC_EYE_048_001',85912),('IMPC_EYE_049_001',85913),('IMPC_EYE_050_001',85914),('IMPC_EYE_051_001',85915),('IMPC_EYE_052_001',85916),('IMPC_EYE_053_001',85917),('IMPC_EYE_054_001',85918),('IMPC_EYE_055_001',85919),('IMPC_EYE_056_001',85920),('IMPC_EYE_057_001',85921),('IMPC_EYE_058_001',85922),('IMPC_EYE_059_001',85923),('IMPC_EYE_060_001',85924),('IMPC_EYE_061_001',85925),('IMPC_EYE_062_001',85926),('IMPC_EYE_063_001',85927),('IMPC_EYE_064_001',85928),('IMPC_EYE_065_001',85929),('IMPC_EYE_066_001',85930),('IMPC_EYE_067_001',85931),('IMPC_EYE_068_001',85932),('IMPC_EYE_069_001',85933),('IMPC_EYE_070_001',85934),('IMPC_EYE_071_001',85935),('IMPC_EYE_072_001',85936),('IMPC_EYE_073_001',85937),('IMPC_EYE_074_001',85938),('IMPC_EYE_075_001',85939),('IMPC_EYE_076_001',85940),('IMPC_EYE_077_001',85941),('IMPC_EYE_078_001',85942),('IMPC_EYE_079_001',85943),('IMPC_EYE_080_001',85944),('IMPC_EYE_081_001',85945),('IMPC_EYE_082_001',85946),('IMPC_EYE_083_001',85947),('IMPC_EYE_084_001',85948),('IMPC_EYE_085_001',85949),('IMPC_EYE_086_001',85950),('IMPC_EYE_087_001',85951),('IMPC_EYE_088_001',85952),('IMPC_EYE_089_001',85953),('IMPC_EYE_090_001',85954),('IMPC_EYE_091_001',85955),('IMPC_EYE_092_002',85956),('IMPC_HOU_003_002',89677),('IMPC_HOU_004_002',89678),('IMPC_HOU_005_002',89679),('IMPC_HOU_009_001',89680),('IMPC_HOU_068_001',89681),('IMPC_HOU_012_001',89682),('IMPC_HOU_069_001',89683),('IMPC_HOU_015_001',89684),('IMPC_HOU_070_001',89685),('IMPC_HOU_019_001',89686),('IMPC_HOU_071_001',89687),('IMPC_HOU_023_001',89688),('IMPC_HOU_072_001',89689),('IMPC_HOU_027_001',89690),('IMPC_HOU_028_001',89691),('IMPC_HOU_073_001',89692),('IMPC_HOU_074_001',89693),('IMPC_HOU_075_001',89694),('IMPC_HOU_076_001',89695),('IMPC_HOU_077_001',89696),('IMPC_HOU_078_001',89697),('IMPC_HOU_079_001',89698),('IMPC_HOU_080_001',89699),('IMPC_HOU_035_002',89700),('IMPC_HOU_036_001',89701),('IMPC_HOU_037_002',89702),('IMPC_HOU_038_001',89703),('IMPC_HOU_039_002',89704),('IMPC_HOU_081_001',89705),('IMPC_HOU_082_001',89706),('IMPC_HOU_083_001',89707),('IMPC_HOU_041_001',89708),('IMPC_HOU_043_002',89709),('IMPC_HOU_044_002',89710),('IMPC_HOU_045_002',89711),('IMPC_HOU_050_001',89712),('IMPC_HOU_051_002',89713),('IMPC_HOU_053_002',89714),('IMPC_HOU_054_001',89715),('IMPC_HOU_055_001',89716),('IMPC_HOU_056_001',89717),('IMPC_HOU_084_001',89718),('IMPC_HOU_085_001',89719),('IMPC_HOU_052_001',89720),('IMPC_ECG_001_001',89737),('IMPC_ECG_002_001',89738),('IMPC_ECG_003_001',89739),('IMPC_ECG_004_001',89740),('IMPC_ECG_005_001',89741),('IMPC_ECG_006_001',89742),('IMPC_ECG_007_001',89743),('IMPC_ECG_008_001',89744),('IMPC_ECG_010_001',89745),('IMPC_ECG_012_001',89747),('IMPC_ECG_013_001',89748),('IMPC_ECG_014_001',89749),('IMPC_ECG_015_001',89750),('IMPC_ECG_016_001',89751),('IMPC_ECG_017_001',89752),('IMPC_ECG_018_001',89753),('IMPC_ECG_019_001',89754),('IMPC_ECG_020_001',89755),('IMPC_ECG_021_001',89756),('IMPC_ECG_022_001',89757),('IMPC_ECG_023_001',89758),('IMPC_ECG_009_002',89759),('IMPC_ECG_024_001',89760),('IMPC_ECG_025_001',89761),('IMPC_ECG_026_001',89762),('IMPC_ECG_027_001',89763),('IMPC_ECG_028_001',89764),('IMPC_ECG_029_001',89765),('IMPC_GEM_079_001',90846),('IMPC_HOU_086_001',90854),('IMPC_ECG_030_001',90855),('IMPC_ECG_031_001',90856),('IMPC_OFD_051_001',90893),('IMPC_OFD_052_001',90894),('IMPC_EXD_003_002',90931),('IMPC_EXD_132_001',90932),('IMPC_EXD_133_001',90933),('IMPC_EXD_004_002',90934),('IMPC_EXD_005_002',90935),('IMPC_EXD_006_001',90936),('IMPC_EXD_007_001',90937),('IMPC_EXD_008_001',90938),('IMPC_EXD_009_001',90939),('IMPC_EXD_012_002',90940),('IMPC_EXD_013_001',90941),('IMPC_EXD_014_001',90942),('IMPC_EXD_098_002',90943),('IMPC_EXD_127_001',90944),('IMPC_EXD_128_001',90945),('IMPC_EXD_129_001',90946),('IMPC_EXD_130_001',90947),('IMPC_EXD_131_001',90948),('IMPC_EXD_134_001',91309),('IMPC_EXD_135_001',91310),('IMPC_EXD_136_001',91311),('IMPC_EXD_015_001',91312),('IMPC_FOR_001_001',91489),('IMPC_FOR_002_001',91490),('IMPC_FOR_003_001',91491),('IMPC_FOR_004_001',91492),('IMPC_FOR_005_001',91493),('IMPC_FOR_006_001',91494),('IMPC_FOR_007_001',91495),('IMPC_FOR_008_001',91496),('IMPC_FOR_009_001',91497),('IMPC_FOR_010_001',91498),('IMPC_FOR_011_001',91499),('IMPC_FOR_012_001',91500),('IMPC_FOR_013_001',91501),('IMPC_FOR_014_001',91502),('IMPC_FOR_015_001',91503),('IMPC_FOR_016_001',91504),('IMPC_FOR_017_001',91505),('IMPC_FOR_018_001',91506),('IMPC_FOR_019_001',91507),('IMPC_FOR_020_001',91571),('IMPC_FOR_021_001',91572),('IMPC_FOR_022_001',91573),('IMPC_FOR_023_001',91574),('IMPC_FOR_024_001',91575),('IMPC_FOR_025_001',91576),('IMPC_FOR_026_001',91577),('IMPC_IMM_328_001',92272),('IMPC_VIA_068_001',92576),('IMPC_FER_024_001',92844),('IMPC_FER_025_001',92845);
/*!40000 ALTER TABLE `parameterXprocedure` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `PhenodigmScores`
--

DROP TABLE IF EXISTS `PhenodigmScores`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `PhenodigmScores` (
  `phenodigm_id` int NOT NULL AUTO_INCREMENT,
  `disease_id` varchar(50) DEFAULT NULL,
  `gene_id` varchar(11) DEFAULT NULL,
  `phenodigm_score` float DEFAULT NULL,
  PRIMARY KEY (`phenodigm_id`),
  KEY `disease_id` (`disease_id`),
  KEY `gene_id` (`gene_id`),
  CONSTRAINT `phenodigmscores_ibfk_1` FOREIGN KEY (`disease_id`) REFERENCES `Diseases` (`disease_id`),
  CONSTRAINT `phenodigmscores_ibfk_2` FOREIGN KEY (`gene_id`) REFERENCES `Genes` (`gene_id`)
) ENGINE=InnoDB AUTO_INCREMENT=2051 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Stores gene-disease association scores (many-to-many) linking Genes and Diseases.';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `PhenodigmScores`
--

LOCK TABLES `PhenodigmScores` WRITE;
/*!40000 ALTER TABLE `PhenodigmScores` DISABLE KEYS */;
INSERT INTO `PhenodigmScores` VALUES (4,'OMIM:200150','MGI:98967',36.02),(5,'OMIM:209850','MGI:98967',45.88),(6,'ORPHA:139399','MGI:98967',13.69),(7,'ORPHA:66624','MGI:98967',44.83),(8,'ORPHA:213','MGI:98967',16.14),(9,'ORPHA:79155','MGI:98967',25.41),(10,'OMIM:157800','MGI:98967',14.96),(11,'OMIM:243910','MGI:98967',16.01),(12,'OMIM:300855','MGI:98967',8.76),(13,'OMIM:259050','MGI:98967',17.78),(14,'OMIM:602440','MGI:98967',12.24),(15,'ORPHA:261494','MGI:98967',15.53),(16,'OMIM:214800','MGI:98967',13.95),(17,'OMIM:619297','MGI:98967',13.07),(18,'ORPHA:276432','MGI:98967',20.94),(19,'ORPHA:107','MGI:98967',31.24),(20,'ORPHA:107','MGI:98967',33.94),(21,'ORPHA:138','MGI:98967',16.04),(22,'OMIM:619648','MGI:98967',10.24),(23,'OMIM:619869','MGI:98967',23.91),(24,'ORPHA:561854','MGI:98967',27.15),(25,'ORPHA:488618','MGI:98967',26.8),(26,'ORPHA:49','MGI:98967',9.21),(27,'ORPHA:648','MGI:98967',13.81),(28,'ORPHA:649','MGI:98967',24.99),(29,'ORPHA:649','MGI:98967',23.91),(30,'ORPHA:247245','MGI:98967',25.72),(31,'ORPHA:95','MGI:98967',13.91),(32,'ORPHA:778','MGI:98967',26.1),(33,'ORPHA:85278','MGI:98967',31.13),(34,'ORPHA:87','MGI:98967',14.19),(35,'ORPHA:319671','MGI:98967',26.09),(36,'ORPHA:705','MGI:98967',41.21),(37,'ORPHA:71272','MGI:98967',7.53),(38,'OMIM:147920','MGI:98967',7.64),(39,'OMIM:220200','MGI:98967',21.7),(40,'OMIM:239500','MGI:98967',35.04),(41,'DECIPHER:45','MGI:98967',37.6),(42,'DECIPHER:8','MGI:98967',32.95),(43,'OMIM:109150','MGI:98967',12.12),(44,'OMIM:113650','MGI:98967',25.57),(45,'OMIM:182290','MGI:98967',22.5),(46,'OMIM:183090','MGI:98967',10.07),(47,'OMIM:194190','MGI:98967',10.17),(48,'OMIM:301094','MGI:98967',21.93),(49,'OMIM:300624','MGI:98967',32.58),(50,'OMIM:301029','MGI:98967',29.45),(51,'OMIM:309000','MGI:98967',9.47),(52,'OMIM:257550','MGI:98967',10.26),(53,'OMIM:602588','MGI:98967',32.14),(54,'OMIM:602588','MGI:98967',37.13),(55,'OMIM:164400','MGI:98967',16.74),(56,'OMIM:606232','MGI:98967',23.55),(57,'ORPHA:261183','MGI:98967',11.96),(58,'OMIM:619312','MGI:98967',19.92),(59,'ORPHA:228384','MGI:98967',15.95),(60,'ORPHA:228402','MGI:98967',27.32),(61,'ORPHA:167','MGI:98967',9.13),(62,'ORPHA:168782','MGI:98967',34.79),(63,'OMIM:610253','MGI:98967',14.03),(64,'OMIM:610688','MGI:98967',18.28),(65,'OMIM:610688','MGI:98967',20.14),(66,'OMIM:610883','MGI:98967',19.83),(67,'OMIM:610954','MGI:98967',18.15),(68,'OMIM:614063','MGI:98967',36.08),(69,'OMIM:615485','MGI:98967',14),(70,'OMIM:615574','MGI:98967',21.19),(71,'OMIM:617682','MGI:98967',18.3),(72,'OMIM:615960','MGI:98967',12.97),(73,'OMIM:618218','MGI:98967',25.02),(74,'OMIM:616268','MGI:98967',12.74),(75,'OMIM:616364','MGI:98967',20.8),(76,'ORPHA:1435','MGI:98967',28.2),(77,'ORPHA:1606','MGI:98967',13.15),(78,'ORPHA:1727','MGI:98967',24.6),(79,'ORPHA:10','MGI:98967',20.85),(80,'ORPHA:1001','MGI:98967',16.77),(81,'ORPHA:100973','MGI:98967',48.31),(82,'OMIM:619695','MGI:98967',23.75),(83,'ORPHA:580','MGI:98967',17.42),(84,'ORPHA:468678','MGI:98967',17.09),(85,'ORPHA:50815','MGI:98967',33.4),(86,'ORPHA:52368','MGI:98967',33.77),(87,'ORPHA:530983','MGI:98967',28.96),(88,'ORPHA:35125','MGI:98967',16.54),(89,'ORPHA:382','MGI:98967',34.46),(90,'ORPHA:64280','MGI:98967',32.13),(91,'ORPHA:208447','MGI:98967',12.59),(92,'ORPHA:2152','MGI:98967',11.86),(93,'ORPHA:217253','MGI:98967',22.15),(94,'ORPHA:251061','MGI:98967',31.36),(95,'ORPHA:238750','MGI:98967',20.17),(96,'ORPHA:819','MGI:98967',17.07),(97,'ORPHA:96121','MGI:98967',19.68),(98,'ORPHA:96148','MGI:98967',20.06),(99,'ORPHA:79414','MGI:98967',27.36),(100,'ORPHA:319182','MGI:98967',19.37),(101,'ORPHA:435638','MGI:98967',20.09),(102,'ORPHA:35689','MGI:98967',17.47),(103,'ORPHA:90646','MGI:98967',26.59),(104,'ORPHA:90646','MGI:98967',31.78),(105,'ORPHA:99965','MGI:98967',11.29),(106,'OMIM:245348','MGI:98967',15.56),(107,'OMIM:249000','MGI:98967',16.1),(108,'OMIM:123450','MGI:98967',25.09),(109,'OMIM:304400','MGI:98967',37.35),(110,'OMIM:301030','MGI:98967',19.22),(111,'OMIM:172700','MGI:98967',48.81),(112,'OMIM:607373','MGI:98967',45.88),(113,'OMIM:607453','MGI:98967',21.8),(114,'OMIM:607453','MGI:98967',43.56),(115,'ORPHA:261197','MGI:98967',26.74),(116,'OMIM:619325','MGI:98967',12.82),(117,'OMIM:619435','MGI:98967',24.67),(118,'ORPHA:293939','MGI:98967',31.76),(119,'ORPHA:3233','MGI:98967',46.29),(120,'OMIM:613174','MGI:98967',18.93),(121,'OMIM:613454','MGI:98967',34.52),(122,'OMIM:608049','MGI:98967',40.84),(123,'OMIM:609425','MGI:98967',41.42),(124,'OMIM:611584','MGI:98967',25.13),(125,'OMIM:611584','MGI:98967',30.57),(126,'OMIM:600430','MGI:98967',26.49),(127,'OMIM:614175','MGI:98967',21.1),(128,'OMIM:615656','MGI:98967',29.72),(129,'OMIM:617435','MGI:98967',26.04),(130,'OMIM:617695','MGI:98967',36.3),(131,'OMIM:618205','MGI:98967',25.94),(132,'OMIM:618778','MGI:98967',40.2),(133,'OMIM:618915','MGI:98967',18.86),(134,'OMIM:618915','MGI:98967',39.4),(135,'OMIM:618347','MGI:98967',17.62),(136,'OMIM:618354','MGI:98967',15.02),(137,'OMIM:617808','MGI:98967',23.2),(138,'OMIM:618013','MGI:98967',56.4),(139,'OMIM:618027','MGI:98967',22.15),(140,'OMIM:619274','MGI:98967',51.39),(141,'ORPHA:157941','MGI:98967',22.23),(142,'ORPHA:157946','MGI:98967',18.29),(143,'ORPHA:18','MGI:98967',19.33),(144,'ORPHA:139431','MGI:98967',6.91),(145,'OMIM:620642','MGI:98967',7.04),(146,'OMIM:619690','MGI:98967',18.32),(147,'OMIM:619877','MGI:98967',30.54),(148,'OMIM:620280','MGI:98967',21.8),(149,'OMIM:620280','MGI:98967',43.56),(150,'OMIM:620281','MGI:98967',49.5),(151,'ORPHA:534','MGI:98967',9.89),(152,'ORPHA:397612','MGI:98967',24.95),(153,'ORPHA:217','MGI:98967',26.56),(154,'ORPHA:2479','MGI:98967',21.44),(155,'ORPHA:251347','MGI:98967',12.21),(156,'ORPHA:231169','MGI:98967',31.13),(157,'ORPHA:231169','MGI:98967',39.7),(158,'ORPHA:231183','MGI:98967',24.58),(159,'ORPHA:231183','MGI:98967',42.19),(160,'ORPHA:98807','MGI:98967',21.24),(161,'ORPHA:79136','MGI:98967',30.2),(162,'ORPHA:309246','MGI:98967',26.25),(163,'ORPHA:434179','MGI:98967',12.42),(164,'ORPHA:363722','MGI:98967',18.1),(165,'OMIM:219090','MGI:98967',12.67),(166,'OMIM:300672','MGI:98967',17.51),(167,'OMIM:602433','MGI:98967',25.89),(168,'OMIM:300352','MGI:98967',28.69),(169,'OMIM:213200','MGI:98967',14.47),(170,'OMIM:619293','MGI:98967',17.6),(171,'OMIM:619317','MGI:98967',21.62),(172,'OMIM:271250','MGI:98967',45.8),(173,'ORPHA:275864','MGI:98967',47.59),(174,'ORPHA:276238','MGI:98967',13.88),(175,'ORPHA:276241','MGI:98967',13.88),(176,'ORPHA:276244','MGI:98967',15.71),(177,'ORPHA:171680','MGI:98967',12.34),(178,'ORPHA:329308','MGI:98967',15.67),(179,'ORPHA:3306','MGI:98967',23.64),(180,'OMIM:614831','MGI:98967',15.45),(181,'OMIM:607625','MGI:98967',17.52),(182,'OMIM:608631','MGI:98967',50.57),(183,'OMIM:608636','MGI:98967',51.92),(184,'OMIM:608638','MGI:98967',50.57),(185,'OMIM:612020','MGI:98967',17.22),(186,'OMIM:610042','MGI:98967',36.06),(187,'OMIM:613886','MGI:98967',23.83),(188,'OMIM:615873','MGI:98967',14.95),(189,'OMIM:616341','MGI:98967',21.34),(190,'OMIM:617830','MGI:98967',27.5),(191,'OMIM:618004','MGI:98967',26.45),(192,'OMIM:618067','MGI:98967',12.81),(193,'OMIM:619621','MGI:98967',8.85),(194,'OMIM:619777','MGI:98967',12.62),(195,'OMIM:620033','MGI:98967',21.06),(196,'OMIM:620208','MGI:98967',8.59),(197,'ORPHA:464306','MGI:98967',15.1),(198,'ORPHA:208441','MGI:98967',32.01),(199,'ORPHA:240103','MGI:98967',15.13),(200,'ORPHA:71518','MGI:98967',45.55),(201,'ORPHA:363558','MGI:98967',4.99),(202,'ORPHA:99027','MGI:98967',16.23),(203,'OMIM:220220','MGI:98967',24.97),(204,'OMIM:300912','MGI:98967',29.49),(205,'OMIM:309548','MGI:98967',36.11),(206,'OMIM:300271','MGI:98967',32.99),(207,'OMIM:300425','MGI:98967',38.99),(208,'OMIM:300495','MGI:98967',35.03),(209,'OMIM:300496','MGI:98967',38.99),(210,'ORPHA:261144','MGI:98967',22.11),(211,'OMIM:212065','MGI:98967',8.84),(212,'OMIM:212066','MGI:98967',22.76),(213,'OMIM:619428','MGI:98967',15.19),(214,'ORPHA:2822','MGI:98967',12.77),(215,'OMIM:607459','MGI:98967',9.87),(216,'OMIM:612474','MGI:98967',10.09),(217,'OMIM:614104','MGI:98967',28.7),(218,'OMIM:615502','MGI:98967',15.44),(219,'OMIM:615516','MGI:98967',30.59),(220,'OMIM:615541','MGI:98967',38.16),(221,'OMIM:615637','MGI:98967',15.7),(222,'OMIM:617330','MGI:98967',23.67),(223,'OMIM:617600','MGI:98967',25.32),(224,'OMIM:617270','MGI:98967',42.67),(225,'OMIM:616682','MGI:98967',15.88),(226,'OMIM:616939','MGI:98967',18.88),(227,'OMIM:616269','MGI:98967',55.11),(228,'OMIM:616351','MGI:98967',31.16),(229,'OMIM:616393','MGI:98967',38.59),(230,'OMIM:618914','MGI:98967',23.94),(231,'OMIM:618504','MGI:98967',33.61),(232,'OMIM:617751','MGI:98967',21.34),(233,'OMIM:617751','MGI:98967',20.18),(234,'OMIM:617796','MGI:98967',22.35),(235,'OMIM:619229','MGI:98967',16.93),(236,'ORPHA:177907','MGI:98967',12.91),(237,'ORPHA:1170','MGI:98967',15.28),(238,'ORPHA:139480','MGI:98967',17),(239,'ORPHA:100924','MGI:98967',30.51),(240,'ORPHA:100986','MGI:98967',24.99),(241,'ORPHA:101085','MGI:98967',12.2),(242,'OMIM:619717','MGI:98967',37.53),(243,'ORPHA:544254','MGI:98967',35.86),(244,'ORPHA:572798','MGI:98967',16.13),(245,'ORPHA:447757','MGI:98967',17.13),(246,'ORPHA:370959','MGI:98967',27.38),(247,'ORPHA:251282','MGI:98967',30.66),(248,'ORPHA:98784','MGI:98967',24.5),(249,'ORPHA:79282','MGI:98967',16.71),(250,'ORPHA:85277','MGI:98967',17.55),(251,'ORPHA:70595','MGI:98967',20.04),(252,'ORPHA:357058','MGI:98967',19.26),(253,'OMIM:300614','MGI:98967',49.04),(254,'ORPHA:261537','MGI:98967',10.33),(255,'OMIM:619475','MGI:98967',18.08),(256,'OMIM:619512','MGI:98967',15.86),(257,'ORPHA:280763','MGI:98967',18.96),(258,'OMIM:619054','MGI:98967',11.19),(259,'OMIM:620786','MGI:98967',33.16),(260,'OMIM:620065','MGI:98967',26.55),(261,'OMIM:620141','MGI:98967',23.3),(262,'ORPHA:457279','MGI:98967',23.27),(263,'ORPHA:395','MGI:98967',16.44),(264,'ORPHA:247815','MGI:98967',24.44),(265,'ORPHA:86822','MGI:98967',16.52),(266,'ORPHA:3077','MGI:98967',32.17),(267,'ORPHA:3078','MGI:98967',23.55),(268,'ORPHA:411511','MGI:98967',30.83),(269,'ORPHA:436151','MGI:98967',47.48),(270,'ORPHA:352490','MGI:98967',20.96),(271,'ORPHA:353277','MGI:98967',14.97),(272,'ORPHA:353281','MGI:98967',19.59),(273,'ORPHA:353284','MGI:98967',14.97),(274,'ORPHA:927','MGI:98967',22.24),(275,'OMIM:300986','MGI:98967',21.79),(276,'OMIM:301040','MGI:98967',13.76),(277,'OMIM:309590','MGI:98967',14.23),(278,'OMIM:256840','MGI:98967',15.73),(279,'OMIM:300260','MGI:98967',28.27),(280,'OMIM:300486','MGI:98967',31.32),(281,'OMIM:606053','MGI:98967',46.53),(282,'OMIM:619306','MGI:98967',14.51),(283,'OMIM:614756','MGI:98967',26.01),(284,'OMIM:600791','MGI:98967',42.61),(285,'OMIM:600795','MGI:98967',40),(286,'OMIM:615282','MGI:98967',20.65),(287,'OMIM:615771','MGI:98967',10.03),(288,'OMIM:617044','MGI:98967',26.42),(289,'OMIM:617061','MGI:98967',20.63),(290,'OMIM:617101','MGI:98967',34.26),(291,'OMIM:618147','MGI:98967',35.85),(292,'OMIM:618825','MGI:98967',23.94),(293,'OMIM:618917','MGI:98967',31.99),(294,'OMIM:618497','MGI:98967',31.42),(295,'OMIM:617802','MGI:98967',26.16),(296,'OMIM:617862','MGI:98967',29.96),(297,'OMIM:619121','MGI:98967',24.76),(298,'OMIM:619150','MGI:98967',41.73),(299,'OMIM:620021','MGI:98967',34.02),(300,'OMIM:620242','MGI:98967',24.91),(301,'ORPHA:457240','MGI:98967',31.71),(302,'ORPHA:466768','MGI:98967',15.9),(303,'ORPHA:508533','MGI:98967',7.14),(304,'ORPHA:513456','MGI:98967',21.87),(305,'ORPHA:529965','MGI:98967',19.8),(306,'ORPHA:370022','MGI:98967',13.05),(307,'ORPHA:647799','MGI:98967',17.12),(308,'ORPHA:313892','MGI:98967',18.92),(309,'ORPHA:369837','MGI:98967',7.35),(310,'ORPHA:261552','MGI:98967',9.07),(311,'ORPHA:300570','MGI:98967',20.78),(312,'OMIM:612069','MGI:98967',35.62),(313,'OMIM:616579','MGI:98967',29.32),(314,'OMIM:615802','MGI:98967',20.67),(315,'OMIM:618718','MGI:98967',43.86),(316,'OMIM:619005','MGI:98967',14.16),(317,'OMIM:618430','MGI:98967',26.99),(318,'OMIM:618653','MGI:98967',18.56),(319,'OMIM:617787','MGI:98967',38.07),(320,'OMIM:620719','MGI:98967',13.81),(321,'OMIM:620747','MGI:98967',37.75),(322,'OMIM:620502','MGI:98967',20.44),(323,'OMIM:619522','MGI:98967',13.82),(324,'OMIM:620330','MGI:98967',22.49),(325,'ORPHA:445062','MGI:98967',29.66),(326,'ORPHA:447997','MGI:98967',29.58),(327,'ORPHA:449291','MGI:98967',39.6),(328,'ORPHA:464311','MGI:98967',15.36),(329,'ORPHA:468631','MGI:98967',12.38),(330,'ORPHA:476126','MGI:98967',17.68),(331,'ORPHA:508498','MGI:98967',8.57),(332,'ORPHA:522077','MGI:98967',18.57),(333,'OMIM:300749','MGI:98967',19.92),(334,'OMIM:619470','MGI:98967',30.84),(335,'OMIM:613443','MGI:98967',13.88),(336,'OMIM:613443','MGI:98967',27.05),(337,'OMIM:609136','MGI:98967',19.25),(338,'OMIM:618342','MGI:98967',24.21),(339,'OMIM:617903','MGI:98967',31.01),(340,'OMIM:619092','MGI:98967',33.09),(341,'OMIM:619103','MGI:98967',21.61),(342,'OMIM:620494','MGI:98967',16.92),(343,'OMIM:619575','MGI:98967',22.78),(344,'OMIM:619725','MGI:98967',29.19),(345,'OMIM:620073','MGI:98967',10.21),(346,'ORPHA:391307','MGI:98967',33.01),(347,'OMIM:301044','MGI:98967',11.83),(348,'OMIM:617393','MGI:98967',27.21),(349,'OMIM:618709','MGI:98967',31.9),(350,'OMIM:617820','MGI:98967',34.04),(351,'OMIM:620469','MGI:98967',42.01),(352,'ORPHA:457351','MGI:98967',19.3),(353,'ORPHA:397933','MGI:98967',43.05),(354,'ORPHA:411986','MGI:98967',25.38),(355,'OMIM:301066','MGI:98967',14.73),(356,'OMIM:613670','MGI:98967',24.93),(357,'OMIM:617807','MGI:98967',27.14),(358,'OMIM:620428','MGI:98967',28.53),(359,'OMIM:619580','MGI:98967',35.64),(360,'OMIM:620292','MGI:98967',29.15),(361,'ORPHA:572013','MGI:98967',16.96),(362,'ORPHA:480880','MGI:98967',15.24),(363,'ORPHA:496641','MGI:98967',17.71),(364,'ORPHA:500159','MGI:98967',17.56),(365,'OMIM:617171','MGI:98967',36.58),(366,'OMIM:618906','MGI:98967',33),(367,'OMIM:208400','MGI:96090',6.06),(368,'OMIM:190330','MGI:98266',70.24),(369,'OMIM:309300','MGI:98266',50.85),(370,'OMIM:614156','MGI:1928271',46.62),(371,'ORPHA:180229','MGI:96090',14.89),(372,'ORPHA:14','MGI:1928271',14.61),(373,'ORPHA:552','MGI:109279',40.04),(374,'ORPHA:533','MGI:1928271',7.66),(375,'ORPHA:3376','MGI:1928271',9.51),(376,'ORPHA:349','MGI:1928271',10.97),(377,'ORPHA:2477','MGI:96090',18.96),(378,'ORPHA:95512','MGI:109279',25.14),(379,'ORPHA:95513','MGI:109279',25.46),(380,'ORPHA:97283','MGI:1928271',14.93),(381,'ORPHA:93','MGI:96090',6.23),(382,'OMIM:250100','MGI:1928271',16.88),(383,'OMIM:230200','MGI:98266',45.07),(384,'OMIM:145750','MGI:109279',42.58),(385,'OMIM:223370','MGI:1928271',5.16),(386,'OMIM:149500','MGI:98266',63.52),(387,'OMIM:106210','MGI:98266',30.37),(388,'OMIM:114290','MGI:3665157',3.79),(389,'OMIM:115660','MGI:98266',58.71),(390,'OMIM:115800','MGI:98266',97.86),(391,'OMIM:115900','MGI:98266',66.5),(392,'OMIM:116400','MGI:98266',64.95),(393,'OMIM:302200','MGI:98266',55.55),(394,'OMIM:310600','MGI:98266',33.4),(395,'OMIM:262300','MGI:98266',25.59),(396,'OMIM:255990','MGI:98266',45.09),(397,'OMIM:601552','MGI:98266',23.99),(398,'OMIM:177650','MGI:98266',58.54),(399,'OMIM:603165','MGI:98266',24.13),(400,'ORPHA:261318','MGI:96090',5.56),(401,'OMIM:211770','MGI:98266',49.85),(402,'OMIM:619290','MGI:109279',53.15),(403,'OMIM:619324','MGI:1928271',57.48),(404,'OMIM:273150','MGI:96090',57.56),(405,'ORPHA:2663','MGI:98266',50.09),(406,'ORPHA:170','MGI:98266',24.97),(407,'ORPHA:325124','MGI:96090',48.73),(408,'OMIM:614691','MGI:98266',96.43),(409,'OMIM:612651','MGI:3665157',10.59),(410,'OMIM:612713','MGI:98266',29.57),(411,'OMIM:609376','MGI:98266',97.86),(412,'OMIM:610019','MGI:98266',64.95),(413,'OMIM:612018','MGI:98266',67.12),(414,'OMIM:612109','MGI:98266',25.64),(415,'OMIM:601202','MGI:98266',54.16),(416,'OMIM:615363','MGI:109279',37.62),(417,'OMIM:614303','MGI:98266',50.21),(418,'OMIM:614422','MGI:98266',96.43),(419,'OMIM:613887','MGI:98266',97.86),(420,'OMIM:617141','MGI:98266',57.37),(421,'OMIM:617142','MGI:98266',49.27),(422,'OMIM:616851','MGI:98266',96.43),(423,'OMIM:616217','MGI:1928271',43.58),(424,'OMIM:616279','MGI:98266',63.52),(425,'OMIM:616509','MGI:98266',76.95),(426,'OMIM:618881','MGI:98266',49.6),(427,'OMIM:618415','MGI:98266',37.1),(428,'ORPHA:1501','MGI:109279',37.66),(429,'ORPHA:1766','MGI:98266',27.57),(430,'ORPHA:190','MGI:98266',42.27),(431,'ORPHA:1359','MGI:96090',18.41),(432,'ORPHA:139466','MGI:3665157',24.23),(433,'OMIM:619593','MGI:98266',44.99),(434,'ORPHA:3385','MGI:109279',8.42),(435,'ORPHA:2075','MGI:1928271',10.96),(436,'ORPHA:250923','MGI:98266',47.37),(437,'ORPHA:2331','MGI:1928271',7.3),(438,'ORPHA:94083','MGI:96090',24.28),(439,'ORPHA:79500','MGI:109279',5.61),(440,'ORPHA:744','MGI:96090',4.58),(441,'ORPHA:75858','MGI:98266',25.34),(442,'ORPHA:778','MGI:1928271',7.72),(443,'ORPHA:781','MGI:1928271',10.14),(444,'ORPHA:96253','MGI:109279',18.93),(445,'ORPHA:79324','MGI:1928271',6.25),(446,'ORPHA:85138','MGI:109279',20.37),(447,'ORPHA:31150','MGI:1928271',17.24),(448,'ORPHA:90041','MGI:1928271',6.28),(449,'ORPHA:439254','MGI:98266',27.72),(450,'ORPHA:67043','MGI:98266',48.59),(451,'ORPHA:708','MGI:98266',53.39),(452,'ORPHA:91','MGI:96090',18.65),(453,'ORPHA:91355','MGI:109279',21.88),(454,'OMIM:246700','MGI:1928271',35.73),(455,'OMIM:136520','MGI:98266',51.27),(456,'OMIM:217700','MGI:98266',58.83),(457,'OMIM:236680','MGI:109279',9.7),(458,'OMIM:237500','MGI:1928271',53.6),(459,'OMIM:240950','MGI:98266',39.67),(460,'OMIM:244450','MGI:1928271',5.53),(461,'OMIM:201400','MGI:109279',56.43),(462,'OMIM:202200','MGI:109279',38.52),(463,'OMIM:121800','MGI:98266',68.48),(464,'OMIM:131430','MGI:1345961',42.29),(465,'OMIM:304730','MGI:98266',65.83),(466,'OMIM:300624','MGI:96090',16.42),(467,'OMIM:300200','MGI:109279',35.55),(468,'OMIM:300602','MGI:96090',10.44),(469,'OMIM:180104','MGI:98266',29.92),(470,'OMIM:607398','MGI:109279',29.93),(471,'ORPHA:263479','MGI:98266',27.17),(472,'OMIM:210500','MGI:1928271',50.49),(473,'OMIM:273395','MGI:109279',12.85),(474,'ORPHA:291','MGI:98266',33.96),(475,'ORPHA:280','MGI:1928271',3.18),(476,'ORPHA:284180','MGI:96090',9.78),(477,'ORPHA:2869','MGI:1928271',10.24),(478,'OMIM:609197','MGI:109279',56.57),(479,'OMIM:611465','MGI:1928271',70.16),(480,'OMIM:610092','MGI:98266',64.19),(481,'OMIM:610883','MGI:1928271',8.75),(482,'OMIM:600803','MGI:1928271',60.64),(483,'OMIM:615184','MGI:98266',31.9),(484,'OMIM:614338','MGI:1928271',52.19),(485,'OMIM:613801','MGI:98266',38.03),(486,'OMIM:615512','MGI:1928271',14.05),(487,'OMIM:615558','MGI:1928271',40.09),(488,'OMIM:615619','MGI:1928271',76.76),(489,'OMIM:617394','MGI:1928271',46.51),(490,'OMIM:615935','MGI:109279',44.42),(491,'OMIM:618156','MGI:1928271',13.47),(492,'OMIM:618220','MGI:98266',28.06),(493,'OMIM:616468','MGI:98266',24.13),(494,'OMIM:618463','MGI:98266',50.46),(495,'OMIM:617825','MGI:109279',46.43),(496,'OMIM:619016','MGI:98266',24.53),(497,'ORPHA:1885','MGI:98266',34.81),(498,'ORPHA:1193','MGI:96090',15.75),(499,'ORPHA:1304','MGI:1345961',26.16),(500,'ORPHA:131','MGI:1928271',26.11),(501,'ORPHA:1377','MGI:98266',62.51),(502,'ORPHA:139474','MGI:96090',16.58),(503,'ORPHA:14','MGI:87868',9.31),(504,'ORPHA:100086','MGI:1928271',27.37),(505,'ORPHA:562','MGI:96090',18.43),(506,'ORPHA:570422','MGI:98266',26.15),(507,'ORPHA:3449','MGI:98266',23.73),(508,'ORPHA:606','MGI:98266',62.42),(509,'ORPHA:2334','MGI:98266',42.26),(510,'ORPHA:95409','MGI:109279',18.76),(511,'ORPHA:8','MGI:96090',17.27),(512,'ORPHA:776','MGI:96090',9.46),(513,'ORPHA:983','MGI:96090',57.08),(514,'ORPHA:320','MGI:109279',17.24),(515,'ORPHA:887','MGI:1928271',6.25),(516,'ORPHA:438274','MGI:1928271',39.27),(517,'ORPHA:71','MGI:1928271',25.34),(518,'ORPHA:361','MGI:109279',26.15),(519,'ORPHA:90363','MGI:1928271',13.43),(520,'ORPHA:908','MGI:96090',9.1),(521,'ORPHA:91348','MGI:96090',27.3),(522,'ORPHA:99867','MGI:1345961',28.77),(523,'OMIM:231550','MGI:109279',22.8),(524,'OMIM:233450','MGI:1345961',28.16),(525,'OMIM:140300','MGI:1345961',50.19),(526,'OMIM:146200','MGI:98266',22.86),(527,'OMIM:147630','MGI:109279',52.59),(528,'OMIM:223370','MGI:87868',3.62),(529,'OMIM:225200','MGI:98266',53.51),(530,'OMIM:239900','MGI:98266',75.51),(531,'OMIM:201710','MGI:109279',47.21),(532,'OMIM:103900','MGI:109279',50.31),(533,'OMIM:106220','MGI:98266',51.26),(534,'OMIM:107250','MGI:98266',60.88),(535,'OMIM:109100','MGI:1345961',52.51),(536,'OMIM:109720','MGI:1928271',58.7),(537,'OMIM:115650','MGI:98266',60.88),(538,'OMIM:115665','MGI:98266',69.88),(539,'OMIM:115700','MGI:98266',96.43),(540,'OMIM:116100','MGI:98266',60.28),(541,'OMIM:116200','MGI:98266',70.76),(542,'OMIM:116300','MGI:98266',63.43),(543,'OMIM:116600','MGI:98266',55.36),(544,'OMIM:116800','MGI:98266',64.79),(545,'OMIM:185070','MGI:1345961',19),(546,'OMIM:193230','MGI:98266',40.67),(547,'OMIM:300752','MGI:1928271',39.78),(548,'OMIM:312910','MGI:98266',37.81),(549,'OMIM:264800','MGI:1351634',7.35),(550,'OMIM:266510','MGI:1928271',20.65),(551,'OMIM:268100','MGI:98266',25.66),(552,'OMIM:256450','MGI:109279',49.21),(553,'OMIM:601371','MGI:98266',64.95),(554,'OMIM:601547','MGI:98266',72.05),(555,'OMIM:601820','MGI:109279',52.12),(556,'OMIM:601885','MGI:98266',73.26),(557,'OMIM:602485','MGI:109279',57.23),(558,'OMIM:174770','MGI:1345961',33.25),(559,'OMIM:176410','MGI:96090',49.76),(560,'OMIM:178900','MGI:98266',79.74),(561,'OMIM:604219','MGI:98266',49.13),(562,'OMIM:604229','MGI:98266',42.87),(563,'OMIM:604307','MGI:98266',52.14),(564,'OMIM:605387','MGI:98266',62.38),(565,'OMIM:606762','MGI:109279',44.85),(566,'ORPHA:2571','MGI:98266',24.62),(567,'OMIM:209950','MGI:1345961',38.94),(568,'OMIM:212400','MGI:98266',78.51),(569,'OMIM:216820','MGI:98266',32.47),(570,'OMIM:619324','MGI:87868',68.02),(571,'OMIM:269400','MGI:98266',50.65),(572,'OMIM:270150','MGI:1345961',42.47),(573,'OMIM:270400','MGI:1928271',5.6),(574,'OMIM:273680','MGI:98266',39.81),(575,'ORPHA:229717','MGI:1345961',32.61),(576,'ORPHA:1656','MGI:1345961',35.09),(577,'ORPHA:171844','MGI:98266',32.06),(578,'ORPHA:3233','MGI:98266',41.8),(579,'ORPHA:329918','MGI:1345961',39.15),(580,'OMIM:614662','MGI:109279',42.82),(581,'OMIM:614885','MGI:98266',29.13),(582,'OMIM:613195','MGI:98266',41.56),(583,'OMIM:608367','MGI:98266',56.1),(584,'OMIM:609741','MGI:98266',68.8),(585,'OMIM:611391','MGI:98266',60.96),(586,'OMIM:611489','MGI:109279',18.06),(587,'OMIM:611544','MGI:98266',57.05),(588,'OMIM:611597','MGI:98266',74.98),(589,'OMIM:611881','MGI:1928271',18.5),(590,'OMIM:612227','MGI:109279',52.64),(591,'OMIM:610021','MGI:109279',56),(592,'OMIM:610202','MGI:98266',50.41),(593,'OMIM:610256','MGI:98266',46.28),(594,'OMIM:610425','MGI:98266',66.93),(595,'OMIM:610623','MGI:98266',46.18),(596,'OMIM:600881','MGI:98266',72.36),(597,'OMIM:615188','MGI:98266',67.97),(598,'OMIM:615274','MGI:98266',60.96),(599,'OMIM:615387','MGI:1345961',44.29),(600,'OMIM:614186','MGI:98266',25.86),(601,'OMIM:614284','MGI:98266',28.85),(602,'OMIM:614377','MGI:1345961',39.47),(603,'OMIM:613677','MGI:109279',30.43),(604,'OMIM:613763','MGI:98266',52.17),(605,'OMIM:613791','MGI:1345961',47.59),(606,'OMIM:613826','MGI:98266',35.58),(607,'OMIM:613829','MGI:98266',40.99),(608,'OMIM:617315','MGI:98266',51.55),(609,'OMIM:617319','MGI:98266',61.2),(610,'OMIM:617053','MGI:1345961',13.2),(611,'OMIM:617251','MGI:98266',59.63),(612,'OMIM:615816','MGI:1345961',18.45),(613,'OMIM:615995','MGI:98266',32.88),(614,'ORPHA:163','MGI:98266',97.86),(615,'ORPHA:199296','MGI:109279',47.58),(616,'ORPHA:2035','MGI:1345961',29.13),(617,'ORPHA:206572','MGI:1345961',32.81),(618,'ORPHA:1068','MGI:98266',63.31),(619,'ORPHA:1069','MGI:98266',32.68),(620,'ORPHA:117','MGI:1345961',19.57),(621,'ORPHA:1303','MGI:1345961',28.69),(622,'ORPHA:1380','MGI:98266',44.67),(623,'ORPHA:1397','MGI:98266',55.24),(624,'OMIM:619649','MGI:98266',24.18),(625,'OMIM:619781','MGI:98266',49.36),(626,'ORPHA:556030','MGI:109279',26.06),(627,'ORPHA:556037','MGI:109279',27.96),(628,'ORPHA:449395','MGI:1928271',7.5),(629,'ORPHA:47612','MGI:1345961',31.51),(630,'ORPHA:482','MGI:1345961',31.04),(631,'ORPHA:48435','MGI:1345961',22.73),(632,'ORPHA:3453','MGI:109279',32.76),(633,'ORPHA:37202','MGI:1345961',28.41),(634,'ORPHA:39041','MGI:1345961',31.77),(635,'ORPHA:400','MGI:1345961',20.65),(636,'ORPHA:403','MGI:109279',30.51),(637,'ORPHA:404','MGI:109279',30.92),(638,'ORPHA:64','MGI:1345961',12.25),(639,'ORPHA:2137','MGI:1345961',39.97),(640,'ORPHA:251274','MGI:109279',22.34),(641,'ORPHA:231183','MGI:98266',25.64),(642,'ORPHA:231580','MGI:109279',24.72),(643,'ORPHA:79480','MGI:1345961',37.31),(644,'ORPHA:81','MGI:1345961',30.9),(645,'ORPHA:818','MGI:1928271',2.18),(646,'ORPHA:758','MGI:1351634',5.83),(647,'ORPHA:786','MGI:109279',32.77),(648,'ORPHA:79324','MGI:87868',3.72),(649,'ORPHA:309263','MGI:1928271',8.25),(650,'ORPHA:309271','MGI:1928271',8.44),(651,'ORPHA:31150','MGI:87868',12.26),(652,'ORPHA:90068','MGI:1345961',8.58),(653,'ORPHA:90186','MGI:1345961',19.15),(654,'ORPHA:90291','MGI:1345961',34.73),(655,'ORPHA:443811','MGI:1345961',24.97),(656,'ORPHA:69663','MGI:1928271',42.6),(657,'ORPHA:69665','MGI:1928271',17.35),(658,'ORPHA:699','MGI:1345961',14),(659,'ORPHA:703','MGI:1345961',31.48),(660,'ORPHA:727','MGI:1345961',30.19),(661,'ORPHA:35737','MGI:98266',30.18),(662,'ORPHA:90654','MGI:98266',35.23),(663,'ORPHA:91139','MGI:1345961',21.34),(664,'ORPHA:91349','MGI:96090',24.56),(665,'ORPHA:91495','MGI:98266',26.56),(666,'ORPHA:99827','MGI:1928271',6.44),(667,'OMIM:246700','MGI:87868',33.29),(668,'OMIM:233420','MGI:3665157',50.7),(669,'OMIM:234700','MGI:1351634',33.44),(670,'OMIM:136800','MGI:98266',63.64),(671,'OMIM:147610','MGI:98266',57.62),(672,'OMIM:217600','MGI:98266',68.48),(673,'OMIM:219080','MGI:109279',31.94),(674,'OMIM:224100','MGI:1928271',36.56),(675,'OMIM:152700','MGI:1345961',52.19),(676,'OMIM:154230','MGI:3665157',21.42),(677,'OMIM:156850','MGI:98266',44.35),(678,'OMIM:161200','MGI:1345961',9.34),(679,'OMIM:235700','MGI:1928271',32.7),(680,'OMIM:244450','MGI:87868',3.88),(681,'OMIM:203780','MGI:98266',26.16),(682,'OMIM:110150','MGI:98266',42.38),(683,'OMIM:120040','MGI:98266',76.82),(684,'OMIM:121900','MGI:98266',72.15),(685,'OMIM:125852','MGI:109279',64.66),(686,'OMIM:300622','MGI:1345961',51.33),(687,'OMIM:300755','MGI:1345961',22.55),(688,'OMIM:300779','MGI:98266',67.46),(689,'OMIM:300833','MGI:3665157',100),(690,'OMIM:312500','MGI:1345961',42.05),(691,'OMIM:400044','MGI:3665157',44.88),(692,'OMIM:400045','MGI:3665157',41.51),(693,'OMIM:266200','MGI:1928271',27.04),(694,'OMIM:601666','MGI:109279',68.85),(695,'OMIM:601859','MGI:1345961',47.82),(696,'OMIM:601941','MGI:109279',63.85),(697,'OMIM:601942','MGI:109279',63.85),(698,'OMIM:602247','MGI:87868',58.07),(699,'OMIM:602361','MGI:1345961',17.09),(700,'OMIM:278850','MGI:3665157',39.35),(701,'OMIM:300018','MGI:3665157',100),(702,'OMIM:165300','MGI:98266',30.12),(703,'OMIM:169610','MGI:1345961',49.97),(704,'OMIM:604901','MGI:1928271',55.85),(705,'OMIM:605479','MGI:1928271',41.26),(706,'ORPHA:254704','MGI:98266',48.63),(707,'ORPHA:293621','MGI:98266',46.69),(708,'ORPHA:2968','MGI:1345961',21.5),(709,'ORPHA:2253','MGI:98266',39.37),(710,'ORPHA:2826','MGI:96090',45.96),(711,'ORPHA:289390','MGI:1345961',27.99),(712,'ORPHA:3261','MGI:1345961',31.75),(713,'ORPHA:33111','MGI:1345961',28.51),(714,'OMIM:614674','MGI:109279',41.23),(715,'OMIM:614809','MGI:1345961',51.19),(716,'OMIM:613470','MGI:1928271',35.74),(717,'OMIM:612520','MGI:109279',64.66),(718,'OMIM:612965','MGI:3665157',50.2),(719,'OMIM:613011','MGI:1345961',35.97),(720,'OMIM:613080','MGI:3665157',44.69),(721,'OMIM:613080','MGI:109279',33.73),(722,'OMIM:613086','MGI:98266',62.43),(723,'OMIM:609140','MGI:98266',71.7),(724,'OMIM:610374','MGI:109279',66.62),(725,'OMIM:610600','MGI:109279',31.24),(726,'OMIM:610883','MGI:87868',6.25),(727,'OMIM:600886','MGI:98266',47.2),(728,'OMIM:600955','MGI:109279',38.73),(729,'OMIM:601186','MGI:1345961',13.3),(730,'OMIM:614279','MGI:3665157',75.62),(731,'OMIM:614338','MGI:87868',56.4),(732,'OMIM:613652','MGI:1345961',67.3),(733,'OMIM:613762','MGI:3665157',50.32),(734,'OMIM:615523','MGI:98266',61.91),(735,'OMIM:615558','MGI:87868',29.14),(736,'OMIM:617133','MGI:98266',40.02),(737,'OMIM:616067','MGI:3665157',84.81),(738,'OMIM:618156','MGI:87868',11.27),(739,'OMIM:616425','MGI:3665157',57.63),(740,'OMIM:616425','MGI:96090',47.37),(741,'OMIM:618835','MGI:109279',21.37),(742,'OMIM:618838','MGI:109279',28.9),(743,'OMIM:618839','MGI:109279',21.32),(744,'OMIM:618660','MGI:98266',46.61),(745,'ORPHA:158061','MGI:1345961',32.28),(746,'ORPHA:199299','MGI:109279',21.84),(747,'OMIM:619849','MGI:1928271',46.12),(748,'OMIM:619858','MGI:1345961',29.33),(749,'ORPHA:54370','MGI:1345961',48.13),(750,'ORPHA:56425','MGI:1345961',43.55),(751,'ORPHA:46488','MGI:1345961',39.51),(752,'ORPHA:470','MGI:1345961',23.35),(753,'ORPHA:48377','MGI:1345961',30.54),(754,'ORPHA:52901','MGI:96090',32.4),(755,'ORPHA:536','MGI:1345961',44.79),(756,'ORPHA:34145','MGI:1345961',32.07),(757,'ORPHA:79506','MGI:1928271',57.4),(758,'ORPHA:79087','MGI:1345961',32.32),(759,'ORPHA:98827','MGI:1345961',35.56),(760,'ORPHA:309256','MGI:1928271',8.53),(761,'ORPHA:90060','MGI:1345961',32.41),(762,'ORPHA:90283','MGI:1345961',50.16),(763,'ORPHA:411593','MGI:1345961',28.87),(764,'ORPHA:71','MGI:87868',13.65),(765,'ORPHA:35664','MGI:98266',61.05),(766,'ORPHA:90363','MGI:87868',9.64),(767,'ORPHA:90674','MGI:96090',16.97),(768,'ORPHA:93126','MGI:1345961',39.55),(769,'ORPHA:99931','MGI:1345961',37.49),(770,'OMIM:221900','MGI:98266',31.45),(771,'OMIM:222100','MGI:1345961',27.77),(772,'OMIM:225100','MGI:98266',98.58),(773,'OMIM:240500','MGI:1345961',35.66),(774,'OMIM:106230','MGI:98266',75.68),(775,'OMIM:116700','MGI:98266',96.43),(776,'OMIM:121390','MGI:98266',57.8),(777,'OMIM:305800','MGI:1345961',27.01),(778,'OMIM:266510','MGI:87868',14.54),(779,'OMIM:256020','MGI:1345961',42.69),(780,'OMIM:300062','MGI:96090',52.31),(781,'OMIM:300143','MGI:96090',14.68),(782,'OMIM:300428','MGI:96090',35.14),(783,'OMIM:177850','MGI:1351634',3.94),(784,'OMIM:212065','MGI:1928271',9.57),(785,'OMIM:217000','MGI:1345961',34.99),(786,'OMIM:619338','MGI:98266',25.04),(787,'OMIM:270400','MGI:87868',2.9),(788,'ORPHA:3000','MGI:96090',30.82),(789,'ORPHA:227982','MGI:1345961',34.11),(790,'ORPHA:227990','MGI:1345961',35.98),(791,'OMIM:614878','MGI:98266',23.47),(792,'OMIM:613179','MGI:1345961',30),(793,'OMIM:613496','MGI:1345961',37.68),(794,'OMIM:607765','MGI:1928271',36.2),(795,'OMIM:608776','MGI:1928271',10.23),(796,'OMIM:609529','MGI:1345961',38.46),(797,'OMIM:612227','MGI:1345961',33.85),(798,'OMIM:610475','MGI:109279',32.06),(799,'OMIM:610489','MGI:109279',30.98),(800,'OMIM:610947','MGI:109279',38.04),(801,'OMIM:610984','MGI:1345961',27.28),(802,'OMIM:615008','MGI:1345961',43.6),(803,'OMIM:615401','MGI:1345961',13.65),(804,'OMIM:614190','MGI:109279',58.77),(805,'OMIM:614196','MGI:1345961',37.71),(806,'OMIM:614380','MGI:1345961',45.32),(807,'OMIM:614420','MGI:1345961',74.56),(808,'OMIM:613783','MGI:1345961',52.13),(809,'OMIM:617609','MGI:1345961',36.28),(810,'OMIM:616730','MGI:1345961',25.85),(811,'OMIM:616834','MGI:1928271',34.16),(812,'OMIM:616892','MGI:1345961',38.01),(813,'OMIM:615830','MGI:109279',36.26),(814,'OMIM:615861','MGI:1345961',48.2),(815,'OMIM:615954','MGI:109279',43),(816,'OMIM:616005','MGI:1345961',31.39),(817,'OMIM:618874','MGI:96090',10.91),(818,'OMIM:618348','MGI:1345961',21.89),(819,'OMIM:618534','MGI:1345961',45.54),(820,'OMIM:617783','MGI:1345961',39.41),(821,'OMIM:619126','MGI:1345961',43.82),(822,'OMIM:619201','MGI:1345961',48.88),(823,'ORPHA:1830','MGI:1345961',18.14),(824,'ORPHA:100026','MGI:1345961',42.15),(825,'OMIM:620642','MGI:1345961',19.51),(826,'OMIM:619644','MGI:1345961',24.37),(827,'OMIM:619813','MGI:98266',45.6),(828,'OMIM:620058','MGI:1928271',52.53),(829,'OMIM:620253','MGI:98266',55.4),(830,'OMIM:620312','MGI:98266',29.42),(831,'ORPHA:449395','MGI:1345961',31.8),(832,'ORPHA:49041','MGI:1345961',33.2),(833,'ORPHA:523','MGI:98266',23.89),(834,'ORPHA:33577','MGI:1345961',34.81),(835,'ORPHA:340','MGI:1345961',14.92),(836,'ORPHA:397596','MGI:1345961',36.5),(837,'ORPHA:401830','MGI:98266',26.85),(838,'ORPHA:60026','MGI:1345961',54.3),(839,'ORPHA:2310','MGI:98266',29.18),(840,'ORPHA:809','MGI:1345961',28.65),(841,'ORPHA:96180','MGI:1928271',13.39),(842,'ORPHA:96181','MGI:109279',21.3),(843,'ORPHA:79281','MGI:98266',43.84),(844,'ORPHA:85286','MGI:96090',20.54),(845,'ORPHA:90002','MGI:1345961',58),(846,'ORPHA:36234','MGI:1345961',15.86),(847,'ORPHA:369929','MGI:109279',16.81),(848,'ORPHA:98908','MGI:1928271',13.35),(849,'OMIM:104200','MGI:1345961',30.91),(850,'OMIM:300706','MGI:96090',34.33),(851,'OMIM:300719','MGI:98266',45.52),(852,'OMIM:300886','MGI:96090',21.58),(853,'OMIM:264120','MGI:96090',59.35),(854,'OMIM:601794','MGI:98266',24.68),(855,'OMIM:300055','MGI:96090',7.58),(856,'OMIM:603909','MGI:1345961',47.68),(857,'OMIM:216950','MGI:1345961',50.94),(858,'ORPHA:2278','MGI:98266',33.85),(859,'ORPHA:325345','MGI:3665157',49.42),(860,'OMIM:612840','MGI:1345961',28.6),(861,'OMIM:608709','MGI:1345961',25.36),(862,'OMIM:614292','MGI:98266',35.93),(863,'OMIM:614470','MGI:1345961',41.8),(864,'OMIM:615559','MGI:1345961',45.58),(865,'OMIM:618912','MGI:98266',0),(866,'OMIM:618999','MGI:1345961',37.32),(867,'OMIM:619183','MGI:1345961',36.91),(868,'ORPHA:1067','MGI:98266',38.96),(869,'ORPHA:1366','MGI:98266',24.89),(870,'ORPHA:1369','MGI:98266',31.1),(871,'ORPHA:1373','MGI:98266',23.55),(872,'OMIM:619950','MGI:96090',2.79),(873,'ORPHA:567548','MGI:1345961',28.57),(874,'ORPHA:449432','MGI:1345961',24.91),(875,'ORPHA:51608','MGI:1351634',5.61),(876,'ORPHA:375','MGI:1345961',30.47),(877,'ORPHA:393','MGI:96090',51.05),(878,'ORPHA:656','MGI:1345961',31.53),(879,'ORPHA:2172','MGI:1345961',19.36),(880,'ORPHA:79506','MGI:87868',64.64),(881,'ORPHA:79302','MGI:1928271',40.23),(882,'ORPHA:85320','MGI:96090',58.79),(883,'ORPHA:85327','MGI:96090',30.47),(884,'ORPHA:85414','MGI:1345961',43.94),(885,'ORPHA:3077','MGI:96090',11.82),(886,'ORPHA:89844','MGI:1345961',8.82),(887,'ORPHA:90033','MGI:1345961',38.39),(888,'ORPHA:90036','MGI:1345961',31.3),(889,'ORPHA:99889','MGI:109279',20.22),(890,'OMIM:137940','MGI:1345961',16.88),(891,'OMIM:162000','MGI:1345961',38.6),(892,'OMIM:201910','MGI:109279',45.8),(893,'OMIM:120790','MGI:1345961',45.87),(894,'OMIM:125851','MGI:109279',64.66),(895,'OMIM:301078','MGI:1345961',41.51),(896,'OMIM:304790','MGI:1345961',35.99),(897,'OMIM:301006','MGI:1345961',18.5),(898,'OMIM:254000','MGI:98266',53.96),(899,'OMIM:300238','MGI:96090',20.19),(900,'OMIM:606392','MGI:109279',69.15),(901,'OMIM:606394','MGI:109279',64.66),(902,'OMIM:212065','MGI:87868',4.82),(903,'OMIM:619428','MGI:1345961',13.05),(904,'ORPHA:293978','MGI:109279',21.38),(905,'ORPHA:26792','MGI:87868',4.92),(906,'OMIM:614736','MGI:109279',38.08),(907,'OMIM:613370','MGI:109279',59.28),(908,'OMIM:613571','MGI:109279',56.72),(909,'OMIM:607765','MGI:87868',15.54),(910,'OMIM:608184','MGI:1345961',42.62),(911,'OMIM:608776','MGI:87868',6.46),(912,'OMIM:609939','MGI:1345961',43.39),(913,'OMIM:610508','MGI:109279',69.15),(914,'OMIM:610539','MGI:1928271',17.8),(915,'OMIM:600496','MGI:109279',60.36),(916,'OMIM:615412','MGI:98266',28.38),(917,'OMIM:614473','MGI:1351634',10.04),(918,'OMIM:613779','MGI:1345961',64.17),(919,'OMIM:617006','MGI:1345961',58.6),(920,'OMIM:616834','MGI:87868',31.49),(921,'OMIM:615952','MGI:1345961',30.86),(922,'OMIM:616511','MGI:109279',48.45),(923,'OMIM:618852','MGI:1345961',58.83),(924,'OMIM:618935','MGI:1345961',39.52),(925,'OMIM:618398','MGI:1345961',40.12),(926,'OMIM:618495','MGI:1345961',46.81),(927,'ORPHA:1473','MGI:98266',27.61),(928,'ORPHA:183675','MGI:1928271',8.74),(929,'ORPHA:189427','MGI:109279',29.93),(930,'ORPHA:1381','MGI:98266',28.62),(931,'OMIM:620425','MGI:98266',29.13),(932,'OMIM:620565','MGI:1345961',27.39),(933,'OMIM:619525','MGI:1345961',13.71),(934,'OMIM:620058','MGI:87868',53.2),(935,'ORPHA:567544','MGI:1345961',35.24),(936,'ORPHA:251004','MGI:1345961',13.48),(937,'ORPHA:73245','MGI:98266',48.66),(938,'ORPHA:96180','MGI:87868',11.14),(939,'ORPHA:90790','MGI:109279',30.63),(940,'ORPHA:90790','MGI:96090',17.12),(941,'ORPHA:911','MGI:1345961',36.15),(942,'OMIM:201470','MGI:87868',0),(943,'OMIM:202110','MGI:109279',31.34),(944,'OMIM:183800','MGI:98266',29.79),(945,'OMIM:307500','MGI:109279',43.51),(946,'OMIM:309520','MGI:96090',6.13),(947,'OMIM:310468','MGI:1345961',38.14),(948,'OMIM:212500','MGI:98266',58.07),(949,'OMIM:212550','MGI:98266',30.06),(950,'OMIM:619313','MGI:1345961',20.04),(951,'OMIM:619375','MGI:1345961',63.49),(952,'ORPHA:169090','MGI:1345961',29.48),(953,'ORPHA:289548','MGI:3665157',17.29),(954,'ORPHA:289548','MGI:109279',21.89),(955,'ORPHA:324410','MGI:96090',8.53),(956,'OMIM:613076','MGI:98266',55.33),(957,'OMIM:609734','MGI:109279',43.95),(958,'OMIM:616722','MGI:98266',48.37),(959,'OMIM:616414','MGI:1345961',38.82),(960,'OMIM:618810','MGI:1928271',14.99),(961,'OMIM:619082','MGI:98266',52.05),(962,'OMIM:619220','MGI:1345961',43.5),(963,'OMIM:620795','MGI:1345961',46.98),(964,'OMIM:619846','MGI:1345961',41.11),(965,'ORPHA:37042','MGI:1345961',30.84),(966,'ORPHA:399808','MGI:96090',47.99),(967,'ORPHA:2084','MGI:98266',62.55),(968,'ORPHA:231154','MGI:1345961',51.19),(969,'ORPHA:95699','MGI:109279',14.13),(970,'ORPHA:90793','MGI:109279',32.86),(971,'ORPHA:90794','MGI:109279',21.52),(972,'ORPHA:90795','MGI:109279',24),(973,'OMIM:202010','MGI:109279',32.08),(974,'OMIM:301109','MGI:1345961',42.35),(975,'OMIM:314000','MGI:1345961',33.08),(976,'OMIM:602450','MGI:1345961',31.93),(977,'OMIM:271320','MGI:98266',51.07),(978,'OMIM:274205','MGI:98266',39.93),(979,'ORPHA:228426','MGI:1345961',33.09),(980,'ORPHA:277','MGI:1345961',42.1),(981,'OMIM:610156','MGI:98266',27.21),(982,'OMIM:610539','MGI:87868',10.88),(983,'OMIM:617718','MGI:1345961',35.26),(984,'OMIM:616871','MGI:1345961',41.19),(985,'ORPHA:79408','MGI:1345961',14.32),(986,'ORPHA:90791','MGI:109279',28.66),(987,'OMIM:247800','MGI:1345961',51.07),(988,'OMIM:136580','MGI:1345961',34.88),(989,'OMIM:201810','MGI:109279',28.2),(990,'ORPHA:331206','MGI:1345961',28.53),(991,'OMIM:611812','MGI:3665157',20.17),(992,'OMIM:611812','MGI:109279',16.74),(993,'OMIM:614199','MGI:1345961',28.45),(994,'OMIM:614376','MGI:1345961',17.97),(995,'OMIM:613743','MGI:3665157',33.45),(996,'OMIM:618810','MGI:87868',9.07),(997,'OMIM:620367','MGI:1928271',24.35),(998,'ORPHA:567546','MGI:1345961',18.17),(999,'ORPHA:399805','MGI:96090',50.86),(1000,'ORPHA:85112','MGI:3665157',57.64),(1001,'OMIM:301066','MGI:1928271',7.74),(1002,'ORPHA:276','MGI:1345961',24.98),(1003,'ORPHA:168558','MGI:3665157',17.59),(1004,'ORPHA:168558','MGI:109279',20.93),(1005,'ORPHA:69063','MGI:1345961',46.56),(1006,'ORPHA:90796','MGI:109279',21.56),(1007,'OMIM:251750','MGI:98266',42.57),(1008,'ORPHA:562639','MGI:1345961',45.56),(1009,'OMIM:607330','MGI:104511',12.07),(1010,'ORPHA:14','MGI:104511',9.16),(1011,'ORPHA:56','MGI:104511',7.12),(1012,'ORPHA:412','MGI:104511',35.59),(1013,'ORPHA:926','MGI:104511',13.94),(1014,'OMIM:613913','MGI:1345961',27.55),(1015,'ORPHA:444463','MGI:1345961',58.88),(1016,'OMIM:120433','MGI:98266',33.48),(1017,'OMIM:145750','MGI:104511',49.33),(1018,'OMIM:223370','MGI:104511',3.56),(1019,'OMIM:203800','MGI:104511',9.39),(1020,'OMIM:205400','MGI:104511',24.67),(1021,'OMIM:264800','MGI:104511',13.79),(1022,'OMIM:277700','MGI:104511',12.53),(1023,'OMIM:604809','MGI:104511',23.94),(1024,'OMIM:210250','MGI:104511',25.16),(1025,'OMIM:619324','MGI:104511',54.41),(1026,'OMIM:618666','MGI:104511',72.36),(1027,'ORPHA:1457','MGI:104511',29.28),(1028,'ORPHA:191','MGI:104511',4.34),(1029,'ORPHA:333','MGI:104511',5.07),(1030,'ORPHA:650','MGI:104511',35.42),(1031,'ORPHA:2067','MGI:104511',5.86),(1032,'ORPHA:2069','MGI:104511',14.41),(1033,'ORPHA:758','MGI:104511',10.84),(1034,'ORPHA:79324','MGI:104511',4.9),(1035,'ORPHA:31150','MGI:104511',27.32),(1036,'ORPHA:90041','MGI:104511',19.52),(1037,'ORPHA:902','MGI:104511',6.04),(1038,'ORPHA:439232','MGI:104511',12.59),(1039,'ORPHA:36913','MGI:104511',14.43),(1040,'ORPHA:909','MGI:104511',4.59),(1041,'OMIM:245900','MGI:104511',35.33),(1042,'OMIM:246700','MGI:104511',30.91),(1043,'OMIM:143890','MGI:104511',45.77),(1044,'OMIM:144010','MGI:104511',57.55),(1045,'OMIM:238600','MGI:104511',35.69),(1046,'OMIM:242900','MGI:104511',6.16),(1047,'OMIM:244450','MGI:104511',6.47),(1048,'OMIM:208060','MGI:104511',21.8),(1049,'OMIM:603813','MGI:104511',71.39),(1050,'OMIM:604091','MGI:104511',69.05),(1051,'ORPHA:229','MGI:104511',44.15),(1052,'OMIM:610883','MGI:104511',6.09),(1053,'OMIM:614338','MGI:104511',45.12),(1054,'OMIM:615558','MGI:104511',27.19),(1055,'OMIM:615947','MGI:104511',36.53),(1056,'OMIM:618156','MGI:104511',10.95),(1057,'OMIM:618463','MGI:104511',47.49),(1058,'ORPHA:2047','MGI:104511',9.28),(1059,'ORPHA:536','MGI:104511',0),(1060,'ORPHA:391665','MGI:104511',39.37),(1061,'ORPHA:2073','MGI:104511',0),(1062,'ORPHA:79474','MGI:104511',7.71),(1063,'ORPHA:785','MGI:104511',9.21),(1064,'ORPHA:79292','MGI:104511',33.7),(1065,'ORPHA:435638','MGI:104511',5.66),(1066,'ORPHA:71','MGI:104511',12.97),(1067,'ORPHA:90363','MGI:104511',9.39),(1068,'OMIM:230650','MGI:104511',12.7),(1069,'OMIM:266510','MGI:104511',13.98),(1070,'OMIM:278000','MGI:104511',17.54),(1071,'OMIM:176670','MGI:104511',22.54),(1072,'OMIM:177850','MGI:104511',18.16),(1073,'OMIM:269600','MGI:104511',22.63),(1074,'OMIM:270400','MGI:104511',4.66),(1075,'ORPHA:264675','MGI:104511',22.58),(1076,'ORPHA:275761','MGI:104511',15.98),(1077,'OMIM:612356','MGI:104511',63.41),(1078,'OMIM:614008','MGI:104511',6.15),(1079,'ORPHA:1830','MGI:104511',9.55),(1080,'OMIM:619802','MGI:104511',9.73),(1081,'ORPHA:565612','MGI:104511',19.18),(1082,'ORPHA:494424','MGI:104511',31.04),(1083,'ORPHA:231160','MGI:104511',36.96),(1084,'ORPHA:93598','MGI:104511',21.03),(1085,'ORPHA:95427','MGI:104511',12.99),(1086,'ORPHA:740','MGI:104511',5),(1087,'ORPHA:747','MGI:104511',17.16),(1088,'ORPHA:75234','MGI:104511',28.96),(1089,'ORPHA:90324','MGI:104511',6.06),(1090,'ORPHA:425','MGI:104511',45.62),(1091,'OMIM:144300','MGI:104511',59.52),(1092,'OMIM:151660','MGI:104511',18.14),(1093,'OMIM:132900','MGI:104511',47.03),(1094,'OMIM:257200','MGI:104511',11.08),(1095,'OMIM:257220','MGI:104511',17.61),(1096,'ORPHA:220295','MGI:104511',8.42),(1097,'ORPHA:2724','MGI:104511',28.87),(1098,'OMIM:607616','MGI:104511',28.05),(1099,'OMIM:607625','MGI:104511',14.45),(1100,'OMIM:608600','MGI:104511',22.4),(1101,'OMIM:611788','MGI:104511',51.48),(1102,'OMIM:615703','MGI:104511',31.5),(1103,'OMIM:617168','MGI:104511',27.98),(1104,'OMIM:616833','MGI:104511',20.9),(1105,'OMIM:616000','MGI:104511',25.24),(1106,'OMIM:618620','MGI:104511',48.57),(1107,'ORPHA:646','MGI:104511',5.05),(1108,'ORPHA:2348','MGI:104511',13.53),(1109,'ORPHA:79506','MGI:104511',55.41),(1110,'ORPHA:77293','MGI:104511',15.85),(1111,'ORPHA:79083','MGI:104511',15.56),(1112,'ORPHA:79084','MGI:104511',14.23),(1113,'ORPHA:412','MGI:104511',15.87),(1114,'ORPHA:363618','MGI:104511',22.34),(1115,'OMIM:249310','MGI:104511',5.33),(1116,'OMIM:300972','MGI:104511',5.76),(1117,'ORPHA:263501','MGI:104511',7.71),(1118,'OMIM:210250','MGI:104511',16.23),(1119,'OMIM:212065','MGI:104511',6.39),(1120,'OMIM:619324','MGI:104511',79.37),(1121,'ORPHA:280365','MGI:104511',14.82),(1122,'OMIM:607765','MGI:104511',14.77),(1123,'OMIM:608320','MGI:104511',45.11),(1124,'OMIM:608776','MGI:104511',6.31),(1125,'OMIM:610947','MGI:104511',30.49),(1126,'OMIM:616834','MGI:104511',29.64),(1127,'OMIM:616222','MGI:104511',8.61),(1128,'OMIM:618666','MGI:104511',53.81),(1129,'ORPHA:1192','MGI:104511',16.56),(1130,'OMIM:620058','MGI:104511',72.39),(1131,'ORPHA:633','MGI:104511',9.16),(1132,'ORPHA:2457','MGI:104511',10.1),(1133,'ORPHA:96180','MGI:104511',10.85),(1134,'ORPHA:79237','MGI:104511',13.9),(1135,'ORPHA:86816','MGI:104511',20.67),(1136,'ORPHA:90041','MGI:104511',11.68),(1137,'OMIM:144010','MGI:104511',43.26),(1138,'OMIM:238600','MGI:104511',27.14),(1139,'OMIM:118450','MGI:104511',4.93),(1140,'OMIM:182290','MGI:104511',4.78),(1141,'OMIM:309000','MGI:104511',6.53),(1142,'OMIM:602247','MGI:104511',72.9),(1143,'OMIM:176270','MGI:104511',4.49),(1144,'OMIM:603776','MGI:104511',45.24),(1145,'OMIM:603813','MGI:104511',53.69),(1146,'ORPHA:273','MGI:104511',2.28),(1147,'OMIM:614338','MGI:104511',47.54),(1148,'OMIM:614025','MGI:104511',44.23),(1149,'ORPHA:186','MGI:104511',9.84),(1150,'ORPHA:1979','MGI:104511',15.43),(1151,'ORPHA:199354','MGI:104511',12.29),(1152,'ORPHA:140905','MGI:104511',51.94),(1153,'ORPHA:470','MGI:104511',10.78),(1154,'ORPHA:528','MGI:104511',9.17),(1155,'ORPHA:391665','MGI:104511',10.07),(1156,'ORPHA:401923','MGI:104511',10.14),(1157,'ORPHA:209902','MGI:104511',37.19),(1158,'ORPHA:247585','MGI:104511',14.47),(1159,'ORPHA:230839','MGI:104511',14.23),(1160,'ORPHA:819','MGI:104511',3.64),(1161,'ORPHA:91387','MGI:104511',26.77),(1162,'OMIM:232700','MGI:104511',33),(1163,'OMIM:144250','MGI:104511',56.84),(1164,'OMIM:207750','MGI:104511',38.26),(1165,'OMIM:306000','MGI:104511',25.58),(1166,'OMIM:301033','MGI:104511',22.12),(1167,'OMIM:256300','MGI:104511',15),(1168,'OMIM:278000','MGI:104511',11.67),(1169,'OMIM:619471','MGI:104511',9.08),(1170,'ORPHA:275761','MGI:104511',8.42),(1171,'OMIM:610539','MGI:104511',10.41),(1172,'OMIM:616730','MGI:104511',11.24),(1173,'OMIM:616267','MGI:104511',20.5),(1174,'OMIM:618348','MGI:104511',7.26),(1175,'OMIM:620211','MGI:104511',21.74),(1176,'ORPHA:488650','MGI:104511',17.07),(1177,'ORPHA:534','MGI:104511',3.92),(1178,'ORPHA:2479','MGI:104511',5.85),(1179,'ORPHA:75234','MGI:104511',19.02),(1180,'ORPHA:77296','MGI:104511',11.8),(1181,'ORPHA:90065','MGI:104511',6.51),(1182,'ORPHA:69663','MGI:104511',9.4),(1183,'OMIM:144300','MGI:104511',45.01),(1184,'OMIM:151660','MGI:104511',10.91),(1185,'OMIM:277460','MGI:104511',19.89),(1186,'OMIM:605814','MGI:104511',30.88),(1187,'OMIM:606721','MGI:104511',5.24),(1188,'ORPHA:280679','MGI:104511',14.78),(1189,'OMIM:612526','MGI:104511',18.16),(1190,'OMIM:610842','MGI:104511',19.18),(1191,'OMIM:615703','MGI:104511',24.02),(1192,'OMIM:615812','MGI:104511',26.69),(1193,'OMIM:618810','MGI:104511',8.73),(1194,'OMIM:619662','MGI:104511',15.38),(1195,'OMIM:619855','MGI:104511',55.99),(1196,'OMIM:619868','MGI:104511',23.87),(1197,'ORPHA:567548','MGI:104511',15.87),(1198,'ORPHA:79506','MGI:104511',72.35),(1199,'ORPHA:363618','MGI:104511',9.06),(1200,'ORPHA:90674','MGI:104511',8.56),(1201,'OMIM:248370','MGI:104511',7.46),(1202,'OMIM:608320','MGI:104511',28.58),(1203,'OMIM:616828','MGI:104511',15.78),(1204,'OMIM:616829','MGI:104511',19.97),(1205,'OMIM:615863','MGI:104511',31.7),(1206,'OMIM:620454','MGI:104511',10.87),(1207,'OMIM:619534','MGI:104511',4.2),(1208,'OMIM:300845','MGI:104511',12.71),(1209,'ORPHA:64753','MGI:104511',15.88),(1210,'ORPHA:209902','MGI:104511',18.37),(1211,'ORPHA:247598','MGI:104511',24.97),(1212,'ORPHA:254531','MGI:104511',10.68),(1213,'ORPHA:94124','MGI:104511',17.4),(1214,'ORPHA:91135','MGI:104511',33.47),(1215,'OMIM:208920','MGI:104511',10.53),(1216,'OMIM:209010','MGI:104511',33.14),(1217,'OMIM:607250','MGI:104511',17.3),(1218,'ORPHA:264580','MGI:104511',7.14),(1219,'ORPHA:96184','MGI:104511',7.31),(1220,'ORPHA:79240','MGI:104511',7.85),(1221,'ORPHA:79259','MGI:104511',7.13),(1222,'OMIM:610644','MGI:104511',14.7);
/*!40000 ALTER TABLE `PhenodigmScores` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `Procedures`
--

DROP TABLE IF EXISTS `Procedures`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `Procedures` (
  `procedure_id` int NOT NULL,
  `procedure_name` varchar(47) DEFAULT NULL,
  `procedure_description` varchar(1090) DEFAULT NULL,
  `procedure_isMandatory` tinyint(1) NOT NULL DEFAULT '0',
  PRIMARY KEY (`procedure_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci COMMENT='Stores procedure details (name, description, mandatory). Linked to Parameters via a many-to-many join.';
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `Procedures`
--

LOCK TABLES `Procedures` WRITE;
/*!40000 ALTER TABLE `Procedures` DISABLE KEYS */;
INSERT INTO `Procedures` VALUES (7636,'MicroCT E14.5-E15.5 Analysis',' ',0),(7637,'MicroCT E14.5-E15.5 Analysis',' ',0),(7638,'MicroCT E14.5-E15.5 Analysis',' ',0),(7639,'MicroCT E14.5-E15.5 Analysis',' ',0),(7640,'MicroCT E14.5-E15.5 Analysis',' ',0),(7641,'MicroCT E14.5-E15.5 Analysis',' ',0),(7642,'MicroCT E14.5-E15.5 Analysis',' ',0),(7643,'MicroCT E14.5-E15.5 Analysis',' ',0),(7644,'MicroCT E14.5-E15.5 Analysis',' ',0),(16384,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16385,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16386,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16387,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16388,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16389,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16390,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16391,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16392,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16393,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16394,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16395,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16396,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16397,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16398,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16399,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16400,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16401,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16402,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16403,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16404,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16405,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16406,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16407,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16408,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16409,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16410,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16411,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16412,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16413,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16414,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16415,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16416,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16417,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16418,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16419,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16420,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16421,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16422,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16423,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16424,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16425,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16426,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16427,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16428,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16429,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16430,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16431,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16432,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(16825,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16826,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16827,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16828,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16829,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16830,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16831,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16832,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16833,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16834,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16835,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16836,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16837,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16838,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16839,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16840,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16841,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16842,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16843,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16844,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16845,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16846,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16847,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16848,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16849,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16850,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16851,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16852,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16853,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16854,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16855,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16856,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16857,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16858,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16859,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16860,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16861,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16862,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16863,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16864,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16865,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16866,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16867,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16868,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16869,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16870,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16871,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16872,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16873,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16874,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16875,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16876,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16877,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16878,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16879,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16880,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16881,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16882,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16883,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16884,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16885,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16886,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16887,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16888,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16889,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16890,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16891,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16892,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16893,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16894,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16895,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16896,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16897,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16898,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16899,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16900,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16901,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16902,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16903,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16904,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16905,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16906,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16907,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16908,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16909,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16910,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(16911,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(17587,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17588,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17589,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17590,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17591,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17592,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17593,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17594,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17595,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17596,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17597,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17598,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17599,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17600,'Grip Strength',' The grip strength test is used to measure the neuromuscular function as maximal muscle strength of forelimbs and combined forelimbs and hind limbs. These are assessed by the grasping applied by the mouse on a grid that is connected to a sensor. Three trials are carried out in succession measuring forelimb-strength only, followed by three successive trials measuring the combined forelimb/hindlimb grip strength. All grip strength values obtained are normalized against mouse body weight.Ontological description: MP:0001515 - abnormal grip strength.',0),(17722,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17723,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17724,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17725,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17726,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17727,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17728,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17729,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17730,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17731,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17732,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17733,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17734,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17735,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17736,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17737,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17738,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17739,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17740,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17741,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17742,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17743,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17744,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17745,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17746,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17747,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17748,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17749,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17750,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17751,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17752,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17753,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17754,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17755,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17756,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17757,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17758,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17759,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(17760,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(18100,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18101,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18102,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18103,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18104,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18105,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18106,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18107,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18108,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18109,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18110,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18111,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18112,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18113,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18114,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18115,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18116,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18117,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18118,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18119,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18120,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18121,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(18301,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18302,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18303,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18304,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18305,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18306,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18307,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18308,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18309,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18310,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18311,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18312,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18313,'Intraperitoneal glucose tolerance test (IPGTT)',' The glucose tolerance test measures the clearance of an intraperitoneally injected glucose load from the body. It is used to detect disturbances in glucose metabolism that can be linked to human conditions such as diabetes or metabolic syndrome. Animals are fasted for approximately 16 hours, fasted blood glucose levels are determined before a solution of glucose is administered by intra-peritoneal (IP) injection. Subsequently, the blood glucose level is measured at different time points during the following 2 hours.Ontological description: MP:0005559 - increased circulating glucose level, MP:0005560 - decreased circulating glucose level, MP:0005293 - impaired glucose tolerance, MP:0005292 - improved glucose tolerance, MP:0005291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal glucose tolerance, MP:0000188 - abnormal circulating glucose level.',0),(18421,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18422,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18423,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18424,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18425,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18426,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18427,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18428,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18429,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18430,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18431,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18432,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18433,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18434,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18435,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18436,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18437,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18438,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18439,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18440,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18441,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18442,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18443,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18444,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18445,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18446,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18447,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18448,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18449,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18450,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18451,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18452,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18453,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18454,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18455,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18456,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18457,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18458,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18459,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18460,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18461,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18462,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18463,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18464,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18465,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18466,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18467,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18468,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18469,'Challenge Whole Body Plethysmography',' The purpose of this procedure is to record the respiratory function of mice, when submitted to methacholine or hypoxia challenge. Other similar protocols, for allergen sensitization and for LPS challenges, will also be available.&nbsp;Ontological description: &nbsp;MP:0002327 - abnormal respiratory function',0),(18547,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18548,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18549,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18550,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18551,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18552,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18553,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18554,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18555,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18556,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18557,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18558,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18559,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18560,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18561,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18562,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18563,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18564,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18565,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18566,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18567,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18568,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18569,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18570,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18571,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18572,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18573,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18574,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18575,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18576,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18577,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18578,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18579,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18580,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18581,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18582,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18583,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18584,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18585,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18586,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18587,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18588,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18589,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18590,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18591,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18592,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18593,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18594,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18595,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18596,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18597,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18598,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18599,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18600,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(18988,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18989,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18990,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18991,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18992,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18993,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18994,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18995,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18996,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18997,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18998,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(18999,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19000,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19001,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19002,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19003,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19004,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19005,'Body Composition (DEXA lean/fat)',' Measure bone mineral content and density as well as body composition in mice using the DEXA (Dual Energy X-ray Absorptiometry) analyser.',0),(19236,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19237,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19238,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19239,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19240,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19241,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19242,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19243,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19244,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19245,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19246,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19247,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19248,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19249,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19250,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19251,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19252,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19253,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19254,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19255,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19256,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19257,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19258,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19259,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19260,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19261,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19262,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19263,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19264,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19265,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19266,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19267,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19268,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19269,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19270,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19271,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19272,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19273,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19274,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19275,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19276,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19277,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19278,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19279,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19280,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19281,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19282,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19283,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19284,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19285,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19286,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19287,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19288,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19289,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19290,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19291,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19292,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19293,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19294,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19295,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19296,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19297,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19298,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19299,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19300,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19301,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19302,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(19303,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(20252,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20253,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20254,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20255,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20256,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20257,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20258,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20259,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20260,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20261,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20262,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20263,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20264,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20265,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20266,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20267,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20268,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20269,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20270,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20271,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20272,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20273,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20274,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20275,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20276,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20277,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20278,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20279,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20280,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20281,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20282,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20283,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20284,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20285,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20286,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20287,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20288,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20289,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20290,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20291,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20292,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20293,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20294,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20295,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20296,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20297,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20298,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20299,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20300,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20301,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20302,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20303,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20304,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20305,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20306,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20307,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20308,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20309,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20310,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20311,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20312,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20313,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20314,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20315,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20316,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20317,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20318,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20319,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20320,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20321,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20322,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20323,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20324,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20325,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20326,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20327,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20328,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20329,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20330,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20331,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20332,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20333,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20334,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20335,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20336,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20337,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20338,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20339,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20340,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20341,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20342,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(20343,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(21172,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21173,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21174,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21175,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21176,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21177,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21178,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21179,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21180,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21181,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21182,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21183,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21184,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21185,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21186,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21187,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21188,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21189,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21190,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21191,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21192,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21193,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21194,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21195,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21196,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21197,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21198,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(21452,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21453,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21454,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21455,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21456,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21457,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21458,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21459,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21460,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21461,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21462,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21463,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21464,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21465,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21466,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21467,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21468,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21469,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21470,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21471,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21472,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21473,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21474,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21475,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21476,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21477,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21478,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21479,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21480,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21481,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21482,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21483,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21484,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21485,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21486,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21487,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21488,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21489,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21490,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21491,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21492,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21493,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21494,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21495,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21496,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21497,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21498,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21499,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21500,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21501,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21502,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21503,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21504,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21505,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21506,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(21861,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21862,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21863,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21864,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21865,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21866,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21867,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21868,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21869,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21870,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21871,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21872,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21873,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21874,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21875,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21876,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21877,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21878,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21879,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21880,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21881,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(21882,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(22110,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22111,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22112,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22113,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22114,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22115,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22116,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22117,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22118,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22119,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22120,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22121,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22122,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22123,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22124,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22125,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22126,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22127,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22128,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22129,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22130,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22131,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22132,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22133,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22134,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22135,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22136,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22137,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22138,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22139,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22140,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22141,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22142,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22143,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22144,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22145,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22146,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22147,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22148,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22149,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22150,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22151,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(22503,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22504,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22505,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22506,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22507,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22508,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22509,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22510,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22511,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22512,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22513,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22514,'Heart Weight',' To evaluate cardiac size using heart weight and body weight.',0),(22656,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22657,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22658,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22659,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22660,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22661,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22662,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22663,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22664,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22665,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22666,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22667,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22668,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22669,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22670,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22671,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22672,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22673,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22674,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22675,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22676,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22677,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22678,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22679,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22680,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22681,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22682,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22683,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22684,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22685,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22686,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22687,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22688,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22689,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22690,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22691,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22692,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22693,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22694,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22695,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22696,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22697,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22698,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22699,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22700,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22701,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22702,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22703,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22704,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22705,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22706,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22707,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22708,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(22709,'Tissue Embedding and Block Banking',' Collect and fix a standard list of tissues from the complete necropsy (see IMPC Gross Pathology &amp; Tissue Collection SOP)Trim the fixed tissues into cassettes for processingEmbed the tissues in paraffin in a standard orientation',0),(23608,'Histopathology',' ',0),(23609,'Histopathology',' ',0),(23610,'Histopathology',' ',0),(23611,'Histopathology',' ',0),(23612,'Histopathology',' ',0),(23613,'Histopathology',' ',0),(23614,'Histopathology',' ',0),(23615,'Histopathology',' ',0),(23616,'Histopathology',' ',0),(23617,'Histopathology',' ',0),(23618,'Histopathology',' ',0),(23619,'Histopathology',' ',0),(23620,'Histopathology',' ',0),(23621,'Histopathology',' ',0),(23622,'Histopathology',' ',0),(23623,'Histopathology',' ',0),(23624,'Histopathology',' ',0),(23625,'Histopathology',' ',0),(23626,'Histopathology',' ',0),(23627,'Histopathology',' ',0),(23628,'Histopathology',' ',0),(23629,'Histopathology',' ',0),(23630,'Histopathology',' ',0),(23631,'Histopathology',' ',0),(23632,'Histopathology',' ',0),(23633,'Histopathology',' ',0),(23634,'Histopathology',' ',0),(23635,'Histopathology',' ',0),(23636,'Histopathology',' ',0),(23637,'Histopathology',' ',0),(23638,'Histopathology',' ',0),(23639,'Histopathology',' ',0),(23640,'Histopathology',' ',0),(23641,'Histopathology',' ',0),(23642,'Histopathology',' ',0),(23643,'Histopathology',' ',0),(23644,'Histopathology',' ',0),(23645,'Histopathology',' ',0),(23646,'Histopathology',' ',0),(23647,'Histopathology',' ',0),(23648,'Histopathology',' ',0),(23649,'Histopathology',' ',0),(23650,'Histopathology',' ',0),(23651,'Histopathology',' ',0),(23652,'Histopathology',' ',0),(23653,'Histopathology',' ',0),(23654,'Histopathology',' ',0),(23655,'Histopathology',' ',0),(23656,'Histopathology',' ',0),(23657,'Histopathology',' ',0),(23658,'Histopathology',' ',0),(23659,'Histopathology',' ',0),(23660,'Histopathology',' ',0),(23661,'Histopathology',' ',0),(23662,'Histopathology',' ',0),(23663,'Histopathology',' ',0),(23664,'Histopathology',' ',0),(23665,'Histopathology',' ',0),(23666,'Histopathology',' ',0),(23667,'Histopathology',' ',0),(23668,'Histopathology',' ',0),(23669,'Histopathology',' ',0),(23670,'Histopathology',' ',0),(23671,'Histopathology',' ',0),(23672,'Histopathology',' ',0),(23673,'Histopathology',' ',0),(23674,'Histopathology',' ',0),(23675,'Histopathology',' ',0),(23676,'Histopathology',' ',0),(23677,'Histopathology',' ',0),(23678,'Histopathology',' ',0),(23679,'Histopathology',' ',0),(23680,'Histopathology',' ',0),(23681,'Histopathology',' ',0),(23682,'Histopathology',' ',0),(23683,'Histopathology',' ',0),(23684,'Histopathology',' ',0),(23685,'Histopathology',' ',0),(23686,'Histopathology',' ',0),(23687,'Histopathology',' ',0),(23688,'Histopathology',' ',0),(23689,'Histopathology',' ',0),(23690,'Histopathology',' ',0),(23691,'Histopathology',' ',0),(23692,'Histopathology',' ',0),(23693,'Histopathology',' ',0),(23694,'Histopathology',' ',0),(23695,'Histopathology',' ',0),(23696,'Histopathology',' ',0),(23697,'Histopathology',' ',0),(23698,'Histopathology',' ',0),(23699,'Histopathology',' ',0),(23700,'Histopathology',' ',0),(23701,'Histopathology',' ',0),(23702,'Histopathology',' ',0),(23703,'Histopathology',' ',0),(23704,'Histopathology',' ',0),(23705,'Histopathology',' ',0),(23706,'Histopathology',' ',0),(23707,'Histopathology',' ',0),(23708,'Histopathology',' ',0),(23709,'Histopathology',' ',0),(23710,'Histopathology',' ',0),(23711,'Histopathology',' ',0),(23712,'Histopathology',' ',0),(23713,'Histopathology',' ',0),(23714,'Histopathology',' ',0),(23715,'Histopathology',' ',0),(23716,'Histopathology',' ',0),(23717,'Histopathology',' ',0),(23718,'Histopathology',' ',0),(23719,'Histopathology',' ',0),(23720,'Histopathology',' ',0),(23721,'Histopathology',' ',0),(23722,'Histopathology',' ',0),(23723,'Histopathology',' ',0),(23724,'Histopathology',' ',0),(23725,'Histopathology',' ',0),(23726,'Histopathology',' ',0),(23727,'Histopathology',' ',0),(23728,'Histopathology',' ',0),(23729,'Histopathology',' ',0),(23730,'Histopathology',' ',0),(23731,'Histopathology',' ',0),(23732,'Histopathology',' ',0),(23733,'Histopathology',' ',0),(23734,'Histopathology',' ',0),(23735,'Histopathology',' ',0),(23736,'Histopathology',' ',0),(23737,'Histopathology',' ',0),(23738,'Histopathology',' ',0),(23739,'Histopathology',' ',0),(23740,'Histopathology',' ',0),(23741,'Histopathology',' ',0),(23742,'Histopathology',' ',0),(23743,'Histopathology',' ',0),(23744,'Histopathology',' ',0),(23745,'Histopathology',' ',0),(23746,'Histopathology',' ',0),(23747,'Histopathology',' ',0),(23748,'Histopathology',' ',0),(23749,'Histopathology',' ',0),(23750,'Histopathology',' ',0),(23751,'Histopathology',' ',0),(23752,'Histopathology',' ',0),(23753,'Histopathology',' ',0),(23754,'Histopathology',' ',0),(23755,'Histopathology',' ',0),(23756,'Histopathology',' ',0),(23757,'Histopathology',' ',0),(23758,'Histopathology',' ',0),(23759,'Histopathology',' ',0),(23760,'Histopathology',' ',0),(23761,'Histopathology',' ',0),(23762,'Histopathology',' ',0),(23763,'Histopathology',' ',0),(23764,'Histopathology',' ',0),(23765,'Histopathology',' ',0),(23766,'Histopathology',' ',0),(23767,'Histopathology',' ',0),(23768,'Histopathology',' ',0),(23769,'Histopathology',' ',0),(23770,'Histopathology',' ',0),(23771,'Histopathology',' ',0),(23772,'Histopathology',' ',0),(23773,'Histopathology',' ',0),(23774,'Histopathology',' ',0),(23775,'Histopathology',' ',0),(23776,'Histopathology',' ',0),(23777,'Histopathology',' ',0),(23778,'Histopathology',' ',0),(23779,'Histopathology',' ',0),(23780,'Histopathology',' ',0),(23781,'Histopathology',' ',0),(23782,'Histopathology',' ',0),(23783,'Histopathology',' ',0),(23784,'Histopathology',' ',0),(23785,'Histopathology',' ',0),(23786,'Histopathology',' ',0),(23787,'Histopathology',' ',0),(23788,'Histopathology',' ',0),(23789,'Histopathology',' ',0),(23790,'Histopathology',' ',0),(23791,'Histopathology',' ',0),(23792,'Histopathology',' ',0),(23793,'Histopathology',' ',0),(23794,'Histopathology',' ',0),(23795,'Histopathology',' ',0),(23796,'Histopathology',' ',0),(23797,'Histopathology',' ',0),(23798,'Histopathology',' ',0),(23799,'Histopathology',' ',0),(23800,'Histopathology',' ',0),(23801,'Histopathology',' ',0),(23802,'Histopathology',' ',0),(23803,'Histopathology',' ',0),(23804,'Histopathology',' ',0),(23805,'Histopathology',' ',0),(23806,'Histopathology',' ',0),(23807,'Histopathology',' ',0),(23808,'Histopathology',' ',0),(23809,'Histopathology',' ',0),(23810,'Histopathology',' ',0),(23811,'Histopathology',' ',0),(23812,'Histopathology',' ',0),(23813,'Histopathology',' ',0),(23814,'Histopathology',' ',0),(23815,'Histopathology',' ',0),(23816,'Histopathology',' ',0),(23817,'Histopathology',' ',0),(23818,'Histopathology',' ',0),(23819,'Histopathology',' ',0),(23820,'Histopathology',' ',0),(23821,'Histopathology',' ',0),(23822,'Histopathology',' ',0),(23823,'Histopathology',' ',0),(23824,'Histopathology',' ',0),(23825,'Histopathology',' ',0),(23826,'Histopathology',' ',0),(23827,'Histopathology',' ',0),(23828,'Histopathology',' ',0),(23829,'Histopathology',' ',0),(23830,'Histopathology',' ',0),(23831,'Histopathology',' ',0),(23832,'Histopathology',' ',0),(23833,'Histopathology',' ',0),(23834,'Histopathology',' ',0),(23835,'Histopathology',' ',0),(23836,'Histopathology',' ',0),(23837,'Histopathology',' ',0),(23838,'Histopathology',' ',0),(23839,'Histopathology',' ',0),(23840,'Histopathology',' ',0),(23841,'Histopathology',' ',0),(23842,'Histopathology',' ',0),(23843,'Histopathology',' ',0),(23844,'Histopathology',' ',0),(23845,'Histopathology',' ',0),(23846,'Histopathology',' ',0),(23847,'Histopathology',' ',0),(23848,'Histopathology',' ',0),(23849,'Histopathology',' ',0),(23850,'Histopathology',' ',0),(23851,'Histopathology',' ',0),(23852,'Histopathology',' ',0),(23853,'Histopathology',' ',0),(23854,'Histopathology',' ',0),(23855,'Histopathology',' ',0),(23856,'Histopathology',' ',0),(23857,'Histopathology',' ',0),(23858,'Histopathology',' ',0),(23859,'Histopathology',' ',0),(23860,'Histopathology',' ',0),(23861,'Histopathology',' ',0),(23862,'Histopathology',' ',0),(23863,'Histopathology',' ',0),(23864,'Histopathology',' ',0),(23865,'Histopathology',' ',0),(23866,'Histopathology',' ',0),(23867,'Histopathology',' ',0),(23868,'Histopathology',' ',0),(23869,'Histopathology',' ',0),(23870,'Histopathology',' ',0),(23871,'Histopathology',' ',0),(23872,'Histopathology',' ',0),(23873,'Histopathology',' ',0),(23874,'Histopathology',' ',0),(23875,'Histopathology',' ',0),(23876,'Histopathology',' ',0),(23877,'Histopathology',' ',0),(23878,'Histopathology',' ',0),(23879,'Histopathology',' ',0),(23880,'Histopathology',' ',0),(23881,'Histopathology',' ',0),(23882,'Histopathology',' ',0),(23883,'Histopathology',' ',0),(23884,'Histopathology',' ',0),(23885,'Histopathology',' ',0),(23886,'Histopathology',' ',0),(23887,'Histopathology',' ',0),(23888,'Histopathology',' ',0),(23889,'Histopathology',' ',0),(23890,'Histopathology',' ',0),(23891,'Histopathology',' ',0),(23892,'Histopathology',' ',0),(23893,'Histopathology',' ',0),(23894,'Histopathology',' ',0),(23895,'Histopathology',' ',0),(23896,'Histopathology',' ',0),(23897,'Histopathology',' ',0),(23898,'Histopathology',' ',0),(23899,'Histopathology',' ',0),(23900,'Histopathology',' ',0),(23901,'Histopathology',' ',0),(23902,'Histopathology',' ',0),(23903,'Histopathology',' ',0),(23904,'Histopathology',' ',0),(23905,'Histopathology',' ',0),(23906,'Histopathology',' ',0),(23907,'Histopathology',' ',0),(23908,'Histopathology',' ',0),(23909,'Histopathology',' ',0),(23910,'Histopathology',' ',0),(23911,'Histopathology',' ',0),(23912,'Histopathology',' ',0),(23913,'Histopathology',' ',0),(23914,'Histopathology',' ',0),(23915,'Histopathology',' ',0),(23916,'Histopathology',' ',0),(23917,'Histopathology',' ',0),(23918,'Histopathology',' ',0),(23919,'Histopathology',' ',0),(23920,'Histopathology',' ',0),(23921,'Histopathology',' ',0),(23922,'Histopathology',' ',0),(23923,'Histopathology',' ',0),(23924,'Histopathology',' ',0),(23925,'Histopathology',' ',0),(23926,'Histopathology',' ',0),(23927,'Histopathology',' ',0),(23928,'Histopathology',' ',0),(23929,'Histopathology',' ',0),(23930,'Histopathology',' ',0),(23931,'Histopathology',' ',0),(23932,'Histopathology',' ',0),(23933,'Histopathology',' ',0),(23934,'Histopathology',' ',0),(23935,'Histopathology',' ',0),(23936,'Histopathology',' ',0),(23937,'Histopathology',' ',0),(23938,'Histopathology',' ',0),(23939,'Histopathology',' ',0),(23940,'Histopathology',' ',0),(23941,'Histopathology',' ',0),(23942,'Histopathology',' ',0),(23943,'Histopathology',' ',0),(23944,'Histopathology',' ',0),(23945,'Histopathology',' ',0),(23946,'Histopathology',' ',0),(23947,'Histopathology',' ',0),(23948,'Histopathology',' ',0),(23949,'Histopathology',' ',0),(23950,'Histopathology',' ',0),(23951,'Histopathology',' ',0),(23952,'Histopathology',' ',0),(23953,'Histopathology',' ',0),(23954,'Histopathology',' ',0),(23955,'Histopathology',' ',0),(23956,'Histopathology',' ',0),(27185,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27186,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27187,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27188,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27189,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27190,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27191,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27192,'Body Weight',' The body weight test measures the weight of the mouse in a time series, allowing monitoring of its evolution; also, it is required in many other procedures.',0),(27320,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27321,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27322,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27323,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27324,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27325,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27326,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27327,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27328,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27329,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27330,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27331,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27332,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27333,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27334,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27335,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27336,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27337,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27338,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27339,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27340,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27341,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27342,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(27568,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27569,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27570,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27571,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27572,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27573,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27574,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27575,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27576,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27577,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27578,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27579,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27580,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27581,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27582,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27583,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27584,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27585,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27586,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27587,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27588,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27589,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27590,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27591,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27592,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27593,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27594,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27595,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27596,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27597,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27598,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27599,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27600,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27601,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27602,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27603,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27604,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27605,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27606,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27607,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27608,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27609,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27610,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27611,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27612,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27613,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27614,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27615,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27616,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27617,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27618,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27619,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27620,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27621,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27622,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27623,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27624,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27625,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27626,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27627,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27628,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27629,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27630,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27631,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27632,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27633,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27634,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27635,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27636,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27637,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27638,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27639,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27640,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27641,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27642,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27643,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27644,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27645,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27646,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27647,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27648,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27649,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27650,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27651,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27652,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27653,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27654,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27655,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27656,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27657,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27658,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27659,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27660,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27661,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27662,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27663,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27664,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27665,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27666,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27667,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27668,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27669,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27670,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27671,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(27672,'Adult LacZ',' To stain adult mutant&nbsp; and control tissues for bacterial beta-galactosidase (LacZ) activity in order to assess the adult organ, tissue, substructure and cell type of gene expression of IKMC alleles utilizing a LacZ reporter.&nbsp; Description: Adult mouse tissues are scored for presence of LacZ staining which is distinct from either nonspecific staining observed in wildtype control mice, or is too faint to score as present.&nbsp; Intensity of staining is not required but can be reported.&nbsp;&nbsp; Anatomical terms to localize staining to the organ, structure, substructure, or cell type will use standard mouse anatomy ontology terms.',0),(28488,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28489,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28490,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28491,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28492,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28493,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28494,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28495,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28496,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28497,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28498,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28499,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28500,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28501,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28502,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28503,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28504,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28505,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28506,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28507,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28508,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28509,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28510,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28511,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28512,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28513,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse.',0),(28674,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28675,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28676,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28677,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28678,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28679,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28680,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28681,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28682,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28683,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28684,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28685,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28686,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28687,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28688,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28689,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28690,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28691,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28692,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28693,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28694,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28695,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28696,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28697,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28698,'Echo',' To assess the functionality of the heart in order to determine the presence of a mutant phenotype.',0),(28829,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28830,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28831,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28832,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28833,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28834,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28835,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28836,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28837,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28838,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28839,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28840,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28841,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28842,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28843,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28844,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28845,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28846,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28847,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28848,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28849,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28850,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28851,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28852,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28853,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28854,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28855,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28856,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28857,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28858,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28859,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28860,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28861,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28862,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28863,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28864,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28865,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(28866,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(29207,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29208,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29209,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29210,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29211,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29212,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29213,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29214,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29215,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29216,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29217,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29218,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29219,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29220,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29221,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29222,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29223,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29224,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29225,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29226,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29227,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29228,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29229,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29230,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29231,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29232,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29233,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29234,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29235,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29236,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29237,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29238,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29239,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29240,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29241,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29242,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29243,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29244,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29245,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29246,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29247,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29248,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29249,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29250,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29251,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29252,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29253,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29254,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29255,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29256,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29257,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29258,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29259,'Auditory Brain Stem Response',' Auditory brainstem response test determines hearing sensitivity and other physiological parameters using evoked potential recordings in anesthetized mice.Ontological description: MP:0004738 - abnormal brainstem auditory evoked potential.',0),(29774,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29775,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29776,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29777,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29778,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29779,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29780,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29781,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29782,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29783,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29784,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29785,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29786,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29787,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29788,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29789,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29790,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29791,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29792,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29793,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29794,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29795,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29796,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29797,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29798,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29799,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29800,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29801,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29802,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29803,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29804,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29805,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29806,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29807,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29808,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29809,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29810,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29811,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29812,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29813,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29814,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(29815,'Hematology',' Hematological assessment of blood determines blood cell counts (white blood cells, red blood cells, hemoglobin, and platelets) and additional hematological parameters (hematocrit, mean cell volume, mean corpuscular hemoglobin, mean cell hemoglobin concentration) can be derived using these indices. These tests will indicate abnormalities in the production of blood and its components (blood cells and hemoglobin) as well as in the associated blood-forming organs.&nbsp;Ontological description: MP:0002429 - abnormal blood cell morphology/development.',0),(30278,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30279,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30280,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30281,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30282,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30283,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30284,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30285,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30286,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30287,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30288,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30289,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30290,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30291,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30292,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30293,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30294,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30295,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30296,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30297,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30298,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30299,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30300,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30301,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30302,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30303,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30304,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30305,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30306,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30307,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30308,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30309,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30310,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30311,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30312,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30313,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30314,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30315,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30316,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30317,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30318,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30319,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30320,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30321,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30322,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30323,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30324,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30325,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30326,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30327,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30328,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30329,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30330,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30331,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(30750,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30751,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30752,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30753,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30754,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30755,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30756,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30757,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30758,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30759,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30760,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30761,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30762,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30763,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30764,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30765,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30766,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30767,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30768,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30769,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30770,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(30936,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30937,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30938,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30939,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30940,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30941,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30942,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30943,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30944,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30945,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30946,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30947,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30948,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30949,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30950,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30951,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30952,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30953,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30954,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30955,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30956,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30957,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30958,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30959,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30960,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30961,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30962,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30963,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30964,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30965,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30966,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30967,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30968,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30969,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30970,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30971,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30972,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30973,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30974,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(30975,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(31377,'Viability Primary Screen',' ',0),(31378,'Viability Primary Screen',' ',0),(31379,'Viability Primary Screen',' ',0),(31380,'Viability Primary Screen',' ',0),(31381,'Viability Primary Screen',' ',0),(31382,'Viability Primary Screen',' ',0),(31383,'Viability Primary Screen',' ',0),(31384,'Viability Primary Screen',' ',0),(31385,'Viability Primary Screen',' ',0),(31386,'Viability Primary Screen',' ',0),(31387,'Viability Primary Screen',' ',0),(31388,'Viability Primary Screen',' ',0),(31389,'Viability Primary Screen',' ',0),(31390,'Viability Primary Screen',' ',0),(31391,'Viability Primary Screen',' ',0),(31392,'Viability Primary Screen',' ',0),(31393,'Viability Primary Screen',' ',0),(31394,'Viability Primary Screen',' ',0),(31395,'Viability Primary Screen',' ',0),(31396,'Viability Primary Screen',' ',0),(31397,'Viability Primary Screen',' ',0),(31398,'Viability Primary Screen',' ',0),(31399,'Viability Primary Screen',' ',0),(31400,'Viability Primary Screen',' ',0),(31401,'Viability Primary Screen',' ',0),(31402,'Viability Primary Screen',' ',0),(31403,'Viability Primary Screen',' ',0),(31404,'Viability Primary Screen',' ',0),(31405,'Viability Primary Screen',' ',0),(31406,'Viability Primary Screen',' ',0),(31407,'Viability Primary Screen',' ',0),(31408,'Viability Primary Screen',' ',0),(31409,'Viability Primary Screen',' ',0),(31881,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31882,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31883,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31884,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31885,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31886,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31887,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31888,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31889,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31890,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31891,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31892,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31893,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31894,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31895,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31896,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31897,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31898,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31899,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31900,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31901,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31902,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31903,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31904,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31905,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31906,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31907,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31908,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31909,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31910,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31911,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31912,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31913,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31914,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31915,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31916,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31917,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31918,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31919,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31920,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31921,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31922,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31923,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31924,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31925,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31926,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31927,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31928,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31929,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31930,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31931,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31932,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31933,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31934,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31935,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31936,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31937,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31938,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31939,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31940,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31941,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31942,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31943,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31944,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31945,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31946,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31947,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31948,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31949,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31950,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31951,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31952,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31953,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31954,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31955,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31956,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31957,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31958,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31959,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31960,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31961,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31962,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31963,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31964,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31965,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31966,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(31967,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(32643,'Embryo LacZ',' ',0),(32644,'Embryo LacZ',' ',0),(32645,'Embryo LacZ',' ',0),(32646,'Embryo LacZ',' ',0),(32647,'Embryo LacZ',' ',0),(32648,'Embryo LacZ',' ',0),(32649,'Embryo LacZ',' ',0),(32650,'Embryo LacZ',' ',0),(32651,'Embryo LacZ',' ',0),(32652,'Embryo LacZ',' ',0),(32653,'Embryo LacZ',' ',0),(32654,'Embryo LacZ',' ',0),(32655,'Embryo LacZ',' ',0),(32656,'Embryo LacZ',' ',0),(32657,'Embryo LacZ',' ',0),(32658,'Embryo LacZ',' ',0),(32659,'Embryo LacZ',' ',0),(32660,'Embryo LacZ',' ',0),(32661,'Embryo LacZ',' ',0),(32662,'Embryo LacZ',' ',0),(32663,'Embryo LacZ',' ',0),(32664,'Embryo LacZ',' ',0),(32665,'Embryo LacZ',' ',0),(32666,'Embryo LacZ',' ',0),(32667,'Embryo LacZ',' ',0),(32668,'Embryo LacZ',' ',0),(32669,'Embryo LacZ',' ',0),(32670,'Embryo LacZ',' ',0),(32671,'Embryo LacZ',' ',0),(32672,'Embryo LacZ',' ',0),(32673,'Embryo LacZ',' ',0),(32674,'Embryo LacZ',' ',0),(32675,'Embryo LacZ',' ',0),(32676,'Embryo LacZ',' ',0),(32677,'Embryo LacZ',' ',0),(32678,'Embryo LacZ',' ',0),(32679,'Embryo LacZ',' ',0),(32680,'Embryo LacZ',' ',0),(32681,'Embryo LacZ',' ',0),(32682,'Embryo LacZ',' ',0),(32683,'Embryo LacZ',' ',0),(32684,'Embryo LacZ',' ',0),(32685,'Embryo LacZ',' ',0),(32686,'Embryo LacZ',' ',0),(32687,'Embryo LacZ',' ',0),(32688,'Embryo LacZ',' ',0),(32689,'Embryo LacZ',' ',0),(32690,'Embryo LacZ',' ',0),(32691,'Embryo LacZ',' ',0),(32692,'Embryo LacZ',' ',0),(32693,'Embryo LacZ',' ',0),(32694,'Embryo LacZ',' ',0),(32695,'Embryo LacZ',' ',0),(32696,'Embryo LacZ',' ',0),(32697,'Embryo LacZ',' ',0),(32698,'Embryo LacZ',' ',0),(32699,'Embryo LacZ',' ',0),(32700,'Embryo LacZ',' ',0),(32701,'Embryo LacZ',' ',0),(32702,'Embryo LacZ',' ',0),(32703,'Embryo LacZ',' ',0),(32704,'Embryo LacZ',' ',0),(32705,'Embryo LacZ',' ',0),(32706,'Embryo LacZ',' ',0),(32707,'Embryo LacZ',' ',0),(32708,'Embryo LacZ',' ',0),(32709,'Embryo LacZ',' ',0),(32710,'Embryo LacZ',' ',0),(32711,'Embryo LacZ',' ',0),(32712,'Embryo LacZ',' ',0),(32713,'Embryo LacZ',' ',0),(32714,'Embryo LacZ',' ',0),(32715,'Embryo LacZ',' ',0),(32716,'Embryo LacZ',' ',0),(32717,'Embryo LacZ',' ',0),(32718,'Embryo LacZ',' ',0),(32719,'Embryo LacZ',' ',0),(32720,'Embryo LacZ',' ',0),(32721,'Embryo LacZ',' ',0),(32722,'Embryo LacZ',' ',0),(32723,'Embryo LacZ',' ',0),(32724,'Embryo LacZ',' ',0),(32725,'Embryo LacZ',' ',0),(32726,'Embryo LacZ',' ',0),(32727,'Embryo LacZ',' ',0),(32728,'Embryo LacZ',' ',0),(32729,'Embryo LacZ',' ',0),(32730,'Embryo LacZ',' ',0),(32731,'Embryo LacZ',' ',0),(32732,'Embryo LacZ',' ',0),(32733,'Embryo LacZ',' ',0),(32734,'Embryo LacZ',' ',0),(33532,'Housing and Husbandry',' ',0),(33533,'Housing and Husbandry',' ',0),(33534,'Housing and Husbandry',' ',0),(33535,'Housing and Husbandry',' ',0),(33536,'Housing and Husbandry',' ',0),(33537,'Housing and Husbandry',' ',0),(33538,'Housing and Husbandry',' ',0),(33539,'Housing and Husbandry',' ',0),(33540,'Housing and Husbandry',' ',0),(33541,'Housing and Husbandry',' ',0),(33542,'Housing and Husbandry',' ',0),(33543,'Housing and Husbandry',' ',0),(33544,'Housing and Husbandry',' ',0),(33545,'Housing and Husbandry',' ',0),(33546,'Housing and Husbandry',' ',0),(33547,'Housing and Husbandry',' ',0),(33548,'Housing and Husbandry',' ',0),(33549,'Housing and Husbandry',' ',0),(33550,'Housing and Husbandry',' ',0),(33551,'Housing and Husbandry',' ',0),(33552,'Housing and Husbandry',' ',0),(33553,'Housing and Husbandry',' ',0),(33554,'Housing and Husbandry',' ',0),(33555,'Housing and Husbandry',' ',0),(33556,'Housing and Husbandry',' ',0),(33557,'Housing and Husbandry',' ',0),(33558,'Housing and Husbandry',' ',0),(33559,'Housing and Husbandry',' ',0),(33560,'Housing and Husbandry',' ',0),(33561,'Housing and Husbandry',' ',0),(33562,'Housing and Husbandry',' ',0),(33563,'Housing and Husbandry',' ',0),(33564,'Housing and Husbandry',' ',0),(33565,'Housing and Husbandry',' ',0),(33566,'Housing and Husbandry',' ',0),(33567,'Housing and Husbandry',' ',0),(33568,'Housing and Husbandry',' ',0),(33569,'Housing and Husbandry',' ',0),(33570,'Housing and Husbandry',' ',0),(33571,'Housing and Husbandry',' ',0),(33572,'Housing and Husbandry',' ',0),(33573,'Housing and Husbandry',' ',0),(33574,'Housing and Husbandry',' ',0),(33575,'Housing and Husbandry',' ',0),(33576,'Housing and Husbandry',' ',0),(33577,'Housing and Husbandry',' ',0),(33578,'Housing and Husbandry',' ',0),(33579,'Housing and Husbandry',' ',0),(33580,'Housing and Husbandry',' ',0),(33581,'Housing and Husbandry',' ',0),(33582,'Housing and Husbandry',' ',0),(33583,'Housing and Husbandry',' ',0),(33584,'Housing and Husbandry',' ',0),(33585,'Housing and Husbandry',' ',0),(33586,'Housing and Husbandry',' ',0),(33587,'Housing and Husbandry',' ',0),(33588,'Housing and Husbandry',' ',0),(33589,'Housing and Husbandry',' ',0),(33590,'Housing and Husbandry',' ',0),(33591,'Housing and Husbandry',' ',0),(33592,'Housing and Husbandry',' ',0),(33593,'Housing and Husbandry',' ',0),(33594,'Housing and Husbandry',' ',0),(33595,'Housing and Husbandry',' ',0),(33596,'Housing and Husbandry',' ',0),(33597,'Housing and Husbandry',' ',0),(33598,'Housing and Husbandry',' ',0),(34548,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34549,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34550,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34551,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34552,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34553,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34554,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34555,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34556,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34557,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34558,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34559,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34560,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34561,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34562,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34563,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34564,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34565,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34566,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34567,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34568,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34569,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34570,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34571,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34572,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34573,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34574,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34575,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34576,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34577,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34578,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34579,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34580,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34581,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34582,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34583,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34584,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34585,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34586,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34587,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34588,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34589,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34590,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34591,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34592,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34593,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34594,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34595,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34596,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34597,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34598,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34599,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34600,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34601,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34602,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34603,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34604,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34605,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34606,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34607,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34608,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34609,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34610,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34611,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34612,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34613,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34614,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34615,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34616,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34617,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34618,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34619,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34620,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34621,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34622,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34623,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34624,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34625,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34626,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34627,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34628,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34629,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34630,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34631,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34632,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34633,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34634,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34635,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34636,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34637,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34638,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34639,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34640,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34641,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34642,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34643,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34644,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34645,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34646,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34647,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34648,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34649,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34650,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34651,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34652,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34653,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34654,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34655,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34656,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34657,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34658,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34659,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34660,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34661,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(34662,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(35564,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35565,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35566,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35567,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35568,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35569,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35570,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35571,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35572,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35573,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35574,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35575,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35576,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35577,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35578,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35579,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35580,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35581,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35582,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35583,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35584,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35585,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35586,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35587,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35588,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35589,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35590,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35591,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35592,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35593,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35594,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35595,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35596,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35597,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35598,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35599,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35600,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35601,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(35602,'Acoustic Startle and Pre-pulse Inhibition (PPI)',' The acoustic startle response is characterized by an exaggerated flinching response to an unexpected strong auditory stimulus (pre-pulse). This response can be attenuated when it is preceded by a weaker stimulus (pre-pulse) and is the principle underlying pre-pulse inhibition (PPI). PPI has been described in numerous species, including mice and humans and provides an operational measure of sensorimotor gating reflecting the ability of an animal to successfully integrate and inhibit sensory information. Several clinical studies have shown that a number of human disorders have impaired PPI including: schizophrenia, Huntington&rsquo;s disease, fragile X syndrome, and autism. The acoustic startle and PPI paradigm is therefore largely used to assess sensorimotor gating and the effects of a number of treatment modalities such as putative anti-psychotics, and to explore genetic and neurobiological mechanisms underlying behaviors of relevance to psychosis (Geyer, 1999; Ouagazzal et al., 2001).Ontological description: MP:0002067 - abnormal sensory capabilities/reflexes/nociception.',0),(36068,'Viability E9.5 Secondary Screen',' ',0),(36069,'Viability E9.5 Secondary Screen',' ',0),(36070,'Viability E9.5 Secondary Screen',' ',0),(36071,'Viability E9.5 Secondary Screen',' ',0),(36072,'Viability E9.5 Secondary Screen',' ',0),(36073,'Viability E9.5 Secondary Screen',' ',0),(36074,'Viability E9.5 Secondary Screen',' ',0),(36075,'Viability E9.5 Secondary Screen',' ',0),(36076,'Viability E9.5 Secondary Screen',' ',0),(36077,'Viability E9.5 Secondary Screen',' ',0),(36078,'Viability E9.5 Secondary Screen',' ',0),(36079,'Viability E9.5 Secondary Screen',' ',0),(36080,'Viability E9.5 Secondary Screen',' ',0),(36081,'Viability E9.5 Secondary Screen',' ',0),(36082,'Viability E9.5 Secondary Screen',' ',0),(36083,'Viability E9.5 Secondary Screen',' ',0),(36084,'Viability E9.5 Secondary Screen',' ',0),(36085,'Viability E9.5 Secondary Screen',' ',0),(36086,'Viability E9.5 Secondary Screen',' ',0),(36087,'Viability E9.5 Secondary Screen',' ',0),(36088,'Viability E9.5 Secondary Screen',' ',0),(36089,'Viability E9.5 Secondary Screen',' ',0),(36090,'Viability E9.5 Secondary Screen',' ',0),(36091,'Viability E9.5 Secondary Screen',' ',0),(36092,'Viability E9.5 Secondary Screen',' ',0),(36093,'Viability E9.5 Secondary Screen',' ',0),(36094,'Viability E9.5 Secondary Screen',' ',0),(36285,'Viability E12.5 Secondary Screen',' ',0),(36286,'Viability E12.5 Secondary Screen',' ',0),(36287,'Viability E12.5 Secondary Screen',' ',0),(36288,'Viability E12.5 Secondary Screen',' ',0),(36289,'Viability E12.5 Secondary Screen',' ',0),(36290,'Viability E12.5 Secondary Screen',' ',0),(36291,'Viability E12.5 Secondary Screen',' ',0),(36292,'Viability E12.5 Secondary Screen',' ',0),(36293,'Viability E12.5 Secondary Screen',' ',0),(36294,'Viability E12.5 Secondary Screen',' ',0),(36295,'Viability E12.5 Secondary Screen',' ',0),(36296,'Viability E12.5 Secondary Screen',' ',0),(36297,'Viability E12.5 Secondary Screen',' ',0),(36298,'Viability E12.5 Secondary Screen',' ',0),(36299,'Viability E12.5 Secondary Screen',' ',0),(36300,'Viability E12.5 Secondary Screen',' ',0),(36301,'Viability E12.5 Secondary Screen',' ',0),(36302,'Viability E12.5 Secondary Screen',' ',0),(36303,'Viability E12.5 Secondary Screen',' ',0),(36304,'Viability E12.5 Secondary Screen',' ',0),(36305,'Viability E12.5 Secondary Screen',' ',0),(36306,'Viability E12.5 Secondary Screen',' ',0),(36307,'Viability E12.5 Secondary Screen',' ',0),(36308,'Viability E12.5 Secondary Screen',' ',0),(36309,'Viability E12.5 Secondary Screen',' ',0),(36310,'Viability E12.5 Secondary Screen',' ',0),(36311,'Viability E12.5 Secondary Screen',' ',0),(36471,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36472,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36473,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36474,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36475,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36476,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36477,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36478,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36479,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36480,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36481,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36482,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36483,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36484,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36485,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36486,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36487,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36488,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36489,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36490,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36491,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36492,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36493,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36494,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36495,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36496,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36497,'Viability E14.5-E15.5 Secondary Screen',' ',0),(36688,'Viability E18.5 Secondary Screen',' ',0),(36689,'Viability E18.5 Secondary Screen',' ',0),(36690,'Viability E18.5 Secondary Screen',' ',0),(36691,'Viability E18.5 Secondary Screen',' ',0),(36692,'Viability E18.5 Secondary Screen',' ',0),(36693,'Viability E18.5 Secondary Screen',' ',0),(36694,'Viability E18.5 Secondary Screen',' ',0),(36695,'Viability E18.5 Secondary Screen',' ',0),(36696,'Viability E18.5 Secondary Screen',' ',0),(36697,'Viability E18.5 Secondary Screen',' ',0),(36698,'Viability E18.5 Secondary Screen',' ',0),(36699,'Viability E18.5 Secondary Screen',' ',0),(36700,'Viability E18.5 Secondary Screen',' ',0),(36701,'Viability E18.5 Secondary Screen',' ',0),(36702,'Viability E18.5 Secondary Screen',' ',0),(36703,'Viability E18.5 Secondary Screen',' ',0),(36704,'Viability E18.5 Secondary Screen',' ',0),(36705,'Viability E18.5 Secondary Screen',' ',0),(36706,'Viability E18.5 Secondary Screen',' ',0),(36707,'Viability E18.5 Secondary Screen',' ',0),(36708,'Viability E18.5 Secondary Screen',' ',0),(36709,'Viability E18.5 Secondary Screen',' ',0),(36710,'Viability E18.5 Secondary Screen',' ',0),(36711,'Viability E18.5 Secondary Screen',' ',0),(36712,'Viability E18.5 Secondary Screen',' ',0),(36713,'Viability E18.5 Secondary Screen',' ',0),(36714,'Viability E18.5 Secondary Screen',' ',0),(36937,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36938,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36939,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36940,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36941,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36942,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36943,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36944,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36945,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36946,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36947,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36948,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36949,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36950,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36951,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36952,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36953,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36954,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36955,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36956,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36957,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36958,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36959,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36960,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36961,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36962,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36963,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36964,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36965,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36966,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36967,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36968,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36969,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36970,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36971,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36972,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36973,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36974,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36975,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36976,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36977,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36978,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36979,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36980,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36981,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36982,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36983,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36984,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36985,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36986,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36987,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36988,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36989,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36990,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36991,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36992,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36993,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36994,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36995,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36996,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(36997,'Gross Pathology and Tissue Collection',' To perform a complete necropsy to detect and record abnormal external findings and macroscopic alterations in internal and external organs, record body and heart weights (see IMPC Heart Weight SOP), and collect a standardized list of tissues for fixation with or without further processing (see non-mandatory IMPC Tissue Embedding &amp; Block Banking SOP).',0),(37378,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37379,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37380,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37381,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37382,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37383,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37384,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37385,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37386,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37387,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37388,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37389,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37390,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37391,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37392,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37393,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37394,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37395,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37396,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37397,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37398,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37399,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37400,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37401,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37402,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37403,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37404,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37405,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37406,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37407,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37408,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37409,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37410,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37411,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37412,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37413,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37414,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37415,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37416,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37417,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37418,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37419,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37420,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37421,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37422,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37423,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37424,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37425,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37426,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37427,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37428,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37429,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37430,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37431,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37432,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37433,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37434,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37435,'Clinical Chemistry',' Clinical chemistry determines biochemical parameters in plasma including enzymatic activity, specific substrates and electrolytes.&nbsp;Ontological description: MP:0001545 &ndash; blood physiology abnormalities.',0),(37882,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37883,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37884,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37885,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37886,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37887,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37888,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37889,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37890,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37891,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37892,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37893,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37894,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37895,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37896,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37897,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37898,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37899,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37900,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37901,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37902,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(37903,'Insulin Blood Level',' The insulin concentration in the blood is an important indicator of diabetes.Ontological description: abnormal circulating insulin level [MP:0001560]; increased circulating insulin level [MP:0002079]; decreased circulating insulin level [MP:0002727].',0),(38099,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38100,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38101,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38102,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38103,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38104,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38105,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38106,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38107,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38108,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38109,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38110,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38111,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38112,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38113,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38114,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38115,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38116,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38117,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38118,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38119,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38120,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38121,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38122,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38123,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38124,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38125,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38126,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38127,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38128,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38129,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38130,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38131,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38132,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38133,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38134,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38135,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38136,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38137,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38138,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38139,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38140,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38141,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38142,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38143,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38144,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38145,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38146,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38147,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38148,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38149,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38150,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38151,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38152,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38153,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38154,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38155,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38156,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38157,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38158,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38159,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38160,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38161,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38162,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38163,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38164,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38165,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38166,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38167,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38168,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38169,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38170,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38171,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38172,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38173,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38174,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38175,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38176,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38177,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38178,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38179,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38180,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38181,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38182,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38183,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38184,'Combined SHIRPA and Dysmorphology',' SHIRPA and dysmorphology were originally always separate assessments.&nbsp; However they have recently been combined as assessments, so that they take place at the same time.The purpose of the assessments is to examine mice for obvious physical characteristics, behaviors and morphological abnormalities.Descriptions include abnormal locomotion/appearance/behavior/reflex reactions.',0),(38988,'Experimental design',' ',0),(38989,'Experimental design',' ',0),(38990,'Experimental design',' ',0),(38991,'Experimental design',' ',0),(38992,'Experimental design',' ',0),(38993,'Experimental design',' ',0),(38994,'Experimental design',' ',0),(38995,'Experimental design',' ',0),(38996,'Experimental design',' ',0),(38997,'Experimental design',' ',0),(38998,'Experimental design',' ',0),(38999,'Experimental design',' ',0),(39000,'Experimental design',' ',0),(39001,'Experimental design',' ',0),(39002,'Experimental design',' ',0),(39003,'Experimental design',' ',0),(39004,'Experimental design',' ',0),(39005,'Experimental design',' ',0),(39006,'Experimental design',' ',0),(39007,'Experimental design',' ',0),(39008,'Experimental design',' ',0),(39009,'Experimental design',' ',0),(39010,'Experimental design',' ',0),(39011,'Experimental design',' ',0),(39012,'Experimental design',' ',0),(39013,'Experimental design',' ',0),(39014,'Experimental design',' ',0),(39015,'Experimental design',' ',0),(39016,'Experimental design',' ',0),(39017,'Experimental design',' ',0),(39018,'Experimental design',' ',0),(39019,'Experimental design',' ',0),(39020,'Experimental design',' ',0),(39021,'Experimental design',' ',0),(39022,'Experimental design',' ',0),(39023,'Experimental design',' ',0),(39024,'Experimental design',' ',0),(39025,'Experimental design',' ',0),(39026,'Experimental design',' ',0),(39027,'Experimental design',' ',0),(39028,'Experimental design',' ',0),(39029,'Experimental design',' ',0),(39030,'Experimental design',' ',0),(39031,'Experimental design',' ',0),(39032,'Experimental design',' ',0),(39033,'Experimental design',' ',0),(39034,'Experimental design',' ',0),(39035,'Experimental design',' ',0),(39036,'Experimental design',' ',0),(39037,'Experimental design',' ',0),(39038,'Experimental design',' ',0),(39039,'Experimental design',' ',0),(39040,'Experimental design',' ',0),(39041,'Experimental design',' ',0),(39042,'Experimental design',' ',0),(39043,'Experimental design',' ',0),(39044,'Experimental design',' ',0),(39045,'Experimental design',' ',0),(39046,'Experimental design',' ',0),(39047,'Experimental design',' ',0),(39048,'Experimental design',' ',0),(39049,'Experimental design',' ',0),(39050,'Experimental design',' ',0),(39051,'Experimental design',' ',0),(39052,'Experimental design',' ',0),(39053,'Experimental design',' ',0),(39054,'Experimental design',' ',0),(39055,'Experimental design',' ',0),(39056,'Experimental design',' ',0),(39057,'Experimental design',' ',0),(39058,'Experimental design',' ',0),(39059,'Experimental design',' ',0),(39060,'Experimental design',' ',0),(39061,'Experimental design',' ',0),(39062,'Experimental design',' ',0),(39063,'Experimental design',' ',0),(39064,'Experimental design',' ',0),(39065,'Experimental design',' ',0),(39066,'Experimental design',' ',0),(39067,'Experimental design',' ',0),(39068,'Experimental design',' ',0),(39069,'Experimental design',' ',0),(39070,'Experimental design',' ',0),(39071,'Experimental design',' ',0),(39072,'Experimental design',' ',0),(39073,'Experimental design',' ',0),(39074,'Experimental design',' ',0),(39075,'Experimental design',' ',0),(39076,'Experimental design',' ',0),(39077,'Experimental design',' ',0),(39078,'Experimental design',' ',0),(39079,'Experimental design',' ',0),(39080,'Experimental design',' ',0),(39081,'Experimental design',' ',0),(39082,'Experimental design',' ',0),(39083,'Experimental design',' ',0),(39084,'Experimental design',' ',0),(39085,'Experimental design',' ',0),(39086,'Experimental design',' ',0),(39087,'Experimental design',' ',0),(39088,'Experimental design',' ',0),(39089,'Experimental design',' ',0),(39090,'Experimental design',' ',0),(39091,'Experimental design',' ',0),(39092,'Experimental design',' ',0),(39093,'Experimental design',' ',0),(39094,'Experimental design',' ',0),(39095,'Experimental design',' ',0),(39096,'Experimental design',' ',0),(39097,'Experimental design',' ',0),(39098,'Experimental design',' ',0),(39099,'Experimental design',' ',0),(39100,'Experimental design',' ',0),(39101,'Experimental design',' ',0),(39102,'Experimental design',' ',0),(39103,'Experimental design',' ',0),(39104,'Experimental design',' ',0),(39105,'Experimental design',' ',0),(39106,'Experimental design',' ',0),(39107,'Experimental design',' ',0),(39108,'Experimental design',' ',0),(39109,'Experimental design',' ',0),(39110,'Experimental design',' ',0),(39111,'Experimental design',' ',0),(39112,'Experimental design',' ',0),(39113,'Experimental design',' ',0),(40004,'Gross Morphology Placenta E9.5',' ',0),(40005,'Gross Morphology Placenta E9.5',' ',0),(40006,'Gross Morphology Placenta E9.5',' ',0),(40007,'Gross Morphology Placenta E9.5',' ',0),(40008,'Gross Morphology Placenta E9.5',' ',0),(40009,'Gross Morphology Placenta E9.5',' ',0),(40010,'Gross Morphology Placenta E9.5',' ',0),(40011,'Gross Morphology Placenta E9.5',' ',0),(40012,'Gross Morphology Placenta E9.5',' ',0),(40013,'Gross Morphology Placenta E9.5',' ',0),(40014,'Gross Morphology Placenta E9.5',' ',0),(40015,'Gross Morphology Placenta E9.5',' ',0),(40016,'Gross Morphology Placenta E9.5',' ',0),(40017,'Gross Morphology Placenta E9.5',' ',0),(40018,'Gross Morphology Placenta E9.5',' ',0),(40019,'Gross Morphology Placenta E9.5',' ',0),(40020,'Gross Morphology Placenta E9.5',' ',0),(40190,'Gross Morphology Placenta E12.5',' ',0),(40191,'Gross Morphology Placenta E12.5',' ',0),(40192,'Gross Morphology Placenta E12.5',' ',0),(40193,'Gross Morphology Placenta E12.5',' ',0),(40194,'Gross Morphology Placenta E12.5',' ',0),(40195,'Gross Morphology Placenta E12.5',' ',0),(40196,'Gross Morphology Placenta E12.5',' ',0),(40197,'Gross Morphology Placenta E12.5',' ',0),(40198,'Gross Morphology Placenta E12.5',' ',0),(40199,'Gross Morphology Placenta E12.5',' ',0),(40200,'Gross Morphology Placenta E12.5',' ',0),(40201,'Gross Morphology Placenta E12.5',' ',0),(40202,'Gross Morphology Placenta E12.5',' ',0),(40203,'Gross Morphology Placenta E12.5',' ',0),(40204,'Gross Morphology Placenta E12.5',' ',0),(40205,'Gross Morphology Placenta E12.5',' ',0),(40206,'Gross Morphology Placenta E12.5',' ',0),(40207,'Gross Morphology Placenta E12.5',' ',0),(40345,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40346,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40347,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40348,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40349,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40350,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40351,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40352,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40353,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40354,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40355,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40356,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40357,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40358,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40359,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40360,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40361,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40362,'Gross Morphology Placenta E14.5-E15.5',' ',0),(40531,'Gross Morphology Placenta E18.5',' ',0),(40532,'Gross Morphology Placenta E18.5',' ',0),(40533,'Gross Morphology Placenta E18.5',' ',0),(40534,'Gross Morphology Placenta E18.5',' ',0),(40535,'Gross Morphology Placenta E18.5',' ',0),(40536,'Gross Morphology Placenta E18.5',' ',0),(40537,'Gross Morphology Placenta E18.5',' ',0),(40538,'Gross Morphology Placenta E18.5',' ',0),(40539,'Gross Morphology Placenta E18.5',' ',0),(40540,'Gross Morphology Placenta E18.5',' ',0),(40541,'Gross Morphology Placenta E18.5',' ',0),(40542,'Gross Morphology Placenta E18.5',' ',0),(40543,'Gross Morphology Placenta E18.5',' ',0),(40544,'Gross Morphology Placenta E18.5',' ',0),(40545,'Gross Morphology Placenta E18.5',' ',0),(40546,'Gross Morphology Placenta E18.5',' ',0),(40547,'Gross Morphology Placenta E18.5',' ',0),(40548,'Gross Morphology Placenta E18.5',' ',0),(40655,'OPT E9.5',' ',0),(40656,'OPT E9.5',' ',0),(40657,'OPT E9.5',' ',0),(40658,'OPT E9.5',' ',0),(40659,'OPT E9.5',' ',0),(40660,'OPT E9.5',' ',0),(40661,'OPT E9.5',' ',0),(40662,'OPT E9.5',' ',0),(40663,'OPT E9.5',' ',0),(40664,'OPT E9.5',' ',0),(40665,'OPT E9.5',' ',0),(40666,'OPT E9.5',' ',0),(40745,'MicroCT E14.5-E15.5',' ',0),(40746,'MicroCT E14.5-E15.5',' ',0),(40747,'MicroCT E14.5-E15.5',' ',0),(40748,'MicroCT E14.5-E15.5',' ',0),(40749,'MicroCT E14.5-E15.5',' ',0),(40750,'MicroCT E14.5-E15.5',' ',0),(40751,'MicroCT E14.5-E15.5',' ',0),(40752,'MicroCT E14.5-E15.5',' ',0),(40753,'MicroCT E14.5-E15.5',' ',0),(40754,'MicroCT E14.5-E15.5',' ',0),(40755,'MicroCT E14.5-E15.5',' ',0),(40756,'MicroCT E14.5-E15.5',' ',0),(40757,'MicroCT E14.5-E15.5',' ',0),(40758,'MicroCT E14.5-E15.5',' ',0),(40759,'MicroCT E14.5-E15.5',' ',0),(40760,'MicroCT E14.5-E15.5',' ',0),(40761,'MicroCT E14.5-E15.5',' ',0),(40931,'MicroCT E18.5',' ',0),(40932,'MicroCT E18.5',' ',0),(40933,'MicroCT E18.5',' ',0),(40934,'MicroCT E18.5',' ',0),(40935,'MicroCT E18.5',' ',0),(40936,'MicroCT E18.5',' ',0),(40937,'MicroCT E18.5',' ',0),(40938,'MicroCT E18.5',' ',0),(40939,'MicroCT E18.5',' ',0),(40940,'MicroCT E18.5',' ',0),(40941,'MicroCT E18.5',' ',0),(40942,'MicroCT E18.5',' ',0),(40943,'MicroCT E18.5',' ',0),(40944,'MicroCT E18.5',' ',0),(40945,'MicroCT E18.5',' ',0),(40946,'MicroCT E18.5',' ',0),(40947,'MicroCT E18.5',' ',0),(41404,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41405,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41406,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41407,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41408,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41409,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41410,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41411,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41412,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41413,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41414,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41415,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41416,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41417,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41418,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41419,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41420,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41421,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41422,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41423,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41424,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41425,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41426,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41427,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41428,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41429,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41430,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41431,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41432,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41433,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41434,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41435,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41436,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41437,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41438,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41439,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41440,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41441,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41442,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41443,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41444,'Indirect Calorimetry',' Indirect calorimetry provides detailed information on the energy metabolism of mutant mice. Energy expenditure is evaluated through indirect calorimetry by measuring oxygen consumption with an open flow respirometric system. CO2 and O2 sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through control or animal cages. The amount of oxygen consumed over a given period of time can thus be calculated, as far as the air flow through the cage is known. Data are expressed as ml O2 h-1animal-1. The system also monitors CO2 production, therefore, the respiratory exchange ratio (RER) and heat production can be calculated. An activity and food and water intake monitoring system can also be integrated into the set up in order to investigate circadian pattern and behaviour.Ontological description: MP:0005266 - abnormal metabolism.',0),(41908,'Gross Morphology Embryo E9.5',' ',0),(41909,'Gross Morphology Embryo E9.5',' ',0),(41910,'Gross Morphology Embryo E9.5',' ',0),(41911,'Gross Morphology Embryo E9.5',' ',0),(41912,'Gross Morphology Embryo E9.5',' ',0),(41913,'Gross Morphology Embryo E9.5',' ',0),(41914,'Gross Morphology Embryo E9.5',' ',0),(41915,'Gross Morphology Embryo E9.5',' ',0),(41916,'Gross Morphology Embryo E9.5',' ',0),(41917,'Gross Morphology Embryo E9.5',' ',0),(41918,'Gross Morphology Embryo E9.5',' ',0),(41919,'Gross Morphology Embryo E9.5',' ',0),(41920,'Gross Morphology Embryo E9.5',' ',0),(41921,'Gross Morphology Embryo E9.5',' ',0),(41922,'Gross Morphology Embryo E9.5',' ',0),(41923,'Gross Morphology Embryo E9.5',' ',0),(41924,'Gross Morphology Embryo E9.5',' ',0),(41925,'Gross Morphology Embryo E9.5',' ',0),(41926,'Gross Morphology Embryo E9.5',' ',0),(41927,'Gross Morphology Embryo E9.5',' ',0),(41928,'Gross Morphology Embryo E9.5',' ',0),(41929,'Gross Morphology Embryo E9.5',' ',0),(41930,'Gross Morphology Embryo E9.5',' ',0),(41931,'Gross Morphology Embryo E9.5',' ',0),(41932,'Gross Morphology Embryo E9.5',' ',0),(41933,'Gross Morphology Embryo E9.5',' ',0),(41934,'Gross Morphology Embryo E9.5',' ',0),(41935,'Gross Morphology Embryo E9.5',' ',0),(41936,'Gross Morphology Embryo E9.5',' ',0),(41937,'Gross Morphology Embryo E9.5',' ',0),(41938,'Gross Morphology Embryo E9.5',' ',0),(41939,'Gross Morphology Embryo E9.5',' ',0),(41940,'Gross Morphology Embryo E9.5',' ',0),(41941,'Gross Morphology Embryo E9.5',' ',0),(41942,'Gross Morphology Embryo E9.5',' ',0),(41943,'Gross Morphology Embryo E9.5',' ',0),(41944,'Gross Morphology Embryo E9.5',' ',0),(41945,'Gross Morphology Embryo E9.5',' ',0),(41946,'Gross Morphology Embryo E9.5',' ',0),(41947,'Gross Morphology Embryo E9.5',' ',0),(41948,'Gross Morphology Embryo E9.5',' ',0),(41949,'Gross Morphology Embryo E9.5',' ',0),(41950,'Gross Morphology Embryo E9.5',' ',0),(41951,'Gross Morphology Embryo E9.5',' ',0),(41952,'Gross Morphology Embryo E9.5',' ',0),(41953,'Gross Morphology Embryo E9.5',' ',0),(41954,'Gross Morphology Embryo E9.5',' ',0),(41955,'Gross Morphology Embryo E9.5',' ',0),(41956,'Gross Morphology Embryo E9.5',' ',0),(41957,'Gross Morphology Embryo E9.5',' ',0),(41958,'Gross Morphology Embryo E9.5',' ',0),(41959,'Gross Morphology Embryo E9.5',' ',0),(41960,'Gross Morphology Embryo E9.5',' ',0),(41961,'Gross Morphology Embryo E9.5',' ',0),(42223,'Gross Morphology Embryo E9.5',' ',0),(42224,'Gross Morphology Embryo E9.5',' ',0),(42225,'Gross Morphology Embryo E9.5',' ',0),(42226,'Gross Morphology Embryo E9.5',' ',0),(42227,'Gross Morphology Embryo E9.5',' ',0),(42228,'Gross Morphology Embryo E9.5',' ',0),(42229,'Gross Morphology Embryo E9.5',' ',0),(42230,'Gross Morphology Embryo E9.5',' ',0),(42231,'Gross Morphology Embryo E9.5',' ',0),(42232,'Gross Morphology Embryo E9.5',' ',0),(42233,'Gross Morphology Embryo E9.5',' ',0),(42234,'Gross Morphology Embryo E9.5',' ',0),(42235,'Gross Morphology Embryo E9.5',' ',0),(42236,'Gross Morphology Embryo E9.5',' ',0),(42237,'Gross Morphology Embryo E9.5',' ',0),(42238,'Gross Morphology Embryo E9.5',' ',0),(42239,'Gross Morphology Embryo E9.5',' ',0),(42240,'Gross Morphology Embryo E9.5',' ',0),(42241,'Gross Morphology Embryo E9.5',' ',0),(42242,'Gross Morphology Embryo E9.5',' ',0),(42243,'Gross Morphology Embryo E9.5',' ',0),(42244,'Gross Morphology Embryo E9.5',' ',0),(42245,'Gross Morphology Embryo E9.5',' ',0),(42246,'Gross Morphology Embryo E9.5',' ',0),(42247,'Gross Morphology Embryo E9.5',' ',0),(42248,'Gross Morphology Embryo E9.5',' ',0),(42249,'Gross Morphology Embryo E9.5',' ',0),(42250,'Gross Morphology Embryo E9.5',' ',0),(42251,'Gross Morphology Embryo E9.5',' ',0),(42252,'Gross Morphology Embryo E9.5',' ',0),(42253,'Gross Morphology Embryo E9.5',' ',0),(42254,'Gross Morphology Embryo E9.5',' ',0),(42255,'Gross Morphology Embryo E9.5',' ',0),(42256,'Gross Morphology Embryo E9.5',' ',0),(42257,'Gross Morphology Embryo E9.5',' ',0),(42258,'Gross Morphology Embryo E9.5',' ',0),(42259,'Gross Morphology Embryo E9.5',' ',0),(42260,'Gross Morphology Embryo E9.5',' ',0),(42261,'Gross Morphology Embryo E9.5',' ',0),(42262,'Gross Morphology Embryo E9.5',' ',0),(42263,'Gross Morphology Embryo E9.5',' ',0),(42264,'Gross Morphology Embryo E9.5',' ',0),(42265,'Gross Morphology Embryo E9.5',' ',0),(42266,'Gross Morphology Embryo E9.5',' ',0),(42267,'Gross Morphology Embryo E9.5',' ',0),(42268,'Gross Morphology Embryo E9.5',' ',0),(42269,'Gross Morphology Embryo E9.5',' ',0),(42270,'Gross Morphology Embryo E9.5',' ',0),(42271,'Gross Morphology Embryo E9.5',' ',0),(42272,'Gross Morphology Embryo E9.5',' ',0),(42273,'Gross Morphology Embryo E9.5',' ',0),(42274,'Gross Morphology Embryo E9.5',' ',0),(42275,'Gross Morphology Embryo E9.5',' ',0),(42276,'Gross Morphology Embryo E9.5',' ',0),(42277,'Gross Morphology Embryo E9.5',' ',0),(42538,'Gross Morphology Embryo E9.5',' ',0),(42539,'Gross Morphology Embryo E9.5',' ',0),(42540,'Gross Morphology Embryo E9.5',' ',0),(42541,'Gross Morphology Embryo E9.5',' ',0),(42542,'Gross Morphology Embryo E9.5',' ',0),(42543,'Gross Morphology Embryo E9.5',' ',0),(42544,'Gross Morphology Embryo E9.5',' ',0),(42545,'Gross Morphology Embryo E9.5',' ',0),(42546,'Gross Morphology Embryo E9.5',' ',0),(42547,'Gross Morphology Embryo E9.5',' ',0),(42548,'Gross Morphology Embryo E9.5',' ',0),(42549,'Gross Morphology Embryo E9.5',' ',0),(42550,'Gross Morphology Embryo E9.5',' ',0),(42551,'Gross Morphology Embryo E9.5',' ',0),(42552,'Gross Morphology Embryo E9.5',' ',0),(42553,'Gross Morphology Embryo E9.5',' ',0),(42554,'Gross Morphology Embryo E9.5',' ',0),(42555,'Gross Morphology Embryo E9.5',' ',0),(42556,'Gross Morphology Embryo E9.5',' ',0),(42557,'Gross Morphology Embryo E9.5',' ',0),(42558,'Gross Morphology Embryo E9.5',' ',0),(42559,'Gross Morphology Embryo E9.5',' ',0),(42560,'Gross Morphology Embryo E9.5',' ',0),(42561,'Gross Morphology Embryo E9.5',' ',0),(42562,'Gross Morphology Embryo E9.5',' ',0),(42563,'Gross Morphology Embryo E9.5',' ',0),(42564,'Gross Morphology Embryo E9.5',' ',0),(42565,'Gross Morphology Embryo E9.5',' ',0),(42566,'Gross Morphology Embryo E9.5',' ',0),(42567,'Gross Morphology Embryo E9.5',' ',0),(42568,'Gross Morphology Embryo E9.5',' ',0),(42569,'Gross Morphology Embryo E9.5',' ',0),(42570,'Gross Morphology Embryo E9.5',' ',0),(42571,'Gross Morphology Embryo E9.5',' ',0),(42572,'Gross Morphology Embryo E9.5',' ',0),(42573,'Gross Morphology Embryo E9.5',' ',0),(42574,'Gross Morphology Embryo E9.5',' ',0),(42575,'Gross Morphology Embryo E9.5',' ',0),(42576,'Gross Morphology Embryo E9.5',' ',0),(42577,'Gross Morphology Embryo E9.5',' ',0),(42578,'Gross Morphology Embryo E9.5',' ',0),(42579,'Gross Morphology Embryo E9.5',' ',0),(42916,'Gross Morphology Embryo E12.5',' ',0),(42917,'Gross Morphology Embryo E12.5',' ',0),(42918,'Gross Morphology Embryo E12.5',' ',0),(42919,'Gross Morphology Embryo E12.5',' ',0),(42920,'Gross Morphology Embryo E12.5',' ',0),(42921,'Gross Morphology Embryo E12.5',' ',0),(42922,'Gross Morphology Embryo E12.5',' ',0),(42923,'Gross Morphology Embryo E12.5',' ',0),(42924,'Gross Morphology Embryo E12.5',' ',0),(42925,'Gross Morphology Embryo E12.5',' ',0),(42926,'Gross Morphology Embryo E12.5',' ',0),(42927,'Gross Morphology Embryo E12.5',' ',0),(42928,'Gross Morphology Embryo E12.5',' ',0),(42929,'Gross Morphology Embryo E12.5',' ',0),(42930,'Gross Morphology Embryo E12.5',' ',0),(42931,'Gross Morphology Embryo E12.5',' ',0),(42932,'Gross Morphology Embryo E12.5',' ',0),(42933,'Gross Morphology Embryo E12.5',' ',0),(42934,'Gross Morphology Embryo E12.5',' ',0),(42935,'Gross Morphology Embryo E12.5',' ',0),(42936,'Gross Morphology Embryo E12.5',' ',0),(42937,'Gross Morphology Embryo E12.5',' ',0),(42938,'Gross Morphology Embryo E12.5',' ',0),(42939,'Gross Morphology Embryo E12.5',' ',0),(42940,'Gross Morphology Embryo E12.5',' ',0),(42941,'Gross Morphology Embryo E12.5',' ',0),(42942,'Gross Morphology Embryo E12.5',' ',0),(42943,'Gross Morphology Embryo E12.5',' ',0),(42944,'Gross Morphology Embryo E12.5',' ',0),(42945,'Gross Morphology Embryo E12.5',' ',0),(42946,'Gross Morphology Embryo E12.5',' ',0),(42947,'Gross Morphology Embryo E12.5',' ',0),(42948,'Gross Morphology Embryo E12.5',' ',0),(42949,'Gross Morphology Embryo E12.5',' ',0),(42950,'Gross Morphology Embryo E12.5',' ',0),(42951,'Gross Morphology Embryo E12.5',' ',0),(42952,'Gross Morphology Embryo E12.5',' ',0),(42953,'Gross Morphology Embryo E12.5',' ',0),(42954,'Gross Morphology Embryo E12.5',' ',0),(42955,'Gross Morphology Embryo E12.5',' ',0),(42956,'Gross Morphology Embryo E12.5',' ',0),(42957,'Gross Morphology Embryo E12.5',' ',0),(42958,'Gross Morphology Embryo E12.5',' ',0),(42959,'Gross Morphology Embryo E12.5',' ',0),(42960,'Gross Morphology Embryo E12.5',' ',0),(42961,'Gross Morphology Embryo E12.5',' ',0),(42962,'Gross Morphology Embryo E12.5',' ',0),(42963,'Gross Morphology Embryo E12.5',' ',0),(42964,'Gross Morphology Embryo E12.5',' ',0),(42965,'Gross Morphology Embryo E12.5',' ',0),(42966,'Gross Morphology Embryo E12.5',' ',0),(42967,'Gross Morphology Embryo E12.5',' ',0),(42968,'Gross Morphology Embryo E12.5',' ',0),(42969,'Gross Morphology Embryo E12.5',' ',0),(42970,'Gross Morphology Embryo E12.5',' ',0),(42971,'Gross Morphology Embryo E12.5',' ',0),(42972,'Gross Morphology Embryo E12.5',' ',0),(42973,'Gross Morphology Embryo E12.5',' ',0),(42974,'Gross Morphology Embryo E12.5',' ',0),(43231,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43232,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43233,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43234,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43235,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43236,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43237,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43238,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43239,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43240,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43241,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43242,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43243,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43244,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43245,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43246,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43247,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43248,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43249,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43250,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43251,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43252,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43253,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43254,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43255,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43256,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43257,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43258,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43259,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43260,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43261,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43262,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43263,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43264,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43265,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43266,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43267,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43268,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43269,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43270,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43271,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43272,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43273,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43274,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43275,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43276,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43277,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43278,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43279,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43280,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43281,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43282,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43283,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43284,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43285,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43286,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43287,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43288,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43289,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43290,'Gross Morphology Embryo E14.5-E15.5',' ',0),(43546,'Gross Morphology Embryo E18.5',' ',0),(43547,'Gross Morphology Embryo E18.5',' ',0),(43548,'Gross Morphology Embryo E18.5',' ',0),(43549,'Gross Morphology Embryo E18.5',' ',0),(43550,'Gross Morphology Embryo E18.5',' ',0),(43551,'Gross Morphology Embryo E18.5',' ',0),(43552,'Gross Morphology Embryo E18.5',' ',0),(43553,'Gross Morphology Embryo E18.5',' ',0),(43554,'Gross Morphology Embryo E18.5',' ',0),(43555,'Gross Morphology Embryo E18.5',' ',0),(43556,'Gross Morphology Embryo E18.5',' ',0),(43557,'Gross Morphology Embryo E18.5',' ',0),(43558,'Gross Morphology Embryo E18.5',' ',0),(43559,'Gross Morphology Embryo E18.5',' ',0),(43560,'Gross Morphology Embryo E18.5',' ',0),(43561,'Gross Morphology Embryo E18.5',' ',0),(43562,'Gross Morphology Embryo E18.5',' ',0),(43563,'Gross Morphology Embryo E18.5',' ',0),(43564,'Gross Morphology Embryo E18.5',' ',0),(43565,'Gross Morphology Embryo E18.5',' ',0),(43566,'Gross Morphology Embryo E18.5',' ',0),(43567,'Gross Morphology Embryo E18.5',' ',0),(43568,'Gross Morphology Embryo E18.5',' ',0),(43569,'Gross Morphology Embryo E18.5',' ',0),(43570,'Gross Morphology Embryo E18.5',' ',0),(43571,'Gross Morphology Embryo E18.5',' ',0),(43572,'Gross Morphology Embryo E18.5',' ',0),(43573,'Gross Morphology Embryo E18.5',' ',0),(43574,'Gross Morphology Embryo E18.5',' ',0),(43575,'Gross Morphology Embryo E18.5',' ',0),(43576,'Gross Morphology Embryo E18.5',' ',0),(43577,'Gross Morphology Embryo E18.5',' ',0),(43578,'Gross Morphology Embryo E18.5',' ',0),(43579,'Gross Morphology Embryo E18.5',' ',0),(43580,'Gross Morphology Embryo E18.5',' ',0),(43581,'Gross Morphology Embryo E18.5',' ',0),(43582,'Gross Morphology Embryo E18.5',' ',0),(43583,'Gross Morphology Embryo E18.5',' ',0),(43584,'Gross Morphology Embryo E18.5',' ',0),(43585,'Gross Morphology Embryo E18.5',' ',0),(43586,'Gross Morphology Embryo E18.5',' ',0),(43587,'Gross Morphology Embryo E18.5',' ',0),(43588,'Gross Morphology Embryo E18.5',' ',0),(43589,'Gross Morphology Embryo E18.5',' ',0),(43590,'Gross Morphology Embryo E18.5',' ',0),(43591,'Gross Morphology Embryo E18.5',' ',0),(43592,'Gross Morphology Embryo E18.5',' ',0),(43593,'Gross Morphology Embryo E18.5',' ',0),(43594,'Gross Morphology Embryo E18.5',' ',0),(43595,'Gross Morphology Embryo E18.5',' ',0),(43596,'Gross Morphology Embryo E18.5',' ',0),(43597,'Gross Morphology Embryo E18.5',' ',0),(43598,'Gross Morphology Embryo E18.5',' ',0),(43599,'Gross Morphology Embryo E18.5',' ',0),(43600,'Gross Morphology Embryo E18.5',' ',0),(43601,'Gross Morphology Embryo E18.5',' ',0),(43602,'Gross Morphology Embryo E18.5',' ',0),(43603,'Gross Morphology Embryo E18.5',' ',0),(43604,'Gross Morphology Embryo E18.5',' ',0),(43605,'Gross Morphology Embryo E18.5',' ',0),(43606,'Gross Morphology Embryo E18.5',' ',0),(43607,'Gross Morphology Embryo E18.5',' ',0),(43608,'Gross Morphology Embryo E18.5',' ',0),(43609,'Gross Morphology Embryo E18.5',' ',0),(43610,'Gross Morphology Embryo E18.5',' ',0),(43611,'Gross Morphology Embryo E18.5',' ',0),(43612,'Gross Morphology Embryo E18.5',' ',0),(43613,'Gross Morphology Embryo E18.5',' ',0),(43614,'Gross Morphology Embryo E18.5',' ',0),(43615,'Gross Morphology Embryo E18.5',' ',0),(43616,'Gross Morphology Embryo E18.5',' ',0),(43617,'Gross Morphology Embryo E18.5',' ',0),(43618,'Gross Morphology Embryo E18.5',' ',0),(43619,'Gross Morphology Embryo E18.5',' ',0),(44181,'Gross Morphology Embryo E12.5',' ',0),(44182,'Gross Morphology Embryo E12.5',' ',0),(44183,'Gross Morphology Embryo E12.5',' ',0),(44184,'Gross Morphology Embryo E12.5',' ',0),(44185,'Gross Morphology Embryo E12.5',' ',0),(44186,'Gross Morphology Embryo E12.5',' ',0),(44187,'Gross Morphology Embryo E12.5',' ',0),(44188,'Gross Morphology Embryo E12.5',' ',0),(44189,'Gross Morphology Embryo E12.5',' ',0),(44190,'Gross Morphology Embryo E12.5',' ',0),(44191,'Gross Morphology Embryo E12.5',' ',0),(44192,'Gross Morphology Embryo E12.5',' ',0),(44193,'Gross Morphology Embryo E12.5',' ',0),(44194,'Gross Morphology Embryo E12.5',' ',0),(44195,'Gross Morphology Embryo E12.5',' ',0),(44196,'Gross Morphology Embryo E12.5',' ',0),(44197,'Gross Morphology Embryo E12.5',' ',0),(44198,'Gross Morphology Embryo E12.5',' ',0),(44199,'Gross Morphology Embryo E12.5',' ',0),(44200,'Gross Morphology Embryo E12.5',' ',0),(44201,'Gross Morphology Embryo E12.5',' ',0),(44202,'Gross Morphology Embryo E12.5',' ',0),(44203,'Gross Morphology Embryo E12.5',' ',0),(44204,'Gross Morphology Embryo E12.5',' ',0),(44205,'Gross Morphology Embryo E12.5',' ',0),(44206,'Gross Morphology Embryo E12.5',' ',0),(44207,'Gross Morphology Embryo E12.5',' ',0),(44208,'Gross Morphology Embryo E12.5',' ',0),(44209,'Gross Morphology Embryo E12.5',' ',0),(44210,'Gross Morphology Embryo E12.5',' ',0),(44211,'Gross Morphology Embryo E12.5',' ',0),(44212,'Gross Morphology Embryo E12.5',' ',0),(44213,'Gross Morphology Embryo E12.5',' ',0),(44214,'Gross Morphology Embryo E12.5',' ',0),(44215,'Gross Morphology Embryo E12.5',' ',0),(44216,'Gross Morphology Embryo E12.5',' ',0),(44217,'Gross Morphology Embryo E12.5',' ',0),(44218,'Gross Morphology Embryo E12.5',' ',0),(44219,'Gross Morphology Embryo E12.5',' ',0),(44220,'Gross Morphology Embryo E12.5',' ',0),(44221,'Gross Morphology Embryo E12.5',' ',0),(44222,'Gross Morphology Embryo E12.5',' ',0),(44223,'Gross Morphology Embryo E12.5',' ',0),(44224,'Gross Morphology Embryo E12.5',' ',0),(44225,'Gross Morphology Embryo E12.5',' ',0),(44226,'Gross Morphology Embryo E12.5',' ',0),(44227,'Gross Morphology Embryo E12.5',' ',0),(44228,'Gross Morphology Embryo E12.5',' ',0),(44229,'Gross Morphology Embryo E12.5',' ',0),(44230,'Gross Morphology Embryo E12.5',' ',0),(44231,'Gross Morphology Embryo E12.5',' ',0),(44232,'Gross Morphology Embryo E12.5',' ',0),(44233,'Gross Morphology Embryo E12.5',' ',0),(44234,'Gross Morphology Embryo E12.5',' ',0),(44235,'Gross Morphology Embryo E12.5',' ',0),(44236,'Gross Morphology Embryo E12.5',' ',0),(44237,'Gross Morphology Embryo E12.5',' ',0),(44238,'Gross Morphology Embryo E12.5',' ',0),(44239,'Gross Morphology Embryo E12.5',' ',0),(44240,'Gross Morphology Embryo E12.5',' ',0),(44496,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44497,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44498,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44499,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44500,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44501,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44502,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44503,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44504,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44505,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44506,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44507,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44508,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44509,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44510,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44511,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44512,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44513,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44514,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44515,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44516,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44517,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44518,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44519,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44520,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44521,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44522,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44523,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44524,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44525,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44526,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44527,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44528,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44529,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44530,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44531,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44532,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44533,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44534,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44535,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44536,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44537,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44538,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44539,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44540,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44541,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44542,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44543,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44544,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44545,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44546,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44547,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44548,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44549,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44550,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44551,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44552,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44553,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44554,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44555,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44556,'Gross Morphology Embryo E14.5-E15.5',' ',0),(44811,'Gross Morphology Embryo E18.5',' ',0),(44812,'Gross Morphology Embryo E18.5',' ',0),(44813,'Gross Morphology Embryo E18.5',' ',0),(44814,'Gross Morphology Embryo E18.5',' ',0),(44815,'Gross Morphology Embryo E18.5',' ',0),(44816,'Gross Morphology Embryo E18.5',' ',0),(44817,'Gross Morphology Embryo E18.5',' ',0),(44818,'Gross Morphology Embryo E18.5',' ',0),(44819,'Gross Morphology Embryo E18.5',' ',0),(44820,'Gross Morphology Embryo E18.5',' ',0),(44821,'Gross Morphology Embryo E18.5',' ',0),(44822,'Gross Morphology Embryo E18.5',' ',0),(44823,'Gross Morphology Embryo E18.5',' ',0),(44824,'Gross Morphology Embryo E18.5',' ',0),(44825,'Gross Morphology Embryo E18.5',' ',0),(44826,'Gross Morphology Embryo E18.5',' ',0),(44827,'Gross Morphology Embryo E18.5',' ',0),(44828,'Gross Morphology Embryo E18.5',' ',0),(44829,'Gross Morphology Embryo E18.5',' ',0),(44830,'Gross Morphology Embryo E18.5',' ',0),(44831,'Gross Morphology Embryo E18.5',' ',0),(44832,'Gross Morphology Embryo E18.5',' ',0),(44833,'Gross Morphology Embryo E18.5',' ',0),(44834,'Gross Morphology Embryo E18.5',' ',0),(44835,'Gross Morphology Embryo E18.5',' ',0),(44836,'Gross Morphology Embryo E18.5',' ',0),(44837,'Gross Morphology Embryo E18.5',' ',0),(44838,'Gross Morphology Embryo E18.5',' ',0),(44839,'Gross Morphology Embryo E18.5',' ',0),(44840,'Gross Morphology Embryo E18.5',' ',0),(44841,'Gross Morphology Embryo E18.5',' ',0),(44842,'Gross Morphology Embryo E18.5',' ',0),(44843,'Gross Morphology Embryo E18.5',' ',0),(44844,'Gross Morphology Embryo E18.5',' ',0),(44845,'Gross Morphology Embryo E18.5',' ',0),(44846,'Gross Morphology Embryo E18.5',' ',0),(44847,'Gross Morphology Embryo E18.5',' ',0),(44848,'Gross Morphology Embryo E18.5',' ',0),(44849,'Gross Morphology Embryo E18.5',' ',0),(44850,'Gross Morphology Embryo E18.5',' ',0),(44851,'Gross Morphology Embryo E18.5',' ',0),(44852,'Gross Morphology Embryo E18.5',' ',0),(44853,'Gross Morphology Embryo E18.5',' ',0),(44854,'Gross Morphology Embryo E18.5',' ',0),(44855,'Gross Morphology Embryo E18.5',' ',0),(44856,'Gross Morphology Embryo E18.5',' ',0),(44857,'Gross Morphology Embryo E18.5',' ',0),(44858,'Gross Morphology Embryo E18.5',' ',0),(44859,'Gross Morphology Embryo E18.5',' ',0),(44860,'Gross Morphology Embryo E18.5',' ',0),(44861,'Gross Morphology Embryo E18.5',' ',0),(44862,'Gross Morphology Embryo E18.5',' ',0),(44863,'Gross Morphology Embryo E18.5',' ',0),(44864,'Gross Morphology Embryo E18.5',' ',0),(44865,'Gross Morphology Embryo E18.5',' ',0),(44866,'Gross Morphology Embryo E18.5',' ',0),(44867,'Gross Morphology Embryo E18.5',' ',0),(44868,'Gross Morphology Embryo E18.5',' ',0),(44869,'Gross Morphology Embryo E18.5',' ',0),(44870,'Gross Morphology Embryo E18.5',' ',0),(44871,'Gross Morphology Embryo E18.5',' ',0),(44872,'Gross Morphology Embryo E18.5',' ',0),(44873,'Gross Morphology Embryo E18.5',' ',0),(44874,'Gross Morphology Embryo E18.5',' ',0),(44875,'Gross Morphology Embryo E18.5',' ',0),(44876,'Gross Morphology Embryo E18.5',' ',0),(44877,'Gross Morphology Embryo E18.5',' ',0),(44878,'Gross Morphology Embryo E18.5',' ',0),(44879,'Gross Morphology Embryo E18.5',' ',0),(44880,'Gross Morphology Embryo E18.5',' ',0),(44881,'Gross Morphology Embryo E18.5',' ',0),(44882,'Gross Morphology Embryo E18.5',' ',0),(44883,'Gross Morphology Embryo E18.5',' ',0),(44884,'Gross Morphology Embryo E18.5',' ',0),(44885,'Gross Morphology Embryo E18.5',' ',0),(45446,'Gross Morphology Embryo E12.5',' ',0),(45447,'Gross Morphology Embryo E12.5',' ',0),(45448,'Gross Morphology Embryo E12.5',' ',0),(45449,'Gross Morphology Embryo E12.5',' ',0),(45450,'Gross Morphology Embryo E12.5',' ',0),(45451,'Gross Morphology Embryo E12.5',' ',0),(45452,'Gross Morphology Embryo E12.5',' ',0),(45453,'Gross Morphology Embryo E12.5',' ',0),(45454,'Gross Morphology Embryo E12.5',' ',0),(45455,'Gross Morphology Embryo E12.5',' ',0),(45456,'Gross Morphology Embryo E12.5',' ',0),(45457,'Gross Morphology Embryo E12.5',' ',0),(45458,'Gross Morphology Embryo E12.5',' ',0),(45459,'Gross Morphology Embryo E12.5',' ',0),(45460,'Gross Morphology Embryo E12.5',' ',0),(45461,'Gross Morphology Embryo E12.5',' ',0),(45462,'Gross Morphology Embryo E12.5',' ',0),(45463,'Gross Morphology Embryo E12.5',' ',0),(45464,'Gross Morphology Embryo E12.5',' ',0),(45465,'Gross Morphology Embryo E12.5',' ',0),(45466,'Gross Morphology Embryo E12.5',' ',0),(45467,'Gross Morphology Embryo E12.5',' ',0),(45468,'Gross Morphology Embryo E12.5',' ',0),(45469,'Gross Morphology Embryo E12.5',' ',0),(45470,'Gross Morphology Embryo E12.5',' ',0),(45471,'Gross Morphology Embryo E12.5',' ',0),(45472,'Gross Morphology Embryo E12.5',' ',0),(45473,'Gross Morphology Embryo E12.5',' ',0),(45474,'Gross Morphology Embryo E12.5',' ',0),(45475,'Gross Morphology Embryo E12.5',' ',0),(45476,'Gross Morphology Embryo E12.5',' ',0),(45477,'Gross Morphology Embryo E12.5',' ',0),(45478,'Gross Morphology Embryo E12.5',' ',0),(45479,'Gross Morphology Embryo E12.5',' ',0),(45480,'Gross Morphology Embryo E12.5',' ',0),(45481,'Gross Morphology Embryo E12.5',' ',0),(45482,'Gross Morphology Embryo E12.5',' ',0),(45483,'Gross Morphology Embryo E12.5',' ',0),(45484,'Gross Morphology Embryo E12.5',' ',0),(45485,'Gross Morphology Embryo E12.5',' ',0),(45486,'Gross Morphology Embryo E12.5',' ',0),(45487,'Gross Morphology Embryo E12.5',' ',0),(45488,'Gross Morphology Embryo E12.5',' ',0),(45489,'Gross Morphology Embryo E12.5',' ',0),(45490,'Gross Morphology Embryo E12.5',' ',0),(45491,'Gross Morphology Embryo E12.5',' ',0),(45492,'Gross Morphology Embryo E12.5',' ',0),(45493,'Gross Morphology Embryo E12.5',' ',0),(45494,'Gross Morphology Embryo E12.5',' ',0),(45824,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45825,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45826,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45827,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45828,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45829,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45830,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45831,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45832,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45833,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45834,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45835,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45836,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45837,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45838,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45839,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45840,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45841,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45842,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45843,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45844,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45845,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45846,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45847,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45848,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45849,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45850,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45851,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45852,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45853,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45854,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45855,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45856,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45857,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45858,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45859,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45860,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45861,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45862,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45863,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45864,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45865,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45866,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45867,'Gross Morphology Embryo E14.5-E15.5',' ',0),(45868,'Gross Morphology Embryo E14.5-E15.5',' ',0),(46202,'Gross Morphology Embryo E18.5',' ',0),(46203,'Gross Morphology Embryo E18.5',' ',0),(46204,'Gross Morphology Embryo E18.5',' ',0),(46205,'Gross Morphology Embryo E18.5',' ',0),(46206,'Gross Morphology Embryo E18.5',' ',0),(46207,'Gross Morphology Embryo E18.5',' ',0),(46208,'Gross Morphology Embryo E18.5',' ',0),(46209,'Gross Morphology Embryo E18.5',' ',0),(46210,'Gross Morphology Embryo E18.5',' ',0),(46211,'Gross Morphology Embryo E18.5',' ',0),(46212,'Gross Morphology Embryo E18.5',' ',0),(46213,'Gross Morphology Embryo E18.5',' ',0),(46214,'Gross Morphology Embryo E18.5',' ',0),(46215,'Gross Morphology Embryo E18.5',' ',0),(46216,'Gross Morphology Embryo E18.5',' ',0),(46217,'Gross Morphology Embryo E18.5',' ',0),(46218,'Gross Morphology Embryo E18.5',' ',0),(46219,'Gross Morphology Embryo E18.5',' ',0),(46220,'Gross Morphology Embryo E18.5',' ',0),(46221,'Gross Morphology Embryo E18.5',' ',0),(46222,'Gross Morphology Embryo E18.5',' ',0),(46223,'Gross Morphology Embryo E18.5',' ',0),(46224,'Gross Morphology Embryo E18.5',' ',0),(46225,'Gross Morphology Embryo E18.5',' ',0),(46226,'Gross Morphology Embryo E18.5',' ',0),(46227,'Gross Morphology Embryo E18.5',' ',0),(46228,'Gross Morphology Embryo E18.5',' ',0),(46229,'Gross Morphology Embryo E18.5',' ',0),(46230,'Gross Morphology Embryo E18.5',' ',0),(46231,'Gross Morphology Embryo E18.5',' ',0),(46232,'Gross Morphology Embryo E18.5',' ',0),(46233,'Gross Morphology Embryo E18.5',' ',0),(46234,'Gross Morphology Embryo E18.5',' ',0),(46235,'Gross Morphology Embryo E18.5',' ',0),(46236,'Gross Morphology Embryo E18.5',' ',0),(46237,'Gross Morphology Embryo E18.5',' ',0),(46238,'Gross Morphology Embryo E18.5',' ',0),(46239,'Gross Morphology Embryo E18.5',' ',0),(46240,'Gross Morphology Embryo E18.5',' ',0),(46241,'Gross Morphology Embryo E18.5',' ',0),(46242,'Gross Morphology Embryo E18.5',' ',0),(46243,'Gross Morphology Embryo E18.5',' ',0),(46244,'Gross Morphology Embryo E18.5',' ',0),(46245,'Gross Morphology Embryo E18.5',' ',0),(46246,'Gross Morphology Embryo E18.5',' ',0),(46247,'Gross Morphology Embryo E18.5',' ',0),(46248,'Gross Morphology Embryo E18.5',' ',0),(46249,'Gross Morphology Embryo E18.5',' ',0),(46250,'Gross Morphology Embryo E18.5',' ',0),(46251,'Gross Morphology Embryo E18.5',' ',0),(46252,'Gross Morphology Embryo E18.5',' ',0),(46253,'Gross Morphology Embryo E18.5',' ',0),(46254,'Gross Morphology Embryo E18.5',' ',0),(46580,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46581,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46582,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46583,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46584,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46585,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46586,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46587,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46588,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46589,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46590,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46591,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46592,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46593,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46594,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46595,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46596,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46597,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46598,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46599,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46600,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46601,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46602,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46603,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46604,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46605,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46606,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46607,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46608,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46609,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46610,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46611,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46612,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46613,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46614,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46615,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46616,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46617,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46618,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46619,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46620,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46621,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46622,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46623,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46624,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46625,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46626,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46627,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46628,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46629,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46630,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46631,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46632,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46633,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46634,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46635,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46636,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46637,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46638,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46639,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46640,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46641,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46642,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46643,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46644,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46645,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46646,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46647,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46648,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46649,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46650,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46651,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46652,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46653,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46654,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46655,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46656,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46657,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46658,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46659,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46660,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46661,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46662,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46663,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46664,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46665,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46666,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46667,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(46668,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(47596,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47597,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47598,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47599,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47600,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47601,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47602,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47603,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47604,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47605,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47606,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47607,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47608,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47609,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47610,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47611,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47612,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47613,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47614,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47615,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47616,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47617,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47618,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47619,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47620,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47621,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(47813,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47814,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47815,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47816,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47817,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47819,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47820,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47821,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47822,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47824,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47825,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47826,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47827,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47828,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47829,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47830,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47831,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47832,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(47968,'Histopathology',' ',0),(47969,'Histopathology',' ',0),(47970,'Histopathology',' ',0),(47971,'Histopathology',' ',0),(47972,'Histopathology',' ',0),(47973,'Histopathology',' ',0),(47974,'Histopathology',' ',0),(47975,'Histopathology',' ',0),(47976,'Histopathology',' ',0),(47977,'Histopathology',' ',0),(47978,'Histopathology',' ',0),(47979,'Histopathology',' ',0),(47980,'Histopathology',' ',0),(47981,'Histopathology',' ',0),(47982,'Histopathology',' ',0),(47983,'Histopathology',' ',0),(47984,'Histopathology',' ',0),(47985,'Histopathology',' ',0),(47986,'Histopathology',' ',0),(47987,'Histopathology',' ',0),(47988,'Histopathology',' ',0),(47989,'Histopathology',' ',0),(47990,'Histopathology',' ',0),(47991,'Histopathology',' ',0),(47992,'Histopathology',' ',0),(47993,'Histopathology',' ',0),(47994,'Histopathology',' ',0),(47995,'Histopathology',' ',0),(47996,'Histopathology',' ',0),(47997,'Histopathology',' ',0),(47998,'Histopathology',' ',0),(47999,'Histopathology',' ',0),(48000,'Histopathology',' ',0),(48001,'Histopathology',' ',0),(48002,'Histopathology',' ',0),(48003,'Histopathology',' ',0),(48004,'Histopathology',' ',0),(48005,'Histopathology',' ',0),(48006,'Histopathology',' ',0),(48007,'Histopathology',' ',0),(48008,'Histopathology',' ',0),(48009,'Histopathology',' ',0),(48010,'Histopathology',' ',0),(48011,'Histopathology',' ',0),(48012,'Histopathology',' ',0),(48013,'Histopathology',' ',0),(48014,'Histopathology',' ',0),(48015,'Histopathology',' ',0),(48016,'Histopathology',' ',0),(48017,'Histopathology',' ',0),(48018,'Histopathology',' ',0),(48019,'Histopathology',' ',0),(48020,'Histopathology',' ',0),(48021,'Histopathology',' ',0),(48022,'Histopathology',' ',0),(48023,'Histopathology',' ',0),(48024,'Histopathology',' ',0),(48025,'Histopathology',' ',0),(48026,'Histopathology',' ',0),(48027,'Histopathology',' ',0),(48028,'Histopathology',' ',0),(48029,'Histopathology',' ',0),(48030,'Histopathology',' ',0),(48031,'Histopathology',' ',0),(48032,'Histopathology',' ',0),(48033,'Histopathology',' ',0),(48034,'Histopathology',' ',0),(48035,'Histopathology',' ',0),(48036,'Histopathology',' ',0),(48037,'Histopathology',' ',0),(48038,'Histopathology',' ',0),(48039,'Histopathology',' ',0),(48040,'Histopathology',' ',0),(48041,'Histopathology',' ',0),(48042,'Histopathology',' ',0),(48043,'Histopathology',' ',0),(48044,'Histopathology',' ',0),(48045,'Histopathology',' ',0),(48046,'Histopathology',' ',0),(48047,'Histopathology',' ',0),(48048,'Histopathology',' ',0),(48049,'Histopathology',' ',0),(48050,'Histopathology',' ',0),(48051,'Histopathology',' ',0),(48052,'Histopathology',' ',0),(48053,'Histopathology',' ',0),(48054,'Histopathology',' ',0),(48055,'Histopathology',' ',0),(48056,'Histopathology',' ',0),(48057,'Histopathology',' ',0),(48058,'Histopathology',' ',0),(48059,'Histopathology',' ',0),(48060,'Histopathology',' ',0),(48061,'Histopathology',' ',0),(48062,'Histopathology',' ',0),(48063,'Histopathology',' ',0),(48064,'Histopathology',' ',0),(48065,'Histopathology',' ',0),(48066,'Histopathology',' ',0),(48067,'Histopathology',' ',0),(48068,'Histopathology',' ',0),(48069,'Histopathology',' ',0),(48070,'Histopathology',' ',0),(48071,'Histopathology',' ',0),(48072,'Histopathology',' ',0),(48073,'Histopathology',' ',0),(48074,'Histopathology',' ',0),(48075,'Histopathology',' ',0),(48076,'Histopathology',' ',0),(48077,'Histopathology',' ',0),(48078,'Histopathology',' ',0),(48079,'Histopathology',' ',0),(48080,'Histopathology',' ',0),(48081,'Histopathology',' ',0),(48082,'Histopathology',' ',0),(48083,'Histopathology',' ',0),(48084,'Histopathology',' ',0),(48085,'Histopathology',' ',0),(48086,'Histopathology',' ',0),(48087,'Histopathology',' ',0),(48088,'Histopathology',' ',0),(48089,'Histopathology',' ',0),(48090,'Histopathology',' ',0),(48091,'Histopathology',' ',0),(48092,'Histopathology',' ',0),(48093,'Histopathology',' ',0),(48094,'Histopathology',' ',0),(48095,'Histopathology',' ',0),(48096,'Histopathology',' ',0),(48097,'Histopathology',' ',0),(48098,'Histopathology',' ',0),(48099,'Histopathology',' ',0),(48100,'Histopathology',' ',0),(48101,'Histopathology',' ',0),(48102,'Histopathology',' ',0),(48103,'Histopathology',' ',0),(48104,'Histopathology',' ',0),(48105,'Histopathology',' ',0),(48106,'Histopathology',' ',0),(48107,'Histopathology',' ',0),(48108,'Histopathology',' ',0),(48109,'Histopathology',' ',0),(48110,'Histopathology',' ',0),(48111,'Histopathology',' ',0),(48112,'Histopathology',' ',0),(48113,'Histopathology',' ',0),(48114,'Histopathology',' ',0),(48115,'Histopathology',' ',0),(48116,'Histopathology',' ',0),(48117,'Histopathology',' ',0),(48118,'Histopathology',' ',0),(48119,'Histopathology',' ',0),(48120,'Histopathology',' ',0),(48121,'Histopathology',' ',0),(48122,'Histopathology',' ',0),(48123,'Histopathology',' ',0),(48124,'Histopathology',' ',0),(48125,'Histopathology',' ',0),(48126,'Histopathology',' ',0),(48127,'Histopathology',' ',0),(48128,'Histopathology',' ',0),(48129,'Histopathology',' ',0),(48130,'Histopathology',' ',0),(48131,'Histopathology',' ',0),(48132,'Histopathology',' ',0),(48133,'Histopathology',' ',0),(48134,'Histopathology',' ',0),(48135,'Histopathology',' ',0),(48136,'Histopathology',' ',0),(48137,'Histopathology',' ',0),(48138,'Histopathology',' ',0),(48139,'Histopathology',' ',0),(48140,'Histopathology',' ',0),(48141,'Histopathology',' ',0),(48142,'Histopathology',' ',0),(48143,'Histopathology',' ',0),(48144,'Histopathology',' ',0),(48145,'Histopathology',' ',0),(48146,'Histopathology',' ',0),(48147,'Histopathology',' ',0),(48148,'Histopathology',' ',0),(48149,'Histopathology',' ',0),(48150,'Histopathology',' ',0),(48151,'Histopathology',' ',0),(48152,'Histopathology',' ',0),(48153,'Histopathology',' ',0),(48154,'Histopathology',' ',0),(48155,'Histopathology',' ',0),(48156,'Histopathology',' ',0),(48157,'Histopathology',' ',0),(48158,'Histopathology',' ',0),(48159,'Histopathology',' ',0),(48160,'Histopathology',' ',0),(48161,'Histopathology',' ',0),(48162,'Histopathology',' ',0),(48163,'Histopathology',' ',0),(48164,'Histopathology',' ',0),(48165,'Histopathology',' ',0),(48166,'Histopathology',' ',0),(48167,'Histopathology',' ',0),(48168,'Histopathology',' ',0),(48169,'Histopathology',' ',0),(48170,'Histopathology',' ',0),(48171,'Histopathology',' ',0),(48172,'Histopathology',' ',0),(48173,'Histopathology',' ',0),(48174,'Histopathology',' ',0),(48175,'Histopathology',' ',0),(48176,'Histopathology',' ',0),(48177,'Histopathology',' ',0),(48178,'Histopathology',' ',0),(48179,'Histopathology',' ',0),(48180,'Histopathology',' ',0),(48181,'Histopathology',' ',0),(48182,'Histopathology',' ',0),(48183,'Histopathology',' ',0),(48184,'Histopathology',' ',0),(48185,'Histopathology',' ',0),(48186,'Histopathology',' ',0),(48187,'Histopathology',' ',0),(48188,'Histopathology',' ',0),(48189,'Histopathology',' ',0),(48190,'Histopathology',' ',0),(48191,'Histopathology',' ',0),(48192,'Histopathology',' ',0),(48193,'Histopathology',' ',0),(48194,'Histopathology',' ',0),(48195,'Histopathology',' ',0),(48196,'Histopathology',' ',0),(48197,'Histopathology',' ',0),(48198,'Histopathology',' ',0),(48199,'Histopathology',' ',0),(48200,'Histopathology',' ',0),(48201,'Histopathology',' ',0),(48202,'Histopathology',' ',0),(48203,'Histopathology',' ',0),(48204,'Histopathology',' ',0),(48205,'Histopathology',' ',0),(48206,'Histopathology',' ',0),(48207,'Histopathology',' ',0),(48208,'Histopathology',' ',0),(48209,'Histopathology',' ',0),(48210,'Histopathology',' ',0),(48211,'Histopathology',' ',0),(48212,'Histopathology',' ',0),(48213,'Histopathology',' ',0),(48214,'Histopathology',' ',0),(48215,'Histopathology',' ',0),(48216,'Histopathology',' ',0),(48217,'Histopathology',' ',0),(48218,'Histopathology',' ',0),(48219,'Histopathology',' ',0),(48220,'Histopathology',' ',0),(48221,'Histopathology',' ',0),(48222,'Histopathology',' ',0),(48223,'Histopathology',' ',0),(48224,'Histopathology',' ',0),(48225,'Histopathology',' ',0),(48226,'Histopathology',' ',0),(48227,'Histopathology',' ',0),(48228,'Histopathology',' ',0),(48229,'Histopathology',' ',0),(48230,'Histopathology',' ',0),(48231,'Histopathology',' ',0),(48232,'Histopathology',' ',0),(48233,'Histopathology',' ',0),(48234,'Histopathology',' ',0),(48235,'Histopathology',' ',0),(48236,'Histopathology',' ',0),(48237,'Histopathology',' ',0),(48238,'Histopathology',' ',0),(48239,'Histopathology',' ',0),(48240,'Histopathology',' ',0),(48241,'Histopathology',' ',0),(48242,'Histopathology',' ',0),(48243,'Histopathology',' ',0),(48244,'Histopathology',' ',0),(48245,'Histopathology',' ',0),(48246,'Histopathology',' ',0),(48247,'Histopathology',' ',0),(48248,'Histopathology',' ',0),(48249,'Histopathology',' ',0),(48250,'Histopathology',' ',0),(48251,'Histopathology',' ',0),(48252,'Histopathology',' ',0),(48253,'Histopathology',' ',0),(48254,'Histopathology',' ',0),(48255,'Histopathology',' ',0),(48256,'Histopathology',' ',0),(48257,'Histopathology',' ',0),(48258,'Histopathology',' ',0),(48259,'Histopathology',' ',0),(48260,'Histopathology',' ',0),(48261,'Histopathology',' ',0),(48262,'Histopathology',' ',0),(48263,'Histopathology',' ',0),(48264,'Histopathology',' ',0),(48265,'Histopathology',' ',0),(48266,'Histopathology',' ',0),(48267,'Histopathology',' ',0),(48268,'Histopathology',' ',0),(48269,'Histopathology',' ',0),(48270,'Histopathology',' ',0),(48271,'Histopathology',' ',0),(48272,'Histopathology',' ',0),(48273,'Histopathology',' ',0),(48274,'Histopathology',' ',0),(48275,'Histopathology',' ',0),(48276,'Histopathology',' ',0),(48277,'Histopathology',' ',0),(48278,'Histopathology',' ',0),(48279,'Histopathology',' ',0),(48280,'Histopathology',' ',0),(48281,'Histopathology',' ',0),(48282,'Histopathology',' ',0),(48283,'Histopathology',' ',0),(48284,'Histopathology',' ',0),(48285,'Histopathology',' ',0),(48286,'Histopathology',' ',0),(48287,'Histopathology',' ',0),(48288,'Histopathology',' ',0),(48289,'Histopathology',' ',0),(48290,'Histopathology',' ',0),(48291,'Histopathology',' ',0),(48292,'Histopathology',' ',0),(48293,'Histopathology',' ',0),(48294,'Histopathology',' ',0),(48295,'Histopathology',' ',0),(48296,'Histopathology',' ',0),(48297,'Histopathology',' ',0),(48298,'Histopathology',' ',0),(48299,'Histopathology',' ',0),(48300,'Histopathology',' ',0),(48301,'Histopathology',' ',0),(48302,'Histopathology',' ',0),(48303,'Histopathology',' ',0),(48304,'Histopathology',' ',0),(48305,'Histopathology',' ',0),(48306,'Histopathology',' ',0),(48307,'Histopathology',' ',0),(48308,'Histopathology',' ',0),(48309,'Histopathology',' ',0),(48310,'Histopathology',' ',0),(48311,'Histopathology',' ',0),(48312,'Histopathology',' ',0),(48313,'Histopathology',' ',0),(48314,'Histopathology',' ',0),(48315,'Histopathology',' ',0),(48316,'Histopathology',' ',0),(51545,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51546,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51547,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51548,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51549,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51550,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51551,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51552,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51553,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51554,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51555,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51556,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51557,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51558,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51559,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51560,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51561,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51562,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51563,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51564,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51565,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51566,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51567,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51568,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51569,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51570,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51571,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51572,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51573,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51574,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51575,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51576,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51577,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51578,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51579,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51580,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51581,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51582,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51583,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51584,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51585,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51586,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51587,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51588,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51589,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51590,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51591,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51592,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51593,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51594,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51595,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51596,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51597,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51598,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51599,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51600,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51601,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51602,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51603,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51604,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51605,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51606,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51607,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51608,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51609,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51610,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51611,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51612,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51613,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51614,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51615,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51616,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51617,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51618,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51619,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51620,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51621,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51622,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51623,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51624,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51625,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51626,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51627,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51628,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51629,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51630,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51631,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51632,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51633,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51634,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51635,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51636,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51637,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51638,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51639,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51640,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51641,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51642,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51643,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51644,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51645,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51646,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51647,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(51648,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(52053,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52054,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52055,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52056,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52057,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52058,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52059,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52060,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52061,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52062,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52063,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52064,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52065,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52067,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52068,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52069,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52070,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52071,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52072,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52073,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52074,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52075,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52076,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52077,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52078,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52079,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52080,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52081,'Y-maze',' Y-maze assesses learning and memory; it can be used instead/in parallel of Fear Conditioning',0),(52084,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52085,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52086,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52087,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52088,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52089,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52090,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52091,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52092,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52093,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52094,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52095,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52096,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52097,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52098,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52099,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52100,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52101,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52102,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52103,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52104,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52105,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52106,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52107,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52108,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52109,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52110,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52111,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52112,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52113,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52114,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(52270,'MicroCT E14.5-E15.5',' ',0),(52271,'MicroCT E14.5-E15.5',' ',0),(52272,'MicroCT E14.5-E15.5',' ',0),(52273,'MicroCT E14.5-E15.5',' ',0),(52274,'MicroCT E14.5-E15.5',' ',0),(52275,'MicroCT E14.5-E15.5',' ',0),(52276,'MicroCT E14.5-E15.5',' ',0),(52277,'MicroCT E14.5-E15.5',' ',0),(52278,'MicroCT E14.5-E15.5',' ',0),(52279,'MicroCT E14.5-E15.5',' ',0),(52280,'MicroCT E14.5-E15.5',' ',0),(52281,'MicroCT E14.5-E15.5',' ',0),(52282,'MicroCT E14.5-E15.5',' ',0),(52283,'MicroCT E14.5-E15.5',' ',0),(52284,'MicroCT E14.5-E15.5',' ',0),(52285,'MicroCT E14.5-E15.5',' ',0),(52286,'MicroCT E14.5-E15.5',' ',0),(52287,'MicroCT E14.5-E15.5',' ',0),(52288,'MicroCT E14.5-E15.5',' ',0),(52289,'MicroCT E14.5-E15.5',' ',0),(52290,'MicroCT E14.5-E15.5',' ',0),(52291,'MicroCT E14.5-E15.5',' ',0),(52292,'MicroCT E14.5-E15.5',' ',0),(52293,'MicroCT E14.5-E15.5',' ',0),(52294,'MicroCT E14.5-E15.5',' ',0),(52295,'MicroCT E14.5-E15.5',' ',0),(52296,'MicroCT E14.5-E15.5',' ',0),(52297,'MicroCT E14.5-E15.5',' ',0),(52298,'MicroCT E14.5-E15.5',' ',0),(52299,'MicroCT E14.5-E15.5',' ',0),(52300,'MicroCT E14.5-E15.5',' ',0),(52301,'MicroCT E14.5-E15.5',' ',0),(52302,'MicroCT E14.5-E15.5',' ',0),(52303,'MicroCT E14.5-E15.5',' ',0),(52304,'MicroCT E14.5-E15.5',' ',0),(52305,'MicroCT E14.5-E15.5',' ',0),(52306,'MicroCT E14.5-E15.5',' ',0),(52307,'MicroCT E14.5-E15.5',' ',0),(52308,'MicroCT E14.5-E15.5',' ',0),(52309,'MicroCT E14.5-E15.5',' ',0),(52310,'MicroCT E14.5-E15.5',' ',0),(52311,'MicroCT E14.5-E15.5',' ',0),(52312,'MicroCT E14.5-E15.5',' ',0),(52313,'MicroCT E14.5-E15.5',' ',0),(52314,'MicroCT E14.5-E15.5',' ',0),(52315,'MicroCT E14.5-E15.5',' ',0),(52316,'MicroCT E14.5-E15.5',' ',0),(52317,'MicroCT E14.5-E15.5',' ',0),(52318,'MicroCT E14.5-E15.5',' ',0),(52319,'MicroCT E14.5-E15.5',' ',0),(52320,'MicroCT E14.5-E15.5',' ',0),(52321,'MicroCT E14.5-E15.5',' ',0),(52322,'MicroCT E14.5-E15.5',' ',0),(52323,'MicroCT E14.5-E15.5',' ',0),(52324,'MicroCT E14.5-E15.5',' ',0),(52325,'MicroCT E14.5-E15.5',' ',0),(52326,'MicroCT E14.5-E15.5',' ',0),(52327,'MicroCT E14.5-E15.5',' ',0),(52328,'MicroCT E14.5-E15.5',' ',0),(52329,'MicroCT E14.5-E15.5',' ',0),(52330,'MicroCT E14.5-E15.5',' ',0),(52331,'MicroCT E14.5-E15.5',' ',0),(52332,'MicroCT E14.5-E15.5',' ',0),(52333,'MicroCT E14.5-E15.5',' ',0),(52334,'MicroCT E14.5-E15.5',' ',0),(52335,'MicroCT E14.5-E15.5',' ',0),(52336,'MicroCT E14.5-E15.5',' ',0),(52337,'MicroCT E14.5-E15.5',' ',0),(52338,'MicroCT E14.5-E15.5',' ',0),(52339,'MicroCT E14.5-E15.5',' ',0),(52340,'MicroCT E14.5-E15.5',' ',0),(52341,'MicroCT E14.5-E15.5',' ',0),(52342,'MicroCT E14.5-E15.5',' ',0),(52343,'MicroCT E14.5-E15.5',' ',0),(52344,'MicroCT E14.5-E15.5',' ',0),(52345,'MicroCT E14.5-E15.5',' ',0),(52346,'MicroCT E14.5-E15.5',' ',0),(52347,'MicroCT E14.5-E15.5',' ',0),(52348,'MicroCT E14.5-E15.5',' ',0),(52349,'MicroCT E14.5-E15.5',' ',0),(52350,'MicroCT E14.5-E15.5',' ',0),(52351,'MicroCT E14.5-E15.5',' ',0),(52352,'MicroCT E14.5-E15.5',' ',0),(52353,'MicroCT E14.5-E15.5',' ',0),(52354,'MicroCT E14.5-E15.5',' ',0),(52355,'MicroCT E14.5-E15.5',' ',0),(52356,'MicroCT E14.5-E15.5',' ',0),(52357,'MicroCT E14.5-E15.5',' ',0),(52358,'MicroCT E14.5-E15.5',' ',0),(52359,'MicroCT E14.5-E15.5',' ',0),(52360,'MicroCT E14.5-E15.5',' ',0),(52361,'MicroCT E14.5-E15.5',' ',0),(52362,'MicroCT E14.5-E15.5',' ',0),(52363,'MicroCT E14.5-E15.5',' ',0),(52364,'MicroCT E14.5-E15.5',' ',0),(52365,'MicroCT E14.5-E15.5',' ',0),(52366,'MicroCT E14.5-E15.5',' ',0),(52367,'MicroCT E14.5-E15.5',' ',0),(52368,'MicroCT E14.5-E15.5',' ',0),(52369,'MicroCT E14.5-E15.5',' ',0),(52370,'MicroCT E14.5-E15.5',' ',0),(52371,'MicroCT E14.5-E15.5',' ',0),(52372,'MicroCT E14.5-E15.5',' ',0),(52373,'MicroCT E14.5-E15.5',' ',0),(52374,'MicroCT E14.5-E15.5',' ',0),(52375,'MicroCT E14.5-E15.5',' ',0),(52376,'MicroCT E14.5-E15.5',' ',0),(52377,'MicroCT E14.5-E15.5',' ',0),(52378,'MicroCT E14.5-E15.5',' ',0),(52379,'MicroCT E14.5-E15.5',' ',0),(52380,'MicroCT E14.5-E15.5',' ',0),(52381,'MicroCT E14.5-E15.5',' ',0),(52382,'MicroCT E14.5-E15.5',' ',0),(52383,'MicroCT E14.5-E15.5',' ',0),(52384,'MicroCT E14.5-E15.5',' ',0),(52385,'MicroCT E14.5-E15.5',' ',0),(52386,'MicroCT E14.5-E15.5',' ',0),(52387,'MicroCT E14.5-E15.5',' ',0),(52388,'MicroCT E14.5-E15.5',' ',0),(52389,'MicroCT E14.5-E15.5',' ',0),(52390,'MicroCT E14.5-E15.5',' ',0),(52391,'MicroCT E14.5-E15.5',' ',0),(52392,'MicroCT E14.5-E15.5',' ',0),(52393,'MicroCT E14.5-E15.5',' ',0),(52394,'MicroCT E14.5-E15.5',' ',0),(52395,'MicroCT E14.5-E15.5',' ',0),(52396,'MicroCT E14.5-E15.5',' ',0),(52397,'MicroCT E14.5-E15.5',' ',0),(52398,'MicroCT E14.5-E15.5',' ',0),(52399,'MicroCT E14.5-E15.5',' ',0),(52400,'MicroCT E14.5-E15.5',' ',0),(52401,'MicroCT E14.5-E15.5',' ',0),(52402,'MicroCT E14.5-E15.5',' ',0),(52403,'MicroCT E14.5-E15.5',' ',0),(52404,'MicroCT E14.5-E15.5',' ',0),(52405,'MicroCT E14.5-E15.5',' ',0),(52406,'MicroCT E14.5-E15.5',' ',0),(52407,'MicroCT E14.5-E15.5',' ',0),(52408,'MicroCT E14.5-E15.5',' ',0),(52409,'MicroCT E14.5-E15.5',' ',0),(52410,'MicroCT E14.5-E15.5',' ',0),(52411,'MicroCT E14.5-E15.5',' ',0),(52412,'MicroCT E14.5-E15.5',' ',0),(52413,'MicroCT E14.5-E15.5',' ',0),(52414,'MicroCT E14.5-E15.5',' ',0),(52415,'MicroCT E14.5-E15.5',' ',0),(52416,'MicroCT E14.5-E15.5',' ',0),(52417,'MicroCT E14.5-E15.5',' ',0),(52418,'MicroCT E14.5-E15.5',' ',0),(52419,'MicroCT E14.5-E15.5',' ',0),(52420,'MicroCT E14.5-E15.5',' ',0),(52421,'MicroCT E14.5-E15.5',' ',0),(52422,'MicroCT E14.5-E15.5',' ',0),(52423,'MicroCT E14.5-E15.5',' ',0),(52424,'MicroCT E14.5-E15.5',' ',0),(52425,'MicroCT E14.5-E15.5',' ',0),(52426,'MicroCT E14.5-E15.5',' ',0),(52427,'MicroCT E14.5-E15.5',' ',0),(52428,'MicroCT E14.5-E15.5',' ',0),(52429,'MicroCT E14.5-E15.5',' ',0),(52430,'MicroCT E14.5-E15.5',' ',0),(52431,'MicroCT E14.5-E15.5',' ',0),(52432,'MicroCT E14.5-E15.5',' ',0),(52433,'MicroCT E14.5-E15.5',' ',0),(52434,'MicroCT E14.5-E15.5',' ',0),(52435,'MicroCT E14.5-E15.5',' ',0),(52436,'MicroCT E14.5-E15.5',' ',0),(52437,'MicroCT E14.5-E15.5',' ',0),(52438,'MicroCT E14.5-E15.5',' ',0),(52439,'MicroCT E14.5-E15.5',' ',0),(52440,'MicroCT E14.5-E15.5',' ',0),(52441,'MicroCT E14.5-E15.5',' ',0),(52442,'MicroCT E14.5-E15.5',' ',0),(52443,'MicroCT E14.5-E15.5',' ',0),(52444,'MicroCT E14.5-E15.5',' ',0),(52445,'MicroCT E14.5-E15.5',' ',0),(52446,'MicroCT E14.5-E15.5',' ',0),(52447,'MicroCT E14.5-E15.5',' ',0),(52448,'MicroCT E14.5-E15.5',' ',0),(57175,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(57176,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(57177,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(57178,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(57179,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(57180,'X-ray',' Construct and analyse digital X-ray images in immobilised mice using a Faxitron X-Ray system or NTB digital X-ray scanner.',0),(66104,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66105,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66106,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66107,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66108,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66109,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66110,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66111,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66112,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66113,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66114,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66115,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66116,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66117,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66118,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66119,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66120,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66121,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66122,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66123,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66124,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66125,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66126,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66127,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66128,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66129,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66130,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66131,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66132,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66133,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66134,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(66135,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(67026,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(67033,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(67034,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(67252,'MicroCT E9.5',' ',0),(67253,'MicroCT E9.5',' ',0),(67254,'MicroCT E9.5',' ',0),(67255,'MicroCT E9.5',' ',0),(67256,'MicroCT E9.5',' ',0),(67257,'MicroCT E9.5',' ',0),(67258,'MicroCT E9.5',' ',0),(67259,'MicroCT E9.5',' ',0),(67260,'MicroCT E9.5',' ',0),(67261,'MicroCT E9.5',' ',0),(67262,'MicroCT E9.5',' ',0),(67263,'MicroCT E9.5',' ',0),(67264,'MicroCT E9.5',' ',0),(67265,'MicroCT E9.5',' ',0),(67266,'MicroCT E9.5',' ',0),(67267,'MicroCT E9.5',' ',0),(67268,'MicroCT E9.5',' ',0),(67597,'Welfare Observations',' The Welfare Observations procedure is used for the recording of welfare issues as and when they occur.',0),(67598,'Welfare Observations',' The Welfare Observations procedure is used for the recording of welfare issues as and when they occur.',0),(67599,'Welfare Observations',' The Welfare Observations procedure is used for the recording of welfare issues as and when they occur.',0),(67600,'Welfare Observations',' The Welfare Observations procedure is used for the recording of welfare issues as and when they occur.',0),(67722,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(67723,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(67724,'Light-Dark Test',' Light-Dark test monitors the anxiety-related behaviour of mice',0),(67929,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67930,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67931,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67932,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67933,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67934,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67935,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67936,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67937,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67938,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67939,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67940,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67941,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67942,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67943,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67944,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67945,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67946,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67947,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67948,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67949,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67950,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67951,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67952,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67953,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67954,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67955,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67956,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67957,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67958,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67959,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67960,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67961,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67962,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67963,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67964,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67965,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67966,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67967,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67968,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67969,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67970,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67971,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67972,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67973,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67974,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67975,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67976,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67977,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67978,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67979,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67980,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67981,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67982,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67983,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67984,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67985,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67986,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67987,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67988,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67989,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67990,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67991,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67992,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67993,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67994,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67995,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67996,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67997,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67998,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(67999,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68000,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68001,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68002,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68003,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68004,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68005,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68006,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68007,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68008,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68009,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68010,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68011,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68012,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68013,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68014,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68015,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68016,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68017,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68018,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68019,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68020,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68021,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68022,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68023,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68024,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68025,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68026,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68027,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68028,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68029,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68030,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68031,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68032,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68033,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68034,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68035,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68036,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68037,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68038,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68039,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68040,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68041,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68042,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68043,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68044,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68045,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68046,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68047,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68048,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68049,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68050,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68051,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68052,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68053,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68054,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68055,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68056,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68057,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68058,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68059,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68060,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68061,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68062,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68063,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68064,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68065,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68066,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68067,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68068,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68069,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68070,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68071,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68072,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68073,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68074,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68075,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68076,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68077,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68078,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68079,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68080,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68081,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68082,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68083,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68084,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68085,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68086,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68087,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68088,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68089,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68090,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68091,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68092,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68093,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68094,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68095,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68096,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68097,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68098,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68099,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68100,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68101,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68102,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68103,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68104,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68105,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68106,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68107,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68108,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68109,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68110,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68111,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68112,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68113,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68114,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68115,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68116,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68117,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68118,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68119,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68120,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68121,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68122,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68123,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68124,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68125,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68126,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68127,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68128,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68129,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68130,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68131,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68132,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68133,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68134,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68135,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68136,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68137,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68138,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68139,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68140,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68141,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68142,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68143,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68144,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68145,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68146,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68147,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68148,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68149,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68150,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68151,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68152,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68153,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68154,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68155,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68156,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68157,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68158,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68159,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68160,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68161,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68162,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68163,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68164,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68165,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68166,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68167,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68168,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68169,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68170,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68171,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68172,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68173,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68174,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68175,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68176,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68177,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68178,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68179,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68180,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68181,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68182,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68183,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68184,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68185,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68186,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68187,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68188,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68189,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68190,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68191,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68192,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68193,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68194,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68195,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68196,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68197,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68198,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68199,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68200,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68201,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68202,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68203,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68204,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68205,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68206,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68207,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68208,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68209,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68210,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68211,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68212,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68213,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68214,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68215,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68216,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68217,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68218,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(68219,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(71972,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(71973,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(71974,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(71975,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(71976,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(72162,'OPT E9.5',' ',0),(72163,'OPT E9.5',' ',0),(72164,'OPT E9.5',' ',0),(72165,'OPT E9.5',' ',0),(72166,'OPT E9.5',' ',0),(72167,'OPT E9.5',' ',0),(72168,'OPT E9.5',' ',0),(72169,'OPT E9.5',' ',0),(72170,'OPT E9.5',' ',0),(72171,'OPT E9.5',' ',0),(72172,'OPT E9.5',' ',0),(72173,'OPT E9.5',' ',0),(72174,'OPT E9.5',' ',0),(72175,'OPT E9.5',' ',0),(72176,'OPT E9.5',' ',0),(72177,'OPT E9.5',' ',0),(72178,'OPT E9.5',' ',0),(72179,'OPT E9.5',' ',0),(72180,'OPT E9.5',' ',0),(72181,'OPT E9.5',' ',0),(72182,'OPT E9.5',' ',0),(72183,'OPT E9.5',' ',0),(72184,'OPT E9.5',' ',0),(72185,'OPT E9.5',' ',0),(72186,'OPT E9.5',' ',0),(72187,'OPT E9.5',' ',0),(72188,'OPT E9.5',' ',0),(72189,'OPT E9.5',' ',0),(72190,'OPT E9.5',' ',0),(72191,'OPT E9.5',' ',0),(72192,'OPT E9.5',' ',0),(72193,'OPT E9.5',' ',0),(72194,'OPT E9.5',' ',0),(72195,'OPT E9.5',' ',0),(72196,'OPT E9.5',' ',0),(72197,'OPT E9.5',' ',0),(72198,'OPT E9.5',' ',0),(72199,'OPT E9.5',' ',0),(72200,'OPT E9.5',' ',0),(72201,'OPT E9.5',' ',0),(72202,'OPT E9.5',' ',0),(72203,'OPT E9.5',' ',0),(72204,'OPT E9.5',' ',0),(72205,'OPT E9.5',' ',0),(72206,'OPT E9.5',' ',0),(72207,'OPT E9.5',' ',0),(72208,'OPT E9.5',' ',0),(72209,'OPT E9.5',' ',0),(72210,'OPT E9.5',' ',0),(72211,'OPT E9.5',' ',0),(72212,'OPT E9.5',' ',0),(72213,'OPT E9.5',' ',0),(72219,'MicroCT E9.5',' ',0),(72220,'MicroCT E9.5',' ',0),(72221,'MicroCT E9.5',' ',0),(72222,'MicroCT E9.5',' ',0),(72223,'MicroCT E9.5',' ',0),(72224,'MicroCT E9.5',' ',0),(72225,'MicroCT E9.5',' ',0),(72226,'MicroCT E9.5',' ',0),(72227,'MicroCT E9.5',' ',0),(72228,'MicroCT E9.5',' ',0),(72229,'MicroCT E9.5',' ',0),(72230,'MicroCT E9.5',' ',0),(72231,'MicroCT E9.5',' ',0),(72232,'MicroCT E9.5',' ',0),(72233,'MicroCT E9.5',' ',0),(72234,'MicroCT E9.5',' ',0),(72235,'MicroCT E9.5',' ',0),(72236,'MicroCT E9.5',' ',0),(72237,'MicroCT E9.5',' ',0),(72238,'MicroCT E9.5',' ',0),(72239,'MicroCT E9.5',' ',0),(72240,'MicroCT E9.5',' ',0),(72241,'MicroCT E9.5',' ',0),(72242,'MicroCT E9.5',' ',0),(72243,'MicroCT E9.5',' ',0),(72244,'MicroCT E9.5',' ',0),(72245,'MicroCT E9.5',' ',0),(72246,'MicroCT E9.5',' ',0),(72247,'MicroCT E9.5',' ',0),(72248,'MicroCT E9.5',' ',0),(72249,'MicroCT E9.5',' ',0),(72250,'MicroCT E9.5',' ',0),(72251,'MicroCT E9.5',' ',0),(72252,'MicroCT E9.5',' ',0),(72253,'MicroCT E9.5',' ',0),(72254,'MicroCT E9.5',' ',0),(72255,'MicroCT E9.5',' ',0),(72256,'MicroCT E9.5',' ',0),(72257,'MicroCT E9.5',' ',0),(72258,'MicroCT E9.5',' ',0),(72259,'MicroCT E9.5',' ',0),(72260,'MicroCT E9.5',' ',0),(72261,'MicroCT E9.5',' ',0),(72262,'MicroCT E9.5',' ',0),(72263,'MicroCT E9.5',' ',0),(72264,'MicroCT E9.5',' ',0),(72265,'MicroCT E9.5',' ',0),(72266,'MicroCT E9.5',' ',0),(72267,'MicroCT E9.5',' ',0),(72268,'MicroCT E9.5',' ',0),(72269,'MicroCT E9.5',' ',0),(72270,'MicroCT E9.5',' ',0),(72271,'MicroCT E9.5',' ',0),(72272,'MicroCT E9.5',' ',0),(72273,'MicroCT E9.5',' ',0),(72274,'MicroCT E9.5',' ',0),(72275,'MicroCT E9.5',' ',0),(72276,'MicroCT E9.5',' ',0),(72720,'OPT E9.5',' ',0),(73074,'MicroCT E18.5',' ',0),(73075,'MicroCT E18.5',' ',0),(73076,'MicroCT E18.5',' ',0),(73077,'MicroCT E18.5',' ',0),(73078,'MicroCT E18.5',' ',0),(73079,'MicroCT E18.5',' ',0),(73080,'MicroCT E18.5',' ',0),(73081,'MicroCT E18.5',' ',0),(73082,'MicroCT E18.5',' ',0),(73083,'MicroCT E18.5',' ',0),(73084,'MicroCT E18.5',' ',0),(73085,'MicroCT E18.5',' ',0),(73086,'MicroCT E18.5',' ',0),(73087,'MicroCT E18.5',' ',0),(73088,'MicroCT E18.5',' ',0),(73089,'MicroCT E18.5',' ',0),(73090,'MicroCT E18.5',' ',0),(73091,'MicroCT E18.5',' ',0),(73092,'MicroCT E18.5',' ',0),(73093,'MicroCT E18.5',' ',0),(73094,'MicroCT E18.5',' ',0),(73095,'MicroCT E18.5',' ',0),(73096,'MicroCT E18.5',' ',0),(73097,'MicroCT E18.5',' ',0),(73098,'MicroCT E18.5',' ',0),(73099,'MicroCT E18.5',' ',0),(73100,'MicroCT E18.5',' ',0),(73101,'MicroCT E18.5',' ',0),(73102,'MicroCT E18.5',' ',0),(73103,'MicroCT E18.5',' ',0),(73104,'MicroCT E18.5',' ',0),(73105,'MicroCT E18.5',' ',0),(73106,'MicroCT E18.5',' ',0),(73107,'MicroCT E18.5',' ',0),(73108,'MicroCT E18.5',' ',0),(73109,'MicroCT E18.5',' ',0),(73110,'MicroCT E18.5',' ',0),(73111,'MicroCT E18.5',' ',0),(73112,'MicroCT E18.5',' ',0),(73113,'MicroCT E18.5',' ',0),(73114,'MicroCT E18.5',' ',0),(73115,'MicroCT E18.5',' ',0),(73116,'MicroCT E18.5',' ',0),(73117,'MicroCT E18.5',' ',0),(73118,'MicroCT E18.5',' ',0),(73119,'MicroCT E18.5',' ',0),(73120,'MicroCT E18.5',' ',0),(73121,'MicroCT E18.5',' ',0),(73122,'MicroCT E18.5',' ',0),(73123,'MicroCT E18.5',' ',0),(73124,'MicroCT E18.5',' ',0),(73125,'MicroCT E18.5',' ',0),(73126,'MicroCT E18.5',' ',0),(73127,'MicroCT E18.5',' ',0),(73128,'MicroCT E18.5',' ',0),(73129,'MicroCT E18.5',' ',0),(73130,'MicroCT E18.5',' ',0),(73131,'MicroCT E18.5',' ',0),(73132,'MicroCT E18.5',' ',0),(73133,'MicroCT E18.5',' ',0),(73134,'MicroCT E18.5',' ',0),(73135,'MicroCT E18.5',' ',0),(73136,'MicroCT E18.5',' ',0),(73137,'MicroCT E18.5',' ',0),(73138,'MicroCT E18.5',' ',0),(73139,'MicroCT E18.5',' ',0),(73140,'MicroCT E18.5',' ',0),(73141,'MicroCT E18.5',' ',0),(73142,'MicroCT E18.5',' ',0),(73143,'MicroCT E18.5',' ',0),(73144,'MicroCT E18.5',' ',0),(73145,'MicroCT E18.5',' ',0),(73146,'MicroCT E18.5',' ',0),(73147,'MicroCT E18.5',' ',0),(73148,'MicroCT E18.5',' ',0),(73149,'MicroCT E18.5',' ',0),(73150,'MicroCT E18.5',' ',0),(73151,'MicroCT E18.5',' ',0),(73152,'MicroCT E18.5',' ',0),(73153,'MicroCT E18.5',' ',0),(73154,'MicroCT E18.5',' ',0),(73155,'MicroCT E18.5',' ',0),(73156,'MicroCT E18.5',' ',0),(73157,'MicroCT E18.5',' ',0),(73158,'MicroCT E18.5',' ',0),(73159,'MicroCT E18.5',' ',0),(73160,'MicroCT E18.5',' ',0),(73161,'MicroCT E18.5',' ',0),(73162,'MicroCT E18.5',' ',0),(73163,'MicroCT E18.5',' ',0),(73164,'MicroCT E18.5',' ',0),(73165,'MicroCT E18.5',' ',0),(73166,'MicroCT E18.5',' ',0),(73167,'MicroCT E18.5',' ',0),(73168,'MicroCT E18.5',' ',0),(73169,'MicroCT E18.5',' ',0),(73170,'MicroCT E18.5',' ',0),(73171,'MicroCT E18.5',' ',0),(73172,'MicroCT E18.5',' ',0),(73173,'MicroCT E18.5',' ',0),(73174,'MicroCT E18.5',' ',0),(73175,'MicroCT E18.5',' ',0),(73176,'MicroCT E18.5',' ',0),(73177,'MicroCT E18.5',' ',0),(73178,'MicroCT E18.5',' ',0),(73179,'MicroCT E18.5',' ',0),(73180,'MicroCT E18.5',' ',0),(73181,'MicroCT E18.5',' ',0),(73182,'MicroCT E18.5',' ',0),(73183,'MicroCT E18.5',' ',0),(73184,'MicroCT E18.5',' ',0),(73185,'MicroCT E18.5',' ',0),(73186,'MicroCT E18.5',' ',0),(73187,'MicroCT E18.5',' ',0),(73188,'MicroCT E18.5',' ',0),(73189,'MicroCT E18.5',' ',0),(73190,'MicroCT E18.5',' ',0),(73191,'MicroCT E18.5',' ',0),(73192,'MicroCT E18.5',' ',0),(73193,'MicroCT E18.5',' ',0),(73194,'MicroCT E18.5',' ',0),(73195,'MicroCT E18.5',' ',0),(73196,'MicroCT E18.5',' ',0),(73197,'MicroCT E18.5',' ',0),(73198,'MicroCT E18.5',' ',0),(73199,'MicroCT E18.5',' ',0),(73200,'MicroCT E18.5',' ',0),(73201,'MicroCT E18.5',' ',0),(73202,'MicroCT E18.5',' ',0),(73203,'MicroCT E18.5',' ',0),(73204,'MicroCT E18.5',' ',0),(73205,'MicroCT E18.5',' ',0),(73206,'MicroCT E18.5',' ',0),(73207,'MicroCT E18.5',' ',0),(73208,'MicroCT E18.5',' ',0),(73209,'MicroCT E18.5',' ',0),(73210,'MicroCT E18.5',' ',0),(73211,'MicroCT E18.5',' ',0),(73212,'MicroCT E18.5',' ',0),(73213,'MicroCT E18.5',' ',0),(73214,'MicroCT E18.5',' ',0),(73215,'MicroCT E18.5',' ',0),(73216,'MicroCT E18.5',' ',0),(73217,'MicroCT E18.5',' ',0),(73218,'MicroCT E18.5',' ',0),(73219,'MicroCT E18.5',' ',0),(73220,'MicroCT E18.5',' ',0),(73221,'MicroCT E18.5',' ',0),(73222,'MicroCT E18.5',' ',0),(73223,'MicroCT E18.5',' ',0),(73974,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73975,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73976,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73977,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73978,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73979,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73980,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73981,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73982,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(73983,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(74092,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(74113,'Organ Weight',' Organ weights from different tissues collected for IMPC',0),(74120,'Welfare Observations',' The Welfare Observations procedure is used for the recording of welfare issues as and when they occur.',0),(74751,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(75512,'Histopathology',' ',0),(75513,'Histopathology',' ',0),(75514,'Histopathology',' ',0),(75515,'Histopathology',' ',0),(75516,'Histopathology',' ',0),(75517,'Histopathology',' ',0),(75518,'Histopathology',' ',0),(75519,'Histopathology',' ',0),(75520,'Histopathology',' ',0),(75521,'Histopathology',' ',0),(75522,'Histopathology',' ',0),(75523,'Histopathology',' ',0),(75524,'Histopathology',' ',0),(75525,'Histopathology',' ',0),(75526,'Histopathology',' ',0),(75527,'Histopathology',' ',0),(75528,'Histopathology',' ',0),(75529,'Histopathology',' ',0),(75530,'Histopathology',' ',0),(75531,'Histopathology',' ',0),(75532,'Histopathology',' ',0),(75533,'Histopathology',' ',0),(75534,'Histopathology',' ',0),(75535,'Histopathology',' ',0),(75536,'Histopathology',' ',0),(75537,'Histopathology',' ',0),(75538,'Histopathology',' ',0),(75539,'Histopathology',' ',0),(75540,'Histopathology',' ',0),(75541,'Histopathology',' ',0),(75542,'Histopathology',' ',0),(75543,'Histopathology',' ',0),(75544,'Histopathology',' ',0),(75545,'Histopathology',' ',0),(75546,'Histopathology',' ',0),(75547,'Histopathology',' ',0),(75548,'Histopathology',' ',0),(75549,'Histopathology',' ',0),(75550,'Histopathology',' ',0),(75551,'Histopathology',' ',0),(75552,'Histopathology',' ',0),(75553,'Histopathology',' ',0),(75554,'Histopathology',' ',0),(75555,'Histopathology',' ',0),(75556,'Histopathology',' ',0),(75557,'Histopathology',' ',0),(75558,'Histopathology',' ',0),(75559,'Histopathology',' ',0),(75560,'Histopathology',' ',0),(75561,'Histopathology',' ',0),(75562,'Histopathology',' ',0),(75563,'Histopathology',' ',0),(75564,'Histopathology',' ',0),(75565,'Histopathology',' ',0),(75566,'Histopathology',' ',0),(75567,'Histopathology',' ',0),(75568,'Histopathology',' ',0),(75569,'Histopathology',' ',0),(75570,'Histopathology',' ',0),(75571,'Histopathology',' ',0),(75572,'Histopathology',' ',0),(75573,'Histopathology',' ',0),(75574,'Histopathology',' ',0),(75575,'Histopathology',' ',0),(75576,'Histopathology',' ',0),(75577,'Histopathology',' ',0),(75578,'Histopathology',' ',0),(75579,'Histopathology',' ',0),(75580,'Histopathology',' ',0),(75581,'Histopathology',' ',0),(75582,'Histopathology',' ',0),(75583,'Histopathology',' ',0),(75584,'Histopathology',' ',0),(75585,'Histopathology',' ',0),(75586,'Histopathology',' ',0),(75587,'Histopathology',' ',0),(75588,'Histopathology',' ',0),(75589,'Histopathology',' ',0),(75590,'Histopathology',' ',0),(75591,'Histopathology',' ',0),(75592,'Histopathology',' ',0),(75593,'Histopathology',' ',0),(75594,'Histopathology',' ',0),(75595,'Histopathology',' ',0),(75596,'Histopathology',' ',0),(75597,'Histopathology',' ',0),(75598,'Histopathology',' ',0),(75599,'Histopathology',' ',0),(75600,'Histopathology',' ',0),(75601,'Histopathology',' ',0),(75602,'Histopathology',' ',0),(75603,'Histopathology',' ',0),(75604,'Histopathology',' ',0),(75605,'Histopathology',' ',0),(75606,'Histopathology',' ',0),(75607,'Histopathology',' ',0),(75608,'Histopathology',' ',0),(75609,'Histopathology',' ',0),(75610,'Histopathology',' ',0),(75611,'Histopathology',' ',0),(75612,'Histopathology',' ',0),(75613,'Histopathology',' ',0),(75614,'Histopathology',' ',0),(75615,'Histopathology',' ',0),(75616,'Histopathology',' ',0),(75617,'Histopathology',' ',0),(75618,'Histopathology',' ',0),(75619,'Histopathology',' ',0),(75620,'Histopathology',' ',0),(75621,'Histopathology',' ',0),(75622,'Histopathology',' ',0),(75623,'Histopathology',' ',0),(75624,'Histopathology',' ',0),(75625,'Histopathology',' ',0),(75626,'Histopathology',' ',0),(75627,'Histopathology',' ',0),(75628,'Histopathology',' ',0),(75629,'Histopathology',' ',0),(75630,'Histopathology',' ',0),(75631,'Histopathology',' ',0),(75632,'Histopathology',' ',0),(75633,'Histopathology',' ',0),(75634,'Histopathology',' ',0),(75635,'Histopathology',' ',0),(75636,'Histopathology',' ',0),(75637,'Histopathology',' ',0),(75638,'Histopathology',' ',0),(75639,'Histopathology',' ',0),(75640,'Histopathology',' ',0),(75641,'Histopathology',' ',0),(75642,'Histopathology',' ',0),(75643,'Histopathology',' ',0),(75644,'Histopathology',' ',0),(75645,'Histopathology',' ',0),(75646,'Histopathology',' ',0),(75647,'Histopathology',' ',0),(75648,'Histopathology',' ',0),(75649,'Histopathology',' ',0),(75650,'Histopathology',' ',0),(75651,'Histopathology',' ',0),(75652,'Histopathology',' ',0),(75653,'Histopathology',' ',0),(75654,'Histopathology',' ',0),(75655,'Histopathology',' ',0),(75656,'Histopathology',' ',0),(75657,'Histopathology',' ',0),(75658,'Histopathology',' ',0),(75659,'Histopathology',' ',0),(75660,'Histopathology',' ',0),(75661,'Histopathology',' ',0),(75662,'Histopathology',' ',0),(75663,'Histopathology',' ',0),(75664,'Histopathology',' ',0),(75665,'Histopathology',' ',0),(75666,'Histopathology',' ',0),(75667,'Histopathology',' ',0),(75668,'Histopathology',' ',0),(75669,'Histopathology',' ',0),(75670,'Histopathology',' ',0),(75671,'Histopathology',' ',0),(75672,'Histopathology',' ',0),(75673,'Histopathology',' ',0),(75674,'Histopathology',' ',0),(75675,'Histopathology',' ',0),(75676,'Histopathology',' ',0),(75677,'Histopathology',' ',0),(75678,'Histopathology',' ',0),(75679,'Histopathology',' ',0),(75680,'Histopathology',' ',0),(75681,'Histopathology',' ',0),(75682,'Histopathology',' ',0),(75683,'Histopathology',' ',0),(75684,'Histopathology',' ',0),(75685,'Histopathology',' ',0),(75686,'Histopathology',' ',0),(75687,'Histopathology',' ',0),(75688,'Histopathology',' ',0),(75689,'Histopathology',' ',0),(75690,'Histopathology',' ',0),(75691,'Histopathology',' ',0),(75692,'Histopathology',' ',0),(75693,'Histopathology',' ',0),(75694,'Histopathology',' ',0),(75695,'Histopathology',' ',0),(75696,'Histopathology',' ',0),(75697,'Histopathology',' ',0),(75698,'Histopathology',' ',0),(75699,'Histopathology',' ',0),(75700,'Histopathology',' ',0),(75701,'Histopathology',' ',0),(75702,'Histopathology',' ',0),(75703,'Histopathology',' ',0),(75704,'Histopathology',' ',0),(75705,'Histopathology',' ',0),(75706,'Histopathology',' ',0),(75707,'Histopathology',' ',0),(75708,'Histopathology',' ',0),(75709,'Histopathology',' ',0),(75710,'Histopathology',' ',0),(75711,'Histopathology',' ',0),(75712,'Histopathology',' ',0),(75713,'Histopathology',' ',0),(75714,'Histopathology',' ',0),(75715,'Histopathology',' ',0),(75716,'Histopathology',' ',0),(75717,'Histopathology',' ',0),(75718,'Histopathology',' ',0),(75719,'Histopathology',' ',0),(75720,'Histopathology',' ',0),(75721,'Histopathology',' ',0),(75722,'Histopathology',' ',0),(75723,'Histopathology',' ',0),(75724,'Histopathology',' ',0),(75725,'Histopathology',' ',0),(75726,'Histopathology',' ',0),(75727,'Histopathology',' ',0),(75728,'Histopathology',' ',0),(75729,'Histopathology',' ',0),(75730,'Histopathology',' ',0),(75731,'Histopathology',' ',0),(75732,'Histopathology',' ',0),(75733,'Histopathology',' ',0),(75734,'Histopathology',' ',0),(75735,'Histopathology',' ',0),(75736,'Histopathology',' ',0),(75737,'Histopathology',' ',0),(75738,'Histopathology',' ',0),(75739,'Histopathology',' ',0),(75740,'Histopathology',' ',0),(75741,'Histopathology',' ',0),(75742,'Histopathology',' ',0),(75743,'Histopathology',' ',0),(75744,'Histopathology',' ',0),(75745,'Histopathology',' ',0),(75746,'Histopathology',' ',0),(75747,'Histopathology',' ',0),(75748,'Histopathology',' ',0),(75749,'Histopathology',' ',0),(75750,'Histopathology',' ',0),(75751,'Histopathology',' ',0),(75752,'Histopathology',' ',0),(75753,'Histopathology',' ',0),(75754,'Histopathology',' ',0),(75755,'Histopathology',' ',0),(75756,'Histopathology',' ',0),(75757,'Histopathology',' ',0),(75758,'Histopathology',' ',0),(75759,'Histopathology',' ',0),(75760,'Histopathology',' ',0),(75761,'Histopathology',' ',0),(75762,'Histopathology',' ',0),(75763,'Histopathology',' ',0),(75764,'Histopathology',' ',0),(75765,'Histopathology',' ',0),(75766,'Histopathology',' ',0),(75767,'Histopathology',' ',0),(75768,'Histopathology',' ',0),(75769,'Histopathology',' ',0),(75770,'Histopathology',' ',0),(75771,'Histopathology',' ',0),(75772,'Histopathology',' ',0),(75773,'Histopathology',' ',0),(75774,'Histopathology',' ',0),(75775,'Histopathology',' ',0),(75776,'Histopathology',' ',0),(75777,'Histopathology',' ',0),(75778,'Histopathology',' ',0),(75779,'Histopathology',' ',0),(75780,'Histopathology',' ',0),(75781,'Histopathology',' ',0),(75782,'Histopathology',' ',0),(75783,'Histopathology',' ',0),(75784,'Histopathology',' ',0),(75785,'Histopathology',' ',0),(75786,'Histopathology',' ',0),(75787,'Histopathology',' ',0),(75788,'Histopathology',' ',0),(75789,'Histopathology',' ',0),(75790,'Histopathology',' ',0),(75791,'Histopathology',' ',0),(75792,'Histopathology',' ',0),(75793,'Histopathology',' ',0),(75794,'Histopathology',' ',0),(75795,'Histopathology',' ',0),(75796,'Histopathology',' ',0),(75797,'Histopathology',' ',0),(75798,'Histopathology',' ',0),(75799,'Histopathology',' ',0),(75800,'Histopathology',' ',0),(75801,'Histopathology',' ',0),(75802,'Histopathology',' ',0),(75803,'Histopathology',' ',0),(75804,'Histopathology',' ',0),(75805,'Histopathology',' ',0),(75806,'Histopathology',' ',0),(75807,'Histopathology',' ',0),(75808,'Histopathology',' ',0),(75809,'Histopathology',' ',0),(75810,'Histopathology',' ',0),(75811,'Histopathology',' ',0),(75812,'Histopathology',' ',0),(75813,'Histopathology',' ',0),(75814,'Histopathology',' ',0),(75815,'Histopathology',' ',0),(75816,'Histopathology',' ',0),(75817,'Histopathology',' ',0),(75818,'Histopathology',' ',0),(75819,'Histopathology',' ',0),(75820,'Histopathology',' ',0),(75821,'Histopathology',' ',0),(75822,'Histopathology',' ',0),(75823,'Histopathology',' ',0),(75824,'Histopathology',' ',0),(75825,'Histopathology',' ',0),(75826,'Histopathology',' ',0),(75827,'Histopathology',' ',0),(75828,'Histopathology',' ',0),(75829,'Histopathology',' ',0),(75830,'Histopathology',' ',0),(75831,'Histopathology',' ',0),(75832,'Histopathology',' ',0),(75833,'Histopathology',' ',0),(75834,'Histopathology',' ',0),(75835,'Histopathology',' ',0),(75836,'Histopathology',' ',0),(75837,'Histopathology',' ',0),(75838,'Histopathology',' ',0),(75839,'Histopathology',' ',0),(75840,'Histopathology',' ',0),(75841,'Histopathology',' ',0),(75842,'Histopathology',' ',0),(75843,'Histopathology',' ',0),(75844,'Histopathology',' ',0),(75845,'Histopathology',' ',0),(75846,'Histopathology',' ',0),(75847,'Histopathology',' ',0),(75848,'Histopathology',' ',0),(75849,'Histopathology',' ',0),(75850,'Histopathology',' ',0),(75851,'Histopathology',' ',0),(75852,'Histopathology',' ',0),(75853,'Histopathology',' ',0),(75854,'Histopathology',' ',0),(75855,'Histopathology',' ',0),(75856,'Histopathology',' ',0),(75857,'Histopathology',' ',0),(75858,'Histopathology',' ',0),(75859,'Histopathology',' ',0),(75860,'Histopathology',' ',0),(75861,'Histopathology',' ',0),(75862,'Histopathology',' ',0),(75863,'Histopathology',' ',0),(75864,'Histopathology',' ',0),(75865,'Histopathology',' ',0),(75866,'Histopathology',' ',0),(75867,'Histopathology',' ',0),(75868,'Histopathology',' ',0),(75869,'Histopathology',' ',0),(75870,'Histopathology',' ',0),(75871,'Histopathology',' ',0),(75872,'Histopathology',' ',0),(75873,'Histopathology',' ',0),(75874,'Histopathology',' ',0),(75875,'Histopathology',' ',0),(75876,'Histopathology',' ',0),(75877,'Histopathology',' ',0),(75878,'Histopathology',' ',0),(75879,'Histopathology',' ',0),(75880,'Histopathology',' ',0),(75881,'Histopathology',' ',0),(75882,'Histopathology',' ',0),(75883,'Histopathology',' ',0),(75884,'Histopathology',' ',0),(75885,'Histopathology',' ',0),(75886,'Histopathology',' ',0),(75887,'Histopathology',' ',0),(75888,'Histopathology',' ',0),(75889,'Histopathology',' ',0),(75890,'Histopathology',' ',0),(75891,'Histopathology',' ',0),(75892,'Histopathology',' ',0),(85373,'Fear Conditioning',' Fear Conditioning test assesses aversive learning and memory',0),(85609,'Histopathology',' ',0),(85868,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85869,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85870,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85871,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85872,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85873,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85874,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85875,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85876,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85877,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85878,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85879,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85880,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85881,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85882,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85883,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85884,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85885,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85886,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85887,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85888,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85889,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85890,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85891,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85892,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85893,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85894,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85895,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85896,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85897,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85898,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85899,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85900,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85901,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85902,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85903,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85904,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85905,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85906,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85907,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85908,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85909,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85910,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85911,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85912,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85913,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85914,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85915,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85916,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85917,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85918,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85919,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85920,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85921,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85922,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85923,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85924,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85925,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85926,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85927,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85928,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85929,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85930,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85931,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85932,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85933,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85934,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85935,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85936,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85937,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85938,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85939,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85940,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85941,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85942,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85943,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85944,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85945,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85946,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85947,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85948,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85949,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85950,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85951,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85952,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85953,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85954,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85955,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(85956,'Eye Morphology',' To detect abnormalities in eye morphology.',0),(89677,'Housing and Husbandry',' Housing_and_husbandry',0),(89678,'Housing and Husbandry',' Housing_and_husbandry',0),(89679,'Housing and Husbandry',' Housing_and_husbandry',0),(89680,'Housing and Husbandry',' Housing_and_husbandry',0),(89681,'Housing and Husbandry',' Housing_and_husbandry',0),(89682,'Housing and Husbandry',' Housing_and_husbandry',0),(89683,'Housing and Husbandry',' Housing_and_husbandry',0),(89684,'Housing and Husbandry',' Housing_and_husbandry',0),(89685,'Housing and Husbandry',' Housing_and_husbandry',0),(89686,'Housing and Husbandry',' Housing_and_husbandry',0),(89687,'Housing and Husbandry',' Housing_and_husbandry',0),(89688,'Housing and Husbandry',' Housing_and_husbandry',0),(89689,'Housing and Husbandry',' Housing_and_husbandry',0),(89690,'Housing and Husbandry',' Housing_and_husbandry',0),(89691,'Housing and Husbandry',' Housing_and_husbandry',0),(89692,'Housing and Husbandry',' Housing_and_husbandry',0),(89693,'Housing and Husbandry',' Housing_and_husbandry',0),(89694,'Housing and Husbandry',' Housing_and_husbandry',0),(89695,'Housing and Husbandry',' Housing_and_husbandry',0),(89696,'Housing and Husbandry',' Housing_and_husbandry',0),(89697,'Housing and Husbandry',' Housing_and_husbandry',0),(89698,'Housing and Husbandry',' Housing_and_husbandry',0),(89699,'Housing and Husbandry',' Housing_and_husbandry',0),(89700,'Housing and Husbandry',' Housing_and_husbandry',0),(89701,'Housing and Husbandry',' Housing_and_husbandry',0),(89702,'Housing and Husbandry',' Housing_and_husbandry',0),(89703,'Housing and Husbandry',' Housing_and_husbandry',0),(89704,'Housing and Husbandry',' Housing_and_husbandry',0),(89705,'Housing and Husbandry',' Housing_and_husbandry',0),(89706,'Housing and Husbandry',' Housing_and_husbandry',0),(89707,'Housing and Husbandry',' Housing_and_husbandry',0),(89708,'Housing and Husbandry',' Housing_and_husbandry',0),(89709,'Housing and Husbandry',' Housing_and_husbandry',0),(89710,'Housing and Husbandry',' Housing_and_husbandry',0),(89711,'Housing and Husbandry',' Housing_and_husbandry',0),(89712,'Housing and Husbandry',' Housing_and_husbandry',0),(89713,'Housing and Husbandry',' Housing_and_husbandry',0),(89714,'Housing and Husbandry',' Housing_and_husbandry',0),(89715,'Housing and Husbandry',' Housing_and_husbandry',0),(89716,'Housing and Husbandry',' Housing_and_husbandry',0),(89717,'Housing and Husbandry',' Housing_and_husbandry',0),(89718,'Housing and Husbandry',' Housing_and_husbandry',0),(89719,'Housing and Husbandry',' Housing_and_husbandry',0),(89720,'Housing and Husbandry',' Housing_and_husbandry',0),(89737,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89738,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89739,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89740,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89741,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89742,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89743,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89744,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89745,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89747,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89748,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89749,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89750,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89751,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89752,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89753,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89754,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89755,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89756,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89757,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89758,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89759,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89760,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89761,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89762,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89763,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89764,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(89765,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(90846,'Gross Morphology Embryo E12.5',' ',0),(90854,'Housing and Husbandry',' Housing_and_husbandry',0),(90855,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(90856,'Electrocardiogram (ECG)',' To provide a high throughput method to obtain Electrocardiograms in a conscious mouse or an anesthetized mouse.',0),(90893,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(90894,'Open Field',' The Open Field test is used to assess anxiety and exploratory behaviors. It is based on the natural tendency of an animal to explore and to protect itself using avoidance which translates to a normal animal spending more time in the periphery of the Open Field arena than in the center (the most anxiogenic area).',0),(90931,'Experimental design',' experimental_design',0),(90932,'Experimental design',' experimental_design',0),(90933,'Experimental design',' experimental_design',0),(90934,'Experimental design',' experimental_design',0),(90935,'Experimental design',' experimental_design',0),(90936,'Experimental design',' experimental_design',0),(90937,'Experimental design',' experimental_design',0),(90938,'Experimental design',' experimental_design',0),(90939,'Experimental design',' experimental_design',0),(90940,'Experimental design',' experimental_design',0),(90941,'Experimental design',' experimental_design',0),(90942,'Experimental design',' experimental_design',0),(90943,'Experimental design',' experimental_design',0),(90944,'Experimental design',' experimental_design',0),(90945,'Experimental design',' experimental_design',0),(90946,'Experimental design',' experimental_design',0),(90947,'Experimental design',' experimental_design',0),(90948,'Experimental design',' experimental_design',0),(91309,'Experimental design',' experimental_design',0),(91310,'Experimental design',' experimental_design',0),(91311,'Experimental design',' experimental_design',0),(91312,'Experimental design',' experimental_design',0),(91489,'Formalin Test',' ',0),(91490,'Formalin Test',' ',0),(91491,'Formalin Test',' ',0),(91492,'Formalin Test',' ',0),(91493,'Formalin Test',' ',0),(91494,'Formalin Test',' ',0),(91495,'Formalin Test',' ',0),(91496,'Formalin Test',' ',0),(91497,'Formalin Test',' ',0),(91498,'Formalin Test',' ',0),(91499,'Formalin Test',' ',0),(91500,'Formalin Test',' ',0),(91501,'Formalin Test',' ',0),(91502,'Formalin Test',' ',0),(91503,'Formalin Test',' ',0),(91504,'Formalin Test',' ',0),(91505,'Formalin Test',' ',0),(91506,'Formalin Test',' ',0),(91507,'Formalin Test',' ',0),(91571,'Formalin Test',' ',0),(91572,'Formalin Test',' ',0),(91573,'Formalin Test',' ',0),(91574,'Formalin Test',' ',0),(91575,'Formalin Test',' ',0),(91576,'Formalin Test',' ',0),(91577,'Formalin Test',' ',0),(92272,'Immunophenotyping',' Immunophenotyping of immune system cells',0),(92576,'Viability Primary Screen',' Assess the viability of mutant mice of each sex and zygosity.',0),(92844,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0),(92845,'Fertility of Homozygous Knock-out Mice',' To assess the fertility of homozygous knockout mice.',0);
/*!40000 ALTER TABLE `Procedures` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2024-12-21 16:29:46
